Citrus Sinensis ID: 015991
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 397 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S713 | 562 | Serine/threonine-protein | yes | no | 0.914 | 0.645 | 0.772 | 1e-168 | |
| Q84V18 | 754 | Serine/threonine-protein | N/A | no | 0.863 | 0.454 | 0.436 | 5e-79 | |
| Q9LZV4 | 495 | Serine/threonine-protein | no | no | 0.695 | 0.557 | 0.413 | 2e-57 | |
| Q869T7 | 1176 | Serine/threonine-protein | yes | no | 0.481 | 0.162 | 0.253 | 1e-09 | |
| P18431 | 514 | Protein kinase shaggy OS= | yes | no | 0.471 | 0.363 | 0.248 | 3e-09 | |
| P49841 | 420 | Glycogen synthase kinase- | yes | no | 0.408 | 0.385 | 0.287 | 5e-09 | |
| P18266 | 420 | Glycogen synthase kinase- | yes | no | 0.408 | 0.385 | 0.287 | 6e-09 | |
| Q9WV60 | 420 | Glycogen synthase kinase- | yes | no | 0.408 | 0.385 | 0.287 | 6e-09 | |
| Q91757 | 420 | Glycogen synthase kinase- | N/A | no | 0.471 | 0.445 | 0.271 | 1e-08 | |
| Q556S2 | 513 | Serine/threonine-protein | no | no | 0.471 | 0.364 | 0.236 | 3e-08 |
| >sp|Q9S713|STT7_ARATH Serine/threonine-protein kinase STN7, chloroplastic OS=Arabidopsis thaliana GN=STN7 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 590 bits (1521), Expect = e-168, Method: Compositional matrix adjust.
Identities = 299/387 (77%), Positives = 338/387 (87%), Gaps = 24/387 (6%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFS--------KNNISSSLTTK 52
MAT++ G A + TP SPFLGK+L KPFS K + + + +
Sbjct: 1 MATISPGGAYI------GTP------SPFLGKKL---KPFSLTSPILSFKPTVKLNSSCR 45
Query: 53 AELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWAT 112
A+LIDTV ++F+GVGVGLPCTVMECGD+IYRSTLPKSNGLTITAPGVALAL+A+SYLWAT
Sbjct: 46 AQLIDTVHNLFIGVGVGLPCTVMECGDMIYRSTLPKSNGLTITAPGVALALTALSYLWAT 105
Query: 113 PGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172
PGVAPGFFDMFVLAFVERLFR T+RKDDFV+GKKLGEG+FGVVY+ SL+KK S++ +G+
Sbjct: 106 PGVAPGFFDMFVLAFVERLFRPTFRKDDFVVGKKLGEGSFGVVYKVSLSKKRSNE-EGEY 164
Query: 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL 232
VLKKATEYGAVEIWMNERVRRAC N CADFVYGF + SSKKG EYWL+W+YEGE+TLA L
Sbjct: 165 VLKKATEYGAVEIWMNERVRRACGNSCADFVYGFLDKSSKKGPEYWLLWKYEGESTLAGL 224
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
M S+EFPYNV+T+ILG+VQDLPKG+EREN+IIQTIM QLLFALDGLHSTGI+HRD+KPQN
Sbjct: 225 MQSKEFPYNVETIILGKVQDLPKGLERENKIIQTIMRQLLFALDGLHSTGIIHRDVKPQN 284
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352
+IFSEGSR+FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVA
Sbjct: 285 IIFSEGSRSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAA 344
Query: 353 ALSPVLWQLNLPDRFDIYSAGLIFLQM 379
ALSPVLWQ+NLPDRFDIYS GLIFLQM
Sbjct: 345 ALSPVLWQMNLPDRFDIYSIGLIFLQM 371
|
Serine/threonine protein kinase required for state transition by phosphorylating light-harvesting complex II outer antennae (LCHII). State transition plays a central role in response to environmental changes and allows to adjust to changing light conditions via the redistribution of light excitation energy between photosystem II (PSII) and photosystem I (PSI). Phosphorylates the minor light harvesting protein LHCB4.2/CP29 and is involved in the light-dependent phosphorylation of TSP9. Acts as a key component of the long-term response (LTR) signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q84V18|STT7_CHLRE Serine/threonine-protein kinase stt7, chloroplastic OS=Chlamydomonas reinhardtii GN=STT7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 162/371 (43%), Positives = 215/371 (57%), Gaps = 28/371 (7%)
Query: 34 LVLIKPFSKNNISSSLTTKAELIDTVRDVFLGV---GVGLPCTVMECGDIIYRSTLPKS- 89
LV +P + + + T E ID + + + + PC VM+CGDI+YRSTL S
Sbjct: 29 LVQRRPGQRRGVPARATP--EFIDALSALVPNLPLEQIAAPCQVMKCGDIVYRSTLDPSL 86
Query: 90 -NGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLG 148
N VAL ++YL+ PGV PG D ++ A ++R K+D VLGK+LG
Sbjct: 87 YNEAGFDEKTVALLAPVLAYLFLPPGVLPGAIDYYIRAPLKRKQTKAIDKNDIVLGKRLG 146
Query: 149 EGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFE 208
G FG V++ L ++ K +++KKA E+G E+WMNER+ R + A+FV F E
Sbjct: 147 TGGFGTVFKGELKEEGGVKTS--IIIKKAKEFGEAEVWMNERMSRVAGHHVAEFVTAFDE 204
Query: 209 N-------------------SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+ S WL+W YEG+ TL+ LM RE+PYN++ L+ G
Sbjct: 205 SLNVPLPAAAGKRAAPVQPTSPLDANSIWLVWVYEGDNTLSSLMERREWPYNLEPLLFGR 264
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
P+G RE I+ QL+ A+ HS GIVHRDIKP N I SE + K+IDLGA
Sbjct: 265 ELRAPRGPVRELVTIKEAFRQLVQAVAACHSVGIVHRDIKPANCIVSERDKKIKLIDLGA 324
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369
AADLR+GINY+P E+LLDPRYA P+QYIMSTQTP P PVA LSP+LW + PDRFD+
Sbjct: 325 AADLRIGINYVPNEYLLDPRYAPPQQYIMSTQTPKPPPKPVAAFLSPILWTMEKPDRFDM 384
Query: 370 YSAGLIFLQMV 380
YS G+ LQMV
Sbjct: 385 YSCGITLLQMV 395
|
Serine/threonine protein kinase required for state transition by phosphorylating light-harvesting complex II outer antennae (LCHII). State transition plays a central role in response to environmental changes and allows to adjust to changing light conditions via the redistribution of light excitation energy between photosystem II (PSII) and photosystem I (PSI). Chlamydomonas reinhardtii (taxid: 3055) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LZV4|STN8_ARATH Serine/threonine-protein kinase STN8, chloroplastic OS=Arabidopsis thaliana GN=STN8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (569), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 129/312 (41%), Positives = 183/312 (58%), Gaps = 36/312 (11%)
Query: 108 YLWATPGVAPGFFDMFVLA----FVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKK 163
YL A PGV G D ++LA ++ L ++ DF++ +KLGEG+FGVVY L K
Sbjct: 96 YLTARPGVLIGAIDAYLLAPLQLGLDTLIGRRLKRSDFLVTEKLGEGSFGVVYAGVLLPK 155
Query: 164 PSSKNDG-------------------DLVLKK-------ATEYGAVEIWMNERVRRACAN 197
S+ D ++LKK A E+G E W N R+ RA +
Sbjct: 156 NSTLVDDVRVSKARAKAMDFTGEFKQRVILKKVKVGVRGAEEFGEYEEWFNYRLSRAAPD 215
Query: 198 CCADFVYGFFENSSK----KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
CA+F+ F + + KGG+ WL+WR+EG+ LAD M R FP N+++++ G V
Sbjct: 216 TCAEFLGSFVADKTNTMFTKGGK-WLVWRFEGDRDLADYMKDRSFPSNLESIMFGRVLQG 274
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
+ ++R II+ IM Q++ +L +H TGIVHRD+KP N++ ++ + K+ID GAAADL
Sbjct: 275 VESVKRRALIIKQIMRQIITSLRKIHGTGIVHRDVKPANLVVTKKGQ-IKLIDFGAAADL 333
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373
R+G NYIP+ LLDP Y PE Y++ +TPS P P+A LSP+LWQLN PD FD+YSAG
Sbjct: 334 RIGKNYIPERTLLDPDYCPPELYVLPEETPSPPPEPIAALLSPILWQLNSPDLFDMYSAG 393
Query: 374 LIFLQMVCTVRR 385
++ LQM R
Sbjct: 394 IVLLQMAVPTLR 405
|
Light-dependent serine/threonine protein kinase that specifically phosphorylates N-terminal threonine residues in psbA/D1, psbD/D2, psbC/CP43 and psbH, which are components of the core antenna complex of photosystem II. Phosphorylation of PSII core components facilitates the exchange of chlorophyll proteins between the grana and the stroma lamellae. Also involved in the phosphorylation of the calcium-sensing receptor (CaS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q869T7|PAKF_DICDI Serine/threonine-protein kinase pakF OS=Dictyostelium discoideum GN=pakF PE=3 SV=1 | Back alignment and function description |
|---|
Score = 64.7 bits (156), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 50/241 (20%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+DF+L +KLG+GA+G VY+ + K+ G + K E E + NC
Sbjct: 392 NDFILDEKLGDGAYGSVYKGT------HKDLGFTLAIKVIEMKESESVSLQNEINILKNC 445
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
+ + +F S + W++ + ++ D++ S E L E Q
Sbjct: 446 KSPNIVSYF-GSLQTESHIWILLDFCALGSIRDIIESTE-------KTLNEAQ------- 490
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
I ++ L L LHS I+HRD+K NV+ SEG KI D G + L ++
Sbjct: 491 -----ISFVVKNTLKGLIYLHSQNIIHRDVKAANVLLSEGC-DVKIADFGVSEKLNGALD 544
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
KE + P + APE V+ + N + DI+S G+ ++
Sbjct: 545 Q-SKEMIGTPLWMAPE----------------------VILKKNYDYKADIWSLGITIIE 581
Query: 379 M 379
M
Sbjct: 582 M 582
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18431|SGG_DROME Protein kinase shaggy OS=Drosophila melanogaster GN=sgg PE=1 SV=3 | Back alignment and function description |
|---|
Score = 63.2 bits (152), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/241 (24%), Positives = 100/241 (41%), Gaps = 54/241 (22%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
K +G G+FGVV++A L + G+LV K ++ R +C +
Sbjct: 58 KVIGNGSFGVVFQAKLC------DTGELVAIKKVLQDRRFKNRELQIMRKLEHCNIVKLL 111
Query: 205 GFFENSSKKGGEYWL--IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
FF +S +K E +L + Y E ++R++ QT+ +
Sbjct: 112 YFFYSSGEKRDEVFLNLVLEYIPETVYK---VARQYAKTKQTIPIN-------------- 154
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
I+ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 155 FIRLYMYQLFRSLAYIHSLGICHRDIKPQNLLLDPETAVLKLCDFGSAKQLLHGEPNVSY 214
Query: 320 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
I + Y APE + +N + D++SAG + ++
Sbjct: 215 ICSRY-----YRAPEL---------------------IFGAINYTTKIDVWSAGCVLAEL 248
Query: 380 V 380
+
Sbjct: 249 L 249
|
Required for several developmental events such as synctial blastoderm formation and embryonic segmentation. Is involved in transcriptional regulation. Required for Arm phosphorylation. Wg signaling operates by inactivating the Sgg repression of en autoactivation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens GN=GSK3B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 62.4 bits (150), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
K +G G+FGVVY+A L + G+LV K ++ R +C +
Sbjct: 60 KVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 205 GFFENSSKKGGEYWL--IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
FF +S +K E +L + Y E ++R + QTL +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVY---RVARHYSRAKQTLPVI-------------- 156
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
++ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 320 IPKEFLLDPRYAAPE 334
I + Y APE
Sbjct: 217 ICSRY-----YRAPE 226
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18266|GSK3B_RAT Glycogen synthase kinase-3 beta OS=Rattus norvegicus GN=Gsk3b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 62.4 bits (150), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
K +G G+FGVVY+A L + G+LV K ++ R +C +
Sbjct: 60 KVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 205 GFFENSSKKGGEYWL--IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
FF +S +K E +L + Y E ++R + QTL +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVY---RVARHYSRAKQTLPV--------------I 156
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
++ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 320 IPKEFLLDPRYAAPE 334
I + Y APE
Sbjct: 217 ICSRY-----YRAPE 226
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9WV60|GSK3B_MOUSE Glycogen synthase kinase-3 beta OS=Mus musculus GN=Gsk3b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 62.4 bits (150), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
K +G G+FGVVY+A L + G+LV K ++ R +C +
Sbjct: 60 KVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 205 GFFENSSKKGGEYWL--IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
FF +S +K E +L + Y E ++R + QTL +
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVY---RVARHYSRAKQTLPV--------------I 156
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INY 319
++ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G ++Y
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 320 IPKEFLLDPRYAAPE 334
I + Y APE
Sbjct: 217 ICSRY-----YRAPE 226
|
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on 'Thr-548', decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at 'Thr-182', leading to sustain its activity. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91757|GSK3B_XENLA Glycogen synthase kinase-3 beta OS=Xenopus laevis GN=gsk3b PE=1 SV=1 | Back alignment and function description |
|---|
Score = 61.6 bits (148), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 97/236 (41%), Gaps = 49/236 (20%)
Query: 104 SAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKK 163
S ++ + ATPG P +R TY K +G G+FGVVY+A L
Sbjct: 35 SKVTTVVATPGQGP-----------DRQQEVTYTDT-----KVIGNGSFGVVYQAKLC-- 76
Query: 164 PSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL--IW 221
+ G+LV K ++ R +C + FF +S +K E +L +
Sbjct: 77 ----DTGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281
Y E ++R + Q L + ++ M QL +L +HS
Sbjct: 133 DYVPETVY---RVARHYSRAKQALPII--------------YVKLYMYQLFRSLAYIHSF 175
Query: 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---INYIPKEFLLDPRYAAPE 334
GI HRDIKPQN++ + K+ D G+A L G ++YI + Y APE
Sbjct: 176 GICHRDIKPQNLLLDPETAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 226
|
Plays a role in the organization of the formation of the main body axis of developing embryo. Acts as an inhibitor of differentiation of primary neurons. Inhibits the ability of ectopically expressed NEUROD1 and other bHLH factors to promote early retinal cell differentiation. May participate in the Wnt signaling pathway. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q556S2|PAKH_DICDI Serine/threonine-protein kinase pakH OS=Dictyostelium discoideum GN=pakH-1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 60.1 bits (144), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 57/241 (23%), Positives = 101/241 (41%), Gaps = 54/241 (22%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
F + +KLGEG+FG VYRA +S + +K+ + A ++ + + C
Sbjct: 42 FEIQEKLGEGSFGSVYRAIHKSSNTS-----IAIKEFEIFEANDVEPISKEIQILKKCNN 96
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLM--ISREFPYNVQTLILGEVQDLPKGIE 258
+V +F + K +YW++ Y ++ D+M I + F E
Sbjct: 97 PYVVSYFGSIMLKN-KYWILMDYCSLSSFNDIMQSIGKTFK------------------E 137
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
+E I I+ Q L L LHS I+HRDIK N++ E + KI D G + ++
Sbjct: 138 KE---ISLILQQSLLGLVYLHSKQIIHRDIKSANILLDETGQV-KIADFGVSQQIQS--T 191
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
+ P + APE +L Q + ++ D++S G++ ++
Sbjct: 192 FSKGSIAGTPYWMAPE----------------------ILNQTDYNNKIDVWSLGIVAIE 229
Query: 379 M 379
+
Sbjct: 230 L 230
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 397 | ||||||
| 224101681 | 574 | predicted protein [Populus trichocarpa] | 0.944 | 0.653 | 0.801 | 1e-178 | |
| 449452072 | 580 | PREDICTED: serine/threonine-protein kina | 0.914 | 0.625 | 0.811 | 1e-174 | |
| 359472994 | 574 | PREDICTED: serine/threonine-protein kina | 0.889 | 0.614 | 0.823 | 1e-172 | |
| 356502478 | 581 | PREDICTED: serine/threonine-protein kina | 0.939 | 0.641 | 0.774 | 1e-171 | |
| 225423883 | 573 | PREDICTED: serine/threonine-protein kina | 0.886 | 0.614 | 0.823 | 1e-171 | |
| 255566845 | 579 | serine/threonine protein kinase, putativ | 0.944 | 0.647 | 0.775 | 1e-171 | |
| 356495992 | 577 | PREDICTED: serine/threonine-protein kina | 0.937 | 0.644 | 0.772 | 1e-171 | |
| 357488271 | 575 | Serine/threonine protein kinase SNT7 [Me | 0.939 | 0.648 | 0.776 | 1e-170 | |
| 388522803 | 575 | unknown [Medicago truncatula] | 0.942 | 0.650 | 0.768 | 1e-169 | |
| 18409136 | 562 | serine/threonine-protein kinase SNT7 [Ar | 0.914 | 0.645 | 0.772 | 1e-166 |
| >gi|224101681|ref|XP_002312380.1| predicted protein [Populus trichocarpa] gi|222852200|gb|EEE89747.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 631 bits (1627), Expect = e-178, Method: Compositional matrix adjust.
Identities = 311/388 (80%), Positives = 338/388 (87%), Gaps = 13/388 (3%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFSKNNISS--------SLTTK 52
MATVASG + I ST + KPPS PFLG++L L P S+ +I++ ++
Sbjct: 1 MATVASGGT--IPIKLHSTHRPKPPS-PFLGRKLNL-NPSSRTSIATLHPKTLAVVASSG 56
Query: 53 AELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWAT 112
E D V ++FLGVGVGLPCTVMECGDIIYRSTLPK +GLT+T PG ALAL +SYLWAT
Sbjct: 57 GEFFDAVHNLFLGVGVGLPCTVMECGDIIYRSTLPKPSGLTLTVPGAALALGTLSYLWAT 116
Query: 113 PGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172
PGVAPGFFDMF LAFVERLFR T++KDDFVLGKKLGEGAFGVVYRASL KKPSSK +GDL
Sbjct: 117 PGVAPGFFDMFFLAFVERLFRPTFKKDDFVLGKKLGEGAFGVVYRASLTKKPSSK-EGDL 175
Query: 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL 232
VLKKATEYGAVEIWMNERVRRACAN CADFV+GF ENSSKKG EYWLIWRYEGEATL DL
Sbjct: 176 VLKKATEYGAVEIWMNERVRRACANSCADFVHGFLENSSKKGAEYWLIWRYEGEATLYDL 235
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
M S+EFPYNV+T+I+ EVQDLP+G+ERENRIIQTIM QLLFALDGLHSTGIVHRDIKPQN
Sbjct: 236 MQSKEFPYNVETMIVKEVQDLPRGLERENRIIQTIMRQLLFALDGLHSTGIVHRDIKPQN 295
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352
+IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT
Sbjct: 296 IIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 355
Query: 353 ALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
ALSPVLWQ+NLPDRFDIYS GLIFLQM
Sbjct: 356 ALSPVLWQMNLPDRFDIYSTGLIFLQMA 383
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449452072|ref|XP_004143784.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1594), Expect = e-174, Method: Compositional matrix adjust.
Identities = 302/372 (81%), Positives = 325/372 (87%), Gaps = 9/372 (2%)
Query: 23 KPPSSPFLGKRLVL-IKP-----FSKNNISSSLTTK--AELIDTVRDVFLGVGVGLPCTV 74
K P+SPFLGK+L KP S N + L + A++I V ++F+GVGVGLPCTV
Sbjct: 24 KQPNSPFLGKKLRFKHKPPHLWTVSVQNPRNVLVSALGADMIHMVHNLFVGVGVGLPCTV 83
Query: 75 MECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRT 134
MECGDIIYRSTLPKSNGLT+T PG LAL +SYLWATPGVAPGFFDMF+LAFVER+FR
Sbjct: 84 MECGDIIYRSTLPKSNGLTLTIPGAILALGTLSYLWATPGVAPGFFDMFILAFVERIFRP 143
Query: 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRA 194
T+RKDDFVLGKKLGEGAFGVVYR SLAK PS K +GDLVLKKATEYGAVEIWMNERVRRA
Sbjct: 144 TFRKDDFVLGKKLGEGAFGVVYRVSLAKNPSDKKEGDLVLKKATEYGAVEIWMNERVRRA 203
Query: 195 CANCCADFVYGFFENSSKKG-GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
CAN CADF+YGF ENSSKKG GEYWLIW++EGEATLADLM S+EFPYNV+ +ILGE Q L
Sbjct: 204 CANSCADFIYGFLENSSKKGDGEYWLIWKFEGEATLADLMQSKEFPYNVERMILGEGQQL 263
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
PKG+ERENRIIQTIM QLLFALD LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL
Sbjct: 264 PKGLERENRIIQTIMRQLLFALDSLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 323
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373
RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ+NLPDRFDIYSAG
Sbjct: 324 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQMNLPDRFDIYSAG 383
Query: 374 LIFLQMVCTVRR 385
LIFLQM R
Sbjct: 384 LIFLQMAFPAMR 395
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472994|ref|XP_003631227.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-172, Method: Compositional matrix adjust.
Identities = 293/356 (82%), Positives = 317/356 (89%), Gaps = 3/356 (0%)
Query: 27 SPFLGKRL---VLIKPFSKNNISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDIIYR 83
SPFLGK+L L P K + + V DVFLGVGVGLPCTVMECGDIIYR
Sbjct: 28 SPFLGKKLRSQSLSLPSKKAVSNLVCAAGGGFFNLVHDVFLGVGVGLPCTVMECGDIIYR 87
Query: 84 STLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVL 143
STLP+SNGLT+TAPG LAL A+SYLWATPGVAPGFFDMFVLAFVERLFR +++K+DFVL
Sbjct: 88 STLPRSNGLTLTAPGAILALGALSYLWATPGVAPGFFDMFVLAFVERLFRPSFKKEDFVL 147
Query: 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFV 203
GKKLGEGAFGVVYR SLAKKP +K +GDLVLKKATEYGAVEIWMNER RRACAN CA FV
Sbjct: 148 GKKLGEGAFGVVYRVSLAKKPGAKREGDLVLKKATEYGAVEIWMNERARRACANSCAYFV 207
Query: 204 YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRI 263
YGF E+SSKKG EYWL+WRYEGE+TL DLM+S+EFPYNV+++ILGEV DLPKG+EREN+I
Sbjct: 208 YGFLESSSKKGSEYWLLWRYEGESTLTDLMLSKEFPYNVESMILGEVPDLPKGLERENKI 267
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
IQTIM QLLFALD LHSTGIVHRDIKPQN+IFSEGSRTFKIIDLGAAADLRVGINYIPKE
Sbjct: 268 IQTIMRQLLFALDSLHSTGIVHRDIKPQNIIFSEGSRTFKIIDLGAAADLRVGINYIPKE 327
Query: 324 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ+NLPDRFDIYSAGLIFLQM
Sbjct: 328 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQMNLPDRFDIYSAGLIFLQM 383
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356502478|ref|XP_003520046.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1566), Expect = e-171, Method: Compositional matrix adjust.
Identities = 306/395 (77%), Positives = 329/395 (83%), Gaps = 22/395 (5%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFSKNNISSSLTT--------- 51
MAT+ G L + PKSK S FLG+RL I PF S
Sbjct: 1 MATIGIGVGVTKL-QQPHRPKSK---SLFLGQRL-RISPFWGEPQCSERRLFGVSNPPRV 55
Query: 52 -------KAELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALS 104
E +DTV ++F+GVGVGLPC+VM+CGD+IYRSTLPKSNGLT+T PGV LAL
Sbjct: 56 VQVFALGGGEWLDTVHNLFVGVGVGLPCSVMQCGDVIYRSTLPKSNGLTLTVPGVILALG 115
Query: 105 AISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKP 164
+SYLWATPGVAPGFFDMFVLAFVERLFR TY+KDDFVLGKKLGEG+FGVVYR SLA KP
Sbjct: 116 TLSYLWATPGVAPGFFDMFVLAFVERLFRPTYKKDDFVLGKKLGEGSFGVVYRVSLANKP 175
Query: 165 SSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYE 224
SSK +GDLVLKKATEYGAVEIWMNERVRRACA+ CADFVYGF E+SSKK EYWLIWR+E
Sbjct: 176 SSK-EGDLVLKKATEYGAVEIWMNERVRRACASSCADFVYGFLESSSKKAAEYWLIWRFE 234
Query: 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284
G+ATLADLM SR+FPYNV+TLILGEVQDLPKG+ERENRIIQTIM Q+LFALDGLHSTGIV
Sbjct: 235 GDATLADLMQSRDFPYNVETLILGEVQDLPKGLERENRIIQTIMRQILFALDGLHSTGIV 294
Query: 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 344
HRDIKPQNVIFSE SRTFKIIDLGAA DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS
Sbjct: 295 HRDIKPQNVIFSEESRTFKIIDLGAATDLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 354
Query: 345 APSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
APS PVATALSPVLWQLNLPDRFDIYSAGLIFLQM
Sbjct: 355 APSVPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 389
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225423883|ref|XP_002281563.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 607 bits (1565), Expect = e-171, Method: Compositional matrix adjust.
Identities = 293/356 (82%), Positives = 317/356 (89%), Gaps = 4/356 (1%)
Query: 27 SPFLGKRL---VLIKPFSKNNISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDIIYR 83
SPFLGK+L L P K + + V DVFLGVGVGLPCTVMECGDIIYR
Sbjct: 28 SPFLGKKLRSQSLSLPSKKAVSNLVCAAGGGFFNLVHDVFLGVGVGLPCTVMECGDIIYR 87
Query: 84 STLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVL 143
STLP+SNGLT+TAPG LAL A+SYLWATPGVAPGFFDMFVLAFVERLFR +++K+DFVL
Sbjct: 88 STLPRSNGLTLTAPGAILALGALSYLWATPGVAPGFFDMFVLAFVERLFRPSFKKEDFVL 147
Query: 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFV 203
GKKLGEGAFGVVYR SLAKKP +K +GDLVLKKATEYGAVEIWMNER RRACAN CA FV
Sbjct: 148 GKKLGEGAFGVVYRVSLAKKPGAK-EGDLVLKKATEYGAVEIWMNERARRACANSCAYFV 206
Query: 204 YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRI 263
YGF E+SSKKG EYWL+WRYEGE+TL DLM+S+EFPYNV+++ILGEV DLPKG+EREN+I
Sbjct: 207 YGFLESSSKKGSEYWLLWRYEGESTLTDLMLSKEFPYNVESMILGEVPDLPKGLERENKI 266
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
IQTIM QLLFALD LHSTGIVHRDIKPQN+IFSEGSRTFKIIDLGAAADLRVGINYIPKE
Sbjct: 267 IQTIMRQLLFALDSLHSTGIVHRDIKPQNIIFSEGSRTFKIIDLGAAADLRVGINYIPKE 326
Query: 324 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ+NLPDRFDIYSAGLIFLQM
Sbjct: 327 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQMNLPDRFDIYSAGLIFLQM 382
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255566845|ref|XP_002524406.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223536367|gb|EEF38017.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1561), Expect = e-171, Method: Compositional matrix adjust.
Identities = 301/388 (77%), Positives = 326/388 (84%), Gaps = 13/388 (3%)
Query: 3 TVASGSATLVLINRRSTPKSKPPSSP-----FLGKRL---VLIKPFSKN--NISSSLTTK 52
T+ SG A +V I + KP +S FLGK+L +P N +S +
Sbjct: 4 TITSGGAGIVPIKLHT---QKPITSSLSSSSFLGKKLSPRFSSRPIFSNPRAVSVIASGG 60
Query: 53 AELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWAT 112
E D V ++FLGVGVGLPCTVMECGDIIYRSTLPKSNGLT+TAPG LA A+SYLWAT
Sbjct: 61 GEFFDAVHNLFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTLTAPGAVLAFGALSYLWAT 120
Query: 113 PGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172
PGVAPGFFDMF LAFVERLFR T+RKDDFVLGKKLGEGAFGVVYR SL KKPSSK +GDL
Sbjct: 121 PGVAPGFFDMFFLAFVERLFRPTFRKDDFVLGKKLGEGAFGVVYRVSLTKKPSSKREGDL 180
Query: 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL 232
VLKKATEYGAVEIWMNERVRRACA+ CADF+YGF E+SSKK EYWL+WR+EGEATL DL
Sbjct: 181 VLKKATEYGAVEIWMNERVRRACASSCADFLYGFLESSSKKEAEYWLVWRFEGEATLYDL 240
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
M S+ FPYNV+++IL EVQDLPKG+ERENRIIQTIM QLLFALDGLHSTGIVHRDIKPQN
Sbjct: 241 MQSKGFPYNVESMILKEVQDLPKGLERENRIIQTIMRQLLFALDGLHSTGIVHRDIKPQN 300
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352
+IFSEGSRTFKIIDLGAAADLRVGINYIP EFLLDPRYAAPEQYIMSTQTPSAPS PVAT
Sbjct: 301 IIFSEGSRTFKIIDLGAAADLRVGINYIPNEFLLDPRYAAPEQYIMSTQTPSAPSPPVAT 360
Query: 353 ALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
LSPVLWQLNLPDRFDIYSAGLIFLQM
Sbjct: 361 VLSPVLWQLNLPDRFDIYSAGLIFLQMA 388
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495992|ref|XP_003516854.1| PREDICTED: serine/threonine-protein kinase STN7, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1561), Expect = e-171, Method: Compositional matrix adjust.
Identities = 305/395 (77%), Positives = 332/395 (84%), Gaps = 23/395 (5%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPF------------SKNN---- 44
MAT+ G L + PKSK S FLG+RL I+PF S +N
Sbjct: 1 MATIGIGVGVTKLQPHK--PKSK---SLFLGQRL-RIRPFWGEPQCSERRLFSVSNPPRV 54
Query: 45 ISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALS 104
+ E +DTV +F+GVGVGLPC+VM+CGD+IYRSTLPKSNGLT+T PGV LAL
Sbjct: 55 VQVFALAGGEWLDTVHSLFVGVGVGLPCSVMQCGDVIYRSTLPKSNGLTLTVPGVILALG 114
Query: 105 AISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKP 164
+SYLWATPGVAPGFFDMFVLAFVERLFR TY+KDDFVLGKKLGEG+FGVVYR SLA KP
Sbjct: 115 TLSYLWATPGVAPGFFDMFVLAFVERLFRPTYKKDDFVLGKKLGEGSFGVVYRVSLANKP 174
Query: 165 SSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYE 224
SSK +GDLVLKKATEYGAVEIWMNERVRRACA+ CADFVYGF E+SSKK EYWLIWR+E
Sbjct: 175 SSK-EGDLVLKKATEYGAVEIWMNERVRRACASSCADFVYGFLESSSKKAAEYWLIWRFE 233
Query: 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284
G+ATLADLM SR+FPYNV+TLILGEVQDLPKG+ERENRIIQTI+ Q+LFALDGLHSTGIV
Sbjct: 234 GDATLADLMQSRDFPYNVETLILGEVQDLPKGLERENRIIQTIVRQILFALDGLHSTGIV 293
Query: 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 344
HRDIKPQN+IFSE SRTFKIIDLGAA DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS
Sbjct: 294 HRDIKPQNIIFSEESRTFKIIDLGAATDLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 353
Query: 345 APSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
APS PVATALSPVLWQLNLPDRFDIYSAGLIFLQM
Sbjct: 354 APSVPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 388
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357488271|ref|XP_003614423.1| Serine/threonine protein kinase SNT7 [Medicago truncatula] gi|355515758|gb|AES97381.1| Serine/threonine protein kinase SNT7 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1556), Expect = e-170, Method: Compositional matrix adjust.
Identities = 303/390 (77%), Positives = 334/390 (85%), Gaps = 17/390 (4%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFSKNN------ISSSLTTKA- 53
MATVA+ + + R P K S FLG+RL IKP + + +TTKA
Sbjct: 1 MATVATKGIGVTKL-RPYNPNKK---SIFLGQRL-RIKPSNNEQPPQPPCSARFITTKAI 55
Query: 54 ----ELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYL 109
L+++ ++F+GVGVGLPCTVMECGD+IYRSTLPKS+GL +T PGV LA A+SYL
Sbjct: 56 HGAEWLLESAHNLFVGVGVGLPCTVMECGDMIYRSTLPKSSGLNVTVPGVVLAFGALSYL 115
Query: 110 WATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKND 169
WATPGVAPGFFDMFVLAFVERLFR T+RKDDFVLGKKLGEG+FGVVYR +LAKKPSSK +
Sbjct: 116 WATPGVAPGFFDMFVLAFVERLFRPTFRKDDFVLGKKLGEGSFGVVYRVTLAKKPSSK-E 174
Query: 170 GDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATL 229
GDLVLKKATEYGAVEIWMNERVRRACAN CADFVYGF E S+KK EYWLIWR+EG+ATL
Sbjct: 175 GDLVLKKATEYGAVEIWMNERVRRACANSCADFVYGFLERSTKKTPEYWLIWRFEGDATL 234
Query: 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
ADL+ SR+FPYNV+TLILGEVQDLPKG+EREN+IIQTI+ QLLFALDGLHSTGIVHRDIK
Sbjct: 235 ADLLQSRDFPYNVETLILGEVQDLPKGLERENKIIQTIIRQLLFALDGLHSTGIVHRDIK 294
Query: 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349
PQN+IFSEGSRTFKIIDLGAA DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP
Sbjct: 295 PQNIIFSEGSRTFKIIDLGAATDLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 354
Query: 350 VATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
VATALSPVLWQLNLPDRFDIYS GLIFLQM
Sbjct: 355 VATALSPVLWQLNLPDRFDIYSTGLIFLQM 384
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388522803|gb|AFK49463.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1551), Expect = e-169, Method: Compositional matrix adjust.
Identities = 299/389 (76%), Positives = 331/389 (85%), Gaps = 15/389 (3%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVL---------IKPFSKNNISSSLTT 51
MATVA+ + + P + S FLG+RL + P S I++
Sbjct: 1 MATVATKGIGVTKLR----PYNPNKKSIFLGQRLRIKPPNNEQPPQPPCSARFITTKAIH 56
Query: 52 KAE-LIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLW 110
AE L+++ ++F+GVGVGLPCTVMECGD+IYRSTLPKS+GL +T PGV LA A+SYLW
Sbjct: 57 GAEWLLESAHNLFVGVGVGLPCTVMECGDMIYRSTLPKSSGLNVTVPGVVLAFGALSYLW 116
Query: 111 ATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDG 170
ATPGVAPGFFDMFVLAFVERLFR T+RKDDFVLGKKLGEG+FGVVYR +LAKKPSSK +G
Sbjct: 117 ATPGVAPGFFDMFVLAFVERLFRPTFRKDDFVLGKKLGEGSFGVVYRVTLAKKPSSK-EG 175
Query: 171 DLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLA 230
DLVLKKATEYGAVEIWMNERVRRACAN CADFVYGF E S+KK EYWLIWR+EG+ATLA
Sbjct: 176 DLVLKKATEYGAVEIWMNERVRRACANSCADFVYGFLERSTKKTPEYWLIWRFEGDATLA 235
Query: 231 DLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290
DL+ SR+FPYNV+TLILGEVQDLPKG+EREN+IIQTI+ QLLFALDGLHSTGIVHRDIKP
Sbjct: 236 DLLQSRDFPYNVETLILGEVQDLPKGLERENKIIQTIIRQLLFALDGLHSTGIVHRDIKP 295
Query: 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 350
QN+IFSEGSRTFKIIDLGAA DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV
Sbjct: 296 QNIIFSEGSRTFKIIDLGAATDLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 355
Query: 351 ATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
ATALSPVLWQLNLPDRFDIYS GLIFLQM
Sbjct: 356 ATALSPVLWQLNLPDRFDIYSTGLIFLQM 384
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18409136|ref|NP_564946.1| serine/threonine-protein kinase SNT7 [Arabidopsis thaliana] gi|62901055|sp|Q9S713.1|STT7_ARATH RecName: Full=Serine/threonine-protein kinase STN7, chloroplastic; AltName: Full=Protein STATE TRANSITION 7; AltName: Full=Stt7 homolog; Flags: Precursor gi|12323224|gb|AAG51596.1|AC011665_17 putative protein kinase [Arabidopsis thaliana] gi|12324136|gb|AAG52037.1|AC011914_7 putative protein kinase; 22015-24834 [Arabidopsis thaliana] gi|133778850|gb|ABO38765.1| At1g68830 [Arabidopsis thaliana] gi|332196725|gb|AEE34846.1| serine/threonine-protein kinase SNT7 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1521), Expect = e-166, Method: Compositional matrix adjust.
Identities = 299/387 (77%), Positives = 338/387 (87%), Gaps = 24/387 (6%)
Query: 1 MATVASGSATLVLINRRSTPKSKPPSSPFLGKRLVLIKPFS--------KNNISSSLTTK 52
MAT++ G A + TP SPFLGK+L KPFS K + + + +
Sbjct: 1 MATISPGGAYI------GTP------SPFLGKKL---KPFSLTSPILSFKPTVKLNSSCR 45
Query: 53 AELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWAT 112
A+LIDTV ++F+GVGVGLPCTVMECGD+IYRSTLPKSNGLTITAPGVALAL+A+SYLWAT
Sbjct: 46 AQLIDTVHNLFIGVGVGLPCTVMECGDMIYRSTLPKSNGLTITAPGVALALTALSYLWAT 105
Query: 113 PGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL 172
PGVAPGFFDMFVLAFVERLFR T+RKDDFV+GKKLGEG+FGVVY+ SL+KK S++ +G+
Sbjct: 106 PGVAPGFFDMFVLAFVERLFRPTFRKDDFVVGKKLGEGSFGVVYKVSLSKKRSNE-EGEY 164
Query: 173 VLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL 232
VLKKATEYGAVEIWMNERVRRAC N CADFVYGF + SSKKG EYWL+W+YEGE+TLA L
Sbjct: 165 VLKKATEYGAVEIWMNERVRRACGNSCADFVYGFLDKSSKKGPEYWLLWKYEGESTLAGL 224
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
M S+EFPYNV+T+ILG+VQDLPKG+EREN+IIQTIM QLLFALDGLHSTGI+HRD+KPQN
Sbjct: 225 MQSKEFPYNVETIILGKVQDLPKGLERENKIIQTIMRQLLFALDGLHSTGIIHRDVKPQN 284
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352
+IFSEGSR+FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVA
Sbjct: 285 IIFSEGSRSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAA 344
Query: 353 ALSPVLWQLNLPDRFDIYSAGLIFLQM 379
ALSPVLWQ+NLPDRFDIYS GLIFLQM
Sbjct: 345 ALSPVLWQMNLPDRFDIYSIGLIFLQM 371
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 397 | ||||||
| TAIR|locus:2205465 | 562 | STN7 "STT7 homolog STN7" [Arab | 0.874 | 0.617 | 0.760 | 1.5e-145 | |
| TAIR|locus:2181067 | 495 | STN8 "State transition 8" [Ara | 0.526 | 0.422 | 0.425 | 2.6e-53 | |
| TAIR|locus:2136917 | 501 | CPK4 "calcium-dependent protei | 0.198 | 0.157 | 0.354 | 2.5e-07 | |
| UNIPROTKB|K7EQN8 | 153 | STK11 "Serine/threonine-protei | 0.123 | 0.320 | 0.48 | 3.5e-07 | |
| TAIR|locus:2014691 | 495 | CDPK2 "AT1G35670" [Arabidopsis | 0.206 | 0.165 | 0.322 | 8.4e-07 | |
| ZFIN|ZDB-GENE-091116-7 | 311 | si:ch211-193e5.3 "si:ch211-193 | 0.186 | 0.237 | 0.324 | 1.2e-06 | |
| UNIPROTKB|G3N1T2 | 247 | GSK3B "Uncharacterized protein | 0.173 | 0.279 | 0.366 | 1.2e-06 | |
| ZFIN|ZDB-GENE-090312-19 | 340 | si:dkey-45j10.1 "si:dkey-45j10 | 0.186 | 0.217 | 0.363 | 1.3e-06 | |
| UNIPROTKB|F8VYH9 | 170 | CDK4 "Cyclin-dependent kinase | 0.136 | 0.317 | 0.438 | 1.6e-06 | |
| UNIPROTKB|F8VXD2 | 132 | CDK4 "Cyclin-dependent kinase | 0.193 | 0.583 | 0.370 | 1.8e-06 |
| TAIR|locus:2205465 STN7 "STT7 homolog STN7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1422 (505.6 bits), Expect = 1.5e-145, P = 1.5e-145
Identities = 273/359 (76%), Positives = 309/359 (86%)
Query: 29 FLGKRLVLIKPFS--------KNNISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDI 80
FLGK+L KPFS K + + + +A+LIDTV ++F+GVGVGLPCTVMECGD+
Sbjct: 17 FLGKKL---KPFSLTSPILSFKPTVKLNSSCRAQLIDTVHNLFIGVGVGLPCTVMECGDM 73
Query: 81 IYRSTLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDD 140
IYRSTLPKSNGLTITAPGVALAL+A+SYLWATPGVAPGFFDMFVLAFVERLFR T+RKDD
Sbjct: 74 IYRSTLPKSNGLTITAPGVALALTALSYLWATPGVAPGFFDMFVLAFVERLFRPTFRKDD 133
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
FV+GKKLGEG+FGVVY+ SL+KK S++ +G+ VLKKATEYGAVEIWMNERVRRAC N CA
Sbjct: 134 FVVGKKLGEGSFGVVYKVSLSKKRSNE-EGEYVLKKATEYGAVEIWMNERVRRACGNSCA 192
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERE 260
DFVYGF + SSKKG EYWL+W+YEGE+TLA LM S+EFPYNV+T+ILG+VQDLPKG+ERE
Sbjct: 193 DFVYGFLDKSSKKGPEYWLLWKYEGESTLAGLMQSKEFPYNVETIILGKVQDLPKGLERE 252
Query: 261 NRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI 320
N+IIQTIM QLLFALDGLHSTGI+HRD+KPQN+IFSEGSR+FKIIDLGAAADLRVGINYI
Sbjct: 253 NKIIQTIMRQLLFALDGLHSTGIIHRDVKPQNIIFSEGSRSFKIIDLGAAADLRVGINYI 312
Query: 321 PKEFLLDPRYAAPEQYIMXXXXXXXXXXXXXXXXXXVLWQLNLPDRFDIYSAGLIFLQM 379
PKEFLLDPRYAAPEQYIM VLWQ+NLPDRFDIYS GLIFLQM
Sbjct: 313 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAAALSPVLWQMNLPDRFDIYSIGLIFLQM 371
|
|
| TAIR|locus:2181067 STN8 "State transition 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 456 (165.6 bits), Expect = 2.6e-53, Sum P(2) = 2.6e-53
Identities = 92/216 (42%), Positives = 134/216 (62%)
Query: 174 LKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK----KGGEYWLIWRYEGEATL 229
++ A E+G E W N R+ RA + CA+F+ F + + KGG+ WL+WR+EG+ L
Sbjct: 192 VRGAEEFGEYEEWFNYRLSRAAPDTCAEFLGSFVADKTNTMFTKGGK-WLVWRFEGDRDL 250
Query: 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
AD M R FP N+++++ G V + ++R II+ IM Q++ +L +H TGIVHRD+K
Sbjct: 251 ADYMKDRSFPSNLESIMFGRVLQGVESVKRRALIIKQIMRQIITSLRKIHGTGIVHRDVK 310
Query: 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMXXXXXXXXXXX 349
P N++ ++ + K+ID GAAADLR+G NYIP+ LLDP Y PE Y++
Sbjct: 311 PANLVVTKKGQ-IKLIDFGAAADLRIGKNYIPERTLLDPDYCPPELYVLPEETPSPPPEP 369
Query: 350 XXXXXXXVLWQLNLPDRFDIYSAGLIFLQM-VCTVR 384
+LWQLN PD FD+YSAG++ LQM V T+R
Sbjct: 370 IAALLSPILWQLNSPDLFDMYSAGIVLLQMAVPTLR 405
|
|
| TAIR|locus:2136917 CPK4 "calcium-dependent protein kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 116 (45.9 bits), Expect = 2.5e-07, Sum P(2) = 2.5e-07
Identities = 34/96 (35%), Positives = 52/96 (54%)
Query: 248 GEVQD--LPKGI--EREN-RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
GE+ D + KG ERE ++I+TI+ ++ HS G++HRD+KP+N +F S
Sbjct: 109 GELFDRIVSKGCFSEREAAKLIKTILG----VVEACHSLGVMHRDLKPENFLFDSPSDDA 164
Query: 303 KIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ A D + + Y P ++L D P Y APE
Sbjct: 165 KL----KATDFGLSVFYKPGQYLYDVVGSPYYVAPE 196
|
|
| UNIPROTKB|K7EQN8 STK11 "Serine/threonine-protein kinase STK11" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 110 (43.8 bits), Expect = 3.5e-07, Sum P(2) = 3.5e-07
Identities = 24/50 (48%), Positives = 32/50 (64%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
++ QL+ L+ LHS GIVH+DIKP N++ + G T KI DLG A L
Sbjct: 95 VKKYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISDLGVAEAL 143
|
|
| TAIR|locus:2014691 CDPK2 "AT1G35670" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 113 (44.8 bits), Expect = 8.4e-07, Sum P(2) = 8.4e-07
Identities = 30/93 (32%), Positives = 48/93 (51%)
Query: 248 GEVQD--LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
GE+ D + KG E ++ I + +L ++ HS G++HRD+KP+N +F K+
Sbjct: 110 GELFDRIVSKGHFSEREAVKLIKT-ILGVVEACHSLGVMHRDLKPENFLFDSPKDDAKL- 167
Query: 306 DLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
A D + + Y P ++L D P Y APE
Sbjct: 168 ---KATDFGLSVFYKPGQYLYDVVGSPYYVAPE 197
|
|
| ZFIN|ZDB-GENE-091116-7 si:ch211-193e5.3 "si:ch211-193e5.3" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 122 (48.0 bits), Expect = 1.2e-06, Sum P(2) = 1.2e-06
Identities = 25/77 (32%), Positives = 44/77 (57%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
+ R+ + ++ QL+ AL S G++HRD+KP+N++ S ++ K++D G L+ Y
Sbjct: 189 DERLAKRVLVQLIAALKHCESRGVLHRDVKPENLLISTETQDIKLLDFGCGDQLKSSA-Y 247
Query: 320 IPKEFLLDPRYAAPEQY 336
+ F P YA PE +
Sbjct: 248 --RYFAGTPAYAPPEWF 262
|
|
| UNIPROTKB|G3N1T2 GSK3B "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 112 (44.5 bits), Expect = 1.2e-06, Sum P(2) = 1.2e-06
Identities = 26/71 (36%), Positives = 38/71 (53%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
++ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G +
Sbjct: 133 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--S 190
Query: 324 FLLDPRYAAPE 334
++ Y APE
Sbjct: 191 YICSRYYRAPE 201
|
|
| ZFIN|ZDB-GENE-090312-19 si:dkey-45j10.1 "si:dkey-45j10.1" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 131 (51.2 bits), Expect = 1.3e-06, Sum P(2) = 1.3e-06
Identities = 28/77 (36%), Positives = 46/77 (59%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
+ R+ + ++ QL+ AL S+G++HRD+KP+N++ S+ S+ K++D G DL Y
Sbjct: 190 DERLAKKVLVQLIAALKHCESSGVLHRDVKPENLLISKESQDIKLLDFGCG-DLLKRSAY 248
Query: 320 IPKEFLLDPRYAAPEQY 336
K F P YA PE +
Sbjct: 249 --KYFAGTPAYAPPEWF 263
|
|
| UNIPROTKB|F8VYH9 CDK4 "Cyclin-dependent kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 115 (45.5 bits), Expect = 1.6e-06, Sum P(2) = 1.6e-06
Identities = 25/57 (43%), Positives = 35/57 (61%)
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
P G+ E I+ +M Q L LD LH+ IVHRD+KP+N++ + G T K+ D G A
Sbjct: 109 PPGLPAET--IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLA 162
|
|
| UNIPROTKB|F8VXD2 CDK4 "Cyclin-dependent kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 117 (46.2 bits), Expect = 1.8e-06, P = 1.8e-06
Identities = 33/89 (37%), Positives = 45/89 (50%)
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA--- 310
P G+ E I+ +M Q L LD LH+ IVHRD+KP+N++ + G T K+ D G A
Sbjct: 35 PPGLPAET--IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIY 91
Query: 311 ------ADLRVGINYIPKEFLLDPRYAAP 333
+ V + Y E LL YA P
Sbjct: 92 SYQMALTPVVVTLWYRAPEVLLQSTYATP 120
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S713 | STT7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7726 | 0.9143 | 0.6459 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 397 | |||
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.0 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-24 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-19 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-13 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-10 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-06 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-04 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 0.001 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.001 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.002 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.002 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.002 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.002 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.003 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.003 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.004 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 0.004 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.004 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.004 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 671 bits (1733), Expect = 0.0
Identities = 282/368 (76%), Positives = 315/368 (85%), Gaps = 7/368 (1%)
Query: 19 TPKSKPPSSPFLGKRLV---LIKPFSKNNISSSLTTKA--ELIDTVRDVFLGVGVGLPCT 73
+ S FLG++L L + ++ + + +LT A ELID V ++F+GVGVGLPCT
Sbjct: 7 VAGASGSPSRFLGRKLSSRRLSRAPARRSRARALTAAAGGELIDAVHNLFVGVGVGLPCT 66
Query: 74 VMECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFR 133
VMECGD+IYRSTLP+SNGLTITAPG ALAL A +YLWATPGVAPGF DMFVLA +E LFR
Sbjct: 67 VMECGDVIYRSTLPRSNGLTITAPGAALALLAATYLWATPGVAPGFVDMFVLAPLEGLFR 126
Query: 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR 193
+++KDDFVLGKKLGEGAFGVVY+ASL K S K +G VLKKATEYGAVEIWMNERVRR
Sbjct: 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKK-EGKYVLKKATEYGAVEIWMNERVRR 185
Query: 194 ACANCCADFVYGFFENSSKKGG-EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
AC N CADFVYGF E S K EYWL+WRYEGE+TLADLM S+EFPYNV+ +LG+VQD
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQD 245
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
LPKG+EREN+IIQTIM Q+LFALDGLHSTGIVHRD+KPQN+IFSEGS +FKIIDLGAAAD
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAAD 305
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372
LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA
Sbjct: 306 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365
Query: 373 GLIFLQMV 380
GLIFLQM
Sbjct: 366 GLIFLQMA 373
|
Length = 566 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 105/332 (31%), Positives = 171/332 (51%), Gaps = 48/332 (14%)
Query: 92 LTITAPGVALALSAISY-LWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEG 150
L+ T PG+ L+A+ Y L++ P +D +V A + + + DDF L KLG G
Sbjct: 98 LSPTLPGIG-RLTALYYLLFSKPNPLFNIWDFYVGAPLADGANSRWSSDDFQLRDKLGGG 156
Query: 151 AFGVVYRA-----------SLAKKPSSKNDGDLVLKK---------------------AT 178
FG+ + +K + + +VLK+ +
Sbjct: 157 NFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSA 216
Query: 179 EYGAVEIWMNERVRR--ACANCCADFVYGFFENSSKKG----GEYWLIWRYEGEATLADL 232
E G VE +M +++R A CA+++ G+F +++ G G WL+W++E +ATL D
Sbjct: 217 ETGMVEAYMCAKIKRNPIAAASCAEYL-GYFTSNTADGAFTKGSQWLVWKFESDATLGDA 275
Query: 233 MISR--EFPYNVQTLILGEVQDLPKGIERENR---IIQTIMSQLLFALDGLHSTGIVHRD 287
+ + FP ++ ++ + +P + ++ R +I+ +M Q+L L LH GIVHRD
Sbjct: 276 LDGKLGPFPGCLEEFMMAG-KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRD 334
Query: 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347
IKP+N++ + + KIID GAA D+ GIN+ P +LDPRY+ PE+ +M P AP+
Sbjct: 335 IKPENLLVTVDGQV-KIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPA 393
Query: 348 APVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
+A LSP W PD FD Y+AG++ +QM
Sbjct: 394 PAMAALLSPFAWLYGRPDLFDSYTAGVLLMQM 425
|
Length = 507 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 62/241 (25%)
Query: 147 LGEGAFGVVYRASL--------AKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
LGEG FG VY A K ++ L+ + E ++ + + +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVK----- 55
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
+YG FE+ +L+ Y +L DL+ E +
Sbjct: 56 ----LYGVFED----ENHLYLVMEYCEGGSLKDLLKENEGKLS----------------- 90
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
E+ I++ I+ Q+L L+ LHS GI+HRD+KP+N++ + K+ D G + L
Sbjct: 91 -EDEILR-ILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT-SDK 147
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
+ K + P Y APE ++ S S DI+S G+I +
Sbjct: 148 SLLKTIVGTPAYMAPEV-LLGKGYYSEKS--------------------DIWSLGVILYE 186
Query: 379 M 379
+
Sbjct: 187 L 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 8e-24
Identities = 58/247 (23%), Positives = 93/247 (37%), Gaps = 59/247 (23%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC---AN 197
+ L +KLG G+FG VY+A K G +V K + + + ++ RR
Sbjct: 1 YELLRKLGSGSFGTVYKAKH------KGTGKIVAVKILKKRSEKSKKDQTARREIRILRR 54
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ FE+ +L+ Y L D +SR P +
Sbjct: 55 LSHPNIVRLIDAFEDKD----HLYLVMEYCEGGDLFDY-LSRGGPLS------------- 96
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
E E + I Q+L L+ LHS GI+HRD+KP+N++ E KI D G A
Sbjct: 97 ---EDE---AKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVV-KIADFGLAK-KL 148
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374
+ + F+ P Y APE ++ D++S G+
Sbjct: 149 LKSSSSLTTFVGTPWYMAPEV-LLGGNGYGPKV--------------------DVWSLGV 187
Query: 375 IFLQMVC 381
I +++
Sbjct: 188 ILYELLT 194
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 88.6 bits (218), Expect = 2e-19
Identities = 62/252 (24%), Positives = 97/252 (38%), Gaps = 56/252 (22%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA--- 196
+ + +KLGEG+FG VY A K + K VL K E + E+ R + A
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALK-----VLAKKLESKSKEVERFLREIQILASLN 55
Query: 197 --NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
F + S +L+ Y +L DL+ +
Sbjct: 56 HPPNIVKLYDFFQDEGS-----LYLVMEYVDGGSLEDLLKKIGRKGPLS----------- 99
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
I++Q+L AL+ LHS GI+HRDIKP+N++ R K+ID G A L
Sbjct: 100 ------ESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153
Query: 315 -----VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369
I +P + P Y APE + + ++ S+ DI
Sbjct: 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSS-------------------DI 194
Query: 370 YSAGLIFLQMVC 381
+S G+ +++
Sbjct: 195 WSLGITLYELLT 206
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 5e-19
Identities = 65/248 (26%), Positives = 95/248 (38%), Gaps = 64/248 (25%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRACA 196
+ + +KLGEG+FG VY A K G LV +KK E + E +
Sbjct: 1 YEILEKLGEGSFGKVYLAR------DKKTGKLVAIKVIKKKKIKKDRERILREI--KILK 52
Query: 197 NCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ Y FE+ K +L+ Y L DL+ R L
Sbjct: 53 KLKHPNIVRLYDVFEDEDK----LYLVMEYCEGGDLFDLLKKRGR--------------L 94
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
E E + + Q+L AL+ LHS GIVHRD+KP+N++ E K+ D G A L
Sbjct: 95 S---EDE---ARFYLRQILSALEYLHSKGIVHRDLKPENILLDE-DGHVKLADFGLARQL 147
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373
G F+ P Y APE ++ + DI+S G
Sbjct: 148 DPGEKL--TTFVGTPEYMAPE--VLLGKGYGKAV--------------------DIWSLG 183
Query: 374 LIFLQMVC 381
+I +++
Sbjct: 184 VILYELLT 191
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 1e-14
Identities = 59/265 (22%), Positives = 90/265 (33%), Gaps = 70/265 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSS----KNDGDLVLKKA--TEYGAVEIWMNERVR 192
DDF GK +GEG+F V A K+ + K +L K + V+ E+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKE-KETNKEYAIK-----ILDKRQLIKEKKVKYVKIEK-- 52
Query: 193 RACANCCADF-----VYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFP 239
+Y F++ GE R G S +
Sbjct: 53 -EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG---------SLDEK 102
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
+ +++L AL+ LHS GI+HRD+KP+N++ +
Sbjct: 103 -----------------------CTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM 139
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA--LSPV 357
KI D G A L N P+ D + + S V TA +SP
Sbjct: 140 HI-KITDFGTAKVL--DPNSSPESNKGDATNIDSQIEKNRRRFASF----VGTAEYVSPE 192
Query: 358 LWQLNLPD-RFDIYSAGLIFLQMVC 381
L D+++ G I QM+
Sbjct: 193 LLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 9e-14
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 46/205 (22%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAV--EIWMNERV 191
F + +K+G+G FG VY+A K G V L+ + + EI
Sbjct: 1 LFEILEKIGKGGFGEVYKAR------HKRTGKEVAIKVIKLESKEKKEKIINEI------ 48
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ C + ++ S K E W++ + +L DL+ S E Q
Sbjct: 49 -QILKKCKHPNIVKYY-GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-------ESQ 99
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAA 310
I + +LL L+ LHS GI+HRDIK N++ S+G K+ID G +
Sbjct: 100 ------------IAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLS 145
Query: 311 ADLRVGINYIPKEFLLDPRYAAPEQ 335
A L + P + APE
Sbjct: 146 AQLSDTK--ARNTMVGTPYWMAPEV 168
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 43/203 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNERV 191
+ F + +KLGEG++G VY+A +A K + + K EI + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-------EISILK-- 53
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
C + ++ ++ S K + W++ Y G +++D+M +TL
Sbjct: 54 -----QCDSPYIVKYY-GSYFKNTDLWIVMEYCGAGSVSDIMKITN-----KTLT----- 97
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
E E I I+ Q L L+ LHS +HRDIK N++ +E K+ D G +
Sbjct: 98 ------EEE---IAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSG 147
Query: 312 DLRVGINYIPKEFLLDPRYAAPE 334
L + P + APE
Sbjct: 148 QL-TDTMAKRNTVIGTPFWMAPE 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 51/208 (24%), Positives = 75/208 (36%), Gaps = 48/208 (23%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-RVR 192
++ G+ LG G+FG VY A K+ G+L+ L +E + E R+
Sbjct: 1 EWTRGELLGRGSFGSVYLAL------DKDTGELMAVKSVELSGDSEEELEAL-EREIRIL 53
Query: 193 RA--CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-FPYNVQTLILGE 249
+ N YG + K + Y +L+ L+ P V
Sbjct: 54 SSLQHPNIVR--YYGSERDEEKNT--LNIFLEYVSGGSLSSLLKKFGKLPEPV------- 102
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
I+ Q+L L LHS GIVHRDIK N++ K+ D G
Sbjct: 103 --------------IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVV-KLADFGC 147
Query: 310 AADLRVGINYIPKEFLL---DPRYAAPE 334
A R+G + P + APE
Sbjct: 148 AK--RLGDIETGEGTGSVRGTPYWMAPE 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 31/162 (19%)
Query: 222 RYEGEATLADLMIS-REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS 280
R+E +L+D+ IS E Y V L+ ++ L E + IQ + Q+L L +HS
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAA--ADLRVGINYIPKEFLLDPRYAAPEQYIM 338
G+VHRD+KP N++ +E KI D G A D ++ Y+ + Y APE IM
Sbjct: 127 AGVVHRDLKPSNILINENC-DLKICDFGLARIQDPQM-TGYVSTRY-----YRAPE--IM 177
Query: 339 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
T WQ DI+SAG IF +M+
Sbjct: 178 LT------------------WQ-KYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 51/187 (27%), Positives = 77/187 (41%), Gaps = 41/187 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC 195
F L + +GEG +G VY+A K G LV K + EI + R
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKT------GQLVAIKIMDIIEDEEEEIKEEYNILRKY 59
Query: 196 AN--CCADFVYGFFENSSKKGG--EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+N A F YG F + G + WL+ G G V
Sbjct: 60 SNHPNIATF-YGAFIKKNPPGNDDQLWLVMELCGG---------------------GSVT 97
Query: 252 DLPKGIERENR-----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
DL KG+ ++ + I I+ + L L LH ++HRDIK QN++ ++ + K++D
Sbjct: 98 DLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV-KLVD 156
Query: 307 LGAAADL 313
G +A L
Sbjct: 157 FGVSAQL 163
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 69/260 (26%), Positives = 97/260 (37%), Gaps = 94/260 (36%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDLV-LKK----ATEYGAV-----EIWMNERVRR-AC 195
+GEGA+G VY+A N G V LKK +E G EI + +++
Sbjct: 7 IGEGAYGTVYKAR------DLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 196 ANCCA--DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV-QD 252
N D +G R + E L TL+ V QD
Sbjct: 61 PNIVRLLDVCHG---------------PRTDRELKL--------------TLVFEHVDQD 91
Query: 253 L--------PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
L G+ E I+ +M QLL +D LHS IVHRD+KPQN++ + KI
Sbjct: 92 LATYLSKCPKPGLPPE--TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS-DGQVKI 148
Query: 305 IDLGAAADLRVGINYIPKEFLLDPR-----YAAPEQYIMSTQTPSAPSAPVATALSPVLW 359
D G A R+ + L Y APE + S+ +PV
Sbjct: 149 ADFGLA---RIYSFEMA----LTSVVVTLWYRAPEVLLQSSY------------ATPV-- 187
Query: 360 QLNLPDRFDIYSAGLIFLQM 379
D++S G IF ++
Sbjct: 188 --------DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 39/196 (19%)
Query: 146 KLGEGAFGVVYRAS-------LAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+GEGA+GVV + +A K +++ D +KK E+ + ++R N
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA---LREVKVLRQLRHE--NI 62
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
+ + ++ G +L++ Y V+ +L ++ P G+
Sbjct: 63 VN------LKEAFRRKGRLYLVFEY------------------VERTLLELLEASPGGLP 98
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
+ +++ + QLL A+ HS I+HRDIKP+N++ SE S K+ D G A LR
Sbjct: 99 PD--AVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPA 155
Query: 319 YIPKEFLLDPRYAAPE 334
+++ Y APE
Sbjct: 156 SPLTDYVATRWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 68/269 (25%), Positives = 87/269 (32%), Gaps = 94/269 (34%)
Query: 143 LGKKLGEGAFGVVYRAS-------LAKKPSSKNDGDLVLKKATE---------------- 179
G K+G G FG VY A +A K D D K
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 180 YGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFP 239
Y VE+ + VY F E Y TL +L
Sbjct: 64 YYGVEVHREK-------------VYIFME--------------YCSGGTLEEL------- 89
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
L G + D +I+ QLL L LHS GIVHRDIKP N IF + +
Sbjct: 90 -----LEHGRILDE--------HVIRVYTLQLLEGLAYLHSHGIVHRDIKPAN-IFLDHN 135
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLL---DPRYAAPEQYIMSTQTPSAPSAPVATALSP 356
K+ D G A L+ + +E P Y APE +A
Sbjct: 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAA-------- 187
Query: 357 VLWQLNLPDRFDIYSAGLIFLQMVCTVRR 385
DI+S G + L+M T +R
Sbjct: 188 -----------DIWSLGCVVLEM-ATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (145), Expect = 4e-10
Identities = 62/258 (24%), Positives = 102/258 (39%), Gaps = 69/258 (26%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC---- 195
+ + K++G+G+FG VY K+DG L + K + M+E+ R
Sbjct: 1 KYEIIKQIGKGSFGKVYLVR------RKSDGKLYVLKEIDLSN----MSEKEREDALNEV 50
Query: 196 ---ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ ++E S ++ G+ ++ Y L+ + ++
Sbjct: 51 KILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQK---KEGKPF------ 100
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAAA 311
E +I+ QL AL LHS I+HRDIKPQN+ + S G K+ D G
Sbjct: 101 ------PEEQILD-WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFG--- 148
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA--LSPVLWQLNLPDRF-- 367
I K ++S+ A + V T LSP L Q N P +
Sbjct: 149 --------ISK--------------VLSSTVDLAKTV-VGTPYYLSPELCQ-NKPYNYKS 184
Query: 368 DIYSAGLIFLQMVCTVRR 385
DI+S G + ++ CT++
Sbjct: 185 DIWSLGCVLYEL-CTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 38/158 (24%), Positives = 61/158 (38%), Gaps = 41/158 (25%)
Query: 236 REFPYNVQTLILGEVQDLPKGIERENR----IIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
E Y V L+LG DL + ++ + ++ + +++ AL+ LHS GI+HRDIKP
Sbjct: 72 EENMYLVVDLLLG--GDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPD 129
Query: 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-----PRYAAPEQYIMSTQTPSAP 346
N++ E I D A + + L P Y APE ++ Q S
Sbjct: 130 NILLDEQGHV-HITDFNIATKV-------TPDTLTTSTSGTPGYMAPE--VLCRQGYSVA 179
Query: 347 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVR 384
D +S G+ + + R
Sbjct: 180 V--------------------DWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 54/188 (28%), Positives = 79/188 (42%), Gaps = 51/188 (27%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRRACAN 197
D K LG+G+ GVVY+ K G + LKK + + +E R+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH------KPTGKIYALKK------IHVDGDEEFRKQLLR 48
Query: 198 -------CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL 247
C + +V YG F K GE ++ Y +LAD +L
Sbjct: 49 ELKTLRSCESPYVVKCYGAFY----KEGEISIVLEYMDGGSLAD--------------LL 90
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNV-IFSEGSRTFKII 305
+V +P+ ++ I Q+L LD LH+ I+HRDIKP N+ I S+G KI
Sbjct: 91 KKVGKIPE------PVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIA 142
Query: 306 DLGAAADL 313
D G + L
Sbjct: 143 DFGISKVL 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 44/190 (23%), Positives = 75/190 (39%), Gaps = 55/190 (28%)
Query: 139 DDFVLGKKLGEGAFGVVYRA-------SLAKK----PSSKNDGDLVLKKATEYGAVEIWM 187
+ F L + +G+G+FG VY+A +A K ++++ + + + EI
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ--------EIQF 52
Query: 188 NERVRRACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQT 244
+ C + ++ YG F SK W+I Y G + DL+ +
Sbjct: 53 -------LSQCRSPYITKYYGSFLKGSK----LWIIMEYCGGGSCLDLLKPGKLD----- 96
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
I I+ ++L L+ LH G +HRDIK N++ SE K+
Sbjct: 97 ----------------ETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE-EGDVKL 139
Query: 305 IDLGAAADLR 314
D G + L
Sbjct: 140 ADFGVSGQLT 149
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-10
Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 30/198 (15%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERVR--RACA 196
DF + K+G+G+FGVV++ K D + +K+ E + R A
Sbjct: 1 DFEILNKIGKGSFGVVFKVV------RKADKRVYAMKQIDLSKMNRREREEAIDEARVLA 54
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
+ ++ ++E S G+ ++ Y L L+ + + LP
Sbjct: 55 KLDSSYIIRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQR------------GRPLP-- 99
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
E+++ + Q+L L LHS I+HRDIK N+ KI DLG A L
Sbjct: 100 ---EDQVWR-FFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNV-KIGDLGVAKLLSDN 154
Query: 317 INYIPKEFLLDPRYAAPE 334
N+ + P Y +PE
Sbjct: 155 TNF-ANTIVGTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 39/120 (32%), Positives = 52/120 (43%), Gaps = 30/120 (25%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGSRTFKIIDLGAAA------DLRVGIN 318
+M Q+L AL H+ GIVHRD+KPQN++ S K++D G D V
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
E L P Y APEQ TP++ D+Y+ GLIFL+
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNS----------------------DLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 40/139 (28%), Positives = 58/139 (41%), Gaps = 31/139 (22%)
Query: 251 QDLPKGIERENR---------IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301
DL K ++ R I++ M QLL + H G++HRD+KPQN++ +
Sbjct: 90 SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL 149
Query: 302 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361
KI DLG + + E ++ Y APE + ST S PV
Sbjct: 150 LKIADLGLGRAFSIPVKSYTHE-IVTLWYRAPEVLLGSTHY----STPV----------- 193
Query: 362 NLPDRFDIYSAGLIFLQMV 380
DI+S G IF +M
Sbjct: 194 ------DIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 38/202 (18%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR------- 192
DF + KKLG+G++G VY+ K+ S D K + G+ M+++ R
Sbjct: 1 DFKVLKKLGKGSYGSVYKV---KRLS---DNQFYALKEVDLGS----MSQKEREDAVNEI 50
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
R A+ + + E + G + ++ Y A DL + + +
Sbjct: 51 RILASVNHPNIISYKE-AFLDGNKLCIVMEY---APFGDL-------SKAIS----KRKK 95
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
K I + I I QLL L LH I+HRD+K N++ KI DLG +
Sbjct: 96 KRKLIPEQ--EIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGIS-- 150
Query: 313 LRVGINYIPKEFLLDPRYAAPE 334
+V + K + P Y APE
Sbjct: 151 -KVLKKNMAKTQIGTPHYMAPE 171
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 43/177 (24%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV-------LKKATEYGAVEIWMNERVRRACAN 197
+K+GEGA G VY+A+ + G V K+ E EI + + C +
Sbjct: 25 EKIGEGASGEVYKAT------DRATGKEVAIKKMRLRKQNKELIINEI----LIMKDCKH 74
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ +++ S G E W++ Y +L D++ N E Q
Sbjct: 75 ---PNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN-------EPQ------ 117
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAAADL 313
I + ++L L+ LHS ++HRDIK N+ + +GS K+ D G AA L
Sbjct: 118 ------IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQL 166
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 8e-09
Identities = 24/65 (36%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 251 QDLPKGIEREN-----RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
DL K +++ +I++IM QLL L HS I+HRD+KPQN++ + K+
Sbjct: 82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR-DGVLKLA 140
Query: 306 DLGAA 310
D G A
Sbjct: 141 DFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 59/258 (22%), Positives = 96/258 (37%), Gaps = 78/258 (30%)
Query: 141 FVLGKKLGEGAFGVVYRA------------SLAKKPSSKNDGDLVLKKATEYGAV---EI 185
+ LG +G G+FGVVY A + + P KN L++K + +
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 186 WMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
+ E ++ N + V F + K +++ +R N L
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHY----------------AR----NNHAL 167
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
L +++ QL AL +HS I HRD+KPQN++ + T K+
Sbjct: 168 PL--------------FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213
Query: 306 DLGAAADLRVG---INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362
D G+A +L G ++YI F Y APE + +T N
Sbjct: 214 DFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGAT---------------------N 247
Query: 363 LPDRFDIYSAGLIFLQMV 380
D++S G I +M+
Sbjct: 248 YTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 58/251 (23%), Positives = 95/251 (37%), Gaps = 74/251 (29%)
Query: 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKA----TEYGAVEIWMNERVRRACAN 197
+ ++GEGA G+V++A + G+ V LKK E G + E +A
Sbjct: 4 ILGRIGEGAHGIVFKAK------DRETGETVALKKVALRRLEGGIPNQALREI--KALQA 55
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
C +V + G + L+ Y L++++ E P LP+
Sbjct: 56 CQHPYVVKLLD-VFPHGSGFVLVMEYMPS-DLSEVLRDEERP-------------LPE-- 98
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
+++ M LL + +H+ GI+HRD+KP N++ S KI D G A R+
Sbjct: 99 ----AQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA-DGVLKIADFGLA---RL-- 148
Query: 318 NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW----QLNLPDRF-----D 368
S + P S VAT W +L R D
Sbjct: 149 --------------------FSEEEPRLYSHQVAT-----RWYRAPELLYGARKYDPGVD 183
Query: 369 IYSAGLIFLQM 379
+++ G IF ++
Sbjct: 184 LWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 32/202 (15%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR--RACA 196
DD+ L + +G GA VVY A + V K + + ++E + +A +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPN------NEKVAIKRIDLEKCQTSVDELRKEVQAMS 54
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
C V ++ S G E WL+ Y +L D+M S P+G
Sbjct: 55 QCNHPNVVKYY-TSFVVGDELWLVMPYLSGGSLLDIMKSS----------------YPRG 97
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE-GSRTFKIIDLGAAADLRV 315
E II T++ ++L L+ LHS G +HRDIK N++ E GS KI D G +A L
Sbjct: 98 GLDEA-IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLAD 154
Query: 316 GINYIP---KEFLLDPRYAAPE 334
G + K F+ P + APE
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+++G+G+FG V++ + + L++A + EI ++ + C + +V
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYVT 65
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII 264
++ S KG + W+I Y G + DL+ R P++ E Q I
Sbjct: 66 KYY-GSYLKGTKLWIIMEYLGGGSALDLL--RAGPFD-------EFQ------------I 103
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEF 324
T++ ++L LD LHS +HRDIK NV+ SE K+ D G A L F
Sbjct: 104 ATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDV-KLADFGVAGQL-TDTQIKRNTF 161
Query: 325 LLDPRYAAPE 334
+ P + APE
Sbjct: 162 VGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 57/244 (23%), Positives = 92/244 (37%), Gaps = 63/244 (25%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKAT--EYGAVEIWMNERVRRACANCCAD 201
K+GEG +GVVY+A K G++V +KK R +
Sbjct: 5 GKIGEGTYGVVYKAR------DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHP 58
Query: 202 FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
+ + KG Y L++ + + L L+ R+ LP
Sbjct: 59 NIIKLLDVFRHKGDLY-LVFEFM-DTDLYKLIKDRQRG-------------LP------E 97
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP 321
+I++ + QLL L HS GI+HRD+KP+N++ + K+ D G A
Sbjct: 98 SLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLA----------- 145
Query: 322 KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF-----DIYSAGLIF 376
+ F R + T+ AP +L L D+ DI+S G IF
Sbjct: 146 RSFGSPVRPYTHY---VVTRWYRAP-------------ELLLGDKGYSTPVDIWSVGCIF 189
Query: 377 LQMV 380
+++
Sbjct: 190 AELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 53/198 (26%), Positives = 79/198 (39%), Gaps = 72/198 (36%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKK-ATEYGAVEIWMNER-------- 190
+ + K+LG+G FG VY LA+ K G+LV +KK ++ + E MN R
Sbjct: 1 YKVIKQLGDGTFGSVY---LARN---KETGELVAIKKMKKKFYSWEECMNLREVKSLRKL 54
Query: 191 -----------VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-- 237
V R N FV+ + E + L LM R+
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYMEGN------------------LYQLMKDRKGK 94
Query: 238 -FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
F +V I++I+ Q+L L +H G HRD+KP+N++ S
Sbjct: 95 PFSESV---------------------IRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS 133
Query: 297 EGSRTFKIIDLGAAADLR 314
G KI D G A ++R
Sbjct: 134 -GPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 55/244 (22%), Positives = 98/244 (40%), Gaps = 66/244 (27%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--------VEIWMNERVRRACANC 198
LG+GAFG VY+A K G K + + VEI + C
Sbjct: 13 LGDGAFGKVYKAQ------HKETGLFAAAKIIQIESEEELEDFMVEI-------DILSEC 59
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
+ G +E + + W++ + L +M+ E L E Q
Sbjct: 60 KHPNIVGLYEAYFYEN-KLWILIEFCDGGALDSIMLELERG-------LTEPQ------- 104
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGI 317
I+ + Q+L AL+ LHS ++HRD+K N++ +G K+ D G +A +
Sbjct: 105 -----IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNK--- 154
Query: 318 NYIPKE--FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375
+ + K F+ P + APE +++ +T +P + + DI+S G+
Sbjct: 155 STLQKRDTFIGTPYWMAPE--VVACETFKD---------NPYDY------KADIWSLGIT 197
Query: 376 FLQM 379
+++
Sbjct: 198 LIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 37/122 (30%), Positives = 55/122 (45%), Gaps = 30/122 (24%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR-VGINYIPK 322
IQ + Q+L L LHS ++HRD+KP N++ + KI D G A R V + K
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLA---RGVDPDEDEK 160
Query: 323 EFLLD---PR-YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
FL + R Y APE ++S S + + DI+S G IF +
Sbjct: 161 GFLTEYVVTRWYRAPE-LLLS---SSRYTKAI-----------------DIWSVGCIFAE 199
Query: 379 MV 380
++
Sbjct: 200 LL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 35/201 (17%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LK--KATEYGAVEIWMNE-RVRR 193
++D+ L +++G G +G VY+A G+LV +K K EI E + +
Sbjct: 2 QEDYELIQRIGSGTYGDVYKAR------DIATGELVAIKVIKLEPGDDFEIIQQEISMLK 55
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
C + +G S + + W++ Y G +L D+ Y V L E+Q
Sbjct: 56 ECRHPNIVAYFG----SYLRRDKLWIVMEYCGGGSLQDI-------YQVTRGPLSELQ-- 102
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
I + + L L LH TG +HRDIK N++ +E K+ D G +A L
Sbjct: 103 ----------IAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDV-KLADFGVSAQL 151
Query: 314 RVGINYIPKEFLLDPRYAAPE 334
I K F+ P + APE
Sbjct: 152 TATIAK-RKSFIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 51/209 (24%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA---- 200
+ +G+G+FG V K K+DG +++ K +YG M E+ ++ +
Sbjct: 6 ETIGKGSFGTVR------KVRRKSDGKILVWKEIDYGN----MTEKEKQQLVSEVNILRE 55
Query: 201 ---DFVYGFFE---NSSKKGGEYWLIWRYEGEATLADLMISR---EFPYNVQTLILGEVQ 251
+ +++ + S + +++ Y LA L I + E Y
Sbjct: 56 LKHPNIVRYYDRIIDRSNQ--TLYIVMEYCEGGDLAQL-IQKCKKERKY----------- 101
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLH-----STGIVHRDIKPQNVIFSEGSRTFKIID 306
IE E I + I++QLL AL H ++HRD+KP N IF + + K+ D
Sbjct: 102 -----IE-EEFIWR-ILTQLLLALYECHNRSDPGNTVLHRDLKPAN-IFLDANNNVKLGD 153
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPEQ 335
G A L + K ++ P Y +PEQ
Sbjct: 154 FGLAKILGHD-SSFAKTYVGTPYYMSPEQ 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 8e-08
Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 57/204 (27%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNER-VRRACANCC 199
LG+G+FG V L +K K+ G L VLKK + VE + ER + +
Sbjct: 1 LGKGSFGKVL---LVRK---KDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-- 52
Query: 200 ADFV----YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
F+ Y F + E Y V G +L
Sbjct: 53 -PFIVKLHYAF---------------------------QTEEKLYLVLEYAPG--GELFS 82
Query: 256 GIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAA 310
+ +E R + ++++ AL+ LHS GI++RD+KP+N++ ++G K+ D G A
Sbjct: 83 HLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLA 140
Query: 311 ADLRVGINYIPKEFLLDPRYAAPE 334
+L + F P Y APE
Sbjct: 141 KELSSEGSRT-NTFCGTPEYLAPE 163
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 25/125 (20%)
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+E ++ + ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A G
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART--AG 177
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376
+++ +++ Y APE V+ + + DI+S G I
Sbjct: 178 TSFMMTPYVVTRYYRAPE----------------------VILGMGYKENVDIWSVGCIM 215
Query: 377 LQMVC 381
+M+
Sbjct: 216 GEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 23/71 (32%), Positives = 40/71 (56%), Gaps = 6/71 (8%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
+ +++++ ++ LH GI+HRDIKP+N++ + K+ D G + R G K+
Sbjct: 99 AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH-LKLTDFGLS---RNG--LENKK 152
Query: 324 FLLDPRYAAPE 334
F+ P Y APE
Sbjct: 153 FVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 5/77 (6%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT--FKIIDLGAAADLRVGI 317
+ + Q +++L+ A+ +H G VHRDIKP+NV+ RT K+ D G+AA L
Sbjct: 100 DEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156
Query: 318 NYIPKEFLLDPRYAAPE 334
K + P Y APE
Sbjct: 157 MVNSKLPVGTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 22/122 (18%)
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
+ R+I+T + Q+L + HS ++HRD+KPQN++ + K+ D G A + +
Sbjct: 99 KNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
E ++ Y APE + S S PV DI+S G IF +
Sbjct: 159 TFTHE-VVTLWYRAPEILLGSRHY----STPV-----------------DIWSVGCIFAE 196
Query: 379 MV 380
MV
Sbjct: 197 MV 198
|
Length = 294 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 27/71 (38%), Positives = 40/71 (56%), Gaps = 8/71 (11%)
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300
N+ LI G + LP E R+ ++ M QLL +LD +H GI HRDIKP+N++ +
Sbjct: 85 NLYELIKGRKRPLP-----EKRV-KSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-- 136
Query: 301 TFKIIDLGAAA 311
K+ D G+
Sbjct: 137 ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 46/145 (31%), Positives = 63/145 (43%), Gaps = 36/145 (24%)
Query: 244 TLILGEV-QDL--------PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294
TL+ V QDL P G+ E I+ +M Q L LD LH+ IVHRD+KP+N++
Sbjct: 83 TLVFEHVDQDLRTYLDKVPPPGLPAET--IKDLMRQFLRGLDFLHANCIVHRDLKPENIL 140
Query: 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354
+ G K+ D G A + P L Y APE + ST
Sbjct: 141 VTSGG-QVKLADFGLARIYSCQMALTPVVVTL--WYRAPEVLLQSTYA------------ 185
Query: 355 SPVLWQLNLPDRFDIYSAGLIFLQM 379
+PV D++S G IF +M
Sbjct: 186 TPV----------DMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 28/89 (31%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
+L +++ P G++ E+R+ + + Q+L ++ HS I+HRDIKP+N++ S+ S K+
Sbjct: 86 VLDDLEKYPNGLD-ESRV-RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ-SGVVKLC 142
Query: 306 DLGAAADLRVGINYIPKEFLLDPRYAAPE 334
D G A L + +++ Y APE
Sbjct: 143 DFGFARTL-AAPGEVYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 17/106 (16%)
Query: 244 TLILGEV-QDLPKGIER------ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
TL+ V QDL +++ I+ +M QLL LD LHS +VHRD+KPQN++ +
Sbjct: 85 TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT 144
Query: 297 EGSRTFKIIDLGAA---------ADLRVGINYIPKEFLLDPRYAAP 333
+ K+ D G A + V + Y E LL YA P
Sbjct: 145 SSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 5e-07
Identities = 33/124 (26%), Positives = 57/124 (45%), Gaps = 25/124 (20%)
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+E ++ + ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A G
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART--AG 170
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376
+++ +++ Y APE V+ + + DI+S G I
Sbjct: 171 TSFMMTPYVVTRYYRAPE----------------------VILGMGYKENVDIWSVGCIM 208
Query: 377 LQMV 380
+MV
Sbjct: 209 GEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 55/184 (29%), Positives = 79/184 (42%), Gaps = 48/184 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIW--MNERVRRAC 195
+F + KK+G+G F VVY+A DG +V LKK V+I+ M+ + R+ C
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAI------CLLDGRVVALKK------VQIFEMMDAKARQDC 49
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI---LGEVQD 252
E K ++ + +Y LA F N + I L + D
Sbjct: 50 LK----------EIDLLKQLDHPNVIKY-----LA------SFIENNELNIVLELADAGD 88
Query: 253 LPKGIER--------ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
L + I+ R I QL AL+ +HS I+HRDIKP NV F + K+
Sbjct: 89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANV-FITATGVVKL 147
Query: 305 IDLG 308
DLG
Sbjct: 148 GDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 28/190 (14%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+++G+G+FG VY+ + + L++A + EI ++ + C + ++
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYIT 65
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII 264
++ S KG + W+I Y G + DL+ K E I
Sbjct: 66 RYY-GSYLKGTKLWIIMEYLGGGSALDLL---------------------KPGPLEETYI 103
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEF 324
TI+ ++L LD LHS +HRDIK NV+ SE K+ D G A L F
Sbjct: 104 ATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDV-KLADFGVAGQL-TDTQIKRNTF 161
Query: 325 LLDPRYAAPE 334
+ P + APE
Sbjct: 162 VGTPFWMAPE 171
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 48/186 (25%), Positives = 75/186 (40%), Gaps = 39/186 (20%)
Query: 204 YGFFENSSKKG--GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
YG F S G + WL+ + G ++ DL+ + KG +
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN------------------TKGNALKE 120
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP 321
I I ++L L LH+ ++HRDIK QNV+ +E + K++D G +A L +
Sbjct: 121 DWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV-KLVDFGVSAQLDRTVGR-R 178
Query: 322 KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
F+ P + APE I + P A R DI+S G+ ++M
Sbjct: 179 NTFIGTPYWMAPE-VIACDENPDA----------------TYDYRSDIWSLGITAIEMAE 221
Query: 382 TVRRLC 387
LC
Sbjct: 222 GAPPLC 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 7e-07
Identities = 33/117 (28%), Positives = 48/117 (41%), Gaps = 35/117 (29%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPR 329
Q+L + LHS GI+HRD+KP N++ T KI+D G A R F++ P
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA---RTAGT----SFMMTPY 177
Query: 330 -----YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
Y APE V+ + + DI+S G I +M+
Sbjct: 178 VVTRYYRAPE----------------------VILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 10/76 (13%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLG----AAADLRVGINYIP 321
+++++ AL+ LHS GI+HRD+KP N++ S G K+ D G ++ +N
Sbjct: 98 YIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDE 155
Query: 322 KE---FLLDPRYAAPE 334
KE + P Y APE
Sbjct: 156 KEDKRIVGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 47/189 (24%), Positives = 71/189 (37%), Gaps = 51/189 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAV---------EIWMN 188
D+ + KLGEG FG VY+A G +V LKK + EI +
Sbjct: 8 RDYEILGKLGEGTFGEVYKAR------QIKTGRVVALKKILMHNEKDGFPITALREIKIL 61
Query: 189 ERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
++++ D + S +K G +++ PY L
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV-----------------TPYMDHDL--- 101
Query: 249 EVQDLPKGIERENRI------IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRT 301
G+ + I+ M QLL ++ LH I+HRDIK N+ I ++G
Sbjct: 102 ------SGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG--I 153
Query: 302 FKIIDLGAA 310
KI D G A
Sbjct: 154 LKIADFGLA 162
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 39/144 (27%), Positives = 62/144 (43%), Gaps = 23/144 (15%)
Query: 204 YGFF--ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
YG F +N + WL+ + G ++ DL+ + KG +
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN------------------TKGNTLKE 110
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP 321
I I ++L L LH ++HRDIK QNV+ +E + K++D G +A L +
Sbjct: 111 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV-KLVDFGVSAQLDRTVGR-R 168
Query: 322 KEFLLDPRYAAPEQYIMSTQTPSA 345
F+ P + APE I + P A
Sbjct: 169 NTFIGTPYWMAPE-VIACDENPDA 191
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 28/190 (14%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+K+G+G+FG V++ + + L++A + EI ++ + C + +V
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYVT 65
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII 264
++ S K + W+I Y G + DL+ + L E Q I
Sbjct: 66 KYY-GSYLKDTKLWIIMEYLGGGSALDLL---------EPGPLDETQ------------I 103
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEF 324
TI+ ++L LD LHS +HRDIK NV+ SE K+ D G A L F
Sbjct: 104 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV-KLADFGVAGQL-TDTQIKRNTF 161
Query: 325 LLDPRYAAPE 334
+ P + APE
Sbjct: 162 VGTPFWMAPE 171
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297
F Y V+ +L ++++P G+ E +++ + QL+ A+ H IVHRDIKP+N++ S
Sbjct: 79 FEY-VEKNMLELLEEMPNGVPPEK--VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
K+ D G A +L G N E++ Y +PE
Sbjct: 136 ND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 32/124 (25%), Positives = 56/124 (45%), Gaps = 25/124 (20%)
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+E ++ + ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLART--AC 174
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376
N++ +++ Y APE V+ + + DI+S G I
Sbjct: 175 TNFMMTPYVVTRYYRAPE----------------------VILGMGYKENVDIWSVGCIM 212
Query: 377 LQMV 380
++V
Sbjct: 213 GELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 59/210 (28%), Positives = 84/210 (40%), Gaps = 49/210 (23%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--------EYGAVEIWM 187
+F L + LG GA+G V+ L +K + G L VLKKAT E+ E +
Sbjct: 1 NFELLRVLGTGAYGKVF---LVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV 57
Query: 188 NERVRRACANCCADFVYGF--FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
E VRR C V F+ +K LI Y L + RE
Sbjct: 58 LEAVRR-----CPFLVTLHYAFQTDTK----LHLILDYVNGGELFTHLYQRE-------- 100
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKI 304
E E R+ +++++ ALD LH GI++RDIK +N++ SEG +
Sbjct: 101 ---------HFTESEVRVY---IAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVL 146
Query: 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
D G + + F Y APE
Sbjct: 147 TDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 23/48 (47%), Positives = 29/48 (60%), Gaps = 3/48 (6%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
I+ M QLL L LHS GI+HRDIK N+ I ++G K+ D G A
Sbjct: 102 IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ IM QLL AL +HS ++HRD+KP N++ + R K+ D G A
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRV-KLADFGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 51/217 (23%), Positives = 78/217 (35%), Gaps = 60/217 (27%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNER---- 190
++ LG +G GAFGVVY+ + GD V K A++ M E
Sbjct: 1 NYQLGDLIGRGAFGVVYKGL------NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLK 54
Query: 191 -------VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQ 243
V+ G E S ++I Y +L + I + P+
Sbjct: 55 NLKHPNIVK----------YIGSIETS----DSLYIILEYAENGSLRQI-IKKFGPFP-- 97
Query: 244 TLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTF 302
E+ + + Q+L L LH G++HRDIK N+ +G
Sbjct: 98 ----------------ESLVA-VYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VV 138
Query: 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 339
K+ D G A L ++ + P + APE MS
Sbjct: 139 KLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS 174
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 53/208 (25%), Positives = 78/208 (37%), Gaps = 51/208 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSK--------NDGDLVLKKATEYGAVEIWMNER 190
DD +LG G GVV + +P+ K + + ++K I
Sbjct: 1 DDLEYLGELGAGNSGVVSKVL--HRPTGKIMAVKTIRLEINEAIQKQ-------ILRELD 51
Query: 191 VRRACANC--CADFVYG-FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL 247
+ C N F YG F+ N G+ + Y +L IL
Sbjct: 52 ILHKC-NSPYIVGF-YGAFYNN-----GDISICMEYMDGGSLDK--------------IL 90
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTFKIID 306
EVQ I RI+ I +L L LH I+HRD+KP N++ + K+ D
Sbjct: 91 KEVQ---GRI--PERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCD 144
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPE 334
G + L +N + K F+ Y APE
Sbjct: 145 FGVSGQL---VNSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 32/199 (16%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRAC 195
+ D+ L +++G G +G VY+A + L+ ++ + EI+M + C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFM----VKEC 63
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+C +G + + K W+ Y G +L D+ Y+V T L E+Q
Sbjct: 64 KHCNIVAYFGSYLSREK----LWICMEYCGGGSLQDI-------YHV-TGPLSELQ---- 107
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRV 315
I + + L L LHS G +HRDIK N++ ++ K+ D G AA +
Sbjct: 108 --------IAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDV-KLADFGVAAKITA 158
Query: 316 GINYIPKEFLLDPRYAAPE 334
I K F+ P + APE
Sbjct: 159 TIAK-RKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 47/208 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERV--- 191
++FV+ K + GAFG VY L +K KN+ L V+KKA + M +V
Sbjct: 4 EEFVIVKPISRGAFGKVY---LGRK---KNNSKLYAVKVVKKAD---MINKNMVHQVQAE 54
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
R A A + F+ + S + +L+ Y LI G+V+
Sbjct: 55 RDALALSKSPFIVHLYY-SLQSANNVYLVMEY---------------------LIGGDVK 92
Query: 252 DLPK--GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLG 308
L G E ++ I S++ ALD LH GI+HRD+KP N++ S EG K+ D G
Sbjct: 93 SLLHIYGYFDEEMAVKYI-SEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFG 149
Query: 309 -AAADLRVGINYIPKEFLLDPRYAAPEQ 335
+ L +N + + L P A P+
Sbjct: 150 LSKVTLNRELNMM--DILTTPSMAKPKN 175
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 1/66 (1%)
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
G V+ L K + I I+ ++L AL +H G++HRDIK N++ + K+ D
Sbjct: 87 GSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNV-KLCDF 145
Query: 308 GAAADL 313
G AA L
Sbjct: 146 GVAALL 151
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ ++ Q+L L +HS GI+HRD+KP N+ +E KI+D G A
Sbjct: 120 IQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 13/82 (15%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSR--TFKIIDLGAAADLRVGIN 318
++++++ Q+L + LHS ++HRD+KP N+ + EG KI DLG A R+ N
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA---RL-FN 163
Query: 319 YIPKEFL-LDPR-----YAAPE 334
K LDP Y APE
Sbjct: 164 APLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 25/71 (35%), Positives = 41/71 (57%), Gaps = 1/71 (1%)
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
Y V L+ ++ ++ K + + +Q ++ QLL L +HS GI+HRD+KP NV +E
Sbjct: 96 YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC 155
Query: 300 RTFKIIDLGAA 310
+I+D G A
Sbjct: 156 E-LRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 66/239 (27%), Positives = 97/239 (40%), Gaps = 54/239 (22%)
Query: 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR-RACANCCADFVY 204
+LG+GAFG VY+A +K G L K E + E + V A C ++
Sbjct: 19 ELGDGAFGKVYKAK------NKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIV 72
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREF-PYNVQTLILGEVQDLPKGIERENRI 263
G YW +G+ L I EF P I+ E L +G+
Sbjct: 73 KLL------GAFYW-----DGK-----LWIMIEFCPGGAVDAIMLE---LDRGLTEPQ-- 111
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPK 322
IQ I Q+L AL LHS I+HRD+K NV+ + +G K+ D G +A + + +
Sbjct: 112 IQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAK---NVKTLQR 166
Query: 323 E--FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
F+ P + APE +M P A DI+S G+ ++M
Sbjct: 167 RDSFIGTPYWMAPE-VVMCETMKDTPYDYKA----------------DIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 28/65 (43%), Positives = 34/65 (52%), Gaps = 1/65 (1%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPR 329
Q+L L LH IVHRDIK NV+ + S KI D G + L GIN + F +
Sbjct: 116 QILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQ 174
Query: 330 YAAPE 334
Y APE
Sbjct: 175 YMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 48/169 (28%), Positives = 72/169 (42%), Gaps = 22/169 (13%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+ +G GAFG+V+ L ++ K D LV+ K VE M + R A N C
Sbjct: 6 RVVGRGAFGIVH---LCRR---KADQKLVIIKQIP---VE-QMTKDERLAAQNEC----- 50
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII 264
K +I YE LMI E Y + +Q + E+ I+
Sbjct: 51 ----QVLKLLSHPNIIEYYENFLEDKALMIVME--YAPGGTLAEYIQKRCNSLLDEDTIL 104
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
+ Q+L AL +H+ I+HRD+K QN++ + KI D G + L
Sbjct: 105 HFFV-QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 34/117 (29%), Positives = 49/117 (41%), Gaps = 19/117 (16%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
+ M QLL L +HS ++HRD+KP NV + KI D G A
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR------------ 163
Query: 324 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
++DP Y+ T S + LSP N D+++AG IF +M+
Sbjct: 164 -IVDPHYSHKGYLSEGLVTKWYRSPRL--LLSPN----NYTKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 44/205 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAV--EIWMNE 189
++DF L +++G G +G VY+A + N G+L L+ ++ V EI M +
Sbjct: 8 QEDFELIQRIGSGTYGDVYKAR------NVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK 61
Query: 190 RVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+C + +F S + + W+ + G +L D+ Y+V T L E
Sbjct: 62 -------DCKHSNIVAYF-GSYLRRDKLWICMEFCGGGSLQDI-------YHV-TGPLSE 105
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
Q I + + L L LHS G +HRDIK N++ ++ K+ D G
Sbjct: 106 SQ------------IAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHV-KLADFGV 152
Query: 310 AADLRVGINYIPKEFLLDPRYAAPE 334
+A + I K F+ P + APE
Sbjct: 153 SAQITATIAK-RKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I++ M L L+ LHS I+HRD+KP N++ + K+ D G A
Sbjct: 104 IKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLA 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 38/178 (21%)
Query: 140 DFVLGKKLGEGAFGVVYRAS--LAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRAC 195
+F + KK+G G F VYRA+ L +KP + LKK V+I+ M+ + R+ C
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKP-------VALKK------VQIFEMMDAKARQDC 49
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
E K + + +Y L + E ++ G++ + K
Sbjct: 50 VK----------EIDLLKQLNHPNVIKY-----LDSFIEDNELNIVLELADAGDLSQMIK 94
Query: 256 GIERENRII--QTIMS---QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+++ R+I +T+ QL A++ +HS ++HRDIKP NV F + K+ DLG
Sbjct: 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANV-FITATGVVKLGDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 39/120 (32%), Positives = 55/120 (45%), Gaps = 25/120 (20%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAAADLRVGINYI 320
+I++ + QLL + HS ++HRD+KPQN+ I EG K+ D G A V +
Sbjct: 99 PLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTY 156
Query: 321 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
E ++ Y APE + S Q S PV DI+S G IF +MV
Sbjct: 157 THE-VVTLWYRAPEILLGSRQY----STPV-----------------DIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 24/74 (32%), Positives = 39/74 (52%), Gaps = 4/74 (5%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP 321
+++ I +L L LHS I+HRDIKP N++ + + K+ D G + +L +N +
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV-KLCDFGVSGEL---VNSLA 160
Query: 322 KEFLLDPRYAAPEQ 335
F Y APE+
Sbjct: 161 GTFTGTSFYMAPER 174
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 46/206 (22%), Positives = 68/206 (33%), Gaps = 60/206 (29%)
Query: 147 LGEGAFGVVYRASLAKKPSSKNDGDL-VLKK-----ATEYGAVEIWMNERVRRACANCCA 200
LG G FG V K+ LK E G E +E+ C
Sbjct: 1 LGVGGFGRVE------LVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK--EILEECNH 52
Query: 201 DFV-----------YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
F+ Y + GGE W I R G L
Sbjct: 53 PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG------LF---------------- 90
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
+ + ++ ++ A + LH+ GI++RD+KP+N++ K++D G
Sbjct: 91 ----------DEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV-KLVDFGF 139
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQ 335
A L+ G F P Y APE
Sbjct: 140 AKKLKSGQK--TWTFCGTPEYVAPEI 163
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 29/175 (16%)
Query: 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANC 198
G K+G G +G VY+A K+ K+D D LK+ G EI + ++
Sbjct: 6 GCKVGRGTYGHVYKA---KRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS 62
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
F ++ +K WL++ Y + R N + + LP+G+
Sbjct: 63 LQKV---FLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV------QLPRGM- 109
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSR--TFKIIDLGAA 310
+++++ Q+L + LH+ ++HRD+KP N+ + EG KI D+G A
Sbjct: 110 -----VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 10/102 (9%)
Query: 248 GEVQDLPKG-IERENR----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
G V DL KG ++R R II I+ + L L LH +HRD+K N++ +
Sbjct: 105 GSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GV 163
Query: 303 KIIDLGAAADL---RVGINY-IPKEFLLDPRYAAPEQYIMST 340
K++D G +A L R+ N + F + P A EQ + ST
Sbjct: 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST 205
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 45/184 (24%), Positives = 73/184 (39%), Gaps = 40/184 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNERVR 192
DDF + K +G GAFG V+ L + K+ G + VL+K+ + + ER
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRD---KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI 54
Query: 193 RACANC--CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
A A+ Y F + +L+ Y L +L+I
Sbjct: 55 LADADSPWIVKLYYSFQDEEH-----LYLVMEYMPGGDLMNLLIR--------------- 94
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
K + E + +++L+ ALD +H G +HRDIKP N++ K+ D G
Sbjct: 95 ----KDVFPEE-TARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA-DGHIKLADFGLC 148
Query: 311 ADLR 314
+
Sbjct: 149 KKMN 152
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 52/179 (29%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERVRRACA-NCC 199
K LG+G+FG V+ L +K + + G L VLKKAT + + +RVR +
Sbjct: 2 KVLGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKAT------LKVRDRVRTKMERDIL 52
Query: 200 ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259
A+ + F L + ++ E L LIL D +G +
Sbjct: 53 AEVNHPFIVK---------LHYAFQTEGKL--------------YLIL----DFLRGGDL 85
Query: 260 ENRIIQTIM----------SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
R+ + +M ++L ALD LHS GI++RD+KP+N++ E K+ D G
Sbjct: 86 FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFG 143
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 22/66 (33%), Positives = 36/66 (54%), Gaps = 7/66 (10%)
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
I ++ K ++I+ IM +L L+ +H GI H DIKP+N++ +R + II
Sbjct: 116 IFKRIKCKNK------KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-II 168
Query: 306 DLGAAA 311
D G A+
Sbjct: 169 DYGIAS 174
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 23/65 (35%), Positives = 36/65 (55%), Gaps = 6/65 (9%)
Query: 251 QDLPK-----GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
QDL K + + I+++ M QLL L HS ++HRD+KPQN++ + + K+
Sbjct: 83 QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN-KNGELKLA 141
Query: 306 DLGAA 310
D G A
Sbjct: 142 DFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 24/68 (35%), Positives = 36/68 (52%), Gaps = 7/68 (10%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQN-VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL 326
M+++ A+D LH G +HRD+KP+N +I + G K+ D G + GI +
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSK----GIVTYANSVVG 160
Query: 327 DPRYAAPE 334
P Y APE
Sbjct: 161 SPDYMAPE 168
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 10/88 (11%)
Query: 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRI----IQTIMSQLLFALDGLHSTGI 283
L D+ + +F V ++ DL K ++R+ R+ ++ I+ Q+L L+ LH
Sbjct: 84 GLVDVYVEGDFINLVMDIMAS---DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYF 140
Query: 284 VHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
+HRD+ P N+ I S+G KI D G A
Sbjct: 141 MHRDLSPANIFINSKG--ICKIADFGLA 166
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 252 DLPK--GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
DL K G +Q ++ Q+L L +HS GI+HRD+KP N+ +E KI+D G
Sbjct: 105 DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGL 163
Query: 310 A 310
A
Sbjct: 164 A 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 32/119 (26%), Positives = 53/119 (44%), Gaps = 28/119 (23%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
I T+ +L AL LH+ G++HRDIK +++ + R K+ D G A + +P+
Sbjct: 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRV-KLSDFGFCAQVSKE---VPRR 172
Query: 324 FLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
L P + APE V+ +L DI+S G++ ++MV
Sbjct: 173 KSLVGTPYWMAPE----------------------VISRLPYGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 46/177 (25%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERVRRACANCC- 199
K LG+G +G V+ +K + + G + VLKKAT + + + R
Sbjct: 2 KVLGKGGYGKVF---QVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK 58
Query: 200 ----ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
D +Y F + GG+ +LI Y L GE L
Sbjct: 59 HPFIVDLIYAF-----QTGGKLYLILEY---------------------LSGGE---LFM 89
Query: 256 GIERENRIIQTI----MSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+ERE ++ +S++ AL+ LH GI++RD+KP+N++ K+ D G
Sbjct: 90 HLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHV-KLTDFG 145
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 61/241 (25%), Positives = 95/241 (39%), Gaps = 58/241 (24%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVY 204
+KLGEG++ VY K S+ +G LV K E +R A
Sbjct: 11 EKLGEGSYATVY------KGISRINGQLVALKVISMKTEEGVPFTAIREA---------- 54
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISRE-----FPYNVQTLILGEVQDLPKGIER 259
S KG ++ I L D++ ++E F Y + T + + P G+
Sbjct: 55 -----SLLKGLKHANI------VLLHDIIHTKETLTFVFEY-MHTDLAQYMIQHPGGLHP 102
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
N ++ M QLL L +H I+HRD+KPQN++ S K+ D G A +
Sbjct: 103 YN--VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE-LKLADFGLARAKSIPSQT 159
Query: 320 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
E ++ Y P+ + +T SA DI+ AG IF++M
Sbjct: 160 YSSE-VVTLWYRPPDVLLGATDYSSA---------------------LDIWGAGCIFIEM 197
Query: 380 V 380
+
Sbjct: 198 L 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 61/249 (24%), Positives = 100/249 (40%), Gaps = 58/249 (23%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA 196
+ D + +KLGEG++ VY K SK +G LV K E +R A
Sbjct: 3 KADSYEKLEKLGEGSYATVY------KGKSKVNGKLVALKVIRLQEEEGTPFTAIREA-- 54
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-----FPYNVQTLILGEVQ 251
S KG ++ L D++ ++E F Y V T + +
Sbjct: 55 -------------SLLKG------LKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMD 94
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
P G+ EN ++ + QLL L +H I+HRD+KPQN++ S+ + K+ D G A
Sbjct: 95 KHPGGLHPEN--VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD-TGELKLADFGLAR 151
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
V + E ++ Y P+ + ST+ + D++
Sbjct: 152 AKSVPSHTYSNE-VVTLWYRPPDVLLGSTEYSTC---------------------LDMWG 189
Query: 372 AGLIFLQMV 380
G IF++M+
Sbjct: 190 VGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 31/126 (24%), Positives = 46/126 (36%), Gaps = 25/126 (19%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR---VG 316
+ +I QLL L LH I+HRD+K N++ + +I D GAAA L G
Sbjct: 101 KEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376
+ L + APE VL D++S G +
Sbjct: 161 AGEFQGQLLGTIAFMAPE----------------------VLRGEQYGRSCDVWSVGCVI 198
Query: 377 LQMVCT 382
++M
Sbjct: 199 IEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 60/253 (23%), Positives = 94/253 (37%), Gaps = 66/253 (26%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
++L ++LG+G+FG VY K + LK E E+ NE V+ AN A
Sbjct: 2 YILQQRLGKGSFGTVYLVK-----DKKAVAEERLKVLKEIPVGELNPNETVQ---ANQEA 53
Query: 201 D------------FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
F F E + + +I Y L + E + +TL
Sbjct: 54 QLLSKLDHPAIVKFHASFLERDA-----FCIITEYCEGRDLDCKL--EELKHTGKTL--- 103
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
EN++ + + QLL + +H I+HRD+K +N+ + KI D G
Sbjct: 104 ----------SENQVCEWFI-QLLLGVHYMHQRRILHRDLKAKNIFLK--NNLLKIGDFG 150
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368
+ L +G + F P Y +PE + Q + S D
Sbjct: 151 VSR-LLMGSCDLATTFTGTPYYMSPEA--LKHQGYDSKS--------------------D 187
Query: 369 IYSAGLIFLQMVC 381
I+S G I +M C
Sbjct: 188 IWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 25/66 (37%), Positives = 37/66 (56%), Gaps = 3/66 (4%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP 328
+Q++ L+ LH IV+RD+KP+NV+ + +I DLG A +L+ G K P
Sbjct: 102 AQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV-RISDLGLAVELKGGKK--IKGRAGTP 158
Query: 329 RYAAPE 334
Y APE
Sbjct: 159 GYMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 22/51 (43%), Positives = 33/51 (64%), Gaps = 2/51 (3%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
E+RI Q ++ Q+L L +H+ GI+HRD+KP N+ +E KI+D G A
Sbjct: 117 EDRI-QFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 32/105 (30%), Positives = 56/105 (53%), Gaps = 7/105 (6%)
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297
F Y T+ L E++ P+G+ +I+ I+ Q L A++ H +HRD+KP+N++ ++
Sbjct: 79 FEYCDHTV-LNELEKNPRGVPEH--LIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135
Query: 298 GSRTFKIIDLGAAADL-RVGINYIPKEFLLDPRYAAPEQYIMSTQ 341
+ K+ D G A L G +Y +++ Y APE + TQ
Sbjct: 136 QGQ-IKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGDTQ 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 36/208 (17%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC 195
D + + + +G+G +G VY+ + +K DG L K + + EI + ++
Sbjct: 22 DTWEIIETIGKGTYGKVYKVT------NKKDGSLAAVKILDPISDVDEEIEAEYNILQSL 75
Query: 196 AN--CCADFVYGFFENSSK-KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
N F YG F + K GG+ WL+ ++ +L+ LI G+ D
Sbjct: 76 PNHPNVVKF-YGMFYKADKLVGGQLWLVLELCNGGSVTELVKG--------LLICGQRLD 126
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAA 311
+I I+ L L LH+ I+HRD+K N++ + EG K++D G +A
Sbjct: 127 EA--------MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSA 176
Query: 312 DL---RVGINY-IPKEFLLDPRYAAPEQ 335
L R+ N + F + P A EQ
Sbjct: 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 41/181 (22%)
Query: 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRA 194
TY+K D KLGEG++ VY+ SK G LV K EI +
Sbjct: 6 TYKKLD-----KLGEGSYATVYKGR------SKLTGQLVALK-------EIRLEHE---E 44
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-----FPYNVQTLILGE 249
A A E S K ++ TL D++ +++ F Y + T +
Sbjct: 45 GAPFTA-----IREASLLKD------LKHANIVTLHDIIHTKKTLTLVFEY-LDTDLKQY 92
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
+ D G+ N ++ + QLL L H ++HRD+KPQN++ SE K+ D G
Sbjct: 93 MDDCGGGLSMHN--VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE-LKLADFGL 149
Query: 310 A 310
A
Sbjct: 150 A 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 9e-05
Identities = 16/42 (38%), Positives = 24/42 (57%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
I+ QL+ AL+ LH I+H DIK +NV++ + D G
Sbjct: 114 IIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYG 155
|
Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 23/66 (34%), Positives = 38/66 (57%), Gaps = 2/66 (3%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP 328
+Q++ L+ LH I++RD+KP+NV+ +I DLG A +L+ G + K + P
Sbjct: 104 AQIISGLEHLHQRRIIYRDLKPENVLLDNDGNV-RISDLGLAVELKDGQSKT-KGYAGTP 161
Query: 329 RYAAPE 334
+ APE
Sbjct: 162 GFMAPE 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 11/69 (15%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPKEFLL- 326
S+++ AL+ LHS IV+RD+KP+N++ EG K+ D G A LR + + L
Sbjct: 108 SEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLR------DRTWTLC 159
Query: 327 -DPRYAAPE 334
P Y APE
Sbjct: 160 GTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 50/204 (24%), Positives = 82/204 (40%), Gaps = 43/204 (21%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKN-------DGDLVLKKATEYGAVEIWMNERVRR 193
+ + KK+GEG+FG +Y LAK S D + K E E+ + +++
Sbjct: 2 YEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLM--ISREFPYNVQTLILGEV 250
N F S ++ G +++ Y +G DLM I+R+
Sbjct: 59 P--NIVT------FFASFQENGRLFIVMEYCDG----GDLMKRINRQ------------- 93
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+G+ I + Q+ L +H I+HRDIK QN+ S+ K+ D G A
Sbjct: 94 ----RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149
Query: 311 ADLRVGINYIPKEFLLDPRYAAPE 334
L + + + P Y +PE
Sbjct: 150 RQLNDSME-LAYTCVGTPYYLSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+ + QLL L +HS ++HRD+KP N++ +E +I D G A
Sbjct: 109 IRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMA 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 23/71 (32%), Positives = 40/71 (56%), Gaps = 1/71 (1%)
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
Y V L+ ++ ++ K + + +Q ++ Q+L L +HS I+HRD+KP N+ +E
Sbjct: 98 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157
Query: 300 RTFKIIDLGAA 310
KI+D G A
Sbjct: 158 E-LKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 34/116 (29%), Positives = 49/116 (42%), Gaps = 24/116 (20%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
+ + QLL A+D +H GI+HRDIK +NV G + D GAA R
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENV-LVNGPEDICLGDFGAACFAR--------- 311
Query: 324 FLLDPRYAAPEQY-IMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
++ P Y I T +AP +P + DI+SAGL+ +
Sbjct: 312 ----GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSV---------DIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 24/63 (38%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 252 DLPKGIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
DL K I + ++ + Q+L L LHS GI+HRDIKP N++ + KI D
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDF 147
Query: 308 GAA 310
G A
Sbjct: 148 GLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 38/138 (27%), Positives = 57/138 (41%), Gaps = 34/138 (24%)
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIID 306
G + D+ + I + + L AL+ LHS ++HRDIK N++ +GS K+ D
Sbjct: 101 GSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTD 158
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQ--TP--SAPSAPVATALSPVLWQLN 362
G A + PEQ ST TP AP A P
Sbjct: 159 FGFCAQI------------------TPEQSKRSTMVGTPYWMAPEVVTRKAYGP------ 194
Query: 363 LPDRFDIYSAGLIFLQMV 380
+ DI+S G++ ++MV
Sbjct: 195 ---KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 42/194 (21%), Positives = 69/194 (35%), Gaps = 38/194 (19%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
+D LGK LGEGAFG V +A + + +K + A
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-------------DATEK 57
Query: 198 CCADFV--------YGFFEN------SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQ 243
+D V G +N + G +++ Y L D + +R P
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 244 TLILGEVQDLPKGIERENRIIQTIMS---QLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300
+ E + ++S Q+ ++ L S +HRD+ +NV+ +E
Sbjct: 118 SPDDPRPP-------EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH- 169
Query: 301 TFKIIDLGAAADLR 314
KI D G A D+
Sbjct: 170 VMKIADFGLARDIH 183
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 26/79 (32%), Positives = 36/79 (45%), Gaps = 13/79 (16%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA-----ADLRVGIN 318
I++ M QLL L+ H +HRDIK N++ + K+ D G A + R N
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTN 176
Query: 319 ------YIPKEFLL-DPRY 330
Y P E LL + RY
Sbjct: 177 KVITLWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 36/118 (30%), Positives = 50/118 (42%), Gaps = 30/118 (25%)
Query: 266 TIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFL 325
TI +LL AL LH GI+HRD+K +N IF + + D GAA L +
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLGDFGAACKLDAHPD------- 240
Query: 326 LDPRYAAPEQY----IMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
P+ Y + T +P AL P + DI+SAGL+ +M
Sbjct: 241 ------TPQCYGWSGTLETNSPE------LLALDPYC------AKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 43/145 (29%), Positives = 59/145 (40%), Gaps = 25/145 (17%)
Query: 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISR-EFPYNVQTLILGEVQDLPKGIERENRI 263
G+ + S + +Y + +G AD+ S E PY+ Q LP ER R
Sbjct: 177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYD---------QYLPSAPERTRRD 227
Query: 264 IQTIMSQLLFALD-------------GLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
S L +D L S VHRD+ +NV+ EG + KI D G A
Sbjct: 228 TLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLVKICDFGLA 286
Query: 311 ADLRVGINYIPKEFLLDP-RYAAPE 334
D+ NYI K P ++ APE
Sbjct: 287 RDIMRDSNYISKGSTFLPLKWMAPE 311
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 42/163 (25%), Positives = 58/163 (35%), Gaps = 32/163 (19%)
Query: 220 IWRYEGEATLAD-LMISREF-PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDG 277
I +Y G D L I E P +L + P+ +I+ Q+L L+
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE------PVIRLYTRQILLGLEY 117
Query: 278 LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 337
LH VHRDIK N I + + K+ D G A +V K F P + APE I
Sbjct: 118 LHDRNTVHRDIKGAN-ILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPE-VI 173
Query: 338 MSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
+ DI+S G L+M
Sbjct: 174 AQQGGYGLAA--------------------DIWSLGCTVLEMA 196
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 52/208 (25%), Positives = 79/208 (37%), Gaps = 45/208 (21%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--------EYGAVEIWM 187
+F L K LG GA+G V+ L +K S + G L VLKKAT E+ E +
Sbjct: 1 NFELLKVLGTGAYGKVF---LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57
Query: 188 NERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE-FPYNVQTLI 246
E +R++ + F+ +K LI Y L + RE F +
Sbjct: 58 LEHIRQSPFLVTLHYA---FQTDTK----LHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
GE+ + AL+ LH GI++RDIK +N++ + D
Sbjct: 111 SGEI---------------------VLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTD 148
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPE 334
G + + F Y AP+
Sbjct: 149 FGLSKEFHEDEVERAYSFCGTIEYMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC 195
+ +D LGK LGEG FG V A K K AV++ ++ +
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDK-------PKEAVTVAVKMLKDDATEKDL 64
Query: 196 ANCCADF----VYGFFEN------SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
++ ++ + G +N + + G ++I Y + L + + +R P +
Sbjct: 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
+ V D + + + Q+ ++ L S +HRD+ +NV+ +E + KI
Sbjct: 125 DIARVPDEQMTFKD----LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE-NNVMKIA 179
Query: 306 DLGAAADLRVGINYIPKEF--LLDPRYAAPE 334
D G A D+ I+Y K L ++ APE
Sbjct: 180 DFGLARDVN-NIDYYKKTTNGRLPVKWMAPE 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 35/139 (25%), Positives = 52/139 (37%), Gaps = 50/139 (35%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI---FSEGSRTFKIIDLGAA-------- 310
I I + + + HS G++HRD+KP N++ F E I+D GAA
Sbjct: 117 SIFHKICATIEYV----HSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEE 168
Query: 311 --ADLRVGINY-------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361
D+ V IP + + P Y APE P +
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPE---------RLLGVPAS---------- 209
Query: 362 NLPDRFDIYSAGLIFLQMV 380
+ DIY+ G+I QM+
Sbjct: 210 ---ESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 12/90 (13%)
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL-- 313
G E E + +++L L+ LH V+RD+KP+N++ + +I DLG A +
Sbjct: 98 GFEEERALFYA--AEILCGLEDLHRENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPE 154
Query: 314 ------RVG-INYIPKEFLLDPRYAAPEQY 336
RVG + Y+ E L + RY Y
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDY 184
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 62/246 (25%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERV-RRA 194
D+F+ K+GEG+ G+V A++ K+ G LV K + E+ NE V R
Sbjct: 23 DNFI---KIGEGSTGIVCIATV------KSSGKLVAVKKMDLRKQQRRELLFNEVVIMRD 73
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ +Y NS G E W++ + L D++ + E Q
Sbjct: 74 YQHENVVEMY----NSYLVGDELWVVMEFLEGGALTDIVTHTR---------MNEEQ--- 117
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
I + +L AL LH+ G++HRDIK +++ + R K+ D G A +
Sbjct: 118 ---------IAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV-KLSDFGFCAQVS 167
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374
+ K + P + APE + ++ P P DI+S G+
Sbjct: 168 KEVPR-RKSLVGTPYWMAPE---LISRLPYGPEV-------------------DIWSLGI 204
Query: 375 IFLQMV 380
+ ++MV
Sbjct: 205 MVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 28/117 (23%), Positives = 52/117 (44%), Gaps = 23/117 (19%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
+++ QLL + H ++HRD+KPQN++ ++ K+ D G A + +N E
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNE 160
Query: 324 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
++ Y AP+ ++ ++T S DI+S G I +M+
Sbjct: 161 -VVTLWYRAPD-VLLGSRTYST--------------------SIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 17/47 (36%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
++ +M QLL + LH I+HRD+K N++ + KI D G A
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 36/177 (20%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIW--MNERVRRACA 196
+F + KK+G G F VYRA+ DG V LKK V+I+ M+ + R C
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLL------DGVPVALKK------VQIFDLMDAKARADCI 50
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
E K + + +Y A + E ++ G++ + K
Sbjct: 51 K----------EIDLLKQLNHPNVIKYY-----ASFIEDNELNIVLELADAGDLSRMIKH 95
Query: 257 IERENRII--QTIMS---QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+++ R+I +T+ QL AL+ +HS ++HRDIKP NV F + K+ DLG
Sbjct: 96 FKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANV-FITATGVVKLGDLG 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR 192
R +D VLGK LGEG FG V A K + + T+ AV++ ++
Sbjct: 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPN------RVTKV-AVKMLKSDATE 64
Query: 193 RACANCCADF----VYGFFEN------SSKKGGEYWLIWRYEGEATLADLMISR-----E 237
+ ++ ++ + G +N + + G ++I Y + L + + +R E
Sbjct: 65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 124
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMS---QLLFALDGLHSTGIVHRDIKPQNVI 294
+ YN P + E + ++S Q+ ++ L S +HRD+ +NV+
Sbjct: 125 YCYN------------PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172
Query: 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEF--LLDPRYAAPE 334
+E KI D G A D+ I+Y K L ++ APE
Sbjct: 173 VTE-DNVMKIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPE 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 35/120 (29%), Positives = 51/120 (42%), Gaps = 20/120 (16%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA----------ADL 313
++ M QLL L H I+HRD+KPQN++ +E K+ D G A ++
Sbjct: 105 VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE-LKLADFGLARAKSVPTKTYSNE 163
Query: 314 RVGINYIPKEFLL-DPRYAAPEQ--------YIMSTQTPSAPSAPVATALSPVLWQLNLP 364
V + Y P + LL Y+ P Y M+T P P + V L + L P
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 24/71 (33%), Positives = 34/71 (47%), Gaps = 6/71 (8%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKE 323
I I L L LHS +HRDIK N++ +E T K+ D G+A+ +
Sbjct: 117 IAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSAS-----LVSPANS 170
Query: 324 FLLDPRYAAPE 334
F+ P + APE
Sbjct: 171 FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 20/43 (46%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
+Q++ AL+ LHS IV+RD+KP+N+ + S+G KI D G A
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFA 148
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 12/88 (13%)
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL- 313
+G+E E I + +Q+ + LHS IV+RD+KP+NV+ + ++ DLG A +L
Sbjct: 90 RGLEMERVIHYS--AQITCGILHLHSMDIVYRDMKPENVLLDDQGNC-RLSDLGLAVELK 146
Query: 314 -------RVGIN-YIPKEFLLDPRYAAP 333
R G N Y+ E L + Y+ P
Sbjct: 147 DGKTITQRAGTNGYMAPEILKEEPYSYP 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 1/40 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
++++ ALD +HS G +HRD+KP N++ + S K+ D G
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 46/172 (26%), Positives = 66/172 (38%), Gaps = 55/172 (31%)
Query: 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLF 273
G E W++ Y +L D+ V + E Q I + + L
Sbjct: 88 GDELWVVMEYLAGGSLTDV---------VTETCMDEGQ------------IAAVCRECLQ 126
Query: 274 ALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAA 332
ALD LHS ++HRDIK N++ +GS K+ D G A +
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQI------------------T 166
Query: 333 PEQYIMSTQ--TP--SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
PEQ ST TP AP A P + DI+S G++ ++MV
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGP---------KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 9/68 (13%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL-- 326
++L+ A + LHS I++RD+KP+N++ + K+ D G A + + F L
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLL-DNKGHVKVTDFGFAKKVP------DRTFTLCG 177
Query: 327 DPRYAAPE 334
P Y APE
Sbjct: 178 TPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 36/135 (26%), Positives = 58/135 (42%), Gaps = 28/135 (20%)
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
G + D+ I T+ +L AL LHS G++HRDIK +++ + R K+ D
Sbjct: 103 GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRV-KLSDF 161
Query: 308 GAAADLRVGINYIPKEFLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365
G A + +PK L P + APE + ++TP
Sbjct: 162 GFCAQIS---KDVPKRKSLVGTPYWMAPE---VISRTPYGTEV----------------- 198
Query: 366 RFDIYSAGLIFLQMV 380
DI+S G++ ++MV
Sbjct: 199 --DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 27/75 (36%), Positives = 37/75 (49%), Gaps = 9/75 (12%)
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP--- 321
Q + QLL AL +H+ + HRD+KP+N I + KI D G A RV N P
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKN-ILANADCKLKICDFGLA---RVAFNDTPTAI 161
Query: 322 --KEFLLDPRYAAPE 334
+++ Y APE
Sbjct: 162 FWTDYVATRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 28/135 (20%)
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
G + D+ I T+ +L AL LH+ G++HRDIK +++ + R K+ D
Sbjct: 104 GALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDF 162
Query: 308 GAAADLRVGINYIPKEFLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365
G A + +PK L P + APE V+ +L
Sbjct: 163 GFCAQVS---KEVPKRKSLVGTPYWMAPE----------------------VISRLPYGT 197
Query: 366 RFDIYSAGLIFLQMV 380
DI+S G++ ++M+
Sbjct: 198 EVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 16/40 (40%), Positives = 27/40 (67%), Gaps = 1/40 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
++++ ALD +HS G +HRD+KP N++ + S K+ D G
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+ +M LL L +H I+HRD+K N++ ++ K+ D G A
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 34/122 (27%), Positives = 51/122 (41%), Gaps = 33/122 (27%)
Query: 252 DLPKGIER--------ENRIIQTIMSQLLFAL-------DGLHSTGIVHRDIKPQNVIFS 296
DL + I++ E I I QLL AL DG + ++HRD+KPQN+ S
Sbjct: 100 DLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159
Query: 297 EGSRTF----------------KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST 340
G R KI D G + + +GI + + P Y +PE + T
Sbjct: 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKN--IGIESMAHSCVGTPYYWSPELLLHET 217
Query: 341 QT 342
++
Sbjct: 218 KS 219
|
Length = 1021 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 37/129 (28%), Positives = 60/129 (46%), Gaps = 25/129 (19%)
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN-VIFSEGSRTFKIIDLGAAA 311
LPKG + ++++ + Q+L + HS ++HRD+KPQN +I ++G K+ D G A
Sbjct: 92 LPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG--VIKLADFGLAR 149
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
+ + E ++ Y APE + S + S PV DI+S
Sbjct: 150 AFGIPVRVYTHE-VVTLWYRAPEVLLGSPRY----STPV-----------------DIWS 187
Query: 372 AGLIFLQMV 380
G IF +M
Sbjct: 188 IGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 11/83 (13%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI-NYIPK 322
IQ + Q+L L +HS ++HRD+KP N++ + KI D G A R+ +
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLA---RIADPEHDHT 163
Query: 323 EFLLD---PR-YAAPEQYIMSTQ 341
FL + R Y APE IM
Sbjct: 164 GFLTEYVATRWYRAPE--IMLNS 184
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 9/75 (12%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYI 320
+I ++ L + + I+HRDIKP N++ S G K+ D G + +L IN I
Sbjct: 107 KIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQ--IKLCDFGVSGEL---INSI 158
Query: 321 PKEFLLDPRYAAPEQ 335
F+ Y +PE+
Sbjct: 159 ADTFVGTSTYMSPER 173
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 35/199 (17%)
Query: 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRAC--ANCCADF 202
+LG+GAFG VY+A K+ ++ K+ E +E +M E + +C N
Sbjct: 12 ELGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLL 68
Query: 203 VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENR 262
++EN+ W++ + + +M+ E P L E Q
Sbjct: 69 DAFYYENN------LWILIEFCAGGAVDAVMLELERP-------LTEPQ----------- 104
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIP 321
I+ + Q L AL+ LH I+HRD+K N++F+ +G K+ D G +A I
Sbjct: 105 -IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQR-R 160
Query: 322 KEFLLDPRYAAPEQYIMST 340
F+ P + APE + T
Sbjct: 161 DSFIGTPYWMAPEVVMCET 179
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 29/100 (29%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMS---QLLFALDGLHSTGIVHRDIKPQNVIF 295
P + + EV++L E ++S Q+ ++ L S VHRD+ +NV+
Sbjct: 211 PASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
++G + KI D G A D+ NY+ K P ++ APE
Sbjct: 271 AQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 22/71 (30%), Positives = 39/71 (54%), Gaps = 10/71 (14%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL--------RVG-INY 319
+++ L+ LH IV+RD+KP+N++ + +I DLG A ++ RVG + Y
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHI-RISDLGLAVEIPEGETIRGRVGTVGY 167
Query: 320 IPKEFLLDPRY 330
+ E + + RY
Sbjct: 168 MAPEVVKNERY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 1/58 (1%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
E +++ + Q+L L+ LH+ GI+HRDIK N I + KI D G + L
Sbjct: 104 EETLVRNFVRQILKGLNYLHNRGIIHRDIKGAN-ILVDNKGGIKISDFGISKKLEANS 160
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 0.001
Identities = 49/201 (24%), Positives = 74/201 (36%), Gaps = 35/201 (17%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNE-RVRRA--CANCCA 200
KKLGEGAFG VY+ L K + + LK+ + ++ E RV + N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERE 260
+ G + +L+ Y DL + P +
Sbjct: 61 --LLGV----CTEEEPLYLVLEY---MEGGDL----------LDYLRKSRPVFPS--PEK 99
Query: 261 NRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ + ++ L FA+ G L S VHRD+ +N + E KI D G + D+
Sbjct: 100 STL--SLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVY 156
Query: 315 VGINYIPKEFLLDP-RYAAPE 334
Y K P R+ APE
Sbjct: 157 DDDYYRKKTGGKLPIRWMAPE 177
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 29/175 (16%)
Query: 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANC 198
G K+G G +G VY+ AK+ K++ + LK+ G EI + ++ N
Sbjct: 6 GCKVGRGTYGHVYK---AKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKH--PNV 60
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
A F +S +K WL++ Y + R N + + LP+
Sbjct: 61 IA-LQKVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPM------QLPRS-- 108
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSR--TFKIIDLGAA 310
++++++ Q+L + LH+ ++HRD+KP N+ + EG KI D+G A
Sbjct: 109 ----MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 29/115 (25%), Positives = 51/115 (44%), Gaps = 23/115 (20%)
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEF 324
Q + QLL L +HS ++HRD+KP N++ + KI D G A +++ E+
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFM-TEY 168
Query: 325 LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379
++ Y APE + ++ +A D++S G IF ++
Sbjct: 169 VVTRWYRAPELLLNCSEYTTA---------------------IDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 28/90 (31%)
Query: 268 MSQLLFA-----LDGLHSTGIVHRDIKPQN-VIFSEGSRTFKIIDLGAAADLRVGI---- 317
M+++ FA L+ LH+ GIVHRD+KP N +I S G K+ D G + ++G+
Sbjct: 102 MARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLS---KIGLMSLT 156
Query: 318 -----NYIPKEF--LLD------PRYAAPE 334
+I K+ LD P Y APE
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 23/67 (34%), Positives = 34/67 (50%), Gaps = 3/67 (4%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLD 327
Q+L ++ LHS IVHRDIK N I + + K+ D GA+ L+ + K
Sbjct: 112 QILEGVEYLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170
Query: 328 PRYAAPE 334
P + +PE
Sbjct: 171 PYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 3/77 (3%)
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY 319
EN++++ + Q+ AL LH I+HRD+K QNV + + K+ DLG A L
Sbjct: 101 ENQVVEWFV-QIAMALQYLHEKHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLE-NQCD 157
Query: 320 IPKEFLLDPRYAAPEQY 336
+ + P Y +PE +
Sbjct: 158 MASTLIGTPYYMSPELF 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 36/122 (29%), Positives = 52/122 (42%), Gaps = 34/122 (27%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPK 322
I + + L AL+ LH+ ++HRDIK NV+ +GS K+ D G A +
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQI--------- 165
Query: 323 EFLLDPRYAAPEQYIMSTQ--TP--SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
PEQ ST TP AP A P + DI+S G++ ++
Sbjct: 166 ---------TPEQSKRSTMVGTPYWMAPEVVTRKAYGP---------KVDIWSLGIMAIE 207
Query: 379 MV 380
MV
Sbjct: 208 MV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 44/211 (20%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
+ L K+LG+GA+G+V A+ + + + +KK T + +I +R
Sbjct: 2 YELIKELGQGAYGIV---CSARNAETSEEETVAIKKITNVFSKKILAKRALR-------- 50
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGE---ATLADLMISREFPYNVQTLILGEVQ--DLPK 255
E L+ + G L D+ I +N + + E+ DL +
Sbjct: 51 ---------------ELKLLRHFRGHKNITCLYDMDIVFPGNFN-ELYLYEELMEADLHQ 94
Query: 256 GIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA- 310
I + Q+ + Q+L L +HS ++HRD+KP N++ + KI D G A
Sbjct: 95 IIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLAR 153
Query: 311 ---ADLRVGINYIPKEFLLDPRYAAPEQYIM 338
+ ++ E++ Y APE IM
Sbjct: 154 GFSENPGENAGFM-TEYVATRWYRAPE--IM 181
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 34/116 (29%), Positives = 50/116 (43%), Gaps = 27/116 (23%)
Query: 266 TIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFL 325
I Q+L L LH+ I+HRD+K +N IF I DLGAA +F
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTEN-IFINDVDQVCIGDLGAA------------QFP 207
Query: 326 LDPRYAAPEQY-IMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
+ AP + T +AP VL + + DI+SAG++ +M+
Sbjct: 208 V----VAPAFLGLAGTVETNAPE---------VLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 15/40 (37%), Positives = 27/40 (67%), Gaps = 1/40 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
++++ ALD +HS G++HRD+KP N++ + K+ D G
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 15/41 (36%), Positives = 25/41 (60%), Gaps = 1/41 (2%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
M++ + A++ +H G +HRDIKP N++ G K+ D G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 17/39 (43%), Positives = 22/39 (56%), Gaps = 1/39 (2%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
Q+L + LH IVHRDIKP N++ + KI D G
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNV-KIADFG 213
|
Length = 353 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 31/151 (20%)
Query: 233 MISREFPYNVQTLILGEV---QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
MI++++ +++ + + E +D P + ++ R IM QLL A++ +H ++HRDIK
Sbjct: 240 MITQKYDFDLYSFMYDEAFDWKDRP--LLKQTR---AIMKQLLCAVEYIHDKKLIHRDIK 294
Query: 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349
+N IF + D G A R A ++
Sbjct: 295 LEN-IFLNCDGKIVLGDFGTAMPFE------------KEREAFDYGWV----------GT 331
Query: 350 VATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
VAT +L + DI+S GLI L M+
Sbjct: 332 VATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 23/68 (33%), Positives = 36/68 (52%), Gaps = 6/68 (8%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLL 326
++++ AL LHS +V+RD+K +N++ + KI D G + GI+ K F
Sbjct: 102 AEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKE---GISDGATMKTFCG 157
Query: 327 DPRYAAPE 334
P Y APE
Sbjct: 158 TPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 57/225 (25%), Positives = 81/225 (36%), Gaps = 73/225 (32%)
Query: 138 KDDFVLGKKLGEGAFGVVYRAS---LAKKPSSKNDGDLVLKKATEYGAVEIWMNE----- 189
+++ GK LG GAFG V A+ L+K + +LK E M+E
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 190 ---------RVRRACAN----------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLA 230
+ AC CC YG N ++ E +L TL
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCC----YGDLLNFLRRKRESFL--------TLE 141
Query: 231 DLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290
DL+ F Y V KG+ F L S +HRD+
Sbjct: 142 DLL---SFSYQVA-----------KGMA--------------F----LASKNCIHRDLAA 169
Query: 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDPRYAAPE 334
+NV+ + G + KI D G A D+ NY+ K L ++ APE
Sbjct: 170 RNVLLTHG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 51/198 (25%), Positives = 76/198 (38%), Gaps = 44/198 (22%)
Query: 147 LGEGAFG--VVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA---- 200
LG+GAFG +YR D LV+ K E ++E+ RR N
Sbjct: 8 LGKGAFGEATLYR--------RTEDDSLVVWK--EVNLTR--LSEKERRDALNEIVILSL 55
Query: 201 ---DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ ++ N + Y TL D I R+ KG
Sbjct: 56 LQHPNIIAYY-NHFMDDNTLLIEMEYANGGTLYD-KIVRQ-----------------KGQ 96
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
E ++ + Q++ A+ +H GI+HRDIK N IF + K+ D G + L G
Sbjct: 97 LFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLN-IFLTKAGLIKLGDFGISKIL--GS 153
Query: 318 NYIPKEFLL-DPRYAAPE 334
Y E ++ P Y +PE
Sbjct: 154 EYSMAETVVGTPYYMSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 19/88 (21%), Positives = 35/88 (39%), Gaps = 9/88 (10%)
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG-- 308
+ ++R + + +++ LL L L +VH D+ P N++ G R +ID
Sbjct: 136 LVAAELLDRLAELWERLLAALLALLPALP-LVLVHGDLHPGNLLVDPGGRVTGVIDFEDA 194
Query: 309 ----AAADLRVGINYIPKEFLLDPRYAA 332
A DL + + +E A
Sbjct: 195 GLGDPAYDLASLLRSLGEEL--GAELLA 220
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 44/212 (20%), Positives = 79/212 (37%), Gaps = 39/212 (18%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADF-- 202
++LGEGAFG VY+ L + + +K E ++ + R+ A +D
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQE-AELMSDLQH 67
Query: 203 -----VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ G +++ Y L + ++ +V G
Sbjct: 68 PNIVCLLGVCTKEQP----TCMLFEYLAHGDLHEFLVRNSPHSDV-------------GA 110
Query: 258 ERENRIIQTIMSQLLF---------ALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
E + +++ + F ++ L S VHRD+ +N + EG T KI D G
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG-LTVKISDFG 169
Query: 309 AAADLRVGINY-IPKEFLLDPRYAAPEQYIMS 339
+ D+ Y + + LL R+ PE I+
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPPEA-ILY 200
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
++ +M QLL L LH I+HRD+K N++ ++ KI D G A
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 2/67 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLD 327
SQ+ +D L S +HRD+ +NV+ ++G R KI D G A D+ NY+ K L
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 328 PRYAAPE 334
++ APE
Sbjct: 278 VKWMAPE 284
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 23/66 (34%), Positives = 35/66 (53%), Gaps = 2/66 (3%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDP 328
Q+ + L S +HRD+ +N++ + G R KI D G A D+R NY+ K L
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 329 RYAAPE 334
++ APE
Sbjct: 281 KWMAPE 286
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.004
Identities = 20/52 (38%), Positives = 25/52 (48%), Gaps = 6/52 (11%)
Query: 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE 189
LGKKLGEGAFG VY+ L K V LK+ +E ++ E
Sbjct: 2 TLGKKLGEGAFGEVYKGKL--KGKGGKKKVEVAVKTLKEDASEQQIEEFLRE 51
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 36/119 (30%), Positives = 55/119 (46%), Gaps = 25/119 (21%)
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQN-VIFSEGSRTFKIIDLGAAADLRVGINYIP 321
+I++ + QLL L HS ++HRD+KPQN +I +EG+ K+ D G A V +
Sbjct: 101 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYT 158
Query: 322 KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
E ++ Y APE ++ + S DI+S G IF +MV
Sbjct: 159 HE-VVTLWYRAPE-ILLGCKYYSTA--------------------VDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 15/44 (34%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
++++ L+ +H+ +V+RD+KP N++ E +I DLG A D
Sbjct: 104 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACD 146
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 16/50 (32%), Positives = 27/50 (54%), Gaps = 1/50 (2%)
Query: 265 QTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
Q +++ + A+D +H G +HRDIKP N++ K+ D G L+
Sbjct: 104 QFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHV-KLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 397 | |||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.98 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.58 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.58 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.91 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.68 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.4 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.08 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.05 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.91 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.59 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.51 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.5 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.43 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.25 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.17 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.87 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.79 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.53 | |
| PLN02236 | 344 | choline kinase | 96.25 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.17 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.1 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.09 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.92 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.68 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.62 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.46 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.31 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.2 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.97 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.95 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.14 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.83 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.72 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.56 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.5 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 92.31 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.26 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.09 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=441.78 Aligned_cols=365 Identities=77% Similarity=1.232 Sum_probs=304.6
Q ss_pred CCCCCCccccccccccCC-----CCCCCccccchhhHHHHHHHhhhhhhcccccccccccccceeeecCCCCCCCcccCc
Q 015991 22 SKPPSSPFLGKRLVLIKP-----FSKNNISSSLTTKAELIDTVRDVFLGVGVGLPCTVMECGDIIYRSTLPKSNGLTITA 96 (397)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~ 96 (397)
+..+.++++|++....+. .....+...+.+..++.+.++.+..|+|+|+||+||+|++.+++++++.+++...+.
T Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~ 89 (566)
T PLN03225 10 ASGSPSRFLGRKLSSRRLSRAPARRSRARALTAAAGGELIDAVHNLFVGVGVGLPCTVMECGDVIYRSTLPRSNGLTITA 89 (566)
T ss_pred ccCCCCcccccccccccccccccccchhhccccccchhHHHHhhhccccccccCceeeeeccceeeeccCCcccCccccC
Confidence 344445555555543331 123334556667778889999999999999999999999999999999999999999
Q ss_pred chhHHHHHHHHHhhcCCCCCCcchhhhhHHHHHHHhhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEee
Q 015991 97 PGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK 176 (397)
Q Consensus 97 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~ 176 (397)
+++........|++.+|+..+++++++.....+..+...+..++|++.++||+|+||.||+|++..+.. .....+++|+
T Consensus 90 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~ 168 (566)
T PLN03225 90 PGAALALLAATYLWATPGVAPGFVDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKK 168 (566)
T ss_pred chHHHHHHHHHHhccCCccccccchheeechhhhccCCCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEE
Confidence 999988888899999999999999999999988888888999999999999999999999999987722 1127899999
Q ss_pred cccchhHHHHHHHHHHHHhhccCCCceeeeeeccc-ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCC
Q 015991 177 ATEYGAVEIWMNERVRRACANCCADFVYGFFENSS-KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255 (397)
Q Consensus 177 ~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~ 255 (397)
+......+.+.++++...+......++..+..... ..+..+|+|+||+++++|.+++....+++.+++++.+.....+.
T Consensus 169 ~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~ 248 (566)
T PLN03225 169 ATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248 (566)
T ss_pred ecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccc
Confidence 88777777777666655444333333333333222 45678999999999999999999999999999999887777777
Q ss_pred cchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCccc
Q 015991 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ 335 (397)
Q Consensus 256 ~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~ 335 (397)
+..+.+..+..++.|++.||+|||+++|+||||||+|||++++...+||+|||+|+.+..+.++......+|+.|||||+
T Consensus 249 ~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~ 328 (566)
T PLN03225 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ 328 (566)
T ss_pred cchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHH
Confidence 77777888999999999999999999999999999999999754499999999998877666666778899999999999
Q ss_pred ccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCC
Q 015991 336 YIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~ 387 (397)
+.+..+++..+..+.+..++|++|+.+++.|+|||||||+||||+++..|+.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 329 YIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred hhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 9999888888888899999999999999999999999999999999877654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=348.75 Aligned_cols=205 Identities=24% Similarity=0.347 Sum_probs=174.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++|.+.++||+|+||+||+|++..++ ..+|||.+.... ..-......++..+...+|+||+.+++... .+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~-----~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-~~ 81 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSG-----TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-DD 81 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCC-----ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-cC
Confidence 3479999999999999999999999988 677788776553 222223345667777788999999998764 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+|||||||.||+|.++++.++ .+++..++.++.||+.||++||+++||||||||+|||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~--------------------~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRG--------------------RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 79999999999999999999876 6789999999999999999999999999999999999
Q ss_pred EeCC--C---CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 295 FSEG--S---RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 295 l~~~--~---~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+.. . ..+||+|||+|+.+..+. ...+.+|++.||||| ++...+|+.|+|+
T Consensus 142 Ls~~~~~~~~~~LKIADFGfAR~L~~~~--~a~tlcGSplYMAPE----------------------V~~~~~YdAKADL 197 (429)
T KOG0595|consen 142 LSTTARNDTSPVLKIADFGFARFLQPGS--MAETLCGSPLYMAPE----------------------VIMSQQYDAKADL 197 (429)
T ss_pred eccCCCCCCCceEEecccchhhhCCchh--HHHHhhCCccccCHH----------------------HHHhccccchhhH
Confidence 9864 1 379999999999887443 346789999999999 5666789999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~ 391 (397)
||+|++||||++|+.||...+.
T Consensus 198 WSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 198 WSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred HHHHHHHHHHHhCCCCccccCH
Confidence 9999999999999999985544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=340.60 Aligned_cols=210 Identities=20% Similarity=0.324 Sum_probs=174.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
...++|++.++||+|+||+||.++..+++ +.+|+|.+++.. ..+......+...+...+||+|+.+...+++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~-----kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTG-----KIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT 96 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccC-----ceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc
Confidence 45689999999999999999999999888 667777665432 2233333445566666899999999887755
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
...+|+|++|+.||.|+.+|++++ .+++..++.++.+|+.||.|||+.|||||||||+|
T Consensus 97 -~~kLylVld~~~GGeLf~hL~~eg--------------------~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPEN 155 (357)
T KOG0598|consen 97 -EEKLYLVLDYLNGGELFYHLQREG--------------------RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPEN 155 (357)
T ss_pred -CCeEEEEEeccCCccHHHHHHhcC--------------------CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 568999999999999999999876 68899999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||||.+| +++|+|||+|+..... .....+++||+.|||||++.. .+|+..+|+||+
T Consensus 156 ILLd~~G-Hi~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~----------------------~gy~~~vDWWsL 211 (357)
T KOG0598|consen 156 ILLDEQG-HIKLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEILLG----------------------KGYDKAVDWWSL 211 (357)
T ss_pred eeecCCC-cEEEeccccchhcccC-CCccccccCCccccChHHHhc----------------------CCCCcccchHhH
Confidence 9999998 9999999999854333 234567899999999995544 456667799999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCcC
Q 015991 373 GLIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~~~~~ 395 (397)
|+++|||++|.+||...+..+.|
T Consensus 212 GillYeML~G~pPF~~~~~~~~~ 234 (357)
T KOG0598|consen 212 GILLYEMLTGKPPFYAEDVKKMY 234 (357)
T ss_pred HHHHHHHhhCCCCCcCccHHHHH
Confidence 99999999999999887765443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=336.51 Aligned_cols=217 Identities=24% Similarity=0.360 Sum_probs=179.9
Q ss_pred HHhhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeee
Q 015991 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGF 206 (397)
Q Consensus 130 ~~~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~ 206 (397)
+..+..+..+||++++.||+|+||.||+|+-+.++ ..+|+|++++..... ......++..+.....++++.+
T Consensus 132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg-----~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKL 206 (550)
T KOG0605|consen 132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTG-----EIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKL 206 (550)
T ss_pred HhccccCCcccchhheeeccccceeEEEEEEccCC-----cEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEE
Confidence 44455677799999999999999999999999998 889999998654332 3333345666777889999999
Q ss_pred eecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
+..+. +...+||||||++||++..+|...+ .+++..++.++.+++.|++.||+.|+|||
T Consensus 207 yYsFQ-D~~~LYLiMEylPGGD~mTLL~~~~--------------------~L~e~~arfYiaE~vlAI~~iH~~gyIHR 265 (550)
T KOG0605|consen 207 YYSFQ-DKEYLYLIMEYLPGGDMMTLLMRKD--------------------TLTEDWARFYIAETVLAIESIHQLGYIHR 265 (550)
T ss_pred EEEec-CCCeeEEEEEecCCccHHHHHHhcC--------------------cCchHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 98774 4578999999999999999998776 68899999999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEeccccccccc---------------c-----ccccc-------------------------
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRV---------------G-----INYIP------------------------- 321 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~---------------~-----~~~~~------------------------- 321 (397)
||||+|+|||..| ++||+||||++-+.. . ....+
T Consensus 266 DIKPdNlLiD~~G-HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~ 344 (550)
T KOG0605|consen 266 DIKPDNLLIDAKG-HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQL 344 (550)
T ss_pred cCChhheeecCCC-CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhh
Confidence 9999999999998 999999999953311 0 00000
Q ss_pred -ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCCCcC
Q 015991 322 -KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 322 -~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~~~~ 395 (397)
...+|||.|||||++.+. +|+..||+||||||+|||+.|.+||+..+.++.|
T Consensus 345 a~StVGTPDYiAPEVll~k----------------------gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~ 397 (550)
T KOG0605|consen 345 AYSTVGTPDYIAPEVLLGK----------------------GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETY 397 (550)
T ss_pred hhcccCCccccchHHHhcC----------------------CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 135899999999966554 4556679999999999999999999999988776
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=322.12 Aligned_cols=203 Identities=23% Similarity=0.281 Sum_probs=174.7
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+..++++..+.||+|..|+||+++++.++ +.+|+|.+....+ .-..+..++...+..+++++|+++++.+...+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~-----~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTG-----KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCC-----eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 34468888999999999999999999998 8999999854332 22333445666777789999999999987766
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCce
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNV 293 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NI 293 (397)
....|+||||++|+|++++...+ ++++..+.+++.++++||.|||+ ++||||||||+||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g--------------------~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG--------------------RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 57999999999999999998654 67899999999999999999995 9999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++..| ++||||||.++.+..+ ..++++||..|||||.+.+..++ .++||||||
T Consensus 211 LvNskG-eVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys----------------------~~sDIWSLG 264 (364)
T KOG0581|consen 211 LVNSKG-EVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYS----------------------VKSDIWSLG 264 (364)
T ss_pred eeccCC-CEEeccccccHHhhhh---hcccccccccccChhhhcCCcCC----------------------cccceeccc
Confidence 999998 9999999999887544 56889999999999988877544 456999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLH 389 (397)
Q Consensus 374 v~l~elltg~~Pf~~~ 389 (397)
++++|+++|+.||...
T Consensus 265 LsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 265 LSLLELAIGRFPYPPP 280 (364)
T ss_pred HHHHHHhhCCCCCCCc
Confidence 9999999999999885
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=324.03 Aligned_cols=210 Identities=23% Similarity=0.301 Sum_probs=175.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-------HHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-------VEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
..+.|.+.+.||+|+||.|-+|....++ +.+|+|.++.... ......+++...+...+||+|+.+.+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tg-----k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTG-----KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccC-----cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 5578999999999999999999999998 8888888764321 122233567788888999999999886
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. ..+..|+||||++||+|.+.+-.++ .+.+..-+.+++|++.|+.|||++||+|||||
T Consensus 245 f~-~~ds~YmVlE~v~GGeLfd~vv~nk--------------------~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiK 303 (475)
T KOG0615|consen 245 FE-VPDSSYMVLEYVEGGELFDKVVANK--------------------YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIK 303 (475)
T ss_pred ee-cCCceEEEEEEecCccHHHHHHhcc--------------------ccccchhHHHHHHHHHHHHHHHHcCcccccCC
Confidence 64 4567899999999999999998776 45666778899999999999999999999999
Q ss_pred CCceEEeCC--CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 290 PQNVIFSEG--SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 290 p~NILl~~~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|+|||+..+ ...+||+|||+|+.... .....+.+|||.|.|||++....... ++.|+
T Consensus 304 PeNILl~~~~e~~llKItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~-------------------~~~kV 362 (475)
T KOG0615|consen 304 PENILLSNDAEDCLLKITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEY-------------------YPSKV 362 (475)
T ss_pred cceEEeccCCcceEEEecccchhhcccc--ceehhhhcCCccccChhheecCCeec-------------------ccchh
Confidence 999999765 23899999999998653 33467899999999999998765542 34688
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~~~~ 393 (397)
|+||+||+||-+++|.+||+.+..++
T Consensus 363 DiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 363 DIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred eeeeccceEEEEeccCCCcccccCCc
Confidence 99999999999999999999887766
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=333.74 Aligned_cols=205 Identities=21% Similarity=0.288 Sum_probs=172.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeeccc-----chhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE-----YGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~-----~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+|..++.||+|||..||++++..++ ..+|+|.+.. ....+... +++.......|+||++|++.+ .+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tg-----e~~A~KvVpk~~l~k~~~reKv~--~EIeIHr~L~HpnIV~f~~~F-ED 89 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTG-----EVVAVKVVPKKLLKKPKQREKVL--NEIEIHRSLKHPNIVQFYHFF-ED 89 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCC-----cEEEEEEeehHHhcCcchHHHHH--HHHHHHHhcCCCcEEeeeeEe-ec
Confidence 68999999999999999999998888 5566665543 33333333 345666778899999999876 44
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.++.|||.|+|.+++|..+++... .++|..+++++.||+.||.|||+++|||||||..|+
T Consensus 90 s~nVYivLELC~~~sL~el~Krrk--------------------~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNl 149 (592)
T KOG0575|consen 90 SNNVYIVLELCHRGSLMELLKRRK--------------------PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNL 149 (592)
T ss_pred CCceEEEEEecCCccHHHHHHhcC--------------------CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhe
Confidence 678999999999999999998654 678999999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
||+++. ++||+|||+|+.+..+ ..+..+.+|||.|.|||++..... +.-+||||+|
T Consensus 150 fL~~~~-~VKIgDFGLAt~le~~-~Erk~TlCGTPNYIAPEVl~k~gH----------------------sfEvDiWSlG 205 (592)
T KOG0575|consen 150 FLNENM-NVKIGDFGLATQLEYD-GERKKTLCGTPNYIAPEVLNKSGH----------------------SFEVDIWSLG 205 (592)
T ss_pred eecCcC-cEEecccceeeeecCc-ccccceecCCCcccChhHhccCCC----------------------CCchhhhhhh
Confidence 999987 9999999999987644 235678999999999997764444 4446999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCcC
Q 015991 374 LIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~~~~~ 395 (397)
|+||.|++|++||......++|
T Consensus 206 cvmYtLL~G~PPFetk~vkety 227 (592)
T KOG0575|consen 206 CVMYTLLVGRPPFETKTVKETY 227 (592)
T ss_pred hHHHhhhhCCCCcccchHHHHH
Confidence 9999999999999887766665
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.36 Aligned_cols=207 Identities=20% Similarity=0.296 Sum_probs=174.6
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
+..++|++.+.||.|+||.|.+++.+.++ .-+|+|.+....-.. ......+.+.+....||+++.++..+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g-----~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~- 114 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSG-----NYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK- 114 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCC-----ceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-
Confidence 56689999999999999999999999887 677778776544222 222334456667777999999987664
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+.+.+++||||++||.|+.++++.+ ++++..++.++.||+.||+|||+++|++||+||+|
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~--------------------rF~e~~arFYAAeivlAleylH~~~iiYRDLKPEN 174 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSG--------------------RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPEN 174 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcC--------------------CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHH
Confidence 4578999999999999999998765 78899999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||||.+| .+||+|||.|+.+... .-+.+|||.|+|||++ ...+|...+|+|||
T Consensus 175 iLlD~~G-~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii----------------------~sk~ynkavDWWal 227 (355)
T KOG0616|consen 175 LLLDQNG-HIKITDFGFAKRVSGR----TWTLCGTPEYLAPEII----------------------QSKGYNKAVDWWAL 227 (355)
T ss_pred eeeccCC-cEEEEeccceEEecCc----EEEecCCccccChHHh----------------------hcCCCCcchhHHHH
Confidence 9999998 9999999999987543 3568999999999955 44456666799999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCcC
Q 015991 373 GLIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~~~~~ 395 (397)
||++|||+.|..||...+.-..|
T Consensus 228 GVLIYEMlaG~pPF~~~~~~~iY 250 (355)
T KOG0616|consen 228 GVLIYEMLAGYPPFYDDNPIQIY 250 (355)
T ss_pred HHHHHHHHcCCCCCcCCChHHHH
Confidence 99999999999999887765555
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=311.50 Aligned_cols=208 Identities=20% Similarity=0.258 Sum_probs=176.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
...+|++.++||+|+||+||++....++ +.+|.|++.-. ...+......+...+...+||||+.++.....++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g-----~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDG-----KLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCc-----chhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 3468999999999999999999999888 88888888732 2334444556678889999999999999666666
Q ss_pred Ce-EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH--CC--ceecCCC
Q 015991 215 GE-YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS--TG--IVHRDIK 289 (397)
Q Consensus 215 ~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~--~g--iiHrDIK 289 (397)
+. ++||||+|..|+|.++++... .....+++..+++++.|++.||..+|. .. |+|||||
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K----------------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK 155 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFK----------------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK 155 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHH----------------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence 66 999999999999999998754 234578999999999999999999999 45 9999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|.||+|+.+| .+||+|||+++.+...... ..+.+|||.||+||. +..-+|+.|+||
T Consensus 156 PaNIFl~~~g-vvKLGDfGL~r~l~s~~tf-A~S~VGTPyYMSPE~----------------------i~~~~Y~~kSDi 211 (375)
T KOG0591|consen 156 PANIFLTANG-VVKLGDFGLGRFLSSKTTF-AHSLVGTPYYMSPER----------------------IHESGYNFKSDI 211 (375)
T ss_pred chheEEcCCC-ceeeccchhHhHhcchhHH-HHhhcCCCcccCHHH----------------------HhcCCCCcchhH
Confidence 9999999998 9999999999988655443 567899999999994 445567788899
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~ 389 (397)
||+||++|||+.=..||.+.
T Consensus 212 WslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 212 WSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred HHHHHHHHHHHhcCCCcccc
Confidence 99999999999999999765
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.49 Aligned_cols=210 Identities=21% Similarity=0.274 Sum_probs=173.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeeccc-----chhHHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE-----YGAVEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~-----~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
.+..++|++.++||+|+||+|++++.+.++ +.+|||.+++ ..+.+..+.|+-+..+.. .||++..++..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~-----e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~ 437 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTN-----EYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSC 437 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCC-----cEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccc
Confidence 567799999999999999999999999998 6777776653 345566555543333333 79999999987
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+.+ .+++|+||||+.||++..+.+.. .+++..++.++..|+.||.|||++||||||||
T Consensus 438 fQT-~~~l~fvmey~~Ggdm~~~~~~~---------------------~F~e~rarfyaAev~l~L~fLH~~~IIYRDlK 495 (694)
T KOG0694|consen 438 FQT-KEHLFFVMEYVAGGDLMHHIHTD---------------------VFSEPRARFYAAEVVLGLQFLHENGIIYRDLK 495 (694)
T ss_pred ccc-CCeEEEEEEecCCCcEEEEEecc---------------------cccHHHHHHHHHHHHHHHHHHHhcCceeeecc
Confidence 755 57999999999999954444333 57889999999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
.+|||||.+| ++||+|||+++..... .....+++|||.|||||++ ....|+..+|+
T Consensus 496 LdNiLLD~eG-h~kiADFGlcKe~m~~-g~~TsTfCGTpey~aPEil----------------------~e~~Yt~aVDW 551 (694)
T KOG0694|consen 496 LDNLLLDTEG-HVKIADFGLCKEGMGQ-GDRTSTFCGTPEFLAPEVL----------------------TEQSYTRAVDW 551 (694)
T ss_pred hhheEEcccC-cEEecccccccccCCC-CCccccccCChhhcChhhh----------------------ccCcccchhhH
Confidence 9999999998 9999999999875433 3356889999999999954 45556667799
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCcCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSCPLAYS 396 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~~~~~~ 396 (397)
|||||+||||+.|..||.+++-.|-||
T Consensus 552 W~lGVLlyeML~Gq~PF~gddEee~Fd 578 (694)
T KOG0694|consen 552 WGLGVLLYEMLVGESPFPGDDEEEVFD 578 (694)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 999999999999999999887766554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=322.75 Aligned_cols=203 Identities=24% Similarity=0.352 Sum_probs=166.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-----hhHHHHHHH-HHHHHhhccCCCceeeeeecc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNE-RVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----~~~e~~~~~-~~~~~~~~~~~~~i~~~~~~~ 210 (397)
...||.+++.||+|+|++|++|+.+.++ +++|+|.+.+. ........| ..+..+ ..||.++.++..+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~-----keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L--~~hPgivkLy~TF 143 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATG-----KEYAIKVLDKRYIIKEKKVKYVTREKEALTQL--SGHPGIVKLYFTF 143 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCC-----ceeeHhhhhHHHHHhhcccchhhHHHHHHHHh--hCCCCeEEEEEEe
Confidence 4589999999999999999999999988 77777776532 111122222 222222 2899999999887
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.+ +..+|+|+||+++|+|.++|+..+ .+++...+.++.||+.||+|||++|||||||||
T Consensus 144 QD-~~sLYFvLe~A~nGdll~~i~K~G--------------------sfde~caR~YAAeIldAleylH~~GIIHRDlKP 202 (604)
T KOG0592|consen 144 QD-EESLYFVLEYAPNGDLLDLIKKYG--------------------SFDETCARFYAAEILDALEYLHSNGIIHRDLKP 202 (604)
T ss_pred ec-ccceEEEEEecCCCcHHHHHHHhC--------------------cchHHHHHHHHHHHHHHHHHHHhcCceeccCCh
Confidence 55 467999999999999999999876 678888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccc------------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY------------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 358 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~ 358 (397)
+|||||.++ ++||+|||.|+.+.+.... ...+++||..|.+||++..+..++.
T Consensus 203 ENILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-------------- 267 (604)
T KOG0592|consen 203 ENILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-------------- 267 (604)
T ss_pred hheeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc--------------
Confidence 999999998 9999999999987543211 1245899999999997777666554
Q ss_pred hccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 359 WQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 359 ~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
+|+|+|||+||+|+.|.+||...+
T Consensus 268 --------sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 268 --------SDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred --------cchHHHHHHHHHHhcCCCCCcccc
Confidence 599999999999999999998765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=302.60 Aligned_cols=202 Identities=23% Similarity=0.328 Sum_probs=170.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|+...++|+|+||+||++++++++ +.||+|+..+..+.+ ....-++++++....|+|++.+++.+.. ...
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~Tg-----qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTG-----QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcc-----cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cce
Confidence 67888999999999999999999998 999999998765543 3344467788899999999999998755 467
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
++||+|||...-| +-++... ...+.+.++.++.|++.|+.|+|++++|||||||+||||+
T Consensus 76 lhLVFE~~dhTvL-~eLe~~p-------------------~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit 135 (396)
T KOG0593|consen 76 LHLVFEYCDHTVL-HELERYP-------------------NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT 135 (396)
T ss_pred eEEEeeecchHHH-HHHHhcc-------------------CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe
Confidence 9999999996444 4444332 1456788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccc-cccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLR-VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
.++ .+||||||+|+.+. .+++| +..+.|.+|.|||.+.+..++. ..+||||+||+
T Consensus 136 ~~g-vvKLCDFGFAR~L~~pgd~Y--TDYVATRWYRaPELLvGDtqYG---------------------~pVDiWAiGCv 191 (396)
T KOG0593|consen 136 QNG-VVKLCDFGFARTLSAPGDNY--TDYVATRWYRAPELLVGDTQYG---------------------KPVDIWAIGCV 191 (396)
T ss_pred cCC-cEEeccchhhHhhcCCcchh--hhhhhhhhccChhhhcccCcCC---------------------CcccchhhhHH
Confidence 998 99999999999987 44444 6789999999999998866543 34699999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+.||++|..-|++..
T Consensus 192 ~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 192 FAELLTGEPLWPGRS 206 (396)
T ss_pred HHHHhcCCcCCCCcc
Confidence 999999999998754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=324.02 Aligned_cols=305 Identities=31% Similarity=0.527 Sum_probs=223.5
Q ss_pred cccceeeecCCCCCCCcccCcchhHHHHHHHHHhhcCCCCCCcchhhhhHHHHHHHhhcccccCCeEEeeeeccCCceEE
Q 015991 76 ECGDIIYRSTLPKSNGLTITAPGVALALSAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVV 155 (397)
Q Consensus 76 ~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~f~i~~~LG~G~fG~V 155 (397)
.|++...+++| +++.||+.+..+...|+|.+|++.++++|+|...+.......++..++|++.++||+|+||+|
T Consensus 88 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~r~~~d~F~i~~~LG~GgFG~V 161 (507)
T PLN03224 88 IGGDLAALATL------SPTLPGIGRLTALYYLLFSKPNPLFNIWDFYVGAPLADGANSRWSSDDFQLRDKLGGGNFGIT 161 (507)
T ss_pred hhhhhhhhhhc------CCCCccHHHHHHHHHHhhcCCccccchhHHhhcccccccCCCCccccCceEeeEeecCCCeEE
Confidence 46666666554 466788888888888899999999999999999999888888889999999999999999999
Q ss_pred EEEEecCCCC-----------CCCCCceEEeecccchhHH---HHH-----------HHHHHHHhhccCCCc-----eee
Q 015991 156 YRASLAKKPS-----------SKNDGDLVLKKATEYGAVE---IWM-----------NERVRRACANCCADF-----VYG 205 (397)
Q Consensus 156 y~a~~~~~~~-----------~~~~~~vavK~~~~~~~~e---~~~-----------~~~~~~~~~~~~~~~-----i~~ 205 (397)
|+|.+...+. ....+.+++|++....... +.. ...+...+....|.+ +..
T Consensus 162 YkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~ 241 (507)
T PLN03224 162 FEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAE 241 (507)
T ss_pred EEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhh
Confidence 9997643321 1122568999876432111 000 000111111112221 222
Q ss_pred eeeccc-------ccCCeEEEEEEecCCCCHHHHHHhcC--CCcchhhhhccc--cccCCCcchhcHHHHHHHHHHHHHH
Q 015991 206 FFENSS-------KKGGEYWLIWRYEGEATLADLMISRE--FPYNVQTLILGE--VQDLPKGIERENRIIQTIMSQLLFA 274 (397)
Q Consensus 206 ~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~--~~~~~~~~~l~~~~i~~i~~qi~~~ 274 (397)
+++.+. ...+..|+||||+++++|.++++... ++..+.+++... +........+++..++.++.|++.+
T Consensus 242 ~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~a 321 (507)
T PLN03224 242 YLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTG 321 (507)
T ss_pred hhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHH
Confidence 322221 12356899999999999999998653 334455544322 2222233456788899999999999
Q ss_pred HHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccc
Q 015991 275 LDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (397)
Q Consensus 275 L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~ 354 (397)
|.|||+.+|+||||||+|||++.++ .+||+|||+++....+.........+|+.|+|||++.....++..+....+..+
T Consensus 322 L~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l 400 (507)
T PLN03224 322 LRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALL 400 (507)
T ss_pred HHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhh
Confidence 9999999999999999999999987 999999999976654433333334558999999999988777777777777778
Q ss_pred hhhhhccCCCCchhhHHHHHHHHHHHcCCC-CCC
Q 015991 355 SPVLWQLNLPDRFDIYSAGLIFLQMVCTVR-RLC 387 (397)
Q Consensus 355 ~~~~~~~~~~~k~Dv~SlGv~l~elltg~~-Pf~ 387 (397)
++..+..+.+.++|+||+||+++||++|.. ||.
T Consensus 401 ~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 401 SPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 888888888889999999999999999986 664
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=315.75 Aligned_cols=208 Identities=26% Similarity=0.318 Sum_probs=177.5
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
...+.|+..++||+|.||.||+|++..++ +.||+||+..+...+ .....+++..+...+|+||+.+.+.....
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tg-----kivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETG-----KIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccC-----cEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 34578999999999999999999999998 999999998655332 34445677888899999999998877665
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
...+|+|+|||+. +|.-++... +..+++.+|+.++.|++.||+|||++||+|||||..|
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p-------------------~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SN 248 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSP-------------------GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSN 248 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCC-------------------CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccc
Confidence 5789999999995 777777654 3478899999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||||.+| .+||+|||+|+.+.......-+..+-|.+|.|||.+.|... |+..+|+||+
T Consensus 249 iLidn~G-~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~---------------------Yg~aVDlWS~ 306 (560)
T KOG0600|consen 249 ILIDNNG-VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATS---------------------YGTAVDLWSV 306 (560)
T ss_pred eEEcCCC-CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcc---------------------cccceeehhh
Confidence 9999998 99999999999876665444567888999999999988764 5556899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||||.||+.|++.|.+.+
T Consensus 307 GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 307 GCILAELFLGKPILQGRT 324 (560)
T ss_pred hHHHHHHHcCCCCcCCcc
Confidence 999999999999986643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.53 Aligned_cols=211 Identities=18% Similarity=0.266 Sum_probs=171.5
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+..+++.+.+.||+|+||+||+|.+.++ ..+++|++..... .......++...+...+||||+.|++.+...
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~------~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGT------DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCc------eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3446777788899999999999999885 3488998875432 2233445566677779999999999987655
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC-ceecCCCCCc
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IVHRDIKPQN 292 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g-iiHrDIKp~N 292 (397)
...+++||||+++|+|.++++... ...+++..+..++.||++|++|||+++ |||||||++|
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~------------------~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~N 173 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKR------------------KRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDN 173 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcc------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhh
Confidence 447999999999999999998731 236788889999999999999999999 9999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++.++||+|||+++...... ...+...||+.|||||++.+. ...|+.|+|||||
T Consensus 174 iLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~--------------------~~~~~~K~DvySF 232 (362)
T KOG0192|consen 174 ILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGE--------------------KSPYTEKSDVYSF 232 (362)
T ss_pred EEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhcCC--------------------CCcCCccchhhhH
Confidence 9999985599999999998764432 223447899999999988754 1257889999999
Q ss_pred HHHHHHHHcCCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~ 391 (397)
|++||||+||+.||..-.+
T Consensus 233 gIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 233 GIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred HHHHHHHHHCCCCCCCCCH
Confidence 9999999999999976543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.84 Aligned_cols=208 Identities=23% Similarity=0.328 Sum_probs=168.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc----hh-HHHHHHHHHHHHhhccC-CCceeeeeec
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY----GA-VEIWMNERVRRACANCC-ADFVYGFFEN 209 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----~~-~e~~~~~~~~~~~~~~~-~~~i~~~~~~ 209 (397)
...++|++++.||+|+||.|++|.+..++ ..+|+|.+... .. .......++...+.... ||||+.+++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~-----~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTG-----EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCC-----CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 35589999999999999999999999888 67777744432 11 11112223444555555 9999999987
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
.... ..+++||||+.+|+|++++...+ ++.+..+++++.|++.|++|||++||+|||||
T Consensus 89 ~~t~-~~~~ivmEy~~gGdL~~~i~~~g--------------------~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK 147 (370)
T KOG0583|consen 89 FATP-TKIYIVMEYCSGGDLFDYIVNKG--------------------RLKEDEARKYFRQLISAVAYCHSRGIVHRDLK 147 (370)
T ss_pred EecC-CeEEEEEEecCCccHHHHHHHcC--------------------CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 7665 45999999999999999998854 56778899999999999999999999999999
Q ss_pred CCceEEeCC-CCeEEEEecccccccccccccccccccCCCCCCCcccccccC-CCCCCCCccccccchhhhhccCCCCch
Q 015991 290 PQNVIFSEG-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST-QTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 290 p~NILl~~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|+|||++.+ + ++||+|||++.... .......+.+||+.|+|||++.+.. +.. .++
T Consensus 148 ~ENilld~~~~-~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g---------------------~~a 204 (370)
T KOG0583|consen 148 PENILLDGNEG-NLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSG---------------------KAA 204 (370)
T ss_pred HHHEEecCCCC-CEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCC---------------------chh
Confidence 999999998 6 99999999998764 2233467899999999999887765 332 357
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
||||+||+||.|++|+.||...+.+
T Consensus 205 DvWS~GViLy~ml~G~~PF~d~~~~ 229 (370)
T KOG0583|consen 205 DVWSLGVILYVLLCGRLPFDDSNVP 229 (370)
T ss_pred hhhhhHHHHHHHHhCCCCCCCccHH
Confidence 9999999999999999999886644
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=310.13 Aligned_cols=205 Identities=25% Similarity=0.356 Sum_probs=178.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-hhHHHHHHHHHHHHhhccC-CCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACANCC-ADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~e~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~ 214 (397)
..++|.+.++||.|.||.||+|+...++ ..||+|+++.. ...+..++.++...+...+ |+||+.+.+......
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~-----~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCC-----ceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 4478999999999999999999999888 77999998754 4577778888888888877 999999999887766
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
..+++|||||. ..|+++|+.++. .+++..++.|+.||++||+|+|++|+.|||+||+|||
T Consensus 83 ~~L~fVfE~Md-~NLYqLmK~R~r-------------------~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiL 142 (538)
T KOG0661|consen 83 RILYFVFEFMD-CNLYQLMKDRNR-------------------LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENIL 142 (538)
T ss_pred ceEeeeHHhhh-hhHHHHHhhcCC-------------------cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheE
Confidence 69999999999 699999998653 5688999999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+..+. .+||+|||+|+.+.....+ ++.+-|.+|.|||++.. .+-|+.++|||++||
T Consensus 143 i~~~~-~iKiaDFGLARev~SkpPY--TeYVSTRWYRAPEvLLr---------------------s~~Ys~pvD~wA~Gc 198 (538)
T KOG0661|consen 143 ISGND-VIKIADFGLAREVRSKPPY--TEYVSTRWYRAPEVLLR---------------------SGYYSSPVDMWAVGC 198 (538)
T ss_pred ecccc-eeEecccccccccccCCCc--chhhhcccccchHHhhh---------------------ccccCCchHHHHHHH
Confidence 99766 9999999999987655444 67889999999997644 445677889999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
+++|+.+=++-|++.+
T Consensus 199 I~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 199 IMAELYSLRPLFPGAS 214 (538)
T ss_pred HHHHHHHhcccCCCCc
Confidence 9999999998887754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=310.15 Aligned_cols=206 Identities=20% Similarity=0.255 Sum_probs=169.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|.-.+.||+|+||.||+|...++ ..++||++.............+...+...+|+|++.+++.+...+.+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~------~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDG------TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCC------CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 348999999999999999999998876 68999988765543011244556677777899999999988665546
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC---CceecCCCCCce
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST---GIVHRDIKPQNV 293 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~---giiHrDIKp~NI 293 (397)
.+|||||+.+|+|.+++..... . .++|..+.+|+.++|+||+|||+. .|||||||++||
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~-----------------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKG-----------------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCC-----------------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 9999999999999999987641 1 569999999999999999999985 399999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccc-cCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEF-LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|||++. ++||+|||+|+......... ... .||.+|++|| |...+.++.|+|||||
T Consensus 209 LLD~~~-~aKlsDFGLa~~~~~~~~~~-~~~~~gt~gY~~PE----------------------y~~~g~lt~KsDVySF 264 (361)
T KOG1187|consen 209 LLDEDF-NAKLSDFGLAKLGPEGDTSV-STTVMGTFGYLAPE----------------------YASTGKLTEKSDVYSF 264 (361)
T ss_pred eECCCC-CEEccCccCcccCCccccce-eeecCCCCccCChh----------------------hhccCCcCcccccccc
Confidence 999987 99999999997654311111 222 8999999999 6666778889999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||+|+||+||+.+.+...
T Consensus 265 GVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 265 GVVLLELITGRKAVDQSR 282 (361)
T ss_pred hHHHHHHHhCCcccCCCC
Confidence 999999999999888654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=301.34 Aligned_cols=205 Identities=26% Similarity=0.345 Sum_probs=168.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC-eE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG-EY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~ 217 (397)
.+|..++.||+|+||.||++.+.+++ ...++|.+...........+++...+...+|++|+.+++.....++ .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g-----~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTG-----ELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCC-----cceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence 57889999999999999999998876 6778887765533334445566777777779999999997555554 79
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
+++|||+.+|+|.+++.+.+ + .+++..++.+.+|+++||+|||++|||||||||+|||++.
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g------------------~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~ 152 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYG------------------G-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP 152 (313)
T ss_pred EeeeeccCCCcHHHHHHHcC------------------C-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC
Confidence 99999999999999998864 2 5789999999999999999999999999999999999999
Q ss_pred -CCCeEEEEeccccccccc--ccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 298 -GSRTFKIIDLGAAADLRV--GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 298 -~~~~~kL~DFGla~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++ .+||+|||+++.... ..........||+.|||||++...... ...+||||+||
T Consensus 153 ~~~-~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~---------------------~~~sDiWSlGC 210 (313)
T KOG0198|consen 153 SNG-DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVA---------------------RRESDIWSLGC 210 (313)
T ss_pred CCC-eEEeccCccccccccccccccccccccCCccccCchhhcCCCcC---------------------CccchhhhcCC
Confidence 56 999999999987663 112224468999999999987742111 12469999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++.||+||+.||...
T Consensus 211 tVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 211 TVVEMLTGKPPWSEF 225 (313)
T ss_pred EEEeccCCCCcchhh
Confidence 999999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=311.80 Aligned_cols=200 Identities=23% Similarity=0.346 Sum_probs=172.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|.+.+.||+|+||+||+|+.+.+. +.||+|.+.+.+ +.+.....++.+......|+||+.+++++.+ ..+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~-----~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTI-----QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccce-----eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cce
Confidence 68889999999999999999988876 888999887654 3444455567778888899999999987754 578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+|+|.||+.| +|+.++...+ .+.++.+..++.|++.||.|||+.+|+|||+||+|||++
T Consensus 76 ~~vVte~a~g-~L~~il~~d~--------------------~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~ 134 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDG--------------------KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE 134 (808)
T ss_pred EEEEehhhhh-hHHHHHHhcc--------------------CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec
Confidence 9999999997 9999998776 788999999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+|+||||+|+....+.. ..+...|||.|||||.+++.. |+..+|+||+||++
T Consensus 135 ~~~-~~KlcdFg~Ar~m~~~t~-vltsikGtPlYmAPElv~e~p----------------------yd~~sDlWslGcil 190 (808)
T KOG0597|consen 135 KGG-TLKLCDFGLARAMSTNTS-VLTSIKGTPLYMAPELVEEQP----------------------YDHTSDLWSLGCIL 190 (808)
T ss_pred CCC-ceeechhhhhhhcccCce-eeeeccCcccccCHHHHcCCC----------------------ccchhhHHHHHHHH
Confidence 987 999999999998765433 456789999999999776544 55556999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|++||+..
T Consensus 191 YE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 191 YELYVGQPPFYAR 203 (808)
T ss_pred HHHhcCCCCchHH
Confidence 9999999999754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.88 Aligned_cols=215 Identities=20% Similarity=0.235 Sum_probs=179.9
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
..+..++|++.+.||+|.-|+||++++.+++ ..+|+|.+.+.. .......+.++..+....||++..++..+
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~-----~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTN-----CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCC-----ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 3456689999999999999999999999987 788888886543 33444555667788889999999998877
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. +...|++||||+||+|+.+.+.+. +..+++..++.++.+++.||+|||..|||+|||||
T Consensus 147 et-~~~~cl~meyCpGGdL~~LrqkQp------------------~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKP 207 (459)
T KOG0610|consen 147 ET-DKYSCLVMEYCPGGDLHSLRQKQP------------------GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKP 207 (459)
T ss_pred ec-cceeEEEEecCCCccHHHHHhhCC------------------CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCc
Confidence 54 568999999999999999998874 56889999999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccc-------------------------------------------------------
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRV------------------------------------------------------- 315 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~------------------------------------------------------- 315 (397)
+||||.++| +++|+||.++.....
T Consensus 208 ENILvredG-HIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ae 286 (459)
T KOG0610|consen 208 ENILVREDG-HIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAE 286 (459)
T ss_pred ceeEEecCC-cEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcC
Confidence 999999998 999999999742210
Q ss_pred ccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCCCcC
Q 015991 316 GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 316 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~~~~ 395 (397)
..+.+.+.++||-+|.|||++.+...+. .+|+|+|||+||||++|..||.+.++-+++
T Consensus 287 p~~~RSnSFVGThEYlAPEvI~G~GHgs----------------------AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl 344 (459)
T KOG0610|consen 287 PTGARSNSFVGTHEYLAPEVIRGEGHGS----------------------AVDWWTFGIFLYEMLYGTTPFKGSNNKETL 344 (459)
T ss_pred CCCccccccccccccccceeeecCCCCc----------------------hhhHHHHHHHHHHHHhCCCCcCCCCchhhH
Confidence 0012234579999999999888776654 459999999999999999999999887654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=308.98 Aligned_cols=211 Identities=22% Similarity=0.320 Sum_probs=176.7
Q ss_pred HHHHHhhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeee
Q 015991 127 FVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGF 206 (397)
Q Consensus 127 ~~~~~~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~ 206 (397)
.+.......-....|...++||+|+-|.||.|+...++ +.||+|++............++...+...+|+|++.|
T Consensus 261 ~l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~-----~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnf 335 (550)
T KOG0578|consen 261 KLKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTK-----QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNF 335 (550)
T ss_pred HhheeccCCChhhhhcchhhhccccccceeeeeeccCC-----ceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHH
Confidence 33333344455578999999999999999999998887 7899998875543333333344556677889999999
Q ss_pred eecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
++.+... +++|+||||+++|+|.|++... .++|.+|..|++++++||+|||.+|||||
T Consensus 336 l~Sylv~-deLWVVMEym~ggsLTDvVt~~---------------------~~~E~qIA~Icre~l~aL~fLH~~gIiHr 393 (550)
T KOG0578|consen 336 LDSYLVG-DELWVVMEYMEGGSLTDVVTKT---------------------RMTEGQIAAICREILQGLKFLHARGIIHR 393 (550)
T ss_pred HHHhccc-ceeEEEEeecCCCchhhhhhcc---------------------cccHHHHHHHHHHHHHHHHHHHhcceeee
Confidence 9877554 8899999999999999998765 46899999999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
|||.+|||++.++ .+||+|||+|..+..... ...+.+|||.||||| +..+..|..|
T Consensus 394 DIKSDnILL~~~g-~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPE----------------------Vvtrk~YG~K 449 (550)
T KOG0578|consen 394 DIKSDNILLTMDG-SVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPE----------------------VVTRKPYGPK 449 (550)
T ss_pred ccccceeEeccCC-cEEEeeeeeeeccccccC-ccccccCCCCccchh----------------------hhhhcccCcc
Confidence 9999999999998 899999999988876654 357789999999999 5555667788
Q ss_pred hhhHHHHHHHHHHHcCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
+||||||++.+||+-|++||-.
T Consensus 450 VDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 450 VDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred ccchhhhhHHHHHhcCCCCccC
Confidence 8999999999999999999975
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.38 Aligned_cols=224 Identities=21% Similarity=0.291 Sum_probs=190.2
Q ss_pred HHHHhhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCcee
Q 015991 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVY 204 (397)
Q Consensus 128 ~~~~~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~ 204 (397)
......-++..+||++.++||+|+||.|..++.+.++ +.+|+|+++... ..+-..+.++...+.+.+.++|+
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~-----~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTE-----KVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccc-----cchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence 3344455677799999999999999999999999998 899999988633 33444555567778888888888
Q ss_pred eeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCce
Q 015991 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (397)
Q Consensus 205 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gii 284 (397)
.+...+ .++.++|+||||++||+|..+|...+ .+++.++++++..|+.||+-||+.|+|
T Consensus 139 ~LhyAF-QD~~~LYlVMdY~pGGDlltLlSk~~--------------------~~pE~~ArFY~aEiVlAldslH~mgyV 197 (1317)
T KOG0612|consen 139 QLHYAF-QDERYLYLVMDYMPGGDLLTLLSKFD--------------------RLPEDWARFYTAEIVLALDSLHSMGYV 197 (1317)
T ss_pred HHHHHh-cCccceEEEEecccCchHHHHHhhcC--------------------CChHHHHHHHHHHHHHHHHHHHhccce
Confidence 887766 55678999999999999999998764 578899999999999999999999999
Q ss_pred ecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 285 HrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
||||||+|||||..| ++||+|||.+-.+..+...+....+|||.|++||++..-.... +.|.
T Consensus 198 HRDiKPDNvLld~~G-HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~-----------------g~yG 259 (1317)
T KOG0612|consen 198 HRDIKPDNVLLDKSG-HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGK-----------------GEYG 259 (1317)
T ss_pred eccCCcceeEecccC-cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCc-----------------cccC
Confidence 999999999999998 9999999999888766666778889999999999987544331 3577
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCCCCCCCcC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~~~~~~~~ 395 (397)
.-||+||+||++|||++|..||-....-++|
T Consensus 260 ~ecDwWSlGV~~YEMlyG~TPFYadslveTY 290 (1317)
T KOG0612|consen 260 RECDWWSLGVFMYEMLYGETPFYADSLVETY 290 (1317)
T ss_pred CccchhhhHHHHHHHHcCCCcchHHHHHHHH
Confidence 7899999999999999999999877766665
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=305.72 Aligned_cols=204 Identities=21% Similarity=0.344 Sum_probs=163.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||+||+|++..++ +.+++|.+...... ......++...+....|++++.++..+. .+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTG-----HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-DKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCC
Confidence 58999999999999999999988876 78899988653221 1122233445566678999998887664 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi 134 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD--------------------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE
Confidence 8999999999999999987653 46788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccc----------------------------------cccccccCCCCCCCcccccccCC
Q 015991 296 SEGSRTFKIIDLGAAADLRVGIN----------------------------------YIPKEFLLDPRYAAPEQYIMSTQ 341 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~ 341 (397)
+.++ .+||+|||+++.+..... ......+||+.|+|||++.+
T Consensus 135 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--- 210 (363)
T cd05628 135 DSKG-HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--- 210 (363)
T ss_pred CCCC-CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC---
Confidence 9987 999999999975432110 00124579999999996643
Q ss_pred CCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 342 TPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
..++.++|||||||++|||++|+.||.....
T Consensus 211 -------------------~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~ 241 (363)
T cd05628 211 -------------------TGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241 (363)
T ss_pred -------------------CCCCCchhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 3456678999999999999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=278.91 Aligned_cols=203 Identities=24% Similarity=0.283 Sum_probs=168.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|...++||+|.||+||+|++..++ +.||+||++.....+ .....+++..+...+|+||+.+.+.+.. .+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~-----~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETG-----KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCC-----cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCc
Confidence 57888999999999999999999988 889999887543332 2233456777788889999999887744 467
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+-||+||++ .+|+..+++... .++...++.++.++++||+|||++.|+||||||.|+|++
T Consensus 76 l~lVfEfm~-tdLe~vIkd~~i-------------------~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis 135 (318)
T KOG0659|consen 76 LSLVFEFMP-TDLEVVIKDKNI-------------------ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS 135 (318)
T ss_pred eEEEEEecc-ccHHHHhccccc-------------------ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc
Confidence 889999999 689999987653 567788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
++| .+||+|||+|+.+...... .+..+-|.+|.|||.+.|+..+. .-+||||.||++
T Consensus 136 ~~g-~lKiADFGLAr~f~~p~~~-~~~~V~TRWYRAPELLfGsr~Yg---------------------~~VDmWavGCI~ 192 (318)
T KOG0659|consen 136 SDG-QLKIADFGLARFFGSPNRI-QTHQVVTRWYRAPELLFGSRQYG---------------------TGVDMWAVGCIF 192 (318)
T ss_pred CCC-cEEeecccchhccCCCCcc-cccceeeeeccChHHhccchhcC---------------------CcchhhhHHHHH
Confidence 998 9999999999987544322 23337899999999999887644 447999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
.||+.|.+-|.+.+
T Consensus 193 AELllr~P~fpG~s 206 (318)
T KOG0659|consen 193 AELLLRVPFFPGDS 206 (318)
T ss_pred HHHHccCCCCCCCc
Confidence 99999987776654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.96 Aligned_cols=208 Identities=22% Similarity=0.272 Sum_probs=175.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
...++|++.++||.|.-++||+|+...++ ..|+||++.... ..+.....++...+...+||||+.++..+.. +
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~-----e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~ 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTN-----EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-D 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccC-----CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-c
Confidence 45589999999999999999999998887 789999987543 3333445566777888999999999987755 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
..+|+||.||.+|++.++++..- ...++|..|..|++++++||+|||++|.||||||+.|||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~------------------~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYY------------------PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHc------------------cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 78999999999999999998763 224789999999999999999999999999999999999
Q ss_pred EeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|+++| .+||+|||.+..+-..... +.+.++||+.|||||+++.... +|+.|+||||
T Consensus 159 i~~dG-~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~--------------------GYdfKaDIwS 217 (516)
T KOG0582|consen 159 IDSDG-TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH--------------------GYDFKADIWS 217 (516)
T ss_pred EcCCC-cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhccc--------------------Cccchhhhhh
Confidence 99998 9999999987655333211 1256799999999998754433 6899999999
Q ss_pred HHHHHHHHHcCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~ 388 (397)
||++..||.+|..||.-
T Consensus 218 fGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 218 FGITACELAHGHAPFSK 234 (516)
T ss_pred hhHHHHHHhcCCCCccc
Confidence 99999999999999954
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=286.81 Aligned_cols=210 Identities=23% Similarity=0.272 Sum_probs=172.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
-...++|+..++|++|.||.||+|+++.++ ..||+|+++-..+.+ -....+++..+.+.+|+||+.+-+....
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~-----eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTD-----EIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcc-----eeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 335578999999999999999999999998 889999987554333 1223345666777789999988665443
Q ss_pred c-CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 213 K-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 213 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
. -+.+|+|||||+. +|..+|..... .+....++.++.|+++||+|||.+.|+|||||++
T Consensus 147 ~~~d~iy~VMe~~Eh-DLksl~d~m~q-------------------~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~S 206 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-DLKSLMETMKQ-------------------PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTS 206 (419)
T ss_pred cccceeeeeHHHHHh-hHHHHHHhccC-------------------CCchHHHHHHHHHHHHHHHHHhhceeEecccchh
Confidence 3 2679999999994 89999987642 4567889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|+|++..| .+||+|||+|+.+...... .+..+-|.+|.|||.+.+... |+..+|+||
T Consensus 207 NLLm~~~G-~lKiaDFGLAR~ygsp~k~-~T~lVVTLWYRaPELLLG~~t---------------------yst~iDMWS 263 (419)
T KOG0663|consen 207 NLLLSHKG-ILKIADFGLAREYGSPLKP-YTPLVVTLWYRAPELLLGAKT---------------------YSTAVDMWS 263 (419)
T ss_pred heeeccCC-cEEecccchhhhhcCCccc-CcceEEEeeecCHHHhcCCcc---------------------cCcchhhhh
Confidence 99999998 9999999999988655332 355688999999999988765 445579999
Q ss_pred HHHHHHHHHcCCCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~~~ 392 (397)
+|||+.||+++++-|.+.+..
T Consensus 264 vGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 264 VGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred HHHHHHHHHhcCCCCCCCchH
Confidence 999999999999999886543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=296.33 Aligned_cols=233 Identities=20% Similarity=0.217 Sum_probs=166.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
++..++|++.++||+|+||.||+|.+.........+.+++|.+..... .+.....++...+... +|+|++.+++.+..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 456689999999999999999999875433333336788888864322 2222222333444444 79999999987766
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchh-hh--------------------h--------cccc-------------
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQ-TL--------------------I--------LGEV------------- 250 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-~~--------------------~--------~~~~------------- 250 (397)
.+..++++|||+++|+|.+++.......... +. . ....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 6677999999999999999997643110000 00 0 0000
Q ss_pred ccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccc-cccccCCCC
Q 015991 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPR 329 (397)
Q Consensus 251 ~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~ 329 (397)
........+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++......... .....+++.
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCcc
Confidence 0000123477888999999999999999999999999999999999987 99999999998654332222 233456788
Q ss_pred CCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-CCCCCCCCC
Q 015991 330 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 330 Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
|+|||++.+ ..++.++|||||||+||||++ |..||....
T Consensus 242 y~aPE~~~~----------------------~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 242 WMAPESIFD----------------------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred ccCcHHhhc----------------------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999996643 345667899999999999996 999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=301.38 Aligned_cols=213 Identities=19% Similarity=0.297 Sum_probs=169.4
Q ss_pred hhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeee
Q 015991 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFE 208 (397)
Q Consensus 132 ~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~ 208 (397)
.......++|++.++||+|+||.||++++..++ +.+++|.+.... ........++...+...+|++++.+++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344556689999999999999999999998876 778888775322 112222334555667788999999987
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+. .++.+++||||+++++|.+++... .+++..+..++.|++.||+|||++||+||||
T Consensus 111 ~~~-~~~~~~lv~Ey~~gg~L~~~l~~~---------------------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDL 168 (370)
T cd05621 111 AFQ-DDKYLYMVMEYMPGGDLVNLMSNY---------------------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168 (370)
T ss_pred EEE-cCCEEEEEEcCCCCCcHHHHHHhc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 664 457899999999999999998654 2466778899999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+|||+++++ .+||+|||+|..+............||+.|+|||++...... ..++.++|
T Consensus 169 Kp~NILl~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~------------------~~~~~~~D 229 (370)
T cd05621 169 KPDNMLLDKHG-HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD------------------GYYGRECD 229 (370)
T ss_pred CHHHEEECCCC-CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCC------------------CCCCcccC
Confidence 99999999987 999999999987644333233467899999999987543211 12566789
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
+||+||+||||++|+.||....
T Consensus 230 iwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 230 WWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred EEeehHHHHHHHhCCCCCCCCC
Confidence 9999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=300.73 Aligned_cols=203 Identities=22% Similarity=0.371 Sum_probs=162.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||+||+|++..++ +.+++|.+..... .......++...+...+|++++.+++.+. .++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTG-----HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-DEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCC
Confidence 48999999999999999999998877 7889998864321 12222334555666778999999887654 467
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+|+||||+.+++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~ 134 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD--------------------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL 134 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE
Confidence 8999999999999999987653 46788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccc-------------------------------------ccccccCCCCCCCcccccc
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY-------------------------------------IPKEFLLDPRYAAPEQYIM 338 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~-------------------------------------~~~~~~gt~~Y~aPE~~~~ 338 (397)
+.++ .+||+|||+++.+...... .....+||+.|+|||++..
T Consensus 135 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 213 (364)
T cd05599 135 DAKG-HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ 213 (364)
T ss_pred CCCC-CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC
Confidence 9987 9999999998754321100 0112469999999996543
Q ss_pred cCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 339 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++|||||||++|||++|..||....
T Consensus 214 ----------------------~~~~~~~DiwSlG~il~el~~G~~Pf~~~~ 243 (364)
T cd05599 214 ----------------------TGYNKECDWWSLGVIMYEMLVGYPPFCSDN 243 (364)
T ss_pred ----------------------CCCCCeeeeecchhHHHHhhcCCCCCCCCC
Confidence 346667899999999999999999997653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=285.51 Aligned_cols=207 Identities=28% Similarity=0.329 Sum_probs=160.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH--HHHHHHHHHhhccCCCc-eeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCCADF-VYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~--~~~~~~~~~~~~~~~~~-i~~~~~~~~~~~~ 215 (397)
..|...++||+|.||+||+|+...++ +.||+|++....+.|- ....+++..+....|.+ ++.+.+.....+.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g-----~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTG-----KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCC-----CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 56777889999999999999999988 8999999875544221 11122333334444444 7777666655443
Q ss_pred -----eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 216 -----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 216 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.+++|+||+. .+|..++.....+ ....+...++.++.||+.||+|||++||+||||||
T Consensus 86 ~~~~~~l~lvfe~~d-~DL~~ymd~~~~~----------------~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKP 148 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLD-RDLKKYMDSLPKK----------------PQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKP 148 (323)
T ss_pred ccccceEEEEEEeec-ccHHHHHHhcccc----------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCc
Confidence 8899999998 5899999876421 02445588999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||||++++ .+||+|||+|+........ -+..++|.+|.|||++.+++.+ +..+|||
T Consensus 149 QNlLi~~~G-~lKlaDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Y---------------------s~~vDiW 205 (323)
T KOG0594|consen 149 QNLLISSSG-VLKLADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSY---------------------STSVDIW 205 (323)
T ss_pred ceEEECCCC-cEeeeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcC---------------------CCCcchH
Confidence 999999987 9999999999977644332 2445789999999998887543 3346999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|+||+++||++++.-|++..
T Consensus 206 s~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 206 SLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred hHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999887754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=298.35 Aligned_cols=212 Identities=19% Similarity=0.298 Sum_probs=168.6
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
......++|++.+.||+|+||.||++++..++ +.+++|.+.... ........++.......+|++++.++..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45566789999999999999999999998887 788888875422 1112222334555666789999998876
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. .++.+++||||+++++|.+++.... +++..+..++.|++.||+|||++||+|||||
T Consensus 112 ~~-~~~~~~lv~Ey~~gg~L~~~~~~~~---------------------~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk 169 (371)
T cd05622 112 FQ-DDRYLYMVMEYMPGGDLVNLMSNYD---------------------VPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169 (371)
T ss_pred EE-cCCEEEEEEcCCCCCcHHHHHHhcC---------------------CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 64 4578999999999999999986542 4567788899999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++ .+||+|||+++.+............||+.|+|||++...... ..++.++||
T Consensus 170 p~NIll~~~~-~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~------------------~~~~~~~Di 230 (371)
T cd05622 170 PDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD------------------GYYGRECDW 230 (371)
T ss_pred HHHEEECCCC-CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCC------------------ccCCCccce
Confidence 9999999987 999999999987654333333457899999999987643221 125678899
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||++|||++|..||...+
T Consensus 231 wSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 231 WSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eehhHHHHHHHhCCCCCCCCC
Confidence 999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.80 Aligned_cols=202 Identities=22% Similarity=0.363 Sum_probs=161.0
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
+|++.+.||+|+||+||+|++..++ +.+++|.+.... ........++...+....|++++.++..+. .++.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTH-----ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-DKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-cCCE
Confidence 6899999999999999999998877 788999886432 122223334455667778999999887764 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+++++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--------------------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~ 135 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME--------------------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID 135 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC
Confidence 999999999999999987653 456778889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccc----------------------------------------------cccccccCCCCC
Q 015991 297 EGSRTFKIIDLGAAADLRVGIN----------------------------------------------YIPKEFLLDPRY 330 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~----------------------------------------------~~~~~~~gt~~Y 330 (397)
.++ .+||+|||+++.+..... .......||+.|
T Consensus 136 ~~~-~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (381)
T cd05626 136 LDG-HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNY 214 (381)
T ss_pred CCC-CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccc
Confidence 887 999999999864321100 001235799999
Q ss_pred CCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 331 AAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 331 ~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 215 ~aPE~~~~~----------------------~~~~~~DiwSlG~il~elltG~~Pf~~~~ 252 (381)
T cd05626 215 IAPEVLLRK----------------------GYTQLCDWWSVGVILFEMLVGQPPFLAPT 252 (381)
T ss_pred cCHHHHcCC----------------------CCCCccceeehhhHHHHHHhCCCCCcCCC
Confidence 999966443 45567799999999999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=300.61 Aligned_cols=203 Identities=21% Similarity=0.362 Sum_probs=160.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.++||+|+||+||++++..++ +.+++|.+..... .......++...+....|++++.+++.+. ..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTG-----KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-DAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-cCC
Confidence 47999999999999999999998877 7889998764321 12222334455666778999999887664 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+|+||||+++++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||+
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll 134 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD--------------------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI 134 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 8999999999999999987643 45678888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccc------------c----------------------------------ccccccCCCC
Q 015991 296 SEGSRTFKIIDLGAAADLRVGIN------------Y----------------------------------IPKEFLLDPR 329 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~------------~----------------------------------~~~~~~gt~~ 329 (397)
+.++ .+||+|||+++.+..... . .....+||+.
T Consensus 135 ~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (377)
T cd05629 135 DRGG-HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213 (377)
T ss_pred CCCC-CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcc
Confidence 9887 999999999964321000 0 0012469999
Q ss_pred CCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 330 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 330 Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 214 y~aPE~~~~----------------------~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 214 YIAPEIFLQ----------------------QGYGQECDWWSLGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred ccCHHHHcc----------------------CCCCCceeeEecchhhhhhhcCCCCCCCCC
Confidence 999996543 345667899999999999999999997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=298.48 Aligned_cols=212 Identities=19% Similarity=0.308 Sum_probs=168.7
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
......++|++.++||+|+||.||++++..++ +.+++|.+..... .......++...+...+|++++.+...
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK-----QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34456689999999999999999999998876 7889998764321 112222344556677789999988875
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+ ..++.+++||||+++|+|.+++... .+++..+..++.|++.||+|||++||+|||||
T Consensus 112 ~-~~~~~~~lv~Ey~~gg~L~~~l~~~---------------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk 169 (370)
T cd05596 112 F-QDDKYLYMVMEYMPGGDLVNLMSNY---------------------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169 (370)
T ss_pred E-ecCCEEEEEEcCCCCCcHHHHHHhc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 5 4457899999999999999998654 24567788899999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++ .+||+|||++...............||+.|+|||++...... ..++.++||
T Consensus 170 p~NILl~~~~-~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~------------------~~~~~~~Di 230 (370)
T cd05596 170 PDNMLLDKSG-HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD------------------GYYGRECDW 230 (370)
T ss_pred HHHEEEcCCC-CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCC------------------CCCCCceee
Confidence 9999999987 999999999987644332233456899999999987643221 135678899
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||++|||++|+.||....
T Consensus 231 wSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 231 WSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred eehhHHHHHHHhCCCCcCCCC
Confidence 999999999999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=287.76 Aligned_cols=202 Identities=25% Similarity=0.291 Sum_probs=161.8
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC----C
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG----G 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~ 215 (397)
.|.-.+++|.|+||.||+|....+. +.+|+|+.-.+...... +...+....|+||+.+...+.... -
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~-----~~vAIKKv~~d~r~knr----El~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETE-----EEVAIKKVLQDKRYKNR----ELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCC-----ceeEEEEecCCCCcCcH----HHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 6888999999999999999998886 89999998765543222 222333677888888765554332 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
...+||||++ .||.+.++... ..+..++.-.++-++.||.+||.|||+.||+||||||+|+|+
T Consensus 96 ~lnlVleymP-~tL~~~~r~~~----------------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLv 158 (364)
T KOG0658|consen 96 YLNLVLEYMP-ETLYRVIRHYT----------------RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLV 158 (364)
T ss_pred HHHHHHHhch-HHHHHHHHHHh----------------hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEE
Confidence 5678999999 59999998531 012244556688899999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
|.+.+.+||||||.|+.+..+... .+...|..|.|||.+.+.+. |+.++||||.||+
T Consensus 159 D~~tg~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~---------------------Yt~~IDiWSaGCV 215 (364)
T KOG0658|consen 159 DPDTGVLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATE---------------------YTTSIDIWSAGCV 215 (364)
T ss_pred cCCCCeEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccc---------------------cCceeEEhhhhHH
Confidence 998779999999999988665432 45678899999999888764 6667899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+.||+.|..-|++..
T Consensus 216 ~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 216 MAELLKGQPLFPGDS 230 (364)
T ss_pred HHHHhcCCcccCCCC
Confidence 999999999998864
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.69 Aligned_cols=202 Identities=21% Similarity=0.355 Sum_probs=160.6
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
+|++.++||+|+||+||+|++..++ +.+++|.+..... .......++...+....|++++.++..+. .++.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTK-----ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-DKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCC-----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-eCCE
Confidence 6899999999999999999998876 7888998764321 22223334555666778999999988764 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+++|+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--------------------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~ 135 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMG--------------------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID 135 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999987643 356788889999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccc----------------------------------------------ccccccccCCCCC
Q 015991 297 EGSRTFKIIDLGAAADLRVGI----------------------------------------------NYIPKEFLLDPRY 330 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~----------------------------------------------~~~~~~~~gt~~Y 330 (397)
.++ .+||+|||+|+.+.... .......+||+.|
T Consensus 136 ~~g-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 214 (382)
T cd05625 136 RDG-HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNY 214 (382)
T ss_pred CCC-CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCccc
Confidence 987 99999999985431100 0001235799999
Q ss_pred CCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 331 AAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 331 ~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 215 ~aPE~~~~~----------------------~~~~~~DiwSlGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 215 IAPEVLLRT----------------------GYTQLCDWWSVGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred CCHHHhcCC----------------------CCCCeeeEEechHHHHHHHhCCCCCCCCC
Confidence 999966433 45667899999999999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=299.61 Aligned_cols=208 Identities=19% Similarity=0.264 Sum_probs=170.9
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
.+.+..+++.+++.||+|+||+||+|++. ..||||.++.. ........+.+...+++..|.||+-|.+.+
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--------GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--------GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--------cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 34556678889999999999999999998 57899988743 344555666777888899999999999987
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
... .+.||+.+|+|.+|+.+++..+ .+++....+.|++|+++|+.|||.++|||||||.
T Consensus 458 ~~p--~~AIiTqwCeGsSLY~hlHv~e-------------------tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKS 516 (678)
T KOG0193|consen 458 MNP--PLAIITQWCEGSSLYTHLHVQE-------------------TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKS 516 (678)
T ss_pred cCC--ceeeeehhccCchhhhhccchh-------------------hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccc
Confidence 654 3599999999999999998754 2567777889999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccc-cccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
.||++++++ .+||+|||++..-..- ....-....|...|||||++++.... .|+..+||
T Consensus 517 nNIFl~~~~-kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~n-------------------PfS~qSDV 576 (678)
T KOG0193|consen 517 NNIFLHEDL-KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDN-------------------PFSFQSDV 576 (678)
T ss_pred cceEEccCC-cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccC-------------------CCCcccch
Confidence 999999986 9999999999643221 11122345677889999999977644 46778999
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~ 389 (397)
||||+++|||+||..||..+
T Consensus 577 YaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 577 YAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred hhhhHHHHHHHhCcCCcCCC
Confidence 99999999999999999943
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.84 Aligned_cols=209 Identities=21% Similarity=0.304 Sum_probs=164.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||+||++++..++ +.+++|.+.... ..+.....++...+...+|++++.+...+. .++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTG-----QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-DEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-cCC
Confidence 58999999999999999999998876 788999876422 112222333444555667888888877654 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+|+||||+.+++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill 135 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFE-------------------DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE
Confidence 8999999999999999987532 145778888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||++..+............||+.|+|||++....... ..++.++||||+||+
T Consensus 136 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~DiwslG~~ 197 (331)
T cd05597 136 DKNG-HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK-----------------GRYGPECDWWSLGVC 197 (331)
T ss_pred CCCC-CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccc-----------------cCCCCcceeehhhhH
Confidence 9887 9999999999766544333333457999999999875422111 135667899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 198 l~el~~g~~Pf~~~~ 212 (331)
T cd05597 198 MYEMLYGETPFYAES 212 (331)
T ss_pred HHHHhhCCCCCCCCC
Confidence 999999999997644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=292.54 Aligned_cols=209 Identities=20% Similarity=0.288 Sum_probs=164.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.++||+|+||+||++++..++ +.+++|.+.... ..+.....++...+....|++++.+...+. ..+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-DEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-cCC
Confidence 58999999999999999999998776 778888875422 122222333445566678899988877654 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~-------------------~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili 135 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFE-------------------DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence 8999999999999999997632 145777888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||++..+............||+.|+|||++...... ...++.++|||||||+
T Consensus 136 ~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----------------~~~~~~~~DvwSlGvi 197 (332)
T cd05623 136 DMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDG-----------------KGKYGPECDWWSLGVC 197 (332)
T ss_pred CCCC-CEEEeecchheecccCCcceecccccCccccCHHHHhccccC-----------------CCCCCCcCCEEeeHHH
Confidence 9887 999999999976543332223346799999999987643211 1235667899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 198 l~ell~g~~Pf~~~~ 212 (332)
T cd05623 198 MYEMLYGETPFYAES 212 (332)
T ss_pred HHHHhcCCCCCCCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=298.81 Aligned_cols=203 Identities=21% Similarity=0.347 Sum_probs=160.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
.+|++.++||+|+||.||+|++..++ +.+++|.+..... .......++...+....|++++.++..+. .++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTN-----ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-DKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC-----CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-cCC
Confidence 47999999999999999999998876 7889998764321 11222334455666778999998887664 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill 134 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG--------------------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI 134 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE
Confidence 8999999999999999987653 45677888999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccc------------------------------------------ccccccccCCCCCCCc
Q 015991 296 SEGSRTFKIIDLGAAADLRVGI------------------------------------------NYIPKEFLLDPRYAAP 333 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~------------------------------------------~~~~~~~~gt~~Y~aP 333 (397)
+.++ .+||+|||+|..+.... ........||+.||||
T Consensus 135 ~~~~-~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 213 (376)
T cd05598 135 DRDG-HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213 (376)
T ss_pred CCCC-CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCH
Confidence 9987 99999999985332100 0001235799999999
Q ss_pred ccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 334 EQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 334 E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|++.+. .++.++|||||||++|||++|+.||....
T Consensus 214 E~~~~~----------------------~~~~~~DiwSlGvilyell~G~~Pf~~~~ 248 (376)
T cd05598 214 EVLLRT----------------------GYTQLCDWWSVGVILYEMLVGQPPFLADT 248 (376)
T ss_pred HHHcCC----------------------CCCcceeeeeccceeeehhhCCCCCCCCC
Confidence 966433 45567799999999999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=295.42 Aligned_cols=201 Identities=27% Similarity=0.375 Sum_probs=170.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-hhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
..|...++||+|+||.||+|.+..++ +.+|+|.+.-. ...+....++++..+..+.++++..+++.+ ..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~-----k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-l~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTK-----KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-LKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeecccc-----ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-eecccH
Confidence 56778899999999999999999988 89999998743 344445555566677777888888877755 456789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
|++||||++|++.++++... .+++..+.-++++++.||.|||.++.+|||||+.|||+..
T Consensus 87 wiiMey~~gGsv~~lL~~~~--------------------~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~ 146 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGN--------------------ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE 146 (467)
T ss_pred HHHHHHhcCcchhhhhccCC--------------------CCccceeeeehHHHHHHhhhhhhcceecccccccceeEec
Confidence 99999999999999998765 2356667779999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||.+..+...... ..+++|||.||||| ++.+..|+.|+||||||++.+
T Consensus 147 ~g-~vkl~DfgVa~ql~~~~~r-r~tfvGTPfwMAPE----------------------VI~~~~Y~~KADIWSLGITai 202 (467)
T KOG0201|consen 147 SG-DVKLADFGVAGQLTNTVKR-RKTFVGTPFWMAPE----------------------VIKQSGYDTKADIWSLGITAI 202 (467)
T ss_pred cC-cEEEEecceeeeeechhhc-cccccccccccchh----------------------hhccccccchhhhhhhhHHHH
Confidence 96 9999999999887665443 48899999999999 445557888999999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
||++|.+|++.-
T Consensus 203 Ela~GePP~s~~ 214 (467)
T KOG0201|consen 203 ELAKGEPPHSKL 214 (467)
T ss_pred HHhcCCCCCccc
Confidence 999999999753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.35 Aligned_cols=203 Identities=18% Similarity=0.297 Sum_probs=164.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.+..++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTG-----EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456689999999999999999999998876 78888887643211 1122233445566678999999988664
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 89 -~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~ 147 (329)
T PTZ00263 89 -DENRVYFLLEFVVGGELFTHLRKAG--------------------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE 147 (329)
T ss_pred -cCCEEEEEEcCCCCChHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 4578999999999999999987653 4567788899999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++..... .....||+.|+|||++.+. .++.++||||
T Consensus 148 NIll~~~~-~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Diws 200 (329)
T PTZ00263 148 NLLLDNKG-HVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSK----------------------GHGKAVDWWT 200 (329)
T ss_pred HEEECCCC-CEEEeeccCceEcCCC----cceecCChhhcCHHHHcCC----------------------CCCCcceeec
Confidence 99999987 9999999999865432 2345799999999976543 3455679999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|..||....
T Consensus 201 lG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 201 MGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred hHHHHHHHHcCCCCCCCCC
Confidence 9999999999999997543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.63 Aligned_cols=209 Identities=20% Similarity=0.275 Sum_probs=164.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||+||++++..++ +.+++|.+.... ..+.....++...+....|++++.+...+. .++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTE-----RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-DEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCC
Confidence 58999999999999999999988776 778888876422 122222333445556678899988877653 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..|+||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill 135 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFE-------------------DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE
Confidence 8999999999999999997632 145677888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+++..............||+.|+|||++.+..... ..++.++|+|||||+
T Consensus 136 ~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~DiwSlGvi 197 (331)
T cd05624 136 DMNG-HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM-----------------GKYGPECDWWSLGVC 197 (331)
T ss_pred cCCC-CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCC-----------------CCCCCcccEEeeehh
Confidence 9887 9999999999766443332233467999999999776432211 135667899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
||||++|+.||....
T Consensus 198 l~ell~g~~Pf~~~~ 212 (331)
T cd05624 198 MYEMLYGETPFYAES 212 (331)
T ss_pred hhhhhhCCCCccCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=292.17 Aligned_cols=199 Identities=19% Similarity=0.318 Sum_probs=162.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.++||+|+||.||+|++..++ +.+++|.+..... .+.....++...+....|++++.++..+ ..++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTG-----EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-QDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-EcCC
Confidence 47999999999999999999998776 7888998764321 1222223344556666799999888765 4467
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 134 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG--------------------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI 134 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 8999999999999999997653 45778888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 135 ~~~~-~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwslG~i 187 (333)
T cd05600 135 DASG-HIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGK----------------------GYDFTVDYWSLGCM 187 (333)
T ss_pred CCCC-CEEEEeCcCCccccc----ccCCcccCccccChhHhcCC----------------------CCCCccceecchHH
Confidence 9987 999999999976533 23456899999999966543 45567799999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|..||....
T Consensus 188 l~ell~g~~pf~~~~ 202 (333)
T cd05600 188 LYEFLCGFPPFSGST 202 (333)
T ss_pred HhhhhhCCCCCCCCC
Confidence 999999999997643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=288.51 Aligned_cols=201 Identities=20% Similarity=0.229 Sum_probs=154.0
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCC-CceeeeeecccccCC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCA-DFVYGFFENSSKKGG 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~ 215 (397)
+|++.+.||+|+||.||+|++..++ +.+++|.+.... ..+......+...+....| +++..+...+ ...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-QTMD 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-EcCC
Confidence 6899999999999999999988876 788999876432 1111112222333344434 4455554443 4457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+|+||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 134 (324)
T cd05587 75 RLYFVMEYVNGGDLMYHIQQVG--------------------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134 (324)
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 8999999999999999887643 45678888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+++....... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 135 ~~~~-~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslGvi 190 (324)
T cd05587 135 DAEG-HIKIADFGMCKENIFGGK-TTRTFCGTPDYIAPEIIAYQ----------------------PYGKSVDWWAFGVL 190 (324)
T ss_pred cCCC-CEEEeecCcceecCCCCC-ceeeecCCccccChhhhcCC----------------------CCCcccchhhhHHH
Confidence 9987 999999999875322211 22346799999999976543 34566799999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 191 l~elltG~~pf~~~~ 205 (324)
T cd05587 191 LYEMLAGQPPFDGED 205 (324)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=284.00 Aligned_cols=209 Identities=22% Similarity=0.279 Sum_probs=173.4
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
..+..++|...++||+|.||.|-+++.+.++ +.+++|.+++. ...|...-..+.+.+..++||++..+-..+
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~-----k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATG-----KLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccC-----ceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 3456789999999999999999999999888 77788877643 233444444566778889999988776655
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
...+.+|+||||.+||.|+-++.+.. .+++...+.+..+|+.||.|||+++||+||+|.
T Consensus 238 -Qt~drlCFVMeyanGGeLf~HLsrer--------------------~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKL 296 (516)
T KOG0690|consen 238 -QTQDRLCFVMEYANGGELFFHLSRER--------------------VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKL 296 (516)
T ss_pred -ccCceEEEEEEEccCceEeeehhhhh--------------------cccchhhhhhhHHHHHHhhhhhhCCeeeeechh
Confidence 44689999999999999998887654 567888899999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|+|+|.+| ++||+|||+++.- .......++++|||.|.||| ++.+-+|...+|+|
T Consensus 297 ENLlLDkDG-HIKitDFGLCKE~-I~~g~t~kTFCGTPEYLAPE----------------------VleDnDYgraVDWW 352 (516)
T KOG0690|consen 297 ENLLLDKDG-HIKITDFGLCKEE-IKYGDTTKTFCGTPEYLAPE----------------------VLEDNDYGRAVDWW 352 (516)
T ss_pred hhheeccCC-ceEeeecccchhc-ccccceeccccCChhhcCch----------------------hhccccccceeehh
Confidence 999999998 9999999999753 22233457899999999999 55556677778999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~~~ 392 (397)
.+||++|||+||+.||......
T Consensus 353 G~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 353 GVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred hhhHHHHHHHhccCcccccchh
Confidence 9999999999999999765543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=286.39 Aligned_cols=199 Identities=22% Similarity=0.265 Sum_probs=162.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.++||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+++.. .+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISE-----HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-HDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-ccCC
Confidence 47999999999999999999998776 7888988764321 1222233455566777899999887655 3457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli 134 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG--------------------RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL 134 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE
Confidence 8999999999999999987653 45777888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||+
T Consensus 135 ~~~~-~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwSlG~i 187 (291)
T cd05612 135 DKEG-HIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSK----------------------GHNKAVDWWALGIL 187 (291)
T ss_pred CCCC-CEEEEecCcchhccCC----cccccCChhhcCHHHHcCC----------------------CCCchhhHHHHHHH
Confidence 9887 9999999999865432 2345789999999966543 34567799999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 188 l~~l~~g~~pf~~~~ 202 (291)
T cd05612 188 IYEMLVGYPPFFDDN 202 (291)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=290.20 Aligned_cols=217 Identities=19% Similarity=0.214 Sum_probs=168.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--------------hHHHHHHHHHHHHhhccCC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--------------AVEIWMNERVRRACANCCA 200 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--------------~~e~~~~~~~~~~~~~~~~ 200 (397)
....++|++++.||+|.||.|-+|++..++ +.+|+|.+.+.. ........+++..+..++|
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~-----~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDG-----KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCC-----cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 345589999999999999999999999887 888888775322 1123345566777888999
Q ss_pred Cceeeeeecccc-cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH
Q 015991 201 DFVYGFFENSSK-KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH 279 (397)
Q Consensus 201 ~~i~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH 279 (397)
+|++.+++.... ..+.+|||+|||..|.+...-. ....+++.++++++++++.||+|||
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~--------------------d~~els~~~Ar~ylrDvv~GLEYLH 227 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP--------------------DKPELSEQQARKYLRDVVLGLEYLH 227 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCCC--------------------CcccccHHHHHHHHHHHHHHHHHHH
Confidence 999999886543 3478999999999887643211 1223889999999999999999999
Q ss_pred HCCceecCCCCCceEEeCCCCeEEEEeccccccccccccc----ccccccCCCCCCCcccccccCCCCCCCCccccccch
Q 015991 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~ 355 (397)
.+|||||||||+|+||++++ ++||+|||.+.....+.+. .-...+|||.|||||...+......
T Consensus 228 ~QgiiHRDIKPsNLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~----------- 295 (576)
T KOG0585|consen 228 YQGIIHRDIKPSNLLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSY----------- 295 (576)
T ss_pred hcCeeccccchhheEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccc-----------
Confidence 99999999999999999997 9999999999766332111 1123689999999998776442111
Q ss_pred hhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCCCcC
Q 015991 356 PVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 356 ~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~~~~ 395 (397)
...+.||||+||+||-|+.|+.||-.....+-|
T Consensus 296 -------~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 296 -------SGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred -------cchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 234679999999999999999999876554443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=284.76 Aligned_cols=203 Identities=19% Similarity=0.278 Sum_probs=176.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.-+|++.+.||+|.||.|-+|+....+ +.|++|-++.+. ..+.....++++.+...+||+|+.+++.+.. .
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sg-----R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-k 125 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSG-----REVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-K 125 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCC-----cEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-C
Confidence 368999999999999999999988777 888888776543 3445555677888889999999999987754 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+...|||||..+|.|+|++.+.+ .+++...+++++||+.|+.|+|.++++|||||.+|||
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~--------------------~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENIL 185 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERG--------------------SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENIL 185 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhc--------------------cccHHHHHHHHHHHHHHHHHHhhccceecccchhhee
Confidence 67999999999999999998876 7899999999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+|+|+ ++||+|||++..+..+. .-++++|+|.|.+||...+..+.... +|.|||||
T Consensus 186 LD~N~-NiKIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPE---------------------VDsWsLGv 241 (668)
T KOG0611|consen 186 LDQNN-NIKIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPE---------------------VDSWSLGV 241 (668)
T ss_pred ecCCC-Ceeeeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCc---------------------cchhhHHH
Confidence 99998 99999999997765443 23679999999999998887776543 69999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
+||.|+.|..||++..
T Consensus 242 LLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 242 LLYTLVYGTMPFDGRD 257 (668)
T ss_pred HHHHHhhcccccCCch
Confidence 9999999999998754
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=270.44 Aligned_cols=212 Identities=22% Similarity=0.265 Sum_probs=176.4
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHH---HHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW---MNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~---~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
.++..++|++++.||+|-||.||+|+.+.+. ..+++|.+....-.... +..++.....+.+||||..+++.+
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~-----~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSL-----FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCC-----cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 3567799999999999999999999998887 78889988765433222 223344556788999999988876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ....||++||..+|+|+..+++.. ...+++.....++.|++.||.|+|..+||||||||
T Consensus 92 hd-~~riyLilEya~~gel~k~L~~~~------------------~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKp 152 (281)
T KOG0580|consen 92 HD-SKRIYLILEYAPRGELYKDLQEGR------------------MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKP 152 (281)
T ss_pred ec-cceeEEEEEecCCchHHHHHHhcc------------------cccccccchhHHHHHHHHHHHHhccCCcccCCCCH
Confidence 44 568999999999999999998653 33677888899999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|+|++.++ .+||+|||.+.... .....+.+||..|.+||+..+. .++..+|+|
T Consensus 153 enlLlg~~~-~lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~----------------------~hd~~Vd~w 206 (281)
T KOG0580|consen 153 ENLLLGSAG-ELKIADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGR----------------------GHDKFVDLW 206 (281)
T ss_pred HHhccCCCC-CeeccCCCceeecC---CCCceeeecccccCCHhhcCCC----------------------CccchhhHH
Confidence 999999987 99999999997643 2345789999999999966554 456677999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCCcC
Q 015991 371 SAGLIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~~~~~~ 395 (397)
++|++.||++.|..||...+..+.|
T Consensus 207 ~lgvl~yeflvg~ppFes~~~~etY 231 (281)
T KOG0580|consen 207 SLGVLCYEFLVGLPPFESQSHSETY 231 (281)
T ss_pred HHHHHHHHHHhcCCchhhhhhHHHH
Confidence 9999999999999999988766665
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=296.31 Aligned_cols=204 Identities=22% Similarity=0.361 Sum_probs=162.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||+||++++..++ +.+++|.+..... ........+...+....|++++.++..+. .++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTG-----HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-DKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCC
Confidence 57999999999999999999998876 7888998764321 11222233445566678999998887654 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli 134 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD--------------------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL 134 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE
Confidence 8999999999999999987653 46778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccc----------------------------------cccccccCCCCCCCcccccccCC
Q 015991 296 SEGSRTFKIIDLGAAADLRVGIN----------------------------------YIPKEFLLDPRYAAPEQYIMSTQ 341 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~ 341 (397)
+.++ .+||+|||+++.+..... ......+||+.|+|||++.+.
T Consensus 135 ~~~~-~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-- 211 (360)
T cd05627 135 DAKG-HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-- 211 (360)
T ss_pred CCCC-CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--
Confidence 9987 999999999875432110 001235799999999966543
Q ss_pred CCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 342 TPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
.++.++|||||||++|||++|+.||.....
T Consensus 212 --------------------~~~~~~DiwSlGvilyel~tG~~Pf~~~~~ 241 (360)
T cd05627 212 --------------------GYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241 (360)
T ss_pred --------------------CCCCcceeccccceeeecccCCCCCCCCCH
Confidence 455677999999999999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=281.37 Aligned_cols=202 Identities=19% Similarity=0.202 Sum_probs=160.8
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+...+|++++.+...+. .++.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-~~~~ 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-TKDA 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCC-----ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-cCCe
Confidence 3788999999999999999998877 7888887754321 11122334556667778999998877654 4568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++|+||+.+++|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+|||++
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~ 136 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNMG------------------NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD 136 (285)
T ss_pred EEEEEEecCCCcHHHHHHhhC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC
Confidence 999999999999988876432 12467788899999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++
T Consensus 137 ~~~-~~kl~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DvwslGvil 191 (285)
T cd05631 137 DRG-HIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNE----------------------KYTFSPDWWGLGCLI 191 (285)
T ss_pred CCC-CEEEeeCCCcEEcCCCCe--ecCCCCCCCccCHhhhcCC----------------------CCCcccCchhHHHHH
Confidence 887 999999999976543322 2345789999999966543 455677999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 192 ~el~~g~~pf~~~~ 205 (285)
T cd05631 192 YEMIQGQSPFRKRK 205 (285)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=287.55 Aligned_cols=201 Identities=19% Similarity=0.216 Sum_probs=155.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHh-hccCCCceeeeeecccccCC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC-ANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~ 215 (397)
+|++.+.||+|+||.||+|++..++ +.+++|.+..... ........+...+ ...+|+++..+...+ ...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-QTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-ecCC
Confidence 6899999999999999999998776 7888887764321 1111111112222 234567777666554 4457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+++++|.+.+.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill 134 (323)
T cd05616 75 RLYFVMEYVNGGDLMYQIQQVG--------------------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134 (323)
T ss_pred EEEEEEcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE
Confidence 8999999999999999887643 45678889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||+
T Consensus 135 ~~~~-~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwSlGvi 190 (323)
T cd05616 135 DSEG-HIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQ----------------------PYGKSVDWWAFGVL 190 (323)
T ss_pred CCCC-cEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCC----------------------CCCCccchhchhHH
Confidence 9987 99999999997543221 123456799999999966543 45567799999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 191 l~elltg~~Pf~~~~ 205 (323)
T cd05616 191 LYEMLAGQAPFEGED 205 (323)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=291.61 Aligned_cols=204 Identities=17% Similarity=0.263 Sum_probs=163.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
....++|++.+.||+|+||.||+|.+..++ ...+++|.+..... .......++...+...+|++++.+++.+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNED----FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCC----CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 446689999999999999999999876543 14688887754321 12222334456667778999999888664
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++.+++||||+.+++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+
T Consensus 102 -~~~~~~lv~Ey~~~g~L~~~i~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~ 160 (340)
T PTZ00426 102 -DESYLYLVLEFVIGGEFFTFLRRNK--------------------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE 160 (340)
T ss_pred -eCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH
Confidence 4578999999999999999997653 4677888999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++..... .....||+.|+|||++.+. .++.++|+||
T Consensus 161 NILl~~~~-~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwS 213 (340)
T PTZ00426 161 NLLLDKDG-FIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNV----------------------GHGKAADWWT 213 (340)
T ss_pred HEEECCCC-CEEEecCCCCeecCCC----cceecCChhhcCHHHHhCC----------------------CCCccccccc
Confidence 99999887 9999999999765322 2346799999999966543 3455679999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|..||....
T Consensus 214 lGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 214 LGIFIYEILVGCPPFYANE 232 (340)
T ss_pred hhhHHHHHhcCCCCCCCCC
Confidence 9999999999999997654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=288.36 Aligned_cols=196 Identities=20% Similarity=0.230 Sum_probs=156.5
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~ 221 (397)
+.||+|+||.||++++..++ +.+++|.+.... ..+.....++...+...+|++++.+...+ ..++.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-~~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-QTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-EcCCEEEEEE
Confidence 47999999999999998876 788889876432 12222333445566677899998887765 3457899999
Q ss_pred EecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCe
Q 015991 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301 (397)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~ 301 (397)
||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++ .
T Consensus 75 e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~ 133 (323)
T cd05571 75 EYANGGELFFHLSRER--------------------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-H 133 (323)
T ss_pred eCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-C
Confidence 9999999999887643 457788899999999999999999999999999999999987 9
Q ss_pred EEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc
Q 015991 302 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381 (397)
Q Consensus 302 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt 381 (397)
+||+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 134 ~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwSlG~il~ellt 190 (323)
T cd05571 134 IKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDN----------------------DYGRAVDWWGLGVVMYEMMC 190 (323)
T ss_pred EEEeeCCCCcccccC-CCcccceecCccccChhhhcCC----------------------CCCccccCcccchhhhhhhc
Confidence 999999999753222 1223456799999999966543 45567799999999999999
Q ss_pred CCCCCCCCC
Q 015991 382 TVRRLCLHS 390 (397)
Q Consensus 382 g~~Pf~~~~ 390 (397)
|..||....
T Consensus 191 g~~Pf~~~~ 199 (323)
T cd05571 191 GRLPFYNQD 199 (323)
T ss_pred CCCCCCCCC
Confidence 999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=296.77 Aligned_cols=204 Identities=22% Similarity=0.251 Sum_probs=170.3
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..+-|++++.||.|+-|.|-+|++..++ +..|||.+... .+......++++-++....|+|++.+++.+..
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TG-----qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~- 83 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETG-----QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN- 83 (786)
T ss_pred cccceeccccccCCCCceehhhhccccc-----ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-
Confidence 3478999999999999999999999998 66777766543 12222333445556666778999999887754
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
..++|+|.||+.+|.|++++-.++ .+.+..+.+++.||+.|+.|+|..+|+|||+||+|+
T Consensus 84 ~~~lylvlEyv~gGELFdylv~kG--------------------~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENl 143 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVRKG--------------------PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENL 143 (786)
T ss_pred CceEEEEEEecCCchhHHHHHhhC--------------------CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhh
Confidence 568999999999999999998876 678888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|||.++ ++||+|||+|.....+. .-.+.||.|.|++||++.|..+... ++||||+|
T Consensus 144 LLd~~~-nIKIADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~---------------------~sDVWSCG 199 (786)
T KOG0588|consen 144 LLDVKN-NIKIADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGR---------------------PSDVWSCG 199 (786)
T ss_pred hhhccc-CEeeeccceeecccCCc--cccccCCCcccCCchhhcCCCCCCC---------------------ccccchhH
Confidence 999998 79999999997644433 2367899999999998888776544 47999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
||||.|+||+.||+..+
T Consensus 200 VILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 200 VILFALLTGKLPFDDDN 216 (786)
T ss_pred HHHHHHHhCCCCCCCcc
Confidence 99999999999998765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=293.84 Aligned_cols=207 Identities=21% Similarity=0.287 Sum_probs=178.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
.++|..++.+|+|+||.++..+++..+ +.+++|++.-.. ..+......+...+....||+|+.+.+.+..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~-----~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDD-----KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCC-----ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence 478999999999999999999988887 789999886433 3333344456667777999999999999888777
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.++|||+||+||++.+.+.... +..++++.+..++.|++.|+.|||+++|+|||||+.||++
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k------------------~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl 139 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQK------------------GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL 139 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHh------------------hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc
Confidence 7999999999999999998764 4567899999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+|+.+..... ...+.+||+.||+|| .+.+.+|..|+|+|||||+
T Consensus 140 tk~~-~VkLgDfGlaK~l~~~~~-~a~tvvGTp~YmcPE----------------------il~d~pYn~KSDiWsLGC~ 195 (426)
T KOG0589|consen 140 TKDK-KVKLGDFGLAKILNPEDS-LASTVVGTPYYMCPE----------------------ILSDIPYNEKSDIWSLGCC 195 (426)
T ss_pred cccC-ceeecchhhhhhcCCchh-hhheecCCCcccCHH----------------------HhCCCCCCccCcchhhcch
Confidence 9987 889999999998765542 346789999999999 5566678888999999999
Q ss_pred HHHHHcCCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHSC 391 (397)
Q Consensus 376 l~elltg~~Pf~~~~~ 391 (397)
+|||++=+++|...+-
T Consensus 196 ~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 196 LYEMCTLKPAFKASNM 211 (426)
T ss_pred HHHHHhcccccCccch
Confidence 9999999999987654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=291.93 Aligned_cols=210 Identities=22% Similarity=0.278 Sum_probs=167.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|.+.+.||+|+||+||++++..++ +.+++|.+..... ......+++...+...+|++++.+...+. .++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATG-----DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-DKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCC
Confidence 47999999999999999999998877 7888998875322 12223334455566678999988876553 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll 135 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYE-------------------DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE
Confidence 8999999999999999997652 146778888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||++..+............||+.|+|||++....... ...++.++|||||||+
T Consensus 136 ~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----------------~~~~~~~~DiwslG~i 198 (330)
T cd05601 136 DRTG-HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG----------------KGTYGVECDWWSLGVI 198 (330)
T ss_pred CCCC-CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccc----------------cCCCCCcceeecccce
Confidence 9987 9999999999876544333334467999999999876433221 1246678899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 199 l~el~~g~~Pf~~~~ 213 (330)
T cd05601 199 AYEMIYGRSPFHEGT 213 (330)
T ss_pred eeeeccCCCCCCCCC
Confidence 999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=293.07 Aligned_cols=203 Identities=22% Similarity=0.357 Sum_probs=164.7
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||+||+|++..++ +.+++|.+..... .+.....++...+...+|++++.++..+ ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTG-----QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-QDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCC-----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-ecCC
Confidence 47999999999999999999998776 7889998864321 2222333455566677799999887655 4467
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll 134 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRKD--------------------VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI 134 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 8999999999999999987653 46778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccc----------------------------ccccccccCCCCCCCcccccccCCCCCCCC
Q 015991 296 SEGSRTFKIIDLGAAADLRVGI----------------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~ 347 (397)
+.++ .+||+|||+++...... ........||+.|+|||++.+.
T Consensus 135 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------- 205 (350)
T cd05573 135 DADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-------- 205 (350)
T ss_pred CCCC-CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--------
Confidence 9987 99999999997664432 1122346799999999966544
Q ss_pred ccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 348 APVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++.++|||||||+||||++|+.||....
T Consensus 206 --------------~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 206 --------------PYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred --------------CCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 45567799999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=294.37 Aligned_cols=204 Identities=18% Similarity=0.232 Sum_probs=163.7
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..+.+.+.+.||+|-||.||+|.++.. ..+++|.++.......... ++...+....|++|+.+++.+..++
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~------~~vavk~ik~~~m~~~~f~-~Ea~iMk~L~H~~lV~l~gV~~~~~- 274 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGS------TKVAVKTIKEGSMSPEAFL-REAQIMKKLRHEKLVKLYGVCTKQE- 274 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCC------CcccceEEeccccChhHHH-HHHHHHHhCcccCeEEEEEEEecCC-
Confidence 3445566788999999999999999886 5778887776543333232 4566777888999999999886544
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.++|||||+..|+|.++++... +..+...+.+.++.||++|++||+++++|||||.++||||
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~------------------~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV 336 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTRE------------------GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV 336 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcC------------------CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee
Confidence 7999999999999999998732 3466778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+++. .+||+|||+|+...++.........-...|.|||.+ ....++.|+|||||||+
T Consensus 337 ~~~~-~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~----------------------~~~~FS~kSDVWSFGVl 393 (468)
T KOG0197|consen 337 DEDL-VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEAL----------------------NYGKFSSKSDVWSFGVL 393 (468)
T ss_pred ccCc-eEEEcccccccccCCCceeecCCCCCCceecCHHHH----------------------hhCCcccccceeehhhh
Confidence 9987 999999999995544443334444556789999944 44567778899999999
Q ss_pred HHHHHc-CCCCCCC
Q 015991 376 FLQMVC-TVRRLCL 388 (397)
Q Consensus 376 l~ellt-g~~Pf~~ 388 (397)
||||+| |+.||..
T Consensus 394 L~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 394 LWELFTYGRVPYPG 407 (468)
T ss_pred HHHHhccCCCCCCC
Confidence 999987 6666643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=279.87 Aligned_cols=206 Identities=23% Similarity=0.328 Sum_probs=170.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc----
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (397)
..|...+.||+|+||.|..+.+..++ +.||+||+.... ......--++.+.+.+..|+|++.+++....
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~-----~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTG-----EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCC-----CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 45666899999999999999999998 899999998433 3333444466777888889999988776654
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.-+..|+|+|+|+ .+|.++++.+. .+++..+..+++|+++||+|+|+.+|+|||+||.|
T Consensus 97 ~f~DvYiV~elMe-tDL~~iik~~~--------------------~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsN 155 (359)
T KOG0660|consen 97 KFNDVYLVFELME-TDLHQIIKSQQ--------------------DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSN 155 (359)
T ss_pred ccceeEEehhHHh-hHHHHHHHcCc--------------------cccHHHHHHHHHHHHHhcchhhcccccccccchhh
Confidence 2367999999996 68999998764 47888999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
+|++.+. .+||+|||+|+...... ....++.+.|.+|.|||.+... ..|+..+||||
T Consensus 156 ll~n~~c-~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~---------------------~~Yt~aiDiWS 213 (359)
T KOG0660|consen 156 LLLNADC-DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS---------------------SEYTKAIDIWS 213 (359)
T ss_pred eeeccCC-CEEeccccceeeccccCcccchhcceeeeeecCHHHHhcc---------------------ccccchhhhhh
Confidence 9999987 89999999999875431 1123667889999999976433 35667789999
Q ss_pred HHHHHHHHHcCCCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~~~ 392 (397)
+||+|.||++|+.-|.+...-
T Consensus 214 vGCI~AEmL~gkplFpG~d~v 234 (359)
T KOG0660|consen 214 VGCILAEMLTGKPLFPGKDYV 234 (359)
T ss_pred hhHHHHHHHcCCCCCCCCchH
Confidence 999999999999999887643
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=295.14 Aligned_cols=194 Identities=19% Similarity=0.240 Sum_probs=164.0
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..+...-++-||.|+.|.||+|++.+ ..|||||+++.++ ..++.+.+..|+||+.|.+.+ ++.
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~n-------etVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVC-tqs 184 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLHN-------ETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVC-TQS 184 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeeccC-------ceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeee-cCC
Confidence 3444555567889999999999999987 7899999875433 345667778899999999987 456
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
..+|||||||..|-|+.+++... .+.......+..+|+.|+.|||.++|||||||.-|||
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~--------------------~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiL 244 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGR--------------------PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNIL 244 (904)
T ss_pred ceeEEeeeccccccHHHHHhccC--------------------ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceE
Confidence 79999999999999999998765 4566778889999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
|..++ .+||+|||.++.+.+-. ....+.||..|||||++. ....++|+|||||||
T Consensus 245 Is~~d-~VKIsDFGTS~e~~~~S--TkMSFaGTVaWMAPEvIr----------------------nePcsEKVDIwSfGV 299 (904)
T KOG4721|consen 245 ISYDD-VVKISDFGTSKELSDKS--TKMSFAGTVAWMAPEVIR----------------------NEPCSEKVDIWSFGV 299 (904)
T ss_pred eeccc-eEEeccccchHhhhhhh--hhhhhhhhHhhhCHHHhh----------------------cCCcccccceehhHH
Confidence 99987 99999999998765442 245789999999999554 445667889999999
Q ss_pred HHHHHHcCCCCCCC
Q 015991 375 IFLQMVCTVRRLCL 388 (397)
Q Consensus 375 ~l~elltg~~Pf~~ 388 (397)
+||||+||..||..
T Consensus 300 VLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 300 VLWEMLTGEIPYKD 313 (904)
T ss_pred HHHHHHhcCCCccc
Confidence 99999999999953
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=286.01 Aligned_cols=205 Identities=19% Similarity=0.274 Sum_probs=156.7
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh----HHHHHHHHHHHHhhcc-CCCceeeeeecccccC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANC-CADFVYGFFENSSKKG 214 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (397)
+|++.++||+|+||.||+++...... ..+.+++|.+..... ........+...+... +|++++.+...+ ..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~ 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHD--TGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-QTE 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCC--CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-ecC
Confidence 58999999999999999998753211 127788887754321 1111122233333333 588888877655 445
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 78 ~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 78 AKLHLILDYVSGGEMFTHLYQRD--------------------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 68999999999999999987643 4677888999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++..............||+.|+|||++.+.. .++.++|||||||
T Consensus 138 i~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DiwslG~ 195 (332)
T cd05614 138 LDSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG---------------------GHGKAVDWWSLGI 195 (332)
T ss_pred ECCCC-CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCC---------------------CCCCccccccchh
Confidence 99987 9999999999865443333334568999999999775432 2445679999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|..||...
T Consensus 196 il~elltg~~pf~~~ 210 (332)
T cd05614 196 LIFELLTGASPFTLE 210 (332)
T ss_pred hhhhhhcCCCCCCCC
Confidence 999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=284.37 Aligned_cols=201 Identities=19% Similarity=0.218 Sum_probs=154.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhc-cCCCceeeeeecccccCC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACAN-CCADFVYGFFENSSKKGG 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 215 (397)
+|++.+.||+|+||+||+|++..++ +.+++|.+..... .+......+...+.. .+|+++..+...+ ...+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-QTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-ecCC
Confidence 5788999999999999999998876 7889998764321 111111112222222 3455666555544 4456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~~~~--------------------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill 134 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQQVG--------------------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134 (323)
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 8999999999999999887643 46788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||+++...... .......||+.|+|||++.+. .++.++|+||+||+
T Consensus 135 ~~~~-~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslGvi 190 (323)
T cd05615 135 DSEG-HIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQ----------------------PYGKSVDWWAYGVL 190 (323)
T ss_pred CCCC-CEEEeccccccccCCCC-ccccCccCCccccCHHHHcCC----------------------CCCCccchhhhHHH
Confidence 9987 99999999997543222 123446799999999966443 35567799999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 191 l~elltG~~pf~~~~ 205 (323)
T cd05615 191 LYEMLAGQPPFDGED 205 (323)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=284.13 Aligned_cols=196 Identities=20% Similarity=0.227 Sum_probs=156.3
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~ 221 (397)
+.||+|+||.||++++..++ +.+++|.+.... ..+.....++...+....|++++.+.+.+. .++.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCEEEEEE
Confidence 47999999999999988776 788999876432 122223334455667778999998877654 456899999
Q ss_pred EecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCe
Q 015991 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301 (397)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~ 301 (397)
||+++++|..++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++ .
T Consensus 75 E~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~ 133 (323)
T cd05595 75 EYANGGELFFHLSRER--------------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-H 133 (323)
T ss_pred eCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-C
Confidence 9999999998886543 467888999999999999999999999999999999999987 9
Q ss_pred EEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc
Q 015991 302 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381 (397)
Q Consensus 302 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt 381 (397)
+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 134 ~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwSlGvil~ell~ 190 (323)
T cd05595 134 IKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDN----------------------DYGRAVDWWGLGVVMYEMMC 190 (323)
T ss_pred EEecccHHhccccCCC-CccccccCCcCcCCcccccCC----------------------CCCchhchhhhHHHHHHHHh
Confidence 9999999987532221 122346799999999966443 45567899999999999999
Q ss_pred CCCCCCCCC
Q 015991 382 TVRRLCLHS 390 (397)
Q Consensus 382 g~~Pf~~~~ 390 (397)
|+.||....
T Consensus 191 g~~Pf~~~~ 199 (323)
T cd05595 191 GRLPFYNQD 199 (323)
T ss_pred CCCCCCCCC
Confidence 999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=282.56 Aligned_cols=195 Identities=24% Similarity=0.298 Sum_probs=152.6
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-----HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
++||+|+||.||+|++..++ +.+++|.+..... .+....++ ........|++++.+++.+. .++.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~~~~hp~i~~~~~~~~-~~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTN-----EFFAIKALKKDVVLEDDDVECTMVER-RVLALAWEHPFLTHLFCTFQ-TKEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHH-HHHHhccCCCCccceeeEEE-cCCEEEE
Confidence 47999999999999998876 7788887764321 11111111 11222357899998887654 4568999
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 74 v~e~~~gg~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~ 133 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSG--------------------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133 (316)
T ss_pred EEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC
Confidence 999999999999887643 467788889999999999999999999999999999999987
Q ss_pred CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 300 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||
T Consensus 134 -~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwslG~il~el 189 (316)
T cd05592 134 -HIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQ----------------------KYNESVDWWSFGVLLYEM 189 (316)
T ss_pred -CEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCC----------------------CCCCcccchhHHHHHHHH
Confidence 99999999997643322 223456799999999976543 355667999999999999
Q ss_pred HcCCCCCCCCC
Q 015991 380 VCTVRRLCLHS 390 (397)
Q Consensus 380 ltg~~Pf~~~~ 390 (397)
++|+.||....
T Consensus 190 l~G~~Pf~~~~ 200 (316)
T cd05592 190 LIGQSPFHGED 200 (316)
T ss_pred HhCCCCCCCCC
Confidence 99999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=286.28 Aligned_cols=196 Identities=19% Similarity=0.229 Sum_probs=153.3
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh----HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||+||+|++..++ +.+++|.+..... .+.....++...+....|++++.++..+ ..++.+++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-~~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE-----KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-QTADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-EcCCeEEEE
Confidence 47999999999999988776 7788888764321 1111122222334566899999887765 345789999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+.+++|.+++.... .+.+..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~- 133 (325)
T cd05602 75 LDYINGGELFYHLQRER--------------------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG- 133 (325)
T ss_pred EeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-
Confidence 99999999999887643 356677888999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 134 ~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwslG~il~el~ 190 (325)
T cd05602 134 HIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHK----------------------QPYDRTVDWWCLGAVLYEML 190 (325)
T ss_pred CEEEccCCCCcccccCC-CCcccccCCccccCHHHHcC----------------------CCCCCccccccccHHHHHHh
Confidence 99999999997543222 12345679999999996644 34556789999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|..||....
T Consensus 191 ~g~~pf~~~~ 200 (325)
T cd05602 191 YGLPPFYSRN 200 (325)
T ss_pred cCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=283.64 Aligned_cols=194 Identities=18% Similarity=0.258 Sum_probs=155.1
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
||+|+||.||+|++..++ +.+++|.+.... ..+.....++...+...+|++++.+...+. .++..++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQ-----RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-SPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-cCCeEEEEEcC
Confidence 799999999999998776 788899876432 122222333455566678999999877553 45789999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+|
T Consensus 75 ~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~k 133 (312)
T cd05585 75 INGGELFHHLQREG--------------------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIA 133 (312)
T ss_pred CCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEE
Confidence 99999999987643 457778889999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCC
Q 015991 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTV 383 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~ 383 (397)
|+|||+++...... .......||+.|+|||++.+. .++.++||||+||++|||++|.
T Consensus 134 l~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwslGvil~el~tg~ 190 (312)
T cd05585 134 LCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGH----------------------GYTKAVDWWTLGVLLYEMLTGL 190 (312)
T ss_pred EEECcccccCccCC-CccccccCCcccCCHHHHcCC----------------------CCCCccceechhHHHHHHHhCC
Confidence 99999997543222 223456799999999966543 4556779999999999999999
Q ss_pred CCCCCCC
Q 015991 384 RRLCLHS 390 (397)
Q Consensus 384 ~Pf~~~~ 390 (397)
.||....
T Consensus 191 ~pf~~~~ 197 (312)
T cd05585 191 PPFYDEN 197 (312)
T ss_pred CCcCCCC
Confidence 9997654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=284.14 Aligned_cols=196 Identities=21% Similarity=0.233 Sum_probs=155.8
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~ 221 (397)
+.||+|+||.||++++..++ +.+++|.+.... ..+.....++...+....|++++.+...+ ..++.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREKASG-----KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-QTKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-EcCCEEEEEE
Confidence 47999999999999998876 788889876432 12222333445566777899998887655 3457899999
Q ss_pred EecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCe
Q 015991 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301 (397)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~ 301 (397)
||+++++|.+.+.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 75 Ey~~~g~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~ 133 (328)
T cd05593 75 EYVNGGELFFHLSRER--------------------VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-H 133 (328)
T ss_pred eCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-c
Confidence 9999999998886543 467788899999999999999999999999999999999987 9
Q ss_pred EEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc
Q 015991 302 FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381 (397)
Q Consensus 302 ~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt 381 (397)
+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 134 ~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslGvil~ellt 190 (328)
T cd05593 134 IKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDN----------------------DYGRAVDWWGLGVVMYEMMC 190 (328)
T ss_pred EEEecCcCCccCCCcc-cccccccCCcCccChhhhcCC----------------------CCCccCCccccchHHHHHhh
Confidence 9999999987543221 122346799999999966543 35567799999999999999
Q ss_pred CCCCCCCCC
Q 015991 382 TVRRLCLHS 390 (397)
Q Consensus 382 g~~Pf~~~~ 390 (397)
|+.||....
T Consensus 191 G~~Pf~~~~ 199 (328)
T cd05593 191 GRLPFYNQD 199 (328)
T ss_pred CCCCCCCCC
Confidence 999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=276.96 Aligned_cols=202 Identities=23% Similarity=0.304 Sum_probs=158.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.+.||+|+||+||+|++..++ +.+++|++...... ......++...+....|++++.+.+.+ ..++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETK-----EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-RRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCC-----cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-ecCCE
Confidence 47999999999999999999998876 77888877643211 112223344556667889999887765 34578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||++++.+..+..... .+++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~ 134 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPN--------------------GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 999999999877765543221 457788899999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||+++..............||+.|+|||++.+. .++.++|+|||||++
T Consensus 135 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DiwslGvil 191 (287)
T cd07848 135 HND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA----------------------PYGKAVDMWSVGCIL 191 (287)
T ss_pred CCC-cEEEeeccCcccccccccccccccccccccCCcHHHcCC----------------------CCCCchhHHhHHHHH
Confidence 987 999999999987644333223456789999999966443 355678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|+.||...
T Consensus 192 ~el~~g~~pf~~~ 204 (287)
T cd07848 192 GELSDGQPLFPGE 204 (287)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=282.30 Aligned_cols=199 Identities=19% Similarity=0.227 Sum_probs=157.8
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-----HH-HHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----VE-IWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
|++.+.||+|+||.||+|.+..++ +.+++|.+..... .+ ...+.++...+....|++++.+++.+ ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-~~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTG-----ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-QTE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-EcC
Confidence 678999999999999999998876 7888998764321 11 11222233344566799999988765 345
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..|+||||+.+++|...+... .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 75 ~~~~lv~E~~~~~~L~~~~~~~---------------------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nil 133 (324)
T cd05589 75 DHVCFVMEYAAGGDLMMHIHTD---------------------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLL 133 (324)
T ss_pred CEEEEEEcCCCCCcHHHHhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeE
Confidence 7899999999999998877543 3577888999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+++++ .+||+|||+++..... ........||+.|+|||.+.+. .++.++|+|||||
T Consensus 134 l~~~~-~~kL~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DiwslG~ 189 (324)
T cd05589 134 LDTEG-FVKIADFGLCKEGMGF-GDRTSTFCGTPEFLAPEVLTET----------------------SYTRAVDWWGLGV 189 (324)
T ss_pred ECCCC-cEEeCcccCCccCCCC-CCcccccccCccccCHhHhcCC----------------------CCCcccchhhHHH
Confidence 99987 9999999998753322 2223456899999999966543 3556779999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|||++|+.||....
T Consensus 190 il~el~~G~~pf~~~~ 205 (324)
T cd05589 190 LIYEMLVGESPFPGDD 205 (324)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=267.25 Aligned_cols=207 Identities=23% Similarity=0.309 Sum_probs=169.8
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
...+.|++.++||+|.|+.||++.+..++..++.+.+-+|++... .....+++.+.+....||+|+.+...... ..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~ 83 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQE-ES 83 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcc-cc
Confidence 345789999999999999999999999986666666656665544 44556677889999999999999886644 56
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++|+|++.|++|..-+-.+. ..++..+..+++||+++|.|+|.+||||||+||+|+|+
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~--------------------~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllL 143 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVARE--------------------FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLL 143 (355)
T ss_pred eeEEEEecccchHHHHHHHHHH--------------------HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheee
Confidence 7899999999999866554432 45788899999999999999999999999999999999
Q ss_pred eC--CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 296 SE--GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 296 ~~--~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
-. ++.-+||+|||+|..+.+ ......+.|||.|||||++....+ +..+|||+.|
T Consensus 144 ASK~~~A~vKL~~FGvAi~l~~--g~~~~G~~GtP~fmaPEvvrkdpy----------------------~kpvDiW~cG 199 (355)
T KOG0033|consen 144 ASKAKGAAVKLADFGLAIEVND--GEAWHGFAGTPGYLSPEVLKKDPY----------------------SKPVDIWACG 199 (355)
T ss_pred eeccCCCceeecccceEEEeCC--ccccccccCCCcccCHHHhhcCCC----------------------CCcchhhhhh
Confidence 54 334799999999998873 334567899999999996665554 4445999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|+||-|+.|.+||.++.
T Consensus 200 ViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 200 VILYILLVGYPPFWDED 216 (355)
T ss_pred HHHHHHHhCCCCCCCcc
Confidence 99999999999998743
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=284.49 Aligned_cols=196 Identities=18% Similarity=0.242 Sum_probs=153.9
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---H-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---E-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||+||+|++..++ +.+++|.+...... + .....+....+....|++++.++..+. ..+..++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-~~~~~~lv 74 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG-----KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TADKLYFV 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-eCCEEEEE
Confidence 47999999999999998877 78899987643211 1 111112222345678999998877653 45689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~- 133 (323)
T cd05575 75 LDYVNGGELFFHLQRER--------------------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG- 133 (323)
T ss_pred EcCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-
Confidence 99999999999887643 456778889999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwslG~il~ell 190 (323)
T cd05575 134 HVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQ----------------------PYDRTVDWWCLGAVLYEML 190 (323)
T ss_pred cEEEeccCCCcccccCC-CccccccCChhhcChhhhcCC----------------------CCCccccccccchhhhhhh
Confidence 99999999997542222 223456799999999966443 3556779999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|..||....
T Consensus 191 ~g~~pf~~~~ 200 (323)
T cd05575 191 YGLPPFYSRD 200 (323)
T ss_pred cCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=289.51 Aligned_cols=201 Identities=20% Similarity=0.279 Sum_probs=161.8
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhh---ccCCCceeeeeecccccC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACA---NCCADFVYGFFENSSKKG 214 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~---~~~~~~i~~~~~~~~~~~ 214 (397)
+|++.+.||+|.||+|.+|.+..++ +.||+|.++.... .+...+.++...+. ..+--|++.+++.+. ..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~-----e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTG-----EIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-FR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCC-----cEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-cc
Confidence 7899999999999999999999998 8999999986543 23333334444444 233446788887664 46
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+++|||+|.+. .+|+++++.+.|. .++...++.++.||+.||.+||+.||||+||||+|||
T Consensus 261 ~HlciVfELL~-~NLYellK~n~f~------------------Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENIL 321 (586)
T KOG0667|consen 261 NHLCIVFELLS-TNLYELLKNNKFR------------------GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENIL 321 (586)
T ss_pred cceeeeehhhh-hhHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhhee
Confidence 79999999988 6999999988752 4677889999999999999999999999999999999
Q ss_pred EeCCC-CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGS-RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|.+.+ ..+||+|||.|+...... -+.+-+..|.||| ++..+.|+.++||||||
T Consensus 322 L~~~~r~~vKVIDFGSSc~~~q~v----ytYiQSRfYRAPE----------------------VILGlpY~~~IDmWSLG 375 (586)
T KOG0667|consen 322 LKDPKRSRIKVIDFGSSCFESQRV----YTYIQSRFYRAPE----------------------VILGLPYDTAIDMWSLG 375 (586)
T ss_pred eccCCcCceeEEecccccccCCcc----eeeeeccccccch----------------------hhccCCCCCccceeehh
Confidence 96533 389999999998754332 2566778999999 45555677788999999
Q ss_pred HHHHHHHcCCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~ 391 (397)
||++||++|.+-|.+.+.
T Consensus 376 CIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 376 CILAELFTGEPLFPGDNE 393 (586)
T ss_pred hhHHhHhcCccccCCCCH
Confidence 999999999888877654
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=283.57 Aligned_cols=196 Identities=18% Similarity=0.219 Sum_probs=153.0
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HH-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||+||+|++..++ +.+++|.+..... .+ .....++...+....|++++.+...+ ...+..++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-~~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDG-----SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-QTAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-EcCCEEEEE
Confidence 47999999999999998776 7888888764321 11 11112222345567899999887655 445689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+++++|.+.+.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++
T Consensus 75 ~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~- 133 (321)
T cd05603 75 LDYVNGGELFFHLQRER--------------------CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG- 133 (321)
T ss_pred EcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-
Confidence 99999999988886543 456777888999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 134 ~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwslG~il~el~ 190 (321)
T cd05603 134 HVVLTDFGLCKEGVEPEE-TTSTFCGTPEYLAPEVLRK----------------------EPYDRTVDWWCLGAVLYEML 190 (321)
T ss_pred CEEEccCCCCccCCCCCC-ccccccCCcccCCHHHhcC----------------------CCCCCcCcccccchhhhhhh
Confidence 999999999875322221 2345679999999996543 34566789999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|..||....
T Consensus 191 ~g~~pf~~~~ 200 (321)
T cd05603 191 YGLPPFYSRD 200 (321)
T ss_pred cCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=285.02 Aligned_cols=197 Identities=18% Similarity=0.232 Sum_probs=154.4
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HH-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||+||+|++..++ +.+++|.+..... .+ .....+....+....|++++.++..+. .++.+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-~~~~~~lv 74 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG-----KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TTEKLYFV 74 (325)
T ss_pred CceeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-cCCEEEEE
Confidence 47999999999999988776 7888888764321 11 111112223455678999998877654 45789999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+.+++|...+.... .+++..+..++.||+.||+|||+.||+||||||+|||+++++
T Consensus 75 ~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~- 133 (325)
T cd05604 75 LDFVNGGELFFHLQRER--------------------SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG- 133 (325)
T ss_pred EcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-
Confidence 99999999998886543 467888899999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 134 ~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DvwslG~il~el~ 190 (325)
T cd05604 134 HVVLTDFGLCKEGIAQSD-TTTTFCGTPEYLAPEVIRK----------------------QPYDNTVDWWCLGAVLYEML 190 (325)
T ss_pred CEEEeecCCcccCCCCCC-CcccccCChhhCCHHHHcC----------------------CCCCCcCccccccceehhhh
Confidence 999999999875422221 2345679999999996543 34566789999999999999
Q ss_pred cCCCCCCCCCC
Q 015991 381 CTVRRLCLHSC 391 (397)
Q Consensus 381 tg~~Pf~~~~~ 391 (397)
+|..||.....
T Consensus 191 ~G~~pf~~~~~ 201 (325)
T cd05604 191 YGLPPFYCRDV 201 (325)
T ss_pred cCCCCCCCCCH
Confidence 99999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.58 Aligned_cols=210 Identities=20% Similarity=0.279 Sum_probs=165.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++|++.+.||+|+||+||+|++..++ +.+++|.+.... ..+.....++...+....|++++.+...+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDG-----EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 4479999999999999999999988777 789999876432 233333444556667778888888765443222
Q ss_pred -------CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecC
Q 015991 215 -------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (397)
Q Consensus 215 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrD 287 (397)
..+++||||+.+|+|.+++..... ....+++..+..++.|++.||+|||++||+|||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~----------------~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrD 168 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAK----------------TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRD 168 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhc----------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 146899999999999999876431 223567888999999999999999999999999
Q ss_pred CCCCceEEeCCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
|||+|||++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.+
T Consensus 169 LKP~NILl~~~~-~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----------------------~~~s~k 225 (496)
T PTZ00283 169 IKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR----------------------KPYSKK 225 (496)
T ss_pred CCHHHEEEeCCC-CEEEEecccCeeccccccccccccccCCcceeCHHHhCC----------------------CCCCcH
Confidence 999999999987 99999999997654322 122345689999999996643 345667
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
+|||||||+||||++|+.||....
T Consensus 226 ~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 226 ADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCC
Confidence 899999999999999999997644
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=283.00 Aligned_cols=196 Identities=18% Similarity=0.235 Sum_probs=152.1
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhh-ccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACA-NCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||.||+|++..++ +.+++|.+..... .+......+...+. ..+|++++.+++.+. .++.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-~~~~~~lv 74 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD-----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-TKDRLFFV 74 (321)
T ss_pred CccccCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCeEEEE
Confidence 46999999999999998776 7888888764321 11111111222222 346889988877664 45689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+++++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 75 ~E~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~- 133 (321)
T cd05591 75 MEYVNGGDLMFQIQRSR--------------------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG- 133 (321)
T ss_pred EeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-
Confidence 99999999998887543 456778889999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 134 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwslG~il~el~ 190 (321)
T cd05591 134 HCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQEL----------------------EYGPSVDWWALGVLMYEMM 190 (321)
T ss_pred CEEEeecccceecccCC-ccccccccCccccCHHHHcCC----------------------CCCCccceechhHHHHHHh
Confidence 99999999997543222 223456799999999966433 4556779999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|+.||....
T Consensus 191 tg~~Pf~~~~ 200 (321)
T cd05591 191 AGQPPFEADN 200 (321)
T ss_pred cCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=279.84 Aligned_cols=196 Identities=21% Similarity=0.258 Sum_probs=152.1
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHh-hccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC-ANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
++||+|+||.||+|++..++ +.+++|.+..... .+......+...+ ....|++++.+++.+. .++.+++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv 74 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG-----EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-TKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-eCCEEEEE
Confidence 47999999999999998876 7888888764321 1111111122222 2346888888877654 45689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 75 ~E~~~~g~L~~~i~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~- 133 (316)
T cd05620 75 MEFLNGGDLMFHIQDKG--------------------RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG- 133 (316)
T ss_pred ECCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-
Confidence 99999999999887643 456778889999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++....... ......||+.|+|||++.+. .++.++||||+||++|||+
T Consensus 134 ~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslGvil~el~ 190 (316)
T cd05620 134 HIKIADFGMCKENVFGDN-RASTFCGTPDYIAPEILQGL----------------------KYTFSVDWWSFGVLLYEML 190 (316)
T ss_pred CEEeCccCCCeecccCCC-ceeccCCCcCccCHHHHcCC----------------------CCCcccchhhhHHHHHHHH
Confidence 999999999875322222 23456799999999966543 3556679999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|..||....
T Consensus 191 ~g~~Pf~~~~ 200 (316)
T cd05620 191 IGQSPFHGDD 200 (316)
T ss_pred hCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=292.48 Aligned_cols=207 Identities=24% Similarity=0.350 Sum_probs=171.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeeccc---chhHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE---YGAVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~---~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.-|..-+.||+|+||.||+|+++.++ +.+|+|.... ....+.|..| ...+...+|+||+.+++...+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG-----~~vAvK~~~~~~~~r~~e~~~~E--ieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETG-----RLVAVKTFNKESSLRPRERWCRE--IEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccc-----cchhHHhhhhhcccchHHHHHHH--HHHHHHcCchhhhhhcccCCcccc
Confidence 56777899999999999999999998 8888888775 3444555443 44556666999999988655443
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
....+|||||.+|+|...|++.. +--.+++..++.++.++..||.|||++||+||||||
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PE-----------------N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP 148 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPE-----------------NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKP 148 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcc-----------------cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCC
Confidence 45689999999999999998753 334678899999999999999999999999999999
Q ss_pred CceEEeCCC---CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 291 QNVIFSEGS---RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 291 ~NILl~~~~---~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
.||++-... ...||+|||+|+.++++. ...+.+||+.|.+||+++. +..|+.-+
T Consensus 149 ~NIvl~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~---------------------q~~y~~tV 205 (732)
T KOG4250|consen 149 GNIVLQIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYER---------------------QKKYTATV 205 (732)
T ss_pred CcEEEeecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhh---------------------ccCcCcee
Confidence 999995322 378999999999987765 3577899999999997764 23456668
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
|.|||||++|+.+||+.||-.+..|
T Consensus 206 DLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 206 DLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9999999999999999999998887
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=280.08 Aligned_cols=196 Identities=18% Similarity=0.236 Sum_probs=152.4
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHh-hccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC-ANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||+||+|++..++ +.+++|.+..... ........+...+ ...+|++++.+++.+ ...+.+|+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-~~~~~~~iv 74 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESG-----RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-QTPDRLFFV 74 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCC-----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-EcCCEEEEE
Confidence 47999999999999988876 7888988764321 1111111222222 234689998887765 345789999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 75 ~Ey~~~g~L~~~i~~~~--------------------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~- 133 (320)
T cd05590 75 MEFVNGGDLMFHIQKSR--------------------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG- 133 (320)
T ss_pred EcCCCCchHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-
Confidence 99999999999887643 467788889999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 134 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG~il~el~ 190 (320)
T cd05590 134 HCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEM----------------------LYGPSVDWWAMGVLLYEML 190 (320)
T ss_pred cEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCC----------------------CCCCccchhhhHHHHHHHh
Confidence 99999999987542221 223456799999999966433 3555679999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|+.||....
T Consensus 191 ~g~~Pf~~~~ 200 (320)
T cd05590 191 CGHAPFEAEN 200 (320)
T ss_pred hCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.70 Aligned_cols=206 Identities=19% Similarity=0.272 Sum_probs=165.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCC-CCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKK-PSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~-~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
..|.+.+.||+|+||.||+|....+ + ..+++|++............++...+....|++++.+++.+. .++.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~-----~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPK-----EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-SDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCC-----eEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-ECCEE
Confidence 4599999999999999999987765 3 567777765444444344445667778889999999988764 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+.+++|.+++.... .....+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~----------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~ 204 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRL----------------KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204 (478)
T ss_pred EEEEECCCCCCHHHHHHHHH----------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC
Confidence 99999999999999886531 11224677888899999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
++ .+||+|||+++.+..... ......+||+.|+|||++.+ ..++.++|||||||++
T Consensus 205 ~~-~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Dv~slG~~l 261 (478)
T PTZ00267 205 TG-IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER----------------------KRYSKKADMWSLGVIL 261 (478)
T ss_pred CC-cEEEEeCcCceecCCccccccccccCCCccccCHhHhCC----------------------CCCCcHHhHHHHHHHH
Confidence 87 999999999987644322 12345679999999996643 3456678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|+.||...
T Consensus 262 ~el~tg~~Pf~~~ 274 (478)
T PTZ00267 262 YELLTLHRPFKGP 274 (478)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=291.38 Aligned_cols=206 Identities=24% Similarity=0.309 Sum_probs=157.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc----
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (397)
..++|+++++||+|+||.||+|.+..++ +.+++|++....... .++...+....|++++.+.+.+..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~----~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTS-----EKVAIKKVLQDPQYK----NRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCC-----CEEEEEEEecCcchH----HHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 4478999999999999999999988776 788999876433221 223445556678888876543321
Q ss_pred ---cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 213 ---KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 213 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
....+++||||+++ +|.+++.... .....+++..++.++.|++.||+|||++||+|||||
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLK 197 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYA----------------RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLK 197 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHh----------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcC
Confidence 12357799999995 7777775431 122356788899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++..+||+|||+|+.+..... .....||+.|+|||++.+.. .++.++||
T Consensus 198 p~NILl~~~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Di 254 (440)
T PTZ00036 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGAT---------------------NYTTHIDL 254 (440)
T ss_pred HHHEEEcCCCCceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCC---------------------CCCcHHHH
Confidence 99999997665799999999987643322 23467899999999764322 36678899
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~ 391 (397)
|||||+||||++|..||.....
T Consensus 255 wSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 255 WSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred HHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999987543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.46 Aligned_cols=204 Identities=19% Similarity=0.222 Sum_probs=158.3
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc----
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK---- 213 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~---- 213 (397)
+|++.++||+|+||.||+|.+..++ ..+++|++.... ........++...+...+|++++.+.+.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCC-----CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence 5899999999999999999998877 788999876421 11222233445566677899998887654322
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...+++||||++ ++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 134 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKAND--------------------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNI 134 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHhcc--------------------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 245899999997 68988886543 467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|++.++ .+||+|||+++....... .......||+.|+|||++.... ..++.++||||
T Consensus 135 ll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--------------------~~~~~~~DvwS 193 (338)
T cd07859 135 LANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAIDIWS 193 (338)
T ss_pred EECCCC-cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccc--------------------cccCchhHHHH
Confidence 999987 999999999976432211 1123467999999999764311 23566789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|+.||....
T Consensus 194 lGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 194 IGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred HHHHHHHHHcCCCCCCCCC
Confidence 9999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=282.37 Aligned_cols=196 Identities=20% Similarity=0.236 Sum_probs=154.5
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~ 221 (397)
+.||+|+||.||++++..++ +.+++|.+.... ..+......+...+....|++++.+...+ ..++.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-~~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATG-----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTHDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-EcCCEEEEEE
Confidence 47999999999999988776 788888876432 11222223344556667899998887655 3457899999
Q ss_pred EecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCceEEeCCCC
Q 015991 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NILl~~~~~ 300 (397)
||+++++|.+++.... .+++..++.++.|++.||+|||+ .||+||||||+|||++.++
T Consensus 75 E~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~- 133 (325)
T cd05594 75 EYANGGELFFHLSRER--------------------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG- 133 (325)
T ss_pred eCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-
Confidence 9999999998886543 46788899999999999999997 7999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 134 ~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG~il~el~ 190 (325)
T cd05594 134 HIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDN----------------------DYGRAVDWWGLGVVMYEMM 190 (325)
T ss_pred CEEEecCCCCeecCCCCc-ccccccCCcccCCHHHHccC----------------------CCCCccccccccceeeeec
Confidence 999999999875432221 22346799999999966443 4556779999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|+.||....
T Consensus 191 tG~~Pf~~~~ 200 (325)
T cd05594 191 CGRLPFYNQD 200 (325)
T ss_pred cCCCCCCCCC
Confidence 9999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=274.70 Aligned_cols=206 Identities=20% Similarity=0.239 Sum_probs=160.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||.||+|++..++ ..+++|.+...... ......++...+....|+|++.+.+.... ++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 76 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ER 76 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCC-----CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CC
Confidence 3578999999999999999999988876 77888877532211 11122234555666789999998876643 56
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+.+ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 77 ~~~lv~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~ 136 (288)
T cd07871 77 CLTLVFEYLDS-DLKQYLDNCG-------------------NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI 136 (288)
T ss_pred eEEEEEeCCCc-CHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 79999999985 8988886543 134677888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||+++....... ......+|+.|+|||++.+.. .++.++||||+||+
T Consensus 137 ~~~~-~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG~~ 193 (288)
T cd07871 137 NEKG-ELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGST---------------------EYSTPIDMWGVGCI 193 (288)
T ss_pred CCCC-CEEECcCcceeeccCCCc-cccCceecccccChHHhcCCc---------------------ccCcHHHHHHHHHH
Confidence 9987 999999999976533222 123457899999999765321 35567899999999
Q ss_pred HHHHHcCCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHSC 391 (397)
Q Consensus 376 l~elltg~~Pf~~~~~ 391 (397)
+|||++|+.||.....
T Consensus 194 l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 194 LYEMATGRPMFPGSTV 209 (288)
T ss_pred HHHHHhCCCCCCCCCH
Confidence 9999999999976553
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=278.07 Aligned_cols=196 Identities=21% Similarity=0.286 Sum_probs=152.0
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHh-hccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC-ANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||+||+|++..++ +.+++|.+..... .+......+...+ ....|++++.+++.+. .++.+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv 74 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-TKENLFFV 74 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-eCCEEEEE
Confidence 47999999999999998876 7888998764321 1111111112222 2357999998887664 45689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+++++
T Consensus 75 ~ey~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~- 133 (316)
T cd05619 75 MEYLNGGDLMFHIQSCH--------------------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG- 133 (316)
T ss_pred EeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-
Confidence 99999999999987643 356777889999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++....... ......||+.|+|||++.+. .++.++||||+||++|||+
T Consensus 134 ~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwslG~il~el~ 190 (316)
T cd05619 134 HIKIADFGMCKENMLGDA-KTCTFCGTPDYIAPEILLGQ----------------------KYNTSVDWWSFGVLLYEML 190 (316)
T ss_pred CEEEccCCcceECCCCCC-ceeeecCCccccCHHHHcCC----------------------CCCchhhhhhHHHHHHHHH
Confidence 999999999875322211 22456799999999966543 3556789999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|+.||....
T Consensus 191 ~G~~pf~~~~ 200 (316)
T cd05619 191 IGQSPFHGHD 200 (316)
T ss_pred hCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=284.88 Aligned_cols=198 Identities=20% Similarity=0.140 Sum_probs=158.3
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.++||+|+||.||+|.+..++ +.+++|+..... ..++...+...+|+||+.+.+.+.. +
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~-----~~vaiK~~~~~~------~~~E~~il~~l~HpnIv~~~~~~~~-~ 155 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTC-----EHVVIKAGQRGG------TATEAHILRAINHPSIIQLKGTFTY-N 155 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCC-----CEEEEechhhhh------hHHHHHHHHhCCCCCCCCEeEEEEE-C
Confidence 455678999999999999999999998887 788888654221 1234455666789999998876643 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++|+|++. ++|.+++.... .+++..++.++.|++.||+|||++|||||||||+|||
T Consensus 156 ~~~~lv~e~~~-~~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl 214 (391)
T PHA03212 156 KFTCLILPRYK-TDLYCYLAAKR--------------------NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF 214 (391)
T ss_pred CeeEEEEecCC-CCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence 67899999987 68888776543 3567788899999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+|+..............||+.|+|||++.+ ..++.++|||||||
T Consensus 215 l~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwSlGv 271 (391)
T PHA03212 215 INHPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR----------------------DPYGPAVDIWSAGI 271 (391)
T ss_pred EcCCC-CEEEEeCCcccccccccccccccccCccCCCChhhhcC----------------------CCCCcHHHHHHHHH
Confidence 99987 99999999997543322222345689999999996643 34566789999999
Q ss_pred HHHHHHcCCCCCCC
Q 015991 375 IFLQMVCTVRRLCL 388 (397)
Q Consensus 375 ~l~elltg~~Pf~~ 388 (397)
++|||++|..||..
T Consensus 272 il~elltg~~p~~~ 285 (391)
T PHA03212 272 VLFEMATCHDSLFE 285 (391)
T ss_pred HHHHHHHCCCCcCC
Confidence 99999999988754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=277.89 Aligned_cols=198 Identities=24% Similarity=0.363 Sum_probs=165.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC---C
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG---G 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~ 215 (397)
++..+.+.||+|.||+||+|.+.+ ..||||... ..+...|+.|.++......+|+||++|+..-..+. .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrG-------e~VAVKiF~-srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRG-------EDVAVKIFS-SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccC-------CceEEEEec-ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 688999999999999999999987 578888765 44556788888888888899999999988655444 5
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC--------CceecC
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--------GIVHRD 287 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~--------giiHrD 287 (397)
++|||++|.+.|||+|++.+. .++.+.+.+++..++.||++||.. .|.|||
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---------------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---------------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---------------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 899999999999999999885 467778889999999999999953 699999
Q ss_pred CCCCceEEeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
||..|||+..++ .+.|+|+|+|.....+.+. ..+..+||.+|||||++....+..... -.
T Consensus 342 lKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fe----------------sy 404 (513)
T KOG2052|consen 342 LKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFE----------------SY 404 (513)
T ss_pred cccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhh----------------hh
Confidence 999999999998 9999999999765544332 245689999999999998776654331 12
Q ss_pred CchhhHHHHHHHHHHHcC
Q 015991 365 DRFDIYSAGLIFLQMVCT 382 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg 382 (397)
.++||||||+++||++..
T Consensus 405 k~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 405 KRADIYAFGLVLWEIARR 422 (513)
T ss_pred hHHHHHHHHHHHHHHHHH
Confidence 357999999999999853
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=276.02 Aligned_cols=203 Identities=22% Similarity=0.268 Sum_probs=158.5
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.++||+|+||.||+|++..++ +.+++|.+...... ......++...+....|+|++.+.+.+.. +..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNG-----KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCC-----CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCe
Confidence 479999999999999999999998776 78888887643221 11122334555666789999988776543 568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||++ ++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~ 137 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHP-------------------GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS 137 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 999999997 57877776532 1356777889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||+++....... ......+|+.|+|||++.+.. .++.++||||+||++
T Consensus 138 ~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG~il 194 (303)
T cd07869 138 DTG-ELKLADFGLARAKSVPSH-TYSNEVVTLWYRPPDVLLGST---------------------EYSTCLDMWGVGCIF 194 (303)
T ss_pred CCC-CEEECCCCcceeccCCCc-cCCCCcccCCCCChHHHcCCC---------------------CCCcHHHHHHHHHHH
Confidence 987 999999999975433221 223457899999999765332 355678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|..||...
T Consensus 195 ~~l~~g~~pf~~~ 207 (303)
T cd07869 195 VEMIQGVAAFPGM 207 (303)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.24 Aligned_cols=194 Identities=18% Similarity=0.250 Sum_probs=152.0
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhc-cCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACAN-CCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||.||+|++..++ +.+++|.+..... .......++...+.. .+|++++.+.+.+. ..+.+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-~~~~~~lv 74 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTR-----RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-TESRLFFV 74 (329)
T ss_pred CeEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-cCCEEEEE
Confidence 47999999999999998876 7888888864321 111112222233322 36899998887653 45689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~g~L~~~~~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~- 133 (329)
T cd05588 75 IEFVSGGDLMFHMQRQR--------------------KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG- 133 (329)
T ss_pred EeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-
Confidence 99999999998886543 467888999999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++..... ........||+.|+|||++.+. .++.++|+|||||++|||+
T Consensus 134 ~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG~~l~el~ 190 (329)
T cd05588 134 HIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGE----------------------DYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred CEEECcCccccccccC-CCccccccCCccccCHHHHcCC----------------------CCCCccceechHHHHHHHH
Confidence 9999999999753221 1223456899999999966543 3556779999999999999
Q ss_pred cCCCCCCC
Q 015991 381 CTVRRLCL 388 (397)
Q Consensus 381 tg~~Pf~~ 388 (397)
+|+.||..
T Consensus 191 ~g~~Pf~~ 198 (329)
T cd05588 191 AGRSPFDI 198 (329)
T ss_pred HCCCCccc
Confidence 99999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=273.48 Aligned_cols=204 Identities=25% Similarity=0.319 Sum_probs=156.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhhccCCCceeeeeeccc--
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSS-- 211 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~-- 211 (397)
++|++.+.||+|+||+||+|++..++. +.+++|.+.... ......+..+...+....|+|++.+++.+.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCC----eEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 479999999999999999999854321 567888765322 112222333344455567999998877553
Q ss_pred --ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 212 --KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 212 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
.....+++|+||++ ++|.+++.... ...+++..+..++.|++.||+|||++||+|||||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVP------------------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 23457899999998 58988886542 1246778899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++ .+||+|||+++..... .......||+.|+|||++.+. .++.++||
T Consensus 138 p~Nil~~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di 192 (290)
T cd07862 138 PQNILVTSSG-QIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQS----------------------SYATPVDL 192 (290)
T ss_pred HHHEEEcCCC-CEEEccccceEeccCC--cccccccccccccChHHHhCC----------------------CCCCccch
Confidence 9999999987 9999999999765433 223456789999999966433 35567799
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||++|||++|..||....
T Consensus 193 wslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 193 WSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred HHHHHHHHHHHcCCCCcCCCC
Confidence 999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.15 Aligned_cols=202 Identities=21% Similarity=0.257 Sum_probs=151.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHh---hccCCCceeeeeeccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRAC---ANCCADFVYGFFENSS 211 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~---~~~~~~~i~~~~~~~~ 211 (397)
..++|++.++||+|+||+||+|.+..++ +.+|+|.+..... .+...+..+...+ ...++.+++.+...+.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRK-----EYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCC-----eEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3478999999999999999999988776 7788998754211 1111122222222 2233445666655555
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKP 290 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp 290 (397)
....++|+|||+++ ++|.+++...+ .+++..++.++.||+.||+|||+ .|||||||||
T Consensus 202 ~~~~~~~iv~~~~g-~~l~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP 260 (467)
T PTZ00284 202 NETGHMCIVMPKYG-PCLLDWIMKHG--------------------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKP 260 (467)
T ss_pred cCCceEEEEEeccC-CCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCH
Confidence 55678999999885 67888776543 46778889999999999999998 5999999999
Q ss_pred CceEEeCCCC---------------eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccch
Q 015991 291 QNVIFSEGSR---------------TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (397)
Q Consensus 291 ~NILl~~~~~---------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~ 355 (397)
+|||++.++. .+||+|||.+..... ......||+.|+|||++.+
T Consensus 261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~----------------- 319 (467)
T PTZ00284 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLG----------------- 319 (467)
T ss_pred HHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhc-----------------
Confidence 9999987542 499999998864321 2345789999999996543
Q ss_pred hhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 356 PVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 356 ~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..|+.++|||||||++|||++|+.||....
T Consensus 320 -----~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 320 -----LGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred -----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 346667899999999999999999997654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=275.94 Aligned_cols=200 Identities=21% Similarity=0.277 Sum_probs=161.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||.||++++..++ ..+++|.+..... .......++...+...+|++++.+++.+. .++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~ 76 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSG-----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-SDG 76 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECC
Confidence 4589999999999999999999998876 6777887764322 22223334455666778999999987654 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCCCceE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVI 294 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~NIL 294 (397)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil 136 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAK--------------------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEE
Confidence 8999999999999999987643 457788899999999999999986 6999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||++..+... ......||+.|+|||++.+. .++.++|+|||||
T Consensus 137 ~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DiwslG~ 190 (331)
T cd06649 137 VNSRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT----------------------HYSVQSDIWSMGL 190 (331)
T ss_pred EcCCC-cEEEccCccccccccc---ccccCCCCcCcCCHhHhcCC----------------------CCCchHhHHHHHH
Confidence 99987 9999999999765432 22446799999999966543 3556789999999
Q ss_pred HHHHHHcCCCCCCC
Q 015991 375 IFLQMVCTVRRLCL 388 (397)
Q Consensus 375 ~l~elltg~~Pf~~ 388 (397)
++|||++|+.||..
T Consensus 191 il~el~tg~~p~~~ 204 (331)
T cd06649 191 SLVELAIGRYPIPP 204 (331)
T ss_pred HHHHHHhCCCCCCC
Confidence 99999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=277.54 Aligned_cols=194 Identities=19% Similarity=0.262 Sum_probs=151.7
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHh-hccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRAC-ANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||.||+|++..++ +.+++|.+..... .+.....++...+ ...+|++++.+.+.+ ...+.+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv 74 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKND-----QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-QTTSRLFLV 74 (327)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-EeCCEEEEE
Confidence 47999999999999998876 7888888865321 1111122222332 334688888887755 445789999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~- 133 (327)
T cd05617 75 IEYVNGGDLMFHMQRQR--------------------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG- 133 (327)
T ss_pred EeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-
Confidence 99999999998886543 467888999999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 134 ~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslGvil~ell 190 (327)
T cd05617 134 HIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGE----------------------EYGFSVDWWALGVLMFEMM 190 (327)
T ss_pred CEEEeccccceeccCC-CCceecccCCcccCCHHHHCCC----------------------CCCchheeehhHHHHHHHH
Confidence 9999999999753221 1123456899999999966543 3556779999999999999
Q ss_pred cCCCCCCC
Q 015991 381 CTVRRLCL 388 (397)
Q Consensus 381 tg~~Pf~~ 388 (397)
+|+.||..
T Consensus 191 ~g~~pf~~ 198 (327)
T cd05617 191 AGRSPFDI 198 (327)
T ss_pred hCCCCCCc
Confidence 99999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=278.18 Aligned_cols=209 Identities=19% Similarity=0.257 Sum_probs=164.8
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
....+.|+.-++||+||||.||-++...+++-++.+..-.|+++.........++ ...+...+.++|+.+-..+. ..
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnE--k~iL~kV~s~FiVslaYAfe-Tk 257 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNE--KQILEKVSSPFIVSLAYAFE-TK 257 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHH--HHHHHHhccCcEEEEeeeec-CC
Confidence 4556889999999999999999999999984333333333333333333333333 34445556678887766554 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+|+|+..|+||+|.-++...+ ...++++.+..++.+|+.||++||+.+||+||+||+|||
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g------------------~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNIL 319 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHG------------------NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENIL 319 (591)
T ss_pred CceEEEEEeecCCceeEEeeccC------------------CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhee
Confidence 78999999999999988776654 247789999999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+|+.| +++|+|+|+|..+..+... ...+||.+|||||++....++ ...|+||+||
T Consensus 320 LDd~G-hvRISDLGLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~----------------------~s~Dwf~lGC 374 (591)
T KOG0986|consen 320 LDDHG-HVRISDLGLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYD----------------------FSPDWFSLGC 374 (591)
T ss_pred eccCC-CeEeeccceEEecCCCCcc--ccccCcccccCHHHHcCCccc----------------------CCccHHHHHh
Confidence 99998 9999999999988766543 456999999999977666544 3449999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||+-|.-||...
T Consensus 375 llYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 375 LLYEMIAGHSPFRQR 389 (591)
T ss_pred HHHHHHcccCchhhh
Confidence 999999999999653
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=278.00 Aligned_cols=194 Identities=18% Similarity=0.253 Sum_probs=151.6
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHH-hhccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRA-CANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||.||+|++..++ +.+++|.+.... ..+.....++... ....+|++++.+++.+. .++.+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv 74 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFV 74 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-eCCEEEEE
Confidence 47999999999999998876 778888876432 1111111222222 23347899999887654 45789999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 75 ~E~~~~~~L~~~~~~~~--------------------~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~- 133 (329)
T cd05618 75 IEYVNGGDLMFHMQRQR--------------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG- 133 (329)
T ss_pred EeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-
Confidence 99999999998886543 467788899999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++..... ........||+.|+|||++.+. .++.++|+|||||++|||+
T Consensus 134 ~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG~il~el~ 190 (329)
T cd05618 134 HIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE----------------------DYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred CEEEeeCCccccccCC-CCccccccCCccccCHHHHcCC----------------------CCCCccceecccHHHHHHh
Confidence 9999999999753222 1223456899999999966543 3555679999999999999
Q ss_pred cCCCCCCC
Q 015991 381 CTVRRLCL 388 (397)
Q Consensus 381 tg~~Pf~~ 388 (397)
+|+.||..
T Consensus 191 ~g~~Pf~~ 198 (329)
T cd05618 191 AGRSPFDI 198 (329)
T ss_pred hCCCCCcc
Confidence 99999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=277.34 Aligned_cols=199 Identities=20% Similarity=0.295 Sum_probs=154.3
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh----HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
++||+|+||.||+++...... ..+.+++|.+..... ........+...+....|+|++.+++.+.. ++.+++|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGAD--TGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCC--CCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEE
Confidence 689999999999998754221 126788888764321 112222344556667789999998876644 5689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+.+++|.+++.... .+.+..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 79 ~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~- 137 (323)
T cd05584 79 LEYLSGGELFMHLEREG--------------------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG- 137 (323)
T ss_pred EeCCCCchHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-
Confidence 99999999999987654 346677888999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||+
T Consensus 138 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG~il~ell 194 (323)
T cd05584 138 HVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAPEILMRS----------------------GHGKAVDWWSLGALMYDML 194 (323)
T ss_pred CEEEeeCcCCeecccCC-CcccccCCCccccChhhccCC----------------------CCCCcceecccHHHHHHHh
Confidence 99999999987543222 223446799999999976543 3455679999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|+.||....
T Consensus 195 ~G~~pf~~~~ 204 (323)
T cd05584 195 TGAPPFTAEN 204 (323)
T ss_pred cCCCCCCCCC
Confidence 9999997644
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=283.19 Aligned_cols=232 Identities=20% Similarity=0.253 Sum_probs=166.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
.+..++|++.+.||+|+||.||+|++...+.......+++|.+...... +.....++...+... .|+|++.+++.+..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 3456799999999999999999999866554444567999988653322 222222334444444 79999999886644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhh-----------------------------------------hc----
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTL-----------------------------------------IL---- 247 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~-----------------------------------------~~---- 247 (397)
++..++||||+.+|+|.+++......+..... ..
T Consensus 114 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 114 -GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred -CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 56899999999999999999754311000000 00
Q ss_pred -----cccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEeccccccccccccc-cc
Q 015991 248 -----GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IP 321 (397)
Q Consensus 248 -----~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~ 321 (397)
...........+++..+.+++.|++.||+|||++||+||||||+|||+++++ .+||+|||+++.+...... ..
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeec
Confidence 0000111233578888999999999999999999999999999999999876 9999999999865443222 12
Q ss_pred ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-CCCCCCCCC
Q 015991 322 KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 322 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
....+++.|||||++... .++.++|||||||++|||++ |+.||....
T Consensus 272 ~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 272 GNARLPVKWMAPESIFDC----------------------VYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred cCCCCccceeCHHHhcCC----------------------CCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 233456789999966433 45667799999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=297.39 Aligned_cols=230 Identities=19% Similarity=0.243 Sum_probs=188.9
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
..+...+.+..++||+|.||+||+|+..+-........|+||.+++..+. ....++++...+...+|+||+.+++.+ .
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-~ 559 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-R 559 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-c
Confidence 45666888999999999999999999877665556688999999987766 677788889999999999999999987 4
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++.+++|+|||..|+|.++|......-.... ...+....++..+.+.|+.|||.|++||-++.+|||||..+|
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~------~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN 633 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLA------SGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN 633 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCcccccc------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence 56789999999999999999998764322110 011124468999999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccc-cccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
+||.++. .+||+|||+++++-..+.|... ......+||+||.+ +.+.|+.++||||
T Consensus 634 CLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI----------------------ly~kFTteSDVWs 690 (774)
T KOG1026|consen 634 CLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI----------------------LYGKFTTESDVWS 690 (774)
T ss_pred ceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHh----------------------hcCcccchhhhhh
Confidence 9999986 9999999999988666655433 34557799999944 4556666779999
Q ss_pred HHHHHHHHHc-CCCCCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHSCPL 393 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~~~~ 393 (397)
|||+|||+++ |+.||.+..++|
T Consensus 691 ~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 691 FGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred hhhhhhhhhccccCcccccchHH
Confidence 9999999975 889997766654
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=289.78 Aligned_cols=204 Identities=25% Similarity=0.312 Sum_probs=173.5
Q ss_pred eeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEecC
Q 015991 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEG 225 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~ 225 (397)
+||+|.||+||-|++..++ ..+++|.+.+....+..-..+++....+.+|.||+.+++.+.. ++.+-|+||.++
T Consensus 582 VLGKGTYG~VYA~RD~~tq-----vrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQ-----VRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccce-----eEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCC
Confidence 7999999999999999988 8899999987776666555666777788899999999998654 568889999999
Q ss_pred CCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEE
Q 015991 226 EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305 (397)
Q Consensus 226 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~ 305 (397)
||+|.+++++.=.| .+-++..+..+.+||++||.|||++.|||||||-+|+|++.-.+.+||+
T Consensus 656 GGSLSsLLrskWGP-----------------lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKIS 718 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGP-----------------LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKIS 718 (1226)
T ss_pred CCcHHHHHHhccCC-----------------CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEec
Confidence 99999999876322 1236788899999999999999999999999999999999777799999
Q ss_pred ecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCC
Q 015991 306 DLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRR 385 (397)
Q Consensus 306 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~P 385 (397)
|||.++.+. +.+....++.||..|||||++..+.. +|...+|||||||++.||.||++|
T Consensus 719 DFGTsKRLA-ginP~TETFTGTLQYMAPEvIDqG~R--------------------GYG~aADIWS~GCT~vEMATGrPP 777 (1226)
T KOG4279|consen 719 DFGTSKRLA-GINPCTETFTGTLQYMAPEVIDQGPR--------------------GYGKAADIWSFGCTMVEMATGRPP 777 (1226)
T ss_pred ccccchhhc-cCCccccccccchhhhChHhhccCCc--------------------CCCchhhhhhccceeEeeccCCCC
Confidence 999998863 44556778999999999998876543 466778999999999999999999
Q ss_pred CCCCCCCC
Q 015991 386 LCLHSCPL 393 (397)
Q Consensus 386 f~~~~~~~ 393 (397)
|---+.|+
T Consensus 778 F~Elgspq 785 (1226)
T KOG4279|consen 778 FVELGSPQ 785 (1226)
T ss_pred eeecCChh
Confidence 96655554
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=268.98 Aligned_cols=197 Identities=20% Similarity=0.258 Sum_probs=154.8
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
||+|+||+||++.+..++ +.+++|++....... ......+...+...+|++++.+...+. .+...++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATG-----KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-TKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCC-----cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-CCCeEEEEEeC
Confidence 799999999999998776 788899876432211 122223445566678999988876554 45679999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+.+.... .....+++..++.++.|++.||+|||++||+||||||+||++++++ .++
T Consensus 75 ~~~g~L~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~ 137 (280)
T cd05608 75 MNGGDLRYHIYNVD----------------EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVR 137 (280)
T ss_pred CCCCCHHHHHHhcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEE
Confidence 99999988875432 1223578888999999999999999999999999999999999887 999
Q ss_pred EEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCC
Q 015991 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTV 383 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~ 383 (397)
|+|||++..+..... ......||+.|+|||++.+. .++.++|+||||+++|||++|+
T Consensus 138 l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DvwslG~il~el~~g~ 194 (280)
T cd05608 138 ISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGE----------------------EYDFSVDYFALGVTLYEMIAAR 194 (280)
T ss_pred EeeCccceecCCCCc-cccccCCCcCccCHHHhcCC----------------------CCCccccHHHHHHHHHHHHhCC
Confidence 999999976644322 23446789999999966543 4556779999999999999999
Q ss_pred CCCCCC
Q 015991 384 RRLCLH 389 (397)
Q Consensus 384 ~Pf~~~ 389 (397)
.||...
T Consensus 195 ~pf~~~ 200 (280)
T cd05608 195 GPFRAR 200 (280)
T ss_pred CCCCCC
Confidence 999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=281.13 Aligned_cols=203 Identities=25% Similarity=0.303 Sum_probs=159.2
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC---
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (397)
+|++.++||+|+||.||++.+..++ +.+++|++.... ........++...+...+|+|++.+++.....+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDG-----KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCC-----CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence 5889999999999999999987776 789999876431 122222334455666678999988877654433
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 215 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...++|+||+. ++|.+.+.... .+++..++.++.|++.||+|||++||+||||||+||
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni 134 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVSPQ--------------------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNL 134 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHE
Confidence 27899999998 57877775432 467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++..............+|+.|+|||++.+.. .++.++||||+|
T Consensus 135 li~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG 192 (372)
T cd07853 135 LVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSR---------------------HYTSAVDIWSVG 192 (372)
T ss_pred EECCCC-CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCC---------------------CCCcHHHHHhHH
Confidence 999987 9999999999865443333334457899999999775432 245678999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|++|||++|+.||....
T Consensus 193 ~il~el~~g~~pf~~~~ 209 (372)
T cd07853 193 CIFAELLGRRILFQAQS 209 (372)
T ss_pred HHHHHHHcCCCCCCCCC
Confidence 99999999999997654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=277.91 Aligned_cols=214 Identities=23% Similarity=0.323 Sum_probs=174.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc---
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (397)
..+..++.+.||+|+||.||+|.+.+ +.||||+... .+.+.+..|+.+..+....|+||+.|++.....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~-------~~VAVKifp~-~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDN-------RLVAVKIFPE-QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccC-------ceeEEEecCH-HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 45678889999999999999999876 7888888754 445566777777777888999999998865332
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC---------Cce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST---------GIV 284 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~---------gii 284 (397)
+..+|||++|.+.|+|.+++..+ .++|....+|+..+++||+|||+. .|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n---------------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia 338 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN---------------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA 338 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc---------------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence 24899999999999999999887 568899999999999999999964 699
Q ss_pred ecCCCCCceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 285 HrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
|||||.+||||..|. ++.|+|||+|..+..+.... ....+||.+|||||++++...... ...
T Consensus 339 HRDlkSkNVLvK~Dl-TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d----------------~~A 401 (534)
T KOG3653|consen 339 HRDLKSKNVLVKNDL-TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD----------------RDA 401 (534)
T ss_pred cccccccceEEccCC-cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc----------------HHH
Confidence 999999999999987 99999999998886543321 223799999999999998766542 112
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCCCCCCCcCCC
Q 015991 364 PDRFDIYSAGLIFLQMVCTVRRLCLHSCPLAYSL 397 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~elltg~~Pf~~~~~~~~~~~ 397 (397)
-.+.||||+|++||||++...-+.. +.++.|++
T Consensus 402 fkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yql 434 (534)
T KOG3653|consen 402 FKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQL 434 (534)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccC-CCCCcccC
Confidence 2467999999999999998876665 55555553
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=280.41 Aligned_cols=213 Identities=23% Similarity=0.361 Sum_probs=173.0
Q ss_pred HHhhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeee
Q 015991 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGF 206 (397)
Q Consensus 130 ~~~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~ 206 (397)
++.+..+.+.-|..++.||-|+||+|.+++-.++. ..++.|.+.+.. ..+....+.++.++.....++++.+
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~-----~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrL 694 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTR-----ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRL 694 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchh-----hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEE
Confidence 44455667778999999999999999999988876 777888776433 2333444556777888889999999
Q ss_pred eecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
+..+. +.+.+|+||+|++||++-.+|.+.+ .+.|..++.++.++..|+++.|..|+|||
T Consensus 695 yySFQ-DkdnLYFVMdYIPGGDmMSLLIrmg--------------------IFeE~LARFYIAEltcAiesVHkmGFIHR 753 (1034)
T KOG0608|consen 695 YYSFQ-DKDNLYFVMDYIPGGDMMSLLIRMG--------------------IFEEDLARFYIAELTCAIESVHKMGFIHR 753 (1034)
T ss_pred EEEec-cCCceEEEEeccCCccHHHHHHHhc--------------------cCHHHHHHHHHHHHHHHHHHHHhccceec
Confidence 88774 4578999999999999999998876 57888999999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEecccccccc---------ccccc--------------------------------cccccc
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLR---------VGINY--------------------------------IPKEFL 325 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~---------~~~~~--------------------------------~~~~~~ 325 (397)
||||+|||||.+| ++||+||||++-+. .++.. .....+
T Consensus 754 DiKPDNILIDrdG-HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslv 832 (1034)
T KOG0608|consen 754 DIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLV 832 (1034)
T ss_pred ccCccceEEccCC-ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhc
Confidence 9999999999998 99999999997442 01000 011358
Q ss_pred CCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 326 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 326 gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
||+.|+|||+ +...+|+..||+||.||+||||+.|+.||-....
T Consensus 833 gt~nyiapev----------------------l~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 833 GTPNYIAPEV----------------------LARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred CCCcccChHH----------------------hcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 9999999994 4455677778999999999999999999965543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=277.42 Aligned_cols=232 Identities=22% Similarity=0.226 Sum_probs=167.7
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~ 213 (397)
+..++|++.+.||+|+||.||+|.+..++.....+.+++|++..... .+......+...+... +|+|++.+++.+...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34578999999999999999999876655444557899998764322 2222222233334444 789999998877777
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhcc-----------------------------------------cccc
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILG-----------------------------------------EVQD 252 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~-----------------------------------------~~~~ 252 (397)
+..+++++||+.+++|.+++............... ....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 77899999999999999998754321100000000 0000
Q ss_pred CCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCC
Q 015991 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYA 331 (397)
Q Consensus 253 ~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~ 331 (397)
......+++..+..++.|++.||+|||++||+||||||+|||+++++ .++|+|||+++.+....... .....++..|+
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 00123578899999999999999999999999999999999999987 99999999998764433222 23345677899
Q ss_pred CcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-CCCCCCCCC
Q 015991 332 APEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 332 aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
|||++.+ ..++.++|||||||+||||++ |..||....
T Consensus 243 aPE~~~~----------------------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 243 APESIFD----------------------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred CcHHhcC----------------------CCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9996544 345667799999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.27 Aligned_cols=208 Identities=22% Similarity=0.312 Sum_probs=169.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
-...+.|+|...||.|+||.||+|..+.++ ...+.|.+......+......++..+..+.||+|+++++.++. +
T Consensus 28 lnP~d~WeIiGELGDGAFGKVyKA~nket~-----~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-e 101 (1187)
T KOG0579|consen 28 LNPRDHWEIIGELGDGAFGKVYKAVNKETK-----LLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-E 101 (1187)
T ss_pred CCHHHHHHHHhhhcCccchhhhhhhcccch-----hhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-c
Confidence 334477999999999999999999988764 3333455544444444444455677888899999999987765 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+|++.|||+||-++.+|-.-+ ..+++.+|..+++|++.||.|||+++|||||||..|||
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~-------------------r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL 162 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELG-------------------RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNIL 162 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhc-------------------cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceE
Confidence 67999999999999999886643 36789999999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.+| .++|+|||.+..... ......++.|||.|||||+.+..+ ..+.+|+.++||||||+
T Consensus 163 ~TldG-dirLADFGVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET-----------------~KD~PYDykaDiWSlGI 223 (1187)
T KOG0579|consen 163 LTLDG-DIRLADFGVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCET-----------------FKDQPYDYKADIWSLGI 223 (1187)
T ss_pred EEecC-cEeeecccccccchh-HHhhhccccCCcccccchheeecc-----------------ccCCCchhhhhHHhhhh
Confidence 99998 999999998865322 223456799999999999876553 34457999999999999
Q ss_pred HHHHHHcCCCCC
Q 015991 375 IFLQMVCTVRRL 386 (397)
Q Consensus 375 ~l~elltg~~Pf 386 (397)
+|.||.-+.+|-
T Consensus 224 TLIEMAqiEPPH 235 (1187)
T KOG0579|consen 224 TLIEMAQIEPPH 235 (1187)
T ss_pred HHHHHhccCCCc
Confidence 999999999875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=278.26 Aligned_cols=205 Identities=23% Similarity=0.317 Sum_probs=166.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccC-CCceeeeeecccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCC-ADFVYGFFENSSK 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~-~~~i~~~~~~~~~ 212 (397)
..+.|++++.||+|.||.||+++.+.++ +.+|+|.+..... .......++...+.+.. |+|++.+.+.+..
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg-----~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTG-----KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCC-----ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 3478999999999999999999999987 7777777654332 12223344445555554 9999999887755
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+.+++|||++.||.|++.+... .+++..+..++.|++.++.|||+.||+||||||+|
T Consensus 108 -~~~~~lvmEL~~GGeLfd~i~~~---------------------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN 165 (382)
T KOG0032|consen 108 -PDSVYLVMELCEGGELFDRIVKK---------------------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPEN 165 (382)
T ss_pred -CCeEEEEEEecCCchHHHHHHHc---------------------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHH
Confidence 45899999999999999998764 14778899999999999999999999999999999
Q ss_pred eEEeCCC---CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 293 VIFSEGS---RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 293 ILl~~~~---~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+|+.... ..+|++|||+|..... .......+||+.|+|||++.. ..|+..+||
T Consensus 166 ~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~----------------------~~y~~~~Di 221 (382)
T KOG0032|consen 166 LLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGG----------------------RPYGDEVDV 221 (382)
T ss_pred eeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcC----------------------CCCCcccch
Confidence 9997543 2799999999988765 334577899999999995544 456667799
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
||+|+++|.|++|..||......
T Consensus 222 WS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 222 WSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred hHHHHHHHHHhhCCCCCcCCChh
Confidence 99999999999999999887643
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=272.71 Aligned_cols=196 Identities=20% Similarity=0.259 Sum_probs=151.9
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhh-ccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACA-NCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||+||+|++..++ +.+++|.+..... .+......+...+. ...|++++.+++.+. ..+.+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-~~~~~~lv 74 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD-----ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-TKDRLFFV 74 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEE
Confidence 47999999999999998776 7888888764321 11111111222222 236899998887654 45689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+.+++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 75 ~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~- 133 (318)
T cd05570 75 MEYVNGGDLMFHIQRSG--------------------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG- 133 (318)
T ss_pred EcCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-
Confidence 99999999998887653 467888999999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++...... .......||+.|+|||++.+. .++.++|+|||||++|||+
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DiwslGvil~~l~ 190 (318)
T cd05570 134 HIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQ----------------------PYGPAVDWWALGVLLYEML 190 (318)
T ss_pred cEEecccCCCeecCcCC-CcccceecCccccCHHHhcCC----------------------CCCcchhhhhHHHHHHHHh
Confidence 99999999987532221 123446799999999966543 4556789999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|+.||....
T Consensus 191 ~G~~pf~~~~ 200 (318)
T cd05570 191 AGQSPFEGDD 200 (318)
T ss_pred hCCCCCCCCC
Confidence 9999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=273.07 Aligned_cols=201 Identities=21% Similarity=0.289 Sum_probs=160.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||.||++.+..++ ..+++|.+.... ........++...+...+|++++.+++.+.. ++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 76 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSG-----LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DG 76 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CC
Confidence 4589999999999999999999998776 667777665432 2222223345555666789999999887644 56
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCCCceE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVI 294 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~NIL 294 (397)
..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nil 136 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAG--------------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEE
Confidence 8999999999999999987643 356778889999999999999985 7999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+++++ .+||+|||++..+... ......||..|+|||++.+. .++.++|+|||||
T Consensus 137 i~~~~-~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwslG~ 190 (333)
T cd06650 137 VNSRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT----------------------HYSVQSDIWSMGL 190 (333)
T ss_pred EcCCC-CEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcCC----------------------CCCcHHHHHHHHH
Confidence 99987 8999999999765332 12345789999999976543 3455779999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|+.||...
T Consensus 191 il~~l~~g~~p~~~~ 205 (333)
T cd06650 191 SLVEMAIGRYPIPPP 205 (333)
T ss_pred HHHHHHHCCCCCCCc
Confidence 999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=275.47 Aligned_cols=200 Identities=21% Similarity=0.290 Sum_probs=155.9
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.++|++.+.||+|+||.||++.+..++ +.+++|++.... ........++...+...+|++++.+++.+...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLG-----INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCC-----ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 479999999999999999999988876 788899875321 111222223455566678999999887654332
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
..+++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~----------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 151 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIHM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 151 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHhc----------------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 357999999985 56555432 245677888999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++..... .......||+.|+|||++.+. .++.++|||
T Consensus 152 ~NIl~~~~~-~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~Diw 206 (359)
T cd07876 152 SNIVVKSDC-TLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGM----------------------GYKENVDIW 206 (359)
T ss_pred HHEEECCCC-CEEEecCCCccccccC--ccCCCCcccCCCCCchhccCC----------------------CCCcchhhH
Confidence 999999987 9999999999764332 223456789999999976543 355677999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 207 SlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 207 SVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=278.18 Aligned_cols=203 Identities=19% Similarity=0.193 Sum_probs=156.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||.||+|++..++ +.+++|.+...... ......++...+....|+|++.+++.+ ..++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 145 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTG-----RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNG 145 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCC-----CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-ccCC
Confidence 3467888999999999999999988776 78899987643322 122233455566677899999988765 4457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+.+++|.+.. ..++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 146 ~~~lv~e~~~~~~L~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 201 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH------------------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI 201 (353)
T ss_pred eEEEEEecCCCCcccccc------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 899999999999885421 22456677899999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||+++.+..... ......||..|+|||++........ ..+.++|||||||+
T Consensus 202 ~~~~-~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~-----------------~~~~~~DvwslGvi 262 (353)
T PLN00034 202 NSAK-NVKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGA-----------------YDGYAGDIWSLGVS 262 (353)
T ss_pred cCCC-CEEEcccccceecccccc-cccccccCccccCccccccccccCc-----------------CCCcchhHHHHHHH
Confidence 9987 999999999987643321 1244679999999997754322111 12347899999999
Q ss_pred HHHHHcCCCCCCC
Q 015991 376 FLQMVCTVRRLCL 388 (397)
Q Consensus 376 l~elltg~~Pf~~ 388 (397)
+|||++|+.||..
T Consensus 263 l~el~~g~~pf~~ 275 (353)
T PLN00034 263 ILEFYLGRFPFGV 275 (353)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999974
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=279.57 Aligned_cols=196 Identities=19% Similarity=0.296 Sum_probs=151.3
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHH---HHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIW---MNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
||+|+||+||+|++..++ +.+++|.+..... .+.. .+..+........|++++.+...+. ..+.+++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-~~~~~~lv 74 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR-----RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-TDSDLYLV 74 (330)
T ss_pred CCCCCceEEEEEEECCCC-----CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-cCCeEEEE
Confidence 799999999999998877 7888888754221 1111 1112222222236899988877653 45689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
|||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 75 ~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~- 133 (330)
T cd05586 75 TDYMSGGELFWHLQKEG--------------------RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG- 133 (330)
T ss_pred EcCCCCChHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-
Confidence 99999999998887543 467888999999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.+||+|||+++...... .......||+.|+|||++.+.. .++.++|||||||++|||+
T Consensus 134 ~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DvwslGvil~ell 191 (330)
T cd05586 134 HIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEK---------------------GYTKHVDFWSLGVLVFEMC 191 (330)
T ss_pred CEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCC---------------------CCCCccceeccccEEEEec
Confidence 99999999997543222 1234567999999999765322 2456789999999999999
Q ss_pred cCCCCCCCCCC
Q 015991 381 CTVRRLCLHSC 391 (397)
Q Consensus 381 tg~~Pf~~~~~ 391 (397)
+|..||.....
T Consensus 192 tG~~Pf~~~~~ 202 (330)
T cd05586 192 CGWSPFYAEDT 202 (330)
T ss_pred cCCCCCCCCCH
Confidence 99999976543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=264.05 Aligned_cols=208 Identities=13% Similarity=0.156 Sum_probs=159.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.+.||+|+||.||+|.+..... ....+++|....... .......++...+....|++++.+.+.+. .++
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~--~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 79 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSK--RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-RGN 79 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCC--ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-cCC
Confidence 45789999999999999999998764322 126788888775432 22223334455666678999999987664 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili 140 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-------------------GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV 140 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE
Confidence 8999999999999999987642 145778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .++++|||.+...............++..|+|||.+.+ ..++.++|||||||+
T Consensus 141 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~~ 197 (266)
T cd05064 141 NSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY----------------------HHFSSASDVWSFGIV 197 (266)
T ss_pred cCCC-cEEECCCcccccccccchhcccCCCCceeecCHHHHhh----------------------CCccchhHHHHHHHH
Confidence 9987 99999999876543222222223345678999996543 345667899999999
Q ss_pred HHHHHc-CCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLH 389 (397)
Q Consensus 376 l~ellt-g~~Pf~~~ 389 (397)
+|||++ |..||...
T Consensus 198 l~ell~~g~~p~~~~ 212 (266)
T cd05064 198 MWEVMSYGERPYWDM 212 (266)
T ss_pred HHHHhcCCCCCcCcC
Confidence 999774 99999643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=267.96 Aligned_cols=227 Identities=17% Similarity=0.174 Sum_probs=162.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCC-----------CCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCcee
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPS-----------SKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVY 204 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~-----------~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~ 204 (397)
..++|++.++||+|+||.||+|.+..... ......+++|.+...... ......++...+....|++++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 45799999999999999999998754321 111235888887653222 222223345556667899999
Q ss_pred eeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCce
Q 015991 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (397)
Q Consensus 205 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gii 284 (397)
.+++.+.. .+..++||||+.+++|.+++............ ............+++..+..++.|++.||.|||+.||+
T Consensus 83 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENG-NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec-CCceEEEEecCCCCcHHHHHHhcccccccccc-ccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99886644 46789999999999999999765321110000 00011112334577888999999999999999999999
Q ss_pred ecCCCCCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 285 HrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
||||||+|||+++++ .+||+|||+++.+...... ......++..|+|||++.. ..+
T Consensus 161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~ 217 (304)
T cd05096 161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM----------------------GKF 217 (304)
T ss_pred ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc----------------------CCC
Confidence 999999999999987 9999999999866443322 1233456789999996543 345
Q ss_pred CCchhhHHHHHHHHHHHc--CCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVC--TVRRLCL 388 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~ellt--g~~Pf~~ 388 (397)
+.++||||||+++|||++ +..||..
T Consensus 218 ~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 218 TTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred CchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 667899999999999986 5566654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=267.18 Aligned_cols=201 Identities=21% Similarity=0.311 Sum_probs=156.3
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhhccCCCceeeeeecccc--
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSK-- 212 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-- 212 (397)
+|++.+.||+|+||+||+|++..++ +.+++|.+.... ......+..+...+....|+|++.+++.+..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSG-----HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence 5899999999999999999998877 778888765321 1122222334444555679999988775432
Q ss_pred --cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 213 --KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 213 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.....++++||+.+ +|.+++.... ...+++..++.++.|++.||+|||++||+||||||
T Consensus 76 ~~~~~~~~lv~e~~~~-~l~~~~~~~~------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp 136 (288)
T cd07863 76 TDRETKVTLVFEHVDQ-DLRTYLDKVP------------------PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKP 136 (288)
T ss_pred CCCCceEEEEEccccc-CHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 23568999999984 8888876542 12467888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||+++++ .+||+|||+++...... ......+|..|+|||++.+ ..++.++|||
T Consensus 137 ~Nili~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Diw 191 (288)
T cd07863 137 ENILVTSGG-QVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQ----------------------STYATPVDMW 191 (288)
T ss_pred HHEEECCCC-CEEECccCccccccCcc--cCCCccccccccCchHhhC----------------------CCCCCcchhh
Confidence 999999987 99999999997654322 1234578999999996543 3456678999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
|+||++|||++|+.||...
T Consensus 192 slG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 192 SVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred hHHHHHHHHHhCCcCcCCC
Confidence 9999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=264.92 Aligned_cols=202 Identities=18% Similarity=0.199 Sum_probs=159.7
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.|++.++||+|+||+||++.+..++ +.+++|++...... ......++...+...+|++++.+.+.+.. ++.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCC-----ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCe
Confidence 4889999999999999999988776 78888887643211 11122234456666789999998876644 468
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMG------------------NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD 136 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcC------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC
Confidence 999999999999998886532 12467888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||++........ .....||+.|+|||++... .++.++|+||+||++
T Consensus 137 ~~~-~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Diws~G~~l 191 (285)
T cd05605 137 DYG-HIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNE----------------------RYTFSPDWWGLGCLI 191 (285)
T ss_pred CCC-CEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcCC----------------------CCCccccchhHHHHH
Confidence 987 999999999976543222 2345789999999976433 345567999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 192 ~el~~g~~pf~~~~ 205 (285)
T cd05605 192 YEMIEGKSPFRQRK 205 (285)
T ss_pred HHHHHCCCCCCCCc
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=257.81 Aligned_cols=203 Identities=21% Similarity=0.319 Sum_probs=167.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeeccc-----chh-HHHHHHH---HHHHHhhccCCCceeeeeec
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE-----YGA-VEIWMNE---RVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~-----~~~-~e~~~~~---~~~~~~~~~~~~~i~~~~~~ 209 (397)
++|.-.+.||+|..++|-++.++.++ +..++|++.. .+. .....+. ++........||+|+.+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~-----~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETG-----KEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccc-----cceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 57888899999999999999999888 6777776642 111 1111111 12222344679999998876
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
. .....+++|+|.|+.|.|+|++.+.- .++++..++|++|+.+|++|||.++|||||+|
T Consensus 92 y-es~sF~FlVFdl~prGELFDyLts~V--------------------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLK 150 (411)
T KOG0599|consen 92 Y-ESDAFVFLVFDLMPRGELFDYLTSKV--------------------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLK 150 (411)
T ss_pred c-cCcchhhhhhhhcccchHHHHhhhhe--------------------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccC
Confidence 5 44578899999999999999998764 68899999999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++++. ++||+|||+|+.+..+... ...+|||+|.|||.+..+-+.... +|+..+|+
T Consensus 151 pENILlddn~-~i~isDFGFa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~p----------------GYs~EVD~ 211 (411)
T KOG0599|consen 151 PENILLDDNM-NIKISDFGFACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHP----------------GYSKEVDE 211 (411)
T ss_pred hhheeecccc-ceEEeccceeeccCCchhH--HHhcCCCcccChhheeeecccCCC----------------CccchhhH
Confidence 9999999997 9999999999998877653 568999999999999876655443 78888999
Q ss_pred HHHHHHHHHHHcCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRL 386 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf 386 (397)
|++||+||.|+.|..||
T Consensus 212 Wa~GVImyTLLaGcpPF 228 (411)
T KOG0599|consen 212 WACGVIMYTLLAGCPPF 228 (411)
T ss_pred HHHHHHHHHHHcCCCch
Confidence 99999999999999998
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=251.26 Aligned_cols=212 Identities=23% Similarity=0.250 Sum_probs=172.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc--
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (397)
+..++|++.+.||+|||..||+++...++ +.+|+|++.-....+.....++++..+..+|+|++.++.....+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~-----~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTG-----HLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcc-----cchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 45689999999999999999999987777 78888888766655555555667777788899998876654432
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--ceecCCC
Q 015991 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIK 289 (397)
Q Consensus 214 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiHrDIK 289 (397)
....||++.|...|||.+.++... .++..+++.++..|+.++++||++||+.. ++|||||
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k----------------~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiK 156 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLK----------------IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIK 156 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHh----------------hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCC
Confidence 356899999999999999998765 34557899999999999999999999998 9999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccc--------cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYI--------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
|.|||+.+.+ .++|.|||.++......... ......|.-|.|||.+.-... .
T Consensus 157 P~NILls~~~-~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~-------------------~ 216 (302)
T KOG2345|consen 157 PANILLSDSG-LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSH-------------------C 216 (302)
T ss_pred cceeEecCCC-ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccC-------------------c
Confidence 9999999976 99999999997653321111 112467889999997764333 2
Q ss_pred CCCCchhhHHHHHHHHHHHcCCCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
..++|+|||||||+||+|++|.-||..
T Consensus 217 ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 217 TITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccccccchhhhhHHHHHHHHcCCcchH
Confidence 467899999999999999999999964
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=271.32 Aligned_cols=209 Identities=21% Similarity=0.238 Sum_probs=165.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecc-----cchhHHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT-----EYGAVEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~-----~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
.++..+|....+||+|+||.|-+|+.+.+. ..+|+|.++ .+.+.|.-+.+.-...+. ...|+++.+..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtd-----ELyAiKiLkKDViiQdDDvectm~EKrvLAL~-~kppFL~qlHS- 417 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTD-----ELYAIKILKKDVIIQDDDVECTMVEKRVLALP-GKPPFLVQLHS- 417 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcc-----hhhhhhhhccceeeecCcccceehhhhheecC-CCCchHHHHHH-
Confidence 456679999999999999999999999888 455555544 455666655553222221 23455555544
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+...-+.+|+||||+.||+|--.++..+ ++.+..+..++.+|+-||-+||++|||+||||
T Consensus 418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~G--------------------kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLK 477 (683)
T KOG0696|consen 418 CFQTMDRLYFVMEYVNGGDLMYHIQQVG--------------------KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK 477 (683)
T ss_pred HhhhhhheeeEEEEecCchhhhHHHHhc--------------------ccCCchhhhhhHHHHHHhhhhhcCCeeeeecc
Confidence 4455678999999999999988888765 67788889999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
.+|||+|.+| ++||+|||+++.---+ .....+++|||.|+|||++....+.. .+|+
T Consensus 478 LDNvmLd~eG-HiKi~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgk----------------------svDW 533 (683)
T KOG0696|consen 478 LDNVMLDSEG-HIKIADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGK----------------------SVDW 533 (683)
T ss_pred ccceEeccCC-ceEeeecccccccccC-CcceeeecCCCcccccceEEeccccc----------------------chhH
Confidence 9999999998 9999999999753222 22356799999999999887665544 4599
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCc
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSCPLA 394 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~~~~ 394 (397)
||+||+||||+.|..||.++...|-
T Consensus 534 Wa~GVLLyEmlaGQpPFdGeDE~el 558 (683)
T KOG0696|consen 534 WAFGVLLYEMLAGQPPFDGEDEDEL 558 (683)
T ss_pred HHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 9999999999999999999875543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=274.86 Aligned_cols=200 Identities=22% Similarity=0.296 Sum_probs=155.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc--
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (397)
.++|++.+.||+|+||.||++.+..++ +.+++|++.... ........++...+...+|++++.+++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCC-----cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 479999999999999999999988776 788899876422 11122222344556667889998887654332
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 214 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
....++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~~----------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp 154 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 154 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHHh----------------------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCH
Confidence 2468999999985 67666643 235677888999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++...... ......+|+.|+|||++.+. .++.++|||
T Consensus 155 ~NIll~~~~-~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~Diw 209 (364)
T cd07875 155 SNIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGM----------------------GYKENVDIW 209 (364)
T ss_pred HHEEECCCC-cEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCC----------------------CCCchhhHH
Confidence 999999987 99999999997653322 23456789999999966443 456678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 210 SlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 210 SVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred hHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=267.52 Aligned_cols=199 Identities=24% Similarity=0.395 Sum_probs=169.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+-|.+.++||+|+||.||+|.++.++ ..+++|++.-..+.+... .++.....+..++++.+++..+. ...+|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG-----~v~AIK~VPV~sDLQEII--KEISIMQQC~S~yVVKYYGSYFK-~sDLW 104 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESG-----HVLAIKKVPVDTDLQEII--KEISIMQQCKSKYVVKYYGSYFK-HSDLW 104 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccC-----cEEEEEecCccchHHHHH--HHHHHHHHcCCchhhhhhhhhcc-CCceE
Confidence 45778899999999999999999988 899999988665544333 23445566778889998887654 46799
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+|||||+.|++.++++.++ ..+++..+..+++..++||+|||...-||||||..|||++.+
T Consensus 105 IVMEYCGAGSiSDI~R~R~-------------------K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~ 165 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARR-------------------KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD 165 (502)
T ss_pred eehhhcCCCcHHHHHHHhc-------------------CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc
Confidence 9999999999999998764 367888899999999999999999999999999999999999
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
| .+||+|||.|..+.+.-. ..++..|||.||||| ++...+|+-++||||||++..|
T Consensus 166 G-~AKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPE----------------------VI~EIGY~~~ADIWSLGITaIE 221 (502)
T KOG0574|consen 166 G-IAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPE----------------------VIEEIGYDTKADIWSLGITAIE 221 (502)
T ss_pred c-hhhhhhccccchhhhhHH-hhCccccCcccccHH----------------------HHHHhccchhhhHhhhcchhhh
Confidence 8 999999999987765433 346789999999999 7777888889999999999999
Q ss_pred HHcCCCCCCC
Q 015991 379 MVCTVRRLCL 388 (397)
Q Consensus 379 lltg~~Pf~~ 388 (397)
|.-|++||..
T Consensus 222 MAEG~PPYsD 231 (502)
T KOG0574|consen 222 MAEGRPPYSD 231 (502)
T ss_pred hhcCCCCccc
Confidence 9999999953
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=287.75 Aligned_cols=212 Identities=22% Similarity=0.297 Sum_probs=169.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhc-cCCCceeeeeeccc-c
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSS-K 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~-~ 212 (397)
++..-++++.+.|.+|||+.||+|++...+ +.+|+|++............+++..++. ..|+||+.|++... .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~-----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGG-----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCC-----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 344567889999999999999999998876 7899999876655444444455555444 45999999998322 1
Q ss_pred c-----CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--cee
Q 015991 213 K-----GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVH 285 (397)
Q Consensus 213 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiH 285 (397)
. .-+++|+||||.+|.|-|+|..+. ...+++..+++|+.|+++|+.+||..+ |||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl------------------q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIH 169 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRL------------------QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIH 169 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHH------------------hccCChHHHHHHHHHHHHHHHHHhcCCCccch
Confidence 1 257899999999999999998763 224889999999999999999999987 999
Q ss_pred cCCCCCceEEeCCCCeEEEEeccccccccccc-c-----ccc--ccccCCCCCCCcccccccCCCCCCCCccccccchhh
Q 015991 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI-N-----YIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 357 (397)
Q Consensus 286 rDIKp~NILl~~~~~~~kL~DFGla~~~~~~~-~-----~~~--~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~ 357 (397)
||||-+||||+.++ +.||||||.|+...... + +.. -....|+-|.|||++. .
T Consensus 170 RDLKiENvLls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID-------------------l 229 (738)
T KOG1989|consen 170 RDLKIENVLLSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID-------------------L 229 (738)
T ss_pred hhhhhhheEEcCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHh-------------------h
Confidence 99999999999998 99999999986432211 0 000 1236799999999886 4
Q ss_pred hhccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 358 LWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 358 ~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
......++|+|||+|||+||-||+...||...
T Consensus 230 ysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 230 YSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred hcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 44567889999999999999999999999766
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=274.38 Aligned_cols=200 Identities=22% Similarity=0.301 Sum_probs=155.5
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc--
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (397)
.++|++.+.||+|+||.||++.+..++ +.+++|++.... ........++...+....|++++.+++.+...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCC-----ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 479999999999999999999988776 788899876432 11222222334455666789998887765432
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 214 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
....++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~~----------------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp 147 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHhh----------------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 2457999999985 56665543 245677888999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++..... .......+|+.|+|||++.+. .++.++|||
T Consensus 148 ~Nill~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~Diw 202 (355)
T cd07874 148 SNIVVKSDC-TLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGM----------------------GYKENVDIW 202 (355)
T ss_pred HHEEECCCC-CEEEeeCcccccCCCc--cccCCccccCCccCHHHHcCC----------------------CCCchhhHH
Confidence 999999987 9999999999765332 223456789999999966443 455678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 203 slG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 203 SVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=276.44 Aligned_cols=231 Identities=19% Similarity=0.226 Sum_probs=163.0
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
.+..++|+++++||+|+||.||+|++...........+++|.++.... .+.....++...+... +|+|++.+++.+.
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~- 109 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT- 109 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec-
Confidence 345578999999999999999999864332222236788998864322 1222222334444444 7999999988664
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchh--------------------------hhhccc------cc---------
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQ--------------------------TLILGE------VQ--------- 251 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~--------------------------~~~~~~------~~--------- 251 (397)
.++..++||||+++|+|.++++.....+... +++... ..
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 4567899999999999999997654211110 000000 00
Q ss_pred --------------cCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEeccccccccccc
Q 015991 252 --------------DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317 (397)
Q Consensus 252 --------------~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~ 317 (397)
.......+++..+..++.|++.||+|||+.||+||||||+|||+++++ .+||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDS 268 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCcc
Confidence 001123578889999999999999999999999999999999999876 99999999998664433
Q ss_pred ccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-CCCCCCCC
Q 015991 318 NYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 318 ~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt-g~~Pf~~~ 389 (397)
... .....++..|+|||++.+. .++.++|||||||++|||++ |..||...
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNC----------------------VYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred cccccCCCCCCcceeChhHhcCC----------------------CCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 221 1223456789999966543 45567799999999999997 89998654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=276.35 Aligned_cols=232 Identities=19% Similarity=0.215 Sum_probs=166.9
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (397)
.+...++|+++++||+|+||.||+|++...........+++|++..... .+.....++...+... .|+|++.+++.+.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3456689999999999999999999986554444446789998864332 2222233344455555 4999999998764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhh----------------------h------------------------
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQT----------------------L------------------------ 245 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~----------------------~------------------------ 245 (397)
.++..++||||+.+|+|.+++......+.... +
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 45689999999999999999876431100000 0
Q ss_pred ------------------------------hccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 246 ------------------------------ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 246 ------------------------------~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.............+++..+..++.|++.||+|||+.+|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 00000000112357788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++++ .+||+|||+++........ ......+++.|+|||++.+. .++.++|||||||
T Consensus 271 ~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DiwSlGv 327 (400)
T cd05105 271 AQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN----------------------LYTTLSDVWSYGI 327 (400)
T ss_pred eCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC----------------------CCCchhhHHHHHH
Confidence 9987 9999999999865433222 12334577899999966433 3556789999999
Q ss_pred HHHHHHc-CCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLH 389 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~ 389 (397)
++|||++ |..||...
T Consensus 328 il~ellt~g~~P~~~~ 343 (400)
T cd05105 328 LLWEIFSLGGTPYPGM 343 (400)
T ss_pred HHHHHHHCCCCCCccc
Confidence 9999996 99998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=267.05 Aligned_cols=205 Identities=19% Similarity=0.256 Sum_probs=158.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||.||+|++..++ +.+++|.+...... ......++...+...+|++++.+.+.+. .++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~ 77 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-TDK 77 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCC-----CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-eCC
Confidence 3478999999999999999999988776 77888877633211 1112223444556667899998888664 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill 137 (309)
T cd07872 78 SLTLVFEYLDK-DLKQYMDDCG-------------------NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI 137 (309)
T ss_pred eEEEEEeCCCC-CHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 89999999985 7887775532 135677788999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+++........ .....+|+.|+|||++.+.. .++.++|||||||+
T Consensus 138 ~~~~-~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG~i 194 (309)
T cd07872 138 NERG-ELKLADFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLGSS---------------------EYSTQIDMWGVGCI 194 (309)
T ss_pred CCCC-CEEECccccceecCCCccc-cccccccccccCCHHHhCCC---------------------CCCcHHHHHHHHHH
Confidence 9987 9999999999764333221 23456789999999764321 35567899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||...+
T Consensus 195 l~el~tg~~pf~~~~ 209 (309)
T cd07872 195 FFEMASGRPLFPGST 209 (309)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=261.96 Aligned_cols=202 Identities=19% Similarity=0.208 Sum_probs=159.2
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.|++.+.||+|+||.||++.+..++ +.+++|.+..... ........+...+....|++++.+.+.+.. ++.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCC-----ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCE
Confidence 4788899999999999999999887 7888887754321 111122234455666788999888776644 468
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~ 136 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMG------------------EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD 136 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC
Confidence 999999999999999886542 12467788899999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||++........ .....||..|+|||++.+. .++.++|+||+|+++
T Consensus 137 ~~~-~~~l~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DiwslG~~l 191 (285)
T cd05630 137 DHG-HIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNE----------------------RYTFSPDWWALGCLL 191 (285)
T ss_pred CCC-CEEEeeccceeecCCCcc--ccCCCCCccccChHHHcCC----------------------CCCCccccHHHHHHH
Confidence 987 899999999976543322 2345789999999966443 455667999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 192 ~~l~~g~~Pf~~~~ 205 (285)
T cd05630 192 YEMIAGQSPFQQRK 205 (285)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=291.51 Aligned_cols=213 Identities=23% Similarity=0.267 Sum_probs=161.7
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.++||+|+||.||+|++..++ +.+++|++..... .......++...+....|++++.+++... .++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg-----~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCS-----RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-DGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCC-----cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-eCC
Confidence 68999999999999999999998876 7899998864321 11122233455666778999999887654 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+++++|.+++......... ........+...+..++.|++.||+|||++||+||||||+|||+
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l---------~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL 146 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESL---------SKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL 146 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhcccc---------chhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE
Confidence 899999999999999998753210000 00012234567788999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccc-----------------ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhh
Q 015991 296 SEGSRTFKIIDLGAAADLRVGI-----------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 358 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~-----------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~ 358 (397)
+.++ .+||+|||+++...... ........||+.|||||++.+.
T Consensus 147 d~dg-~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~------------------- 206 (932)
T PRK13184 147 GLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV------------------- 206 (932)
T ss_pred cCCC-CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-------------------
Confidence 9987 99999999997652110 0112235799999999965443
Q ss_pred hccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 359 WQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 359 ~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
.++.++|||||||++|||++|..||...
T Consensus 207 ---~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 207 ---PASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred ---CCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 4556779999999999999999999754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=267.15 Aligned_cols=209 Identities=18% Similarity=0.158 Sum_probs=160.0
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+...+|++.+.||+|+||.||+|++..++... ...+++|....... .......++...+....|+|++.+++.+..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-- 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKV-KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-- 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCcc-ceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--
Confidence 45579999999999999999999986654322 23578888764322 222223334456667789999999887654
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++++||+.+|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nil 141 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHK-------------------DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVL 141 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhcc-------------------ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 35789999999999999987643 13566778899999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++++ .+||+|||+++.+....... .....++..|+|||++. ...++.++||||||
T Consensus 142 l~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~----------------------~~~~~~~~Di~slG 198 (316)
T cd05108 142 VKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL----------------------HRIYTHQSDVWSYG 198 (316)
T ss_pred ecCCC-cEEEccccccccccCCCcceeccCCccceeecChHHhc----------------------cCCCCchhhhHHHH
Confidence 99987 99999999998765433221 12234467899999554 33466778999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
+++|||++ |..||...
T Consensus 199 v~l~el~t~g~~p~~~~ 215 (316)
T cd05108 199 VTVWELMTFGSKPYDGI 215 (316)
T ss_pred HHHHHHHcCCCCCCCCC
Confidence 99999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.00 Aligned_cols=219 Identities=18% Similarity=0.226 Sum_probs=180.7
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+..+...+.+.||+|.||.||+|.............|++|.+.+.. ..+....-++...+.+.+|+||+.+++.+.. .
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-S 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-C
Confidence 4457888999999999999999998776544334668999888653 4445555667778889999999999998877 6
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...+|++|||.+|+|..++++..-.. .....++......++.|||+|+.||+++++|||||..+|+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~-------------~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCL 834 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAP-------------FQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCL 834 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhccccc-------------CCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhhee
Confidence 67899999999999999998763110 11346677889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccc-cCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEF-LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|+... .+||+|||+|+++...+.++.... ....+||||| ++.++.++.|+||||||
T Consensus 835 L~~~r-~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PE----------------------sl~d~iFtskSDvWsFG 891 (1025)
T KOG1095|consen 835 LDERR-VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPE----------------------SLKDGIFTSKSDVWSFG 891 (1025)
T ss_pred ecccC-cEEEcccchhHhhhhchheeccCccccceecCCHH----------------------HHhhcccccccchhhhH
Confidence 99986 999999999998777666665544 5567999999 77778888999999999
Q ss_pred HHHHHHHc-CCCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~~ 391 (397)
|+|||+++ |..||....+
T Consensus 892 VllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 892 VLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred HHHHHHHhCCCCCCCCcch
Confidence 99999987 8888866554
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=272.22 Aligned_cols=199 Identities=22% Similarity=0.285 Sum_probs=155.1
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWR 222 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e 222 (397)
+.||+|+||.||++++..... ..+.+++|.+..... .+......+...+...+|+|++.+++.+. .++.+++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPD--AGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-TEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-cCCEEEEEEc
Confidence 689999999999998643211 126788888764321 12222333455667778999999877654 4578999999
Q ss_pred ecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeE
Q 015991 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302 (397)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~ 302 (397)
|+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+++++ .+
T Consensus 79 ~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~ 137 (318)
T cd05582 79 FLRGGDLFTRLSKEV--------------------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HI 137 (318)
T ss_pred CCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cE
Confidence 999999999886543 467888999999999999999999999999999999999987 99
Q ss_pred EEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcC
Q 015991 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCT 382 (397)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg 382 (397)
||+|||+++....... ......||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 138 kL~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DiwslG~il~el~tg 194 (318)
T cd05582 138 KLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRR----------------------GHTQSADWWSFGVLMFEMLTG 194 (318)
T ss_pred EEeeccCCcccCCCCC-ceecccCChhhcCHHHHcCC----------------------CCCCccceeccceEeeeeccC
Confidence 9999999976533321 22346799999999966543 345677999999999999999
Q ss_pred CCCCCCCC
Q 015991 383 VRRLCLHS 390 (397)
Q Consensus 383 ~~Pf~~~~ 390 (397)
+.||....
T Consensus 195 ~~p~~~~~ 202 (318)
T cd05582 195 SLPFQGKD 202 (318)
T ss_pred CCCCCCCC
Confidence 99997654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=269.80 Aligned_cols=232 Identities=20% Similarity=0.205 Sum_probs=165.1
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhc-cCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACAN-CCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~ 213 (397)
+..++|++.+.||+|+||+||+|.+.........+.+++|.+..... .+.....++...+.. .+|++++.+++.+...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 45579999999999999999999876544444457899998865332 222222222333333 3688999888877666
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchh------------------hhhcccc-------------------------
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQ------------------TLILGEV------------------------- 250 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~------------------~~~~~~~------------------------- 250 (397)
+...+++|||+++|+|.+++......+... +......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 678899999999999999997653211100 0000000
Q ss_pred ----ccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEeccccccccccccc-cccccc
Q 015991 251 ----QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFL 325 (397)
Q Consensus 251 ----~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~ 325 (397)
........+++..+..++.|++.||+|||++||+||||||+|||+++++ .+||+|||++......... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCC
Confidence 0000123467888899999999999999999999999999999999887 9999999999765333221 122344
Q ss_pred CCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-CCCCCCCCC
Q 015991 326 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 326 gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
++..|+|||++.+. .++.++|+||||+++|||++ |..||....
T Consensus 243 ~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 243 LPLKWMAPETIFDR----------------------VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCcceECcHHhcCC----------------------CCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 56789999966433 45567899999999999996 999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=256.95 Aligned_cols=200 Identities=28% Similarity=0.374 Sum_probs=161.2
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHH--HHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMN--ERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~--~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
|+++++||+|+||+||++.+..++ +.+++|............. .++........|++++.+++.... +...+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNG-----QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTT-----EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCC-----eEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-ccccc
Confidence 789999999999999999999887 7899998876544333221 223444555578999888776644 67888
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
++|||+.+++|.+++.... .+++..+..++.|+++||++||+.||+|+||||+||+++.+
T Consensus 75 ~v~~~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~ 134 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNK--------------------PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN 134 (260)
T ss_dssp EEEEEETTEBHHHHHHHHS--------------------SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT
T ss_pred ccccccccccccccccccc--------------------ccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999998433 56788899999999999999999999999999999999987
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||.+...... ........+|..|+|||++.. ...++.++|+||+|+++|+
T Consensus 135 ~-~~~l~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---------------------~~~~~~~~Di~slG~il~~ 191 (260)
T PF00069_consen 135 G-EVKLIDFGSSVKLSEN-NENFNPFVGTPEYMAPEVLQQ---------------------GKKYTRKSDIWSLGIILYE 191 (260)
T ss_dssp S-EEEESSGTTTEESTST-TSEBSSSSSSGGGSCHHHHTT---------------------TSSBSTHHHHHHHHHHHHH
T ss_pred c-cccccccccccccccc-ccccccccccccccccccccc---------------------ccccccccccccccccccc
Confidence 7 9999999999754211 222345678999999997651 2245667899999999999
Q ss_pred HHcCCCCCCCC
Q 015991 379 MVCTVRRLCLH 389 (397)
Q Consensus 379 lltg~~Pf~~~ 389 (397)
|++|..||...
T Consensus 192 l~~~~~p~~~~ 202 (260)
T PF00069_consen 192 LLTGKLPFEES 202 (260)
T ss_dssp HHHSSSSSTTS
T ss_pred ccccccccccc
Confidence 99999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=282.11 Aligned_cols=199 Identities=24% Similarity=0.330 Sum_probs=167.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHH-HHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNE-RVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~-~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+.|.-.+.||.|+||.||-|++..+. ..|+||++.-.+ ..+.|... .+.+.+....|||.+.+-+++ ..+.
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~-----evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy-Lre~ 99 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY-LREH 99 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCcc-----ceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee-eccc
Confidence 45777889999999999999998887 899999997543 44555443 456778888999999987755 5567
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..|||||||- |+-.|++.-... .+-+..|..|+.+.+.||.|||+.+.||||||..|||+
T Consensus 100 TaWLVMEYCl-GSAsDlleVhkK-------------------plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL 159 (948)
T KOG0577|consen 100 TAWLVMEYCL-GSASDLLEVHKK-------------------PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL 159 (948)
T ss_pred hHHHHHHHHh-ccHHHHHHHHhc-------------------cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe
Confidence 7999999998 578888876543 34566788999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++.+ .+||+|||.|....+ .++++|||.|||||++. .+..+.|+.|+||||||++
T Consensus 160 se~g-~VKLaDFGSAsi~~P-----AnsFvGTPywMAPEVIL-------------------AMDEGqYdgkvDvWSLGIT 214 (948)
T KOG0577|consen 160 SEPG-LVKLADFGSASIMAP-----ANSFVGTPYWMAPEVIL-------------------AMDEGQYDGKVDVWSLGIT 214 (948)
T ss_pred cCCC-eeeeccccchhhcCc-----hhcccCCccccchhHhe-------------------eccccccCCccceeeccch
Confidence 9998 999999999977543 36789999999999886 5667889999999999999
Q ss_pred HHHHHcCCCCCCC
Q 015991 376 FLQMVCTVRRLCL 388 (397)
Q Consensus 376 l~elltg~~Pf~~ 388 (397)
..||.-.++|+..
T Consensus 215 CIELAERkPPlFn 227 (948)
T KOG0577|consen 215 CIELAERKPPLFN 227 (948)
T ss_pred hhhhhhcCCCccC
Confidence 9999999998753
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=262.02 Aligned_cols=226 Identities=20% Similarity=0.277 Sum_probs=167.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.+.||+|+||.||+|.+...+.....+.+++|.+......+ .....++...+....|++++.+++.+. ...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-KEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-CCC
Confidence 346899999999999999999998776544555678889886543222 222233455566678999998887654 446
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+.+++|.+++............. ........+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAES----GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCccccccc----ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 7899999999999999998653211110000 000112356788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++++ .++|+|||+++........ ......+|+.|+|||.+... .++.++|||||||
T Consensus 158 ~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sDv~slG~ 214 (283)
T cd05048 158 GEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG----------------------KFTTESDIWSFGV 214 (283)
T ss_pred cCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC----------------------cCchhhhHHHHHH
Confidence 9987 9999999999765433222 23345678899999965433 4556789999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |..||....
T Consensus 215 il~el~~~g~~p~~~~~ 231 (283)
T cd05048 215 VLWEIFSYGLQPYYGFS 231 (283)
T ss_pred HHHHHHcCCCCCCCCCC
Confidence 9999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=260.10 Aligned_cols=202 Identities=18% Similarity=0.200 Sum_probs=158.5
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.|+..+.||+|+||+||+|.+..++ +.+++|.+..... .......++...+....|++++.+...+. .++.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATG-----KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-TKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCC-----cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-cCCE
Confidence 3778899999999999999998876 7888887754321 11122233445566667888888776554 3568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.+++|||+.+++|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~ 136 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMG------------------NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136 (285)
T ss_pred EEEEEEeccCccHHHHHHHhc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC
Confidence 999999999999998886532 12467888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||++........ .....|+..|+|||.+.+. .++.++|+||||+++
T Consensus 137 ~~~-~~kl~Dfg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~----------------------~~~~~~Di~slG~~l 191 (285)
T cd05632 137 DYG-HIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQ----------------------RYTLSPDYWGLGCLI 191 (285)
T ss_pred CCC-CEEEecCCcceecCCCCc--ccCCCCCcCccChHHhcCC----------------------CCCcccchHHHHHHH
Confidence 987 999999999976533221 2345789999999966443 355667999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|..||....
T Consensus 192 ~~l~~g~~P~~~~~ 205 (285)
T cd05632 192 YEMIEGQSPFRGRK 205 (285)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=260.03 Aligned_cols=194 Identities=21% Similarity=0.214 Sum_probs=151.8
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
||+|+||.||++++..++ +.+++|.+...... .......+...+...+|++++.+...+. .+...++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTG-----KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-SKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCC-----cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-cCCeEEEEEec
Confidence 799999999999998877 78888877532211 1111122344556678999998877653 45789999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+||++++++ .++
T Consensus 75 ~~g~~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~ 135 (277)
T cd05607 75 MNGGDLKYHIYNVG------------------ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCR 135 (277)
T ss_pred CCCCCHHHHHHhcc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEE
Confidence 99999998886542 12356778889999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCC
Q 015991 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTV 383 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~ 383 (397)
|+|||++........ .....||+.|+|||++.+. .++.++|+||+||++|||++|+
T Consensus 136 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwslGv~l~el~~g~ 191 (277)
T cd05607 136 LSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEE----------------------PYSYPVDWFAMGCSIYEMVAGR 191 (277)
T ss_pred EeeceeeeecCCCce--eeccCCCCCccCHHHHccC----------------------CCCCchhHHHHHHHHHHHHhCC
Confidence 999999976543321 2345789999999965433 3556779999999999999999
Q ss_pred CCCCCC
Q 015991 384 RRLCLH 389 (397)
Q Consensus 384 ~Pf~~~ 389 (397)
.||...
T Consensus 192 ~p~~~~ 197 (277)
T cd05607 192 TPFKDH 197 (277)
T ss_pred CCCCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=257.55 Aligned_cols=205 Identities=19% Similarity=0.233 Sum_probs=158.8
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|++.++||+|+||.||+|.+..+ ..+++|.+...... .....++...+....|++++.+++... .++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~------~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 74 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT-KEE 74 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCC------ceEEEEEccCCchh-HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCC
Confidence 4558999999999999999999986544 56888877643221 122223344555667999998877654 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++++||+.+++|.+++.... +..+++..+..++.|++.||+|||+.+++||||||+||++
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili 136 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDE------------------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV 136 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe
Confidence 7899999999999999987642 2245677788999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .++|+|||++...............++..|+|||.+.+. .++.++|+||||++
T Consensus 137 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~~ 193 (261)
T cd05072 137 SESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG----------------------SFTIKSDVWSFGIL 193 (261)
T ss_pred cCCC-cEEECCCccceecCCCceeccCCCccceecCCHHHhccC----------------------CCChhhhhhhhHHH
Confidence 9987 999999999987644332222334567789999966443 34556799999999
Q ss_pred HHHHHc-CCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLH 389 (397)
Q Consensus 376 l~ellt-g~~Pf~~~ 389 (397)
+|||++ |..||...
T Consensus 194 l~~l~t~g~~p~~~~ 208 (261)
T cd05072 194 LYEIVTYGKIPYPGM 208 (261)
T ss_pred HHHHHccCCCCCCCC
Confidence 999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=259.40 Aligned_cols=206 Identities=21% Similarity=0.323 Sum_probs=162.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||.||+|++..++ +.+++|.............+++...+....|++++.+++.+. .++.
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-~~~~ 80 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTG-----ELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-SREK 80 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCC-----eEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-eCCE
Confidence 3478999999999999999999987776 778888876443333333334455666778999998887654 4568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++|+||+++++|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~ 140 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVTG--------------------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 999999999999999886543 356788889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||++..+..... ......+++.|+|||.+..... ..++.++|+||+||++
T Consensus 141 ~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~-------------------~~~~~~~Dvws~G~il 199 (267)
T cd06646 141 DNG-DVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKN-------------------GGYNQLCDIWAVGITA 199 (267)
T ss_pred CCC-CEEECcCccceeeccccc-ccCccccCccccCHhHcccccC-------------------CCCcchhhHHHHHHHH
Confidence 887 899999999986533221 2234578899999997643221 1345678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|..||...
T Consensus 200 ~el~~g~~p~~~~ 212 (267)
T cd06646 200 IELAELQPPMFDL 212 (267)
T ss_pred HHHHhCCCCcccc
Confidence 9999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=291.77 Aligned_cols=214 Identities=21% Similarity=0.273 Sum_probs=164.8
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.....++|++.++||+|+||+||+|++..++ ..+++|.+.... .........+...+....|++|+.+++.+.
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg-----~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQ-----EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCC-----eEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 3456689999999999999999999998876 677777765322 222233334556667778999999988664
Q ss_pred cc-CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-------Cc
Q 015991 212 KK-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-------GI 283 (397)
Q Consensus 212 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-------gi 283 (397)
.. ...+||||||+.+++|.+++.... .....+++..++.|+.||+.||.|||+. +|
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~----------------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~I 146 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCY----------------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERV 146 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHh----------------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCc
Confidence 43 467899999999999999987532 0123578889999999999999999985 49
Q ss_pred eecCCCCCceEEeCCC----------------CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCC
Q 015991 284 VHRDIKPQNVIFSEGS----------------RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347 (397)
Q Consensus 284 iHrDIKp~NILl~~~~----------------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~ 347 (397)
|||||||+||||+.+. ..+||+|||++..+.... ......||+.|+|||++.+..
T Consensus 147 VHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~------- 217 (1021)
T PTZ00266 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHET------- 217 (1021)
T ss_pred eeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccC-------
Confidence 9999999999996421 258999999998654332 234567999999999775432
Q ss_pred ccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 348 APVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++|||||||+||||++|..||....
T Consensus 218 -------------~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 218 -------------KSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred -------------CCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 135667899999999999999999996543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=260.08 Aligned_cols=220 Identities=18% Similarity=0.225 Sum_probs=162.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.+.||+|+||.||+|.+...........+++|+...... .+.....++...+....|++++.+++.+ ..+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-SQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCC
Confidence 4578999999999999999999876543333336788988754322 1222222334556667899999988765 4456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++++|.+++........ .......+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~ 152 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEME----------NNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 152 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCcccc----------ccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE
Confidence 78999999999999999976431100 00112245677888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++++ .++|+|||+++......... .....+++.|+|||++.+ ..++.++|+|||||
T Consensus 153 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~ 209 (277)
T cd05062 153 AEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD----------------------GVFTTYSDVWSFGV 209 (277)
T ss_pred cCCC-CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc----------------------CCcCchhHHHHHHH
Confidence 9987 99999999997654333222 122355788999996543 34556779999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |..||....
T Consensus 210 ~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 210 VLWEIATLAEQPYQGMS 226 (277)
T ss_pred HHHHHHcCCCCCCCCCC
Confidence 9999999 788886543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=260.09 Aligned_cols=208 Identities=24% Similarity=0.395 Sum_probs=159.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc-----
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK----- 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~----- 213 (397)
+.|++.+.||+|+||.||+|.+..++ +.+++|........+.....++........|++++.+.+.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCC-----cEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 67889999999999999999988776 77888877543322222222222222223688988887765432
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...+|++|||+++++|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ni 142 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK------------------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 142 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHE
Confidence 256899999999999999987632 22467788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
++++++ .++|+|||++........ ......|++.|+|||++...... +..++.++|+||||
T Consensus 143 li~~~~-~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~-----------------~~~~~~~~Dv~slG 203 (272)
T cd06637 143 LLTENA-EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENP-----------------DATYDFKSDLWSLG 203 (272)
T ss_pred EECCCC-CEEEccCCCceecccccc-cCCcccccccccCHhHhccccCc-----------------CCCCCchhhHHHHH
Confidence 999987 999999999976543222 23456789999999987643221 12466788999999
Q ss_pred HHHHHHHcCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCL 388 (397)
Q Consensus 374 v~l~elltg~~Pf~~ 388 (397)
|++|||++|..||..
T Consensus 204 v~l~el~~g~~p~~~ 218 (272)
T cd06637 204 ITAIEMAEGAPPLCD 218 (272)
T ss_pred HHHHHHHhCCCCccc
Confidence 999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=256.93 Aligned_cols=204 Identities=14% Similarity=0.225 Sum_probs=157.9
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.+.||+|+||.||++.+... ..+++|........+. ....+...+...+|++++.+++.+. .++..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~------~~~a~K~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQ------IKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT-QQKPL 74 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccC------ceEEEEecccCCccHH-HHHHHHHHHHHCCCCCceeEEEEEc-cCCCE
Confidence 36899999999999999999987653 5688887664332222 1223444556677999998887653 45679
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||++++
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQ-------------------GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 99999999999999887542 13567888999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||.++..............++..|+|||++.+. .++.++|+||||+++|
T Consensus 136 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~s~G~~l~ 192 (256)
T cd05114 136 TG-VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS----------------------KYSSKSDVWSFGVLMW 192 (256)
T ss_pred CC-eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccC----------------------ccchhhhhHHHHHHHH
Confidence 87 999999999976543322222233456789999966433 3556789999999999
Q ss_pred HHHc-CCCCCCCCCC
Q 015991 378 QMVC-TVRRLCLHSC 391 (397)
Q Consensus 378 ellt-g~~Pf~~~~~ 391 (397)
||++ |+.||.....
T Consensus 193 el~~~g~~p~~~~~~ 207 (256)
T cd05114 193 EVFTEGKMPFEKKSN 207 (256)
T ss_pred HHHcCCCCCCCCCCH
Confidence 9999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=260.17 Aligned_cols=226 Identities=21% Similarity=0.280 Sum_probs=169.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|.+.+.||+|+||.||+|.+...........+++|..............++...+....|++++.+.+.+. .++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 81 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-DGDP 81 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-cCCc
Confidence 446899999999999999999987654434444668888877655443333444556667778999999888664 4567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++......... .. ..........+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMI--LV--DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCccccc--cc--ccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 99999999999999999876432110 00 001111223578889999999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+++ .++|+|||+++........ ......++..|+|||.+.+. .++.++||||||++
T Consensus 158 ~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~i 214 (291)
T cd05094 158 ANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR----------------------KFTTESDVWSFGVI 214 (291)
T ss_pred cCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC----------------------CCCchhhHHHHHHH
Confidence 987 9999999999765433221 22334567899999965433 35567899999999
Q ss_pred HHHHHc-CCCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLHS 390 (397)
Q Consensus 376 l~ellt-g~~Pf~~~~ 390 (397)
+|||++ |..||....
T Consensus 215 l~el~t~g~~p~~~~~ 230 (291)
T cd05094 215 LWEIFTYGKQPWFQLS 230 (291)
T ss_pred HHHHHhCCCCCCCCCC
Confidence 999998 999985543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=269.23 Aligned_cols=199 Identities=23% Similarity=0.315 Sum_probs=156.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeeccccc---
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (397)
++|++.+.||+|+||+||+|.+..++ +.+++|++..... .......++...+....|++++.+++.+...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCC-----CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 78999999999999999999988776 7889998764321 1122222345566677889998887654322
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 214 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
....+++++++ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~---------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~ 147 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ---------------------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPS 147 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 24578999988 57888877543 3577889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||+++++ .+||+|||+++..... .....||+.|+|||++.+.. .++.++||||
T Consensus 148 Nil~~~~~-~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diws 201 (343)
T cd07878 148 NVAVNEDC-ELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWM---------------------HYNQTVDIWS 201 (343)
T ss_pred hEEECCCC-CEEEcCCccceecCCC----cCCccccccccCchHhcCCc---------------------cCCchhhhHh
Confidence 99999987 9999999999865432 24467899999999765321 3556789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|+.||....
T Consensus 202 lG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 202 VGCIMAELLKGKALFPGND 220 (343)
T ss_pred HHHHHHHHHHCCCCCCCCC
Confidence 9999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=259.24 Aligned_cols=210 Identities=16% Similarity=0.187 Sum_probs=160.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+..++|++.+.||+|+||+||+|.+..++...+ ..+++|....... ........+...+....|+|++.+++... +
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIK-IPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCcee-eEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--C
Confidence 455799999999999999999999876553221 2467777654332 22222333344556778999999888653 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++++||+.+++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+|||
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nil 141 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-------------------DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 55789999999999999997643 14577888999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++++ .+||+|||+++.+..... .......++..|++||.+.+ ..++.++||||||
T Consensus 142 i~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~----------------------~~~~~~~Dv~slG 198 (279)
T cd05111 142 LKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF----------------------GRYTHQSDVWSYG 198 (279)
T ss_pred EcCCC-cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc----------------------CCcCchhhHHHHH
Confidence 99987 999999999986543322 12234456778999996543 3456678999999
Q ss_pred HHHHHHHc-CCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~ 390 (397)
+++|||++ |..||....
T Consensus 199 ~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 199 VTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred HHHHHHHcCCCCCCCCCC
Confidence 99999998 999997643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=260.49 Aligned_cols=206 Identities=21% Similarity=0.344 Sum_probs=164.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
...++|++.++||+|+||.||+|++..++ +.+++|.+......+.....++...+....|++++.+++... .++
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-~~~ 79 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTG-----ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-RRD 79 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCC-----cEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCC
Confidence 34478999999999999999999988776 778888776544333333344455666778999999988664 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++++||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||||+||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili 139 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG--------------------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL 139 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 8999999999999999987543 46788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .++|+|||++........ ......||..|+|||++.... ...++.++|+|||||+
T Consensus 140 ~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-------------------~~~~~~~~DvwSlG~i 198 (267)
T cd06645 140 TDNG-HVKLADFGVSAQITATIA-KRKSFIGTPYWMAPEVAAVER-------------------KGGYNQLCDIWAVGIT 198 (267)
T ss_pred CCCC-CEEECcceeeeEccCccc-ccccccCcccccChhhhcccc-------------------CCCCCchhhhHHHHHH
Confidence 9887 999999999876543221 234467899999999764221 1235567899999999
Q ss_pred HHHHHcCCCCCCC
Q 015991 376 FLQMVCTVRRLCL 388 (397)
Q Consensus 376 l~elltg~~Pf~~ 388 (397)
+|||++|..||..
T Consensus 199 l~~l~~~~~p~~~ 211 (267)
T cd06645 199 AIELAELQPPMFD 211 (267)
T ss_pred HHHHhcCCCCccc
Confidence 9999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=258.34 Aligned_cols=204 Identities=15% Similarity=0.204 Sum_probs=157.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||.||+|.+..+ ..+++|++........ ...++...+....|++++.+++.. .+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~------~~valK~~~~~~~~~~-~~~~E~~~l~~l~~~~i~~~~~~~--~~~~ 74 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV--SEEP 74 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC------ceEEEEecccCccCHH-HHHHHHHHHHhCCCCCcceEEEEE--CCCC
Confidence 447899999999999999999987654 4588888874332111 122334455556788988887654 2456
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++.... +..+++..+..++.|++.||+|||+.+|+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~ 136 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEM------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG 136 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhcc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc
Confidence 899999999999999997532 12456788899999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||.++.+............++..|+|||+..+ ..++.++|+||||+++
T Consensus 137 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----------------------~~~~~~~DvwslG~~l 193 (262)
T cd05071 137 ENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY----------------------GRFTIKSDVWSFGILL 193 (262)
T ss_pred CCC-cEEeccCCceeeccccccccccCCcccceecCHhHhcc----------------------CCCCchhhHHHHHHHH
Confidence 987 99999999997665433222233456778999995533 3456678999999999
Q ss_pred HHHHc-CCCCCCCCC
Q 015991 377 LQMVC-TVRRLCLHS 390 (397)
Q Consensus 377 ~ellt-g~~Pf~~~~ 390 (397)
|||++ |..||....
T Consensus 194 ~ellt~g~~p~~~~~ 208 (262)
T cd05071 194 TELTTKGRVPYPGMV 208 (262)
T ss_pred HHHHcCCCCCCCCCC
Confidence 99999 888886543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=272.81 Aligned_cols=200 Identities=20% Similarity=0.194 Sum_probs=156.4
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
..+|++.++||+|+||.||++...+... .+.+++|.+...... .++...+...+|++++.+++.+. .+...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~---~~~v~vK~~~~~~~~-----~~E~~il~~l~h~~iv~~~~~~~-~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQ---RKKVIVKAVTGGKTP-----GREIDILKTISHRAIINLIHAYR-WKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCcc---ceeEEEEeccccccH-----HHHHHHHHhcCCCCccceeeeEe-eCCEE
Confidence 4689999999999999999997654321 267788877643221 23344555667899998877654 35689
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
+++||++. ++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~--------------------~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~ 220 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSG--------------------PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE 220 (392)
T ss_pred EEEehhcC-CCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC
Confidence 99999997 57888774332 4678889999999999999999999999999999999999
Q ss_pred CCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
++ .+||+|||+++.+...... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 221 ~~-~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DvwslGvil 277 (392)
T PHA03207 221 PE-NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD----------------------PYCAKTDIWSAGLVL 277 (392)
T ss_pred CC-CEEEccCccccccCcccccccccccccccCccCHhHhcCC----------------------CCCchhhHHHHHHHH
Confidence 87 9999999999766543222 12346799999999966543 355678999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 278 ~el~~g~~pf~~~~ 291 (392)
T PHA03207 278 FEMSVKNVTLFGKQ 291 (392)
T ss_pred HHHHHCCCCCCCCC
Confidence 99999999997644
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=259.03 Aligned_cols=222 Identities=19% Similarity=0.271 Sum_probs=165.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|.+.+.||+|+||.||++.............+++|.+............++...+....|++++.+++.+. .++.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 81 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-EGDP 81 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCc
Confidence 457999999999999999999986443222223567888876544333333334455666677899999887654 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++++||+.+++|.+++.........+. +......+++..+..++.|++.||+|||++|++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~ 154 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMA-------EGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCcccccc-------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 9999999999999999986543211111 111223578899999999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+++ .+||+|||+++........ ......++..|+|||++.+. .++.++|+|||||+
T Consensus 155 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sDiwslG~i 211 (288)
T cd05093 155 ENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR----------------------KFTTESDVWSLGVV 211 (288)
T ss_pred cCC-cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC----------------------CCCchhhHHHHHHH
Confidence 987 9999999999865433221 12234557889999966433 35567899999999
Q ss_pred HHHHHc-CCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLH 389 (397)
Q Consensus 376 l~ellt-g~~Pf~~~ 389 (397)
+|||++ |..||...
T Consensus 212 l~~l~t~g~~p~~~~ 226 (288)
T cd05093 212 LWEIFTYGKQPWYQL 226 (288)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=259.89 Aligned_cols=207 Identities=20% Similarity=0.300 Sum_probs=162.9
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.-.....+|++.+.||+|+||.||+|.+..++ +.+++|.+............++...+....|++++.+.+.+.
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~- 87 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL- 87 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCC-----cEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-
Confidence 33445579999999999999999999987776 778888776543322222333344555667899998887654
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+...++||||+.+++|.+++... .+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~N 146 (296)
T cd06654 88 VGDELWVVMEYLAGGSLTDVVTET---------------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146 (296)
T ss_pred eCCEEEEeecccCCCCHHHHHHhc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 456899999999999999998653 24567788999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|+++.++ .++|+|||++......... .....+++.|+|||.+... .++.++|+|||
T Consensus 147 ill~~~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~s~ 202 (296)
T cd06654 147 ILLGMDG-SVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK----------------------AYGPKVDIWSL 202 (296)
T ss_pred EEEcCCC-CEEECccccchhccccccc-cCcccCCccccCHHHHcCC----------------------CCCccchHHHH
Confidence 9999887 9999999998765433221 2345788999999966543 34456799999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||++|||++|+.||....
T Consensus 203 Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 203 GIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=257.37 Aligned_cols=207 Identities=15% Similarity=0.225 Sum_probs=160.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+...+|++.++||+|+||.||+|.+...+ +.+++|........ .....++...+....|++++.+++.+. .++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 75 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT-REP 75 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCC-----ceEEEEEecCCchH-HHHHHHHHHHHHhCCCCChhheEEEEc-CCC
Confidence 34468999999999999999999988766 78888887644322 112223344555567899998887654 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.++++|||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~ 137 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECN------------------RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE
Confidence 7899999999999999987542 1245777888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||++...............++..|+|||.+.+. .++.++|||||||+
T Consensus 138 ~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~i 194 (263)
T cd05052 138 GENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN----------------------KFSIKSDVWAFGVL 194 (263)
T ss_pred cCCC-cEEeCCCccccccccceeeccCCCCCccccCCHHHhccC----------------------CCCchhHHHHHHHH
Confidence 9887 999999999987654332222223446789999965443 34556799999999
Q ss_pred HHHHHc-CCCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLHS 390 (397)
Q Consensus 376 l~ellt-g~~Pf~~~~ 390 (397)
+|||++ |..||....
T Consensus 195 l~el~t~g~~p~~~~~ 210 (263)
T cd05052 195 LWEIATYGMSPYPGID 210 (263)
T ss_pred HHHHHcCCCCCCCCCC
Confidence 999998 999987643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=275.36 Aligned_cols=210 Identities=23% Similarity=0.251 Sum_probs=163.8
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
+.+.-++..+.++||+|+||.||+|+....+.... ..||+|..+.. ........-.+.+.....+|+|++.+++..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~-~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKV-VPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCcee-eeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34455677778999999999999999887654221 12788887742 233333333455666778999999999977
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. +..+++|||+|.||+|.++|+..+ ..++..+...++.+.+.||+|||++++|||||-.
T Consensus 231 ~~-~~Pl~ivmEl~~gGsL~~~L~k~~-------------------~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAA 290 (474)
T KOG0194|consen 231 VL-EEPLMLVMELCNGGSLDDYLKKNK-------------------KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAA 290 (474)
T ss_pred cC-CCccEEEEEecCCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhH
Confidence 55 467999999999999999999864 1466777889999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccccc-c-cccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIP-K-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~-~-~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
+|+|++.++ .+||+|||+++... .+.. . ......+|+|||. +..+-|+.++|
T Consensus 291 RNcL~~~~~-~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEt----------------------l~~~~~s~kTD 344 (474)
T KOG0194|consen 291 RNCLYSKKG-VVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPET----------------------LNTGIFSFKTD 344 (474)
T ss_pred HHheecCCC-eEEeCccccccCCc---ceeeccccccCcceecChhh----------------------hccCccccccc
Confidence 999999986 89999999997643 1211 1 2235679999994 44556778889
Q ss_pred hHHHHHHHHHHHc-CCCCCCCCC
Q 015991 369 IYSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
||||||++||+++ |..||.+-.
T Consensus 345 V~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 345 VWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred hhheeeeEEeeeccCCCCCCCCC
Confidence 9999999999998 888987654
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=277.27 Aligned_cols=204 Identities=24% Similarity=0.276 Sum_probs=169.7
Q ss_pred EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC-CeEEEE
Q 015991 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG-GEYWLI 220 (397)
Q Consensus 142 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~lv 220 (397)
+...+||+|+|-+||+|.+..++..++...+.+..+..... +......+.+++....|+||+.|+..+.... ..+-+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~-~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPE-ELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChH-HHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 34578999999999999998888666666555555443322 2234445678888899999999998766543 568899
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC--CceecCCCCCceEEeCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--GIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~--giiHrDIKp~NILl~~~ 298 (397)
+|.+..|+|..+.++.+ +.+.+.++.|++||++||.|||++ -|||||||-+||+|+.+
T Consensus 122 TEL~TSGtLr~Y~kk~~--------------------~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHR--------------------RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred eecccCCcHHHHHHHhc--------------------cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 99999999999999876 567788999999999999999988 59999999999999988
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
.+.+||+|+|+|+...... .....|||.|||||+|+ .+|++.+||||||++|+|
T Consensus 182 ~G~VKIGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-----------------------E~YnE~VDVYaFGMCmLE 235 (632)
T KOG0584|consen 182 LGEVKIGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-----------------------ENYNELVDVYAFGMCMLE 235 (632)
T ss_pred cCceeecchhHHHHhhccc---cceeccCccccChHHHh-----------------------hhcchhhhhhhhhHHHHH
Confidence 8899999999998875443 34589999999999876 358888999999999999
Q ss_pred HHcCCCCCCCCCCC
Q 015991 379 MVCTVRRLCLHSCP 392 (397)
Q Consensus 379 lltg~~Pf~~~~~~ 392 (397)
|+|+..||+-..+|
T Consensus 236 MvT~eYPYsEC~n~ 249 (632)
T KOG0584|consen 236 MVTSEYPYSECTNP 249 (632)
T ss_pred HHhccCChhhhCCH
Confidence 99999999877766
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=259.65 Aligned_cols=210 Identities=21% Similarity=0.299 Sum_probs=166.0
Q ss_pred HHhhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 130 ~~~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
+....+-..++|++.+.||+|+||.||++.+..++ +.+++|.+............++...+....|++++.+++.
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 84 (297)
T cd06656 10 SIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATG-----QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84 (297)
T ss_pred hhcccCChhhhceeeeeeccCCCeEEEEEEECCCC-----CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 33334445589999999999999999999987776 7888988865433333333334455666789999998876
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. .++..++||||+++++|.+++... .+++..+..++.|++.+|.|||+.||+|||||
T Consensus 85 ~~-~~~~~~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~ 142 (297)
T cd06656 85 YL-VGDELWVVMEYLAGGSLTDVVTET---------------------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142 (297)
T ss_pred Ee-cCCEEEEeecccCCCCHHHHHHhC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 64 456899999999999999998653 24667788999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++ .++|+|||++......... .....+++.|+|||.+.+ ..++.++|+
T Consensus 143 p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di 198 (297)
T cd06656 143 SDNILLGMDG-SVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR----------------------KAYGPKVDI 198 (297)
T ss_pred HHHEEECCCC-CEEECcCccceEccCCccC-cCcccCCccccCHHHHcC----------------------CCCCcHHHH
Confidence 9999999887 9999999999765433222 234578899999996543 345567899
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+++|+|++|..||....
T Consensus 199 ~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 199 WSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred HHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=254.95 Aligned_cols=202 Identities=21% Similarity=0.252 Sum_probs=160.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
++|++.+.||+|+||.||+|.+..++ +.+++|...... ..+....+++...+....|++++.+++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTG-----RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD- 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCC-----cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-
Confidence 57999999999999999999987776 778888765322 1122233444556677789999998887654
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++++||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 135 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYG--------------------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 468999999999999999987643 356778889999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccccc--ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
++++++ .++|+|||+++.......... ....++..|+|||++.+.. ++.++||||
T Consensus 136 lv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~Di~s 192 (263)
T cd06625 136 LRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG----------------------YGRKADVWS 192 (263)
T ss_pred EEcCCC-CEEEeecccceeccccccccccccCCCcCccccCcceeccCC----------------------CCchhhhHH
Confidence 999887 999999999976543221111 3456788999999775433 455679999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~ 389 (397)
+|+++|||++|+.||...
T Consensus 193 lG~il~el~~g~~p~~~~ 210 (263)
T cd06625 193 VGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred HHHHHHHHHhCCCCcccc
Confidence 999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=251.52 Aligned_cols=203 Identities=19% Similarity=0.270 Sum_probs=161.6
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||+|+||.||++.+..++ +.+++|++.... ..+....+++...+....|++++.+.+.+...+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDG-----KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCC-----cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEE
Confidence 5899999999999999999988776 778888876432 222223344455566667899998877665555678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++++||+++++|.+++.... ...+++.++..++.|++.||++||+.||+||||||+||+++.
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~------------------~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~ 137 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQK------------------GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR 137 (257)
T ss_pred EEEecccCCCcHHHHHHHhc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec
Confidence 99999999999999987532 224678889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++........ ......+++.|+|||++... .++.++|+||+|++++
T Consensus 138 ~~-~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~il~ 193 (257)
T cd08223 138 TN-IIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNK----------------------PYNYKSDVWALGCCVY 193 (257)
T ss_pred CC-cEEEecccceEEecccCC-ccccccCCcCccChhHhcCC----------------------CCCchhhhHHHHHHHH
Confidence 87 999999999976543222 23446789999999966543 3455679999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
||++|+.||...
T Consensus 194 ~l~~g~~~~~~~ 205 (257)
T cd08223 194 EMATLKHAFNAK 205 (257)
T ss_pred HHHcCCCCCCCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=262.74 Aligned_cols=207 Identities=22% Similarity=0.318 Sum_probs=152.2
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc-cCCeEEEEEE
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK-KGGEYWLIWR 222 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e 222 (397)
+++||+|+||+||+|++..... .+.+++|.+......... .++...+....|+|++.+.+.+.. .+...|+++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~---~~~~aiK~~~~~~~~~~~--~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKD---DRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCC---CceEEEEEECCCCCcHHH--HHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 5789999999999998754221 167888887654322221 233455566789999988776543 3457899999
Q ss_pred ecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe----CC
Q 015991 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS----EG 298 (397)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~----~~ 298 (397)
|+++ +|.+++....... .......+++..++.++.|++.||+|||++||+||||||+|||++ .+
T Consensus 81 ~~~~-~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~ 148 (317)
T cd07868 81 YAEH-DLWHIIKFHRASK-----------ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred ccCC-CHHHHHHhccccc-----------ccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCc
Confidence 9874 8888876543110 001223578888999999999999999999999999999999994 33
Q ss_pred CCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+ .+||+|||+|+........ ......+|+.|+|||++.+.. .++.++||||+||++
T Consensus 149 ~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwslG~il 206 (317)
T cd07868 149 G-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR---------------------HYTKAIDIWAIGCIF 206 (317)
T ss_pred C-cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCC---------------------CcCchhhHHHHHHHH
Confidence 3 8999999999865432211 123467899999999765432 355678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|+.||...
T Consensus 207 ~el~~g~~~f~~~ 219 (317)
T cd07868 207 AELLTSEPIFHCR 219 (317)
T ss_pred HHHHhCCCCccCC
Confidence 9999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=253.73 Aligned_cols=203 Identities=23% Similarity=0.238 Sum_probs=159.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-----hhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+|++++.||+|+||.||+|.+..++ +.+++|.+... ...+....+++...+....|++++.+.+.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTG-----RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCC-----cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 58999999999999999999988776 78888876421 112223334445566677899999988765433
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+..+++++||+++++|.+++.... .+++..+..++.|++.+|+|||+.+|+|+||||+|
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYG--------------------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGAN 136 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 356889999999999999987643 34667788999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|++++++ .++|+|||+++........ ......++..|+|||++.+. .++.++|+|
T Consensus 137 il~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~ 193 (265)
T cd06652 137 ILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE----------------------GYGRKADIW 193 (265)
T ss_pred EEecCCC-CEEECcCccccccccccccccccccCCCCccccChhhhcCC----------------------CCCcchhHH
Confidence 9999887 9999999999765422111 12335688999999976543 344567999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
|||+++|||++|+.||...
T Consensus 194 slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 194 SVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred HHHHHHHHHhhCCCCCCcc
Confidence 9999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=259.44 Aligned_cols=208 Identities=20% Similarity=0.209 Sum_probs=145.0
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHH--------HHHHHHHhhccCCCcee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWM--------NERVRRACANCCADFVY 204 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~--------~~~~~~~~~~~~~~~i~ 204 (397)
+..++|++.++||+|+||+||+|.+..+.... +.+++|....... .+... ............|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~--~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCIN--NQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccc--cceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34579999999999999999999987662211 4455554322111 11111 11112234455677777
Q ss_pred eeeecccccC---CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC
Q 015991 205 GFFENSSKKG---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281 (397)
Q Consensus 205 ~~~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~ 281 (397)
.+++...... ...+++++++.. ++.+.+.... ..++..+..++.|++.||+|||+.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~ 145 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--------------------CKNKKLIKNIMKDMLTTLEYIHEH 145 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc--------------------cCCHHHHHHHHHHHHHHHHHHHhC
Confidence 7766443322 234667776653 5555554321 235667889999999999999999
Q ss_pred CceecCCCCCceEEeCCCCeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccch
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~ 355 (397)
+|+||||||+|||++.++ .++|+|||+|+.+...... ......||+.|+|||++.+.
T Consensus 146 ~iiHrDiKp~Nill~~~~-~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~---------------- 208 (294)
T PHA02882 146 GISHGDIKPENIMVDGNN-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA---------------- 208 (294)
T ss_pred CeecCCCCHHHEEEcCCC-cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC----------------
Confidence 999999999999999887 9999999999876432211 11235799999999966544
Q ss_pred hhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 356 PVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 356 ~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
.++.++|||||||++|||++|..||...
T Consensus 209 ------~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 209 ------CVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred ------CCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 3556779999999999999999999766
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=257.88 Aligned_cols=224 Identities=20% Similarity=0.249 Sum_probs=166.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|.+.+.||+|+||.||+|.+.........+.+++|........ ......++...+....|++++.+++.+.. +.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CC
Confidence 34689999999999999999998865433333477889988654333 22233334455666778999888876644 46
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+++++|.+++...+....... ........+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili 155 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLK------SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV 155 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhc------ccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE
Confidence 89999999999999999987642111100 011223457888899999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+.++ .+||+|||+++........ ......+++.|+|||++.+. .++.++||||||+
T Consensus 156 ~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~ 212 (280)
T cd05049 156 GYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR----------------------KFTTESDVWSFGV 212 (280)
T ss_pred cCCC-eEEECCcccceecccCcceecCCCCcccceecChhhhccC----------------------CcchhhhHHHHHH
Confidence 9987 9999999999765332221 12334567899999966543 3555679999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |..||....
T Consensus 213 il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 213 VLWEIFTYGKQPWYGLS 229 (280)
T ss_pred HHHHHHhcCCCCCCCCC
Confidence 9999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=257.83 Aligned_cols=209 Identities=23% Similarity=0.302 Sum_probs=165.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..+.|++.++||+|+||.||+|++..++ +.+++|........+.....++...+....|++++.+.+.+.. ++.
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETG-----ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGK 83 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCC-----ceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCe
Confidence 3367999999999999999999998876 7888888765544433333444555667789999998886543 568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+++++|..++.... ..+++..+..++.|++.+|.|||+.|++||||||+||+++
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~ 144 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELD-------------------RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT 144 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc
Confidence 999999999999988876542 1357788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||++...... ........+++.|+|||.+.+.... ...++.++|+|||||++
T Consensus 145 ~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-----------------~~~~~~~~Dv~slG~il 205 (292)
T cd06644 145 LDG-DIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMK-----------------DTPYDYKADIWSLGITL 205 (292)
T ss_pred CCC-CEEEccCccceecccc-ccccceecCCccccCceeecccccc-----------------CCCCCchhhhHhHHHHH
Confidence 877 9999999998754322 1223456788999999987543221 12366788999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|..||...
T Consensus 206 ~el~~g~~p~~~~ 218 (292)
T cd06644 206 IEMAQIEPPHHEL 218 (292)
T ss_pred HHHhcCCCCCccc
Confidence 9999999998653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=250.46 Aligned_cols=203 Identities=23% Similarity=0.343 Sum_probs=162.1
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|.+.+.||+|+||.||+|.+..++ +.+++|.+... ...+......+...+....|++++.+++.+. .++..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADK-----RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-DKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCC-----cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-cCCEE
Confidence 5889999999999999999998776 77888876532 2222333334455566778999999887664 45689
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+.+++|.+++.... +..+++..+..++.|++.||.|||+.|++|+||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~ 136 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQR------------------GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA 136 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC
Confidence 99999999999999987642 224677888899999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||+++.+...... .....+++.|+|||++.. ..++.++|+||||+++|
T Consensus 137 ~~-~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~il~ 192 (256)
T cd08529 137 YD-NVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCED----------------------KPYNEKSDVWALGVVLY 192 (256)
T ss_pred CC-CEEEcccccceeccCccch-hhccccCccccCHHHhcC----------------------CCCCCccchHHHHHHHH
Confidence 87 9999999999876543322 234578899999996543 34556779999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||++|+.||....
T Consensus 193 ~l~~g~~p~~~~~ 205 (256)
T cd08529 193 ECCTGKHPFDANN 205 (256)
T ss_pred HHHhCCCCCCCCC
Confidence 9999999997554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=256.84 Aligned_cols=212 Identities=21% Similarity=0.310 Sum_probs=160.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhcc-CCCceeeeeeccc----
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSS---- 211 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~---- 211 (397)
..++|++.+.||+|+||.||++.+..++ +.+++|............. .+...+... .|++++.+++.+.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~-~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNG-----SKAAVKILDPIHDIDEEIE-AEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCC-----ceeEEEeeccccchHHHHH-HHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 4479999999999999999999998776 6788887654322221111 122223333 5889888877543
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..++.++++|||+++++|.+++.... .....+++..+..++.|++.||.|||+.+|+||||||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 153 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFL----------------KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGN 153 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhh----------------ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHH
Confidence 23467999999999999999876431 12235678889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++++++ .++|+|||+++.+.... .......|++.|+|||++...... ...++.++|+||
T Consensus 154 nili~~~~-~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-----------------~~~~~~~~Dv~s 214 (286)
T cd06638 154 NILLTTEG-GVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQL-----------------DSTYDARCDVWS 214 (286)
T ss_pred hEEECCCC-CEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhc-----------------cccccchhhhhh
Confidence 99999987 89999999997654322 223345789999999987543211 124667889999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~ 389 (397)
+||++|||++|+.||...
T Consensus 215 lGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 215 LGITAIELGDGDPPLADL 232 (286)
T ss_pred HHHHHHHHhcCCCCCCCC
Confidence 999999999999998654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=255.74 Aligned_cols=208 Identities=17% Similarity=0.162 Sum_probs=157.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||+||+|++..++... ...+++|....... .......++...+....|+++..+++.+.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~-~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENV-KIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCcc-ceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--C
Confidence 4579999999999999999999977665332 13478887764322 222222334445566778999888776543 4
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~ 142 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK-------------------DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 5779999999999999987642 145678888999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++++ .+||+|||+++.+...... ......+++.|+|||...+ ..++.++|||||||
T Consensus 143 ~~~~-~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----------------------~~~~~~~Di~slG~ 199 (279)
T cd05109 143 KSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH----------------------RRFTHQSDVWSYGV 199 (279)
T ss_pred cCCC-cEEECCCCceeecccccceeecCCCccchhhCCHHHhcc----------------------CCCCchhHHHHHHH
Confidence 9877 8999999999876433221 1122345678999996543 34667789999999
Q ss_pred HHHHHHc-CCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLH 389 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~ 389 (397)
++|||++ |..||...
T Consensus 200 ~l~el~t~g~~p~~~~ 215 (279)
T cd05109 200 TVWELMTFGAKPYDGI 215 (279)
T ss_pred HHHHHHcCCCCCCCCC
Confidence 9999998 99998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=260.78 Aligned_cols=201 Identities=13% Similarity=0.093 Sum_probs=157.8
Q ss_pred CCeEEe--eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecccc-
Q 015991 139 DDFVLG--KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSK- 212 (397)
Q Consensus 139 ~~f~i~--~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~~- 212 (397)
++++.. ..||+|++|.||+|.+.+ +.+++|.+....... .....++...+....|+|++.+++.+..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIFNN-------KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEECC-------EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 444444 679999999999998843 788999886543221 2333455667777889999999876543
Q ss_pred -c-CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCC
Q 015991 213 -K-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIK 289 (397)
Q Consensus 213 -~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIK 289 (397)
. ...+++||||+.+|+|.+++.... .+++.....++.|++.||.|||+ .+++|||||
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~--------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlk 150 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKEK--------------------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhCC--------------------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCC
Confidence 2 357899999999999999997643 35677788999999999999998 499999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||+++++ .+||+|||+++.+... .....+|..|+|||++.+.. ..++.++||
T Consensus 151 p~nill~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~--------------------~~~~~k~Di 205 (283)
T PHA02988 151 SVSFLVTENY-KLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIF--------------------SEYTIKDDI 205 (283)
T ss_pred hhhEEECCCC-cEEEcccchHhhhccc----cccccCcccccCHHHhhhcc--------------------ccccchhhh
Confidence 9999999987 9999999999865432 12356889999999765411 246678899
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~ 391 (397)
|||||++|||++|..||.....
T Consensus 206 ~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 206 YSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred hHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999986543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=259.44 Aligned_cols=200 Identities=22% Similarity=0.267 Sum_probs=159.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.++||+|+||.||++.+..++ ..+++|.+......+ .....++...+....|++++.+++.+. .++.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSG-----LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-SDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCC-----eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCEE
Confidence 47999999999999999999988776 667777765432221 222334455666678999999988664 46789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCceEEe
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFS 296 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NILl~ 296 (397)
++|+||+++++|.++++... .+++..+..++.|++.||.|||+ .+++||||||+|||++
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAG--------------------RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred EEEeeccCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 99999999999999997643 45678888999999999999997 6999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||++...... ......+++.|+|||.+.+. .++.++|+||||+++
T Consensus 135 ~~~-~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~DiwslG~~l 188 (308)
T cd06615 135 SRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGT----------------------HYTVQSDIWSLGLSL 188 (308)
T ss_pred cCC-cEEEccCCCccccccc---ccccCCCCcCccChhHhcCC----------------------CCCccchHHHHHHHH
Confidence 987 9999999998765322 12446789999999976543 344567999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 189 ~~l~~g~~p~~~~~ 202 (308)
T cd06615 189 VEMAIGRYPIPPPD 202 (308)
T ss_pred HHHHhCCCCCCCcc
Confidence 99999999996543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=260.08 Aligned_cols=226 Identities=19% Similarity=0.250 Sum_probs=165.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
...+|++.++||+|+||.||+|.+..+......+.+++|.+....... .....++........|++++.+++.... ..
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~ 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQ 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CC
Confidence 345788999999999999999998765433344778999887543322 1223334455566779999998886644 45
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++++||+.+++|.+++............ .........+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGST----DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCcccccc----ccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 689999999999999998654322111110 0011123356788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++++ .+||+|||+++........ ......+++.|+|||++.+. .++.++||||||+
T Consensus 158 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~ 214 (283)
T cd05091 158 FDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG----------------------KFSIDSDIWSYGV 214 (283)
T ss_pred cCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcC----------------------CCCcchhHHHHHH
Confidence 9887 8999999999865433221 12334567899999966433 3455679999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |..||....
T Consensus 215 ~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 215 VLWEVFSYGLQPYCGYS 231 (283)
T ss_pred HHHHHHcCCCCCCCCCC
Confidence 9999998 888887644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=254.40 Aligned_cols=221 Identities=19% Similarity=0.232 Sum_probs=166.5
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+..++|++.+.||+|+||.||+|.+.........+.+++|....... .......++...+....|++++.+++.+.. +
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-G 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-C
Confidence 45589999999999999999999987654333447889998764432 222222334455566789999998886644 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++||||+++++|.+++........ .......+++..+..++.|++.||.|||+.+|+||||||+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nil 151 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAE----------NNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCM 151 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchh----------hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEE
Confidence 678999999999999999976431100 0012234677889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++++ .+||+|||+++.+...... ......+|..|+|||.+... .++.++||||||
T Consensus 152 l~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG 208 (277)
T cd05032 152 VAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG----------------------VFTTKSDVWSFG 208 (277)
T ss_pred EcCCC-CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC----------------------CCCcccchHHHH
Confidence 99987 9999999999866443322 12334567899999966433 345567999999
Q ss_pred HHHHHHHc-CCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~ 390 (397)
|++|||++ |+.||....
T Consensus 209 ~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 209 VVLWEMATLAEQPYQGLS 226 (277)
T ss_pred HHHHHhhccCCCCCccCC
Confidence 99999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=271.97 Aligned_cols=196 Identities=23% Similarity=0.256 Sum_probs=154.9
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
...|.+.+.||+|+||.||+|++..++ +.+++|...... ..++...+...+|+||+.+++... .++..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~-----~~vavK~~~~~~------~~~E~~iL~~L~HpnIv~l~~~~~-~~~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYP-----QRVVVKAGWYAS------SVHEARLLRRLSHPAVLALLDVRV-VGGLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCC-----CEEEEecccccC------HHHHHHHHHHCCCCCCCcEEEEEE-ECCEE
Confidence 458999999999999999999998876 778888643221 123345556678999999887654 35678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|||++. ++|.+++.... ..+++..++.++.|++.||.|||++|||||||||+|||++.
T Consensus 236 ~lv~e~~~-~~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~ 295 (461)
T PHA03211 236 CLVLPKYR-SDLYTYLGARL-------------------RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295 (461)
T ss_pred EEEEEccC-CCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC
Confidence 99999996 68888876532 14678889999999999999999999999999999999999
Q ss_pred CCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
++ .+||+|||+++.+...... ......||+.|+|||++.+. .++.++|||||||+|
T Consensus 296 ~~-~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----------------------~~~~~sDvwSlGviL 352 (461)
T PHA03211 296 PE-DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD----------------------PYTPSVDIWSAGLVI 352 (461)
T ss_pred CC-CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC----------------------CCCchHHHHHHHHHH
Confidence 87 9999999999865433221 12346799999999966443 456678999999999
Q ss_pred HHHHcCCCCCCC
Q 015991 377 LQMVCTVRRLCL 388 (397)
Q Consensus 377 ~elltg~~Pf~~ 388 (397)
|||++|..|+..
T Consensus 353 ~El~~g~~~lf~ 364 (461)
T PHA03211 353 FEAAVHTASLFS 364 (461)
T ss_pred HHHHHcCCCccc
Confidence 999998876543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=252.88 Aligned_cols=206 Identities=15% Similarity=0.194 Sum_probs=157.6
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|++.+.||+|+||.||+|.+..+ +.+++|.+........ ...++...+...+|++++.++..+ ..++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~------~~v~iK~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 74 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNT------TPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVC-TLEE 74 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCC------eEEEEEeeCCCcccHH-HHHHHHHHHHHCCCCCccceeEEE-ecCC
Confidence 3457899999999999999999987543 5788888765332211 122334455556788998887754 4456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+.+++|.+++.... +..+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 136 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGA------------------GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV 136 (261)
T ss_pred CeeeeeecccCCcHHHHHhccC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE
Confidence 7899999999999999987642 2246778899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||+++...............+..|+|||...+. .++.++|+||||++
T Consensus 137 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~~ 193 (261)
T cd05068 137 GENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN----------------------RFSIKSDVWSFGIL 193 (261)
T ss_pred cCCC-CEEECCcceEEEccCCcccccCCCcCceeccCccccccC----------------------CCCchhhHHHHHHH
Confidence 9987 999999999987653221111122334589999965433 35567799999999
Q ss_pred HHHHHc-CCCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLHS 390 (397)
Q Consensus 376 l~ellt-g~~Pf~~~~ 390 (397)
+|||++ |+.||....
T Consensus 194 l~el~t~g~~p~~~~~ 209 (261)
T cd05068 194 LTEIVTYGRMPYPGMT 209 (261)
T ss_pred HHHHHhcCCCCCCCCC
Confidence 999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=255.05 Aligned_cols=226 Identities=18% Similarity=0.224 Sum_probs=164.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||+||+|.+...+.. ....+++|.+......+ .....++...+....|++++.+++... .++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMD-HAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-QEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCC-CcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-cCC
Confidence 447899999999999999999986433221 12678888886433222 222334455666778999999887653 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..|++|||+++++|.+++............. .........+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS---DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCcccccc---ccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 7899999999999999987543221111100 0001112356788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++++ .+||+|||+++....... .......++..|+|||++.+. .++.++|+||||+
T Consensus 158 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~ 214 (283)
T cd05090 158 GEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG----------------------KFSSDSDIWSFGV 214 (283)
T ss_pred cCCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC----------------------CCCchhhhHHHHH
Confidence 9987 999999999976543321 122334567789999966433 3556779999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |..||....
T Consensus 215 il~el~~~g~~p~~~~~ 231 (283)
T cd05090 215 VLWEIFSFGLQPYYGFS 231 (283)
T ss_pred HHHHHHcCCCCCCCCCC
Confidence 9999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=254.08 Aligned_cols=206 Identities=17% Similarity=0.222 Sum_probs=159.5
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|++.++||+|+||.||+|..... +.+++|.+........ ...++...+...+|++++.+.+.. ..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~------~~~a~K~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~--~~~ 73 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVV--TQE 73 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCC------ceEEEEEecCCCCcHH-HHHHHHHHHHhcCCcCeeeEEEEE--ccC
Confidence 4558999999999999999999986543 6788998765332221 222334455666789998887754 345
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++++||+.+++|.+++.... +..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i 135 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPE------------------GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV 135 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE
Confidence 6899999999999999986542 2356778888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .++|+|||++...............++..|+|||.+... .++.++|+||||++
T Consensus 136 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~----------------------~~~~~~Di~slG~~ 192 (260)
T cd05067 136 SETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG----------------------TFTIKSDVWSFGIL 192 (260)
T ss_pred cCCC-CEEEccCcceeecCCCCcccccCCcccccccCHHHhccC----------------------CcCcccchHHHHHH
Confidence 9987 999999999976653322222334567789999966543 34456799999999
Q ss_pred HHHHHc-CCCCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 376 l~ellt-g~~Pf~~~~~ 391 (397)
+|||++ |+.||.....
T Consensus 193 l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 193 LTEIVTYGRIPYPGMTN 209 (260)
T ss_pred HHHHHhCCCCCCCCCCh
Confidence 999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=255.52 Aligned_cols=211 Identities=24% Similarity=0.358 Sum_probs=160.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhc-cCCCceeeeeecccc---
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSK--- 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~--- 212 (397)
..+.|++.+.||+|+||.||+|.+..++ +.+++|........... .+.+...+.. .+|++++.+++.+..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~a~K~~~~~~~~~~~-~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTEDEEEE-IKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCC-----cEEEEEEEecChHHHHH-HHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 3378999999999999999999998776 67888876543322211 2222222222 368999988776642
Q ss_pred --cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 213 --KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 213 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.++.++++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.||+||||||
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~ 149 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTK------------------GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKG 149 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 2467899999999999999987642 12456778889999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||++++++ .++|+|||++........ ......+++.|+|||++...... ...++.++|+|
T Consensus 150 ~nili~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~-----------------~~~~~~~~Dvw 210 (282)
T cd06636 150 QNVLLTENA-EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENP-----------------DATYDYRSDIW 210 (282)
T ss_pred HHEEECCCC-CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCc-----------------CcCCCcccchh
Confidence 999999987 899999999876543221 23456789999999987532211 12466788999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|..||....
T Consensus 211 slG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 211 SLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred HHHHHHHHHHhCCCCccccC
Confidence 99999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=253.46 Aligned_cols=211 Identities=17% Similarity=0.182 Sum_probs=153.4
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
++||+|+||.||+|...... ....+++|.+...... ......++...+....|+|++.+++.+. ..+..++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGM---SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-ESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCC---CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCceEEEEEe
Confidence 36999999999999765431 1256777876543322 1222223344555678999999988664 45679999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++...... .....++..+..++.|++.||+|||++||+||||||+|||+++++ .+|
T Consensus 77 ~~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~k 140 (269)
T cd05042 77 CPLGDLKNYLRSNRGM---------------VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVK 140 (269)
T ss_pred CCCCcHHHHHHhcccc---------------ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEE
Confidence 9999999999775311 112345677889999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-
Q 015991 304 IIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC- 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt- 381 (397)
|+|||++.......... .....+++.|+|||++....... ....++.++|||||||++|||++
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---------------~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05042 141 IGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL---------------LPKDQTKKSNIWSLGVTMWELFTA 205 (269)
T ss_pred EeccccccccccchheeccCCCCCcccccCHHHHhhccccc---------------cccccchhhHHHHHHHHHHHHHhC
Confidence 99999986543322211 22345677899999876433211 12246778999999999999999
Q ss_pred CCCCCCCCC
Q 015991 382 TVRRLCLHS 390 (397)
Q Consensus 382 g~~Pf~~~~ 390 (397)
|..||....
T Consensus 206 ~~~p~~~~~ 214 (269)
T cd05042 206 ADQPYPDLS 214 (269)
T ss_pred CCCCCCcCC
Confidence 788886543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=276.55 Aligned_cols=210 Identities=25% Similarity=0.389 Sum_probs=172.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc----
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (397)
..+-|++.++||.|.+|.||+++...++ ...++|+.....+.+...+.+........+|+|+..|++.+..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~-----~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTG-----QLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecC-----ceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 4578999999999999999999988876 5666666654444333333333334455678888777665543
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++++|||||||++||..|+++.- .+.+++|..+..|++.++.||.+||.+.+||||||-.|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~------------------~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~N 153 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNT------------------KGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQN 153 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhh------------------cccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCce
Confidence 358999999999999999999864 26688999999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||.+..++... .+..+..|||.|||||++........ .|+.++|+|||
T Consensus 154 iLLT~e~-~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~-----------------tyd~R~D~WsL 214 (953)
T KOG0587|consen 154 VLLTENA-EVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDA-----------------TYDYRSDLWSL 214 (953)
T ss_pred EEEeccC-cEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCC-----------------Ccccccchhhc
Confidence 9999998 99999999998875543 34678899999999999876655443 48899999999
Q ss_pred HHHHHHHHcCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCL 388 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~ 388 (397)
|++..||.-|.+|++.
T Consensus 215 GITaIEladG~PPl~D 230 (953)
T KOG0587|consen 215 GITAIEMAEGAPPLCD 230 (953)
T ss_pred cceeehhcCCCCCccC
Confidence 9999999999999864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=255.38 Aligned_cols=199 Identities=22% Similarity=0.313 Sum_probs=160.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||.||++.+..++ +.+++|.+..... .......++...+....|++++.+++... .++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSG-----KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-DDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-cCC
Confidence 47999999999999999999998766 7888887764321 11222333445566667999998887654 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili 134 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG--------------------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL 134 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 8999999999999999987653 46778888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||++...... .....+++.|+|||.+... .++.++|+||||++
T Consensus 135 ~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~i 187 (290)
T cd05580 135 DSDG-YIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSK----------------------GYGKAVDWWALGIL 187 (290)
T ss_pred CCCC-CEEEeeCCCccccCCC----CCCCCCCccccChhhhcCC----------------------CCCccccHHHHHHH
Confidence 9987 9999999999876433 2345789999999966433 34456799999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|+|++|+.||....
T Consensus 188 l~~l~~g~~p~~~~~ 202 (290)
T cd05580 188 IYEMLAGYPPFFDDN 202 (290)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999996544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=255.23 Aligned_cols=224 Identities=20% Similarity=0.245 Sum_probs=164.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
...+|++.++||+|+||.||++.............+++|..............++...+....|++++.+++.+. .++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 81 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-EGRP 81 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-cCCc
Confidence 447899999999999999999976543222223567788776554444434444555666778999999887654 3567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++++||+.+++|.+++........... .........+++..+..++.|++.||+|||+.|++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~-----~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILA-----GGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhc-----ccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 8999999999999999986542111000 00011223578888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+++ .+||+|||+++.......+. .....+++.|+|||.+.+ ..++.++|||||||+
T Consensus 157 ~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~i 213 (280)
T cd05092 157 QGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY----------------------RKFTTESDIWSFGVV 213 (280)
T ss_pred CCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc----------------------CCcCchhhHHHHHHH
Confidence 887 99999999997654332211 223345788999995543 345667899999999
Q ss_pred HHHHHc-CCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLH 389 (397)
Q Consensus 376 l~ellt-g~~Pf~~~ 389 (397)
+|||++ |..||...
T Consensus 214 l~el~~~g~~p~~~~ 228 (280)
T cd05092 214 LWEIFTYGKQPWYQL 228 (280)
T ss_pred HHHHHcCCCCCCccC
Confidence 999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=260.32 Aligned_cols=224 Identities=18% Similarity=0.243 Sum_probs=158.3
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
.+..++|++.+.||+|+||.||+|++..++.. ..+++|+...... .......++...+... .|++++.+++.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~- 78 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE- 78 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCce---eeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-
Confidence 45668999999999999999999998765421 2456666553221 1111222233334444 7899998887654
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++.+++++||+++++|.+++........-.. . .........+++..++.++.|++.||+|||++||+||||||+|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~-~---~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA-F---AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhccccccccc-c---cccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 45679999999999999999976531100000 0 0000123467888999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||+++++ .+||+|||++...... .......++..|+|||.+... .++.++|||||
T Consensus 155 ili~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~sl 209 (303)
T cd05088 155 ILVGENY-VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYS----------------------VYTTNSDVWSY 209 (303)
T ss_pred EEecCCC-cEEeCccccCcccchh--hhcccCCCcccccCHHHHhcc----------------------CCcccccchhh
Confidence 9999987 9999999998643211 111223346789999965433 34556799999
Q ss_pred HHHHHHHHc-CCCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~~ 391 (397)
||++|||++ |..||.....
T Consensus 210 G~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 210 GVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred hhHHHHHHhcCCCCcccCCh
Confidence 999999998 9999975443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=254.88 Aligned_cols=206 Identities=20% Similarity=0.282 Sum_probs=163.1
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
......++|++.++||.|+||.||+|.+..++ +.+++|.+............++...+....|++++.+.+.+.
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATG-----QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL- 86 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCC-----cEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-
Confidence 33445578999999999999999999987776 788888776433222222233445556677999998887653
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++..++|+||+.+++|.+++... .+++..+..++.|++.||+|||+.|++||||||+|
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~~---------------------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~N 145 (296)
T cd06655 87 VGDELFVVMEYLAGGSLTDVVTET---------------------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDN 145 (296)
T ss_pred cCceEEEEEEecCCCcHHHHHHhc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 457899999999999999988653 35678899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|+++.++ .+||+|||++......... .....++..|+|||.+... .++.++|+|||
T Consensus 146 ili~~~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~sl 201 (296)
T cd06655 146 VLLGMDG-SVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK----------------------AYGPKVDIWSL 201 (296)
T ss_pred EEECCCC-CEEEccCccchhccccccc-CCCcCCCccccCcchhcCC----------------------CCCchhhHHHH
Confidence 9999887 9999999998765443222 2345788999999966433 34556799999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~ 389 (397)
||++|+|++|+.||...
T Consensus 202 Gvil~~lltg~~pf~~~ 218 (296)
T cd06655 202 GIMAIEMVEGEPPYLNE 218 (296)
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=253.98 Aligned_cols=213 Identities=21% Similarity=0.304 Sum_probs=160.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc---
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (397)
..++|.+.+.||+|+||.||++.+..++ +.+++|..............+.........|++++.+.+.+...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~-----~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDG-----SLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCC-----CEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 3578999999999999999999988776 77888877643322222222222222223688888877655432
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+...++|+||+++++|.++++... ..+..+++..++.++.|++.||+|||+.|++||||||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~----------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~n 158 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLL----------------ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhh----------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 256899999999999999886431 122356788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|++++++ .+||+|||++........ ......++..|+|||.+...... ...++.++|+|||
T Consensus 159 ili~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-----------------~~~~~~~~Di~sl 219 (291)
T cd06639 159 ILLTTEG-GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQY-----------------DYSYDARCDVWSL 219 (291)
T ss_pred EEEcCCC-CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCc-----------------ccccCCccchHHH
Confidence 9999987 899999999976543221 22345788999999987543321 1235678899999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~ 389 (397)
||++|||++|+.||...
T Consensus 220 Gvi~~el~~g~~p~~~~ 236 (291)
T cd06639 220 GITAIELGDGDPPLFDM 236 (291)
T ss_pred HHHHHHHhhCCCCCCCC
Confidence 99999999999999654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=253.55 Aligned_cols=204 Identities=15% Similarity=0.213 Sum_probs=157.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.+.||+|+||+||+|.+.+. ..+++|.+......+. ...++...+....|++++.+++.+. ..+..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~------~~~aik~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT-KQRPI 74 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCC------CcEEEEEcCCCcccHH-HHHHHHHHHhcCCCCCeeeEEEEEc-cCCCc
Confidence 46899999999999999999987653 4688887764332221 1223444556667999999887654 44678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
+++|||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||++++
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG-------------------KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 99999999999999987642 14577889999999999999999999999999999999998
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||.++..............++..|++||++.+. .++.++|+||||+++|
T Consensus 136 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~----------------------~~~~~~Di~slG~~l~ 192 (256)
T cd05113 136 QG-CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS----------------------KFSSKSDVWAFGVLMW 192 (256)
T ss_pred CC-CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC----------------------cccchhHHHHHHHHHH
Confidence 87 999999999976543322112223456789999966433 3556779999999999
Q ss_pred HHHc-CCCCCCCCCC
Q 015991 378 QMVC-TVRRLCLHSC 391 (397)
Q Consensus 378 ellt-g~~Pf~~~~~ 391 (397)
||++ |..||.....
T Consensus 193 ~l~~~g~~p~~~~~~ 207 (256)
T cd05113 193 EVYSLGKMPYERFNN 207 (256)
T ss_pred HHhcCCCCCcCcCCH
Confidence 9998 9999865443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=253.79 Aligned_cols=212 Identities=16% Similarity=0.182 Sum_probs=157.7
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC----
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG---- 214 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---- 214 (397)
|.+++.||+|+||.||+|.+..+... ...+++|++.... ..+......+...+...+|++++.+++......
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGS--QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCC--cceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 56889999999999999987654321 1678888876432 222222333445566678999998877554322
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 215 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...++++||+.+++|..++...... .....+++..+..++.|++.||+|||+.+|+||||||+||
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~--------------~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Ni 144 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLG--------------GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNC 144 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhcc--------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheE
Confidence 2479999999999999998664311 0123567888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccccc-ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++++++ .+||+|||+++.......+.. ....++..|+|||.+.. ..++.++|||||
T Consensus 145 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----------------------~~~~~~~Dv~Sl 201 (273)
T cd05035 145 MLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD----------------------RVYTSKSDVWAF 201 (273)
T ss_pred EECCCC-eEEECCccceeeccccccccccccccCCccccCHhhccc----------------------CCCCcccchHHH
Confidence 999987 999999999987644332221 12345678999996543 335567799999
Q ss_pred HHHHHHHHc-CCCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~~ 391 (397)
|+++|||++ |..||.....
T Consensus 202 G~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 202 GVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred HHHHHHHHhCCCCCCCCCCH
Confidence 999999999 8899866543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=253.71 Aligned_cols=204 Identities=17% Similarity=0.245 Sum_probs=156.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||.||+|.+... ..+++|.......... ...++...+....|++++.++.... ...
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~~k~~~~~~~~~~-~~~~E~~~l~~l~~~~i~~~~~~~~--~~~ 74 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGN------TKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS--EEP 74 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCC------ceeEEEEecCCCCCHH-HHHHHHHHHHhcCCCceEEEEeEEC--CCC
Confidence 457899999999999999999987644 5688887764332221 1223344555667888888876542 356
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~ 136 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGE------------------GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG 136 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe
Confidence 889999999999999987642 12457788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||++..+............++..|+|||.+.+. .++.++|+||||+++
T Consensus 137 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~~l 193 (260)
T cd05070 137 DGL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG----------------------RFTIKSDVWSFGILL 193 (260)
T ss_pred CCc-eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcC----------------------CCcchhhhHHHHHHH
Confidence 987 999999999976544332222233456789999965433 345567999999999
Q ss_pred HHHHc-CCCCCCCCC
Q 015991 377 LQMVC-TVRRLCLHS 390 (397)
Q Consensus 377 ~ellt-g~~Pf~~~~ 390 (397)
|||++ |..||....
T Consensus 194 ~~l~~~g~~p~~~~~ 208 (260)
T cd05070 194 TELVTKGRVPYPGMN 208 (260)
T ss_pred HHHHhcCCCCCCCCC
Confidence 99999 899996643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=250.01 Aligned_cols=206 Identities=22% Similarity=0.357 Sum_probs=164.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.+.||.|+||.||+|.+..++ +.+++|..............++...+...+|++++.+++.. ..++.+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATG-----ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-LRRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCC-----CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-EeCCEE
Confidence 378999999999999999999987766 67888877654333333334445566677899999988765 345789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
|++|||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||++++
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 136 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTR-------------------GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC
Confidence 99999999999999987652 14567888999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||++........ ......++..|+|||.+..... ..++.++|+||||+++|
T Consensus 137 ~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~-------------------~~~~~~~Di~slG~~l~ 195 (262)
T cd06613 137 DG-DVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERK-------------------GGYDGKCDIWALGITAI 195 (262)
T ss_pred CC-CEEECccccchhhhhhhh-ccccccCCccccCchhhccccc-------------------CCcCchhhhHHHHHHHH
Confidence 87 999999999976543221 2234578889999997654311 13556789999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
||++|..||...
T Consensus 196 ~~~tg~~p~~~~ 207 (262)
T cd06613 196 ELAELQPPMFDL 207 (262)
T ss_pred HHHhCCCCCCCC
Confidence 999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.30 Aligned_cols=208 Identities=21% Similarity=0.279 Sum_probs=177.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH--HHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~--~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
...+.|.+.+.||+|.|+.|.+|++..++ ..|++|.+.+...... ....++...+...+||||+.++.....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~-----~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t- 126 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTG-----TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET- 126 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCC-----ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-
Confidence 35589999999999999999999999998 8999998876543322 234456677788899999999887644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...+++||||+.+|.+++++..++ +..+..+..++.|++++++|||+++|||||||++||
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~g--------------------r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNi 186 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHG--------------------RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENI 186 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhcc--------------------cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhc
Confidence 468999999999999999999876 445577889999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
||+.+. ++||+|||++..+..+. .-.+++|++-|+|||++.+..+... .+|+||+|
T Consensus 187 lL~~~m-nikIaDfgfS~~~~~~~--~lqt~cgsppyAaPEl~~g~~y~gp---------------------e~D~Wslg 242 (596)
T KOG0586|consen 187 LLDENM-NIKIADFGFSTFFDYGL--MLQTFCGSPPYAAPELFNGKKYDGP---------------------EVDIWSLG 242 (596)
T ss_pred cccccc-ceeeeccccceeecccc--cccccCCCCCccChHhhcCcccCCc---------------------ceehhhhh
Confidence 999987 89999999998876443 3467899999999998887775433 47999999
Q ss_pred HHHHHHHcCCCCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~~~ 393 (397)
++||.|++|..||+++..++
T Consensus 243 vvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 243 VVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred hhheeeeecccccCCccccc
Confidence 99999999999999988765
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=252.32 Aligned_cols=206 Identities=18% Similarity=0.267 Sum_probs=165.4
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeeccc-----chhHHHHHHHHHHHHhhccCCCceeeee
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE-----YGAVEIWMNERVRRACANCCADFVYGFF 207 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~-----~~~~e~~~~~~~~~~~~~~~~~~i~~~~ 207 (397)
...+..++|.+..+||+|+|..|.++++..+. +.+++|.+++ +.+.+ |...+..-.-...++|+++++.
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~-----qiyamkvvkkel~nddedid-wvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTD-----QIYAMKVVKKELVNDDEDID-WVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccc-----eeeehhhHHHHhcCCcccch-hHHhhHHHHHhccCCCeEEehh
Confidence 34566789999999999999999999999988 5666665542 22222 2222112222346799999887
Q ss_pred ecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecC
Q 015991 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (397)
Q Consensus 208 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrD 287 (397)
..+. .+..+++|.||++||+|--+|+++. +++++.++.+..+|..||.|||++|||+||
T Consensus 318 scfq-tesrlffvieyv~ggdlmfhmqrqr--------------------klpeeharfys~ei~lal~flh~rgiiyrd 376 (593)
T KOG0695|consen 318 SCFQ-TESRLFFVIEYVNGGDLMFHMQRQR--------------------KLPEEHARFYSAEICLALNFLHERGIIYRD 376 (593)
T ss_pred hhhc-ccceEEEEEEEecCcceeeehhhhh--------------------cCcHHHhhhhhHHHHHHHHHHhhcCeeeee
Confidence 6654 4578999999999999988887765 678899999999999999999999999999
Q ss_pred CCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
+|.+|+|+|.++ ++||+|+|+++.--. ......+++|||.|+|||.+.+..+. ..+
T Consensus 377 lkldnvlldaeg-hikltdygmcke~l~-~gd~tstfcgtpnyiapeilrgeeyg----------------------fsv 432 (593)
T KOG0695|consen 377 LKLDNVLLDAEG-HIKLTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYG----------------------FSV 432 (593)
T ss_pred ccccceEEccCC-ceeecccchhhcCCC-CCcccccccCCCcccchhhhcccccC----------------------cee
Confidence 999999999998 999999999976432 23345789999999999988776654 446
Q ss_pred hhHHHHHHHHHHHcCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
|+|++||+++||+.|+.||+.-
T Consensus 433 dwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 433 DWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred hHHHHHHHHHHHHcCCCCccee
Confidence 9999999999999999999753
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=257.06 Aligned_cols=228 Identities=19% Similarity=0.258 Sum_probs=165.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~ 213 (397)
+..++|++.+.||+|+||.||++.............+++|....... .+.....++...+... .|++++.+++.+. .
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~ 87 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-Q 87 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc-C
Confidence 45578999999999999999999987654333346788887764322 2222222233334344 6899999887654 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++.++++|||+.+++|.++++.......... ..........+++..++.++.|++.||.|||+.||+||||||+||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYAS----PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 5679999999999999999986531110000 000112344678899999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|+++++ .+||+|||+++.+....... .....++..|+|||.+.+ ..++.++|||||
T Consensus 164 l~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~sl 220 (293)
T cd05053 164 LVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD----------------------RVYTHQSDVWSF 220 (293)
T ss_pred EEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc----------------------CCcCcccceeeh
Confidence 999987 99999999998764432221 122345678999995543 345667899999
Q ss_pred HHHHHHHHc-CCCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~~ 391 (397)
||++|||++ |..||.....
T Consensus 221 G~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 221 GVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred hhHHHHHhcCCCCCCCCCCH
Confidence 999999997 9999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=258.22 Aligned_cols=214 Identities=20% Similarity=0.251 Sum_probs=162.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
.+..++|++.+.||+|+||.||++.+...........+++|....... .......++...+... +|++++.+++.+.
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 109 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT- 109 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe-
Confidence 456679999999999999999999875443333346788887764322 2222223334444555 7999999887654
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
..+..+++|||+.+++|.++++... ...+++..+..++.|++.||.|||+++|+|+||||+|
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N 171 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKR------------------ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 171 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccce
Confidence 4567999999999999999987643 1136788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||+++++ .++|+|||+++.+...... ......++..|+|||.+.+. .++.++||||
T Consensus 172 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Diws 228 (302)
T cd05055 172 VLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC----------------------VYTFESDVWS 228 (302)
T ss_pred EEEcCCC-eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC----------------------CCCcHhHHHH
Confidence 9999876 9999999999866433221 12234567889999966443 3456779999
Q ss_pred HHHHHHHHHc-CCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~ 390 (397)
+||++|||++ |..||....
T Consensus 229 lGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCC
Confidence 9999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=254.17 Aligned_cols=207 Identities=22% Similarity=0.292 Sum_probs=161.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+-|++.++||+|+||.||+|.+..++ ..+++|........+.....++...+....|++++.+.+.+. .++..+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~~~~ 78 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETG-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-YENNLW 78 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCC-----eEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-eCCEEE
Confidence 34688899999999999999988776 677777775443333333333445566678999999887654 456899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+|+||+++++|..++.... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 79 ~v~e~~~~~~l~~~~~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~ 139 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELE-------------------RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD 139 (282)
T ss_pred EEEEecCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC
Confidence 9999999999988876532 145778889999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .+||+|||++....... .......+|+.|+|||++...... ...++.++|+|||||++||
T Consensus 140 ~-~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-----------------~~~~~~~~Dv~slGvil~e 200 (282)
T cd06643 140 G-DIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSK-----------------DRPYDYKADVWSLGITLIE 200 (282)
T ss_pred C-CEEEccccccccccccc-cccccccccccccCHhhccccCCC-----------------CCCCCccchhhhHHHHHHH
Confidence 7 99999999987643322 223446789999999987533221 1235678899999999999
Q ss_pred HHcCCCCCCCC
Q 015991 379 MVCTVRRLCLH 389 (397)
Q Consensus 379 lltg~~Pf~~~ 389 (397)
|++|..||...
T Consensus 201 l~~g~~p~~~~ 211 (282)
T cd06643 201 MAQIEPPHHEL 211 (282)
T ss_pred HccCCCCcccc
Confidence 99999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=257.39 Aligned_cols=205 Identities=19% Similarity=0.255 Sum_probs=159.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+.+.+. .++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~ 77 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-TEK 77 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCC-----cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-cCC
Confidence 4578999999999999999999988776 7788887753221 11112223445566678999999888764 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++|+||++ ++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+|||+
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~ 137 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDCG-------------------NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI 137 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE
Confidence 8999999998 58888876542 135677888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||++........ ......+++.|+|||++.+.. .++.++|||||||+
T Consensus 138 ~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~---------------------~~~~~~Dv~slG~~ 194 (301)
T cd07873 138 NERG-ELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGST---------------------DYSTQIDMWGVGCI 194 (301)
T ss_pred CCCC-cEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCC---------------------CCccHHHHHHHHHH
Confidence 9987 999999999976433221 123346789999999765322 24567899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 195 l~el~tg~~~f~~~~ 209 (301)
T cd07873 195 FYEMSTGRPLFPGST 209 (301)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=253.72 Aligned_cols=219 Identities=16% Similarity=0.180 Sum_probs=161.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|.+.+.||+|+||.||+|.+...........+++|........ ......++...+....|++++.+++.+.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CC
Confidence 44789999999999999999999876222222267888877643322 12222334445566779999998886544 45
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+.+++|.+++....... .....+++..+..++.|++.||+|||+++++||||||+||++
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~ 149 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRP-------------ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLL 149 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEE
Confidence 6789999999999999997654110 122357888999999999999999999999999999999999
Q ss_pred eCCC--CeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 296 SEGS--RTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 296 ~~~~--~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++++ ..+||+|||+++.+....... ......+..|+|||++. ...++.++|||||
T Consensus 150 ~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~Diwsl 207 (277)
T cd05036 150 TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL----------------------DGIFTSKTDVWSF 207 (277)
T ss_pred eccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh----------------------cCCcCchhHHHHH
Confidence 8653 369999999998763322211 11223456899999553 3456677899999
Q ss_pred HHHHHHHHc-CCCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~~ 391 (397)
||++|||++ |..||.....
T Consensus 208 G~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 208 GVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred HHHHHHHHcCCCCCCCCCCH
Confidence 999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=256.73 Aligned_cols=209 Identities=19% Similarity=0.264 Sum_probs=162.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.+.||+|+||.||++.+..++ +.+++|.+.... ........++...+...+|++++.+++.+. ..+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTG-----VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-IEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCC-----cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-cCCeE
Confidence 47899999999999999999998776 788888776432 222223333445566678999998888654 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCceEEe
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFS 296 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NILl~ 296 (397)
++|+||+++++|.+++.... ....+++..+..++.|++.||.|||+ .||+||||||+||+++
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~-----------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 137 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGV-----------------ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137 (286)
T ss_pred EEEEeecCCCCHHHHHHhcc-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC
Confidence 99999999999999887642 11246788899999999999999997 5999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||++..+... ......+++.|+|||.+.+..... ...++.++|+|||||++
T Consensus 138 ~~~-~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~----------------~~~~~~~~DiwslG~il 197 (286)
T cd06622 138 GNG-QVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQ----------------NPTYTVQSDVWSLGLSI 197 (286)
T ss_pred CCC-CEEEeecCCcccccCC---ccccCCCccCccCcchhcCCCCCc----------------cCCCCcccchHhHHHHH
Confidence 976 9999999999765322 223456888999999876544321 12456788999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 198 ~~l~~g~~pf~~~~ 211 (286)
T cd06622 198 LEMALGRYPYPPET 211 (286)
T ss_pred HHHHhCCCCCCCcc
Confidence 99999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=255.43 Aligned_cols=219 Identities=18% Similarity=0.229 Sum_probs=159.8
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+..++|++.++||+|+||.||+|.............+++|........ ......++...+....|++++.+++.+. ..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-KG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 345799999999999999999998764322222357888877643321 1122223444556667889998887654 44
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+++|.+++....... .........+...+..++.|++.||.|||+++|+||||||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nil 151 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEA----------ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 151 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhcccc----------ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEE
Confidence 67899999999999999997643100 00011234466778899999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++++ .++|+|||+++......... .....++..|+|||.+.. ..++.++|+||||
T Consensus 152 i~~~~-~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~----------------------~~~~~~~DvwslG 208 (288)
T cd05061 152 VAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD----------------------GVFTTSSDMWSFG 208 (288)
T ss_pred EcCCC-cEEECcCCccccccccccccccCCCcccccccCHHHhcc----------------------CCCChHhHHHHHH
Confidence 99987 99999999997654332221 122345778999996543 3456678999999
Q ss_pred HHHHHHHc-CCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCL 388 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~ 388 (397)
|++|||++ |..||..
T Consensus 209 ~~l~el~~~~~~p~~~ 224 (288)
T cd05061 209 VVLWEITSLAEQPYQG 224 (288)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 99999998 7888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=251.16 Aligned_cols=206 Identities=17% Similarity=0.207 Sum_probs=158.2
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.+.||+|+||.||+|.+...+.. ...+++|........ ......++...+....|++++.+++... .++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~--~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKK--EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-KSRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCC--cceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-cCCc
Confidence 36899999999999999999998754321 256888877643222 2222233445566677899998887653 4567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.+++|||+.+++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~ 140 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND-------------------GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN 140 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 899999999999999987643 1457788899999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+++ .++|+|||+++...... ........++..|+|||.+.+. .++.++||||||++
T Consensus 141 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~----------------------~~~~~~Dv~slG~~ 197 (266)
T cd05033 141 SNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR----------------------KFTSASDVWSFGIV 197 (266)
T ss_pred CCC-CEEECccchhhcccccccceeccCCCCCccccChhhhccC----------------------CCccccchHHHHHH
Confidence 987 99999999998764221 1112223456789999966443 34556799999999
Q ss_pred HHHHHc-CCCCCCC
Q 015991 376 FLQMVC-TVRRLCL 388 (397)
Q Consensus 376 l~ellt-g~~Pf~~ 388 (397)
+|||++ |..||..
T Consensus 198 l~~l~~~g~~p~~~ 211 (266)
T cd05033 198 MWEVMSYGERPYWD 211 (266)
T ss_pred HHHHHccCCCCCCC
Confidence 999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=253.66 Aligned_cols=193 Identities=18% Similarity=0.241 Sum_probs=150.0
Q ss_pred eeccCCceEEEEEEecCCCCCCCCCceEEeecccch----h-H-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----A-V-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~-~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
.||+|+||.||++.+..++ +.+++|.+.... . . .......+.......+|++++.+...+. .++..++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~l 74 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-TPDKLCF 74 (279)
T ss_pred CcccCCCeEEEEEEECCCC-----cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-cCCeEEE
Confidence 4899999999999988776 678888665321 1 1 1122222334455567888887766553 3567899
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
||||+.+++|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+|||+++++
T Consensus 75 v~e~~~~~~L~~~i~~~~--------------------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~ 134 (279)
T cd05633 75 ILDLMNGGDLHYHLSQHG--------------------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG 134 (279)
T ss_pred EEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC
Confidence 999999999999887543 467888999999999999999999999999999999999987
Q ss_pred CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 300 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.++|+|||++....... .....||+.|+|||.+... ..++.++|+||+||++|||
T Consensus 135 -~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~Di~slG~~l~~l 189 (279)
T cd05633 135 -HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKG---------------------TAYDSSADWFSLGCMLFKL 189 (279)
T ss_pred -CEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCC---------------------CCCCchhhhHHHHHHHHHH
Confidence 99999999997653321 2335789999999966421 1355678999999999999
Q ss_pred HcCCCCCCCC
Q 015991 380 VCTVRRLCLH 389 (397)
Q Consensus 380 ltg~~Pf~~~ 389 (397)
++|..||...
T Consensus 190 ~~g~~pf~~~ 199 (279)
T cd05633 190 LRGHSPFRQH 199 (279)
T ss_pred HhCCCCcCCC
Confidence 9999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=249.90 Aligned_cols=203 Identities=18% Similarity=0.273 Sum_probs=159.9
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+|++.++||+|+||.||++.+..++ +.+++|.+.... .........+...+....|++++.+.+.+ ..++.++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSD-----QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-EADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCC-----ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-EECCEEE
Confidence 5889999999999999999988776 778888765322 22222223344455666789998888765 4457899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+++||+++++|.+++.... +..+++..+..++.|++.||.|||++||+|+||||+||+++++
T Consensus 75 lv~e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQR------------------GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred EEEeeCCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 9999999999999886532 2245778889999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||++........ ......+++.|+|||++.+. .++.++|+||||+++|+
T Consensus 137 ~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~Dv~slG~i~~~ 192 (255)
T cd08219 137 G-KVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENM----------------------PYNNKSDIWSLGCILYE 192 (255)
T ss_pred C-cEEEcccCcceeeccccc-ccccccCCccccCHHHHccC----------------------CcCchhhhhhhchhhee
Confidence 7 999999999976543222 22346789999999966443 35556799999999999
Q ss_pred HHcCCCCCCCCC
Q 015991 379 MVCTVRRLCLHS 390 (397)
Q Consensus 379 lltg~~Pf~~~~ 390 (397)
|++|..||....
T Consensus 193 l~~g~~p~~~~~ 204 (255)
T cd08219 193 LCTLKHPFQANS 204 (255)
T ss_pred hhhccCCCCCCC
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=258.10 Aligned_cols=205 Identities=20% Similarity=0.267 Sum_probs=160.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||.||+|.+..++ +.+++|........ .......+...+....|++++.+++.. ..+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTG-----KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-QTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCC-----cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-ecCC
Confidence 47999999999999999999998766 78888887643221 222333344556666789998887765 3457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+.+++|.+++.... +..+++..++.++.|++.||+|||+.|++||||||+||++
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili 136 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQP------------------GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL 136 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCC------------------CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE
Confidence 8999999999999999987542 2356778888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccc----------------------------cccccccCCCCCCCcccccccCCCCCCCC
Q 015991 296 SEGSRTFKIIDLGAAADLRVGIN----------------------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~----------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~ 347 (397)
+.++ .++|+|||++........ .......||..|+|||++.+.
T Consensus 137 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------- 207 (316)
T cd05574 137 HESG-HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-------- 207 (316)
T ss_pred cCCC-CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--------
Confidence 9987 999999999865432211 011234788999999966433
Q ss_pred ccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 348 APVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++.++||||||+++|+|++|..||....
T Consensus 208 --------------~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 208 --------------GHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred --------------CCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 35567899999999999999999997554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=254.91 Aligned_cols=205 Identities=19% Similarity=0.284 Sum_probs=162.9
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.++||.|+||.||+|.+.. + +.+++|.+.............+...+....|++++.+++... .+...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 77 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-R-----VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-VGEPV 77 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-C-----CcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-cCCCe
Confidence 4689999999999999999999877 3 778888877554433333444455666778999998887654 45678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+++++|.+++.... +..+++..+..++.|++.||.|||++||+||||||+||++++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~ 139 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE------------------GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE 139 (261)
T ss_pred EEEEeecccCCHHHHHhcCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC
Confidence 99999999999999997642 224677889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||.+....... .......++..|++||.+... .++.++|+||||+++|
T Consensus 140 ~~-~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~----------------------~~~~~~DiwslG~~l~ 195 (261)
T cd05148 140 DL-VCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHG----------------------TFSTKSDVWSFGILLY 195 (261)
T ss_pred Cc-eEEEccccchhhcCCcc-ccccCCCCceEecCHHHHccC----------------------CCCchhhHHHHHHHHH
Confidence 87 99999999997664332 222344567789999965433 3455679999999999
Q ss_pred HHHc-CCCCCCCCCC
Q 015991 378 QMVC-TVRRLCLHSC 391 (397)
Q Consensus 378 ellt-g~~Pf~~~~~ 391 (397)
+|++ |+.||.....
T Consensus 196 ~l~~~g~~p~~~~~~ 210 (261)
T cd05148 196 EMFTYGQVPYPGMNN 210 (261)
T ss_pred HHHcCCCCCCCcCCH
Confidence 9998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=252.04 Aligned_cols=201 Identities=19% Similarity=0.260 Sum_probs=154.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
.+|++.+.||+|+||.||++.+... +.+++|........+... .++...+....|++++.+++... ..+..+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~------~~~~iK~~~~~~~~~~~~-~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~ 75 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGK------IDVAIKMIREGAMSEDDF-IEEAKVMMKLSHPNLVQLYGVCT-KQRPIF 75 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCC------ccEEEEEeccCCCCHHHH-HHHHHHHHhCCCCCEEEEEEEEc-CCCceE
Confidence 5789999999999999999987643 578888776432221111 12334455567899998877653 456789
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++++
T Consensus 76 lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~ 136 (256)
T cd05059 76 IVTEYMANGCLLNYLRERK-------------------GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED 136 (256)
T ss_pred EEEecCCCCCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC
Confidence 9999999999999987643 145778899999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .+||+|||+++..............++..|+|||.+.+. .++.++|+||||+++||
T Consensus 137 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~----------------------~~~~~~Di~slG~il~~ 193 (256)
T cd05059 137 N-VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS----------------------RFSSKSDVWSFGVLMWE 193 (256)
T ss_pred C-cEEECCcccceecccccccccCCCCCCccccCHHHhccC----------------------CCCchhhHHHHHHHHHH
Confidence 7 999999999976543322212222345689999966543 34556799999999999
Q ss_pred HHc-CCCCCCCC
Q 015991 379 MVC-TVRRLCLH 389 (397)
Q Consensus 379 llt-g~~Pf~~~ 389 (397)
|++ |+.||...
T Consensus 194 l~~~g~~p~~~~ 205 (256)
T cd05059 194 VFSEGKMPYERF 205 (256)
T ss_pred HhccCCCCCCCC
Confidence 999 89998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=251.90 Aligned_cols=204 Identities=16% Similarity=0.239 Sum_probs=156.3
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||.||+|.+..+ ..+++|.......... ...++...+....|++++.+++... .+.
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~lK~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~~--~~~ 74 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT------TKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS--EEP 74 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC------ceEEEEEcccCCccHH-HHHHHHHHHHhCCCCCeeeEEEEEc--CCC
Confidence 346899999999999999999987665 4578887764332221 1223344555667888888776542 456
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~ 136 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGD------------------GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG 136 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 889999999999999997642 12356778889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||+++..............++..|+|||...+. .++.++|+||||+++
T Consensus 137 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~----------------------~~~~~~Di~slG~~l 193 (260)
T cd05069 137 DNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG----------------------RFTIKSDVWSFGILL 193 (260)
T ss_pred CCC-eEEECCCccceEccCCcccccCCCccchhhCCHHHhccC----------------------CcChHHHHHHHHHHH
Confidence 987 999999999976543322222234567789999955433 355678999999999
Q ss_pred HHHHc-CCCCCCCCC
Q 015991 377 LQMVC-TVRRLCLHS 390 (397)
Q Consensus 377 ~ellt-g~~Pf~~~~ 390 (397)
|||++ |+.||....
T Consensus 194 ~el~t~g~~p~~~~~ 208 (260)
T cd05069 194 TELVTKGRVPYPGMV 208 (260)
T ss_pred HHHHhCCCCCCCCCC
Confidence 99999 999997643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=250.88 Aligned_cols=205 Identities=21% Similarity=0.279 Sum_probs=160.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||.||+|++..++ +.+++|.+.... ........++...+....|++++.+++.+.. .+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDR-----KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCC-----CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CC
Confidence 68999999999999999999988776 788888764321 1222222334556667789999988876543 56
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++++||+++++|.+++..... ....+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~ 139 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKK----------------QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhh----------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE
Confidence 88999999999999998864320 12246778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .++|+|||++........ ......+++.|+|||.+.+. .++.++|+||+|++
T Consensus 140 ~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~Di~slG~~ 195 (267)
T cd08228 140 TATG-VVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHEN----------------------GYNFKSDIWSLGCL 195 (267)
T ss_pred cCCC-CEEECccccceeccchhH-HHhcCCCCccccChhhhccC----------------------CCCchhhHHHHHHH
Confidence 9987 999999999876543221 12345788999999966543 34556799999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|+.||...
T Consensus 196 l~el~~g~~p~~~~ 209 (267)
T cd08228 196 LYEMAALQSPFYGD 209 (267)
T ss_pred HHHHhcCCCCCccc
Confidence 99999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=257.32 Aligned_cols=207 Identities=21% Similarity=0.318 Sum_probs=151.8
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc-cCCeEEEEEE
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK-KGGEYWLIWR 222 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e 222 (397)
+.+||+|+||+||+|+...... .+.+++|.+........ ..++...+....|++++.+.+.+.. .+...++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~---~~~~a~k~~~~~~~~~~--~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKD---EKEYALKQIEGTGISMS--ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCc---cceEEEEEecCCCCcHH--HHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999998754321 16788888765432222 2234455666779999988776543 3467899999
Q ss_pred ecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe----CC
Q 015991 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS----EG 298 (397)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~----~~ 298 (397)
|+++ +|.+++....... .......+++..+..++.|++.||+|||+.||+||||||+|||+. .+
T Consensus 81 ~~~~-~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 148 (317)
T cd07867 81 YAEH-DLWHIIKFHRASK-----------ANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred eeCC-cHHHHHHhhhccc-----------cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCC
Confidence 9885 7878776432100 001223567888999999999999999999999999999999994 34
Q ss_pred CCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+ .+||+|||+++........ ......+|+.|+|||++.+.. .++.++|||||||++
T Consensus 149 ~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwSlG~il 206 (317)
T cd07867 149 G-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR---------------------HYTKAIDIWAIGCIF 206 (317)
T ss_pred C-cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCC---------------------ccCcHHHHHhHHHHH
Confidence 4 8999999999866433221 123457899999999765422 245678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||+||+.||...
T Consensus 207 ~el~tg~~~f~~~ 219 (317)
T cd07867 207 AELLTSEPIFHCR 219 (317)
T ss_pred HHHHhCCCCcccc
Confidence 9999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=262.32 Aligned_cols=208 Identities=22% Similarity=0.279 Sum_probs=173.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH--HHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~--~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
+-|.+.+.||+|.|.+|-+|++--++ ..|++|.+.+....+. ...-++.+.+...+|+||+.+++...+ +..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTG-----ekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTK 91 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTG-----EKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTK 91 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhccc-----ceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cce
Confidence 66889999999999999999998888 7888888765443322 222234566677889999999987754 467
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+|||.|.=.+|+|++++-.+. ..+++...++++.||+.|+.|+|+..+|||||||+|+.+-
T Consensus 92 lyLiLELGD~GDl~DyImKHe-------------------~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF 152 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHE-------------------EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF 152 (864)
T ss_pred EEEEEEecCCchHHHHHHhhh-------------------ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe
Confidence 999999999999999997764 2578888999999999999999999999999999999987
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+.-+-+||+|||++..+.++... ++.+|...|.|||++.+..+..++ +|||||||+|
T Consensus 153 EKlGlVKLTDFGFSNkf~PG~kL--~TsCGSLAYSAPEILLGDsYDAPA---------------------VDiWSLGVIL 209 (864)
T KOG4717|consen 153 EKLGLVKLTDFGFSNKFQPGKKL--TTSCGSLAYSAPEILLGDSYDAPA---------------------VDIWSLGVIL 209 (864)
T ss_pred eecCceEeeeccccccCCCcchh--hcccchhhccCchhhhcCccCCcc---------------------hhhhHHHHHH
Confidence 76669999999999888776543 678999999999998888776554 6999999999
Q ss_pred HHHHcCCCCCCCCCCCCc
Q 015991 377 LQMVCTVRRLCLHSCPLA 394 (397)
Q Consensus 377 ~elltg~~Pf~~~~~~~~ 394 (397)
|.|+||+.||.-.+..|.
T Consensus 210 yMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 210 YMLVCGQPPFQEANDSET 227 (864)
T ss_pred HHHHhCCCccccccchhh
Confidence 999999999976665543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=253.45 Aligned_cols=194 Identities=21% Similarity=0.249 Sum_probs=154.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.++||+|+||.||+|.+..++ +.+++|........ ......++...+...+|++++.+++.+.. .+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTR-----RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCC-----cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEE
Confidence 47889999999999999999988776 77888877543211 11222234445566789999999887644 5678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~------------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 75 SICTEFMDGGSLDVYR------------------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred EEEEecCCCCChHHhh------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 8999999999986542 2356678899999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++..+.... .....+|..|+|||++.+. .++.++|+||||+++|
T Consensus 131 ~~-~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwslG~~l~ 184 (279)
T cd06619 131 RG-QVKLCDFGVSTQLVNSI---AKTYVGTNAYMAPERISGE----------------------QYGIHSDVWSLGISFM 184 (279)
T ss_pred CC-CEEEeeCCcceeccccc---ccCCCCChhhcCceeecCC----------------------CCCCcchHHHHHHHHH
Confidence 87 99999999997654322 2346789999999966543 3456779999999999
Q ss_pred HHHcCCCCCCC
Q 015991 378 QMVCTVRRLCL 388 (397)
Q Consensus 378 elltg~~Pf~~ 388 (397)
||++|..||..
T Consensus 185 ~l~~g~~pf~~ 195 (279)
T cd06619 185 ELALGRFPYPQ 195 (279)
T ss_pred HHHhCCCCchh
Confidence 99999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=255.06 Aligned_cols=207 Identities=22% Similarity=0.283 Sum_probs=163.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
++|++.++||.|+||.||++.+..++ ..+++|...............+...+....|++++.+.+.+. .+...+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETG-----LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-YENKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCC-----cEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-cCCeEE
Confidence 68999999999999999999987765 778888876544333333333445556667999999988764 456899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+||||+++++|.+++...+ ..+++..++.++.|++.||.|||++||+|+||||+||+++.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~ 139 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-------------------RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD 139 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC
Confidence 9999999999999987643 146778899999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||++...... ........+|+.|++||.+....... ..++.++|+||||+++||
T Consensus 140 ~-~~~l~d~g~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~-----------------~~~~~~sDi~slG~il~~ 200 (280)
T cd06611 140 G-DVKLADFGVSAKNKST-LQKRDTFIGTPYWMAPEVVACETFKD-----------------NPYDYKADIWSLGITLIE 200 (280)
T ss_pred C-CEEEccCccchhhccc-ccccceeecchhhcCHHHHhhcccCC-----------------CCCCccccHHHHHHHHHH
Confidence 7 9999999998654322 12234467899999999876432211 235668899999999999
Q ss_pred HHcCCCCCCCC
Q 015991 379 MVCTVRRLCLH 389 (397)
Q Consensus 379 lltg~~Pf~~~ 389 (397)
|++|+.||...
T Consensus 201 l~~g~~p~~~~ 211 (280)
T cd06611 201 LAQMEPPHHEL 211 (280)
T ss_pred HHhCCCCcccC
Confidence 99999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=249.19 Aligned_cols=205 Identities=19% Similarity=0.248 Sum_probs=157.8
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|++.++||+|+||.||++.+... ..+++|......... ....++...+...+|++++.+.+.... .
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~------~~~~iK~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 73 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK--E 73 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCC------ccEEEEecCCChhHH-HHHHHHHHHHHhcCCCCcceEEEEEcC--C
Confidence 4568999999999999999999986543 568888776433221 122233445566678899888776544 5
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+++++|.+++.... +..+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i 135 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDE------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 135 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCC------------------ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE
Confidence 6899999999999999987642 2245677788999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||++..+............++..|+|||++... .++.++|+||||++
T Consensus 136 ~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Di~slG~~ 192 (260)
T cd05073 136 SASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG----------------------SFTIKSDVWSFGIL 192 (260)
T ss_pred cCCC-cEEECCCcceeeccCCCcccccCCcccccccCHhHhccC----------------------CcCccccchHHHHH
Confidence 9987 999999999976644322222233456789999966433 34556799999999
Q ss_pred HHHHHc-CCCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLHS 390 (397)
Q Consensus 376 l~ellt-g~~Pf~~~~ 390 (397)
+|+|++ |+.||....
T Consensus 193 l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 193 LMEIVTYGRIPYPGMS 208 (260)
T ss_pred HHHHHhcCCCCCCCCC
Confidence 999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=248.95 Aligned_cols=203 Identities=19% Similarity=0.266 Sum_probs=158.2
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEE
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWR 222 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e 222 (397)
.+.||+|+|+.|--+....++ +++++|.+.+..... .....++.....-..|+||+.+++.+ .++..+|||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~-----~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-Edd~~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTG-----KEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-EDDTRFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccc-----hhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-cccceEEEEEe
Confidence 468999999999999988887 788888876543322 22223333333345689999988866 45678999999
Q ss_pred ecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC--C
Q 015991 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS--R 300 (397)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~--~ 300 (397)
-+.||+|...++.+. .+++..+.++..+|+.||++||.+||.|||+||+|||-.+-. .
T Consensus 157 Km~GGplLshI~~~~--------------------~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKRK--------------------HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVS 216 (463)
T ss_pred cccCchHHHHHHHhh--------------------hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcC
Confidence 999999999998765 678889999999999999999999999999999999986533 2
Q ss_pred eEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
-+|||||.++..+.....- .-.+.+|+..|||||+..-.... ..-|+.++|.|||||
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~q-----------------A~~YDKrCDlwSLGv 279 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQ-----------------ATFYDKRCDLWSLGV 279 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccc-----------------cccccccccHHHHHH
Confidence 6999999998654332211 11346888899999987643222 234788999999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
+||-|++|..||.+.
T Consensus 280 IlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 280 ILYIMLSGYPPFVGH 294 (463)
T ss_pred HHHHHHhCCCCccCc
Confidence 999999999999654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=250.14 Aligned_cols=203 Identities=22% Similarity=0.240 Sum_probs=159.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-----hhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+|++.+.||+|+||.||+|++..++ +.+++|.+... ...+....+++...+....|++++.+.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTG-----RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCC-----CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 58999999999999999999988776 77888876421 122223334455566677899999888765433
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+..+++++||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~n 136 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAYG--------------------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN 136 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 356889999999999999987643 35677788999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|++++++ .++|+|||+++....... .......++..|+|||.+.+. .++.++|+|
T Consensus 137 i~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~ 193 (264)
T cd06653 137 ILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE----------------------GYGRKADVW 193 (264)
T ss_pred EEEcCCC-CEEECccccccccccccccCccccccCCcccccCHhhhcCC----------------------CCCccccHH
Confidence 9999987 999999999986533211 112345688999999976543 344567999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
||||++|||++|+.||...
T Consensus 194 slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 194 SVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred HHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=255.90 Aligned_cols=219 Identities=17% Similarity=0.227 Sum_probs=154.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.+.||+|+||.||+|.+..++.. ..+++|.++.... .......++...+... +|++++.+++.+. ..+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLK---MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-NRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCc---ceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-cCCc
Confidence 6899999999999999999988766422 2356666653221 1111122223333333 6899988887653 4567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++++||+++++|.+++........ ..... ........+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~---~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLET-DPAFA---KEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG 153 (297)
T ss_pred ceEEEEecCCCcHHHHHHhcccccc-ccccc---cccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC
Confidence 8999999999999999976432100 00000 0011223578888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||++....... .......+..|+|||++.. ..++.++|||||||++
T Consensus 154 ~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~DvwSlG~il 208 (297)
T cd05089 154 ENL-ASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNY----------------------SVYTTKSDVWSFGVLL 208 (297)
T ss_pred CCC-eEEECCcCCCcccccee--ccCCCCcCccccCchhhcc----------------------CCCCchhhHHHHHHHH
Confidence 987 99999999986432111 1112233567999996543 3455678999999999
Q ss_pred HHHHc-CCCCCCCCC
Q 015991 377 LQMVC-TVRRLCLHS 390 (397)
Q Consensus 377 ~ellt-g~~Pf~~~~ 390 (397)
|||++ |..||....
T Consensus 209 ~el~t~g~~pf~~~~ 223 (297)
T cd05089 209 WEIVSLGGTPYCGMT 223 (297)
T ss_pred HHHHcCCCCCCCCCC
Confidence 99997 999996654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=255.33 Aligned_cols=227 Identities=20% Similarity=0.220 Sum_probs=162.9
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+|++.+.||+|+||.||+|.+...........+++|....... .+.....++...+....|++++.+++.+. .++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-QDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-cCCCcE
Confidence 5889999999999999999876544333446677887764332 22223334455666678999999887654 456789
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhh---hhccc-cccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQT---LILGE-VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~---~~~~~-~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+++||+.+++|.+++........... ..... .........+++..+..++.|++.||+|||+.||+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 99999999999999876431100000 00000 000112235788899999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++++ .+||+|||+++.......+. .....++..|+|||.+.+. .++.++||||||
T Consensus 160 l~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~----------------------~~~~~~Di~slG 216 (290)
T cd05045 160 VAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH----------------------IYTTQSDVWSFG 216 (290)
T ss_pred EcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC----------------------CcchHhHHHHHH
Confidence 99987 99999999997654333222 2233556789999965432 355678999999
Q ss_pred HHHHHHHc-CCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~ 390 (397)
+++|||++ |..||....
T Consensus 217 ~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 217 VLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred HHHHHHHhcCCCCCCCCC
Confidence 99999998 999996543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=252.24 Aligned_cols=206 Identities=20% Similarity=0.291 Sum_probs=159.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.+.||+|+||.||++.+..++ +.+++|.+.... ..+.....++.......+|++++.+++.+. .++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTG-----TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-REGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCC-----cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-cCCc
Confidence 58999999999999999999998877 888998876432 122222223333445567899998888664 4567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCCCceEE
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIF 295 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~NILl 295 (397)
.++++||++ ++|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||++
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~ 137 (283)
T cd06617 75 VWICMEVMD-TSLDKFYKKVY----------------DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137 (283)
T ss_pred EEEEhhhhc-ccHHHHHHHhc----------------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 999999998 68888876532 1223578899999999999999999997 99999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||++....... ......++..|+|||.+.+.... ..++.++|+||||++
T Consensus 138 ~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~------------------~~~~~~~Di~slG~~ 196 (283)
T cd06617 138 NRNG-QVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQ------------------KGYDVKSDVWSLGIT 196 (283)
T ss_pred CCCC-CEEEeeccccccccccc--ccccccCCccccChhhcCCcccc------------------cccCccccchhhHHH
Confidence 9987 99999999997653321 12335688899999987643221 235667899999999
Q ss_pred HHHHHcCCCCCCC
Q 015991 376 FLQMVCTVRRLCL 388 (397)
Q Consensus 376 l~elltg~~Pf~~ 388 (397)
+|||++|+.||..
T Consensus 197 l~~l~~g~~p~~~ 209 (283)
T cd06617 197 MIELATGRFPYDS 209 (283)
T ss_pred HHHHHhCCCCCCc
Confidence 9999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=249.05 Aligned_cols=199 Identities=17% Similarity=0.231 Sum_probs=156.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.+.||+|+||.||++...+ ..+++|........+. ..++...+....|++++.+++.....++.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~k~~~~~~~~~~--~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEcC-------CcEEEEEeCCCchHHH--HHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 45799999999999999999997653 5678887765443322 22334455566788999888766556677
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++++||+++++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 136 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRG------------------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc
Confidence 899999999999999987643 12356788889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||+++...... ....++..|+|||++.+. .++.++|||||||++
T Consensus 137 ~~~-~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~i~ 189 (256)
T cd05082 137 EDN-VAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREK----------------------KFSTKSDVWSFGILL 189 (256)
T ss_pred CCC-cEEecCCccceeccccC----CCCccceeecCHHHHccC----------------------CCCchhhhHHHHHHH
Confidence 987 99999999987643221 233456689999966443 345567999999999
Q ss_pred HHHHc-CCCCCCCC
Q 015991 377 LQMVC-TVRRLCLH 389 (397)
Q Consensus 377 ~ellt-g~~Pf~~~ 389 (397)
|||++ |+.||...
T Consensus 190 ~~l~~~g~~p~~~~ 203 (256)
T cd05082 190 WEIYSFGRVPYPRI 203 (256)
T ss_pred HHHHhCCCCCCCCC
Confidence 99997 99998653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=249.74 Aligned_cols=201 Identities=22% Similarity=0.302 Sum_probs=159.3
Q ss_pred ccCCeEEe-eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeee---eecccc
Q 015991 137 RKDDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGF---FENSSK 212 (397)
Q Consensus 137 ~~~~f~i~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~---~~~~~~ 212 (397)
..++|++. ++||-|-.|.|-.+.++.++ .++|+|.+.+...... | +........|++|+.+ ++....
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~-----ekfALKvL~Ds~KARr---E-VeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQ-----EKFALKVLLDSPKARR---E-VELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccch-----hhhHHHHHhcCHHHHh---H-hhhhhhhcCCCceEEeehhhhhhcc
Confidence 44788885 68999999999999999998 8888898875543322 1 1112222345665555 555556
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
....+.+|||.++||.|++.+++++ ...++++.+..|+.||..|+.|||+.+|.||||||+|
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g------------------~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpEN 191 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRG------------------DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPEN 191 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcc------------------cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhh
Confidence 6789999999999999999999875 3367899999999999999999999999999999999
Q ss_pred eEEeCCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|..... ..+||+|||+|+..... ..-.+.+-||.|.|||++- ...|+..+|+|
T Consensus 192 LLyt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg----------------------~eKydkscdmw 247 (400)
T KOG0604|consen 192 LLYTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLG----------------------PEKYDKSCDMW 247 (400)
T ss_pred eeeecCCCCcceEecccccccccCCC--ccccCCcccccccCHHHhC----------------------chhcCCCCCcc
Confidence 9997543 37999999999875432 2346778999999999554 44566667999
Q ss_pred HHHHHHHHHHcCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~ 388 (397)
|+||++|-|++|.+||-.
T Consensus 248 SlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 248 SLGVIMYILLCGYPPFYS 265 (400)
T ss_pred chhHHHHHhhcCCCcccc
Confidence 999999999999999954
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=256.01 Aligned_cols=226 Identities=19% Similarity=0.224 Sum_probs=159.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCC--CCCCceEEeecccch-hHHHHHHHHHHHHhhcc-CCCceeeeeeccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYG-AVEIWMNERVRRACANC-CADFVYGFFENSS 211 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (397)
...++|.+++.||+|+||.||++++...... .....+++|...... ..+......+...+... .|++++.+++.+.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 3447899999999999999999987553221 122468888876432 22222222223333333 6899998887664
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++..|+||||+++++|.+++........ ..+.+. .......+++..++.++.|++.||+|||++|++||||||+
T Consensus 95 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~--~~~~~~--~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 95 -QDGPLYVIVEYASKGNLREYLRARRPPGM--EYCYNP--TQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred -cCCceEEEEecCCCCcHHHHHHhcCCccc--cccccc--ccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 45679999999999999999987532100 000000 0012235778889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
||++++++ .+||+|||+++......... .....+++.|+|||++.+. .++.++|+|
T Consensus 170 Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dvw 226 (307)
T cd05098 170 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR----------------------IYTHQSDVW 226 (307)
T ss_pred heEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC----------------------CCCcHHHHH
Confidence 99999987 99999999997654322111 1122345789999966443 355678999
Q ss_pred HHHHHHHHHHc-CCCCCCCC
Q 015991 371 SAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~ellt-g~~Pf~~~ 389 (397)
||||++|||++ |..||...
T Consensus 227 slG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcC
Confidence 99999999998 88888543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=252.12 Aligned_cols=207 Identities=19% Similarity=0.221 Sum_probs=156.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccc-ccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS-KKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~ 216 (397)
.++|++.+.||+|+||.||++...... ......+++|++............++...+....|++++.+.+.+. .....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCc-CCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 368999999999999999999853211 0112678899887654443333344555666778999999877543 33457
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++|+||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~ 142 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR-------------------ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE 142 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC
Confidence 899999999999999987542 1357788889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+++ .+||+|||+++......... .....++..|+|||++.+. .++.++|+||||+
T Consensus 143 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~ 199 (284)
T cd05081 143 SEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES----------------------KFSVASDVWSFGV 199 (284)
T ss_pred CCC-eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC----------------------CcChHHHHHHHHH
Confidence 987 99999999998764432211 1112234569999966433 3556789999999
Q ss_pred HHHHHHcCCCCCC
Q 015991 375 IFLQMVCTVRRLC 387 (397)
Q Consensus 375 ~l~elltg~~Pf~ 387 (397)
++|||++|..|+.
T Consensus 200 ~l~el~~~~~~~~ 212 (284)
T cd05081 200 VLYELFTYSDKSC 212 (284)
T ss_pred HHHHHhhcCCcCC
Confidence 9999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=252.54 Aligned_cols=203 Identities=23% Similarity=0.311 Sum_probs=157.7
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||+|+||.||+|++..++ ..+++|++...... ......++...+....|++++.+.+.+. .++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTG-----QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-QESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCC-----cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-eCCeE
Confidence 6899999999999999999988776 78888887533211 1112223344555566999999888764 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+. ++|.+++.... .+..+++..++.++.|++.||.|||++||+||||||+||++++
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~ 136 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLP-----------------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN 136 (285)
T ss_pred EEEEecCC-CCHHHHHhcCC-----------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC
Confidence 99999998 68888876532 2235788889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++........ ......+++.|+|||++.+.. .++.++|+||||+++|
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv~slG~il~ 193 (285)
T cd07861 137 KG-VIKLADFGLARAFGIPVR-VYTHEVVTLWYRAPEVLLGSP---------------------RYSTPVDIWSIGTIFA 193 (285)
T ss_pred CC-cEEECcccceeecCCCcc-cccCCcccccccChHHhcCCC---------------------CcCcHHHHHHHHHHHH
Confidence 87 999999999976533221 123346788999999765432 2455789999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
||++|+.||...
T Consensus 194 ~l~tg~~~~~~~ 205 (285)
T cd07861 194 EMATKKPLFHGD 205 (285)
T ss_pred HHHHCCCCCCCC
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=265.41 Aligned_cols=232 Identities=21% Similarity=0.247 Sum_probs=165.6
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccC-CCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCC-ADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~-~~~i~~~~~~~~ 211 (397)
..+..++|.++++||+|+||.||+|++.........+.+++|++......+ .....++...+.... |+|++.+++.+.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 345667899999999999999999998654333344679999987542221 112223344444444 899999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhh---------hh------------------------------------
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQT---------LI------------------------------------ 246 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~---------~~------------------------------------ 246 (397)
. ++..++|+||+.+|+|.++++.......... .+
T Consensus 112 ~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 K-GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred c-CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 4 4679999999999999999986532110000 00
Q ss_pred -------------------------------ccc--cccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 247 -------------------------------LGE--VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 247 -------------------------------~~~--~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
... .........+++..+..++.|++.||+|||+.+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 000 00001223567788899999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|+++++ .+||+|||+++........ ......+++.|+|||.+... .++.++|+|||
T Consensus 271 Ll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dvwsl 327 (401)
T cd05107 271 LICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN----------------------LYTTLSDVWSF 327 (401)
T ss_pred EEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC----------------------CCCcHhHHHHH
Confidence 999876 9999999999765332221 12234578899999966433 35567799999
Q ss_pred HHHHHHHHc-CCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~ 389 (397)
|+++|||++ |..||...
T Consensus 328 Gvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 328 GILLWEIFTLGGTPYPEL 345 (401)
T ss_pred HHHHHHHHHcCCCCCCCC
Confidence 999999998 88998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=250.02 Aligned_cols=203 Identities=21% Similarity=0.229 Sum_probs=158.7
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+|+..+.||+|+||.||+|.+..++ +.+++|++.... .......+++...+....|++++.+.+.+...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTG-----RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCC-----cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 47899999999999999999988776 788888765321 12222333445566667899999888765433
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+..+++++||+++++|.+++.... .+++..++.++.|++.||+|||+.+|+||||||+|
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~n 136 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAYG--------------------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGAN 136 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 467889999999999999987643 35677788999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|++++++ .+||+|||+++.+...... ......++..|+|||.+.+. .++.++|+|
T Consensus 137 il~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~ 193 (266)
T cd06651 137 ILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE----------------------GYGRKADVW 193 (266)
T ss_pred EEECCCC-CEEEccCCCccccccccccCCccccCCccccccCHHHhCCC----------------------CCCchhhhH
Confidence 9999887 9999999999765322111 12235688999999966433 355677999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
|+||++|||++|+.||...
T Consensus 194 slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 194 SLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred HHHHHHHHHHHCCCCcccc
Confidence 9999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=250.29 Aligned_cols=211 Identities=16% Similarity=0.209 Sum_probs=154.7
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
+.||+|+||.||+|.+..... ...+++|++..... .+.....++...+....|++++.+++.+.. ....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYT---PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCC---ceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEEC
Confidence 468999999999998754221 25688888765432 222233344556677789999998876543 4678999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+++...... .....++..+..++.|++.||+|||+.+++||||||+||+++.++ .+|
T Consensus 77 ~~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~k 140 (269)
T cd05087 77 CPLGDLKGYLRSCRKA---------------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVK 140 (269)
T ss_pred CCCCcHHHHHHHhhhc---------------ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEE
Confidence 9999999999764310 112345677888999999999999999999999999999999986 999
Q ss_pred EEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-
Q 015991 304 IIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC- 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt- 381 (397)
|+|||+++......... .....++..|+|||++....... ....++.++|+||||+++|||++
T Consensus 141 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---------------~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05087 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNL---------------LVVDQTKESNVWSLGVTIWELFEL 205 (269)
T ss_pred ECCccccccccCcceeecCCCcCCcccccCHhHhccccccc---------------cccCCCccchhHHHHHHHHHHHhC
Confidence 99999997543322111 23356788999999875432110 01135678899999999999996
Q ss_pred CCCCCCCCC
Q 015991 382 TVRRLCLHS 390 (397)
Q Consensus 382 g~~Pf~~~~ 390 (397)
|+.||....
T Consensus 206 g~~p~~~~~ 214 (269)
T cd05087 206 GSQPYRHLS 214 (269)
T ss_pred CCCCCCCCC
Confidence 999997544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=249.87 Aligned_cols=209 Identities=19% Similarity=0.226 Sum_probs=159.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|.+.++||+|+||.||+|.+...... ...+++|...... ........++...+....|++++.+++.+. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~--~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENE--KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT--EN 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCC--CcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc--CC
Confidence 457899999999999999999987654211 1567888776543 222223333455666678899999887654 35
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili 140 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK-------------------YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE
Confidence 5789999999999999997643 135778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+++.......+......++..|+|||.+... .++.++|+||||++
T Consensus 141 ~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~i 197 (270)
T cd05056 141 SSPD-CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR----------------------RFTSASDVWMFGVC 197 (270)
T ss_pred ecCC-CeEEccCceeeecccccceecCCCCccccccChhhhccC----------------------CCCchhhhHHHHHH
Confidence 9987 999999999986654432222333455689999965432 34567799999999
Q ss_pred HHHHHc-CCCCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 376 l~ellt-g~~Pf~~~~~ 391 (397)
+|||++ |..||.....
T Consensus 198 l~el~~~g~~pf~~~~~ 214 (270)
T cd05056 198 MWEILMLGVKPFQGVKN 214 (270)
T ss_pred HHHHHHcCCCCCCCCCH
Confidence 999985 9999976543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=255.34 Aligned_cols=203 Identities=21% Similarity=0.322 Sum_probs=158.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||.||++.+..++ +.+++|.+..... .+.....++...+....|++++.+++.+. .++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETR-----QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-TKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCC-----cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-cCC
Confidence 47999999999999999999988876 7888888764421 11222223445566678899998887654 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||++
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll 134 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNIG--------------------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE
Confidence 8999999999999999997653 45777888899999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccc--------------ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 296 SEGSRTFKIIDLGAAADLRVGI--------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~--------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
+.++ .+||+|||+++...... ........++..|+|||.+.. .
T Consensus 135 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~ 191 (305)
T cd05609 135 TSMG-HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR----------------------Q 191 (305)
T ss_pred CCCC-CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC----------------------C
Confidence 9987 99999999986321110 001123467889999996543 2
Q ss_pred CCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++.++|+||||+++|||++|..||....
T Consensus 192 ~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 192 GYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 35567899999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=251.47 Aligned_cols=218 Identities=14% Similarity=0.217 Sum_probs=165.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+..++|++.+.||+|+||.||+|.+..+. ......+++|.+.... ..+.....++...+....|++++.+.+.....+
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34589999999999999999999987632 1112667788776432 222233333445566668999999888766666
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...+++++|+++++|.+++...... ....+..+++..++.++.|++.||+|||+.+++||||||+||+
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~------------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil 149 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLG------------EANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhcccc------------ccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEE
Confidence 7889999999999999998764311 0012346788899999999999999999999999999999999
Q ss_pred EeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++++ .+||+|||+++.+..+... ......++..|+|||++.+. .++.++||||||
T Consensus 150 ~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~----------------------~~~~~~Di~slG 206 (280)
T cd05043 150 IDEEL-QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK----------------------EYSSASDVWSFG 206 (280)
T ss_pred EcCCC-cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC----------------------CCCchhhHHHhH
Confidence 99886 9999999999866443221 12234567789999966433 355678999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
+++||+++ |+.||...
T Consensus 207 ~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 207 VLLWELMTLGQTPYVEI 223 (280)
T ss_pred HHHHHHhcCCCCCcCcC
Confidence 99999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-33 Score=235.86 Aligned_cols=212 Identities=23% Similarity=0.304 Sum_probs=164.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHH-HHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVE-IWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++..-+..||+|++|.|-+-++..++ ...|+|++...- ..+ .....++.-.......|+++.|++....+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg-----~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re- 117 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSG-----TIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE- 117 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCC-----eEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc-
Confidence 4466777889999999999999998887 889999886432 222 22222233334456678999999976554
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCCCce
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNV 293 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~NI 293 (397)
...|+.||.|. .||..+...- +..+...+|..+-+|+..++.||.|||++ .+|||||||.||
T Consensus 118 gdvwIcME~M~-tSldkfy~~v----------------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNi 180 (282)
T KOG0984|consen 118 GDVWICMELMD-TSLDKFYRKV----------------LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNI 180 (282)
T ss_pred ccEEEeHHHhh-hhHHHHHHHH----------------HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceE
Confidence 57999999998 5676655432 13566888999999999999999999976 999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
||+.+| ++||||||.+-.+.++... +-..|..-|||||.+..... +.+|+-|+||||||
T Consensus 181 LIn~~G-qVKiCDFGIsG~L~dSiAk--t~daGCkpYmaPEri~~e~n------------------~~gY~vksDvWSLG 239 (282)
T KOG0984|consen 181 LINYDG-QVKICDFGISGYLVDSIAK--TMDAGCKPYMAPERINPELN------------------QKGYSVKSDVWSLG 239 (282)
T ss_pred EEccCC-cEEEcccccceeehhhhHH--HHhcCCCccCChhhcCcccC------------------cccceeehhhhhhh
Confidence 999998 9999999999877554321 22467788999998765443 33689999999999
Q ss_pred HHHHHHHcCCCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~~ 392 (397)
++++||.+++.||..-..|
T Consensus 240 ItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 240 ITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hhhhhhhhccccccccCCH
Confidence 9999999999999765554
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=250.07 Aligned_cols=212 Identities=24% Similarity=0.367 Sum_probs=162.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhc-cCCCceeeeeecccc---
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSK--- 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~--- 212 (397)
..++|++.+.||+|+||.||+|.+..++ +.+++|............ .++...+.. ..|++++.+++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~-~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTG-----QLVAIKIMDIIEDEEEEI-KEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCC-----cEEEEEEEecCchhHHHH-HHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 3489999999999999999999987765 678888776543322222 222333333 368888888776543
Q ss_pred --cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 213 --KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 213 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.+..+++||||+.+++|.+++.... .....+++..+..++.|++.||.|||+.|++|+||+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p 141 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLR----------------KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKG 141 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHh----------------hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCH
Confidence 2356899999999999999887532 0123567888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||++++++ .++|+|||++........ ......++..|+|||++....... ..++.++|||
T Consensus 142 ~ni~~~~~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~-----------------~~~~~~~Dv~ 202 (275)
T cd06608 142 QNILLTKNA-EVKLVDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPD-----------------ASYDARSDVW 202 (275)
T ss_pred HHEEEccCC-eEEECCCccceecccchh-hhcCccccccccCHhHhccccccc-----------------CCccccccHH
Confidence 999999987 999999999876543222 234467899999999876543322 2466788999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
|||++||||++|..||...
T Consensus 203 slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 203 SLGITAIELADGKPPLCDM 221 (275)
T ss_pred HhHHHHHHHHhCCCCcccc
Confidence 9999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=251.35 Aligned_cols=217 Identities=16% Similarity=0.202 Sum_probs=165.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.+.||+|+||.||+|+...+......+.+++|........ ......++.+.+....|++++.++..+ ...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-REAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-CCCC
Confidence 34789999999999999999999887666666678888887654333 222233445556667789998887755 4456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++++|.+++....... .......+++..+..++.|++.+|+|||+.+|+||||||+||++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~-----------~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili 150 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKD-----------EKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV 150 (275)
T ss_pred cceEEEEecCCCcHHHHHHhccccc-----------ccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE
Confidence 7899999999999999997653100 00112256888999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .++|+|||++...............++..|++||.+.+. .++.++||||||++
T Consensus 151 ~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Di~slG~~ 207 (275)
T cd05046 151 SSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED----------------------DFSTKSDVWSFGVL 207 (275)
T ss_pred eCCC-cEEEcccccccccCcccccccCCceeEEeecChhhhccC----------------------CCCchhhHHHHHHH
Confidence 9987 999999999875433322223344567789999966433 34456799999999
Q ss_pred HHHHHc-CCCCCCC
Q 015991 376 FLQMVC-TVRRLCL 388 (397)
Q Consensus 376 l~ellt-g~~Pf~~ 388 (397)
+|||++ |..||..
T Consensus 208 l~~l~~~~~~p~~~ 221 (275)
T cd05046 208 MWEVFTQGELPFYG 221 (275)
T ss_pred HHHHHhCCCCCccc
Confidence 999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=251.48 Aligned_cols=210 Identities=16% Similarity=0.180 Sum_probs=153.2
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeecccc-----c
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSK-----K 213 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~ 213 (397)
|.++++||+|+||.||+|.+..++.. ..+++|..... ...+.....++...+...+|++++.+++.+.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSI---LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCe---eeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 45789999999999999998765421 35777876532 12222222333445556678998888764422 1
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
....++++||+.+++|.+++...... .....+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 143 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLG--------------DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNC 143 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhccc--------------CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhe
Confidence 23578999999999999987543210 0123468888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|+++++ .+||+|||+++.+....... .....+++.|++||.+... .++.++|+|||
T Consensus 144 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~----------------------~~~~~~Di~sl 200 (272)
T cd05075 144 MLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR----------------------VYTTKSDVWSF 200 (272)
T ss_pred EEcCCC-CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCC----------------------CcChHHHHHHH
Confidence 999887 99999999998764433221 1223456789999966443 35567799999
Q ss_pred HHHHHHHHc-CCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~ 390 (397)
|+++|||++ |+.||....
T Consensus 201 G~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 201 GVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred HHHHHHHHcCCCCCCCCCC
Confidence 999999999 889986543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=274.65 Aligned_cols=209 Identities=20% Similarity=0.218 Sum_probs=150.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCC--------------CCceEEeecccchhHHHHHHHHHHHHhhccCCCc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKN--------------DGDLVLKKATEYGAVEIWMNERVRRACANCCADF 202 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~--------------~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~ 202 (397)
..++|++.++||+|+||+||++.......... .+.++.|+...... .....+++...+...+|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSR-AAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchH-HHHHHHHHHHHHHhCCCCC
Confidence 34789999999999999999987654321110 01112222222111 1222334556667778999
Q ss_pred eeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC
Q 015991 203 VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG 282 (397)
Q Consensus 203 i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g 282 (397)
++.+++.+. ..+..+++++++. ++|.+++....... ........++.++.|++.||+|||++|
T Consensus 225 Iv~l~~~~~-~~~~~~lv~e~~~-~~l~~~l~~~~~~~---------------~~~~~~~~~~~i~~ql~~aL~yLH~~g 287 (501)
T PHA03210 225 ILKIEEILR-SEANTYMITQKYD-FDLYSFMYDEAFDW---------------KDRPLLKQTRAIMKQLLCAVEYIHDKK 287 (501)
T ss_pred cCcEeEEEE-ECCeeEEEEeccc-cCHHHHHhhccccc---------------cccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 999887654 4567889999986 57777776543211 112234567789999999999999999
Q ss_pred ceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC
Q 015991 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362 (397)
Q Consensus 283 iiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
||||||||+|||++.++ .+||+|||+++.+............||+.|+|||++.+. .
T Consensus 288 IiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~ 344 (501)
T PHA03210 288 LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD----------------------G 344 (501)
T ss_pred eecCCCCHHHEEECCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC----------------------C
Confidence 99999999999999987 999999999987654433333456899999999966543 4
Q ss_pred CCCchhhHHHHHHHHHHHcCCCCC
Q 015991 363 LPDRFDIYSAGLIFLQMVCTVRRL 386 (397)
Q Consensus 363 ~~~k~Dv~SlGv~l~elltg~~Pf 386 (397)
++.++|||||||+||||++|..++
T Consensus 345 ~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 345 YCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCC
Confidence 566789999999999999988654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=251.17 Aligned_cols=193 Identities=18% Similarity=0.236 Sum_probs=151.0
Q ss_pred eeccCCceEEEEEEecCCCCCCCCCceEEeecccch----h-HH-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----A-VE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~-~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
.||+|+||.||+|.+..++ +.+++|.+.... . .. ......+........|++++.+...+. .++..++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 74 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSF 74 (278)
T ss_pred CcccCCCeEEEEEEEecCC-----CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-cCCEEEE
Confidence 4899999999999988776 778888765321 1 11 122223334455567899988776553 4568999
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
||||+.+++|.+++.... .+++..++.++.|++.||+|||+.+|+||||||+||+++.++
T Consensus 75 v~e~~~g~~L~~~l~~~~--------------------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~ 134 (278)
T cd05606 75 ILDLMNGGDLHYHLSQHG--------------------VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 134 (278)
T ss_pred EEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC
Confidence 999999999998886543 467888999999999999999999999999999999999987
Q ss_pred CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 300 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.++|+|||++..+.... .....|+..|+|||.+.... .++.++|+||+|+++|||
T Consensus 135 -~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Di~s~G~~l~~l 189 (278)
T cd05606 135 -HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGV---------------------AYDSSADWFSLGCMLFKL 189 (278)
T ss_pred -CEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCC---------------------CCCcccchHhHHHHHHHH
Confidence 99999999997653321 23457899999999764321 245677999999999999
Q ss_pred HcCCCCCCCC
Q 015991 380 VCTVRRLCLH 389 (397)
Q Consensus 380 ltg~~Pf~~~ 389 (397)
++|+.||...
T Consensus 190 ~~g~~p~~~~ 199 (278)
T cd05606 190 LRGHSPFRQH 199 (278)
T ss_pred HhCCCCCCCC
Confidence 9999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=247.76 Aligned_cols=207 Identities=27% Similarity=0.391 Sum_probs=163.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.+.||.|+||+||+|....++ ..+++|...... ..+.....++...+....|++++.+.+.. ..+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNN-----EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-VVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCC-----cEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-eeCCEE
Confidence 58999999999999999999987765 678888775432 12223333444455667889999888765 445789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++++|++.+++|.+++.... ....+++..+..++.|++.||.|||+.||+||||||+||++++
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~-----------------~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSY-----------------PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137 (267)
T ss_pred EEEEeccCCCcHHHHHHHhc-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC
Confidence 99999999999999997643 1125678889999999999999999999999999999999999
Q ss_pred CCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++ .++|+|||++..+...... ......++..|++||++.... .++.++|+||||+
T Consensus 138 ~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~---------------------~~~~~~Dv~slG~ 195 (267)
T cd06610 138 DG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH---------------------GYDFKADIWSFGI 195 (267)
T ss_pred CC-CEEEcccchHHHhccCccccccccccccCChhhcChHHHcccc---------------------CcCcccchHhHhH
Confidence 87 9999999999766543222 223457889999999765431 3556789999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|||++|+.||....
T Consensus 196 i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 196 TAIELATGAAPYSKYP 211 (267)
T ss_pred HHHHHHhCCCCccccC
Confidence 9999999999997543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=247.65 Aligned_cols=206 Identities=18% Similarity=0.241 Sum_probs=158.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|++.++||+|+||.||+|.+.++ ..+++|.+........ ...++...+....|++++.+++... .+.
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~------~~~~vK~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 74 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGT------TKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS-EEE 74 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCC------ceEEEEEecCCccCHH-HHHHHHHHHhhCCCCCEeeeeeeee-cCC
Confidence 4568999999999999999999987643 5688888765332221 1223344555667899988877653 346
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+.+++|.+++.... +..+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~------------------~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili 136 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGE------------------GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV 136 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccc------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE
Confidence 7899999999999999987642 2246778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||++..+............++..|+|||.+.+. .++.++|+||+|++
T Consensus 137 ~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Di~slG~i 193 (261)
T cd05034 137 GENL-VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG----------------------RFTIKSDVWSFGIL 193 (261)
T ss_pred cCCC-CEEECccccceeccchhhhhhhccCCCccccCHHHhccC----------------------CcCchhHHHHHHHH
Confidence 9987 999999999977643322222233456789999966543 34456799999999
Q ss_pred HHHHHc-CCCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLHS 390 (397)
Q Consensus 376 l~ellt-g~~Pf~~~~ 390 (397)
+|||++ |+.||....
T Consensus 194 l~~l~t~g~~p~~~~~ 209 (261)
T cd05034 194 LTEIVTYGRVPYPGMT 209 (261)
T ss_pred HHHHHhCCCCCCCCCC
Confidence 999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=246.10 Aligned_cols=206 Identities=23% Similarity=0.273 Sum_probs=161.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||.||+|.+..++ +.+++|.++... ........++...+....|++++.+++.+.. ++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDG-----RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCC-----CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CC
Confidence 68999999999999999999998666 778888765321 1212223334555666788999888876644 56
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+++++|.+++.... .....+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~ 139 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFK----------------KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI 139 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhc----------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE
Confidence 8899999999999999987532 112346788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .++|+|||++..+..... ......+++.|+|||.+.+ ..++.++|+||||++
T Consensus 140 ~~~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~----------------------~~~~~~~Di~slG~i 195 (267)
T cd08224 140 TATG-VVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE----------------------NGYNFKSDIWSLGCL 195 (267)
T ss_pred CCCC-cEEEeccceeeeccCCCc-ccceecCCccccCHHHhcc----------------------CCCCchhcHHHHHHH
Confidence 9987 999999999876543221 1234568899999996543 345567799999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 196 l~~l~~g~~p~~~~~ 210 (267)
T cd08224 196 LYEMAALQSPFYGDK 210 (267)
T ss_pred HHHHHHCCCCcccCC
Confidence 999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=250.94 Aligned_cols=203 Identities=21% Similarity=0.291 Sum_probs=159.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||.||+|++..++ +.+++|+....... ......++...+....|++++.+.+.+. .+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETG-----QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-RKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCC-----cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-eCCE
Confidence 57999999999999999999998776 77888877543211 1112233445556667899998887654 4568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|..++.... .+++..++.++.|++.+|.|||++|++||||||+||+++
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~ 134 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPR--------------------GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT 134 (286)
T ss_pred EEEEEeccCccHHHHHHhCCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc
Confidence 899999999988887765432 467888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .++|+|||++..+..... ......++..|+|||.+.+.. .++.++|+||||+++
T Consensus 135 ~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Di~slG~i~ 191 (286)
T cd07847 135 KQG-QIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDT---------------------QYGPPVDVWAIGCVF 191 (286)
T ss_pred CCC-cEEECccccceecCCCcc-cccCcccccccCCHHHHhCCC---------------------CcCchhhhHHHHHHH
Confidence 987 999999999987644321 123456788999999765422 245678999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 192 ~~l~~g~~p~~~~~ 205 (286)
T cd07847 192 AELLTGQPLWPGKS 205 (286)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=245.85 Aligned_cols=205 Identities=19% Similarity=0.243 Sum_probs=163.2
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||.|+||.||.++...++ +.+++|++.... ........++...+...+|++++.+++.+.. ++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDD-----SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCC-----cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeE
Confidence 5899999999999999999988776 778888765322 2222222344556666789999999887754 5789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
+++|||+++++|.+++.... +..+++..+..++.|++.+|.|||+.|++|+||||+||++++
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~ 136 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQK------------------GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK 136 (256)
T ss_pred EEEEEecCCCcHHHHHHhcc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC
Confidence 99999999999999987642 224677889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||++........ ......+++.|+|||.+.+. .++.++|+||||+++|
T Consensus 137 ~~-~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~----------------------~~~~~~Dv~slG~i~~ 192 (256)
T cd08221 137 AG-LIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGV----------------------KYNFKSDIWALGCVLY 192 (256)
T ss_pred CC-CEEECcCcceEEcccccc-cccccCCCccccCHhhcCCC----------------------CCCCcchhHHHHHHHH
Confidence 87 999999999976643332 23456789999999966543 3445679999999999
Q ss_pred HHHcCCCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHSCP 392 (397)
Q Consensus 378 elltg~~Pf~~~~~~ 392 (397)
||++|..||.....+
T Consensus 193 ~l~~g~~~~~~~~~~ 207 (256)
T cd08221 193 ELLTLKRTFDATNPL 207 (256)
T ss_pred HHHHCCCCCCCCCHH
Confidence 999999999775543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=249.35 Aligned_cols=205 Identities=21% Similarity=0.268 Sum_probs=160.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++|++.+.||+|+||.||++++..++ +.+++|.+..... .......++...+....|++++.+++.+. .++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-EDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCC-----ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-eCC
Confidence 57899999999999999999987776 7888887654221 11222223445566677999988877654 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 139 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKK----------------QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhc----------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 88999999999999998875321 12356788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .++|+|||++........ ......++..|+|||.+.+. .++.++|+||||++
T Consensus 140 ~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~----------------------~~~~~~Dv~slG~i 195 (267)
T cd08229 140 TATG-VVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHEN----------------------GYNFKSDIWSLGCL 195 (267)
T ss_pred cCCC-CEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCC----------------------CccchhhHHHHHHH
Confidence 9987 999999999876543322 12345788999999966443 34456799999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|..||...
T Consensus 196 l~~l~~g~~p~~~~ 209 (267)
T cd08229 196 LYEMAALQSPFYGD 209 (267)
T ss_pred HHHHHhCCCCcccc
Confidence 99999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=260.48 Aligned_cols=193 Identities=22% Similarity=0.223 Sum_probs=151.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
...+|++.+.||+|+||.||+|++..++ +.+++|........ .+...+...+|++++.+++.+.. +..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~valK~~~~~~~~------~E~~~l~~l~h~~iv~~~~~~~~-~~~ 131 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQP-----DPVVLKIGQKGTTL------IEAMLLQNVNHPSVIRMKDTLVS-GAI 131 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCC-----ceEEEEeCCccccH------HHHHHHHhCCCCCCcChhheEEe-CCe
Confidence 3368999999999999999999988776 67888865432221 12334556678999988876544 567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++|+|++. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 191 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRS-------------------RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN 191 (357)
T ss_pred eEEEEEccC-CcHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 899999996 58888876542 2457788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 192 ~~~-~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwSlGvvl 246 (357)
T PHA03209 192 DVD-QVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARD----------------------KYNSKADIWSAGIVL 246 (357)
T ss_pred CCC-CEEEecCccccccccCc--ccccccccccccCCeecCCC----------------------CCCchhhHHHHHHHH
Confidence 987 99999999997533221 12345789999999966543 456678999999999
Q ss_pred HHHHcCCCCC
Q 015991 377 LQMVCTVRRL 386 (397)
Q Consensus 377 ~elltg~~Pf 386 (397)
|||+++..|+
T Consensus 247 ~ell~~~~~~ 256 (357)
T PHA03209 247 FEMLAYPSTI 256 (357)
T ss_pred HHHHHcCCcc
Confidence 9999866655
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=247.36 Aligned_cols=207 Identities=14% Similarity=0.143 Sum_probs=157.2
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.+.||+|+||.||+|++..++... ..+++|...... .........+...+....|+|++.+++.+ ..+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKRE--IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-TKSRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCc--eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-CCCCc
Confidence 367999999999999999999987765321 458888876432 22223333445566667899999988765 44567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~ 140 (269)
T cd05065 80 VMIITEFMENGALDSFLRQND-------------------GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN 140 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc
Confidence 899999999999999987542 1356788889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccc--cccc--cCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYI--PKEF--LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~--~~~~--~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
.++ .+||+|||++.......... .... ..+..|+|||.+.. ..++.++|||||
T Consensus 141 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----------------------~~~~~~~Dvwsl 197 (269)
T cd05065 141 SNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY----------------------RKFTSASDVWSY 197 (269)
T ss_pred CCC-cEEECCCccccccccCccccccccccCCCcceeecCHhHhcc----------------------Ccccchhhhhhh
Confidence 887 99999999987654322111 1111 12457999996543 345567799999
Q ss_pred HHHHHHHHc-CCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~ 389 (397)
|+++|||++ |..||...
T Consensus 198 G~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 198 GIVMWEVMSYGERPYWDM 215 (269)
T ss_pred HHHHHHHhcCCCCCCCCC
Confidence 999999886 99998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=252.10 Aligned_cols=227 Identities=19% Similarity=0.235 Sum_probs=161.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCC--CCCCCCceEEeecccch-hHHHHHHHHHHHHhhcc-CCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKP--SSKNDGDLVLKKATEYG-AVEIWMNERVRRACANC-CADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~--~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (397)
.+..++|.+++.||+|+||.||+|++.... .......+++|...... ..+.....++...+... .|++++.+.+.+
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345689999999999999999999864321 11222467888776432 22222223333444444 689998887765
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. .....+++|||+.+++|.+++............. .. ......+++..+..++.|++.||.|||++||+||||||
T Consensus 91 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 91 T-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD---IA-RVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred e-cCCceEEEEecCCCCcHHHHHHhcCCcccccccc---cc-cCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 4 3467899999999999999998754211100000 00 01233567888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+||++++++ .+||+|||+++......... .....+++.|+|||++.+. .++.++||
T Consensus 166 ~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di 222 (304)
T cd05101 166 RNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR----------------------VYTHQSDV 222 (304)
T ss_pred ceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC----------------------CCCchhhH
Confidence 999999887 99999999998764332221 2233456789999966443 35567799
Q ss_pred HHHHHHHHHHHc-CCCCCCCC
Q 015991 370 YSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~ellt-g~~Pf~~~ 389 (397)
||||+++|||++ |..||...
T Consensus 223 ~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccC
Confidence 999999999998 78888653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=267.54 Aligned_cols=213 Identities=19% Similarity=0.295 Sum_probs=172.3
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
......++++...||-||||.|-++..+... ..+|+|.+++.. ..+......+.+.+..++.++|+.++..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~-----~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQK-----ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccc-----hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 3456678888999999999999999887764 345555554322 22222222344556667789999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.++...|++||-|-||.|..+++.++ .+++...+.++..+++|++|||++|||+|||||
T Consensus 490 -rd~kyvYmLmEaClGGElWTiLrdRg--------------------~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKP 548 (732)
T KOG0614|consen 490 -RDSKYVYMLMEACLGGELWTILRDRG--------------------SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKP 548 (732)
T ss_pred -ccchhhhhhHHhhcCchhhhhhhhcC--------------------CcccchhhhhHHHHHHHHHHHHhcCceeccCCh
Confidence 44568899999999999999998876 677888899999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|+|++.+| -+||.|||+|+.+..+.. .-+++|||.|.|||++.. .+-+..+|.|
T Consensus 549 ENllLd~~G-y~KLVDFGFAKki~~g~K--TwTFcGTpEYVAPEIILn----------------------KGHD~avDyW 603 (732)
T KOG0614|consen 549 ENLLLDNRG-YLKLVDFGFAKKIGSGRK--TWTFCGTPEYVAPEIILN----------------------KGHDRAVDYW 603 (732)
T ss_pred hheeeccCC-ceEEeehhhHHHhccCCc--eeeecCCcccccchhhhc----------------------cCcchhhHHH
Confidence 999999998 999999999998765543 467999999999995544 4455567999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCCcCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHSCPLAYSL 397 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~~~~~~~~ 397 (397)
|||+++|||++|++||++.....+|.+
T Consensus 604 aLGIli~ELL~G~pPFs~~dpmktYn~ 630 (732)
T KOG0614|consen 604 ALGILIYELLTGSPPFSGVDPMKTYNL 630 (732)
T ss_pred HHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 999999999999999999988887753
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=252.57 Aligned_cols=220 Identities=15% Similarity=0.144 Sum_probs=162.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCC-----------CCCceEEeecccchhH-HHHHHHHHHHHhhccCCCcee
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSK-----------NDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVY 204 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~-----------~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~ 204 (397)
..++|++.++||+|+||.||+|++...+... ....+++|.+...... ......++...+....|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4579999999999999999999987654322 2355788887654322 222223344555666789999
Q ss_pred eeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCce
Q 015991 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (397)
Q Consensus 205 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gii 284 (397)
.+++.+.. ++..++++||+.+++|.+++.......... ......+++..++.++.|++.||+|||+.||+
T Consensus 83 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~ 152 (296)
T cd05051 83 RLLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGL---------ACNSKSLSFSTLLYMATQIASGMRYLESLNFV 152 (296)
T ss_pred EEEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccc---------cccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 88876544 478999999999999999997653111000 11223578889999999999999999999999
Q ss_pred ecCCCCCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 285 HrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
||||||+||++++++ .++|+|||+++.+...... ......+++.|+|||.+.. ..+
T Consensus 153 H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~ 209 (296)
T cd05051 153 HRDLATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL----------------------GKF 209 (296)
T ss_pred ccccchhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc----------------------CCC
Confidence 999999999999986 9999999999765433221 2234566789999996543 345
Q ss_pred CCchhhHHHHHHHHHHHc--CCCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVC--TVRRLCLH 389 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~ellt--g~~Pf~~~ 389 (397)
+.++|||||||++|||++ |..||...
T Consensus 210 ~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 210 TTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred CccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 567799999999999998 67777643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=247.89 Aligned_cols=201 Identities=20% Similarity=0.279 Sum_probs=157.5
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---------HHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---------VEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---------~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
+|.+++.||+|+||.||+|.+..++ +.+++|.+..... ......+++...+....|++++.+++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSG-----ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCC-----cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 4788899999999999999987766 6788886653211 1112333445566677899999988765
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. .+..++++||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||
T Consensus 76 ~~-~~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p 134 (267)
T cd06628 76 LD-ADHLNIFLEYVPGGSVAALLNNYG--------------------AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKG 134 (267)
T ss_pred Ee-CCccEEEEEecCCCCHHHHHHhcc--------------------CccHHHHHHHHHHHHHHHHHHHhcCcccccCCH
Confidence 44 568899999999999999997643 356778889999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccc-----ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY-----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (397)
+||++++++ .++|+|||.++........ ......++..|+|||.+.+. .++.
T Consensus 135 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~----------------------~~~~ 191 (267)
T cd06628 135 ANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT----------------------SYTR 191 (267)
T ss_pred HHEEEcCCC-CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC----------------------CCCc
Confidence 999999987 9999999999876532111 11234688899999966433 3455
Q ss_pred chhhHHHHHHHHHHHcCCCCCCCC
Q 015991 366 RFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 366 k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
++|+||+|+++|+|++|..||...
T Consensus 192 ~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 192 KADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred hhhhHHHHHHHHHHhhCCCCCCCc
Confidence 679999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-31 Score=246.41 Aligned_cols=208 Identities=15% Similarity=0.156 Sum_probs=157.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|+..+.||+|+||.||+|.+..++... ..+++|++.... .........+...+....|++++.+.+.+. ..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 79 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKE--VAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-KFK 79 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCc--eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-cCC
Confidence 3468999999999999999999987654221 467888876432 222222333445566678899999887664 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili 140 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-------------------GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV 140 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE
Confidence 7899999999999999987542 245677888999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccccc--ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
++++ .+||+|||++........... .....+..|+|||++.. ..++.++|+||||
T Consensus 141 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----------------------~~~~~~~Dv~slG 197 (268)
T cd05063 141 NSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY----------------------RKFTSASDVWSFG 197 (268)
T ss_pred cCCC-cEEECCCccceecccccccceeccCCCcCceecCHHHhhc----------------------CCcChHhHHHHHH
Confidence 9887 999999999976543221111 11223457999996543 3455678999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
|++|||++ |+.||...
T Consensus 198 ~il~ell~~g~~p~~~~ 214 (268)
T cd05063 198 IVMWEVMSFGERPYWDM 214 (268)
T ss_pred HHHHHHHhCCCCCCCcC
Confidence 99999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=247.91 Aligned_cols=210 Identities=13% Similarity=0.156 Sum_probs=149.9
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
+.||+|+||.||+|+...... ...+++|...... ..+.....++........|++++.+++.+.. ....++||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTG---VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCC---cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEec
Confidence 369999999999998654321 1345566555332 1222222233344556689999999886643 5678999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++..... .....++..+..++.|++.||+|||+.+++||||||+|||++.++ .++
T Consensus 77 ~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~ 139 (268)
T cd05086 77 CELGDLKSYLSQEQW----------------HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVK 139 (268)
T ss_pred CCCCcHHHHHHhhhc----------------ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEE
Confidence 999999999976531 112345667888999999999999999999999999999999987 999
Q ss_pred EEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-
Q 015991 304 IIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC- 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt- 381 (397)
|+|||++........ .......++..|+|||++........ ...++.++||||||+++|||++
T Consensus 140 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---------------~~~~~~~~DiwslG~~l~el~~~ 204 (268)
T cd05086 140 VGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI---------------TAEQTKPSNVWALGVTLWELFEN 204 (268)
T ss_pred ecccccccccCcchhhhcccCCcCcccccCchhcccccCccc---------------cCCCCCcchhHHHHHHHHHHHhC
Confidence 999999864322111 11234567889999998754322111 1245678899999999999996
Q ss_pred CCCCCCCCC
Q 015991 382 TVRRLCLHS 390 (397)
Q Consensus 382 g~~Pf~~~~ 390 (397)
|..||....
T Consensus 205 ~~~p~~~~~ 213 (268)
T cd05086 205 AAQPYSHLS 213 (268)
T ss_pred CCCCCCCCC
Confidence 577886543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=251.51 Aligned_cols=220 Identities=18% Similarity=0.203 Sum_probs=160.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCC---------CCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeee
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPS---------SKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGF 206 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~---------~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~ 206 (397)
..++|++.++||+|+||.||++++...+. ......+++|....... .......++...+....|++++.+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 45799999999999999999998754321 11123578888765322 222223344556667789999988
Q ss_pred eecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
++.+. .++..++||||+.+++|.+++......... ........+++..+..++.|++.||.|||+.|++||
T Consensus 83 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 83 LGVCV-SDDPLCMITEYMENGDLNQFLSQREIESTF--------THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred EEEEc-CCCccEEEEecCCCCcHHHHHHhccccccc--------cccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 88664 456789999999999999998754311000 000111245778889999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (397)
||||+||++++++ .+||+|||++..+...... ......++..|+|||++... .++.
T Consensus 154 dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~ 210 (295)
T cd05097 154 DLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG----------------------KFTT 210 (295)
T ss_pred ccChhhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC----------------------CcCc
Confidence 9999999999887 9999999999765433221 12234557789999965433 4556
Q ss_pred chhhHHHHHHHHHHHc--CCCCCCC
Q 015991 366 RFDIYSAGLIFLQMVC--TVRRLCL 388 (397)
Q Consensus 366 k~Dv~SlGv~l~ellt--g~~Pf~~ 388 (397)
++|+||||+++|||++ |..||..
T Consensus 211 ~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 211 ASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 7899999999999988 6667754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=247.29 Aligned_cols=205 Identities=20% Similarity=0.267 Sum_probs=154.4
Q ss_pred EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 142 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
++.+.||.|.||.||+|++.. ........+++|.+...... +.....++...+...+|+|++.+++.+. ..+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-ENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-SSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-cccccccc
Confidence 578899999999999999983 12222377889988653322 2233333455566669999999998776 45569999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
+||+.+++|.+++.... ...+++..+..++.|++.||.|||+++++|+||+++||++++++
T Consensus 80 ~e~~~~g~L~~~L~~~~------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~- 140 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKN------------------KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG- 140 (259)
T ss_dssp EE--TTEBHHHHHHHTC------------------TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-
T ss_pred ccccccccccccccccc------------------cccccccccccccccccccccccccccccccccccccccccccc-
Confidence 99999999999998861 22567888999999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.+||+|||++........ ...........|+|||.+. +..++.++||||||+++|||
T Consensus 141 ~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----------------------~~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 141 QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLK----------------------DGEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHH----------------------HSEESHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccc----------------------cccccccccccccccccccc
Confidence 999999999987632221 1223345677899999544 44466788999999999999
Q ss_pred Hc-CCCCCCCC
Q 015991 380 VC-TVRRLCLH 389 (397)
Q Consensus 380 lt-g~~Pf~~~ 389 (397)
++ |+.||...
T Consensus 199 ~~~~~~p~~~~ 209 (259)
T PF07714_consen 199 LTLGKFPFSDY 209 (259)
T ss_dssp HTTSSGTTTTS
T ss_pred ccccccccccc
Confidence 99 78888654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=250.75 Aligned_cols=203 Identities=21% Similarity=0.303 Sum_probs=158.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||.||+|.+..++ +.+++|......... .....++...+....|++++.+.+.+. .++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETG-----QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-RKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCC-----CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-cCCe
Confidence 47999999999999999999988766 788888765432211 111223345556677899888877664 4678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++|+||+.+++|.++..... .+++..++.++.|++.||.|||+.|++|+||+|+||+++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~ 134 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPN--------------------GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS 134 (286)
T ss_pred EEEEEecCCccHHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 999999999988887765432 357888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||++..+.... .......++..|+|||.+.+.. .++.++||||||+++
T Consensus 135 ~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv~slG~~l 191 (286)
T cd07846 135 QSG-VVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDT---------------------KYGRAVDIWAVGCLV 191 (286)
T ss_pred CCC-cEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhcccc---------------------ccCchHhHHHHHHHH
Confidence 987 99999999997654332 2223456789999999765321 244578999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 192 ~el~~g~~~~~~~~ 205 (286)
T cd07846 192 TEMLTGEPLFPGDS 205 (286)
T ss_pred HHHHcCCCCCCCCc
Confidence 99999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=247.06 Aligned_cols=203 Identities=21% Similarity=0.300 Sum_probs=159.1
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch------hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+|+.++.||+|+||.||++.+..++ +.+++|.+.... .........+...+....|++++.+++.+. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTG-----TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-E 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCC-----cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-c
Confidence 4788899999999999999987776 778888775322 111223334455666678999999888654 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+.+++|+||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ni 134 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKYG--------------------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANL 134 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHhC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 568999999999999999987643 456788899999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccc---cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+++.++..+||+|||.+........ .......+|..|+|||.+... .++.++|+|
T Consensus 135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----------------------~~~~~~Dv~ 192 (268)
T cd06630 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE----------------------QYGRSCDVW 192 (268)
T ss_pred EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccC----------------------CCCcccchH
Confidence 9987765799999999976643211 112335688999999976443 344567999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|+|+++|+|++|..||....
T Consensus 193 slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 193 SVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=254.25 Aligned_cols=201 Identities=21% Similarity=0.315 Sum_probs=157.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+.|.....||+|+||.||++.+..++ +.+++|++............++...+....|++++.+.+.+. .++..+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTG-----KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-VGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCC-----CEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-cCCeEE
Confidence 44555678999999999999987776 788888876543333333333445566678999988877653 457899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+||||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++++
T Consensus 96 lv~e~~~~~~L~~~~~~~---------------------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 154 (292)
T cd06658 96 VVMEFLEGGALTDIVTHT---------------------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154 (292)
T ss_pred EEEeCCCCCcHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 999999999999987543 34677788999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||++........ ......++..|+|||.+.. ..++.++|+||||+++||
T Consensus 155 ~-~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Dv~slGvil~e 210 (292)
T cd06658 155 G-RIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISR----------------------LPYGTEVDIWSLGIMVIE 210 (292)
T ss_pred C-CEEEccCcchhhcccccc-cCceeecCccccCHHHHcc----------------------CCCCchhhHHHHHHHHHH
Confidence 7 999999999875533222 1234578999999996543 235567899999999999
Q ss_pred HHcCCCCCCCCC
Q 015991 379 MVCTVRRLCLHS 390 (397)
Q Consensus 379 lltg~~Pf~~~~ 390 (397)
|++|+.||....
T Consensus 211 l~~g~~p~~~~~ 222 (292)
T cd06658 211 MIDGEPPYFNEP 222 (292)
T ss_pred HHhCCCCCCCCC
Confidence 999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=255.14 Aligned_cols=227 Identities=18% Similarity=0.213 Sum_probs=160.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCC--CCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSK--NDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~--~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (397)
.+...+|++++.||+|+||.||+|++...++.. ....+++|....... .......++...+... .|++++.+++.+
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 345568999999999999999999876533221 123578887764322 2222222333344444 689999888866
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ++..++++||+++++|.+++........ ...... .......+++..+..++.|++.||.|||++||+||||||
T Consensus 88 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~--~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 88 TQ-DGPLYVLVEYASKGNLREYLRARRPPGM--DYSFDT--CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred cc-CCceEEEEecCCCCcHHHHHHhcCCccc--cccccc--ccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 44 5678999999999999999986532100 000000 001233567888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+|||+++++ .+||+|||+++......... .....++..|+|||++.. ..++.++||
T Consensus 163 ~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di 219 (334)
T cd05100 163 RNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD----------------------RVYTHQSDV 219 (334)
T ss_pred ceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc----------------------CCcCchhhh
Confidence 999999987 99999999998664332221 122344568999996643 345567899
Q ss_pred HHHHHHHHHHHc-CCCCCCCC
Q 015991 370 YSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~ellt-g~~Pf~~~ 389 (397)
||||+++|||++ |..||...
T Consensus 220 ~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCC
Confidence 999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=246.73 Aligned_cols=207 Identities=14% Similarity=0.157 Sum_probs=157.0
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.+.||+|+||.||+|++..++... ..+++|.+.... .........+...+....|++++.+.+.+. .++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKRE--IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-KSKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCc--eEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCc
Confidence 368999999999999999999886543211 467888776432 222222333444556667999999877654 4568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~ 140 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-------------------GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN 140 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC
Confidence 999999999999999987643 1356777889999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccccc--ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
.++ .++|+|||++..+........ ....++..|++||.+.+. .++.++|+||||+
T Consensus 141 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~----------------------~~~~~~Dv~slG~ 197 (267)
T cd05066 141 SNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR----------------------KFTSASDVWSYGI 197 (267)
T ss_pred CCC-eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC----------------------ccCchhhhHHHHH
Confidence 987 999999999987644322111 122345689999966433 3556779999999
Q ss_pred HHHHHHc-CCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLH 389 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~ 389 (397)
++||+++ |..||...
T Consensus 198 ~l~ell~~g~~p~~~~ 213 (267)
T cd05066 198 VMWEVMSYGERPYWEM 213 (267)
T ss_pred HHHHHhcCCCCCcccC
Confidence 9999886 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=248.97 Aligned_cols=200 Identities=25% Similarity=0.415 Sum_probs=160.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.+.||.|+||.||+|.+..++ ..+++|...... ..+.....++...+....|++++.+.+.+. .+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTN-----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-KGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCC-----eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-ECCeE
Confidence 47889999999999999999988776 788888776432 222222333445556667999988887654 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+++++|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||++++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG---------------------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc---------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 9999999999999998754 3567889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||+++.+..... ......+++.|+|||.+.+ ..++.++||||||+++|
T Consensus 134 ~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~----------------------~~~~~~sDv~slG~il~ 189 (274)
T cd06609 134 EG-DVKLADFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQ----------------------SGYDEKADIWSLGITAI 189 (274)
T ss_pred CC-CEEEcccccceeeccccc-ccccccCCccccChhhhcc----------------------CCCCchhhHHHHHHHHH
Confidence 87 999999999987654322 2344678899999996543 34566789999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
||++|..||...
T Consensus 190 ~l~tg~~p~~~~ 201 (274)
T cd06609 190 ELAKGEPPLSDL 201 (274)
T ss_pred HHHhCCCCcccC
Confidence 999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=243.64 Aligned_cols=204 Identities=20% Similarity=0.267 Sum_probs=160.9
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||+|+||.||++.+..++ +.+++|.+.... ..+.....++...+...+|++++.+.+.+ ..++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQ-----KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-LEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCC-----cEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-ecCCEE
Confidence 5899999999999999999988766 788888775432 22233333445566667799998887755 345789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+++++|.+++.... +..+++..+..++.|++.+|+|||++|++|+||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~ 136 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRC------------------NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK 136 (256)
T ss_pred EEEEecCCCCCHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 99999999999999997642 224577889999999999999999999999999999999987
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++..+||+|||.+....... ......++..|+|||.+... .++.++|+||||+++|
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~~l~ 192 (256)
T cd08220 137 HKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGK----------------------PYNQKSDIWALGCVLY 192 (256)
T ss_pred CCCEEEEccCCCceecCCCc--cccccccCCcccCchhccCC----------------------CCCcccchHHHHHHHH
Confidence 66578999999998654322 12345688999999966432 3455679999999999
Q ss_pred HHHcCCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHSC 391 (397)
Q Consensus 378 elltg~~Pf~~~~~ 391 (397)
+|++|..||.....
T Consensus 193 ~l~~~~~~~~~~~~ 206 (256)
T cd08220 193 ELASLKRAFEAANL 206 (256)
T ss_pred HHHhCCCCcccCch
Confidence 99999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=245.52 Aligned_cols=200 Identities=18% Similarity=0.229 Sum_probs=148.1
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
+.||+|+||.||+|.+...... ...+++|+...... .+.....++...+....|++++.+++.+...++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQ--KIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCc--eEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 4689999999999987643211 15688888754322 22222223344556678999999988665556678899999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++..... ..++..+..++.|++.||.|||+.+++||||||+|||+++++ .+|
T Consensus 79 ~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~k 138 (262)
T cd05058 79 MKHGDLRNFIRSETH-------------------NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVK 138 (262)
T ss_pred CCCCCHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEE
Confidence 999999999875421 234566778999999999999999999999999999999987 999
Q ss_pred EEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 304 IIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 304 L~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
|+|||+++.+...... ......++..|+|||.+.. ..++.++||||||+++|||+
T Consensus 139 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~~l~el~ 196 (262)
T cd05058 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT----------------------QKFTTKSDVWSFGVLLWELM 196 (262)
T ss_pred ECCccccccccCCcceeecccccCcCCccccChhHhcc----------------------CccchHHHHHHHHHHHHHHH
Confidence 9999999765432211 1123345778999995543 34566789999999999999
Q ss_pred cC-CCCCCC
Q 015991 381 CT-VRRLCL 388 (397)
Q Consensus 381 tg-~~Pf~~ 388 (397)
+| ..||..
T Consensus 197 ~~~~~~~~~ 205 (262)
T cd05058 197 TRGAPPYPD 205 (262)
T ss_pred cCCCCCCCC
Confidence 95 555543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=247.46 Aligned_cols=209 Identities=18% Similarity=0.154 Sum_probs=160.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.+.||+|+||.||+|.+..++... ...+++|........ ......++...+....|++++.+++.+.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~-~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKV-KIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCc-ceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 4478999999999999999999987655322 245788877654322 22223334445556678999888876544 6
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++++||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~ 142 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-------------------DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV 142 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE
Confidence 7899999999999999987643 135778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++++ .+||+|||.++.+....+.. .....++..|+|||.+.. ..++.++|+||||+
T Consensus 143 ~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----------------------~~~~~~~Di~slG~ 199 (279)
T cd05057 143 KTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH----------------------RIYTHKSDVWSYGV 199 (279)
T ss_pred cCCC-eEEECCCcccccccCcccceecCCCcccccccCHHHhhc----------------------CCcCchhhHHHHHH
Confidence 9887 99999999998765433221 112234568999995532 34566789999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |+.||....
T Consensus 200 ~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 200 TVWELMTFGAKPYEGIP 216 (279)
T ss_pred HHHHHhcCCCCCCCCCC
Confidence 9999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=245.70 Aligned_cols=199 Identities=20% Similarity=0.238 Sum_probs=156.0
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch------hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+|++++.||+|+||.||+|... ++ ..+++|.+.... ........++...+....|++++.+.+.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~-----~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QG-----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD- 73 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CC-----CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-
Confidence 5888999999999999999864 33 678888765321 1122233344556677789999998887644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++++||+.+++|.+++.+.. .+++..+..++.|++.||+|||+.+|+|+||||+||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 133 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRFG--------------------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV 133 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhE
Confidence 578999999999999999997643 356778889999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccc-----ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
++++++ .++|+|||++....... ........++..|+|||.+... .++.++|
T Consensus 134 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~----------------------~~~~~~D 190 (265)
T cd06631 134 MLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES----------------------GYGRKSD 190 (265)
T ss_pred EECCCC-eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC----------------------CCcchhh
Confidence 999887 99999999997653211 1112345688999999965433 3456779
Q ss_pred hHHHHHHHHHHHcCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~ 388 (397)
+||||+++|||++|..||..
T Consensus 191 v~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 191 IWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred HHHHHHHHHHHHhCCCcccc
Confidence 99999999999999999965
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=244.87 Aligned_cols=196 Identities=18% Similarity=0.235 Sum_probs=148.1
Q ss_pred eeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
+||+|+||.||+|.+..... .+.+++|.+....... .....++...+....|++++.+++... ++..++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKS---EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCC---ceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEec
Confidence 68999999999997643221 1678888775432211 112223344555668999998887643 4567899999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||++++++ .+|
T Consensus 77 ~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~k 135 (257)
T cd05116 77 AELGPLNKFLQKNK--------------------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAK 135 (257)
T ss_pred CCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEE
Confidence 99999999986543 457788899999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc
Q 015991 304 IIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt 381 (397)
|+|||+++.+....... .....++..|+|||.+... .++.++|+||||+++|||++
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~~l~el~t 193 (257)
T cd05116 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY----------------------KFSSKSDVWSFGVLMWEAFS 193 (257)
T ss_pred ECCCccccccCCCCCeeeecCCCCCCccccCHhHhccC----------------------CcCchhHHHHHHHHHHHHHh
Confidence 99999998764433211 1223446799999965432 34557799999999999997
Q ss_pred -CCCCCCCC
Q 015991 382 -TVRRLCLH 389 (397)
Q Consensus 382 -g~~Pf~~~ 389 (397)
|..||...
T Consensus 194 ~g~~p~~~~ 202 (257)
T cd05116 194 YGQKPYKGM 202 (257)
T ss_pred CCCCCCCCC
Confidence 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=249.15 Aligned_cols=203 Identities=22% Similarity=0.260 Sum_probs=154.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++...+....|++++.+.+... .++.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~ 77 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRING-----QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-TKET 77 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCC-----cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-cCCe
Confidence 378999999999999999999988776 77888887543211 1112223344555567899988877654 4568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++|+||+. ++|.+.+.... ..+.+..+..++.|++.||.|||+.||+||||||+|||++
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~ 137 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHP-------------------GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS 137 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc
Confidence 999999997 67766665432 1345667788999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .++|+|||+++....... ......+++.|+|||++.+.. .++.++|+||||+++
T Consensus 138 ~~~-~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv~slG~~l 194 (291)
T cd07870 138 YLG-ELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGAT---------------------DYSSALDIWGAGCIF 194 (291)
T ss_pred CCC-cEEEeccccccccCCCCC-CCCCccccccccCCceeecCC---------------------CCCcHHHHHHHHHHH
Confidence 887 999999999976433221 123346789999999765422 245567999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|..||...
T Consensus 195 ~~l~~g~~~f~~~ 207 (291)
T cd07870 195 IEMLQGQPAFPGV 207 (291)
T ss_pred HHHHhCCCCCCCc
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=258.57 Aligned_cols=213 Identities=19% Similarity=0.307 Sum_probs=160.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
+....|++.++||+||.+.||++...+. ..+++|++......+ .-...++........|.+|+.+++.-..
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~------~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDK------QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCC------cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 4456899999999999999999976654 677777776433221 1112223333344567889999886644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++.+|+|||| +..+|..+++.... ....-.++.+..|++.++.++|++||||.||||.|
T Consensus 432 -d~~lYmvmE~-Gd~DL~kiL~k~~~-------------------~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPAN 490 (677)
T KOG0596|consen 432 -DGYLYMVMEC-GDIDLNKILKKKKS-------------------IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPAN 490 (677)
T ss_pred -CceEEEEeec-ccccHHHHHHhccC-------------------CCchHHHHHHHHHHHHHHHHHHHhceeecCCCccc
Confidence 6789999995 66899999987641 11112678899999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
.|+-+ | .+||+|||.|..+..+... ...+.+||+.||+||.+..-..+... ---....+.++||||
T Consensus 491 FLlVk-G-~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~-----------~~~k~Ki~r~SDvWS 557 (677)
T KOG0596|consen 491 FLLVK-G-RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSREN-----------GKSKIKISRKSDVWS 557 (677)
T ss_pred EEEEe-e-eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccC-----------CCcceeecCccchhh
Confidence 99987 3 8999999999888765443 45678999999999988765444222 001123567899999
Q ss_pred HHHHHHHHHcCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~ 388 (397)
|||+||+|++|+.||-.
T Consensus 558 LGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 558 LGCILYQMVYGKTPFGQ 574 (677)
T ss_pred hhhHHHHHHhcCCchHH
Confidence 99999999999999943
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=243.27 Aligned_cols=200 Identities=18% Similarity=0.229 Sum_probs=158.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.+.||.|+||.||+|...+ +.+++|....... .......+...+....|++++.+++.... ++.
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~-------~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 74 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRG-------QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNP 74 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecC-------cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCC
Confidence 45789999999999999999998753 6789998876544 22223334455666678999988876654 678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~ 136 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRG------------------RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS 136 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe
Confidence 999999999999999987653 12467888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||.++...... .....+..|+|||.+... .++.++|+||||+++
T Consensus 137 ~~~-~~~l~d~g~~~~~~~~~----~~~~~~~~~~ape~~~~~----------------------~~~~~~Di~slG~il 189 (256)
T cd05039 137 EDL-VAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALREK----------------------KFSTKSDVWSFGILL 189 (256)
T ss_pred CCC-CEEEccccccccccccc----ccCCCcccccCchhhcCC----------------------cCCcHHHHHHHHHHH
Confidence 987 99999999998763221 123345689999965433 345577999999999
Q ss_pred HHHHc-CCCCCCCCC
Q 015991 377 LQMVC-TVRRLCLHS 390 (397)
Q Consensus 377 ~ellt-g~~Pf~~~~ 390 (397)
|||++ |..||....
T Consensus 190 ~~l~~~g~~p~~~~~ 204 (256)
T cd05039 190 WEIYSFGRVPYPRIP 204 (256)
T ss_pred HHHHhcCCCCCCCCC
Confidence 99997 999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=246.35 Aligned_cols=194 Identities=20% Similarity=0.206 Sum_probs=152.1
Q ss_pred CCeEEeeee--ccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKL--GEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~L--G~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.+.+ |+|+||.||++....++ ..+++|........+.... .... ..+|++++.+++.+.. ++.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~e~~---~~~~-~~~h~~iv~~~~~~~~-~~~ 83 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQ-----KLFVQKIIKAKNFNAIEPM---VHQL-MKDNPNFIKLYYSVTT-LKG 83 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCC-----cEEEEEEEehhhcchhhHH---HHHH-hhcCCCEEEEEEEEec-CCe
Confidence 566776665 99999999999988876 6777777654322211111 1111 1258899888876644 468
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+++++|.+++.... .+++..+..++.|+++||.|||+.|++||||||+||+++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--------------------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe
Confidence 999999999999999997653 467888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++..++|+|||+++..... ....++..|+|||++.+. .++.++|+||+|+++
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwslG~il 196 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGH----------------------NYDVSFDWWAVGVLT 196 (267)
T ss_pred CCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCC----------------------CCCchhhHHHHHHHH
Confidence 87668999999998765322 234688999999966543 345567999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|+.||...
T Consensus 197 ~~l~~g~~p~~~~ 209 (267)
T PHA03390 197 YELLTGKHPFKED 209 (267)
T ss_pred HHHHHCCCCCCCC
Confidence 9999999999743
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=243.82 Aligned_cols=201 Identities=21% Similarity=0.270 Sum_probs=158.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+|+..+.||+|+||+||+|.+..++ ..+++|.+.... ........++...+....|++++.+.+.. ..+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDG-----DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-REE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCC-----cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-ecC
Confidence 4778899999999999999988666 678888765422 11222333444566667899999888755 445
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
..+++++||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~ 134 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYG--------------------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANIL 134 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 68999999999999999987543 3567788899999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||++....... ......++..|++||.+.... .++.++|+||||+
T Consensus 135 ~~~~~-~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~---------------------~~~~~~D~~slG~ 190 (258)
T cd06632 135 VDTNG-VVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQG---------------------GYGLAADIWSLGC 190 (258)
T ss_pred ECCCC-CEEEccCccceeccccc--cccccCCCcceeCHHHhcCCC---------------------CCCchhhhHHHHH
Confidence 99987 99999999987654332 224567889999999654322 1556789999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|+|++|+.||....
T Consensus 191 ~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 191 TVLEMATGKPPWSQLE 206 (258)
T ss_pred HHHHHHhCCCCcccCc
Confidence 9999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=249.68 Aligned_cols=220 Identities=16% Similarity=0.190 Sum_probs=159.3
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCC-----------CCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCcee
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPS-----------SKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVY 204 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~-----------~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~ 204 (397)
..++|++.++||+|+||.||++++..... ......+++|........ ......++...+....|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 34689999999999999999997543211 111245788887643221 112222334455666789998
Q ss_pred eeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCce
Q 015991 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (397)
Q Consensus 205 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gii 284 (397)
.+++.+.. ++..+++|||+.+++|.+++......... .......+++..+..++.|++.||+|||+.||+
T Consensus 83 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~ 152 (296)
T cd05095 83 RLLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAA---------EKADVVTISYSTLIFMATQIASGMKYLSSLNFV 152 (296)
T ss_pred eEEEEEec-CCccEEEEEeCCCCcHHHHHHhcCccccc---------ccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 88876543 46789999999999999999875421100 011233567888999999999999999999999
Q ss_pred ecCCCCCceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 285 HrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
||||||+|||+++++ .++|+|||+++.+....... .....++..|++||...+ ..+
T Consensus 153 H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----------------------~~~ 209 (296)
T cd05095 153 HRDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL----------------------GKF 209 (296)
T ss_pred cccCChheEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc----------------------CCc
Confidence 999999999999887 99999999998654332211 222345678999995543 345
Q ss_pred CCchhhHHHHHHHHHHHc--CCCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVC--TVRRLCLH 389 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~ellt--g~~Pf~~~ 389 (397)
+.++|+|||||++|||++ |..||...
T Consensus 210 ~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 210 TTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred cchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 667899999999999998 77888644
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=250.23 Aligned_cols=203 Identities=21% Similarity=0.313 Sum_probs=159.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.+.||+|+||.||++.+..++ +.+++|..............++...+....|++++.+.+.+.. ++.
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~ 90 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATG-----QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDE 90 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCC-----CEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCc
Confidence 3479999999999999999999887665 6788888754332222222233445566678999888776533 567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.|+|+||+.+++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~---------------------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~ 149 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET---------------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc---------------------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence 89999999999999998654 245677889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .++|+|||++......... .....+++.|++||.+... .++.++|+||||+++
T Consensus 150 ~~~-~~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Dv~slG~ll 205 (293)
T cd06647 150 MDG-SVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK----------------------AYGPKVDIWSLGIMA 205 (293)
T ss_pred CCC-CEEEccCcceecccccccc-cccccCChhhcCchhhccC----------------------CCCchhhHHHHHHHH
Confidence 987 9999999998765443322 2345788999999966543 345567999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 206 ~~ll~g~~pf~~~~ 219 (293)
T cd06647 206 IEMVEGEPPYLNEN 219 (293)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=252.58 Aligned_cols=225 Identities=20% Similarity=0.226 Sum_probs=159.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCC--CCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPS--SKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
..++|.++++||+|+||.||++++..... ......+++|....... ........+...+... .|++++.+++.+.
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 88 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT- 88 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence 44789999999999999999998643221 11225677887764322 2222222233334334 5999999888654
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++..++++||+.+++|.+++............. ........+++..+..++.|++.||.|||++||+||||||+|
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~----~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD----ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCccccccc----ccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 3567899999999999999998753211100000 001122357888899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||+++++ .+||+|||+++......... .....++..|+|||++.+. .++.++|+||
T Consensus 165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Diws 221 (314)
T cd05099 165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR----------------------VYTHQSDVWS 221 (314)
T ss_pred EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC----------------------CcCccchhhH
Confidence 9999987 99999999998664322211 1122345689999966433 3556779999
Q ss_pred HHHHHHHHHc-CCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~ 389 (397)
||+++|||++ |..||...
T Consensus 222 lG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 222 FGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999 88888654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=243.67 Aligned_cols=206 Identities=17% Similarity=0.221 Sum_probs=160.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHH--HHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE--RVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~--~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++.+....||.|..|+||+++...++ ..+|+|.+...+..|..... .+.-.+.....++|+..++.+...
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~-----~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n- 163 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTG-----HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN- 163 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccc-----eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-
Confidence 3467777889999999999999999988 89999999876655542221 222233444578999999877553
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCce
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNV 293 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NI 293 (397)
...|+.||.|.. -++.+++... ..++|..+-++...++.||.||.+ +|||||||||+||
T Consensus 164 ~dV~IcMelMs~-C~ekLlkrik-------------------~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNI 223 (391)
T KOG0983|consen 164 TDVFICMELMST-CAEKLLKRIK-------------------GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 223 (391)
T ss_pred chHHHHHHHHHH-HHHHHHHHhc-------------------CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccce
Confidence 567888888762 3444444432 246788888999999999999985 5999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|+|+.| ++||||||.+-.+.++.. .+...|.+.|||||.+.-... -.|+.|+||||||
T Consensus 224 LlDe~G-niKlCDFGIsGrlvdSkA--htrsAGC~~YMaPERidp~~~-------------------~kYDiRaDVWSlG 281 (391)
T KOG0983|consen 224 LLDERG-NIKLCDFGISGRLVDSKA--HTRSAGCAAYMAPERIDPPDK-------------------PKYDIRADVWSLG 281 (391)
T ss_pred EEccCC-CEEeecccccceeecccc--cccccCCccccCccccCCCCC-------------------Cccchhhhhhhhc
Confidence 999998 999999999977655433 245678899999998865432 1588899999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
++|+||.||..||.+..
T Consensus 282 ITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 282 ITLVELATGQYPYKGCK 298 (391)
T ss_pred cchhhhhcccCCCCCCC
Confidence 99999999999998743
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=244.09 Aligned_cols=199 Identities=19% Similarity=0.243 Sum_probs=152.0
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
++||+|+||.||+|.+...+.. ...+++|........ ......++...+....|++++.+++... ++..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~--~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGK--EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCC--cceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEe
Confidence 4799999999999987654321 157888887754431 2222223344556667899999887543 4568999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++.... .+++..+..++.|++.+|+|||+.+++||||||+|||++.++ .+|
T Consensus 77 ~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~k 135 (257)
T cd05060 77 APLGPLLKYLKKRR--------------------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAK 135 (257)
T ss_pred CCCCcHHHHHHhCC--------------------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEE
Confidence 99999999997643 457788999999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccccc--cccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc
Q 015991 304 IIDLGAAADLRVGINYIPK--EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~--~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt 381 (397)
|+|||+++........... ...++..|+|||.+... .++.++|+||||+++|||++
T Consensus 136 l~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~~l~~~~~ 193 (257)
T cd05060 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG----------------------KFSSKSDVWSYGVTLWEAFS 193 (257)
T ss_pred eccccccceeecCCcccccccCccccccccCHHHhcCC----------------------CCCccchHHHHHHHHHHHHc
Confidence 9999999876544332211 12335689999965433 45567799999999999997
Q ss_pred -CCCCCCCCC
Q 015991 382 -TVRRLCLHS 390 (397)
Q Consensus 382 -g~~Pf~~~~ 390 (397)
|..||....
T Consensus 194 ~g~~p~~~~~ 203 (257)
T cd05060 194 YGAKPYGEMK 203 (257)
T ss_pred CCCCCcccCC
Confidence 999997544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=247.16 Aligned_cols=203 Identities=22% Similarity=0.335 Sum_probs=158.6
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+....|++++.+.+.+.. +...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETG-----ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCC-----ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCee
Confidence 5899999999999999999988776 788888876433 1111222333445555668999888776543 6789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+ +++|.+++.... ..+++..++.++.|++.+|.|||+.|++|+||||+||++++
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~ 134 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEE-------------------RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA 134 (286)
T ss_pred EEEeccc-CCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC
Confidence 9999999 899999987543 24677889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++...............++..|+|||.+.+.. .++.++||||+|+++|
T Consensus 135 ~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Di~slG~~l~ 192 (286)
T cd07832 135 DG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR---------------------KYDPGVDLWAVGCIFA 192 (286)
T ss_pred CC-cEEEeeeeecccccCCCCCccccccCcccccCceeeeccc---------------------cCCchhHHHHHHHHHH
Confidence 87 9999999999876543321223457899999999765422 2445789999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||++|..||....
T Consensus 193 ~l~tg~~~~~~~~ 205 (286)
T cd07832 193 ELLNGSPLFPGEN 205 (286)
T ss_pred HHHcCCcCcCCCC
Confidence 9999988876543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=249.24 Aligned_cols=209 Identities=25% Similarity=0.326 Sum_probs=153.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
++|++.+.||+|+||.||+|++..++ +.+++|+.......+ .....++.......+|++++.+.+.....+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCC-----cEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 47999999999999999999998776 788888765432111 111122222222235688877776554332
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 215 ---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 215 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
...+++|||+++ +|.+++..... .....+++..++.++.|++.||.|||++||+||||||+
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ 139 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGR---------------GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcc---------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChH
Confidence 247999999995 78888765431 01235688899999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||+++.+...+||+|||+++.+...... .....+++.|+|||.+.+.. .++.++|+||
T Consensus 140 nil~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Di~s 197 (295)
T cd07837 140 NLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGST---------------------HYSTPVDIWS 197 (295)
T ss_pred HEEEecCCCeEEEeecccceecCCCccc-cCCcccccCCCChHHhhCCC---------------------CCCchHHHHH
Confidence 9999983349999999999765332211 12235688999999764321 2456789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|||++|..||...+
T Consensus 198 lG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 198 VGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred HHHHHHHHHcCCCCCCCCC
Confidence 9999999999999997654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=243.69 Aligned_cols=197 Identities=14% Similarity=0.201 Sum_probs=149.6
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
+.||+|+||.||+|++..++ +.+++|........ ......++...+....|++++.+.+.+.. +...++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADN-----TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCC-----ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEee
Confidence 47999999999999998776 77888876543221 11222334445566789999998876644 5678999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+|
T Consensus 75 ~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~k 134 (252)
T cd05084 75 VQGGDFLTFLRTEG-------------------PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLK 134 (252)
T ss_pred ccCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEE
Confidence 99999999986532 1356788899999999999999999999999999999999887 999
Q ss_pred EEeccccccccccccccc-ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-
Q 015991 304 IIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC- 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt- 381 (397)
|+|||++........... .....+..|+|||.+.+ ..++.++|+||||+++|||++
T Consensus 135 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Dv~slG~il~e~~~~ 192 (252)
T cd05084 135 ISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY----------------------GRYSSESDVWSFGILLWEAFSL 192 (252)
T ss_pred ECccccCcccccccccccCCCCCCceeecCchhhcC----------------------CCCChHHHHHHHHHHHHHHHhC
Confidence 999999976543211111 11123457999996543 335567899999999999997
Q ss_pred CCCCCCCC
Q 015991 382 TVRRLCLH 389 (397)
Q Consensus 382 g~~Pf~~~ 389 (397)
|..||...
T Consensus 193 ~~~p~~~~ 200 (252)
T cd05084 193 GAVPYANL 200 (252)
T ss_pred CCCCcccc
Confidence 88888643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=244.14 Aligned_cols=204 Identities=25% Similarity=0.314 Sum_probs=161.3
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|.+.+.||+|+||.||+|.+..++ +.+++|.+...... .......+...+...+|++++.+++.. ...+.+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTG-----ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-VHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCC-----cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-ecCCEE
Confidence 5889999999999999999987766 77888887644332 233333445566667889999888764 345789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+.+++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~ 134 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGR--------------------ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH 134 (264)
T ss_pred EEEEecCCCCcHHHHHhhcC--------------------CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 99999999999999987643 3467778899999999999999999999999999999999
Q ss_pred CCCeEEEEeccccccccccccccc---ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIP---KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++ .+||+|||++........... ....++..|++||++..... ..++.++||||||+
T Consensus 135 ~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-------------------~~~~~~~Dv~s~G~ 194 (264)
T cd06626 135 NG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG-------------------KGHGRAADIWSLGC 194 (264)
T ss_pred CC-CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCC-------------------CCCCcccchHHHHH
Confidence 76 999999999987654332211 13567889999998765431 12456789999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|+.||...
T Consensus 195 il~~l~~g~~pf~~~ 209 (264)
T cd06626 195 VVLEMATGKRPWSEL 209 (264)
T ss_pred HHHHHHhCCCCccCC
Confidence 999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=248.10 Aligned_cols=203 Identities=25% Similarity=0.320 Sum_probs=158.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||.||+|.+..++ +.+++|.+......+ .....++...+....|++++.+.+.+.. ++.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATG-----EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCC-----cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCE
Confidence 47999999999999999999998776 788888876432111 1222233445555668888888776644 678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++++||++++.+..+..... .+++..+..++.|++.||.|||+.|++||||||+||+++
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~ 134 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPG--------------------GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS 134 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 999999999877766554322 357788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||++...............++..|+|||++.... .++.++|+||||+++
T Consensus 135 ~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~---------------------~~~~~~Dv~slG~~l 192 (288)
T cd07833 135 ESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT---------------------NYGKPVDVWAIGCIM 192 (288)
T ss_pred CCC-CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCC---------------------CcCchhhHHHHHHHH
Confidence 987 9999999999876544322234467889999999765431 345678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|+.||...
T Consensus 193 ~~l~~g~~~~~~~ 205 (288)
T cd07833 193 AELLDGEPLFPGD 205 (288)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=243.21 Aligned_cols=200 Identities=23% Similarity=0.356 Sum_probs=161.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
++|++.++||+|+||.||+|.+..++ +.+++|.+...... ....++...+....|++++.+.+.+.. +...|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~--~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETG-----QVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYGSYFK-NTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCC-----cEEEEEEeecHHHH--HHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEE
Confidence 78999999999999999999988765 78888887655432 222233444555589999998886644 47899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++||||+|+||+++++
T Consensus 75 l~~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~ 135 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-------------------KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE 135 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC
Confidence 9999999999999986532 246788899999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||++........ ......++..|+|||++.+. .++.++||||||+++||
T Consensus 136 ~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Di~s~G~il~~ 191 (256)
T cd06612 136 G-QAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEI----------------------GYNNKADIWSLGITAIE 191 (256)
T ss_pred C-cEEEcccccchhcccCcc-ccccccCCccccCHHHHhcC----------------------CCCchhhHHHHHHHHHH
Confidence 7 999999999987644321 22345688999999965433 45567899999999999
Q ss_pred HHcCCCCCCCC
Q 015991 379 MVCTVRRLCLH 389 (397)
Q Consensus 379 lltg~~Pf~~~ 389 (397)
|++|+.||...
T Consensus 192 l~~g~~p~~~~ 202 (256)
T cd06612 192 MAEGKPPYSDI 202 (256)
T ss_pred HHhCCCCCCCc
Confidence 99999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=248.37 Aligned_cols=205 Identities=18% Similarity=0.170 Sum_probs=154.0
Q ss_pred CCe-EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc-CC
Q 015991 139 DDF-VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK-GG 215 (397)
Q Consensus 139 ~~f-~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~ 215 (397)
++| ++.+.||+|+||+||++...... ......+++|....... .......++...+....|++++.+.+.+... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 89999999999999987643221 11126788887764322 1112222345566667899999988765433 35
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+.+++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~---------------------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili 140 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH---------------------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL 140 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE
Confidence 689999999999999998654 35778899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
++++ .++|+|||+++......... .....++..|+|||.+... .++.++||||||
T Consensus 141 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~----------------------~~~~~~Di~slG 197 (283)
T cd05080 141 DNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN----------------------KFSYASDVWSFG 197 (283)
T ss_pred cCCC-cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc----------------------CCCcccccHHHH
Confidence 9886 99999999998764432211 1223456679999966433 355677999999
Q ss_pred HHHHHHHcCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCL 388 (397)
Q Consensus 374 v~l~elltg~~Pf~~ 388 (397)
+++|||++|..||..
T Consensus 198 ~~l~el~tg~~p~~~ 212 (283)
T cd05080 198 VTLYELLTHCDSKQS 212 (283)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=249.93 Aligned_cols=200 Identities=22% Similarity=0.311 Sum_probs=153.9
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.++||+|+||.||+|++..++ +.+++|.+......+ .....++...+...+|++++.+++... .....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g-----~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-SDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCC-----cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-cCCce
Confidence 5889999999999999999998876 678888775322111 111122344555567899998877654 45689
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++++||++ ++|.+++.... ..+++..++.++.|+++||.|||++||+||||||+||+++.
T Consensus 75 ~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~ 134 (284)
T cd07839 75 TLVFEYCD-QDLKKYFDSCN-------------------GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK 134 (284)
T ss_pred EEEEecCC-CCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC
Confidence 99999998 47877776532 14678889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||+++........ .....+++.|+|||++.+.. .++.++|+|||||++|
T Consensus 135 ~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG~il~ 191 (284)
T cd07839 135 NG-ELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAK---------------------LYSTSIDMWSAGCIFA 191 (284)
T ss_pred CC-cEEECccchhhccCCCCCC-cCCCccccCCcChHHHhCCc---------------------ccCcHHHHHHHHHHHH
Confidence 87 9999999999865433221 23346788999999765432 2455789999999999
Q ss_pred HHHcCCCCCCC
Q 015991 378 QMVCTVRRLCL 388 (397)
Q Consensus 378 elltg~~Pf~~ 388 (397)
||++|..||..
T Consensus 192 ~l~tg~~p~~~ 202 (284)
T cd07839 192 ELANAGRPLFP 202 (284)
T ss_pred HHHhcCCCCcC
Confidence 99999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=254.12 Aligned_cols=201 Identities=16% Similarity=0.145 Sum_probs=154.7
Q ss_pred EeeeeccC--CceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 143 LGKKLGEG--AFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 143 i~~~LG~G--~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+.++||+| +||+||++.+..++ +.+++|++.... ........++...+...+|+|++.+++.+. .++..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTG-----EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-ADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccC-----cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-ECCEEE
Confidence 56789999 78999999998887 889999886432 222223333455666678999999887664 457899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+|+||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~ 137 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHF------------------MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137 (327)
T ss_pred EEEeccCCCcHHHHHHhhc------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC
Confidence 9999999999999987542 1135778889999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccc------cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 299 SRTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
+ .++++||+.+........ .......++..|+|||++.... ..++.++|||||
T Consensus 138 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------------------~~~~~~~Diwsl 196 (327)
T cd08227 138 G-KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNL--------------------QGYDAKSDIYSV 196 (327)
T ss_pred C-cEEEcccchhhccccccccccccccccccccceecccChHHhhccc--------------------CCCCchhhHHHH
Confidence 7 999999987644321110 0112235677899999765321 135667899999
Q ss_pred HHHHHHHHcCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCL 388 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~ 388 (397)
||++|||++|+.||..
T Consensus 197 G~il~el~~g~~pf~~ 212 (327)
T cd08227 197 GITACELANGHVPFKD 212 (327)
T ss_pred HHHHHHHHHCCCCCCC
Confidence 9999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=290.93 Aligned_cols=208 Identities=23% Similarity=0.303 Sum_probs=164.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
-+|.-+.+||.|.||.||-|.+.+++ ...++|.+.... ..-.-.-.++...+...+|+|++.+++.-.. +..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tG-----ellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rek 1308 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTG-----ELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REK 1308 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCcc-----chhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHH
Confidence 46777889999999999999999998 555555443211 1112222345667777899999999886543 467
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.+|.||||.+|+|.++++... ..++.....+..|++.|+.|||+.|||||||||+||+|+
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gr--------------------i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld 1368 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR--------------------IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD 1368 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcc--------------------hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee
Confidence 899999999999999998654 456777788999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccccc---ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIP---KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
.+| .+|++|||.|..+.......+ +..+||+.|||||++.+..... -....||||+|
T Consensus 1369 ~~g-~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG-------------------~~~A~DiWslG 1428 (1509)
T KOG4645|consen 1369 FNG-LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKG-------------------HGGAADIWSLG 1428 (1509)
T ss_pred cCC-cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCC-------------------CCcchhhhccc
Confidence 998 999999999988765532222 3479999999999998765322 12345999999
Q ss_pred HHHHHHHcCCCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~~ 392 (397)
|+.+||+||++||..-.+.
T Consensus 1429 CVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1429 CVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred ceEEEeecCCCchhhccch
Confidence 9999999999999765443
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=242.81 Aligned_cols=199 Identities=16% Similarity=0.143 Sum_probs=155.7
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
++||+|+||.||+|.+...+.. ...+++|.+..... .......++...+....|++++.+++.... ...++++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGK--VIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCC--ceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEe
Confidence 4789999999999998663311 13588888876544 333344455566777789999998877655 789999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+.+.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++ .+|
T Consensus 77 ~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~k 137 (257)
T cd05040 77 APLGSLLDRLRKDA------------------LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVK 137 (257)
T ss_pred cCCCcHHHHHHhcc------------------cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEE
Confidence 99999999987653 02467888999999999999999999999999999999999987 999
Q ss_pred EEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc
Q 015991 304 IIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt 381 (397)
|+|||+++.+...... ......++..|+|||.+.. ..++.++||||||+++|||++
T Consensus 138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~----------------------~~~~~~~Di~slG~~l~el~t 195 (257)
T cd05040 138 IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT----------------------RTFSHASDVWMFGVTLWEMFT 195 (257)
T ss_pred eccccccccccccccceecccCCCCCceecCHHHhcc----------------------cCcCchhhhHHHHHHHHHHHh
Confidence 9999999876442221 1123457789999995543 345567799999999999998
Q ss_pred -CCCCCCC
Q 015991 382 -TVRRLCL 388 (397)
Q Consensus 382 -g~~Pf~~ 388 (397)
|..||..
T Consensus 196 ~g~~p~~~ 203 (257)
T cd05040 196 YGEEPWAG 203 (257)
T ss_pred CCCCCCCC
Confidence 9999854
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=243.03 Aligned_cols=206 Identities=21% Similarity=0.319 Sum_probs=162.0
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc-cCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK-KGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~ 216 (397)
+|++.+.||.|+||.||++.+..++ ..+++|.+.... ..+......+...+....|++++.+++.... .+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDG-----KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCE
Confidence 5889999999999999999988876 678888765322 2222223334455666788999988775543 3467
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH-----HCCceecCCCCC
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH-----STGIVHRDIKPQ 291 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH-----~~giiHrDIKp~ 291 (397)
.++++||+++++|.+++.... .....+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~----------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ 139 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCK----------------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139 (265)
T ss_pred EEEEehhccCCCHHHHHHHHh----------------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHH
Confidence 899999999999999997642 12235678889999999999999999 899999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++++++ .+||+|||++......... .....+++.|+|||.+... .++.++|+||
T Consensus 140 nili~~~~-~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~----------------------~~~~~~Dv~s 195 (265)
T cd08217 140 NIFLDANN-NVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHM----------------------SYDEKSDIWS 195 (265)
T ss_pred HEEEecCC-CEEEecccccccccCCccc-ccccccCCCccChhhhcCC----------------------CCCchhHHHH
Confidence 99999987 9999999999876543321 2345789999999965433 3455679999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|+|++|..||....
T Consensus 196 lG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 196 LGCLIYELCALSPPFTARN 214 (265)
T ss_pred HHHHHHHHHHCCCcccCcC
Confidence 9999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=244.56 Aligned_cols=208 Identities=22% Similarity=0.250 Sum_probs=157.9
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
+.||+|+||.||+|.+.... .....+++|.+....... .....++...+....|++++.+++.... +...+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEe
Confidence 47999999999999987641 112788888887544332 2233334445555669999988876654 6789999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++....... .......+++..+..++.|++.||+|||++|++||||||+||++++++ .+|
T Consensus 78 ~~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~ 145 (262)
T cd00192 78 MEGGDLLDYLRKSRPVF-----------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVK 145 (262)
T ss_pred ccCCcHHHHHhhccccc-----------cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEE
Confidence 99999999998752100 001124678899999999999999999999999999999999999987 999
Q ss_pred EEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-
Q 015991 304 IIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC- 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt- 381 (397)
|+|||.+........ .......++..|+|||.+... .++.++|+||+|+++|||++
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~il~~l~~~ 203 (262)
T cd00192 146 ISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG----------------------IFTSKSDVWSFGVLLWEIFTL 203 (262)
T ss_pred EcccccccccccccccccccCCCcCccccCHHHhccC----------------------CcchhhccHHHHHHHHHHHhc
Confidence 999999987654321 112345678899999965443 45567899999999999999
Q ss_pred CCCCCCCC
Q 015991 382 TVRRLCLH 389 (397)
Q Consensus 382 g~~Pf~~~ 389 (397)
|..||...
T Consensus 204 g~~p~~~~ 211 (262)
T cd00192 204 GATPYPGL 211 (262)
T ss_pred CCCCCCCC
Confidence 69998765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=242.92 Aligned_cols=197 Identities=17% Similarity=0.224 Sum_probs=148.3
Q ss_pred eeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEec
Q 015991 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYE 224 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~ 224 (397)
.||+|+||.||+|.+...+.. ..+++|......... .....++...+....|++++.+++.+. ....++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~---~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQ---IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCc---eeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeC
Confidence 489999999999987543211 457888776543221 122233445556678999999887653 45789999999
Q ss_pred CCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEE
Q 015991 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304 (397)
Q Consensus 225 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL 304 (397)
++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++.++ .+||
T Consensus 77 ~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl 136 (257)
T cd05115 77 SGGPLNKFLSGKK-------------------DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKI 136 (257)
T ss_pred CCCCHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEe
Confidence 9999999987532 1457788999999999999999999999999999999999887 9999
Q ss_pred Eeccccccccccccccc--ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-
Q 015991 305 IDLGAAADLRVGINYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC- 381 (397)
Q Consensus 305 ~DFGla~~~~~~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt- 381 (397)
+|||++..+........ ....++..|+|||.+.+. .++.++|+||||+++|||++
T Consensus 137 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~~l~el~~~ 194 (257)
T cd05115 137 SDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR----------------------KFSSRSDVWSYGITMWEAFSY 194 (257)
T ss_pred ccCCccccccCCccceeccCCCCCCcccCCHHHHccC----------------------CCCchhhHHHHHHHHHHHhcC
Confidence 99999976544332211 122335789999966433 34567799999999999996
Q ss_pred CCCCCCCC
Q 015991 382 TVRRLCLH 389 (397)
Q Consensus 382 g~~Pf~~~ 389 (397)
|..||...
T Consensus 195 g~~p~~~~ 202 (257)
T cd05115 195 GQKPYKKM 202 (257)
T ss_pred CCCCcCcC
Confidence 99999643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=243.18 Aligned_cols=208 Identities=23% Similarity=0.235 Sum_probs=160.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..+++.....||+|+||.||+|++..++ ..+++|..............++...+....|++++.+++.+. .++.
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 79 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQ-----VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-ENGF 79 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCC-----cEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-cCCE
Confidence 3455555679999999999999987766 778888876554443334444555666778999999887654 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++++||+.+++|.+++.....+ ...++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~ 142 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGP-----------------LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN 142 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhccc-----------------CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 99999999999999998764211 1125677888999999999999999999999999999998
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.+...++|+|||++....... .......+++.|+|||.+..... .++.++|+||||+++
T Consensus 143 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~--------------------~~~~~~Dv~slGvvl 201 (268)
T cd06624 143 TYSGVVKISDFGTSKRLAGIN-PCTETFTGTLQYMAPEVIDKGPR--------------------GYGAPADIWSLGCTI 201 (268)
T ss_pred CCCCeEEEecchhheecccCC-CccccCCCCccccChhhhccccc--------------------cCCchhhhHHHHHHH
Confidence 744499999999997653322 12233568899999997644321 245678999999999
Q ss_pred HHHHcCCCCCCC
Q 015991 377 LQMVCTVRRLCL 388 (397)
Q Consensus 377 ~elltg~~Pf~~ 388 (397)
|+|++|..||..
T Consensus 202 ~~l~~g~~p~~~ 213 (268)
T cd06624 202 VEMATGKPPFIE 213 (268)
T ss_pred HHHHhCCCCCcc
Confidence 999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=252.45 Aligned_cols=201 Identities=22% Similarity=0.289 Sum_probs=156.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
..|.....||+|+||.||++.+..++ +.+++|.+............++...+....|++++.+++.+. .++..+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSG-----RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-VGEELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCC-----CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-eCCeEE
Confidence 34455668999999999999987766 778888875433222222233445566677999988877654 457899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+++||+++++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 95 iv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~ 153 (297)
T cd06659 95 VLMEFLQGGALTDIVSQT---------------------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD 153 (297)
T ss_pred EEEecCCCCCHHHHHhhc---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC
Confidence 999999999999877543 35677889999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .+||+|||++........ ......++..|+|||++.+. .++.++|+||||+++||
T Consensus 154 ~-~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~il~e 209 (297)
T cd06659 154 G-RVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRT----------------------PYGTEVDIWSLGIMVIE 209 (297)
T ss_pred C-cEEEeechhHhhcccccc-cccceecCccccCHHHHccC----------------------CCCchhhHHHHHHHHHH
Confidence 7 999999999976543221 12346789999999966443 34556799999999999
Q ss_pred HHcCCCCCCCCC
Q 015991 379 MVCTVRRLCLHS 390 (397)
Q Consensus 379 lltg~~Pf~~~~ 390 (397)
|++|+.||....
T Consensus 210 l~~g~~p~~~~~ 221 (297)
T cd06659 210 MVDGEPPYFSDS 221 (297)
T ss_pred HHhCCCCCCCCC
Confidence 999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=242.16 Aligned_cols=197 Identities=16% Similarity=0.210 Sum_probs=149.8
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
+.||+|+||.||+|.... + +.+++|........+ .....++...+....|++++.+++.+. ..+..++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~-----~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-K-----TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-QRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEecC-C-----cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-cCCccEEEEEC
Confidence 479999999999998653 3 678888876543221 112233444556668999988887654 45678999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+||++++++ .+|
T Consensus 74 ~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~ 133 (250)
T cd05085 74 VPGGDFLSFLRKKK-------------------DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLK 133 (250)
T ss_pred CCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEE
Confidence 99999999886542 1356788889999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-C
Q 015991 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC-T 382 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt-g 382 (397)
|+|||++...............+++.|+|||++.. ..++.++|+||||+++|||++ |
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~ll~~~~~~g 191 (250)
T cd05085 134 ISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY----------------------GRYSSESDVWSYGILLWETFSLG 191 (250)
T ss_pred ECCCccceeccccccccCCCCCCcccccCHHHhcc----------------------CCCCchhHHHHHHHHHHHHhcCC
Confidence 99999997543332222222344678999996543 345567899999999999998 9
Q ss_pred CCCCCCCC
Q 015991 383 VRRLCLHS 390 (397)
Q Consensus 383 ~~Pf~~~~ 390 (397)
..||....
T Consensus 192 ~~p~~~~~ 199 (250)
T cd05085 192 VCPYPGMT 199 (250)
T ss_pred CCCCCCCC
Confidence 99996543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=254.50 Aligned_cols=202 Identities=22% Similarity=0.297 Sum_probs=155.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccc----c
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK----K 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~ 213 (397)
++|++.++||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+.+.... .
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTG-----VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCC-----CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 78999999999999999999988776 7889998764221 112222234445556668888887654332 2
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
....++++||+++ +|.+++... .+++..++.++.|++.||.|||+.||+||||||+||
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~~---------------------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Ni 137 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKTQ---------------------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNL 137 (336)
T ss_pred cceEEEEehhccc-CHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 2468999999984 787776543 357788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
+++.++ .+||+|||++.......... .....+|+.|+|||.+.+. ..++.++||||
T Consensus 138 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~Dvws 195 (336)
T cd07849 138 LLNTNC-DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS---------------------KGYTKAIDIWS 195 (336)
T ss_pred EECCCC-CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCC---------------------CCCCcHHHHHH
Confidence 999987 99999999997654332211 2345789999999965432 13556789999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~ 389 (397)
+||++|||++|+.||...
T Consensus 196 lGvil~el~~G~~~f~~~ 213 (336)
T cd07849 196 VGCILAEMLSNRPLFPGK 213 (336)
T ss_pred HHHHHHHHHhCCCCCCCC
Confidence 999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=249.86 Aligned_cols=203 Identities=18% Similarity=0.241 Sum_probs=160.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||+||++.+..++ +.+++|........ ......++...+....|++++.+.+.+.. .+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 76 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTG-----TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-EN 76 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCC-----cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CC
Confidence 4478999999999999999999988776 67788776543221 11222234445566689999998887654 47
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCceE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVI 294 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NIL 294 (397)
.+++|+||+++++|.+++...+ .+++..+..++.|++.+|.|||+ .+++||||||+||+
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGG--------------------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhcc--------------------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 8999999999999999886543 35678888999999999999997 69999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+++++ .++|+|||++....... .....||..|+|||++.+ ..++.++|+|||||
T Consensus 137 ~~~~~-~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~----------------------~~~~~~~Di~slG~ 190 (284)
T cd06620 137 VNSRG-QIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQG----------------------GKYTVKSDVWSLGI 190 (284)
T ss_pred ECCCC-cEEEccCCcccchhhhc---cCccccCcccCCHHHHcc----------------------CCCCccchHHHHHH
Confidence 99887 99999999986543221 234578999999996543 34556789999999
Q ss_pred HHHHHHcCCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~~ 391 (397)
++|||++|+.||.....
T Consensus 191 ~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 191 SIIELALGKFPFAFSNI 207 (284)
T ss_pred HHHHHHhCCCCCcccch
Confidence 99999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-33 Score=249.27 Aligned_cols=208 Identities=20% Similarity=0.238 Sum_probs=163.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHH-HHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIW-MNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+..++.+-...||.|+||+|++-.++.++ +..|+|+++.... .+.. ...+........+.++|+.|++..+.+
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg-----~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E 135 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSG-----KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE 135 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccC-----cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence 44567777889999999999999999888 9999999986543 2222 222333445667889999999988776
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCc
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQN 292 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~N 292 (397)
+ ..|+.||.|. .||+.+.+.-- . .....++|+.+-+|..-.+.||+||.+ .+||||||||+|
T Consensus 136 G-dcWiCMELMd-~SlDklYk~vy---~------------vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSN 198 (361)
T KOG1006|consen 136 G-DCWICMELMD-ISLDKLYKRVY---S------------VQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSN 198 (361)
T ss_pred C-ceeeeHHHHh-hhHHHHHHHHH---H------------HHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhh
Confidence 5 5899999998 56655543211 1 123467888999999999999999985 599999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++..| .+||||||.+..+.++.. .+.-.|..-|||||.+.... .+|+.|+|||||
T Consensus 199 ILldr~G-~vKLCDFGIcGqLv~SiA--kT~daGCrpYmAPERi~p~~--------------------~gyDiRSDvWSL 255 (361)
T KOG1006|consen 199 ILLDRHG-DVKLCDFGICGQLVDSIA--KTVDAGCRPYMAPERIDPSD--------------------KGYDIRSDVWSL 255 (361)
T ss_pred eEEecCC-CEeeecccchHhHHHHHH--hhhccCCccccChhccCCcc--------------------CCcchhhhhhhh
Confidence 9999988 999999999987755432 24457788999999775332 258889999999
Q ss_pred HHHHHHHHcCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCL 388 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~ 388 (397)
|++|+|+.||+.||..
T Consensus 256 GITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 256 GITLYEVATGNFPYRK 271 (361)
T ss_pred cceEeeeecCCCCcch
Confidence 9999999999999964
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=243.73 Aligned_cols=200 Identities=22% Similarity=0.288 Sum_probs=160.7
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
+|++.+.||.|+||.||+|.+..++ +.+++|.+..... .......++...+...+|++++.++..+ ..+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTK-----KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-QDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCC-----cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-cCCCe
Confidence 5899999999999999999988776 7888888764321 1222333344556677899999887765 44678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++|+||+.+++|.+++.... .+++..+..++.|+++||.|||++|++|+||||+||+++
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~ 134 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQKV--------------------KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhcC--------------------CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc
Confidence 999999999999999987652 456788899999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||.+....... ......++..|+|||.+... .++.++|+||||+++
T Consensus 135 ~~~-~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Di~slG~~l 189 (258)
T cd05578 135 EQG-HVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQ----------------------GYSVAVDWWSLGVTA 189 (258)
T ss_pred CCC-CEEEeecccccccCCCc--cccccCCChhhcCHHHHccc----------------------CCCCcccchhhHHHH
Confidence 987 99999999997664432 12345688899999965433 345677999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|+|++|+.||....
T Consensus 190 ~~l~~g~~p~~~~~ 203 (258)
T cd05578 190 YECLRGKRPYRGHS 203 (258)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999998655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=254.10 Aligned_cols=200 Identities=21% Similarity=0.303 Sum_probs=155.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+++.+....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTG-----QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCC-----CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 378999999999999999999998877 788999875321 111112223445566677899888876554322
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
...++|+||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||
T Consensus 90 ~~~~~~~~lv~e~~~~-~l~~~~~~~----------------------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp 146 (353)
T cd07850 90 LEEFQDVYLVMELMDA-NLCQVIQMD----------------------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 146 (353)
T ss_pred ccccCcEEEEEeccCC-CHHHHHhhc----------------------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 457999999974 787776532 45677888999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||+++.++ .+||+|||+++...... ......+|+.|+|||++.+. .++.++|||
T Consensus 147 ~Nil~~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dvw 201 (353)
T cd07850 147 SNIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGM----------------------GYKENVDIW 201 (353)
T ss_pred HHEEECCCC-CEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCC----------------------CCCCchhhH
Confidence 999999987 99999999998654322 23345688999999966443 455677999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|+|++|+.||....
T Consensus 202 slG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 202 SVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred hHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999997554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=247.39 Aligned_cols=204 Identities=20% Similarity=0.238 Sum_probs=157.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++...+...+|++++.+.+... .++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 77 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTG-----QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-TKKT 77 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCC-----cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-cCCe
Confidence 479999999999999999999987766 77888887543211 1111223445556667899998887654 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~-------------------~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~ 137 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCG-------------------GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS 137 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc
Confidence 9999999995 8988886542 1456788899999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||+++........ .....++..|+|||++.+. ..++.++||||+|+++
T Consensus 138 ~~~-~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~---------------------~~~~~~~Dv~slG~il 194 (291)
T cd07844 138 ERG-ELKLADFGLARAKSVPSKT-YSNEVVTLWYRPPDVLLGS---------------------TEYSTSLDMWGVGCIF 194 (291)
T ss_pred CCC-CEEECccccccccCCCCcc-ccccccccccCCcHHhhcC---------------------cccCcHHHHHHHHHHH
Confidence 987 9999999998754322211 1223568899999966532 1355678999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 195 ~~l~~g~~~~~~~~ 208 (291)
T cd07844 195 YEMATGRPLFPGST 208 (291)
T ss_pred HHHHhCCCCCCCCc
Confidence 99999999996544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=247.66 Aligned_cols=205 Identities=18% Similarity=0.201 Sum_probs=155.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc-CCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK-GGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~ 216 (397)
.-|++.++||+|+||.||++...... ....+.+++|.+.... ........++...+....|++++.+.+.+... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45789999999999999999864321 1112678899876432 22223344455566777899999887765444 356
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~ 143 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-------------------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 143 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc
Confidence 899999999999999986542 1356778889999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
.++ .++|+|||+++.+...... ......++..|+|||.+.+. .++.++|+||||+
T Consensus 144 ~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~----------------------~~~~~~Di~slG~ 200 (284)
T cd05079 144 SEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS----------------------KFYIASDVWSFGV 200 (284)
T ss_pred CCC-CEEECCCccccccccCccceeecCCCCCCccccCHHHhccC----------------------CCCccccchhhhh
Confidence 987 9999999999876433221 12345567789999966443 3455679999999
Q ss_pred HHHHHHcCCCCC
Q 015991 375 IFLQMVCTVRRL 386 (397)
Q Consensus 375 ~l~elltg~~Pf 386 (397)
++|||+++..|+
T Consensus 201 il~ellt~~~~~ 212 (284)
T cd05079 201 TLYELLTYCDSE 212 (284)
T ss_pred hhhhhhcCCCCC
Confidence 999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=243.92 Aligned_cols=200 Identities=17% Similarity=0.120 Sum_probs=148.9
Q ss_pred eeeccCCceEEEEEEecCCCC-------CCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 145 KKLGEGAFGVVYRASLAKKPS-------SKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~-------~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+.||+|+||.||+|+...+.. ......+++|.+............++...+....|+|++.+++.+.. +...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCCC
Confidence 478999999999998643221 11123567777654433333333344556667789999999887643 4578
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
+++|||+++++|..++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 140 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS-------------------DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAR 140 (262)
T ss_pred EEEEecccCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEec
Confidence 89999999999988876542 13577788899999999999999999999999999999986
Q ss_pred CCC------eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 298 GSR------TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 298 ~~~------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
++. .++++|||++..... .....++..|+|||.+... ..++.++||||
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~Diws 194 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVLS-----RQECVERIPWIAPECVEDS---------------------KNLSIAADKWS 194 (262)
T ss_pred CCccCCCCceeEeCCCCCCccccC-----cccccccccccChhhhcCC---------------------CCCCchhHHHH
Confidence 542 389999999865432 2335678899999965422 23556789999
Q ss_pred HHHHHHHHH-cCCCCCCCCC
Q 015991 372 AGLIFLQMV-CTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~ell-tg~~Pf~~~~ 390 (397)
|||++|||+ .|..||....
T Consensus 195 lG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 195 FGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred HHHHHHHHHhCCCCCCCCcc
Confidence 999999997 5888886543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=240.90 Aligned_cols=202 Identities=14% Similarity=0.230 Sum_probs=154.8
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
..+|++.+.||+|+||.||++.+..+ ..+++|.+......+.. ...+...+....|++++.+++.+. .....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~------~~~~~k~~~~~~~~~~~-~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 74 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEK------RKVAIKTIREGAMSEED-FIEEAQVMMKLSHPKLVQLYGVCT-ERSPI 74 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCC------CeEEEEECCCCCCCHHH-HHHHHHHHHhCCCCCeeeEEEEEc-cCCce
Confidence 36899999999999999999987643 57888877643322211 222344555567889988877653 34678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++++||+.+++|.+++.... ..++++.+..++.|++.+|+|||+.+++||||||+||+++.
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQR-------------------GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 99999999999999987543 13567788899999999999999999999999999999998
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||+++..............++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 136 ~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~----------------------~~~~~~~Dv~slG~~l~ 192 (256)
T cd05112 136 NQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF----------------------SKYSSKSDVWSFGVLMW 192 (256)
T ss_pred CC-eEEECCCcceeecccCcccccCCCccchhhcCHhHhcc----------------------CCcChHHHHHHHHHHHH
Confidence 77 99999999997653322211223345678999996643 23556789999999999
Q ss_pred HHHc-CCCCCCCC
Q 015991 378 QMVC-TVRRLCLH 389 (397)
Q Consensus 378 ellt-g~~Pf~~~ 389 (397)
||++ |..||...
T Consensus 193 el~~~g~~p~~~~ 205 (256)
T cd05112 193 EVFSEGKTPYENR 205 (256)
T ss_pred HHHcCCCCCCCcC
Confidence 9998 99998644
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=244.77 Aligned_cols=213 Identities=20% Similarity=0.269 Sum_probs=168.7
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..|++.++||+|.||.||+|.-.+++... .+.+|+|+++...+. -....-+++..+....|+|++.+...+-..+..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKR-TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCccc-chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 67999999999999999999766655432 358899988754221 112223456667777899999888777666789
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.|+++||.+. +|.++++-+.. .+...++...++.|+.||+.|+.|||++=|+|||+||.|||+.
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~---------------~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvm 166 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRA---------------SKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVM 166 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhcc---------------chhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEe
Confidence 9999999984 78888876542 2334677888999999999999999999999999999999998
Q ss_pred CC----CCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 297 EG----SRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 297 ~~----~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
.+ | .+||+|||+|+.+...-.. .....+-|.+|.|||.+.+... |+..+|||
T Consensus 167 gdgperG-~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~h---------------------YT~AiDvW 224 (438)
T KOG0666|consen 167 GDGPERG-RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARH---------------------YTKAIDVW 224 (438)
T ss_pred ccCCccC-eeEeecccHHHHhhccccccccCCceEEEEEecChHHhccccc---------------------ccchhhhH
Confidence 76 5 9999999999988654322 2345678999999999988765 44457999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
+.||++.||++-++-|.+.+
T Consensus 225 AiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 225 AIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred HHHHHHHHHHccCccccchh
Confidence 99999999999998887643
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=244.33 Aligned_cols=204 Identities=22% Similarity=0.281 Sum_probs=160.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccc-cCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK-KGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~ 216 (397)
++|+..++||.|++|.||++.+..++ +.+++|....... .......++...+....|++++.+++.+.. ..+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTG-----MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCC-----eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCe
Confidence 57999999999999999999998766 7788887764322 122222334556666789999998876543 3457
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~ 139 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVK----------------KRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 899999999999999876432 1223467788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||++....... .....++..|++||.+.+ ..++.++|+||||+++
T Consensus 140 ~~~-~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~----------------------~~~~~~~Dv~slG~il 193 (287)
T cd06621 140 RKG-QVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQG----------------------KPYSITSDVWSLGLTL 193 (287)
T ss_pred cCC-eEEEeeccccccccccc---cccccCCccccCHHHhcC----------------------CCCCchhhHHHHHHHH
Confidence 987 99999999987553221 123467889999995543 3456678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|..||...
T Consensus 194 ~~l~~g~~p~~~~ 206 (287)
T cd06621 194 LEVAQNRFPFPPE 206 (287)
T ss_pred HHHHhCCCCCCcc
Confidence 9999999999866
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=243.56 Aligned_cols=192 Identities=20% Similarity=0.336 Sum_probs=150.5
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHH-HHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIW-MNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+|+||.||+|.+..++ +.+++|........ ... ...+.........|++++.+++.+. .++..+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv 75 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG-----DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-SKDYLYLV 75 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC-----CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-cCCeEEEE
Confidence 57999999999999988776 77888887543211 111 1111122233447888888887653 45789999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
+||+++++|.++++... .+++..+..++.|++.||.|||+.+++||||+|+||++++++
T Consensus 76 ~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~- 134 (260)
T cd05611 76 MEYLNGGDCASLIKTLG--------------------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG- 134 (260)
T ss_pred EeccCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-
Confidence 99999999999987643 356788889999999999999999999999999999999987
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
.++|+|||++..... .....++..|++||.+.+.. ++.++|+||||+++|||+
T Consensus 135 ~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~----------------------~~~~~Dv~slG~il~~l~ 187 (260)
T cd05611 135 HLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVG----------------------DDKMSDWWSLGCVIFEFL 187 (260)
T ss_pred cEEEeecccceeccc-----cccCCCCcCccChhhhcCCC----------------------CcchhhhHHHHHHHHHHH
Confidence 999999999875432 23456889999999765432 455779999999999999
Q ss_pred cCCCCCCCCC
Q 015991 381 CTVRRLCLHS 390 (397)
Q Consensus 381 tg~~Pf~~~~ 390 (397)
+|..||....
T Consensus 188 ~g~~p~~~~~ 197 (260)
T cd05611 188 FGYPPFHAET 197 (260)
T ss_pred HCCCCCCCCC
Confidence 9999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=245.67 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=158.7
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
..|+..++||.|+||.||+|.+..++ ..+++|...... ..+.....++...+....|++++.+.+.+. .++..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCC-----EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECCEE
Confidence 46778899999999999999988766 778888766432 222333344455666678999999888654 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+++++|.+++... .+++..+..++.|++.||+|||+.+++|+||+|+||++++
T Consensus 78 ~lv~e~~~~~~L~~~i~~~---------------------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~ 136 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAG---------------------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred EEEEecCCCCcHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence 9999999999999988653 2456778889999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~----------------------~~~~~~Dv~slG~il~ 192 (277)
T cd06640 137 QG-DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQS----------------------AYDSKADIWSLGITAI 192 (277)
T ss_pred CC-CEEEcccccceeccCCcc-ccccccCcccccCHhHhccC----------------------CCccHHHHHHHHHHHH
Confidence 87 999999999976543321 22335678899999966433 3456779999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
||++|..||...
T Consensus 193 el~tg~~p~~~~ 204 (277)
T cd06640 193 ELAKGEPPNSDM 204 (277)
T ss_pred HHHHCCCCCCCc
Confidence 999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=249.00 Aligned_cols=209 Identities=16% Similarity=0.139 Sum_probs=158.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+..++|+..+.||+|+||.||+|.+..++..+ ...+++|......... .....++........|+|++.+++.+..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-- 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETV-KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-- 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcc-eeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--
Confidence 45689999999999999999999987665332 2356778776433221 1122333445566789999998886543
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++++||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nil 141 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHK-------------------DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVL 141 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceee
Confidence 34678999999999999987643 13567778899999999999999999999999999999
Q ss_pred EeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++++ .+||+|||+++........ ......++..|++||.+.+. .++.++||||||
T Consensus 142 l~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~DiwslG 198 (303)
T cd05110 142 VKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR----------------------KFTHQSDVWSYG 198 (303)
T ss_pred ecCCC-ceEEccccccccccCcccccccCCCccccccCCHHHhccC----------------------CCChHHHHHHHH
Confidence 99877 8999999999866433221 12234457789999965432 455678999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
+++|||++ |..||...
T Consensus 199 ~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 199 VTIWELMTFGGKPYDGI 215 (303)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999997 99998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=245.48 Aligned_cols=214 Identities=18% Similarity=0.241 Sum_probs=149.8
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccccCCeEEEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSKKGGEYWLIWR 222 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~lv~e 222 (397)
+.||+|+||.||+|++..++.. ..+++|....... ........+...+... .|++++.+++.+.. .+..+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCe---eEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEE
Confidence 4689999999999998776421 2456776664321 1111222233333333 78999988876644 467899999
Q ss_pred ecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeE
Q 015991 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302 (397)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~ 302 (397)
|+.+++|.+++........... . .........+++..+..++.|++.||+|||+.|++||||||+|||+++++ .+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~-~---~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~ 151 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPA-F---AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VA 151 (270)
T ss_pred eCCCCcHHHHHHhccccccccc-c---ccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eE
Confidence 9999999999976531100000 0 00011223577889999999999999999999999999999999999987 99
Q ss_pred EEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-
Q 015991 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC- 381 (397)
Q Consensus 303 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt- 381 (397)
||+|||++...... ........+..|+|||++.. ..++.++|+||||+++|||++
T Consensus 152 kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~----------------------~~~~~~~Di~slG~il~el~~~ 207 (270)
T cd05047 152 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNY----------------------SVYTTNSDVWSYGVLLWEIVSL 207 (270)
T ss_pred EECCCCCccccchh--hhccCCCCccccCChHHHcc----------------------CCCCchhhHHHHHHHHHHHHcC
Confidence 99999998643211 11122334668999996543 335567799999999999996
Q ss_pred CCCCCCCCCC
Q 015991 382 TVRRLCLHSC 391 (397)
Q Consensus 382 g~~Pf~~~~~ 391 (397)
|..||.....
T Consensus 208 g~~pf~~~~~ 217 (270)
T cd05047 208 GGTPYCGMTC 217 (270)
T ss_pred CCCCccccCH
Confidence 9999965543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=241.38 Aligned_cols=202 Identities=27% Similarity=0.334 Sum_probs=162.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.+.||+|++|.||+|.+..++ +.+++|++..... ........+...+....|++++.+++.+.. .+..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTG-----KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCC-----cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeE
Confidence 47899999999999999999998876 7888888765433 222223334445555669999998876644 4789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCceEEe
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFS 296 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NILl~ 296 (397)
++++||+++++|.+++.... .+++..+..++.|++++|.|||+ .|++||||+|+||+++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVG--------------------KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred EEEEEecCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 99999999999999997643 45778889999999999999999 9999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .++|+|||.+......... .....++..|+|||.+... .++.++|+||||+++
T Consensus 135 ~~~-~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~----------------------~~~~~~Dv~slG~il 190 (264)
T cd06623 135 SKG-EVKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGE----------------------SYSYAADIWSLGLTL 190 (264)
T ss_pred CCC-CEEEccCccceecccCCCc-ccceeecccccCHhhhCCC----------------------CCCchhhHHHHHHHH
Confidence 987 9999999999866433222 2345688999999965443 345677999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|..||....
T Consensus 191 ~~l~tg~~p~~~~~ 204 (264)
T cd06623 191 LECALGKFPFLPPG 204 (264)
T ss_pred HHHHhCCCCCcccc
Confidence 99999999997664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=245.02 Aligned_cols=205 Identities=20% Similarity=0.275 Sum_probs=153.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH----HHHHHHHHHHHhhcc-CCCceeeeeecccccC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV----EIWMNERVRRACANC-CADFVYGFFENSSKKG 214 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (397)
+|++.+.||+|+||.||++++...... .+.+++|.+...... ......++...+... +|++++.+...+. .+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~--g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~ 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDS--GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-TD 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCC--CceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-cC
Confidence 588999999999999999987532111 167888877542211 111112223333333 5788888766543 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 78 TKLHLILDYINGGELFTHLSQRE--------------------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred CeEEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 67899999999999999987643 3567788889999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+++++ .+||+|||++...............|+..|+|||.+..... .++.++|+||||+
T Consensus 138 ~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--------------------~~~~~~Dv~slG~ 196 (290)
T cd05613 138 LDSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG--------------------GHDKAVDWWSMGV 196 (290)
T ss_pred ECCCC-CEEEeeCccceecccccccccccccCCcccCChhhccCCCC--------------------CCCccccHHHHHH
Confidence 99987 99999999998764433222334678999999997653221 2445679999999
Q ss_pred HHHHHHcCCCCCCC
Q 015991 375 IFLQMVCTVRRLCL 388 (397)
Q Consensus 375 ~l~elltg~~Pf~~ 388 (397)
++|+|++|..||..
T Consensus 197 ~l~~ll~g~~p~~~ 210 (290)
T cd05613 197 LMYELLTGASPFTV 210 (290)
T ss_pred HHHHHhcCCCCCCc
Confidence 99999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=241.49 Aligned_cols=203 Identities=22% Similarity=0.321 Sum_probs=160.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||+|+||.||++.+..++ +.+++|.+... ...+.....++...+....|++++.+.+.+ ...+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDG-----KQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-EENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCC-----CEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-cCCCeE
Confidence 5899999999999999999988776 78888887532 122222333445566677899999988765 445789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+.+++|.+.+.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~ 136 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQR------------------GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 136 (256)
T ss_pred EEEEecCCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 99999999999999887542 124567888899999999999999999999999999999998
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++........ ......+++.|+|||++.+. .++.++|+|||||+++
T Consensus 137 ~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~----------------------~~~~~~Dv~slG~i~~ 192 (256)
T cd08218 137 DG-TIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENR----------------------PYNNKSDIWALGCVLY 192 (256)
T ss_pred CC-CEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCC----------------------CCCCccchhHHHHHHH
Confidence 87 999999999976543221 22345688999999966443 3445679999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
+|++|+.||....
T Consensus 193 ~l~~g~~~~~~~~ 205 (256)
T cd08218 193 EMCTLKHAFEAGN 205 (256)
T ss_pred HHHcCCCCccCCC
Confidence 9999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=241.50 Aligned_cols=206 Identities=23% Similarity=0.282 Sum_probs=158.2
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
|++.+.||+|+||.||++.+...+. .....+++|........ .......+...+....|++++.+++.+... +..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEE
Confidence 4678899999999999999876432 12267888888755432 222333344455555889999888866543 68999
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
+|||+.+++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||++++++
T Consensus 79 i~e~~~~~~l~~~~~~~~~------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~ 140 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP------------------KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL 140 (258)
T ss_pred EEeccCCCCHHHHHHhhhh------------------ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC
Confidence 9999999999999976531 1167888999999999999999999999999999999999987
Q ss_pred CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 300 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.++|+|||++........+......+++.|+|||.+.. ..++.++|+||+|+++|||
T Consensus 141 -~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~----------------------~~~~~~~Di~slG~i~~~l 197 (258)
T smart00219 141 -VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD----------------------GKFTSKSDVWSFGVLLWEI 197 (258)
T ss_pred -eEEEcccCCceecccccccccccCCCcccccChHHhcc----------------------CCCCcchhHHHHHHHHHHH
Confidence 99999999998765443332222347789999996532 3455678999999999999
Q ss_pred Hc-CCCCCCCC
Q 015991 380 VC-TVRRLCLH 389 (397)
Q Consensus 380 lt-g~~Pf~~~ 389 (397)
++ |..||...
T Consensus 198 ~~~g~~p~~~~ 208 (258)
T smart00219 198 FTLGESPYPGM 208 (258)
T ss_pred HhCCCCCCCCC
Confidence 98 78888643
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=244.50 Aligned_cols=201 Identities=23% Similarity=0.349 Sum_probs=156.7
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-h---HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-A---VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
.|++.+.||+|+||.||+|.+..++ +.+++|.+.... . .+...+..+...+....|++++.+.+.+ ..+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-~~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTG-----RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-LKGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCC-----cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-eeCC
Confidence 5778899999999999999987776 788888765321 1 1122222333344444689999988765 3457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+.+++|.++++.. .+++..+..++.|++.+|.|||+.||+|+||+|+||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~---------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAG---------------------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred EEEEEEecCCCCcHHHHHHcc---------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 899999999999999988653 35677888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .++|+|||++..+..... ......|+..|+|||.+.... .++.++|+||||++
T Consensus 135 ~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv~slG~~ 191 (277)
T cd06917 135 TNTG-NVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGK---------------------YYDTKADIWSLGIT 191 (277)
T ss_pred cCCC-CEEEccCCceeecCCCcc-ccccccCCcceeCHHHhccCC---------------------ccccchhHHHHHHH
Confidence 9987 999999999987654332 223457899999999764321 24557899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|+|++|..||....
T Consensus 192 l~~ll~g~~p~~~~~ 206 (277)
T cd06917 192 IYEMATGNPPYSDVD 206 (277)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999996543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=245.28 Aligned_cols=205 Identities=20% Similarity=0.270 Sum_probs=158.1
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+|++.++||.|++|.||+|++..++ ..+++|.+...... ......++...+....|++++.+.+.+.. .+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTG-----EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCC-----eEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEE
Confidence 5899999999999999999998776 77888877643211 11112223445555678999888876644 46789
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+||||+++ +|.+++.... ....+++..+..++.|++.||+|||+.|++||||||+||+++++
T Consensus 75 lv~e~~~~-~l~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHG-----------------VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR 136 (284)
T ss_pred EEEecCCc-cHHHHHHhcC-----------------CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 99999995 8888876543 12356888899999999999999999999999999999999988
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||++......... .....+|..|++||++.+.. .++.++|+||||+++||
T Consensus 137 ~-~~~l~d~g~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~---------------------~~~~~~Dv~slG~~l~~ 193 (284)
T cd07836 137 G-ELKLADFGLARAFGIPVNT-FSNEVVTLWYRAPDVLLGSR---------------------TYSTSIDIWSVGCIMAE 193 (284)
T ss_pred C-cEEEeecchhhhhcCCccc-cccccccccccChHHhcCCC---------------------CCCcHHHHHHHHHHHHH
Confidence 7 9999999999765433221 23346788999999764321 24567899999999999
Q ss_pred HHcCCCCCCCCCC
Q 015991 379 MVCTVRRLCLHSC 391 (397)
Q Consensus 379 lltg~~Pf~~~~~ 391 (397)
|++|+.||.....
T Consensus 194 l~~g~~~~~~~~~ 206 (284)
T cd07836 194 MITGRPLFPGTNN 206 (284)
T ss_pred HHhCCCCCCCCCc
Confidence 9999999986553
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=247.32 Aligned_cols=199 Identities=27% Similarity=0.377 Sum_probs=157.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+.|+..+.||+|+||.||+|.+..++ ..+++|...... ........++...+....|++++.+.+.+. .++..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-KGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCC-----eEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-cCCce
Confidence 45677889999999999999987765 678888776332 222223334455666678999998887664 45689
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||++++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~ 136 (277)
T cd06642 78 WIIMEYLGGGSALDLLKPG---------------------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE 136 (277)
T ss_pred EEEEEccCCCcHHHHhhcC---------------------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC
Confidence 9999999999999988643 3567788899999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++..+..... ......++..|+|||++.+. .++.++|+||||+++|
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slG~il~ 192 (277)
T cd06642 137 QG-DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQS----------------------AYDFKADIWSLGITAI 192 (277)
T ss_pred CC-CEEEccccccccccCcch-hhhcccCcccccCHHHhCcC----------------------CCchhhhHHHHHHHHH
Confidence 87 999999999976543221 22345688899999966433 3456789999999999
Q ss_pred HHHcCCCCCCC
Q 015991 378 QMVCTVRRLCL 388 (397)
Q Consensus 378 elltg~~Pf~~ 388 (397)
||++|+.||..
T Consensus 193 el~tg~~p~~~ 203 (277)
T cd06642 193 ELAKGEPPNSD 203 (277)
T ss_pred HHHhCCCCCcc
Confidence 99999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=242.44 Aligned_cols=197 Identities=17% Similarity=0.257 Sum_probs=153.4
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.+.||+|+||.||++...+ +.+++|........+.. .++...+....|++++.+++.... +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~iK~~~~~~~~~~~--~~e~~~l~~~~~~~i~~~~~~~~~--~~~ 73 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEYTG-------QKVAVKNIKCDVTAQAF--LEETAVMTKLHHKNLVRLLGVILH--NGL 73 (254)
T ss_pred HHHceeeeeeccCCCCceEecccCC-------CceEEEeecCcchHHHH--HHHHHHHHhCCCCCcCeEEEEEcC--CCc
Confidence 4689999999999999999986432 67888887654333222 233445566788999988876543 447
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||+++.
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~ 135 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRG------------------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135 (254)
T ss_pred EEEEECCCCCCHHHHHHhcC------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 99999999999999997643 124567778899999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||++....... .....+..|+|||.+.+ ..++.++|+||||+++|
T Consensus 136 ~~-~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~----------------------~~~~~~~Dv~slG~~l~ 188 (254)
T cd05083 136 DG-VAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKH----------------------KKFSSKSDVWSYGVLLW 188 (254)
T ss_pred CC-cEEECCCccceeccccC----CCCCCCceecCHHHhcc----------------------CCcCchhhHHHHHHHHH
Confidence 87 99999999987543221 22334568999996543 34556789999999999
Q ss_pred HHHc-CCCCCCCCC
Q 015991 378 QMVC-TVRRLCLHS 390 (397)
Q Consensus 378 ellt-g~~Pf~~~~ 390 (397)
||++ |+.||....
T Consensus 189 el~~~g~~p~~~~~ 202 (254)
T cd05083 189 EVFSYGRAPYPKMS 202 (254)
T ss_pred HHHhCCCCCCccCC
Confidence 9997 999996554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=244.73 Aligned_cols=198 Identities=16% Similarity=0.151 Sum_probs=148.3
Q ss_pred eeeccCCceEEEEEEecCCCCC--CCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWR 222 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e 222 (397)
+.||+|+||.||+|.+...+.. .....+++|..............++...+....|++++.+++.+.. ++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence 4799999999999988654321 2234577777654333222222334455566778999988877654 456889999
Q ss_pred ecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC--
Q 015991 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR-- 300 (397)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~-- 300 (397)
|+++++|.++++... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.
T Consensus 80 ~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~ 140 (258)
T cd05078 80 YVKFGSLDTYLKKNK-------------------NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRK 140 (258)
T ss_pred cCCCCcHHHHHhcCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccc
Confidence 999999999997653 14567788899999999999999999999999999999987652
Q ss_pred -----eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 301 -----TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 301 -----~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
.++++|||++..... .....++..|+|||++.+.. .++.++|+||||++
T Consensus 141 ~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG~~ 194 (258)
T cd05078 141 TGNPPFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQ---------------------NLSLAADKWSFGTT 194 (258)
T ss_pred cCCCceEEecccccccccCC-----chhccccCCccCchhccCCC---------------------CCCchhhHHHHHHH
Confidence 279999999865432 23356788999999765322 24567899999999
Q ss_pred HHHHHcCC-CCCCC
Q 015991 376 FLQMVCTV-RRLCL 388 (397)
Q Consensus 376 l~elltg~-~Pf~~ 388 (397)
+|||++|. .||..
T Consensus 195 l~~l~~g~~~~~~~ 208 (258)
T cd05078 195 LWEIFSGGDKPLSA 208 (258)
T ss_pred HHHHHcCCCCChhh
Confidence 99999995 55543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=241.04 Aligned_cols=198 Identities=17% Similarity=0.163 Sum_probs=149.5
Q ss_pred eeeccCCceEEEEEEecCCCC-----CCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPS-----SKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~-----~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
++||+|+||.||+|.+..++. ......+++|........ .....++...+....|++++.+++.+.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence 479999999999999887641 122234666665543332 2233334455666789999988886655 56799
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
|+||+++++|.+++..... .+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 78 v~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~ 138 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN-------------------NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYG 138 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc-------------------CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCc
Confidence 9999999999999986531 356777889999999999999999999999999999998764
Q ss_pred C------eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 300 R------TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 300 ~------~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
. .+||+|||++..... .....++..|+|||++.+... .++.++|+||||
T Consensus 139 ~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~--------------------~~~~~~Di~slG 193 (259)
T cd05037 139 LNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQA--------------------SLTIAADKWSFG 193 (259)
T ss_pred cccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCC--------------------CcchhhHHHHHH
Confidence 2 599999999976533 223456778999997755421 345678999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
+++|||++ |..||...
T Consensus 194 ~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 194 TTLLEICSNGEEPLSTL 210 (259)
T ss_pred HHHHHHHhCCCCCcccC
Confidence 99999999 57777554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=244.09 Aligned_cols=204 Identities=25% Similarity=0.337 Sum_probs=156.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||+||+|.+..++ +.+++|+.......+ .....++...+....|++++.+++.+. .+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTN-----ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCC-----cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-cCCe
Confidence 68999999999999999999988776 778888875432111 111222344555667899999888764 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||++ ++|.+.+.... ...+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSP------------------DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCC------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 999999997 57877775432 12346777889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++..+||+|||++......... .....+++.|+|||.+.+.. .++.++|+||+|+++
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~---------------------~~~~~~Dv~slG~i~ 194 (294)
T PLN00009 137 RRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLGSR---------------------HYSTPVDIWSVGCIF 194 (294)
T ss_pred CCCCEEEEcccccccccCCCccc-cccCceeecccCHHHHhCCC---------------------CCCcHHHHHHHHHHH
Confidence 75558999999999765332211 13346788999999764321 355678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|+|++|..||...
T Consensus 195 ~~l~tg~~pf~~~ 207 (294)
T PLN00009 195 AEMVNQKPLFPGD 207 (294)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=241.65 Aligned_cols=203 Identities=19% Similarity=0.238 Sum_probs=156.7
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-------HH---HHHHHHHHHHhhccCCCceeeeeec
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-------VE---IWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~e---~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
+|.+.+.||.|+||.||+|.+..++ +.+++|....... .. ......+...+....|++++.+++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTG-----EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCC-----ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 5888999999999999999987766 6778886642110 00 1112233445566678999888876
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. ..+..++|+||+.+++|.+++.... .+++..+..++.|++.||.|||+++++|||||
T Consensus 77 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 135 (272)
T cd06629 77 ET-TEEYLSIFLEYVPGGSIGSCLRTYG--------------------RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLK 135 (272)
T ss_pred ec-cCCceEEEEecCCCCcHHHHHhhcc--------------------CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCC
Confidence 53 4578899999999999999987643 45677888999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|+||++++++ .++|+|||+++....... .......++..|+|||.+..... .++.++|
T Consensus 136 ~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--------------------~~~~~~D 194 (272)
T cd06629 136 ADNLLVDADG-ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ--------------------GYSAKVD 194 (272)
T ss_pred hhhEEEcCCC-eEEEeeccccccccccccccccccccCCccccCHHHhccccC--------------------CCCccch
Confidence 9999999887 999999999976532211 11234568899999997654331 2456789
Q ss_pred hHHHHHHHHHHHcCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~ 389 (397)
+||||+++|||++|..||...
T Consensus 195 v~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 195 IWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred hHHHHHHHHHHHhCCCCCcCc
Confidence 999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=249.57 Aligned_cols=206 Identities=24% Similarity=0.287 Sum_probs=157.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeeccccc-
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (397)
..++|++.+.||+|+||.||+|.+..++ ..+++|.+......+ .....++...+....|++++.+.+.+...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSG-----EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH 79 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence 4479999999999999999999998777 778888775332111 11112234455566788888887765433
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+.+++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus 80 ~~~~~lv~e~~~~-~l~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 139 (309)
T cd07845 80 LDSIFLVMEYCEQ-DLASLLDNMP-------------------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL 139 (309)
T ss_pred CCeEEEEEecCCC-CHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 2568999999985 7888876532 2467788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
++++++ .+||+|||++......... .....+++.|+|||.+.+.. .++.++|+||+|
T Consensus 140 l~~~~~-~~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DvwslG 196 (309)
T cd07845 140 LLTDKG-CLKIADFGLARTYGLPAKP-MTPKVVTLWYRAPELLLGCT---------------------TYTTAIDMWAVG 196 (309)
T ss_pred EECCCC-CEEECccceeeecCCccCC-CCcccccccccChhhhcCCC---------------------CcCchHHHHHHH
Confidence 999987 9999999999876543221 12334578899999765422 245678999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
+++|||++|+.||...+
T Consensus 197 ~il~el~~g~~~f~~~~ 213 (309)
T cd07845 197 CILAELLAHKPLLPGKS 213 (309)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=247.92 Aligned_cols=208 Identities=20% Similarity=0.271 Sum_probs=157.2
Q ss_pred CeEEeeeeccCCceEEEEEEecC--CCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccccc-
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAK--KPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK- 213 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~--~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (397)
+|++.++||+|+||.||+|.+.. ++ +.+++|.+.... ........++...+...+|++++.+.+.+...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDG-----KEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCC-----CeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 48899999999999999999877 44 788888877522 11111122234455667789988888766543
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+..+++||||+++ +|.+++..... .....+++..++.++.|++.||.|||+.+|+||||||+||
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Ni 139 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQ---------------AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANI 139 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhcc---------------CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 2679999999985 67776654321 1123567888999999999999999999999999999999
Q ss_pred EEeC----CCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 294 IFSE----GSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 294 Ll~~----~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
+++. ++ .+||+|||+++....... .......+|..|+|||++.+.. .++.++
T Consensus 140 l~~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~ 197 (316)
T cd07842 140 LVMGEGPERG-VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGAR---------------------HYTKAI 197 (316)
T ss_pred EEcCCCCccc-eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCC---------------------CCCcHH
Confidence 9998 76 999999999986543322 1223457789999999764322 345678
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|+||||+++|||++|+.||....
T Consensus 198 Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 198 DIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred HHHHHHHHHHHHHhcCCCCcCCc
Confidence 99999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=246.01 Aligned_cols=201 Identities=24% Similarity=0.315 Sum_probs=156.1
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-----HHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+|++.+.||+|+||.||+|.+..++ +.+++|++...... .......+...+....|++++.+.+.+.. +
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETG-----RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-K 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCC-----cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-C
Confidence 4888999999999999999988776 78888887643322 11112223445556678999888876654 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+ +++|.+++.... ..+++..+..++.|+++||.|||++||+|+||||+||+
T Consensus 75 ~~~~lv~e~~-~~~L~~~i~~~~-------------------~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 134 (298)
T cd07841 75 SNINLVFEFM-ETDLEKVIKDKS-------------------IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL 134 (298)
T ss_pred CEEEEEEccc-CCCHHHHHhccC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEE
Confidence 7899999999 889999987542 14677888999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .++|+|||+++....... ......+++.|+|||.+.+.. .++.++|+|||||
T Consensus 135 l~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv~slG~ 191 (298)
T cd07841 135 IASDG-VLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGAR---------------------HYGVGVDMWSVGC 191 (298)
T ss_pred EcCCC-CEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCC---------------------CCCcHHHHHHHHH
Confidence 99987 999999999987644321 123345678899999764321 2455789999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|..||...
T Consensus 192 il~e~~~g~~~~~~~ 206 (298)
T cd07841 192 IFAELLLRVPFLPGD 206 (298)
T ss_pred HHHHHHcCCccccCC
Confidence 999999997777643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=243.88 Aligned_cols=228 Identities=15% Similarity=0.178 Sum_probs=161.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.+.||+|+||.||+|.+...........+++|.+...... ......++...+....|++++.+++.+. .++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-VGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-CCC
Confidence 44789999999999999999998754211112267888887654322 1222333455566678999999887654 456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhh--ccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLI--LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
..++++||+++++|.+++............. ............+++..++.++.|++.||+|||+++++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 7899999999999999998653211100000 00000111223568888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++++++ .++|+|||++..+....... ......+..|+|||.+.+ ..++.++|||||
T Consensus 162 l~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Dv~sl 218 (288)
T cd05050 162 LVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY----------------------NRYTTESDVWAY 218 (288)
T ss_pred EecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc----------------------CCCCchhHHHHH
Confidence 999987 99999999987654332211 122345678999995543 345667899999
Q ss_pred HHHHHHHHc-CCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCL 388 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~ 388 (397)
||++|||++ |..||..
T Consensus 219 G~il~el~~~~~~p~~~ 235 (288)
T cd05050 219 GVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 999999997 8888854
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=243.75 Aligned_cols=203 Identities=24% Similarity=0.291 Sum_probs=157.8
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||.|+||.||+|++..++ +.+++|++...... ......++...+....|++++.+.+.+. .++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-TENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCC-----CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-cCCcE
Confidence 5889999999999999999988776 78888877643211 1112233455566678999999887654 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
+++|||+. ++|.+++.... +..+++..+..++.|++.||+|||+.|++||||||+||++++
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~ 135 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASP------------------LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 135 (284)
T ss_pred EEEeeccc-cCHHHHHHhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 99999997 58888876532 235678889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||++..+...... .....+++.|+|||.+.+.. .++.++|+||||+++|
T Consensus 136 ~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv~slG~il~ 192 (284)
T cd07860 136 EG-AIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCK---------------------YYSTAVDIWSLGCIFA 192 (284)
T ss_pred CC-CEEEeeccchhhcccCccc-cccccccccccCCeEEecCC---------------------CCCcHHHHHHHHHHHH
Confidence 87 9999999999765432211 22345688999999775432 1345679999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||+||+.||....
T Consensus 193 ~l~tg~~p~~~~~ 205 (284)
T cd07860 193 EMVTRRALFPGDS 205 (284)
T ss_pred HHHHCCCCCCCCC
Confidence 9999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=242.30 Aligned_cols=200 Identities=22% Similarity=0.332 Sum_probs=151.0
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc-CCeE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-GGEY 217 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~ 217 (397)
|++.++||+|+||.||+|.+..++ +.+++|+..... ........++........|++++.+.+.+... .+.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTG-----KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCC-----cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 678899999999999999988776 778888776432 11111222222223333588888877765443 2678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||++ ++|.+.+.... ..+++..+..++.|++.||+|||+.|++||||||+||++++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~ 135 (282)
T cd07831 76 ALVFELMD-MNLYELIKGRK-------------------RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135 (282)
T ss_pred EEEEecCC-ccHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC
Confidence 99999998 57877776532 14577889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
+ .+||+|||+++.+..... .....++..|+|||++.... .++.++|+||+||++|
T Consensus 136 -~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Di~slGv~l~ 190 (282)
T cd07831 136 -D-ILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDG---------------------YYGPKMDIWAVGCVFF 190 (282)
T ss_pred -C-CeEEEecccccccccCCC--cCCCCCCcccCChhHhhcCC---------------------CCCcchhHHHHHHHHH
Confidence 5 999999999987643322 23356789999999654322 2345689999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||++|..||+..+
T Consensus 191 el~~~~~p~~~~~ 203 (282)
T cd07831 191 EILSLFPLFPGTN 203 (282)
T ss_pred HHHcCCcCCCCCC
Confidence 9999999997643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=243.25 Aligned_cols=200 Identities=23% Similarity=0.311 Sum_probs=158.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.+.||+|+||.||++.+..++ +.+++|.+...... ......++...+....|++++.+++.+.. ++..
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTG-----KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCC-----cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEE
Confidence 47888999999999999999998776 77888877654322 11222233444455569999888776544 4789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCceEEe
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFS 296 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NILl~ 296 (397)
++++||+++++|.+++.... ..+++..+..++.|++.+|.|||+ .|++|+||||+||+++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-------------------GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-------------------CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 99999999999999987642 145677888999999999999999 9999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .++|+|||.+........ ....++..|+|||.+.+. .++.++|+||||+++
T Consensus 136 ~~~-~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~----------------------~~~~~~Dv~slG~~l 189 (265)
T cd06605 136 SRG-QIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQGN----------------------DYSVKSDIWSLGLSL 189 (265)
T ss_pred CCC-CEEEeecccchhhHHHHh---hcccCChhccCHHHHcCC----------------------CCCchhhHHHHHHHH
Confidence 987 999999999876543222 226788999999966443 355678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|+|++|..||...
T Consensus 190 ~~l~~g~~p~~~~ 202 (265)
T cd06605 190 IELATGRFPYPPE 202 (265)
T ss_pred HHHHhCCCCCCcc
Confidence 9999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=242.72 Aligned_cols=200 Identities=21% Similarity=0.284 Sum_probs=156.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
.+|...+.||+|++|.||++.+..++ ..+++|++............++...+....|++++.+++.+. .++..+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-~~~~~~ 92 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTG-----RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-VGDELW 92 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCC-----CEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-cCCeEE
Confidence 35666789999999999999987776 778888775433222222223334555567899988887653 457889
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+++||+.+++|.+++... .+++..+..++.|++.+|+|||++||+||||||+||+++++
T Consensus 93 ~v~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 93 VVMEFLEGGALTDIVTHT---------------------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred EEEeccCCCCHHHHHHhC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 999999999999988763 35677788999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||.+........ ......|++.|+|||.+.+. .++.++|+||||+++||
T Consensus 152 ~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dv~slGv~l~e 207 (285)
T cd06648 152 G-RVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRL----------------------PYGTEVDIWSLGIMVIE 207 (285)
T ss_pred C-cEEEcccccchhhccCCc-ccccccCCccccCHHHhcCC----------------------CCCCcccHHHHHHHHHH
Confidence 7 999999999876543322 12345689999999966433 34567799999999999
Q ss_pred HHcCCCCCCCC
Q 015991 379 MVCTVRRLCLH 389 (397)
Q Consensus 379 lltg~~Pf~~~ 389 (397)
|++|..||...
T Consensus 208 ll~g~~p~~~~ 218 (285)
T cd06648 208 MVDGEPPYFNE 218 (285)
T ss_pred HHhCCCCCcCC
Confidence 99999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=241.80 Aligned_cols=199 Identities=26% Similarity=0.373 Sum_probs=157.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+-|++.++||+|+||.||+|.+..++ ..+++|...... ........++...+....|++++.+++.+. .++.+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KDTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCC-----cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-eCCeE
Confidence 34778899999999999999987765 788888765332 222223334455666778999999988664 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+++++|.+++... .+++..+..++.|++.+|.|||+.|++|+||||+||+++.
T Consensus 78 ~lv~e~~~~~~l~~~i~~~---------------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~ 136 (277)
T cd06641 78 WIIMEYLGGGSALDLLEPG---------------------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred EEEEEeCCCCcHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC
Confidence 9999999999999988643 3467788899999999999999999999999999999998
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++..+.... .......++..|+|||.+... .++.++|+|||||++|
T Consensus 137 ~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Dv~slG~~l~ 192 (277)
T cd06641 137 HG-EVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQS----------------------AYDSKADIWSLGITAI 192 (277)
T ss_pred CC-CEEEeecccceecccch-hhhccccCCccccChhhhccC----------------------CCCchhhHHHHHHHHH
Confidence 87 99999999987654322 122345688899999966432 3455679999999999
Q ss_pred HHHcCCCCCCC
Q 015991 378 QMVCTVRRLCL 388 (397)
Q Consensus 378 elltg~~Pf~~ 388 (397)
||++|..||..
T Consensus 193 ~l~~g~~p~~~ 203 (277)
T cd06641 193 ELAKGEPPHSE 203 (277)
T ss_pred HHHcCCCCCCc
Confidence 99999999964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=238.46 Aligned_cols=203 Identities=22% Similarity=0.331 Sum_probs=159.8
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|.+.+.||+|+||.||++.+..++ +.+++|...... ..+.....++...+....|++++.+++.+ ..++..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDS-----EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-QENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCC-----ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-ccCCeE
Confidence 5889999999999999999998876 678888775431 11222223345556667799999888755 445789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++++||+.+++|.+++.... +..+++..+..++.|++.||.|||+.+++|+||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~ 136 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQR------------------GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK 136 (257)
T ss_pred EEEEecCCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC
Confidence 99999999999999987542 224578889999999999999999999999999999999998
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++..+||+|||.+........ ......|++.|+|||++... .++.++|+||||+++|
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~----------------------~~~~~~Dv~slG~il~ 193 (257)
T cd08225 137 NGMVAKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNR----------------------PYNNKTDIWSLGCVLY 193 (257)
T ss_pred CCCeEEecccccchhccCCcc-cccccCCCccccCHHHHcCC----------------------CCCchhhHHHHHHHHH
Confidence 865789999999976643322 22345688999999965433 3456779999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
||++|..||...
T Consensus 194 ~l~~g~~p~~~~ 205 (257)
T cd08225 194 ELCTLKHPFEGN 205 (257)
T ss_pred HHHhCCCCCCCc
Confidence 999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=275.59 Aligned_cols=200 Identities=23% Similarity=0.325 Sum_probs=152.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc----
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK---- 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~---- 213 (397)
.+|+..+.||+||||.||+++++-++ ..+|+||+.... +.......++...+...+|||++.++..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDG-----r~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDG-----REYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccc-----hhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 68999999999999999999999998 788888887554 33334444577788899999999887644320
Q ss_pred --------------------------------------------------------------------------------
Q 015991 214 -------------------------------------------------------------------------------- 213 (397)
Q Consensus 214 -------------------------------------------------------------------------------- 213 (397)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchh
Q 015991 214 --------------------------G--------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259 (397)
Q Consensus 214 --------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (397)
+ ..+||-||||+..+|.+++.++.+..
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~------------------- 694 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS------------------- 694 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-------------------
Confidence 0 12455666666666666665544210
Q ss_pred cHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEeccccccccc----------------cccc-ccc
Q 015991 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRV----------------GINY-IPK 322 (397)
Q Consensus 260 ~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~----------------~~~~-~~~ 322 (397)
.....+++++||++||.|+|++|||||||||.||+|++++ .+||+|||+|+.... +.+. ..+
T Consensus 695 ~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T 773 (1351)
T KOG1035|consen 695 QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT 773 (1351)
T ss_pred hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence 2455778999999999999999999999999999999887 999999999987210 0111 234
Q ss_pred cccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcC
Q 015991 323 EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCT 382 (397)
Q Consensus 323 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg 382 (397)
..+||.-|+|||++.+... ..|+.|+|+||||++|+||+..
T Consensus 774 s~VGTalYvAPEll~~~~~-------------------~~Yn~KiDmYSLGIVlFEM~yP 814 (1351)
T KOG1035|consen 774 SQVGTALYVAPELLSDTSS-------------------NKYNSKIDMYSLGIVLFEMLYP 814 (1351)
T ss_pred cccceeeeecHHHhccccc-------------------ccccchhhhHHHHHHHHHHhcc
Confidence 5799999999997765432 2588999999999999999864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=250.43 Aligned_cols=203 Identities=22% Similarity=0.264 Sum_probs=154.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc-----
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK----- 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~----- 213 (397)
++|++.+.||.|+||.||+|.+..++ +.+++|++............++...+....|++++.+++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~-----~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCD-----KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCC-----cEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 79999999999999999999998877 78888877554333222233344455666788888776544332
Q ss_pred --------CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCcee
Q 015991 214 --------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (397)
Q Consensus 214 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiH 285 (397)
....++|+||++ ++|.+++... .+++..++.++.|++.||.|||+.||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---------------------~l~~~~~~~~~~qi~~aL~~LH~~givH 137 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQG---------------------PLSEEHARLFMYQLLRGLKYIHSANVLH 137 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 235789999998 5888877543 3567888899999999999999999999
Q ss_pred cCCCCCceEEeCCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 286 rDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
|||||+||+++.++..+||+|||+++.+....... .....++..|+|||.+... ..+
T Consensus 138 ~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------------------~~~ 196 (342)
T cd07854 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP---------------------NNY 196 (342)
T ss_pred CCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCc---------------------ccc
Confidence 99999999998655589999999997653321111 1224578899999965421 135
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
+.++|+|||||++|||++|+.||...
T Consensus 197 ~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 197 TKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=234.88 Aligned_cols=200 Identities=24% Similarity=0.349 Sum_probs=161.0
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
+|++.+.||+|++|.||++.+..++ +.+++|+.............++...+....|+++..+.+.+.. +...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTG-----KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCC-----cEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEE
Confidence 5889999999999999999988765 7888998876543222333334455556668999888876544 478899
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
++||+++++|.+++.... ..+++..+..++.|++.+|.|||+.|++|+||+|+||++++++
T Consensus 75 ~~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~ 135 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-------------------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG 135 (253)
T ss_pred EEecCCCCcHHHHHhhcC-------------------CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC
Confidence 999999999999987642 2467788899999999999999999999999999999999987
Q ss_pred CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 300 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.++|+|||.+........ .....++..|++||.+.... ++.++|+||||+++|+|
T Consensus 136 -~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~----------------------~~~~~Dv~slG~il~~l 190 (253)
T cd05122 136 -EVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKP----------------------YDYKADIWSLGITAIEL 190 (253)
T ss_pred -eEEEeecccccccccccc--ccceecCCcccCHHHHcCCC----------------------CCccccHHHHHHHHHHH
Confidence 999999999977654322 24567889999999665433 44567999999999999
Q ss_pred HcCCCCCCCC
Q 015991 380 VCTVRRLCLH 389 (397)
Q Consensus 380 ltg~~Pf~~~ 389 (397)
++|+.||...
T Consensus 191 ~~g~~p~~~~ 200 (253)
T cd05122 191 AEGKPPYSEL 200 (253)
T ss_pred HhCCCCCCCC
Confidence 9999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=253.11 Aligned_cols=208 Identities=20% Similarity=0.283 Sum_probs=168.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH-------HHHHHHHHHhhccCCCceeeeeeccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI-------WMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~-------~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
++|-+...||+|||+.||+|.+...+ +-+++|.-........ ...-++.+......|+.|+.+++.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~Eq-----RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQ-----RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchh-----heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 67888999999999999999988876 5666665443222211 11123445566688999999999999
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC--CceecCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--GIVHRDIK 289 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~--giiHrDIK 289 (397)
.+.+.+|-|.|||+|-+|+-+++.+. ..++..++.|+.||+.||.||.+. -|||=|||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhk--------------------lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLK 597 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHK--------------------LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLK 597 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhh--------------------hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccC
Confidence 99999999999999999999998775 568889999999999999999976 69999999
Q ss_pred CCceEEeCCC--CeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 290 PQNVIFSEGS--RTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 290 p~NILl~~~~--~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
|.||||-+.. +.+||+|||+++.++++... ......||.+|.+||.+.-++..+
T Consensus 598 PgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePP------------------ 659 (775)
T KOG1151|consen 598 PGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPP------------------ 659 (775)
T ss_pred CccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCC------------------
Confidence 9999996432 38999999999988654322 234578999999999887654433
Q ss_pred CCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
..+.|+||||+||++|+.++|+.||.-.
T Consensus 660 KIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 660 KISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccccceeeEeeehhhhhhhccCCCCCCc
Confidence 4678999999999999999999999654
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=242.21 Aligned_cols=199 Identities=17% Similarity=0.109 Sum_probs=146.4
Q ss_pred eeccCCceEEEEEEecCCCC-------------------CCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeee
Q 015991 146 KLGEGAFGVVYRASLAKKPS-------------------SKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGF 206 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~-------------------~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~ 206 (397)
+||+|+||.||+|....++. ......+++|.+............++...+....|+|++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998643221 11123577777754333222222233455666789999999
Q ss_pred eecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
++.+. .++..++||||+++++|..++.... ..+++..+..++.|++.||+|||++||+||
T Consensus 82 ~~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~ 141 (274)
T cd05076 82 HGVCV-RGSENIMVEEFVEHGPLDVCLRKEK-------------------GRVPVAWKITVAQQLASALSYLEDKNLVHG 141 (274)
T ss_pred EEEEE-eCCceEEEEecCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHcCCccCC
Confidence 88664 4567899999999999999886532 145677788999999999999999999999
Q ss_pred CCCCCceEEeCCC------CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhc
Q 015991 287 DIKPQNVIFSEGS------RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 360 (397)
Q Consensus 287 DIKp~NILl~~~~------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (397)
||||+|||++..+ ..+|++|||++...... ....++..|+|||.+...
T Consensus 142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~--------------------- 195 (274)
T cd05076 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGG--------------------- 195 (274)
T ss_pred CCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCC---------------------
Confidence 9999999998643 14899999988643221 234577889999976432
Q ss_pred cCCCCchhhHHHHHHHHHH-HcCCCCCCCCC
Q 015991 361 LNLPDRFDIYSAGLIFLQM-VCTVRRLCLHS 390 (397)
Q Consensus 361 ~~~~~k~Dv~SlGv~l~el-ltg~~Pf~~~~ 390 (397)
..++.++|+||||+++||| ++|..||....
T Consensus 196 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 196 NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 1356678999999999999 47999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=245.80 Aligned_cols=203 Identities=23% Similarity=0.286 Sum_probs=156.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH--HHHHHHHHHhhccCCCceeeeeeccccc-CC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCCADFVYGFFENSSKK-GG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~--~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~ 215 (397)
++|++.+.||+|+||.||+|.+..++ +.+++|.+......+. ....++...+....|++++.+.+..... .+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTG-----EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCC-----cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 68999999999999999999998776 6788888764322111 1112233445555689998887755433 27
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++|+||+++ +|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||++
T Consensus 80 ~~~lv~e~~~~-~L~~~~~~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 80 KIYMVMEYVEH-DLKSLMETMK-------------------QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred cEEEEehhcCc-CHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 89999999984 8998887643 146788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .++|+|||++........ ......+++.|+|||.+.+.. .++.++|+||+|++
T Consensus 140 ~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Di~slG~~ 196 (293)
T cd07843 140 NNRG-ILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAK---------------------EYSTAIDMWSVGCI 196 (293)
T ss_pred CCCC-cEEEeecCceeeccCCcc-ccccccccccccCchhhcCCc---------------------cccchhhHHHHHHH
Confidence 9987 999999999987654321 123356788999999765332 23456899999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|..||...
T Consensus 197 l~~l~~g~~~f~~~ 210 (293)
T cd07843 197 FAELLTKKPLFPGK 210 (293)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=249.03 Aligned_cols=203 Identities=21% Similarity=0.317 Sum_probs=156.7
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
++|.+.+.||+|+||+||+|++..++ +.+++|.+.... ........++...+....|++++.+.+.+....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETN-----EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCC-----CeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence 68999999999999999999988776 788888875421 111112223344555667899988876543322
Q ss_pred --CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 215 --GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 215 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
...++++||++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~N 138 (337)
T cd07858 80 AFNDVYIVYELMD-TDLHQIIRSSQ--------------------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN 138 (337)
T ss_pred ccCcEEEEEeCCC-CCHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 45899999997 68888876543 46788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|+++.++ .+||+|||++....... .......++..|+|||.+.... .++.++|+|||
T Consensus 139 il~~~~~-~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Diwsl 195 (337)
T cd07858 139 LLLNANC-DLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCS---------------------EYTTAIDVWSV 195 (337)
T ss_pred EEEcCCC-CEEECcCccccccCCCc-ccccccccccCccChHHHhcCC---------------------CCCCcccHHHH
Confidence 9999987 99999999998654332 2223456789999999765321 24556799999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||++|+|++|+.||...+
T Consensus 196 G~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 196 GCIFAELLGRKPLFPGKD 213 (337)
T ss_pred HHHHHHHHcCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=236.15 Aligned_cols=205 Identities=22% Similarity=0.304 Sum_probs=162.3
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||.|+||.||++.+..++ ..+++|.+..... .......++...+....|++++.+.+.... +...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG-----KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC-----cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEE
Confidence 5889999999999999999998766 7888888764322 222223334445556668998888776544 4789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++++||+++++|.+++.... ..+..+++..+..++.|++.||.|||++|++|+||+|+||++++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~ 138 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQK----------------KEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS 138 (258)
T ss_pred EEEEEecCCCcHHHHHHHhh----------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC
Confidence 99999999999999998752 12336788889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||.+....... .......+++.|+|||.+... .++.++|+||+|++++
T Consensus 139 ~~-~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~----------------------~~~~~~Dv~slG~~~~ 194 (258)
T cd08215 139 NG-LVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNK----------------------PYNYKSDIWSLGCVLY 194 (258)
T ss_pred CC-cEEECCccceeecccCc-ceecceeeeecccChhHhccC----------------------CCCccccHHHHHHHHH
Confidence 86 99999999997654432 223445788999999965433 3455679999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
+|++|..||....
T Consensus 195 ~l~~g~~p~~~~~ 207 (258)
T cd08215 195 ELCTLKHPFEGEN 207 (258)
T ss_pred HHHcCCCCCCCCc
Confidence 9999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=250.47 Aligned_cols=203 Identities=24% Similarity=0.315 Sum_probs=156.0
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhcc-CCCceeeeeeccccc-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC-CADFVYGFFENSSKK- 213 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~- 213 (397)
.++|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+... +|++++.+++.+...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTK-----EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCC-----eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 478999999999999999999988766 778888774321 11111122234445555 899999988765433
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+...++|+||++ ++|.+++... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~---------------------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ni 138 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRAN---------------------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNI 138 (337)
T ss_pred CceEEEEecccc-cCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 456899999998 5888887653 245667788999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccc----ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINY----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+++.++ .+||+|||++..+...... ......+|..|+|||.+.... .++.++|+
T Consensus 139 ll~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~sDi 196 (337)
T cd07852 139 LLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGST---------------------RYTKGVDM 196 (337)
T ss_pred EEcCCC-cEEEeeccchhccccccccccCcchhcccccccccCceeeeccc---------------------cccccchH
Confidence 999987 9999999999866443221 223457899999999765321 24557899
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~ 389 (397)
||||+++|||++|+.||...
T Consensus 197 ~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 197 WSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred HHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=240.84 Aligned_cols=195 Identities=21% Similarity=0.237 Sum_probs=151.2
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
||+|+||+||++.+..++ +.+++|.+..... ........+...+...+|++++.+.+.+. ..+..++||||
T Consensus 1 lg~g~~g~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATG-----KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-TKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCC-----cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-cCCeEEEEEec
Confidence 699999999999988776 7788887753221 11111122344555667899988876653 45689999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||++++++ .++
T Consensus 75 ~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~ 135 (277)
T cd05577 75 MNGGDLKYHIYNVG------------------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVR 135 (277)
T ss_pred CCCCcHHHHHHHcC------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEE
Confidence 99999999987653 12467888889999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCC
Q 015991 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTV 383 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~ 383 (397)
|+|||.+....... ......++..|++||.+.+. .++.++|+||+|+++|+|++|+
T Consensus 136 l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Di~slG~il~~l~~g~ 191 (277)
T cd05577 136 ISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGE----------------------VYDFSVDWFALGCTLYEMIAGR 191 (277)
T ss_pred EccCcchhhhccCC--ccccccCCCCcCCHHHhcCC----------------------CCCchhhhHHHHHHHHHHhhCC
Confidence 99999997654321 22345678899999965433 3455679999999999999999
Q ss_pred CCCCCCC
Q 015991 384 RRLCLHS 390 (397)
Q Consensus 384 ~Pf~~~~ 390 (397)
.||....
T Consensus 192 ~p~~~~~ 198 (277)
T cd05577 192 SPFRQRK 198 (277)
T ss_pred CCCCCCc
Confidence 9996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=241.24 Aligned_cols=203 Identities=24% Similarity=0.299 Sum_probs=156.7
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc-CCeE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-GGEY 217 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~ 217 (397)
|++.++||+|+||.||+|.+..++ +.+++|.+.... ........++...+....|++++.+.+..... .+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTG-----ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCC-----eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcE
Confidence 678999999999999999998776 788888887542 11111122233444555688888887766544 3689
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+++ +|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||++++
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~ 135 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDSPE-------------------VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN 135 (287)
T ss_pred EEEeccccc-cHHHHHhccC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC
Confidence 999999985 8888876542 24677889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||++...............++..|+|||.+.+.. .++.++||||||+++|
T Consensus 136 ~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---------------------~~~~~~Dv~slG~~l~ 193 (287)
T cd07840 136 DG-VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT---------------------RYGPEVDMWSVGCILA 193 (287)
T ss_pred CC-CEEEccccceeeccCCCcccccccccccccCCceeeEccc---------------------cCChHHHHHHHHHHHH
Confidence 87 9999999999876544321223346688999999765422 2455789999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||++|+.||....
T Consensus 194 el~t~~~p~~~~~ 206 (287)
T cd07840 194 ELFLGKPIFQGST 206 (287)
T ss_pred HHHhCCCCCCCCC
Confidence 9999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=241.53 Aligned_cols=206 Identities=19% Similarity=0.280 Sum_probs=154.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH----HHHHHHHHHHHhhcc-CCCceeeeeecccccC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV----EIWMNERVRRACANC-CADFVYGFFENSSKKG 214 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (397)
+|++.+.||+|+||.||+++....... .+.+++|.+...... .......+...+... +|++++.+.+.+ ..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~--~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-~~~ 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDA--GKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-QTD 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccC--CcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-ecC
Confidence 588999999999999999986543211 166888876532211 111112223333333 688888877655 445
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++||||+.+++|.+.+.... .+++..++.++.|++++|.|||+.+++||||||+||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLYQRE--------------------HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC--------------------CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 67899999999999999886543 3567788899999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .++|+|||+++.+............++..|++||.+.+... ..+.++|+||||+
T Consensus 138 ~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--------------------~~~~~~Dv~slG~ 196 (288)
T cd05583 138 LDSEG-HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG--------------------GHDKAVDWWSLGV 196 (288)
T ss_pred ECCCC-CEEEEECccccccccccccccccccCCccccCHHHhcCCCC--------------------CCcchhhhHHHHH
Confidence 99987 99999999997765443322334568899999997654321 1345789999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|..||...
T Consensus 197 il~el~tg~~p~~~~ 211 (288)
T cd05583 197 LTFELLTGASPFTVD 211 (288)
T ss_pred HHHHHHhCCCCcccC
Confidence 999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=247.85 Aligned_cols=200 Identities=22% Similarity=0.291 Sum_probs=154.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc--
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (397)
.++|.+.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+...+|++++.+.+.+...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCC-----eEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 388999999999999999999987776 788899876432 11112222344556667899998887654322
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 214 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
....+++++++ +++|.++++.. .+++..++.++.|++.||+|||++||+||||||
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~---------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 148 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ---------------------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 148 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence 24578888887 57888877543 356778889999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||++++++ .+||+|||+++..... .....+|..|+|||.+.+. ..++.++|+|
T Consensus 149 ~NIll~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~Dvw 202 (345)
T cd07877 149 SNLAVNEDC-ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNW---------------------MHYNQTVDIW 202 (345)
T ss_pred HHEEEcCCC-CEEEeccccccccccc----ccccccCCCccCHHHHhCc---------------------cCCCchhhHH
Confidence 999999987 9999999999764322 2345778999999966431 2355678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 203 slG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 203 SVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=246.31 Aligned_cols=206 Identities=24% Similarity=0.315 Sum_probs=153.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeeccccc--
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK-- 213 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (397)
.++|++.++||+|+||.||+|.+..++ +.+++|++......+ .....++...+....|++++.+.+.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTG-----RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 589999999999999999999988776 678888765322111 11112233445556788888776644322
Q ss_pred -----CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 214 -----GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 214 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
...+++|+||+.+ +|.+.+.... ..+++..++.++.|+++||+|||++||+||||
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~-------------------~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl 141 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPS-------------------VKLTESQIKCYMLQLLEGINYLHENHILHRDI 141 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 3458999999985 6666665432 24678889999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccc----------cccccCCCCCCCcccccccCCCCCCCCccccccchhhh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYI----------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 358 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~----------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~ 358 (397)
||+||++++++ .++|+|||+++......... .....+++.|+|||.+.+..
T Consensus 142 ~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------ 202 (311)
T cd07866 142 KAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER------------------ 202 (311)
T ss_pred CHHHEEECCCC-CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCC------------------
Confidence 99999999987 99999999997654322111 12346688899999765422
Q ss_pred hccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 359 WQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 359 ~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++.++||||||+++|||++|+.||...+
T Consensus 203 ---~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 203 ---RYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred ---ccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 24557899999999999999999997543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=239.05 Aligned_cols=203 Identities=21% Similarity=0.271 Sum_probs=154.5
Q ss_pred CeEEeeeeccCCceEEEEEEecC-CCCCCCCCceEEeecccc----------hhHHHHHHHHHHHH-hhccCCCceeeee
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAK-KPSSKNDGDLVLKKATEY----------GAVEIWMNERVRRA-CANCCADFVYGFF 207 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~-~~~~~~~~~vavK~~~~~----------~~~e~~~~~~~~~~-~~~~~~~~i~~~~ 207 (397)
+|++.+.||+|+||.||+|.+.. .+ +.+++|.+... ..........+... .....|++++.++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~-----~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQ-----NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCC-----ceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence 47889999999999999999877 33 66777765421 11111111222222 2346799999988
Q ss_pred ecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceec
Q 015991 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHR 286 (397)
Q Consensus 208 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHr 286 (397)
+.+. .++..+++|||+.+++|.+++.... .....+++..++.++.|++.+|.|||+ .+++|+
T Consensus 76 ~~~~-~~~~~~lv~e~~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~ 138 (269)
T cd08528 76 KTFL-ENDRLYIVMDLIEGAPLGEHFNSLK----------------EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHR 138 (269)
T ss_pred eeEc-cCCeEEEEEecCCCCcHHHHHHHHH----------------hccCCCCHHHHHHHHHHHHHHHHHhccCCceeec
Confidence 8664 4578999999999999999886432 112356778899999999999999996 789999
Q ss_pred CCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
||||+||++++++ .++|+|||.+....... ......++..|++||.+.+. .++.+
T Consensus 139 dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~----------------------~~~~~ 193 (269)
T cd08528 139 DLTPNNIMLGEDD-KVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNE----------------------PYGEK 193 (269)
T ss_pred CCCHHHEEECCCC-cEEEecccceeeccccc--ccccccCcccCcChhhhcCC----------------------CCchH
Confidence 9999999999987 99999999997654332 22456788999999966432 34567
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
+|+||||+++|||++|..||...
T Consensus 194 ~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 194 ADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred HHHHHHHHHHHHHHhCCCccccc
Confidence 89999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=237.55 Aligned_cols=193 Identities=21% Similarity=0.324 Sum_probs=153.9
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
||.|+||.||++++..++ +.+++|.+..... .......++...+....|++++.+.+.+ ..+...++++||
T Consensus 1 lg~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN-----RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-KDKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEECCCC-----cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-EcCCccEEEEec
Confidence 799999999999998765 7888888764321 1122233344556667899999988865 445789999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus 75 ~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~ 133 (262)
T cd05572 75 CLGGELWTILRDRG--------------------LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVK 133 (262)
T ss_pred CCCCcHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEE
Confidence 99999999997653 356788889999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCC
Q 015991 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTV 383 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~ 383 (397)
|+|||++....... ......+++.|++||.+... .++.++|+||+|+++|||++|.
T Consensus 134 l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~----------------------~~~~~~Di~slG~il~~l~~g~ 189 (262)
T cd05572 134 LVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNK----------------------GYDFSVDYWSLGILLYELLTGR 189 (262)
T ss_pred EeeCCcccccCccc--ccccccCCcCccChhHhcCC----------------------CCCChhhhhhhHHHHHHHHhCC
Confidence 99999998764432 12345788999999965433 3455679999999999999999
Q ss_pred CCCCCCC
Q 015991 384 RRLCLHS 390 (397)
Q Consensus 384 ~Pf~~~~ 390 (397)
.||....
T Consensus 190 ~p~~~~~ 196 (262)
T cd05572 190 PPFGEDD 196 (262)
T ss_pred CCcCCCC
Confidence 9997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=240.77 Aligned_cols=201 Identities=27% Similarity=0.388 Sum_probs=156.3
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccC-CCceeeeeecccccCCeEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCC-ADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 218 (397)
|.+.+.||+|+||+||+|.+..++ +.+++|++..... .+.....++...+.... |++++.+++.+.. ++..+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCC-----cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEE
Confidence 678899999999999999998776 7788888764321 12212222333444445 8999888876644 67899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+||||+ +++|.+.+.... +..+++..+..++.|++.+|.|||++|++|+||||+||+++++
T Consensus 75 lv~e~~-~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 75 FVFEYM-EGNLYQLMKDRK------------------GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred EEEecC-CCCHHHHHHhcc------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 999999 689988887642 2246788899999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||++........ .....++..|+|||++.... .++.++|+||||+++||
T Consensus 136 ~-~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Di~s~G~~l~e 191 (283)
T cd07830 136 E-VVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRST---------------------SYSSPVDIWALGCIMAE 191 (283)
T ss_pred C-CEEEeecccceeccCCCC--cCCCCCcccccCceeeecCc---------------------CcCCccchhhHHHHHHH
Confidence 7 999999999976543222 23456888999999765422 24557899999999999
Q ss_pred HHcCCCCCCCCC
Q 015991 379 MVCTVRRLCLHS 390 (397)
Q Consensus 379 lltg~~Pf~~~~ 390 (397)
|++|+.||....
T Consensus 192 l~~g~~~~~~~~ 203 (283)
T cd07830 192 LYTLRPLFPGSS 203 (283)
T ss_pred HHhCCCccCCCC
Confidence 999999997654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=248.24 Aligned_cols=204 Identities=22% Similarity=0.304 Sum_probs=157.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeeccc---cc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSS---KK 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~ 213 (397)
++|++.+.||+|+||.||+|.+..++ +.+++|++..... .......++...+....|++++.+.+.+. ..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSG-----KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence 78999999999999999999998877 7888888764321 11111222344555666888887665433 23
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
....++|+||++ ++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Ni 138 (334)
T cd07855 80 FKDVYVVMDLME-SDLHHIIHSDQ--------------------PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138 (334)
T ss_pred CceEEEEEehhh-hhHHHHhccCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 457899999997 58888876543 367888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccc---cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
++++++ .+||+|||++........ .......++..|+|||.+.... .++.++|+|
T Consensus 139 l~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---------------------~~~~~~Di~ 196 (334)
T cd07855 139 LVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLP---------------------EYTTAIDMW 196 (334)
T ss_pred EEcCCC-cEEecccccceeecccCcCCCcccccccccccccChHHhcCCc---------------------ccccccchH
Confidence 999987 999999999976543221 1123457889999999764321 245678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+++|||++|+.||....
T Consensus 197 slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 197 SVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred HHHHHHHHHHcCCCccCCCC
Confidence 99999999999999996643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=248.96 Aligned_cols=203 Identities=23% Similarity=0.345 Sum_probs=158.3
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC---
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (397)
+|++.+.||.|+||.||+|++..++ +.+++|++.... ........++...+...+|++++.+.+.+....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTG-----RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCC-----cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence 5889999999999999999987766 788888876532 122222233344555566899888877654433
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 215 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...+++|||++ ++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~~~--------------------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~ni 134 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIKSPQ--------------------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNI 134 (330)
T ss_pred ccceEEEecchh-hhHHHHHhCCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 47899999999 47888876542 567888899999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|+++++ .++|+|||++........ .......+|..|+|||++.+.. .++.++|+||
T Consensus 135 li~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~sDi~s 192 (330)
T cd07834 135 LVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS---------------------RYTKAIDIWS 192 (330)
T ss_pred EEcCCC-CEEEcccCceEeecccccccccccccccccCcCCceeeeccc---------------------CCCcchhHHH
Confidence 999986 999999999987654321 1123456789999999775542 3456789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|+|++|+.||...+
T Consensus 193 lG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 193 VGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred HHHHHHHHHcCCCCcCCCC
Confidence 9999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=239.23 Aligned_cols=203 Identities=21% Similarity=0.326 Sum_probs=157.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccC-CCceeeeeecccccC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCC-ADFVYGFFENSSKKG 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~-~~~i~~~~~~~~~~~ 214 (397)
++|.+.+.||+|+||.||++.+..++ +.+++|...... ........++...+.... |++++.+++.+ ..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETN-----KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-QDE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCC-----CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-cCC
Confidence 47999999999999999999998776 778888765421 111112222233344444 99999887765 345
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~ 134 (280)
T cd05581 75 ENLYFVLEYAPNGELLQYIRKYG--------------------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENIL 134 (280)
T ss_pred ceEEEEEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 68999999999999999987653 4678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccc-------------------cccccccCCCCCCCcccccccCCCCCCCCccccccch
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGIN-------------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~-------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~ 355 (397)
++.++ .++|+|||++........ .......++..|++||+....
T Consensus 135 i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~---------------- 197 (280)
T cd05581 135 LDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK---------------- 197 (280)
T ss_pred ECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC----------------
Confidence 99887 999999999976543221 112345678999999965433
Q ss_pred hhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 356 PVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 356 ~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++.++|+||||+++++|++|+.||....
T Consensus 198 ------~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 198 ------PAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ------CCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 34556799999999999999999997653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=240.83 Aligned_cols=209 Identities=21% Similarity=0.201 Sum_probs=158.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccc-cCC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK-KGG 215 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~ 215 (397)
.++|++.+.||+|+||.||++.+...+ ....+.+++|.+...... ......++...+....|++++.+.+.+.. .+.
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 368889999999999999999875432 111267889988754432 22233334445566678888887765433 245
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-------------------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~ 142 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-------------------DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-------------------cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 7899999999999999997643 146778889999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+.++ .++|+|||++.......... .....++..|++||..... .++.++|+||||
T Consensus 143 ~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~----------------------~~~~~~Di~slG 199 (284)
T cd05038 143 ESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS----------------------KFSSASDVWSFG 199 (284)
T ss_pred cCCC-CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC----------------------CCCcccchHHHh
Confidence 9987 99999999998765332211 1123445679999965433 345567999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLH 389 (397)
Q Consensus 374 v~l~elltg~~Pf~~~ 389 (397)
+++|||++|..||...
T Consensus 200 ~~l~el~tg~~p~~~~ 215 (284)
T cd05038 200 VTLYELFTYGDPSQSP 215 (284)
T ss_pred hhhheeeccCCCcccc
Confidence 9999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=234.42 Aligned_cols=197 Identities=15% Similarity=0.208 Sum_probs=150.6
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
++||+|+||.||++.+.. + +.+++|........ .......+...+....|++++.+++.+. .....++|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~-----~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-N-----TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-QKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-C-----CcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-cCCCeEEEEEc
Confidence 479999999999999876 4 78889987654332 2223334455666778999998877654 44678999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++.... ..+++..+..++.|++.+|+|||+++++||||||+||+++.++ .++
T Consensus 74 ~~~~~l~~~l~~~~-------------------~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~ 133 (251)
T cd05041 74 VPGGSLLTFLRKKK-------------------NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLK 133 (251)
T ss_pred CCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEE
Confidence 99999999986542 1356777889999999999999999999999999999999987 999
Q ss_pred EEeccccccccccccccc-ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-
Q 015991 304 IIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC- 381 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt- 381 (397)
|+|||++........... .....+..|+|||.+.+. .++.++|+||||+++|||++
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Di~slG~i~~~l~t~ 191 (251)
T cd05041 134 ISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG----------------------RYTSESDVWSYGILLWETFSL 191 (251)
T ss_pred EeeccccccccCCcceeccccCcceeccCChHhhccC----------------------CCCcchhHHHHHHHHHHHHhc
Confidence 999999976542221111 122345679999966443 34556799999999999998
Q ss_pred CCCCCCCCC
Q 015991 382 TVRRLCLHS 390 (397)
Q Consensus 382 g~~Pf~~~~ 390 (397)
|..||....
T Consensus 192 ~~~p~~~~~ 200 (251)
T cd05041 192 GDTPYPGMS 200 (251)
T ss_pred cCCCCccCC
Confidence 888886543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=238.69 Aligned_cols=195 Identities=21% Similarity=0.331 Sum_probs=151.8
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
||.|+||.||++++..++ +.+++|.+..... .......++...+....|++++.+.+.. ..++..++++||
T Consensus 1 lg~g~~~~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG-----DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-QGKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEECCCC-----CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-ecCcEEEEEEec
Confidence 689999999999998766 7888888764322 1222233334455566689988877654 446789999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+.+++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||+|+||++++++ .++
T Consensus 75 ~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~ 133 (265)
T cd05579 75 LPGGDLASLLENVG--------------------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLK 133 (265)
T ss_pred CCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEE
Confidence 99999999987643 457788899999999999999999999999999999999987 999
Q ss_pred EEecccccccccccc-------cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 304 IIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 304 L~DFGla~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
|+|||++........ .......++..|++||..... .++.++|+||||+++
T Consensus 134 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~----------------------~~~~~~Dv~slG~~~ 191 (265)
T cd05579 134 LTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ----------------------GHSKTVDWWSLGCIL 191 (265)
T ss_pred EEecccchhcccCcccccccccccccCcccCccccCHHHhcCC----------------------CCCcchhhHHHHHHH
Confidence 999999875433211 012345678899999965443 345567999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|..||....
T Consensus 192 ~~l~~g~~p~~~~~ 205 (265)
T cd05579 192 YEFLVGIPPFHGET 205 (265)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=241.96 Aligned_cols=204 Identities=22% Similarity=0.273 Sum_probs=157.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
....+.|++.+.||+|+||+||+|.+..++ +.+++|.+.... ........++...+....|++++.+.+.+.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTN-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCC-----cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 344467999999999999999999988766 788888775322 111122233445566678999999888664
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++..++|+||+. +++.+++.... ..+++..+..++.|++.||.|||+.||+||||+|+
T Consensus 86 -~~~~~~lv~e~~~-g~l~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~ 144 (307)
T cd06607 86 -REHTAWLVMEYCL-GSASDILEVHK-------------------KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAG 144 (307)
T ss_pred -eCCeEEEEHHhhC-CCHHHHHHHcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcc
Confidence 4567899999998 57777665432 13577888999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++++++ .++|+|||++...... ....+++.|+|||++.... ...++.++||||
T Consensus 145 nIl~~~~~-~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-------------------~~~~~~~sDv~s 199 (307)
T cd06607 145 NILLTEPG-TVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMD-------------------EGQYDGKVDVWS 199 (307)
T ss_pred cEEECCCC-CEEEeecCcceecCCC-----CCccCCccccCceeeeccC-------------------CCCCCcccchHH
Confidence 99999987 9999999998754322 3456788999999764321 123556789999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~ 389 (397)
||+++|||++|+.||...
T Consensus 200 ~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 200 LGITCIELAERKPPLFNM 217 (307)
T ss_pred HHHHHHHHHcCCCCCCCc
Confidence 999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=239.22 Aligned_cols=201 Identities=24% Similarity=0.293 Sum_probs=154.4
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-----HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
|++.+.||+|+||.||+|++..++ +.+++|.+...... ....+..+...+....|++++.+.+.+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC-----CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence 678999999999999999998765 78888887632211 11112223344455578999888876654332
Q ss_pred ----eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 216 ----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 216 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+++|||+.+ +|.+++.... ...+++..++.++.|++.||.|||+.+++|+||||+
T Consensus 76 ~~~~~~~l~~e~~~~-~l~~~l~~~~------------------~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~ 136 (287)
T cd07838 76 DRELKLTLVFEHVDQ-DLATYLSKCP------------------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136 (287)
T ss_pred CCCceeEEEehhccc-CHHHHHHHcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChh
Confidence 48999999985 7888876542 124678889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++++++ .+||+|||++........ .....++..|+|||.+.+. .++.++|+||
T Consensus 137 nili~~~~-~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~----------------------~~~~~~Di~s 191 (287)
T cd07838 137 NILVTSDG-QVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQS----------------------SYATPVDMWS 191 (287)
T ss_pred hEEEccCC-CEEEeccCcceeccCCcc--cccccccccccChHHhccC----------------------CCCCcchhhh
Confidence 99999986 999999999977643322 2334578899999966443 3455679999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|||++|..||....
T Consensus 192 ~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 192 VGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred HHHHHHHHHhCCCcccCCC
Confidence 9999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=252.58 Aligned_cols=196 Identities=22% Similarity=0.248 Sum_probs=157.8
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
.++||.|-||+||-|.+..++ +.||+|.+.+. ...| ...+.+...+...+||-|+.+-..+.+ .+..++|
T Consensus 569 devLGSGQFG~VYgg~hRktG-----rdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVV 641 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTG-----RDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFET-PERVFVV 641 (888)
T ss_pred HhhccCCcceeeecceecccC-----ceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEE
Confidence 468999999999999999998 77888876532 2222 333445667788889999888666644 4689999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC--
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG-- 298 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~-- 298 (397)
||-+.|.-|.-++.+. .++++++..+.+..||+.||.|||-++|+|+|+||+|||+.+.
T Consensus 642 MEKl~GDMLEMILSsE-------------------kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~ 702 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSE-------------------KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASP 702 (888)
T ss_pred ehhhcchHHHHHHHhh-------------------cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCC
Confidence 9999987777777654 3478889999999999999999999999999999999999754
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
..++||||||.|+.+.+.. ...+.+|||.|.|||++.. .+|...-|+||.||++|.
T Consensus 703 FPQvKlCDFGfARiIgEks--FRrsVVGTPAYLaPEVLrn----------------------kGyNrSLDMWSVGVIiYV 758 (888)
T KOG4236|consen 703 FPQVKLCDFGFARIIGEKS--FRRSVVGTPAYLAPEVLRN----------------------KGYNRSLDMWSVGVIIYV 758 (888)
T ss_pred CCceeeccccceeecchhh--hhhhhcCCccccCHHHHhh----------------------ccccccccceeeeEEEEE
Confidence 3589999999999875442 3467899999999995554 455555699999999999
Q ss_pred HHcCCCCCCCC
Q 015991 379 MVCTVRRLCLH 389 (397)
Q Consensus 379 lltg~~Pf~~~ 389 (397)
-+.|..||.-.
T Consensus 759 sLSGTFPFNEd 769 (888)
T KOG4236|consen 759 SLSGTFPFNED 769 (888)
T ss_pred EecccccCCCc
Confidence 99999999543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=245.30 Aligned_cols=200 Identities=25% Similarity=0.340 Sum_probs=156.2
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.++|++.+.||+|+||.||++.+..++ ..+++|+..... ........++...+....|++++.+.+.+....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCC-----cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 478999999999999999999988776 788888875322 111112223455666778999988877654432
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
..+++||||+ +++|.+++... .+++..++.++.|++.||+|||+.||+||||||
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~---------------------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp 146 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE---------------------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKP 146 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 3568999999 56888887643 356788899999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||++++++ .++|+|||++...... .....+++.|++||.+.+.. .++.++|+|
T Consensus 147 ~Nill~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Di~ 200 (343)
T cd07880 147 GNLAVNEDC-ELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWM---------------------HYTQTVDIW 200 (343)
T ss_pred HHEEEcCCC-CEEEeecccccccccC----ccccccCCcccCHHHHhCCC---------------------CCCcHHHHH
Confidence 999999887 9999999999765322 23456789999999764321 245678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|+|+++|+|++|+.||....
T Consensus 201 slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 201 SVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=243.12 Aligned_cols=207 Identities=22% Similarity=0.278 Sum_probs=156.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeeccccc-
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKK- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (397)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+...... ......++........|++++.+.+.+...
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTG-----ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCC-----cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 4579999999999999999999998776 67888877543211 111222334455566789998887655432
Q ss_pred --------CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCcee
Q 015991 214 --------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (397)
Q Consensus 214 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiH 285 (397)
+..+++++||+++ ++.+.+.... ..+++..+..++.|++.||.|||+.||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~i~H 139 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGL-------------------VHFSEDHIKSFMKQLLEGLNYCHKKNFLH 139 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 2378999999986 6767665432 14677889999999999999999999999
Q ss_pred cCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC
Q 015991 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365 (397)
Q Consensus 286 rDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (397)
|||||+||++++++ .+||+|||++..+............++..|+|||++.+.. .++.
T Consensus 140 ~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---------------------~~~~ 197 (302)
T cd07864 140 RDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEE---------------------RYGP 197 (302)
T ss_pred CCCCHHHEEECCCC-cEEeCcccccccccCCcccccccceeccCccChHHhcCCC---------------------CCCc
Confidence 99999999999987 9999999999876443322122345678899999775322 2345
Q ss_pred chhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 366 RFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 366 k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
++|||||||++|||++|+.||...+
T Consensus 198 ~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 198 AIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6799999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=232.61 Aligned_cols=200 Identities=21% Similarity=0.301 Sum_probs=159.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.+.||+|++|.||++.+..++ +.+++|....... .......++...+....|++++.+.+... .+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETG-----DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-TSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCC-----cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-eCCEE
Confidence 5889999999999999999988776 7788888765442 22223334445555667888888776553 35789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++++||+++++|.+++.... .+++..+..++.|++.+|.|||+.||+||||||+||+++.
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 134 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFG--------------------PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK 134 (254)
T ss_pred EEEEecCCCCcHHHHHHhcc--------------------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC
Confidence 99999999999999987643 4678889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .++|+|||.+......... .....++..|++||.+.+. ..+.++|+||+|+++|
T Consensus 135 ~~-~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~----------------------~~~~~~Dv~~lG~~l~ 190 (254)
T cd06627 135 DG-VVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMS----------------------GASTASDIWSLGCTVI 190 (254)
T ss_pred CC-CEEEeccccceecCCCccc-ccccccchhhcCHhhhcCC----------------------CCCcchhHHHHHHHHH
Confidence 76 9999999999876543321 2345788999999966433 2445679999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
+|++|..||...
T Consensus 191 ~l~~g~~p~~~~ 202 (254)
T cd06627 191 ELLTGNPPYYDL 202 (254)
T ss_pred HHHhCCCCCCCc
Confidence 999999998643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=234.16 Aligned_cols=204 Identities=26% Similarity=0.319 Sum_probs=160.0
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|++.++||+|+||.||++.+..++ +.+++|.+.... ..+.....++...+....|++++.+.+.+.. +...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDN-----QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCC-----CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEE
Confidence 5889999999999999999987776 778888876432 2222222233445566678888887765544 4789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+++++|.+++.... ..+..+++..+..++.|++.||.|||+.|++|+||||+||++++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~ 138 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRK----------------KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA 138 (256)
T ss_pred EEEehhcCCCCHHHHHHHHH----------------hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec
Confidence 99999999999999987642 11235678889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||++...... ......+++.|++||.+.+. .++.++|+||+|+++|
T Consensus 139 ~~-~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~----------------------~~~~~~D~~slG~~~~ 192 (256)
T cd08530 139 ND-LVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGR----------------------PYSYKSDIWSLGCLLY 192 (256)
T ss_pred CC-cEEEeeccchhhhccC---CcccccCCccccCHHHHCCC----------------------CCCchhhHHHHHHHHH
Confidence 76 9999999999776443 22335688999999966443 3445679999999999
Q ss_pred HHHcCCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHSC 391 (397)
Q Consensus 378 elltg~~Pf~~~~~ 391 (397)
||++|+.||...+.
T Consensus 193 ~l~~g~~p~~~~~~ 206 (256)
T cd08530 193 EMATFAPPFEARSM 206 (256)
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999976543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=232.24 Aligned_cols=203 Identities=24% Similarity=0.279 Sum_probs=162.6
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccC-Ce
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKG-GE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~ 216 (397)
+|.+.+.||+|++|.||+|.+..++ +.+++|....... .+.....++...+....|++++.+++...... ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTG-----ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCe
Confidence 5788999999999999999998766 7888888765432 23333344555666677999999887664432 67
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++++||+.+++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~ 135 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG--------------------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD 135 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc
Confidence 899999999999999987653 467788899999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+++ .++|+|||.+......... ......++..|++||.+... ..+.++|+||||++
T Consensus 136 ~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~----------------------~~~~~~Dv~slG~i 192 (260)
T cd06606 136 SDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE----------------------EYGRAADIWSLGCT 192 (260)
T ss_pred CCC-CEEEcccccEEecccccccccccCCCCCccccCHhhhcCC----------------------CCCchhhHHHHHHH
Confidence 987 9999999999876544321 12345788999999965443 34567799999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|+|++|..||....
T Consensus 193 l~~l~~g~~p~~~~~ 207 (260)
T cd06606 193 VIEMATGKPPWSELG 207 (260)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=242.03 Aligned_cols=207 Identities=22% Similarity=0.317 Sum_probs=155.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeeccccc-
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (397)
..++|++.++||+|+||.||+|.+..++ +.+++|.+......+ .....++...+....|++++.+.+.+...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTK-----QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCC-----cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 4478999999999999999999988776 788888775322111 11112233445556788887776644322
Q ss_pred ------CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecC
Q 015991 214 ------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (397)
Q Consensus 214 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrD 287 (397)
....++|+||+++ +|.+.+.... ..+++..++.++.|++.||.|||++|++|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 144 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-------------------VKFTLSEIKKVMKMLLNGLYYIHRNKILHRD 144 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 2467999999985 7877776532 2457788999999999999999999999999
Q ss_pred CCCCceEEeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
|||+||+++.++ .+||+|||++......... ......++..|+|||.+.+.. .++
T Consensus 145 l~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~ 202 (310)
T cd07865 145 MKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER---------------------DYG 202 (310)
T ss_pred CCHHHEEECCCC-cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCc---------------------ccC
Confidence 999999999987 9999999999765432221 122346788999999765332 244
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++|+||||+++|||++|+.||....
T Consensus 203 ~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 203 PPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred chhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 56899999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=237.82 Aligned_cols=211 Identities=18% Similarity=0.198 Sum_probs=153.4
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC----
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG---- 214 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---- 214 (397)
|.+.+.||+|+||.||+|.+...... ...+++|.+.... ........++...+....|++++.+++......
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGS--FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCC--ceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 67788999999999999987543211 1678888776432 222222233445566678999998887543322
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 215 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...+++++|+.+++|.+++...... .....+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~--------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ni 144 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIG--------------EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNC 144 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhccc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhE
Confidence 2347889999999999887543210 0112467788899999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++++++ .+||+|||+++....+..+. .....+++.|++||.+.. ..++.++|||||
T Consensus 145 li~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----------------------~~~~~~sDi~sl 201 (273)
T cd05074 145 MLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD----------------------NVYTTHSDVWAF 201 (273)
T ss_pred EEcCCC-CEEECcccccccccCCcceecCCCccCchhhcCHhHHhc----------------------CccchhhhhHHH
Confidence 999877 99999999998664332221 223345678999995543 345567899999
Q ss_pred HHHHHHHHc-CCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~ 390 (397)
|+++|||++ |+.||....
T Consensus 202 G~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 202 GVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred HHHHHHHhhCCCCCCCCCC
Confidence 999999999 888986544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=243.85 Aligned_cols=203 Identities=22% Similarity=0.304 Sum_probs=151.5
Q ss_pred CeEEeeeeccCCceEEEEEEecCC--CCCCCCCceEEeecccchhHH--HHHHHHHHHHhhc-cCCCceeeeeeccc---
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKK--PSSKNDGDLVLKKATEYGAVE--IWMNERVRRACAN-CCADFVYGFFENSS--- 211 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~--~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~-~~~~~i~~~~~~~~--- 211 (397)
+|++.+.||+|+||.||++.+... + ..+++|++....... .....++...+.. ..|++++.+++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEE-----ETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcC-----ceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence 588999999999999999998766 4 678888876421111 1111122223333 35888888876432
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
......+++++|++ ++|.+.+.... .+++..++.++.|++.||+|||+.||+||||||+
T Consensus 76 ~~~~~~~~~~e~~~-~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~ 134 (332)
T cd07857 76 GNFNELYLYEELME-ADLHQIIRSGQ--------------------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPG 134 (332)
T ss_pred ccCCcEEEEEeccc-CCHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 22346788999987 58888886543 4677888999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|||+++++ .+||+|||+++.+...... ......||+.|+|||++.+. ..++.++|
T Consensus 135 Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---------------------~~~~~~~D 192 (332)
T cd07857 135 NLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF---------------------QSYTKAID 192 (332)
T ss_pred HeEEcCCC-CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCC---------------------CCCCcHHH
Confidence 99999987 9999999999866433221 12345789999999965432 13556789
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
+||+|+++|+|++|..||....
T Consensus 193 i~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 193 VWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred HHHHHHHHHHHHhCCcCCCCCC
Confidence 9999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=241.30 Aligned_cols=195 Identities=22% Similarity=0.309 Sum_probs=152.5
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
..+||+|+||.||++.+..++ ..+++|+.............++...+....|++++.+++.+. .++..+++|||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCC-----eEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-eCCEEEEEEec
Confidence 468999999999999988776 788888875433322222233334555667889888877653 45789999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+++... .+++..+..++.|++.+|+|||+.|++|+||||+||++++++ .++
T Consensus 99 ~~~~~L~~~~~~~---------------------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~ 156 (292)
T cd06657 99 LEGGALTDIVTHT---------------------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVK 156 (292)
T ss_pred CCCCcHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEE
Confidence 9999999887543 246677889999999999999999999999999999999987 899
Q ss_pred EEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCC
Q 015991 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTV 383 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~ 383 (397)
|+|||++........ ......+++.|++||.+... .++.++|+||+|+++|||++|.
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~----------------------~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 157 LSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRL----------------------PYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred Ecccccceecccccc-cccccccCccccCHHHhcCC----------------------CCCchhhHHHHHHHHHHHHhCC
Confidence 999999876543222 12345688999999966433 3445679999999999999999
Q ss_pred CCCCCC
Q 015991 384 RRLCLH 389 (397)
Q Consensus 384 ~Pf~~~ 389 (397)
.||...
T Consensus 214 ~p~~~~ 219 (292)
T cd06657 214 PPYFNE 219 (292)
T ss_pred CCCCCC
Confidence 999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=219.19 Aligned_cols=201 Identities=20% Similarity=0.277 Sum_probs=156.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHH--HHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW--MNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.+|.-.++||+|.||+||+|++.++. ..+++|++..+.+.|-. ...+++-.+....|.|++.+.+.. ..+..
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~-----eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-hsdkk 75 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKK 75 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCcc-----ceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-ccCce
Confidence 35667889999999999999999887 88899988755443321 112233344556688888876654 34577
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+.+|+|||. .+|..+..+.+ +.++.+.++.++.|+++||.++|+++++|||+||+|+||+
T Consensus 76 ltlvfe~cd-qdlkkyfdsln-------------------g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin 135 (292)
T KOG0662|consen 76 LTLVFEFCD-QDLKKYFDSLN-------------------GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN 135 (292)
T ss_pred eEEeHHHhh-HHHHHHHHhcC-------------------CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec
Confidence 999999998 47777766543 3567888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.+| ++|++|||+|+.+.....- -...+-|.+|.+|.++.+.+.+.. ..|+||.||++
T Consensus 136 ~ng-elkladfglarafgipvrc-ysaevvtlwyrppdvlfgakly~t---------------------sidmwsagcif 192 (292)
T KOG0662|consen 136 RNG-ELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYST---------------------SIDMWSAGCIF 192 (292)
T ss_pred cCC-cEEecccchhhhcCCceEe-eeceeeeeeccCcceeeeeehhcc---------------------chHhhhcchHH
Confidence 998 9999999999988655432 234567999999999988876443 47999999999
Q ss_pred HHHHc-CCCCCCC
Q 015991 377 LQMVC-TVRRLCL 388 (397)
Q Consensus 377 ~ellt-g~~Pf~~ 388 (397)
.|+.. |++-|++
T Consensus 193 aelanagrplfpg 205 (292)
T KOG0662|consen 193 AELANAGRPLFPG 205 (292)
T ss_pred HHHhhcCCCCCCC
Confidence 99976 4444544
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=237.42 Aligned_cols=203 Identities=23% Similarity=0.364 Sum_probs=160.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..+.|++.+.||+|+||.||+|.+..++ ..+++|.+..... .......+...+....|++++.+++.+.. ++.
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 89 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATG-----KEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-GDE 89 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCC-----cEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCE
Confidence 4577999999999999999999988665 7788888765443 12222233445566678999988876644 478
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.|+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~ 150 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-------------------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc
Confidence 999999999999999998753 1356777889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .++|+|||++........ ......++..|++||.+.+. .++.++|+||||+++
T Consensus 151 ~~~-~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~----------------------~~~~~~Dv~slGvil 206 (286)
T cd06614 151 KDG-SVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRK----------------------DYGPKVDIWSLGIMC 206 (286)
T ss_pred CCC-CEEECccchhhhhccchh-hhccccCCcccCCHhHhcCC----------------------CCCCccccHHHHHHH
Confidence 887 999999999876543221 22345678899999965432 355678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|+|++|..||...
T Consensus 207 ~~l~~g~~p~~~~ 219 (286)
T cd06614 207 IEMAEGEPPYLRE 219 (286)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=251.47 Aligned_cols=206 Identities=18% Similarity=0.256 Sum_probs=168.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
++..+...++++||+|-||.|.+++.... ..||+|+++..... ......++++.+....||||+.+++.+..
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~------lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~- 606 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGP------LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ- 606 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCc------eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-
Confidence 45567899999999999999999988763 78999999865433 33455566777888899999999998855
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++.+++++||+++|+|.+++..+..+. .+.....+|+.||+.|++||.+.++|||||.+.|+
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt------------------~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc 668 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPT------------------AETAPGVSICTQIASGMAYLESLNFVHRDLATRNC 668 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcc------------------cccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence 467999999999999999999886432 23334556999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccccc-ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|++.++ ++||+|||+++.+-.++.++. ...+...+|||+|.+..+ .++.++|+|+|
T Consensus 669 Lv~~e~-~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg----------------------kFttaSDvWaf 725 (807)
T KOG1094|consen 669 LVDGEF-TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG----------------------KFTTASDVWAF 725 (807)
T ss_pred eecCcc-cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc----------------------cccchhhhhhh
Confidence 999998 999999999998876666543 346778899999966555 45556799999
Q ss_pred HHHHHHHH--cCCCCCCC
Q 015991 373 GLIFLQMV--CTVRRLCL 388 (397)
Q Consensus 373 Gv~l~ell--tg~~Pf~~ 388 (397)
|++|||++ +...||..
T Consensus 726 gvTlwE~~~~C~e~Py~~ 743 (807)
T KOG1094|consen 726 GVTLWEVFMLCREQPYSQ 743 (807)
T ss_pred HHHHHHHHHHHhhCchhh
Confidence 99999984 67778754
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=240.68 Aligned_cols=207 Identities=19% Similarity=0.205 Sum_probs=152.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhcc-CCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANC-CADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~ 216 (397)
++|...++||+|+||.||++.+..++ ..+++|.+.... .........+...+... .|++++.+++.... ++.
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSG-----TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCC-----CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCc
Confidence 57778899999999999999998776 788999876432 12222222233333444 48999998886644 567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCCCceEE
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIF 295 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~NILl 295 (397)
.+++|||+.. ++.++...... .....+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 78 ~~~~~e~~~~-~l~~l~~~~~~---------------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~ 141 (288)
T cd06616 78 CWICMELMDI-SLDKFYKYVYE---------------VLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL 141 (288)
T ss_pred EEEEEecccC-CHHHHHHHHHH---------------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE
Confidence 8899999884 66554432100 0123567888999999999999999975 99999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+++.+..... .....+|..|+|||++..... ..++.++|+||+|++
T Consensus 142 ~~~~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-------------------~~~~~~~Di~slG~i 199 (288)
T cd06616 142 DRNG-NIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSAR-------------------DGYDVRSDVWSLGIT 199 (288)
T ss_pred ccCC-cEEEeecchhHHhccCCc--cccccCccCccCHHHhccccc-------------------cCCcchhhhhHHHHH
Confidence 9887 999999999976543221 233468899999997754320 135567899999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|+.||...
T Consensus 200 l~el~~g~~p~~~~ 213 (288)
T cd06616 200 LYEVATGKFPYPKW 213 (288)
T ss_pred HHHHHhCCCCchhc
Confidence 99999999999654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=242.51 Aligned_cols=201 Identities=25% Similarity=0.305 Sum_probs=156.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++|++.+.||+|+||.||+|.+..++ +.+++|++.... .........+...+....|++++.+.+.+...+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTG-----QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCC-----CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 3478999999999999999999988877 788888764321 111112223344556667999999888776656
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++++||++ ++|.+++... .+++..+..++.|++.||.|||+.||+||||||+||+
T Consensus 83 ~~~~lv~e~~~-~~L~~~~~~~---------------------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil 140 (328)
T cd07856 83 EDIYFVTELLG-TDLHRLLTSR---------------------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL 140 (328)
T ss_pred CcEEEEeehhc-cCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence 77899999996 5888887643 2456667789999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+++++ .++|+|||++...... .....+++.|+|||.+.+.. .++.++|+||||+
T Consensus 141 i~~~~-~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Dv~slG~ 194 (328)
T cd07856 141 INENC-DLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQ---------------------KYDVEVDIWSAGC 194 (328)
T ss_pred ECCCC-CEEeCccccccccCCC----cCCCcccccccCceeeeccC---------------------CcCcHHHHHHHHH
Confidence 99887 9999999999754321 23456788999999764321 2456789999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|||++|+.||....
T Consensus 195 il~el~tg~~~f~~~~ 210 (328)
T cd07856 195 IFAEMLEGKPLFPGKD 210 (328)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=236.73 Aligned_cols=201 Identities=24% Similarity=0.304 Sum_probs=154.0
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
|++.++||.|++|.||+|.+..++ +.+++|++......+ .....++...+....|++++.+.+.+. .++..+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTG-----EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-SENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCC-----CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-cCCeEE
Confidence 677899999999999999988776 788888776432111 111122344555667888888877654 457899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+++||++ ++|.+++.... ...+++..+..++.|++.||+|||+++++||||+|+||+++++
T Consensus 75 iv~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~ 135 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSP------------------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE 135 (283)
T ss_pred EEEeccC-cCHHHHHhhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC
Confidence 9999996 68999887643 1246788899999999999999999999999999999999997
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||++......... .....+++.|+|||++.+.. .++.++|+||||+++||
T Consensus 136 ~-~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Di~slG~~l~~ 192 (283)
T cd07835 136 G-ALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSR---------------------QYSTPVDIWSIGCIFAE 192 (283)
T ss_pred C-cEEEeecccccccCCCccc-cCccccccCCCCCceeecCc---------------------ccCcHHHHHHHHHHHHH
Confidence 6 9999999999765332211 12235688999999764321 24567899999999999
Q ss_pred HHcCCCCCCCC
Q 015991 379 MVCTVRRLCLH 389 (397)
Q Consensus 379 lltg~~Pf~~~ 389 (397)
|++|+.||...
T Consensus 193 l~~g~~pf~~~ 203 (283)
T cd07835 193 MVNRRPLFPGD 203 (283)
T ss_pred HHhCCCCCCCC
Confidence 99999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=234.55 Aligned_cols=206 Identities=22% Similarity=0.316 Sum_probs=153.1
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeeccc--chhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE--YGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~--~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+|.+.++||+|+||.||++.+....... ...++|.... ....+......+...+...+|++++.+++... .....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEE--RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-ERDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcc--eEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-cCCce
Confidence 5889999999999999999887654221 2223333221 11112222223344556678999998877654 34678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+++++|.+++.... ..+..+++..++.++.|++.||.|||+.|++|+||||+||++++
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~ 141 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELK----------------HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN 141 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHh----------------hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec
Confidence 99999999999999887532 12335788899999999999999999999999999999999986
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
+ .++|+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|
T Consensus 142 ~--~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~----------------------~~~~~~~Dv~slG~~~~ 196 (260)
T cd08222 142 N--LLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKH----------------------QGYDSKSDIWSLGCILY 196 (260)
T ss_pred C--CEeecccCceeecCCCcc-cccCCCCCcCccCHHHHcc----------------------CCCCchhhHHHHHHHHH
Confidence 3 699999999976543322 2334568899999996543 34556789999999999
Q ss_pred HHHcCCCCCCCC
Q 015991 378 QMVCTVRRLCLH 389 (397)
Q Consensus 378 elltg~~Pf~~~ 389 (397)
+|++|..||...
T Consensus 197 ~l~~~~~~~~~~ 208 (260)
T cd08222 197 EMCCLAHAFEGQ 208 (260)
T ss_pred HHHhCCCCCCCc
Confidence 999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=262.21 Aligned_cols=148 Identities=24% Similarity=0.370 Sum_probs=121.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.++|.+.++||+|+||+||+|++..++ +.+++|.+.... .........+...+....|++++.++... ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~ 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNS-----KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-QSA 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-EEC
Confidence 479999999999999999999998776 788888876432 11122333445556667899999887655 445
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+++||||+.+++|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~~--------------------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NIL 136 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIYG--------------------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNML 136 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEE
Confidence 78999999999999999987543 3566778999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccc
Q 015991 295 FSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~ 312 (397)
++.++ .+||+|||+++.
T Consensus 137 l~~~g-~vkL~DFGls~~ 153 (669)
T cd05610 137 ISNEG-HIKLTDFGLSKV 153 (669)
T ss_pred EcCCC-CEEEEeCCCCcc
Confidence 99887 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=239.38 Aligned_cols=207 Identities=22% Similarity=0.273 Sum_probs=154.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
.|.+-.+.||.|+||+||..++..++ +.+++||+..... ......-++...+....|.|+.+.++......
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdg-----rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSG-----KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCc-----cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 45566789999999999999999888 8899998865322 22222233455555667788776665433222
Q ss_pred --CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 215 --GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 215 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++|+++|.+. .+|+.++-+ ...++...++-+.+||++||+|||+.+|+||||||.|
T Consensus 128 fFqEiYV~TELmQ-SDLHKIIVS--------------------PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGN 186 (449)
T KOG0664|consen 128 FFQELYVLTELMQ-SDLHKIIVS--------------------PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGN 186 (449)
T ss_pred HHHHHHHHHHHHH-hhhhheecc--------------------CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCcc
Confidence 12344444444 234444332 2367778888999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
+|++.|- .+||||||+|+..+.++....+..+-|-.|.|||.+++... |+..+||||.
T Consensus 187 LLVNSNC-vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRh---------------------Ys~AvDiWSV 244 (449)
T KOG0664|consen 187 LLVNSNC-ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARR---------------------YTGAVDIWSV 244 (449)
T ss_pred EEeccCc-eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchh---------------------hcCccceehh
Confidence 9999987 99999999999876665555556677899999999988765 4455799999
Q ss_pred HHHHHHHHcCCCCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~~~ 393 (397)
||++.||+-.+.-|...+.-+
T Consensus 245 GCIFaELLgRrILFQAq~Piq 265 (449)
T KOG0664|consen 245 GCIFAELLQRKILFQAAGPIE 265 (449)
T ss_pred hHHHHHHHhhhhhhhccChHH
Confidence 999999998888887665433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=252.49 Aligned_cols=199 Identities=19% Similarity=0.276 Sum_probs=157.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++...+|.|+|+.|-.+.+..++ +..++|.+.+...... ++.--......|+|++.+.+.. .++.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~-----~~~~vkii~~~~~~~~---~e~~~~~~~~~h~niv~~~~v~-~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTD-----QEPAVKIISKRADDNQ---DEIPISLLVRDHPNIVKSHDVY-EDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccc-----cchhheeccccccccc---cccchhhhhcCCCcceeeccee-cCCce
Confidence 4588999999999999999999998887 6777777765521111 1111233456799999887765 45678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.|+|||.+.++-+.+.+.... ... ..+..|+.||+.+++|||++||||||+||+|||++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~--------------------~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~ 449 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP--------------------EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD 449 (612)
T ss_pred eeeeehhccccHHHHHHHhcc--------------------hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence 999999999998887776653 112 55678999999999999999999999999999995
Q ss_pred -CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 -EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 -~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.+ +++|+|||.++.+... ..+.+-|..|.|||++. ...|++.||+||||++
T Consensus 450 ~~~g-~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~----------------------~~~yt~acD~WSLGvl 502 (612)
T KOG0603|consen 450 GSAG-HLRLTYFGFWSELERS----CDTPALTLQYVAPEVLA----------------------IQEYTEACDWWSLGVL 502 (612)
T ss_pred CCCC-cEEEEEechhhhCchh----hcccchhhcccChhhhc----------------------cCCCCcchhhHHHHHH
Confidence 555 9999999999877544 23557788999999554 4467788899999999
Q ss_pred HHHHHcCCCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 376 l~elltg~~Pf~~~~~~ 392 (397)
||+|++|..||-.+...
T Consensus 503 Ly~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 503 LYEMLTGRTLFAAHPAG 519 (612)
T ss_pred HHHHHhCCCccccCCch
Confidence 99999999999776554
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=237.01 Aligned_cols=207 Identities=16% Similarity=0.228 Sum_probs=157.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.+..++|++.++||+|+||.||+|.+..++ +.+++|.+..... .......++........|++++.+++.+..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTG-----HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCC-----eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 345689999999999999999999998766 7888888764321 112222222223334458999988886644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQ 291 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~ 291 (397)
+...+++|||++ ++|.+++.... ..+++..+..++.|++.||.|||+ .||+||||||+
T Consensus 86 -~~~~~~v~e~~~-~~l~~l~~~~~-------------------~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ 144 (296)
T cd06618 86 -DSDVFICMELMS-TCLDKLLKRIQ-------------------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPS 144 (296)
T ss_pred -CCeEEEEeeccC-cCHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHH
Confidence 567999999986 47777765532 146778888999999999999997 69999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++++++ .+||+|||++..+..... .....++..|+|||.+.+.... ..++.++|+||
T Consensus 145 nill~~~~-~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~------------------~~~~~~~Di~s 203 (296)
T cd06618 145 NILLDASG-NVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPN------------------PKYDIRADVWS 203 (296)
T ss_pred HEEEcCCC-CEEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCc------------------cccccchhHHH
Confidence 99999887 999999999976543222 1334578899999987644311 13566889999
Q ss_pred HHHHHHHHHcCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~ 388 (397)
||+++|||++|+.||..
T Consensus 204 lG~il~el~~g~~p~~~ 220 (296)
T cd06618 204 LGISLVELATGQFPYKN 220 (296)
T ss_pred HHHHHHHHHhCCCCCCc
Confidence 99999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=249.07 Aligned_cols=199 Identities=25% Similarity=0.357 Sum_probs=164.2
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHH----------HHHHHHhhccCCCceeee
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMN----------ERVRRACANCCADFVYGF 206 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~----------~~~~~~~~~~~~~~i~~~ 206 (397)
..+|...+.+|.|+||.|++|.++... ..|++|.+.+.. ..+.|+. ..++..+....|+||+.+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~-----~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENN-----YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred cccceeeeeccccccceEEEeeecccc-----eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 357999999999999999999998876 889999886543 2223322 234455566669999999
Q ss_pred eecccccCCeEEEEEEecC-CCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCcee
Q 015991 207 FENSSKKGGEYWLIWRYEG-EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiH 285 (397)
+..+ .+++.+||+||-.+ +.+|+++++.+. .++|...+.|+.|++.|+++||++||||
T Consensus 635 LdfF-Eddd~yyl~te~hg~gIDLFd~IE~kp--------------------~m~E~eAk~IFkQV~agi~hlh~~~ivh 693 (772)
T KOG1152|consen 635 LDFF-EDDDYYYLETEVHGEGIDLFDFIEFKP--------------------RMDEPEAKLIFKQVVAGIKHLHDQGIVH 693 (772)
T ss_pred hhee-ecCCeeEEEecCCCCCcchhhhhhccC--------------------ccchHHHHHHHHHHHhccccccccCcee
Confidence 8866 44678899998776 458999998764 6788999999999999999999999999
Q ss_pred cCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC
Q 015991 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365 (397)
Q Consensus 286 rDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (397)
||||-+|++++.+| -+||+|||.|.....+. -..++||..|+|||++.+..+-...
T Consensus 694 rdikdenvivd~~g-~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~-------------------- 749 (772)
T KOG1152|consen 694 RDIKDENVIVDSNG-FVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKP-------------------- 749 (772)
T ss_pred cccccccEEEecCC-eEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCc--------------------
Confidence 99999999999998 99999999997654432 3568999999999999988776443
Q ss_pred chhhHHHHHHHHHHHcCCCCCC
Q 015991 366 RFDIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 366 k~Dv~SlGv~l~elltg~~Pf~ 387 (397)
-|||++|++||.+++.+.||-
T Consensus 750 -qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 750 -QDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred -chhhhhhheeeEEEeccCCCc
Confidence 399999999999999998874
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=234.11 Aligned_cols=210 Identities=19% Similarity=0.174 Sum_probs=152.7
Q ss_pred eeeccCCceEEEEEEecCCCC-CCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPS-SKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWR 222 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~-~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e 222 (397)
+.||+|+||.||+|++..... ......+++|.+.... ........++...+....|++++.+++.+.. .+..++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence 368999999999998765321 1112456777665432 1222233344556667789999998876543 467899999
Q ss_pred ecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC---
Q 015991 223 YEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS--- 299 (397)
Q Consensus 223 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~--- 299 (397)
|+++++|.+++...... ......+++..+..++.|++.||.|||+.+++|+||||+||+++.++
T Consensus 80 ~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~ 146 (269)
T cd05044 80 LMEGGDLLSYLRDARVE-------------RFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDA 146 (269)
T ss_pred ccCCCcHHHHHHHhhhc-------------ccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCC
Confidence 99999999999764210 00123467788999999999999999999999999999999998753
Q ss_pred -CeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 300 -RTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 300 -~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
..++|+|||+++......... .....++..|+|||.+.. ..++.++||||||+++|
T Consensus 147 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Dv~slG~il~ 204 (269)
T cd05044 147 DRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD----------------------GKFTTQSDVWSFGVLMW 204 (269)
T ss_pred CcceEECCcccccccccccccccCcccCCCccccCHHHHcc----------------------CCcccchhHHHHHHHHH
Confidence 279999999997654332221 223456789999995543 34556779999999999
Q ss_pred HHHc-CCCCCCCCC
Q 015991 378 QMVC-TVRRLCLHS 390 (397)
Q Consensus 378 ellt-g~~Pf~~~~ 390 (397)
||++ |..||....
T Consensus 205 ellt~g~~p~~~~~ 218 (269)
T cd05044 205 EILTLGQQPYPALN 218 (269)
T ss_pred HHHHcCCCCCcccC
Confidence 9998 999996543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=237.12 Aligned_cols=200 Identities=22% Similarity=0.277 Sum_probs=154.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..|...+.||+|+||.||++.+..++ ..+++|++.... .........+...+...+|++++.+.+.+. .++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTN-----EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-REH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCC-----cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-eCC
Confidence 45888999999999999999988776 788888875322 111122223445566678999999887654 356
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 99 ~~~lv~e~~~g-~l~~~~~~~~-------------------~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~ 158 (317)
T cd06635 99 TAWLVMEYCLG-SASDLLEVHK-------------------KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 158 (317)
T ss_pred eEEEEEeCCCC-CHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE
Confidence 78999999984 7777765432 135778888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .++|+|||++..... .....+++.|+|||.+.... ...++.++|+|||||+
T Consensus 159 ~~~~-~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-------------------~~~~~~~~Dv~slGvi 213 (317)
T cd06635 159 TEPG-QVKLADFGSASIASP-----ANSFVGTPYWMAPEVILAMD-------------------EGQYDGKVDVWSLGIT 213 (317)
T ss_pred CCCC-CEEEecCCCccccCC-----cccccCCccccChhhhhcCC-------------------CCCCCccccHHHHHHH
Confidence 9887 999999999865432 23456889999999764311 1235567899999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|..||...
T Consensus 214 l~el~~g~~p~~~~ 227 (317)
T cd06635 214 CIELAERKPPLFNM 227 (317)
T ss_pred HHHHHhCCCCCCCc
Confidence 99999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=241.82 Aligned_cols=198 Identities=24% Similarity=0.347 Sum_probs=151.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
++|.+.+.||+|+||.||+|.+..++ ..+++|++......+ .....++...+....|++++.+.+.+....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTG-----EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCC-----cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 68999999999999999999988776 788888875422111 111223344556667889888776554322
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 215 ---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 215 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+++|+||+.. +|.+++.. .+++..+..++.|++.||.|||+.||+||||||+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~----------------------~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~ 146 (342)
T cd07879 90 DEFQDFYLVMPYMQT-DLQKIMGH----------------------PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPG 146 (342)
T ss_pred CCCceEEEEeccccc-CHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 457999999874 66554421 3466778899999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||+++.++ .+||+|||+++..... .....+|..|+|||.+.+. ..++.++|+||
T Consensus 147 NIll~~~~-~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~Dv~s 200 (342)
T cd07879 147 NLAVNEDC-ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNW---------------------MHYNQTVDIWS 200 (342)
T ss_pred HEEECCCC-CEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCc---------------------cccCchHHHHH
Confidence 99999987 9999999999764322 2345678899999976432 13456789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|+.||....
T Consensus 201 lGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 201 VGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=244.14 Aligned_cols=207 Identities=18% Similarity=0.240 Sum_probs=162.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..+...+.++||.|-||.||+|....-.+.. .-.||+|..+.+...+ ......+.....+..||+|+.+++.+. +.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge-~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~--e~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGE-RIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV--EQ 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCc-ceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee--cc
Confidence 3355666789999999999999876543222 2458888877533221 222223345667888999999998864 35
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..|||||.++-|.|..+++.+.. .++......++.||+.+|.|||+.++|||||..+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~-------------------sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV 524 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD-------------------SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV 524 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc-------------------cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee
Confidence 79999999999999999998652 45667778899999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
.... .+||+|||+++-+.++..|..........|||||.+... .++..+|||.|||+
T Consensus 525 sSp~-CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfR----------------------rFTtASDVWMFgVC 581 (974)
T KOG4257|consen 525 SSPQ-CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFR----------------------RFTTASDVWMFGVC 581 (974)
T ss_pred cCcc-eeeecccchhhhccccchhhccccccceeecCccccchh----------------------cccchhhHHHHHHH
Confidence 9987 999999999999988877766666677899999965443 35556799999999
Q ss_pred HHHHH-cCCCCCCC
Q 015991 376 FLQMV-CTVRRLCL 388 (397)
Q Consensus 376 l~ell-tg~~Pf~~ 388 (397)
+||++ .|..||.+
T Consensus 582 mWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 582 MWEILSLGVKPFQG 595 (974)
T ss_pred HHHHHHhcCCcccc
Confidence 99996 57777743
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=241.41 Aligned_cols=203 Identities=20% Similarity=0.250 Sum_probs=154.1
Q ss_pred CCeE-EeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH--------------HHHHHHHHHhhccCCCce
Q 015991 139 DDFV-LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--------------WMNERVRRACANCCADFV 203 (397)
Q Consensus 139 ~~f~-i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~--------------~~~~~~~~~~~~~~~~~i 203 (397)
++|. +.+.||.|+||+||+|.+..++ +.+++|+......... ....++...+....|+++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTG-----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCC-----CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 5665 4578999999999999988766 7788887754322110 012233445566678999
Q ss_pred eeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCc
Q 015991 204 YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (397)
Q Consensus 204 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gi 283 (397)
+.+++.+. .++..+++|||+. ++|.+++.... .+++..+..++.|++.||+|||+.||
T Consensus 83 v~~~~~~~-~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~~~~~~~~ql~~aL~~LH~~~i 140 (335)
T PTZ00024 83 MGLVDVYV-EGDFINLVMDIMA-SDLKKVVDRKI--------------------RLTESQVKCILLQILNGLNVLHKWYF 140 (335)
T ss_pred eeeeEEEe-cCCcEEEEEeccc-cCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 98887654 4568999999998 58988886543 45778889999999999999999999
Q ss_pred eecCCCCCceEEeCCCCeEEEEeccccccccccc-------------ccccccccCCCCCCCcccccccCCCCCCCCccc
Q 015991 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI-------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 350 (397)
Q Consensus 284 iHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~ 350 (397)
+||||||+||+++.++ .++|+|||++....... ........+++.|+|||.+.+..
T Consensus 141 ~H~dl~~~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------- 209 (335)
T PTZ00024 141 MHRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE---------- 209 (335)
T ss_pred ecccccHHHeEECCCC-CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCC----------
Confidence 9999999999999987 99999999997654110 01112335688899999765432
Q ss_pred cccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 351 ATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 351 ~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++.++|+|||||++|||++|..||...+
T Consensus 210 -----------~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 210 -----------KYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred -----------CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 24557899999999999999999997553
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=242.88 Aligned_cols=200 Identities=25% Similarity=0.341 Sum_probs=154.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.++|++.+.||+|+||.||+|++..++ ..+++|++.... ........++...+....|++++.+.+.....+
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTG-----RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCC-----cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 478999999999999999999998876 788888875321 111111222344455567888877765443322
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
...++|+||++ ++|.+++... .+++..+..++.|++.||.|||+.||+||||||
T Consensus 89 ~~~~~~~~lv~e~~~-~~L~~~~~~~---------------------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp 146 (343)
T cd07851 89 LEDFQDVYLVTHLMG-ADLNNIVKCQ---------------------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKP 146 (343)
T ss_pred ccccccEEEEEecCC-CCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 34899999995 6898888653 357788899999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||++++++ .++|+|||++...... .....+|..|+|||.+... ..++.++|||
T Consensus 147 ~Nill~~~~-~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~Dvw 200 (343)
T cd07851 147 SNIAVNEDC-ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNW---------------------MHYNQTVDIW 200 (343)
T ss_pred HHeEECCCC-CEEEcccccccccccc----ccCCcccccccCHHHHhCC---------------------CCCCchHhHH
Confidence 999999987 9999999999765432 2345678899999965432 1345678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+++|||++|+.||....
T Consensus 201 slGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 201 SVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=241.06 Aligned_cols=200 Identities=16% Similarity=0.136 Sum_probs=150.3
Q ss_pred eeeccC--CceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEE
Q 015991 145 KKLGEG--AFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 145 ~~LG~G--~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
+.||+| +||+||++++..++ +.+++|...... .......+++.......+|+|++.+++.+.. ++..++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTG-----TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCC-----cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEE
Confidence 456666 99999999998777 788888775322 2222333344455666789999998887654 5678999
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
+||+.+++|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+|||++.++
T Consensus 78 ~e~~~~~~l~~~l~~~~------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~- 138 (328)
T cd08226 78 SPFMAYGSANSLLKTYF------------------PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG- 138 (328)
T ss_pred EecccCCCHHHHHHhhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-
Confidence 99999999999987643 11367788889999999999999999999999999999999887
Q ss_pred eEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
.++++||+.+......... ......++..|+|||++.+... .++.++||||+||
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--------------------~~~~~~DiwslG~ 198 (328)
T cd08226 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY--------------------GYNVKSDIYSVGI 198 (328)
T ss_pred cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCC--------------------CCCchhhHHHHHH
Confidence 9999999865433211110 0111234567999997754321 3556789999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|+.||...
T Consensus 199 ~l~el~~g~~p~~~~ 213 (328)
T cd08226 199 TACELATGRVPFQDM 213 (328)
T ss_pred HHHHHHhCCCCCCCc
Confidence 999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-31 Score=233.71 Aligned_cols=209 Identities=20% Similarity=0.300 Sum_probs=158.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-----HHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----EIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+.|+-..+||+|.||.||+|+..+++ +.|++|+..-..+. ....+.++...+.|.+..|++..+....+.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~-----kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTG-----KKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCcc-----chhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 56777889999999999999999988 66777765432222 222333333444444444455444443333
Q ss_pred C----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 214 G----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 214 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
. ..+++|+.+|+. +|.-++.... .+++...|++++.+++.||.|+|+..|+|||+|
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~-------------------vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK 151 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRK-------------------VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK 151 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCcc-------------------ccccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence 3 349999999994 7888876542 366778899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEeccccccccccccccc---ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIP---KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
++|+||+.++ .+||+|||+|+.+....+... +..+-|.+|.+||.+.+... |+.+
T Consensus 152 aaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~---------------------yg~~ 209 (376)
T KOG0669|consen 152 AANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE---------------------YGPP 209 (376)
T ss_pred HhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccc---------------------cCCc
Confidence 9999999988 999999999988766555432 33567999999998877654 4455
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCCCc
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLHSCPLA 394 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~~~~~~ 394 (397)
.|+|..||++.||.++.+-|.+...+.+
T Consensus 210 iDiWgAgCimaeMwtrspimqgnteqqq 237 (376)
T KOG0669|consen 210 IDIWGAGCIMAEMWTRSPIMQGNTEQQQ 237 (376)
T ss_pred chhHhHHHHHHHHHccCccccCChHHHH
Confidence 7999999999999999999887766543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=255.67 Aligned_cols=213 Identities=15% Similarity=0.149 Sum_probs=172.1
Q ss_pred HHhhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-hhHHHHHHHHHHHHhhccCCCceeeeee
Q 015991 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACANCCADFVYGFFE 208 (397)
Q Consensus 130 ~~~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~e~~~~~~~~~~~~~~~~~~i~~~~~ 208 (397)
+.+..++......|.++||.|.||.|++|+++..++.. ..||||.++.. .+.+...+..+...+.+..||||+.+.+
T Consensus 620 reFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre--~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 620 REFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKRE--ITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred HHhhhhcChhheEEEEEEecccccceecccccCCCCcc--eeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 55566777788999999999999999999998766443 78999998853 3444455556677788899999999988
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.. ++.....||+|||++|+|+.+|+.++.. ++..++.-++++|+.|++||-+.++|||||
T Consensus 698 VV-Tks~PvMIiTEyMENGsLDsFLR~~DGq-------------------ftviQLVgMLrGIAsGMkYLsdm~YVHRDL 757 (996)
T KOG0196|consen 698 VV-TKSKPVMIITEYMENGSLDSFLRQNDGQ-------------------FTVIQLVGMLRGIASGMKYLSDMNYVHRDL 757 (996)
T ss_pred EE-ecCceeEEEhhhhhCCcHHHHHhhcCCc-------------------eEeehHHHHHHHHHHHhHHHhhcCchhhhh
Confidence 65 5567899999999999999999987633 455667789999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccC--CCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
..+|||++.+- .+|++|||+++.+.++.....++.-| ..+|.|||.+...+.+. .
T Consensus 758 AARNILVNsnL-vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTs----------------------A 814 (996)
T KOG0196|consen 758 AARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTS----------------------A 814 (996)
T ss_pred hhhheeeccce-EEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCc----------------------h
Confidence 99999999986 99999999999876654222222222 46999999776655544 4
Q ss_pred hhhHHHHHHHHHHH-cCCCCCC
Q 015991 367 FDIYSAGLIFLQMV-CTVRRLC 387 (397)
Q Consensus 367 ~Dv~SlGv~l~ell-tg~~Pf~ 387 (397)
+||||+|++|||.+ +|++||=
T Consensus 815 SDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 815 SDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred hhccccceEEEEecccCCCccc
Confidence 59999999999975 6999983
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=228.14 Aligned_cols=181 Identities=16% Similarity=0.228 Sum_probs=143.3
Q ss_pred CCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEecCCCCH
Q 015991 150 GAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATL 229 (397)
Q Consensus 150 G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL 229 (397)
|.||.||++++..++ +.+++|++........ +........|++++.+.+.+. ..+..+++|||+++++|
T Consensus 4 g~~~~v~~~~~~~~~-----~~~~~K~i~~~~~~~~-----~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQ-----QTFILKGLRKSSEYSR-----ERLTIIPHCVPNMVCLHKYIV-SEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCC-----cEEEEEeecchhhhhh-----HHHHHHhcCCCceeehhhhee-cCCeEEEEEecCCCCCH
Confidence 899999999998887 7899998875432211 122223345889988877654 45789999999999999
Q ss_pred HHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEeccc
Q 015991 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309 (397)
Q Consensus 230 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGl 309 (397)
.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++ .++++|||.
T Consensus 73 ~~~l~~~~--------------------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~ 131 (237)
T cd05576 73 WSHISKFL--------------------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSR 131 (237)
T ss_pred HHHHHHhc--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccc
Confidence 99987643 357788899999999999999999999999999999999987 999999998
Q ss_pred ccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 015991 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 310 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
+...... .....++..|+|||.+... .++.++|+||+|+++|||++|+.||..
T Consensus 132 ~~~~~~~----~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 132 WSEVEDS----CDGEAVENMYCAPEVGGIS----------------------EETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred hhccccc----cccCCcCccccCCcccCCC----------------------CCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 8665332 1234567789999965433 244567999999999999999988754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=222.89 Aligned_cols=198 Identities=22% Similarity=0.321 Sum_probs=159.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhc-cCCCceeeeeeccccc-C
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSKK-G 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~-~ 214 (397)
..++|++.+++|+|-|++||+|....++ .++++|.++.-....+..+. ..+.+ ..++||+.+++..... .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~-----eK~ViKiLKPVkkkKIkREi---kIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNN-----EKCVIKILKPVKKKKIKREI---KILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCC-----ceEEEeeechHHHHHHHHHH---HHHHhccCCCCeeehhhhhcCccc
Confidence 5589999999999999999999987776 78899998876655544333 33333 3489999998865543 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...-|++||+++.+...+.. .++.-.++.++.|++.||+|+|++||+|||+||.|++
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~-----------------------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYP-----------------------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM 164 (338)
T ss_pred cCchhHhhhhccccHHHHhh-----------------------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence 45678999999988766654 3455668899999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
||.....++|+|||+|.....+..+ +..+.+..|--||.+..... |+..-|+|||||
T Consensus 165 Idh~~rkLrlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~---------------------YDYSLD~WS~Gc 221 (338)
T KOG0668|consen 165 IDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQM---------------------YDYSLDMWSLGC 221 (338)
T ss_pred echhhceeeeeecchHhhcCCCcee--eeeeehhhcCCchheeechh---------------------ccccHHHHHHHH
Confidence 9988889999999999887766554 34566778899998876554 334469999999
Q ss_pred HHHHHHcCCCCCCC
Q 015991 375 IFLQMVCTVRRLCL 388 (397)
Q Consensus 375 ~l~elltg~~Pf~~ 388 (397)
+|..|++.+.||.-
T Consensus 222 mlA~miFrkepFFh 235 (338)
T KOG0668|consen 222 MLASMIFRKEPFFH 235 (338)
T ss_pred HHHHHHhccCcccC
Confidence 99999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=247.04 Aligned_cols=216 Identities=16% Similarity=0.216 Sum_probs=171.4
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+++...+.....+||.|-||.||.|.++.-. -.+++|.++++...-. .+..+...+....|+|++.+++.+. .
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkys-----lTvAVKtLKEDtMeve-EFLkEAAvMKeikHpNLVqLLGVCT-~ 334 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT-H 334 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccc-----eeeehhhhhhcchhHH-HHHHHHHHHHhhcCccHHHHhhhhc-c
Confidence 3445567888899999999999999998765 6788898886653322 2223344556677999999999874 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+..+|||+|||..|+|.+++++.+ ...++.-..++++.||..|++||..+++|||||...|+
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecn------------------r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNC 396 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECN------------------RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 396 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhc------------------hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhc
Confidence 578999999999999999998764 33456677889999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|+.++. .+|++|||+++.+..+.......-.-...|.|||.+...+ ++.|+|||+||
T Consensus 397 LVgEnh-iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNt----------------------FSiKSDVWAFG 453 (1157)
T KOG4278|consen 397 LVGENH-IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT----------------------FSIKSDVWAFG 453 (1157)
T ss_pred cccccc-eEEeeccchhhhhcCCceecccCccCcccccCcccccccc----------------------cccchhhHHHH
Confidence 999987 9999999999988766543333334467899999876654 44577999999
Q ss_pred HHHHHHHc-CCCCCCCCCCCCcCCC
Q 015991 374 LIFLQMVC-TVRRLCLHSCPLAYSL 397 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~~~~~~~~ 397 (397)
|+|||+.| |--||++-...+-|+|
T Consensus 454 VLLWEIATYGMsPYPGidlSqVY~L 478 (1157)
T KOG4278|consen 454 VLLWEIATYGMSPYPGIDLSQVYGL 478 (1157)
T ss_pred HHHHHHHhcCCCCCCCccHHHHHHH
Confidence 99999975 8889887666665553
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=231.55 Aligned_cols=201 Identities=23% Similarity=0.341 Sum_probs=154.3
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
|++.+.||+|++|.||+|.+..++ +.+++|.+...... .......+...+....|++++.+.+... .++..+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTG-----EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-HKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCC-----cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-cCCCEE
Confidence 567889999999999999987766 77888877643222 1122222334445556888888877654 357899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+++||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||||+||+++++
T Consensus 75 ~v~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~ 134 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQ-------------------RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE 134 (283)
T ss_pred EEEeccCC-CHHHHHHhhc-------------------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC
Confidence 99999985 8888876642 245778899999999999999999999999999999999988
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||.+........ ......++..|+|||.+.+.. .++.++|+||+|+++|+
T Consensus 135 ~-~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~---------------------~~~~~~Di~slG~~l~~ 191 (283)
T cd05118 135 G-VLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDK---------------------GYSTPVDIWSVGCIFAE 191 (283)
T ss_pred C-cEEEeeeeeeEecCCCcc-cccCccCcccccCcHHHhcCC---------------------CCCchhHHHHHHHHHHH
Confidence 7 999999999977654431 122356788999999764321 35567899999999999
Q ss_pred HHcCCCCCCCCC
Q 015991 379 MVCTVRRLCLHS 390 (397)
Q Consensus 379 lltg~~Pf~~~~ 390 (397)
|++|+.||...+
T Consensus 192 l~tg~~~~~~~~ 203 (283)
T cd05118 192 LLSRRPLFPGKS 203 (283)
T ss_pred HHhCCCCCCCCC
Confidence 999999996544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=233.59 Aligned_cols=200 Identities=23% Similarity=0.294 Sum_probs=153.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+-|...++||+|+||+||+|.+..++ ..+++|++.... ........++...+....|++++.+.+.+. .+.
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~ 94 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTN-----EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-KEH 94 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCC-----cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-eCC
Confidence 34777889999999999999987776 778888875322 112122223445566667899988887654 356
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..|+||||+. +++.+++.... ..+++..+..++.|++.+|.|||+.|++||||||+||++
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~-------------------~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili 154 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHK-------------------KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 154 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE
Confidence 7899999997 57777775432 135678888999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||++..... .....++..|+|||++.... ...++.++|+||||++
T Consensus 155 ~~~~-~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-------------------~~~~~~~sDv~slGvi 209 (313)
T cd06633 155 TEPG-QVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMD-------------------EGQYDGKVDVWSLGIT 209 (313)
T ss_pred CCCC-CEEEeecCCCcccCC-----CCCccccccccChhhccccC-------------------CCCCCchhhHHHHHHH
Confidence 9987 999999999864321 23457889999999764321 1235567899999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|..||...
T Consensus 210 l~el~~g~~p~~~~ 223 (313)
T cd06633 210 CIELAERKPPLFNM 223 (313)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=235.20 Aligned_cols=208 Identities=21% Similarity=0.290 Sum_probs=156.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhc-cCCCceeeeeeccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACAN-CCADFVYGFFENSS 211 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~ 211 (397)
...++|.+.+.+|+|.||.|-++.+..++ ..+|+|.++.-.. ......+.+.+.... ++..+.+.....+.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~-----~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETK-----EHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCC-----ceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 34589999999999999999999998875 6778887764322 111111222222121 23333333333334
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.-.++.|||+|.++ -|+++++..+++ ..+....++.|+.|+++++.+||+.+++|-||||+
T Consensus 161 dyrghiCivfellG-~S~~dFlk~N~y------------------~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPE 221 (415)
T KOG0671|consen 161 DYRGHICIVFELLG-LSTFDFLKENNY------------------IPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPE 221 (415)
T ss_pred hccCceEEEEeccC-hhHHHHhccCCc------------------cccchHHHHHHHHHHHHHHHHHHhcceeecCCChh
Confidence 44678999999887 689999998753 24566789999999999999999999999999999
Q ss_pred ceEEeCC-------------------CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccc
Q 015991 292 NVIFSEG-------------------SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352 (397)
Q Consensus 292 NILl~~~-------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~ 352 (397)
|||+-+. ...++|+|||.|+.-... ..+.+-|..|.|||
T Consensus 222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPE------------------ 279 (415)
T KOG0671|consen 222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPE------------------ 279 (415)
T ss_pred eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCch------------------
Confidence 9998421 127999999999764332 25678899999999
Q ss_pred cchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 015991 353 ALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 353 ~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~~ 393 (397)
++..++|+.+|||||+||+|+|++||..-|..+++-|
T Consensus 280 ----ViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 280 ----VILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ----heeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 5566788999999999999999999999998887543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=234.38 Aligned_cols=201 Identities=21% Similarity=0.275 Sum_probs=153.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..+.|...+.||+|+||.||+|++..++ ..+++|.+... .........++...+....|++++.+.+.+..
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 86 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR- 86 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCC-----cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-
Confidence 3356888899999999999999988766 67888877532 11111122233445566678888888775543
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+...++|+||+. +++.+++.... ..+++..+..++.|++.||.|||+.+++||||||+||
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~-------------------~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 146 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHK-------------------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence 567899999997 57877765432 1356778889999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++.++ .++|+|||++...... ....+++.|+|||.+..... ..++.++||||||
T Consensus 147 l~~~~~-~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~-------------------~~~~~~~Di~slG 201 (308)
T cd06634 147 LLSEPG-LVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDE-------------------GQYDGKVDVWSLG 201 (308)
T ss_pred EECCCC-cEEECCcccceeecCc-----ccccCCccccCHHHHhhccc-------------------CCCCcccchHHHH
Confidence 999987 9999999998765322 33568889999997643211 2345678999999
Q ss_pred HHHHHHHcCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCL 388 (397)
Q Consensus 374 v~l~elltg~~Pf~~ 388 (397)
|++|||++|..||..
T Consensus 202 ~il~el~~g~~p~~~ 216 (308)
T cd06634 202 ITCIELAERKPPLFN 216 (308)
T ss_pred HHHHHHHcCCCCCcc
Confidence 999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=234.05 Aligned_cols=202 Identities=15% Similarity=0.151 Sum_probs=149.5
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+.+++.+|.|+++.||++.. ++ +.+++|++... ........+++...+....|++++.+++.+ ..++..+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~--~~-----~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-~~~~~~~ 75 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP--TN-----TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-IVDSELY 75 (314)
T ss_pred hhhhHhhcCCceEEEEEecC--CC-----CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-ecCCeEE
Confidence 34555566666665555544 44 78899987643 222233334445556666799999887765 3456789
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
++|||+++++|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+||+++.+
T Consensus 76 ~~~e~~~~~~l~~~l~~~~------------------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~ 137 (314)
T cd08216 76 VVSPLMAYGSCEDLLKTHF------------------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD 137 (314)
T ss_pred EEEeccCCCCHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC
Confidence 9999999999999997642 1235677888999999999999999999999999999999988
Q ss_pred CCeEEEEecccccccccccc------cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 299 SRTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
+ .+||+|||.+..+..... .......++..|+|||++.... ..++.++|+|||
T Consensus 138 ~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------------------~~~~~~~Diws~ 196 (314)
T cd08216 138 G-KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL--------------------QGYNEKSDIYSV 196 (314)
T ss_pred C-ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCC--------------------CCCCcchhHHHH
Confidence 7 999999999875532211 1123346778899999775432 135567899999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~ 389 (397)
||++|||++|..||...
T Consensus 197 G~il~el~~g~~pf~~~ 213 (314)
T cd08216 197 GITACELANGHVPFKDM 213 (314)
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=229.15 Aligned_cols=201 Identities=26% Similarity=0.327 Sum_probs=154.1
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
|++.+.||+|+||.||+|....++ +.+++|...... .........+...+....|++++.+.+.... .+..+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTG-----EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCC-----cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceE
Confidence 667889999999999999998876 788888776532 1111111223334445568888887776543 47899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+|+||++ ++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++++
T Consensus 75 ~v~e~~~-~~l~~~i~~~~-------------------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~ 134 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRP-------------------GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD 134 (282)
T ss_pred EEecCcC-cCHHHHHHhhc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC
Confidence 9999998 58999987652 146778899999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .++|+|||.++........ .....++..|+|||.+.... .++.++|+||||+++||
T Consensus 135 ~-~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~Dv~slG~~l~~ 191 (282)
T cd07829 135 G-VLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGSK---------------------HYSTAVDIWSVGCIFAE 191 (282)
T ss_pred C-CEEEecCCcccccCCCccc-cCccccCcCcCChHHhcCCc---------------------CCCccccHHHHHHHHHH
Confidence 7 9999999999766433221 22345678899999765431 24456799999999999
Q ss_pred HHcCCCCCCCCC
Q 015991 379 MVCTVRRLCLHS 390 (397)
Q Consensus 379 lltg~~Pf~~~~ 390 (397)
|++|+.||....
T Consensus 192 l~~~~~~~~~~~ 203 (282)
T cd07829 192 MITGKPLFPGDS 203 (282)
T ss_pred HHhCCCCCCCcc
Confidence 999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=222.48 Aligned_cols=194 Identities=21% Similarity=0.312 Sum_probs=151.4
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEe
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
||+|+||.||++.+..++ +.+++|.+...... .......+...+....|++++.+...+ ..++..+++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG-----KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-QTEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCC-----cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-ecCCeeEEEEec
Confidence 699999999999987765 67888876543211 122223333455566688888877654 346789999999
Q ss_pred cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEE
Q 015991 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFK 303 (397)
Q Consensus 224 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~k 303 (397)
+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++
T Consensus 75 ~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~ 133 (250)
T cd05123 75 APGGELFSHLSKEG--------------------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIK 133 (250)
T ss_pred CCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEE
Confidence 99999999987653 457788899999999999999999999999999999999987 999
Q ss_pred EEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCC
Q 015991 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTV 383 (397)
Q Consensus 304 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~ 383 (397)
|+|||++....... .......++..|++||...... .+.++|+||||+++|||++|.
T Consensus 134 l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~----------------------~~~~~D~~slG~~~~~l~~g~ 190 (250)
T cd05123 134 LTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKG----------------------YGKAVDWWSLGVLLYEMLTGK 190 (250)
T ss_pred EeecCcceecccCC-CcccCCcCCccccChHHhCCCC----------------------CCchhhHHHHHHHHHHHHHCC
Confidence 99999997654332 1234467888999999665432 445679999999999999999
Q ss_pred CCCCCCC
Q 015991 384 RRLCLHS 390 (397)
Q Consensus 384 ~Pf~~~~ 390 (397)
.||....
T Consensus 191 ~p~~~~~ 197 (250)
T cd05123 191 PPFYAED 197 (250)
T ss_pred CCCCCCC
Confidence 9996554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=245.79 Aligned_cols=208 Identities=17% Similarity=0.172 Sum_probs=163.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++.++.++||+|.||.|++|.|...+... ..|+||-+...... ..-.+.++...+....|++++.+++.... .
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~--V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--q 183 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKH--VNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--Q 183 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcE--EeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--c
Confidence 3467788899999999999999998754333 57889988765543 34444556667778889999999987643 5
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
...+|+|.+..|+|.+.++... ...+--.....++.||+.|+.||.++++|||||...|+||
T Consensus 184 p~mMV~ELaplGSLldrLrka~------------------~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll 245 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAK------------------KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL 245 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhcc------------------ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee
Confidence 6789999999999999998722 1233445677899999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccc-c-ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYI-P-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~-~-~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
-... .+||+|||+.+.+..+..+- . ....-...|+|||.+ ..+.++.++|||+||
T Consensus 246 aspr-tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsL----------------------rh~kFShaSDvWmyG 302 (1039)
T KOG0199|consen 246 ASPR-TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESL----------------------RHRKFSHASDVWMYG 302 (1039)
T ss_pred cccc-eeeeecccceeccCCCCcceEecCCCcCcccccCHhHh----------------------ccccccccchhhhhh
Confidence 8865 99999999999887765432 1 123345689999954 445566778999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
|++|||++ |+.||.+.
T Consensus 303 VTiWEMFtyGEePW~G~ 319 (1039)
T KOG0199|consen 303 VTIWEMFTYGEEPWVGC 319 (1039)
T ss_pred hhHHhhhccCCCCCCCC
Confidence 99999986 78898654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=251.19 Aligned_cols=198 Identities=23% Similarity=0.358 Sum_probs=170.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
-..++|++..++|.|.||.||+++++.++ +..++|.++-.....+...+.++.....+.|+||+.+++.. ...+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~-----elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-lr~d 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSG-----ELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-LRRD 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccC-----chhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-hhhc
Confidence 35589999999999999999999999988 66777777766666665666667777889999999999865 5567
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+|++||||++|+|.++.+..+ .+++.++.+++++.++||+|||++|-+|||||-.|||+
T Consensus 86 klwicMEycgggslQdiy~~Tg--------------------plselqiayvcRetl~gl~ylhs~gk~hRdiKGanill 145 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTG--------------------PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL 145 (829)
T ss_pred CcEEEEEecCCCcccceeeecc--------------------cchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence 8999999999999999876554 67899999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++.+ .+|+.|||.+..+...... .+.+.||+.|||||+-. +-..+.|..+||+|++|+.
T Consensus 146 td~g-DvklaDfgvsaqitati~K-rksfiGtpywmapEvaa-------------------verkggynqlcdiwa~git 204 (829)
T KOG0576|consen 146 TDEG-DVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVAA-------------------VERKGGYNQLCDIWALGIT 204 (829)
T ss_pred cccC-ceeecccCchhhhhhhhhh-hhcccCCccccchhHHH-------------------HHhcccccccccccccccc
Confidence 9998 9999999999876544433 46799999999999764 5666789999999999999
Q ss_pred HHHHH
Q 015991 376 FLQMV 380 (397)
Q Consensus 376 l~ell 380 (397)
..|+-
T Consensus 205 Aiel~ 209 (829)
T KOG0576|consen 205 AIELG 209 (829)
T ss_pred hhhhh
Confidence 99985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=265.23 Aligned_cols=188 Identities=16% Similarity=0.226 Sum_probs=147.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+.|...+.||+|+||.||+|++..++ ..+++|++......+. .+...+...+|++++.+++.+.. ++..+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~----~~~~~l~~l~HpnIv~~~~~~~~-~~~~~ 759 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNG-----MQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCRS-EKGAY 759 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCC-----cEEEEEEccCCccccH----HHHHHHhhCCCCCcceEEEEEEc-CCCCE
Confidence 45667789999999999999987766 7889998865432221 12344556689999999987754 46789
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH---HCCceecCCCCCceEE
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH---STGIVHRDIKPQNVIF 295 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH---~~giiHrDIKp~NILl 295 (397)
+||||+++++|.++++. +++..+..++.|+++||+||| +.+|+||||||+||++
T Consensus 760 lv~Ey~~~g~L~~~l~~-----------------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~ 816 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----------------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----------------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence 99999999999999853 356778899999999999999 6699999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ ..++. ||.+..... .....+|+.|||||++.+ ..++.|+|||||||+
T Consensus 817 ~~~~-~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~----------------------~~~~~~sDv~S~Gvv 867 (968)
T PLN00113 817 DGKD-EPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRET----------------------KDITEKSDIYGFGLI 867 (968)
T ss_pred CCCC-ceEEE-ecccccccc-----CCCccccccccCcccccC----------------------CCCCcccchhhHHHH
Confidence 9876 66665 666543321 123468899999996543 346677899999999
Q ss_pred HHHHHcCCCCCCC
Q 015991 376 FLQMVCTVRRLCL 388 (397)
Q Consensus 376 l~elltg~~Pf~~ 388 (397)
+|||+||+.||..
T Consensus 868 l~el~tg~~p~~~ 880 (968)
T PLN00113 868 LIELLTGKSPADA 880 (968)
T ss_pred HHHHHhCCCCCCc
Confidence 9999999999854
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=247.64 Aligned_cols=226 Identities=20% Similarity=0.260 Sum_probs=170.3
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCC--CCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeee
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFE 208 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~ 208 (397)
...+..++..+.+.||+|.||.|++|........ .....+++|.++..... ......++........|+|++.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3455556778888999999999999987654332 12467889988754322 2333344455566678999999999
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCc--chhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG--IERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
.+.. +..+++|.||+..|+|.++++..... ..+.. ...... ..++......++.||+.|++||++.++|||
T Consensus 370 ~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~----~~~~~--~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 370 ACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVT----ESIDG--SGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred eecc-CCceEEEEEeccCCcHHHHHHhcccc----ccccc--cCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 8766 67899999999999999999987600 00000 000111 247888999999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEeccccccccccccccccccc--CCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFL--LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
||-.+|||+.++. .+||+|||+|+.......+..+... ....|||||.+ ....|+
T Consensus 443 DLAaRNVLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl----------------------~~~~ft 499 (609)
T KOG0200|consen 443 DLAARNVLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL----------------------FDRVFT 499 (609)
T ss_pred hhhhhhEEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHh----------------------ccCccc
Confidence 9999999999986 9999999999977666666533333 34579999944 445677
Q ss_pred CchhhHHHHHHHHHHHc-CCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVC-TVRRLCL 388 (397)
Q Consensus 365 ~k~Dv~SlGv~l~ellt-g~~Pf~~ 388 (397)
.|+||||||++||||++ |..||..
T Consensus 500 ~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 500 SKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred ccchhhHHHHHHHHHhhCCCCCCCC
Confidence 78899999999999986 7788865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=211.95 Aligned_cols=201 Identities=26% Similarity=0.323 Sum_probs=156.4
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
|.+.+.||.|++|.||++.+..++ +.+++|........ ......++........|+++..+++... ..+..++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG-----ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-DPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC-----cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-cCCceEE
Confidence 567899999999999999998765 78888988754432 2222333344445557888888777653 3467899
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
++||+.+++|.+++..... .+++..+..++.+++.+|.+||+.+++|+||+|.||+++.++
T Consensus 75 v~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~ 135 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGG-------------------KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG 135 (225)
T ss_pred EEeccCCCCHHHHHHhccc-------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 9999999999999876531 156778889999999999999999999999999999999986
Q ss_pred CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 300 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.++|+|||.+...............++..|++||.+. . ...++.++|+||||++++||
T Consensus 136 -~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~--------------------~~~~~~~~Dv~~lG~~~~~l 193 (225)
T smart00221 136 -LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL-G--------------------GKGYGEAVDIWSLGVILYEL 193 (225)
T ss_pred -CEEEeeCceeeEecCcccccccceeccCCcCCHhHhc-C--------------------CCCCCchhhHHHHHHHHHHH
Confidence 9999999999876543211223456788999999764 1 11344577999999999999
Q ss_pred HcCCCCCCC
Q 015991 380 VCTVRRLCL 388 (397)
Q Consensus 380 ltg~~Pf~~ 388 (397)
++|+.||..
T Consensus 194 ~~g~~pf~~ 202 (225)
T smart00221 194 LWGPEPFSG 202 (225)
T ss_pred HHCCCCccc
Confidence 999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-28 Score=215.50 Aligned_cols=203 Identities=20% Similarity=0.291 Sum_probs=158.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+.|.|.+.||+|.||.+-+++++.++ ..+++|.+.........+..+...-.....|.+|+.-++..+...+.+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~-----t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSK-----TRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCc-----eEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 78999999999999999999999987 8899998876554444444444455566678888887777777778999
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe-C
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-E 297 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~-~ 297 (397)
+++||++.|+|.+-+...+ +-+...++++.|++.||+|||+.++||||||.+||||- .
T Consensus 99 F~qE~aP~gdL~snv~~~G---------------------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~ 157 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG---------------------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA 157 (378)
T ss_pred EeeccCccchhhhhcCccc---------------------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC
Confidence 9999999999988766543 44666788999999999999999999999999999984 4
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
+...+||||||+.+.......+ ..-+-.|.+||......... ...+..+|+|.||+++|
T Consensus 158 df~rvKlcDFG~t~k~g~tV~~----~~~~~~y~~pe~~~~~~ne~-----------------~~~~ps~D~WqfGIi~f 216 (378)
T KOG1345|consen 158 DFYRVKLCDFGLTRKVGTTVKY----LEYVNNYHAPELCDTVVNEK-----------------LVVNPSTDIWQFGIIFF 216 (378)
T ss_pred CccEEEeeecccccccCceehh----hhhhcccCCcHHHhhccccc-----------------eEecccccchheeeeee
Confidence 4559999999999765432222 23355799999776543221 11223459999999999
Q ss_pred HHHcCCCCCCC
Q 015991 378 QMVCTVRRLCL 388 (397)
Q Consensus 378 elltg~~Pf~~ 388 (397)
.++||+.||..
T Consensus 217 ~cltG~~PWQk 227 (378)
T KOG1345|consen 217 YCLTGKFPWQK 227 (378)
T ss_pred eeecCCCcchh
Confidence 99999999953
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=225.48 Aligned_cols=209 Identities=17% Similarity=0.256 Sum_probs=158.0
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH--HHHHHHHHHhhccC---CCceeeeee
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACANCC---ADFVYGFFE 208 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~--~~~~~~~~~~~~~~---~~~i~~~~~ 208 (397)
+....++|.+....|+|-|++|.+|.+...+ ..||||++....-+.. ..+.++...+.... .-+.+.++.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~-----~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARG-----QEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCC-----CeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3445589999999999999999999988776 6899999876543321 11112222221111 112334444
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+.. .+++|||+|-+. .+|.++++..+ ....+....+..++.|+..||..|...||+|.||
T Consensus 502 ~F~h-knHLClVFE~Ls-lNLRevLKKyG-----------------~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDI 562 (752)
T KOG0670|consen 502 HFKH-KNHLCLVFEPLS-LNLREVLKKYG-----------------RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADI 562 (752)
T ss_pred Hhhh-cceeEEEehhhh-chHHHHHHHhC-----------------cccceeehHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence 4433 579999999887 68999998775 4446677789999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+|||+++....+||||||.|.....+. + +...-+..|.|||++.|..+ +.-.|
T Consensus 563 KPDNiLVNE~k~iLKLCDfGSA~~~~ene--i-tPYLVSRFYRaPEIiLG~~y----------------------d~~iD 617 (752)
T KOG0670|consen 563 KPDNILVNESKNILKLCDFGSASFASENE--I-TPYLVSRFYRAPEIILGLPY----------------------DYPID 617 (752)
T ss_pred CccceEeccCcceeeeccCcccccccccc--c-cHHHHHHhccCcceeecCcc----------------------cCCcc
Confidence 99999999988899999999997654332 2 33455678999997766554 44569
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~~ 391 (397)
+||+||+||||.||+.-|++.++
T Consensus 618 ~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 618 TWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ceeeceeeEEeeccceecCCCCc
Confidence 99999999999999999998665
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=213.11 Aligned_cols=137 Identities=24% Similarity=0.364 Sum_probs=102.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch------hHHHHHHHHHHHHh-hccCCCceeeee
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVEIWMNERVRRAC-ANCCADFVYGFF 207 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~e~~~~~~~~~~~-~~~~~~~i~~~~ 207 (397)
.+..++|.+.++||.|.|++||+|.+.... +-||+|..+... ..|+.....+...- .+.....++.++
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~-----r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNK-----RYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCC-----eEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 344489999999999999999999998886 788888876433 22222222222211 122334577777
Q ss_pred ecccc---cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCc
Q 015991 208 ENSSK---KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGI 283 (397)
Q Consensus 208 ~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~gi 283 (397)
+.+.. .+.++|+|+|+++ .+|..+++...+. .++...++.|++||+.||+|||. .||
T Consensus 149 D~FkhsGpNG~HVCMVfEvLG-dnLLklI~~s~Yr------------------Glpl~~VK~I~~qvL~GLdYLH~ecgI 209 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVLG-DNLLKLIKYSNYR------------------GLPLSCVKEICRQVLTGLDYLHRECGI 209 (590)
T ss_pred ccceecCCCCcEEEEEehhhh-hHHHHHHHHhCCC------------------CCcHHHHHHHHHHHHHHHHHHHHhcCc
Confidence 76654 4579999999998 5788888776532 45667899999999999999996 599
Q ss_pred eecCCCCCceEE
Q 015991 284 VHRDIKPQNVIF 295 (397)
Q Consensus 284 iHrDIKp~NILl 295 (397)
||-||||+|||+
T Consensus 210 IHTDlKPENvLl 221 (590)
T KOG1290|consen 210 IHTDLKPENVLL 221 (590)
T ss_pred cccCCCcceeee
Confidence 999999999997
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=202.58 Aligned_cols=187 Identities=25% Similarity=0.329 Sum_probs=147.4
Q ss_pred CceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEecCCCCH
Q 015991 151 AFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATL 229 (397)
Q Consensus 151 ~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL 229 (397)
+||.||+|.+..++ ..+++|........+ .....++........|+++..+.+.... ....++++||+++++|
T Consensus 1 ~~g~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTG-----KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCC-----cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCH
Confidence 68999999998765 788899887544322 2222233344445588888887776543 4688999999999999
Q ss_pred HHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEeccc
Q 015991 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309 (397)
Q Consensus 230 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGl 309 (397)
.+++.... .+++..+..++.+++.+|.|||+.+++|+||+|+||++++++ .++|+|||.
T Consensus 75 ~~~~~~~~--------------------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~ 133 (244)
T smart00220 75 FDLLKKRG--------------------RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGL 133 (244)
T ss_pred HHHHHhcc--------------------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccc
Confidence 99987643 256788899999999999999999999999999999999986 999999999
Q ss_pred ccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 015991 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 310 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
+....... ......++..|++||.+.. ..++.++|+||+|+++++|++|..||..
T Consensus 134 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~----------------------~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 134 ARQLDPGG--LLTTFVGTPEYMAPEVLLG----------------------KGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred eeeecccc--ccccccCCcCCCCHHHHcc----------------------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 98765432 2244668889999996642 3455678999999999999999999966
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=231.06 Aligned_cols=207 Identities=16% Similarity=0.138 Sum_probs=158.6
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
..+..++||.|+||+||+|.+.-.++.+. ..|++|.+.+.... ......++...+....|+|++.+++.+.... +-
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vK-ipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVK-IPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceec-ceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HH
Confidence 45556799999999999999877754443 46778877654322 2222223445567788999999998776543 78
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
||++|++.|+|.++++.++. .+-.+..+.|+.||++|+.|||+++++||||-.+|||+..-
T Consensus 774 lvtq~mP~G~LlDyvr~hr~-------------------~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP 834 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD-------------------NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP 834 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc-------------------cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC
Confidence 99999999999999988653 33345677899999999999999999999999999999987
Q ss_pred CCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
. ++||.|||+|+.+..+... ......-.+.|||-|.+....+ +-++|||||||++|
T Consensus 835 ~-hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~----------------------thqSDVWsfGVtiW 891 (1177)
T KOG1025|consen 835 N-HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKY----------------------THQSDVWSFGVTIW 891 (1177)
T ss_pred C-eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCC----------------------CchhhhhhhhhhHH
Confidence 6 9999999999988665443 2333344567999996655544 44569999999999
Q ss_pred HHHc-CCCCCCCCCC
Q 015991 378 QMVC-TVRRLCLHSC 391 (397)
Q Consensus 378 ellt-g~~Pf~~~~~ 391 (397)
|++| |..|+.+-..
T Consensus 892 ElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 892 ELMTFGAKPYDGIPA 906 (1177)
T ss_pred HHHhcCCCccCCCCH
Confidence 9986 8889876543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=208.85 Aligned_cols=198 Identities=23% Similarity=0.327 Sum_probs=157.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
.+|.-.+.+|.|.- .|--+.+.-.. ..+++|++...... ......++.......+|+|+++++..+....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~-----~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLG-----RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhcc-----CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 67888899999998 77778777666 77888887643211 1222334556667788999999988776544
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 215 ---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 215 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
...++|||++. .+|.+.+.- .++-+.+.++..|++.|++|||+.||+||||||+
T Consensus 91 ~~~~e~y~v~e~m~-~nl~~vi~~----------------------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPs 147 (369)
T KOG0665|consen 91 EEFQEVYLVMELMD-ANLCQVILM----------------------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPS 147 (369)
T ss_pred HHHHhHHHHHHhhh-hHHHHHHHH----------------------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcc
Confidence 46899999998 588887762 3466789999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++..+. .+||.|||+|+.-.. ....+..+.|..|.|||++.+- +|.+.+||||
T Consensus 148 nivv~~~~-~lKi~dfg~ar~e~~--~~~mtpyVvtRyyrapevil~~----------------------~~ke~vdiwS 202 (369)
T KOG0665|consen 148 NIVVNSDC-TLKILDFGLARTEDT--DFMMTPYVVTRYYRAPEVILGM----------------------GYKENVDIWS 202 (369)
T ss_pred cceecchh-heeeccchhhcccCc--ccccCchhheeeccCchheecc----------------------CCcccchhhh
Confidence 99999987 999999999986433 2556778899999999966543 4566789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
+||++.||++|..-|.+..
T Consensus 203 vGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 203 VGCIMGELILGTVLFPGKD 221 (369)
T ss_pred hhhHHHHHhhceEEecCch
Confidence 9999999999999887653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=231.34 Aligned_cols=199 Identities=23% Similarity=0.273 Sum_probs=151.7
Q ss_pred eEEeeeeccCCceE-EEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 141 FVLGKKLGEGAFGV-VYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 141 f~i~~~LG~G~fG~-Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
|.-.+.+|.|+-|+ ||+|...+ +.||+|++-..... ....++........|+|++.+++.- .++..+||
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~-------R~VAVKrll~e~~~--~A~rEi~lL~eSD~H~NviRyyc~E-~d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEG-------REVAVKRLLEEFFD--FAQREIQLLQESDEHPNVIRYYCSE-QDRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCC-------ceehHHHHhhHhHH--HHHHHHHHHHhccCCCceEEEEeec-cCCceEEE
Confidence 44456789999976 89998876 78999988643322 1222334455567899999999865 44568999
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC--
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE-- 297 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~-- 297 (397)
..|.|. .+|.++++....... .... ...+.++.|++.||++||+.+||||||||+||||+.
T Consensus 581 alELC~-~sL~dlie~~~~d~~-------------~~~~---i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGLDVE-------------MQSD---IDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred EehHhh-hhHHHHHhccccchh-------------hccc---ccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 999998 699999987411100 0001 224568899999999999999999999999999986
Q ss_pred -CC-CeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 298 -GS-RTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 298 -~~-~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
++ ..++|+|||+++.+..+.... ..+..||-+|+|||++.....+.. +||||+|
T Consensus 644 ~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~a----------------------vDiFslG 701 (903)
T KOG1027|consen 644 ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQA----------------------VDIFSLG 701 (903)
T ss_pred CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcc----------------------cchhhcC
Confidence 23 489999999999987765432 346789999999999987766543 5999999
Q ss_pred HHHHHHHcC-CCCCCC
Q 015991 374 LIFLQMVCT-VRRLCL 388 (397)
Q Consensus 374 v~l~elltg-~~Pf~~ 388 (397)
|++|+.++| .+||..
T Consensus 702 CvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 702 CVFYYVLTGGSHPFGD 717 (903)
T ss_pred ceEEEEecCCccCCCc
Confidence 999999988 899954
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=208.22 Aligned_cols=206 Identities=23% Similarity=0.274 Sum_probs=149.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhc-cCCCceeeeeecccccCC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACAN-CCADFVYGFFENSSKKGG 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 215 (397)
+|.+.++||+|+||.||++.+..++ ...+|+|........ ....+..+...+.. .....+..+.......+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 8999999999999999999987764 246666665542211 22222223333221 111233344443323456
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..|+||+.++ .+|.++..... ...++...+.+++.|++.+|++||+.|+|||||||+|+++
T Consensus 95 ~~~iVM~l~G-~sL~dl~~~~~------------------~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~ 155 (322)
T KOG1164|consen 95 FNFIVMSLLG-PSLEDLRKRNP------------------PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVV 155 (322)
T ss_pred eeEEEEeccC-ccHHHHHHhCC------------------CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeee
Confidence 7899999877 79999876542 3467888899999999999999999999999999999999
Q ss_pred eCCC----CeEEEEeccccc--ccccccc-----cc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC
Q 015991 296 SEGS----RTFKIIDLGAAA--DLRVGIN-----YI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362 (397)
Q Consensus 296 ~~~~----~~~kL~DFGla~--~~~~~~~-----~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
.... ..+.|.|||+|+ ......+ .+ ...+.||.+|++++.+.+..+...+
T Consensus 156 g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~D----------------- 218 (322)
T KOG1164|consen 156 GQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRD----------------- 218 (322)
T ss_pred cCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCch-----------------
Confidence 8653 479999999998 4322221 11 1235699999999988777766555
Q ss_pred CCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 363 LPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 363 ~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|+||++.++.|+..|..||....
T Consensus 219 -----Dles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 219 -----DLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred -----hhhhHHHHHHHHhcCCCCCcccc
Confidence 99999999999999999996544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=209.59 Aligned_cols=169 Identities=21% Similarity=0.213 Sum_probs=120.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-----hhHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-----GAVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
..++|++.+.||+|+||+||+|++..+.. ..+++|+.... .........++...+....|++++..+...
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPG----TARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCC----eEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 44789999999999999999998875321 44688875422 111222344556666667777776433222
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC-CC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI-KP 290 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI-Kp 290 (397)
+..++||||+.+++|... .... ...++.|++++|.|||++||+|||| ||
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~~~--------------------------~~~~~~~i~~aL~~lH~~gIiHrDL~KP 140 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RPHG--------------------------DPAWFRSAHRALRDLHRAGITHNDLAKP 140 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cccc--------------------------hHHHHHHHHHHHHHHHHCCCeeCCCCCc
Confidence 357999999999999632 1100 1357889999999999999999999 99
Q ss_pred CceEEeCCCCeEEEEecccccccccccc-cc------cccccCCCCCCCcccccccCC
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGIN-YI------PKEFLLDPRYAAPEQYIMSTQ 341 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~-~~------~~~~~gt~~Y~aPE~~~~~~~ 341 (397)
+|||++.++ .+||+|||+|+.+..... .. -....+++.|++||.+.....
T Consensus 141 ~NILv~~~~-~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~ 197 (365)
T PRK09188 141 QNWLMGPDG-EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRER 197 (365)
T ss_pred ceEEEcCCC-CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhh
Confidence 999998876 899999999986644321 11 134678889999998765443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=202.59 Aligned_cols=222 Identities=17% Similarity=0.216 Sum_probs=170.3
Q ss_pred HHhhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeee
Q 015991 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFE 208 (397)
Q Consensus 130 ~~~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~ 208 (397)
+...-++..+++++...+-+|.||.||+|.+.+.......+.+-+|.++... ..+..+...+...+-...|+|+....+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 4444456668899999999999999999988876555555677777776533 333333334444555667999999998
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+..+....++++.+++-|+|..++...+.. +-.....++..++..++.|++.|++|||++||||.||
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~------------~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDi 422 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGD------------DPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDI 422 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccC------------CCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchh
Confidence 8888888899999999999999999843210 1112346677888999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
..+|++||+.- .+||+|=.+++++-+.+.+. .........||+||.+... .|+..+
T Consensus 423 AaRNCvIdd~L-qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~----------------------~yssas 479 (563)
T KOG1024|consen 423 AARNCVIDDQL-QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS----------------------HYSSAS 479 (563)
T ss_pred hhhcceehhhe-eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh----------------------hhcchh
Confidence 99999999985 99999999999886554332 2233445689999966554 455566
Q ss_pred hhHHHHHHHHHHHc-CCCCC
Q 015991 368 DIYSAGLIFLQMVC-TVRRL 386 (397)
Q Consensus 368 Dv~SlGv~l~ellt-g~~Pf 386 (397)
|+|||||+||||+| |+.|+
T Consensus 480 DvWsfGVllWELmtlg~~Py 499 (563)
T KOG1024|consen 480 DVWSFGVLLWELMTLGKLPY 499 (563)
T ss_pred hhHHHHHHHHHHHhcCCCCc
Confidence 99999999999986 77776
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=208.69 Aligned_cols=205 Identities=24% Similarity=0.327 Sum_probs=152.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..+.|.+.++||+|.|++||++.+... ....+.+++|.+...........| +.-.....-+.|++++.+.. ..+++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts~p~ri~~E-l~~L~~~gG~~ni~~~~~~~-rnnd~ 109 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTSSPSRILNE-LEMLYRLGGSDNIIKLNGCF-RNNDQ 109 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeecccccCchHHHHH-HHHHHHhccchhhhcchhhh-ccCCe
Confidence 347899999999999999999998772 112278999988765443332222 22222233456677766654 55688
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
..+|+||++..+..++...- +-..++.+++.++.||.++|.+|||||||||.|+|.+
T Consensus 110 v~ivlp~~~H~~f~~l~~~l-----------------------~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n 166 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRSL-----------------------SLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN 166 (418)
T ss_pred eEEEecccCccCHHHHHhcC-----------------------CHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc
Confidence 99999999999998888754 3466888999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccc---------------------------------cccc----------cccccCCCCCCCc
Q 015991 297 EGSRTFKIIDLGAAADLRVG---------------------------------INYI----------PKEFLLDPRYAAP 333 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~---------------------------------~~~~----------~~~~~gt~~Y~aP 333 (397)
.....-.|+|||+|...+.. .++. .-...||++|.||
T Consensus 167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP 246 (418)
T KOG1167|consen 167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP 246 (418)
T ss_pred cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence 87778999999999721100 0000 0124799999999
Q ss_pred ccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 334 EQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 334 E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
|++...... +.++||||.||+++-+++++.||.-.
T Consensus 247 EvL~k~~~Q---------------------ttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 247 EVLFRCPRQ---------------------TTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred HHHhhccCc---------------------CCccceeeccceeehhhccccccccC
Confidence 987654322 33579999999999999999999643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=190.11 Aligned_cols=201 Identities=21% Similarity=0.293 Sum_probs=157.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHH-HHHHHhh-ccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRACA-NCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~-~~~~~~~-~~~~~~i~~~~~~~~~~~~~ 216 (397)
-+|+++++||+|+||+.++|++.-++ ..||||......+......| +.-+.+. ....|+++-| + ..+.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nn-----e~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYF-G---qeG~~ 98 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNN-----EPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYF-G---QEGKY 98 (449)
T ss_pred ccceeccccccCcceeeecccccccC-----ceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeee-c---cccch
Confidence 48999999999999999999988776 88999987765555444443 2223332 3344554433 2 33566
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
-.||+|.++ .+|+|++.-.+ .+++.+.+..++.|++.-++|+|++..|.|||||+|.||.
T Consensus 99 NiLVidLLG-PSLEDLFD~Cg-------------------R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG 158 (449)
T KOG1165|consen 99 NILVIDLLG-PSLEDLFDLCG-------------------RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG 158 (449)
T ss_pred hhhhhhhhC-cCHHHHHHHhc-------------------CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence 789999887 79999876443 3667788999999999999999999999999999999995
Q ss_pred C----CCCeEEEEecccccccccccccc------cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 297 E----GSRTFKIIDLGAAADLRVGINYI------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 297 ~----~~~~~kL~DFGla~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
. +...+.|+|||+|+...+..... .+...||.+||+-..+.+..++..+
T Consensus 159 rp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRD--------------------- 217 (449)
T KOG1165|consen 159 RPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRD--------------------- 217 (449)
T ss_pred CCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhh---------------------
Confidence 3 22389999999999887654321 3467899999999988888877665
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|+-|||-+++..+-|..||-+-.
T Consensus 218 -DLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 218 -DLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred -hHHHhhhhhhhhccCCCcccccc
Confidence 99999999999999999997643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=179.70 Aligned_cols=185 Identities=26% Similarity=0.391 Sum_probs=141.2
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEecC
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEG 225 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~ 225 (397)
||+|++|.||++.+..++ +.+++|........ ......++...+....|+++..+...... ....++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG-----KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCC-----cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCC
Confidence 689999999999998755 78899988765442 11122223334444556788887776544 368899999999
Q ss_pred CCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC-CCCeEEE
Q 015991 226 EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE-GSRTFKI 304 (397)
Q Consensus 226 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~-~~~~~kL 304 (397)
+++|.+++.... ..+++..+..++.+++++|.+||+.|++|+||+|.||+++. ++ .++|
T Consensus 75 ~~~l~~~~~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l 134 (215)
T cd00180 75 GGSLKDLLKENE-------------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKL 134 (215)
T ss_pred CCcHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEE
Confidence 999999987642 13567888899999999999999999999999999999998 65 9999
Q ss_pred EecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 305 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
+|||.+........ ......+...|++||...... ..+.+.|+|++|+++++|
T Consensus 135 ~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~---------------------~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 135 ADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKG---------------------YYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ecCCceEEccCCcc-hhhcccCCCCccChhHhcccC---------------------CCCchhhhHHHHHHHHHH
Confidence 99999976543321 123356778999999765440 234567999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=184.03 Aligned_cols=203 Identities=19% Similarity=0.251 Sum_probs=154.7
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHH-HHHHHhhc-cCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRACAN-CCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~-~~~~~~~~-~~~~~i~~~~~~~~~~ 213 (397)
+..++|.+.++||.|+||.+|+|.....+ ..||+|..+..........| ++-+.+.. .-.|.+..+ ..+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~g-----e~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y----~~e 82 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSG-----EEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHY----GTE 82 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCC-----ceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhh----ccc
Confidence 45689999999999999999999998887 88999987765544333333 33333333 233444333 234
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+..-.+||+.++ .||.+++.-.. ..++...+..++.|++.-++|+|.+++|||||||+|.
T Consensus 83 ~~ynvlVMdLLG-PsLEdLfnfC~-------------------R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 83 KDYNVLVMDLLG-PSLEDLFNFCS-------------------RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred cccceeeeeccC-ccHHHHHHHHh-------------------hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 567789999887 79999875332 2567778889999999999999999999999999999
Q ss_pred EEeCC--CCeEEEEeccccccccccccc-----c-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC
Q 015991 294 IFSEG--SRTFKIIDLGAAADLRVGINY-----I-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365 (397)
Q Consensus 294 Ll~~~--~~~~kL~DFGla~~~~~~~~~-----~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (397)
|..-+ ...+.++|||+|+...+.... + .....||.+|++-..+.+..++..+
T Consensus 143 LMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRD-------------------- 202 (341)
T KOG1163|consen 143 LMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRD-------------------- 202 (341)
T ss_pred eeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhh--------------------
Confidence 98532 237999999999877553221 1 2346899999999988777766555
Q ss_pred chhhHHHHHHHHHHHcCCCCCCCC
Q 015991 366 RFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 366 k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
|+-|+|.+|....-|..||.+-
T Consensus 203 --DmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 203 --DMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred --hhhhhcceeeeeecCCCccccc
Confidence 9999999999999999999653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=223.53 Aligned_cols=131 Identities=16% Similarity=0.205 Sum_probs=98.0
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
..++.++|+++ ++|.+++.... ..+++..++.++.||++||+|||++|||||||||+|||
T Consensus 53 ~~~~~~~e~~~-~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 53 DSIVRALECED-VSLRQWLDNPD-------------------RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred chhhhhhccCC-ccHHHHHhccc-------------------ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 45777888875 69999996432 24678889999999999999999999999999999999
Q ss_pred EeCCC------------------CeEEEEecccccccccccc---------------cccccccCCCCCCCcccccccCC
Q 015991 295 FSEGS------------------RTFKIIDLGAAADLRVGIN---------------YIPKEFLLDPRYAAPEQYIMSTQ 341 (397)
Q Consensus 295 l~~~~------------------~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~Y~aPE~~~~~~~ 341 (397)
|+..+ ..+||+|||+++....... ......+||+.|||||++.+
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--- 189 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG--- 189 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc---
Confidence 96432 2566667776653211000 00112468999999996544
Q ss_pred CCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCC
Q 015991 342 TPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~ 387 (397)
..|+.++|||||||+||||++|..|+.
T Consensus 190 -------------------~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 190 -------------------SSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred -------------------CCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 345667899999999999999998875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-21 Score=179.09 Aligned_cols=205 Identities=26% Similarity=0.341 Sum_probs=152.3
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCC-ceeeeeecccccCCe
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCAD-FVYGFFENSSKKGGE 216 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~-~i~~~~~~~~~~~~~ 216 (397)
|.+.+.||.|+||.||++.+. ..+++|.+....... .....++........++ ++..+.... .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~ 72 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-QDEGS 72 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-ecCCE
Confidence 788999999999999999887 456667665432221 22222233344444455 577776666 33455
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.+++++++.++++.+++...... ..+.......++.|++.+++|+|+.+++|||+||+||+++
T Consensus 73 ~~~~~~~~~~~~l~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~ 135 (384)
T COG0515 73 LYLVMEYVDGGSLEDLLKKIGRK-----------------GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD 135 (384)
T ss_pred EEEEEecCCCCcHHHHHHhcccc-----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec
Confidence 89999999999999777654311 2456778889999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccc-----ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINY-----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
..+..++++|||.++.+...... ......||..|++||.+.+.. ...++...|+||
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~-------------------~~~~~~~~D~~s 196 (384)
T COG0515 136 RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS-------------------LAYASSSSDIWS 196 (384)
T ss_pred CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC-------------------CCCCCchHhHHH
Confidence 87546999999999865443322 235678999999999776532 012334569999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
+|++++++++|..||....
T Consensus 197 ~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 197 LGITLYELLTGLPPFEGEK 215 (384)
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999977655
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=174.43 Aligned_cols=173 Identities=14% Similarity=0.106 Sum_probs=118.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHH---------HHHHHHHhhccCCCceeee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWM---------NERVRRACANCCADFVYGF 206 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~---------~~~~~~~~~~~~~~~i~~~ 206 (397)
+..++|++.+.||.|+||.||+... . + +.+++|...+........ .+++...+....|+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~-~-----~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-D-Y-----GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-C-C-----CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 3458999999999999999999755 2 2 679999886432211111 3444444444455555544
Q ss_pred eeccccc-------CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH
Q 015991 207 FENSSKK-------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH 279 (397)
Q Consensus 207 ~~~~~~~-------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH 279 (397)
....... ....+++|||++|.+|.++... ++ ....+++.+|..+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~------------------------~~----~~~~~i~~~l~~lH 152 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEI------------------------SE----DVKAKIKASIESLH 152 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhhc------------------------cH----HHHHHHHHHHHHHH
Confidence 3332211 2468999999999999776311 11 24569999999999
Q ss_pred HCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhh
Q 015991 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (397)
+.|++|||+||+||++++++ ++|+|||..+........ +. +..
T Consensus 153 ~~gi~H~Dikp~Nili~~~g--i~liDfg~~~~~~e~~a~--------------d~---------------------~vl 195 (232)
T PRK10359 153 QHGMVSGDPHKGNFIVSKNG--LRIIDLSGKRCTAQRKAK--------------DR---------------------IDL 195 (232)
T ss_pred HcCCccCCCChHHEEEeCCC--EEEEECCCcccccchhhH--------------HH---------------------HHH
Confidence 99999999999999999875 999999988654221110 10 233
Q ss_pred ccCCCCchhhHHHHHHHHHHH
Q 015991 360 QLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 360 ~~~~~~k~Dv~SlGv~l~ell 380 (397)
+..|+.+.|+||||+++..+.
T Consensus 196 er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 196 ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HhHhcccccccceeEeehHHH
Confidence 334556789999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=167.28 Aligned_cols=107 Identities=24% Similarity=0.277 Sum_probs=88.6
Q ss_pred CCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEe
Q 015991 227 ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306 (397)
Q Consensus 227 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~D 306 (397)
|+|.+++...+ ..+++..++.++.|++.||+|||+++ ||+|||++.++ .+|+
T Consensus 1 GsL~~~l~~~~-------------------~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~-- 52 (176)
T smart00750 1 VSLADILEVRG-------------------RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL-- 52 (176)
T ss_pred CcHHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--
Confidence 57888887543 24788999999999999999999999 99999999987 8888
Q ss_pred cccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCC
Q 015991 307 LGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRL 386 (397)
Q Consensus 307 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf 386 (397)
||+++..... ...||+.|||||++.+. .++.++|||||||++|||++|+.||
T Consensus 53 fG~~~~~~~~------~~~g~~~y~aPE~~~~~----------------------~~~~~~DiwSlG~il~elltg~~p~ 104 (176)
T smart00750 53 DGSVAFKTPE------QSRVDPYFMAPEVIQGQ----------------------SYTEKADIYSLGITLYEALDYELPY 104 (176)
T ss_pred ccceEeeccc------cCCCcccccChHHhcCC----------------------CCcchhhHHHHHHHHHHHHhCCCCc
Confidence 9999765432 22688999999966543 4556789999999999999999999
Q ss_pred CCC
Q 015991 387 CLH 389 (397)
Q Consensus 387 ~~~ 389 (397)
...
T Consensus 105 ~~~ 107 (176)
T smart00750 105 NEE 107 (176)
T ss_pred ccc
Confidence 653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=169.23 Aligned_cols=134 Identities=15% Similarity=0.174 Sum_probs=92.5
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---H------------------------HHHH--HHHHHHH
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---V------------------------EIWM--NERVRRA 194 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~------------------------e~~~--~~~~~~~ 194 (397)
.+.||+|+||.||+|.+. ++ +.+++|.++.... . +.+. +.+....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g-----~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NG-----EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCccccccceEEEEEECC-CC-----CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999999986 55 7888998764311 0 0000 1111222
Q ss_pred hhcc--CCCceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHH
Q 015991 195 CANC--CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272 (397)
Q Consensus 195 ~~~~--~~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~ 272 (397)
+... .+|.++ . ....++||||++++++........ .+++..+..++.|++
T Consensus 76 l~~~~v~~p~~~---~-----~~~~~iVmE~i~g~~l~~~~~~~~--------------------~~~~~~~~~i~~qi~ 127 (190)
T cd05147 76 LVTAGIPCPEPI---L-----LKSHVLVMEFIGDDGWAAPRLKDA--------------------PLSESKARELYLQVI 127 (190)
T ss_pred HHHCCCCCCcEE---E-----ecCCEEEEEEeCCCCCcchhhhcC--------------------CCCHHHHHHHHHHHH
Confidence 2211 122222 1 122389999999887655432211 356778899999999
Q ss_pred HHHHHh-HHCCceecCCCCCceEEeCCCCeEEEEeccccccc
Q 015991 273 FALDGL-HSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 273 ~~L~yL-H~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~ 313 (397)
.+|+|+ |+.||+||||||+|||+++ + .++|+|||+|...
T Consensus 128 ~~L~~l~H~~giiHrDlkP~NIli~~-~-~v~LiDFG~a~~~ 167 (190)
T cd05147 128 QIMRILYQDCRLVHADLSEYNLLYHD-G-KLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHHhCCcccCCCCHHHEEEEC-C-cEEEEEccccccC
Confidence 999999 7999999999999999985 4 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=165.37 Aligned_cols=187 Identities=15% Similarity=0.106 Sum_probs=125.7
Q ss_pred EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH----HHHHHHHHHHhhcc-CCCceeeeeecccccCCe
Q 015991 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE----IWMNERVRRACANC-CADFVYGFFENSSKKGGE 216 (397)
Q Consensus 142 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e----~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~ 216 (397)
.+...|++|+||+||.+...+ .+++.+.+....... .+..+++...+... +++++..++.. +.
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~-------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~ 72 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGE-------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DG 72 (218)
T ss_pred ccceeecCCCcceEEEeecCC-------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cC
Confidence 356799999999999776532 566666665443311 12233344444443 23444444443 34
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC-CCCceEE
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI-KPQNVIF 295 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI-Kp~NILl 295 (397)
.+++|||+.|.+|.+..... ...++.|++.+|+++|++||+|||| ||+|||+
T Consensus 73 ~~lvmeyI~G~~L~~~~~~~---------------------------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv 125 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPRG---------------------------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV 125 (218)
T ss_pred EEEEEeeecCccHHhhhhhh---------------------------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE
Confidence 68999999999886543211 1246789999999999999999999 7999999
Q ss_pred eCCCCeEEEEeccccccccccccc------------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY------------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
+.++ .++|+|||+|......... ...-...++.|++|+......... +
T Consensus 126 ~~~g-~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~-------------------~ 185 (218)
T PRK12274 126 QEDG-SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTS-------------------W 185 (218)
T ss_pred cCCC-CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccch-------------------h
Confidence 9877 8999999999754332210 011124678889998665432211 1
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
.+.++++-|..+|.++|+..++-.
T Consensus 186 -~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 186 -IRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred -HHHHHHHhcchHHHHHhccCCccc
Confidence 235899999999999999988644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=196.38 Aligned_cols=200 Identities=20% Similarity=0.258 Sum_probs=154.0
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|.|.+.||+|+||.||+|...+ + +.+|+|.-+.....|+....++...+...-.+-+..+.... .-.+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~-----~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~-~~~~ 767 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-G-----KLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAH-VFQN 767 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-C-----cEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHH-ccCC
Confidence 344789999999999999999999887 4 89999999988888877666665555521112222222111 2235
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.-+||+||.+-|||.++++..+ ..++..++.+..|++.-++.||..+|||+||||+|.||
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~--------------------~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll 827 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNK--------------------VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLL 827 (974)
T ss_pred cceeeeeccccccHHHhhccCC--------------------CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEe
Confidence 5679999999999999998544 45778899999999999999999999999999999999
Q ss_pred eC------CCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 296 SE------GSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 296 ~~------~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
.. +...++|+|||.+.++..-. ...-+...+|-.+-.+|+.. ...|++.+|
T Consensus 828 ~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~----------------------grpWtYq~D 885 (974)
T KOG1166|consen 828 RREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE----------------------GRPWTYQID 885 (974)
T ss_pred ecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc----------------------CCCCchhhh
Confidence 52 22479999999997664311 12234567888999999554 456888899
Q ss_pred hHHHHHHHHHHHcCCC
Q 015991 369 IYSAGLIFLQMVCTVR 384 (397)
Q Consensus 369 v~SlGv~l~elltg~~ 384 (397)
.|.+..+++-|++|+.
T Consensus 886 yfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 886 YFGLAATVHVMLFGKY 901 (974)
T ss_pred hHHHHHHHHHHHHHHH
Confidence 9999999999999974
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.3e-20 Score=162.24 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=92.9
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-----H---------------------HHHHHHHHHHhhc
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----E---------------------IWMNERVRRACAN 197 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----e---------------------~~~~~~~~~~~~~ 197 (397)
.+.||+|+||+||+|++. ++ +.+++|........ + ....+.+...+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g-----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DG-----EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CceeecCCCcEEEEEEcC-CC-----CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999999976 55 78888887643110 0 0000111222222
Q ss_pred cCCCceeeeeecccccCCeEEEEEEecCCCCHHHH-HHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHH
Q 015991 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADL-MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD 276 (397)
Q Consensus 198 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~ 276 (397)
..++++........ ...++||||++++++... +... .++......++.|++.+|.
T Consensus 76 l~~~~i~~p~~~~~---~~~~lVmE~~~g~~~~~~~l~~~---------------------~~~~~~~~~i~~~l~~~l~ 131 (190)
T cd05145 76 LYEAGVPVPEPILL---KKNVLVMEFIGDDGSPAPRLKDV---------------------PLEEEEAEELYEQVVEQMR 131 (190)
T ss_pred HHhCCCCCceEEEe---cCCEEEEEEecCCCchhhhhhhc---------------------cCCHHHHHHHHHHHHHHHH
Confidence 22232211111010 124899999998855333 3221 3456678899999999999
Q ss_pred HhHH-CCceecCCCCCceEEeCCCCeEEEEecccccccc
Q 015991 277 GLHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (397)
Q Consensus 277 yLH~-~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~ 314 (397)
++|+ .||+||||||+|||++ ++ .++|+|||+|+.+.
T Consensus 132 ~lH~~~givHrDlkP~NIll~-~~-~~~liDFG~a~~~~ 168 (190)
T cd05145 132 RLYQEAGLVHGDLSEYNILYH-DG-KPYIIDVSQAVELD 168 (190)
T ss_pred HHHHhCCEecCCCChhhEEEE-CC-CEEEEEcccceecC
Confidence 9999 9999999999999999 55 89999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-21 Score=195.57 Aligned_cols=205 Identities=23% Similarity=0.269 Sum_probs=149.1
Q ss_pred EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHH---HHhhccCCCceeeeeecccccCCeEE
Q 015991 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR---RACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 142 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~---~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
...+.+|.|.+|.|+.............+.+.++ .. ..+.+......+. -.-....|++++..+...... ....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-~~~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-DGIL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-ccch
Confidence 3567899999998888877766655554555543 21 2222222222121 122335677766555444332 2333
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
..||||+. +|+.++.+.. .+....+..++.|++.|++|||+.||.|||+|++|+++..+
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~--------------------~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~ 456 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNG--------------------KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN 456 (601)
T ss_pred hhhhcccH-HHHHHHhccc--------------------ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC
Confidence 44999998 9999988753 23445577899999999999999999999999999999999
Q ss_pred CCeEEEEecccccccccccc---cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+ .+||+|||.+..+.-+.. ......+|+..|+|||++.+..+.+.. .||||.|++
T Consensus 457 g-~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~---------------------vDiwS~~ii 514 (601)
T KOG0590|consen 457 G-ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRA---------------------VDVWSCGII 514 (601)
T ss_pred C-ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcch---------------------hhhhhccce
Confidence 8 999999999976654332 345678999999999988888777654 599999999
Q ss_pred HHHHHcCCCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 376 l~elltg~~Pf~~~~~~ 392 (397)
+..|++|+.||......
T Consensus 515 ~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 515 YICMILGRFPWKVAKKS 531 (601)
T ss_pred EEEEecCCCcccccccc
Confidence 99999999999765443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-20 Score=183.79 Aligned_cols=188 Identities=20% Similarity=0.209 Sum_probs=137.6
Q ss_pred eeccCCceEEEEEEecCCCCCCCCCceEEeecccc----hhHHHHHHHHHHHHhhcc-CCCceeeeeecccccCCeEEEE
Q 015991 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY----GAVEIWMNERVRRACANC-CADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----~~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~lv 220 (397)
++|+|.||.|++++-.... .+...++.|..+.. +... ....+...+... ++++++.+...+.. +...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~--da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGA--DAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccc--cccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecc-ccchhHh
Confidence 4799999999987533211 11133444433221 1111 111222333333 38888887776654 4568899
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCC
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~ 300 (397)
.+|..+|.|...+.... .+++.....+...++-+++.+|+.+|+|||+|++||+++.+|
T Consensus 76 ld~~rgg~lft~l~~~~--------------------~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G- 134 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV--------------------MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG- 134 (612)
T ss_pred hhhcccchhhhccccCC--------------------chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-
Confidence 99999999888776554 567777888999999999999999999999999999999998
Q ss_pred eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 301 TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 301 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
++++.|||+++..-.... .+||..|||||+..+.. ...|+||||++++||+
T Consensus 135 hi~~tdfglske~v~~~~-----~cgt~eymApEI~~gh~------------------------~a~D~ws~gvl~fell 185 (612)
T KOG0603|consen 135 HIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIINGHL------------------------SAADWWSFGVLAFELL 185 (612)
T ss_pred ccccCCchhhhHhHhhhh-----cccchhhhhhHhhhccC------------------------CcccchhhhhhHHHHh
Confidence 999999999987643322 28999999999887221 2349999999999999
Q ss_pred cCCCCCCC
Q 015991 381 CTVRRLCL 388 (397)
Q Consensus 381 tg~~Pf~~ 388 (397)
||..||..
T Consensus 186 tg~~pf~~ 193 (612)
T KOG0603|consen 186 TGTLPFGG 193 (612)
T ss_pred hCCCCCch
Confidence 99999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=160.94 Aligned_cols=212 Identities=17% Similarity=0.218 Sum_probs=124.7
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHh-hc---c----CC-Ccee
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRAC-AN---C----CA-DFVY 204 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~-~~---~----~~-~~i~ 204 (397)
..+..++.||.|+|+.||++++..++ ..+++|...... ..+...++.+.... .. . .| ..++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~-----~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETG-----EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred eEEEEccccccCCceEEEEEEEccCC-----ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 35677899999999999999999998 777777654221 22233333221111 00 0 01 1111
Q ss_pred ee-----------eecccccCC-----eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHH
Q 015991 205 GF-----------FENSSKKGG-----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIM 268 (397)
Q Consensus 205 ~~-----------~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~ 268 (397)
.+ +... .+.. ..+++|+-+. ++|.+++..-... . .....+.......+.
T Consensus 87 P~d~~~i~~~~~~~~~~-~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~-----------~--~~~~~l~~~arl~lT 151 (288)
T PF14531_consen 87 PLDLLRIPGKPPFFERG-PGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSR-----------A--QTHSPLAFAARLSLT 151 (288)
T ss_dssp -SEEEEETTS-SEEEEC-ETTEEEEEESEEEEEE--S-EEHHHHHHHHHHH-----------T--TTSHHHHHHHHHHHH
T ss_pred eeEEEEEcCCCcceecC-CCCccceeehhhhccchhh-hcHHHHHHHHhhc-----------c--cccchhHHHHHHHHH
Confidence 11 1100 1111 2366777664 6887776532100 0 001223334455677
Q ss_pred HHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCc
Q 015991 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSA 348 (397)
Q Consensus 269 ~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 348 (397)
.|+++.+++||+.|++|+||||+|++++.+| .++|+||+...... ..... ...+..|.+||..........
T Consensus 152 ~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v~Lg~F~~~~r~g--~~~~~--~~~~~~~~PPe~~~~~~~~~~---- 222 (288)
T PF14531_consen 152 VQMIRLVANLHSYGLVHGDIKPENFLLDQDG-GVFLGDFSSLVRAG--TRYRC--SEFPVAFTPPELESCAGQFGQ---- 222 (288)
T ss_dssp HHHHHHHHHHHHTTEEEST-SGGGEEE-TTS--EEE--GGGEEETT--EEEEG--GGS-TTTS-HHHHHHHTSCHH----
T ss_pred HHHHHHHHHHhhcceEecccceeeEEEcCCC-CEEEcChHHHeecC--ceeec--cCCCcccCChhhhhhhcccCc----
Confidence 9999999999999999999999999999998 99999999876432 22221 344578999996644322100
Q ss_pred cccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 349 PVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 349 ~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
....++.+.|.|++|+++|.|.|++.||...
T Consensus 223 ----------~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 223 ----------NNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp ----------SEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred ----------ccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 2345677889999999999999999999865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=154.06 Aligned_cols=139 Identities=19% Similarity=0.163 Sum_probs=93.7
Q ss_pred EeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhcc-----CCCceeeeeecccccC--C
Q 015991 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-----CADFVYGFFENSSKKG--G 215 (397)
Q Consensus 143 i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~-----~~~~i~~~~~~~~~~~--~ 215 (397)
-.+.||+|+||.||. +..+. ..++|+.............++...+... .|+||+.+++...++. +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~------~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDA------QRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred CcceecCCCceEEEE--CCCCc------CeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 357899999999995 44432 2357766543111111122223333322 5899999988776653 2
Q ss_pred e-EEEEEEecC--CCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHH-HHhHHCCceecCCCCC
Q 015991 216 E-YWLIWRYEG--EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFAL-DGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 216 ~-~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L-~yLH~~giiHrDIKp~ 291 (397)
. +++|+||++ ++||.+++.+.. +++. ..++.|++.++ +|||+++||||||||+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~~---------------------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~ 134 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQCR---------------------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQ 134 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHccc---------------------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 3 458899944 899999997642 2333 25678888888 9999999999999999
Q ss_pred ceEEeCC---CCeEEEEecccccc
Q 015991 292 NVIFSEG---SRTFKIIDLGAAAD 312 (397)
Q Consensus 292 NILl~~~---~~~~kL~DFGla~~ 312 (397)
|||++.+ ...++|+||+.++.
T Consensus 135 NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred HEEEeccCCCCCcEEEEECCCCcc
Confidence 9999743 23799999444433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.3e-18 Score=154.27 Aligned_cols=143 Identities=17% Similarity=0.151 Sum_probs=96.6
Q ss_pred CeEEeeeeccCCceEEEEEE-ecCCCCCCCCCceEEeecccchh----------------------HH--HHHHHHHHHH
Q 015991 140 DFVLGKKLGEGAFGVVYRAS-LAKKPSSKNDGDLVLKKATEYGA----------------------VE--IWMNERVRRA 194 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~-~~~~~~~~~~~~vavK~~~~~~~----------------------~e--~~~~~~~~~~ 194 (397)
.|++.+.||+|+||.||+|. +..++ ..+++|....... .+ ....+.+...
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSG-----KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCC-----cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 58899999999999999998 44455 7788887753210 00 0011111121
Q ss_pred hhccC--CCceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHH
Q 015991 195 CANCC--ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272 (397)
Q Consensus 195 ~~~~~--~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~ 272 (397)
+.... ...+...+.. ...++||||+++.+|........ ..+...+..++.|++
T Consensus 104 L~~L~~~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~~~~--------------------~~~~~~~~~i~~qi~ 158 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRLKDV--------------------EPEEEEEFELYDDIL 158 (237)
T ss_pred HHHHHhcCCCCCeeeEe-----cCceEEEEEecCCcccccccccC--------------------CcchHHHHHHHHHHH
Confidence 11111 1112222321 23589999999988765432211 234455678999999
Q ss_pred HHHHHhHHCC-ceecCCCCCceEEeCCCCeEEEEecccccccc
Q 015991 273 FALDGLHSTG-IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (397)
Q Consensus 273 ~~L~yLH~~g-iiHrDIKp~NILl~~~~~~~kL~DFGla~~~~ 314 (397)
.+|.+||+.| |+||||||+||+++ ++ .++|+|||.|....
T Consensus 159 ~~l~~LH~~g~iiH~Dikp~NIli~-~~-~i~LiDFg~a~~~~ 199 (237)
T smart00090 159 EEMRKLYKEGELVHGDLSEYNILVH-DG-KVVIIDVSQSVELD 199 (237)
T ss_pred HHHHHHHhcCCEEeCCCChhhEEEE-CC-CEEEEEChhhhccC
Confidence 9999999999 99999999999999 55 89999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=179.72 Aligned_cols=169 Identities=22% Similarity=0.367 Sum_probs=120.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
.+|..++.|..|+||.||..+++.+. ..+++ ++.+....- .|+..+-+. .+
T Consensus 83 ~df~~IklisngAygavylvrh~~tr-----qrfa~-kiNkq~lil----------------Rnilt~a~n-------pf 133 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETR-----QRFAM-KINKQNLIL----------------RNILTFAGN-------PF 133 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccc-----cchhh-cccccchhh----------------hccccccCC-------cc
Confidence 79999999999999999999998876 66666 443221110 012222221 22
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
.| |+-..+++..+ .+. .+++.+++|||+.||+|||+||+|.||+.-
T Consensus 134 vv------gDc~tllk~~g--------------------~lP--------vdmvla~Eylh~ygivhrdlkpdnllIT~m 179 (1205)
T KOG0606|consen 134 VV------GDCATLLKNIG--------------------PLP--------VDMVLAVEYLHSYGIVHRDLKPDNLLITSM 179 (1205)
T ss_pred ee------chhhhhcccCC--------------------CCc--------chhhHHhHhhccCCeecCCCCCCcceeeec
Confidence 22 44444444332 111 133889999999999999999999999998
Q ss_pred CCeEEEEecccccccccc--------------cccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 299 SRTFKIIDLGAAADLRVG--------------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~--------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
| ++|++|||+.+..... .....+..+|||.|.|||+ +...+|.
T Consensus 180 G-hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV----------------------ilrqgyg 236 (1205)
T KOG0606|consen 180 G-HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV----------------------ILRQGYG 236 (1205)
T ss_pred c-cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh----------------------hhhhccC
Confidence 7 9999999998644221 0112345699999999994 4445566
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~~~~~~ 393 (397)
.-+|+|++|+++||.+.|..||.+....|
T Consensus 237 kpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 237 KPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred CCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 66799999999999999999999885544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=155.65 Aligned_cols=217 Identities=20% Similarity=0.292 Sum_probs=140.9
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCC-----------------------CCC-------CceEEeecccc---
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSS-----------------------KND-------GDLVLKKATEY--- 180 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~-----------------------~~~-------~~vavK~~~~~--- 180 (397)
..+..++|+|++.||+|-...||.|+..+++.. ... -..++|.+...
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 456779999999999999999999987653210 001 12344444321
Q ss_pred hhHHHH---HHHHHH---------------------HHhhccCCCceeeeeecccc------------------------
Q 015991 181 GAVEIW---MNERVR---------------------RACANCCADFVYGFFENSSK------------------------ 212 (397)
Q Consensus 181 ~~~e~~---~~~~~~---------------------~~~~~~~~~~i~~~~~~~~~------------------------ 212 (397)
...+.. +..++. ...+...||||+.++..+..
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 111110 111100 01223679999888766543
Q ss_pred --cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 213 --KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 213 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
+...+|+||.-.. .||.+++..+. ++.....-++.|+++|+.|||++||.|||+|.
T Consensus 312 ~g~~~tlylvMkrY~-~tLr~yl~~~~---------------------~s~r~~~~~laQlLEav~hL~~hgvAhRDlKS 369 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYR-QTLREYLWTRH---------------------RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKS 369 (598)
T ss_pred cCCCceEEEehhcch-hhHHHHHhcCC---------------------CchHHHHHHHHHHHHHHHHHHHccchhhcccc
Confidence 2346777877666 47777776553 45556677999999999999999999999999
Q ss_pred CceEEeCCC---CeEEEEecccccccccc---ccccc--ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC
Q 015991 291 QNVIFSEGS---RTFKIIDLGAAADLRVG---INYIP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362 (397)
Q Consensus 291 ~NILl~~~~---~~~kL~DFGla~~~~~~---~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
+|||+.-++ ..+.|+|||++-.-+.- -.+.+ -..-|...-||||+...-...... .+
T Consensus 370 DNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av---------------vn 434 (598)
T KOG4158|consen 370 DNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV---------------VN 434 (598)
T ss_pred cceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee---------------ec
Confidence 999995332 37899999987421110 01111 124567789999976432221110 11
Q ss_pred CCCchhhHHHHHHHHHHHcCCCCCCC
Q 015991 363 LPDRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 363 ~~~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
..|+|.|+.|.+.||++....||-.
T Consensus 435 -y~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 435 -YEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred -cchhhhhhhhhhHHHHhccCCcccc
Confidence 2478999999999999999999965
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.7e-17 Score=144.17 Aligned_cols=137 Identities=16% Similarity=0.132 Sum_probs=93.5
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--H--------------------HHHHHHHHHHhhc
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--E--------------------IWMNERVRRACAN 197 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e--------------------~~~~~~~~~~~~~ 197 (397)
.|.+.+.||+|+||.||++... ++ +.+++|........ + ......+...+..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DG-----NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CC-----CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3788899999999999999875 33 78888875432100 0 0001111111221
Q ss_pred cCCC--ceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHH
Q 015991 198 CCAD--FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFAL 275 (397)
Q Consensus 198 ~~~~--~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L 275 (397)
..+. .+...+. ....+++|||+++++|..+... .....++.+++.++
T Consensus 90 l~~~~i~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~--------------------------~~~~~~~~~i~~~l 138 (198)
T cd05144 90 LYEEGFPVPKPID-----WNRHAVVMEYIDGVELYRVRVL--------------------------EDPEEVLDEILEEI 138 (198)
T ss_pred HHHcCCCCCceee-----cCCceEEEEEeCCcchhhcccc--------------------------ccHHHHHHHHHHHH
Confidence 2222 1222222 2345899999999988664321 12346888999999
Q ss_pred HHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccc
Q 015991 276 DGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (397)
Q Consensus 276 ~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~ 314 (397)
.++|+.||+||||||+||++++++ .++|+|||.+..+.
T Consensus 139 ~~lh~~gi~H~Dl~p~Nill~~~~-~~~liDfg~~~~~~ 176 (198)
T cd05144 139 VKAYKHGIIHGDLSEFNILVDDDE-KIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHCCCCcCCCCcccEEEcCCC-cEEEEECCccccCC
Confidence 999999999999999999999876 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-18 Score=166.51 Aligned_cols=124 Identities=27% Similarity=0.412 Sum_probs=105.4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
..+++.|++|...+|.+++.+.. .+...++..++.++.|++.+++| +|.+|||+||.||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-----------------~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif 388 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-----------------TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIF 388 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-----------------cccccchhHHHHHHHhhccchhh---ccchhhhccccccc
Confidence 36899999999999999998654 34456777889999999999999 99999999999999
Q ss_pred EeCCCCeEEEEeccccccccccc-----ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGI-----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+..+. .+||.|||+........ ....+...||..||+||++.+.. |++|+||
T Consensus 389 ~~~d~-q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~----------------------y~~kvdI 445 (516)
T KOG1033|consen 389 FSDDD-QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ----------------------YSEKVDI 445 (516)
T ss_pred cccch-hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhh----------------------hhhhcch
Confidence 99887 99999999997765544 22345679999999999887664 5677899
Q ss_pred HHHHHHHHHHHc
Q 015991 370 YSAGLIFLQMVC 381 (397)
Q Consensus 370 ~SlGv~l~ellt 381 (397)
||||++|+|+++
T Consensus 446 yaLGlil~EL~~ 457 (516)
T KOG1033|consen 446 YALGLILAELLI 457 (516)
T ss_pred hhHHHHHHHHHH
Confidence 999999999997
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.3e-16 Score=140.83 Aligned_cols=134 Identities=22% Similarity=0.200 Sum_probs=91.0
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccch----hH----HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AV----EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~----e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
+.||+|++|.||+|.+.+ ..+++|+..... .. ......++...+....++++....... .....
T Consensus 2 ~~l~~G~~~~vy~~~~~~-------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~-~~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG-------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYF-VDPEN 73 (211)
T ss_pred cccccCceEEEEEEeeCC-------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEE-EeCCC
Confidence 579999999999998733 556777543211 00 111111222222222233222111111 12345
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.+++|||++|++|.+++.... . ....++.+++.+|.++|+.|++|||++|+|||++
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~-----------------------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNG-----------------------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS 129 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhcc-----------------------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE
Confidence 789999999999999886532 1 5668899999999999999999999999999999
Q ss_pred CCCCeEEEEecccccc
Q 015991 297 EGSRTFKIIDLGAAAD 312 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~ 312 (397)
++ .++|+|||.++.
T Consensus 130 -~~-~~~liDf~~a~~ 143 (211)
T PRK14879 130 -GG-KIYLIDFGLAEF 143 (211)
T ss_pred -CC-CEEEEECCcccC
Confidence 44 899999999875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=161.17 Aligned_cols=142 Identities=17% Similarity=0.146 Sum_probs=93.4
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.|...+.||+|+||+||+|.+.... ...+....|...... ........++...+....++++........ ....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~ 410 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV-DPEE 410 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE-eCCC
Confidence 4566889999999999999876532 101111111111111 011122223344444445555443322221 2345
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++.. ...++.|++++|.+||+.|++||||||+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~~----------------------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~ 462 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLEG----------------------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR 462 (535)
T ss_pred CEEEEEecCCCcHHHHHHH----------------------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE
Confidence 7899999999999887752 246889999999999999999999999999994
Q ss_pred CCCCeEEEEecccccccc
Q 015991 297 EGSRTFKIIDLGAAADLR 314 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~ 314 (397)
++ .++|+|||+++...
T Consensus 463 -~~-~~~liDFGla~~~~ 478 (535)
T PRK09605 463 -DD-RLYLIDFGLGKYSD 478 (535)
T ss_pred -CC-cEEEEeCcccccCC
Confidence 44 89999999997643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.6e-16 Score=137.61 Aligned_cols=129 Identities=16% Similarity=0.227 Sum_probs=86.6
Q ss_pred eeccCCceEEEEEEecCCCCCCCCCceEEeecccch----hHH----HHHHHHHHHHhhccCCCc--eeeeeecccccCC
Q 015991 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AVE----IWMNERVRRACANCCADF--VYGFFENSSKKGG 215 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~e----~~~~~~~~~~~~~~~~~~--i~~~~~~~~~~~~ 215 (397)
.||+|+||.||+|.+.+ ..+++|...... ..+ .....++...+....+.+ +...+.. ..+
T Consensus 1 ~ig~G~~~~vy~~~~~~-------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~---~~~ 70 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG-------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV---DPD 70 (199)
T ss_pred CCCCCceEEEEEeecCC-------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE---ECC
Confidence 38999999999998543 567777643211 111 111111222222222221 1112211 234
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+++|||++|++|.+++.... . .++.|++.+|.+||+.|++|+|+||+||++
T Consensus 71 ~~~lv~e~~~g~~l~~~~~~~~--------------------------~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~ 123 (199)
T TIGR03724 71 NKTIVMEYIEGKPLKDVIEEGN--------------------------D-ELLREIGRLVGKLHKAGIVHGDLTTSNIIV 123 (199)
T ss_pred CCEEEEEEECCccHHHHHhhcH--------------------------H-HHHHHHHHHHHHHHHCCeecCCCCcceEEE
Confidence 5689999999999998875432 0 688999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccc
Q 015991 296 SEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~ 313 (397)
+ ++ .++++|||++...
T Consensus 124 ~-~~-~~~liDfg~a~~~ 139 (199)
T TIGR03724 124 R-DD-KLYLIDFGLGKYS 139 (199)
T ss_pred E-CC-cEEEEECCCCcCC
Confidence 9 44 8999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3e-16 Score=138.38 Aligned_cols=136 Identities=18% Similarity=0.180 Sum_probs=86.4
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH----HHHH--------------------HHHHHHHhhccC
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV----EIWM--------------------NERVRRACANCC 199 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----e~~~--------------------~~~~~~~~~~~~ 199 (397)
.+.||+|+||+||+|.+. ++ ..+++|........ .... .+.+...+....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~-----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DG-----EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CcccccccceeEEEEECC-CC-----CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 578999999999999876 33 67889876542211 0000 000011110000
Q ss_pred CC--ceeeeeecccccCCeEEEEEEecCCCCHHH-HHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHH
Q 015991 200 AD--FVYGFFENSSKKGGEYWLIWRYEGEATLAD-LMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD 276 (397)
Q Consensus 200 ~~--~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~ 276 (397)
+. .+...+.. ...+++|||++++++.. .+.... .. ..+..++.+++.++.
T Consensus 76 ~~~~~~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~---------------------~~-~~~~~~~~~~~~~l~ 128 (187)
T cd05119 76 EAGVPVPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR---------------------LL-EDPEELYDQILELMR 128 (187)
T ss_pred HcCCCCCceEec-----CCCEEEEEEeCCCCccChhhhhhh---------------------hc-ccHHHHHHHHHHHHH
Confidence 00 11112211 23589999999855321 111100 00 346689999999999
Q ss_pred HhHH-CCceecCCCCCceEEeCCCCeEEEEecccccccc
Q 015991 277 GLHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (397)
Q Consensus 277 yLH~-~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~ 314 (397)
++|. .||+||||||+||+++ ++ .++|+|||.+....
T Consensus 129 ~lh~~~~ivH~Dl~p~Nili~-~~-~~~liDfg~a~~~~ 165 (187)
T cd05119 129 KLYREAGLVHGDLSEYNILVD-DG-KVYIIDVPQAVEID 165 (187)
T ss_pred HHhhccCcCcCCCChhhEEEE-CC-cEEEEECccccccc
Confidence 9999 9999999999999999 55 99999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=133.43 Aligned_cols=71 Identities=14% Similarity=0.220 Sum_probs=58.7
Q ss_pred EEEEEEecCC-CCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 217 YWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 217 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.++|+|++++ .+|.+++.... +++. .+.|++.+|.+||+.||+||||||+|||+
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~~~---------------------l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv 175 (239)
T PRK01723 121 ADILIERIEGARDLVALLQEAP---------------------LSEE----QWQAIGQLIARFHDAGVYHADLNAHNILL 175 (239)
T ss_pred eeEEEEecCCCCCHHHHHhcCC---------------------CCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEE
Confidence 3599999997 68988876432 1222 35689999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccc
Q 015991 296 SEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~ 313 (397)
+.++ .++|+|||.++..
T Consensus 176 ~~~~-~v~LIDfg~~~~~ 192 (239)
T PRK01723 176 DPDG-KFWLIDFDRGELR 192 (239)
T ss_pred cCCC-CEEEEECCCcccC
Confidence 9876 8999999998753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-15 Score=135.10 Aligned_cols=204 Identities=14% Similarity=0.090 Sum_probs=141.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeeccc--chhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATE--YGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~--~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+..++..+.-+|.+...|+.|+|++.+. .+++|.+.- ....-.....++.-.+....|||++..++.+...
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn-------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN-------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc-------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 4445667778899999999999999874 344454431 1111111222233455667799999998877543
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--ceecCCCCC
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKPQ 291 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiHrDIKp~ 291 (397)
.++.++..||+.|+|+.++++.. +...+..++.+++.++++|+.|||+.. |----+...
T Consensus 260 -pnlv~isq~mp~gslynvlhe~t------------------~vvvd~sqav~faldiargmaflhslep~ipr~~lns~ 320 (448)
T KOG0195|consen 260 -PNLVIISQYMPFGSLYNVLHEQT------------------SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSK 320 (448)
T ss_pred -CCceEeeeeccchHHHHHHhcCc------------------cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccc
Confidence 67889999999999999998763 335577888999999999999999873 333357888
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
.+++|++- +++|.- +-++. .+......-.|.||+||.+........ -+.+|+||
T Consensus 321 hvmidedl-tarism-ad~kf-----sfqe~gr~y~pawmspealqrkped~n-------------------~raadmws 374 (448)
T KOG0195|consen 321 HVMIDEDL-TARISM-ADTKF-----SFQEVGRAYSPAWMSPEALQRKPEDLN-------------------IRAADMWS 374 (448)
T ss_pred eEEecchh-hhheec-cccee-----eeeccccccCcccCCHHHHhcCchhcc-------------------hhhhhHHH
Confidence 89999875 666541 11110 112233455789999997765443211 13579999
Q ss_pred HHHHHHHHHcCCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~~ 391 (397)
|.+++|||.|.+.||..-.+
T Consensus 375 faillwel~trevpfadlsp 394 (448)
T KOG0195|consen 375 FAILLWELNTREVPFADLSP 394 (448)
T ss_pred HHHHHHHhhccccccccCCc
Confidence 99999999999999965443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-15 Score=158.01 Aligned_cols=206 Identities=22% Similarity=0.207 Sum_probs=136.2
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch----hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
++...+.||.+.|=.|.+|++.+ +.+++|..-... -.++....+.++ .....+||.+.|.....+ +.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-------G~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t-~k 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-------GLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT-DK 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-------ceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh-hH
Confidence 78889999999999999998876 446666553322 222222222222 455567777766554322 33
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
-.|+|-+|... +|+|.+..+.| +....-+.|+.|++.||.-+|..||+|+|||.+||||
T Consensus 95 AAylvRqyvkh-nLyDRlSTRPF--------------------L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTRPF--------------------LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccchH--------------------HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 45566666663 77777766553 3444455699999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccc-c-----cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC-CCCchh
Q 015991 296 SEGSRTFKIIDLGAAADLRVGI-N-----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN-LPDRFD 368 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~-~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~k~D 368 (397)
+.-. =+.|+||..-+..--.. + +.-.+......|.|||.+........ ..++-. ++.+-|
T Consensus 154 TSWN-W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~------------~~q~~~~L~paMD 220 (1431)
T KOG1240|consen 154 TSWN-WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTS------------VGQDAPLLTPAMD 220 (1431)
T ss_pred eeec-hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccc------------cCCcccccChhhh
Confidence 9865 68899998664331111 1 11111222236999998876442111 222222 566779
Q ss_pred hHHHHHHHHHHHc-CCCCCCC
Q 015991 369 IYSAGLIFLQMVC-TVRRLCL 388 (397)
Q Consensus 369 v~SlGv~l~ellt-g~~Pf~~ 388 (397)
|||+||+++||++ |++||..
T Consensus 221 IFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 221 IFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hhhhhHHHHHHHhcCCCcccH
Confidence 9999999999977 5777753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.2e-14 Score=141.27 Aligned_cols=161 Identities=20% Similarity=0.261 Sum_probs=123.9
Q ss_pred ccCCCceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHH
Q 015991 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD 276 (397)
Q Consensus 197 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~ 276 (397)
...|.|+..|.+.+... ...++|++||..|+|.|.+..... .+++.....++++++.||.
T Consensus 3 ~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~~-------------------~~d~~F~~s~~rdi~~Gl~ 62 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNEDI-------------------KLDYFFILSFIRDISKGLA 62 (484)
T ss_pred ccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcccc-------------------CccHHHHHHHHHHHHHHHH
Confidence 45688888888877655 789999999999999999987542 4566778889999999999
Q ss_pred HhHHCCc-eecCCCCCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccc
Q 015991 277 GLHSTGI-VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (397)
Q Consensus 277 yLH~~gi-iHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~ 354 (397)
|||.-.| .|+-++..|+++|... .+||+|||+.......... ......-..-|.|||.+.........
T Consensus 63 ylh~s~i~~hg~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~--------- 132 (484)
T KOG1023|consen 63 YLHNSPIGYHGALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLE--------- 132 (484)
T ss_pred HHhcCcceeeeeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccc---------
Confidence 9998765 9999999999999986 9999999998765421110 01112234579999998876433211
Q ss_pred hhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 015991 355 SPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 355 ~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~~ 393 (397)
...+.+.|+||||++++|+++...||+.....+
T Consensus 133 ------~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~ 165 (484)
T KOG1023|consen 133 ------SALTQKGDIYSFGIIMYEILFRSGPFDLRNLVE 165 (484)
T ss_pred ------ccccccCCeehHHHHHHHHHhccCccccccccC
Confidence 124567899999999999999999998755443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.4e-13 Score=114.34 Aligned_cols=133 Identities=23% Similarity=0.220 Sum_probs=92.9
Q ss_pred EeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEE
Q 015991 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (397)
Q Consensus 143 i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~ 221 (397)
+.+.||+|.++.||++...+ +.+++|....... .....+......+.+. ...+..++... ..++..++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~-~~~~p~~~~~~-~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREKGADREREVAILQLLARK-GLPVPKVLASG-ESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC-------CeEEEEecCCCCchhHHHHHHHHHHHHHHc-CCCCCeEEEEc-CCCCccEEEE
Confidence 45789999999999998754 5678887765432 2222223333333332 12333333332 2236789999
Q ss_pred EecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC---CceecCCCCCceEEeCC
Q 015991 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST---GIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~---giiHrDIKp~NILl~~~ 298 (397)
||+++.++..+ +......++.+++++|.+||.. +++|+|+||+||++++.
T Consensus 73 e~~~g~~~~~~---------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 73 EWIEGETLDEV---------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred EecCCeecccC---------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 99998766543 1233456788999999999985 79999999999999986
Q ss_pred CCeEEEEecccccc
Q 015991 299 SRTFKIIDLGAAAD 312 (397)
Q Consensus 299 ~~~~kL~DFGla~~ 312 (397)
+ .++++|||.++.
T Consensus 126 ~-~~~l~Df~~~~~ 138 (155)
T cd05120 126 K-ILGIIDWEYAGY 138 (155)
T ss_pred c-EEEEEecccccC
Confidence 5 999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.5e-15 Score=153.00 Aligned_cols=208 Identities=23% Similarity=0.299 Sum_probs=147.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..|.+.+.||+|+|+.|-......... ..++.|.+......+ .....+.........|.+++.+++... ...
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~----~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-~~~ 94 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPE----SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-SPR 94 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCc----ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-CCc
Confidence 578888889999999998887644431 445555554332111 111111111122223888988888653 346
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH-HCCceecCCCCCceE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH-STGIVHRDIKPQNVI 294 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH-~~giiHrDIKp~NIL 294 (397)
..+++.+|..++++++.+.... ....+......++.|+..++.|+| ..++.||||||+|.+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~------------------~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPD------------------STGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred ccccccCcccccccccccccCC------------------ccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 7899999999999988873111 012233445679999999999999 999999999999999
Q ss_pred EeCCCCeEEEEeccccccccc--ccccccccccC-CCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRV--GINYIPKEFLL-DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~--~~~~~~~~~~g-t~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
++..+..+++.|||+|..+.. +........+| ++.|+|||.+.+..+.. ...|+||
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~---------------------~~~d~~S 215 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRG---------------------PSVDVWS 215 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcC---------------------CCccccc
Confidence 998754899999999987765 33333445678 99999999887743222 2359999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
+|+++.-|++|..||....
T Consensus 216 ~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 216 LGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred ccccccccccCCCCccccc
Confidence 9999999999999996543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-12 Score=130.55 Aligned_cols=77 Identities=19% Similarity=0.263 Sum_probs=59.1
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHH-HHHHhHHCCceecCCCCCceE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLF-ALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~-~L~yLH~~giiHrDIKp~NIL 294 (397)
..+|||||++|++|.++....... . ....++.+++. .+..+|..|++|+|+||.||+
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~~-------------------~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNil 289 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEAG-------------------L---DRKALAENLARSFLNQVLRDGFFHADLHPGNIF 289 (437)
T ss_pred CceEEEEeECCcccccHHHHHhcC-------------------C---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEE
Confidence 468999999999998876532100 0 12245555555 467889999999999999999
Q ss_pred EeCCCCeEEEEeccccccccc
Q 015991 295 FSEGSRTFKIIDLGAAADLRV 315 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~ 315 (397)
+++++ .++++|||++..+..
T Consensus 290 v~~~g-~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 290 VLKDG-KIIALDFGIVGRLSE 309 (437)
T ss_pred ECCCC-cEEEEeCCCeeECCH
Confidence 99887 999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-11 Score=124.15 Aligned_cols=145 Identities=19% Similarity=0.221 Sum_probs=90.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHH-------------------------------H
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIW-------------------------------M 187 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~-------------------------------~ 187 (397)
.+|+. +.||.|++|+||+|++++++ +.||+|.....-...+. .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G-----~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNG-----REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCC-----CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 56776 79999999999999998755 78999987643111000 0
Q ss_pred HH-------------HHHHHhhcc-CCC--ceeeeeecccccCCeEEEEEEecCCCCHHHHH--HhcCCCcchhhhhccc
Q 015991 188 NE-------------RVRRACANC-CAD--FVYGFFENSSKKGGEYWLIWRYEGEATLADLM--ISREFPYNVQTLILGE 249 (397)
Q Consensus 188 ~~-------------~~~~~~~~~-~~~--~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~ 249 (397)
.+ +..+...+. +.+ .+...+... ....+|||||+.|+++.++- ...+.
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~~~g~----------- 259 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALRAAGT----------- 259 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHHhcCC-----------
Confidence 00 000010110 111 111222221 23457999999999997752 22211
Q ss_pred cccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC---CeEEEEeccccccccc
Q 015991 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS---RTFKIIDLGAAADLRV 315 (397)
Q Consensus 250 ~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~---~~~kL~DFGla~~~~~ 315 (397)
....+.+..+..++.|+. ..|++|+|+||.||+++.++ ..++++|||++..+..
T Consensus 260 -----d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 260 -----DMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----CHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 112344555555666654 58999999999999998764 3899999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=106.73 Aligned_cols=126 Identities=18% Similarity=0.151 Sum_probs=83.6
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhc-cCCCceeeeeecccccCCeEEEE
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACAN-CCADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~lv 220 (397)
.+.|+.|.++.||+++..+ +.+++|....... .....+.+....+.. ...|.++.+. ....++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~-------~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~------~~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVAN-------KKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD------PETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECC-------eEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe------CCCCeEE
Confidence 4678999999999998652 6788888654431 111111122222221 2234443321 1234799
Q ss_pred EEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCc-----eecCCCCCceEE
Q 015991 221 WRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI-----VHRDIKPQNVIF 295 (397)
Q Consensus 221 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gi-----iHrDIKp~NILl 295 (397)
|||+++.++.+. .. ....++.+++++|..||+.++ +|+|++|.||++
T Consensus 70 ~e~i~G~~l~~~--~~--------------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~ 121 (170)
T cd05151 70 TEFIEGSELLTE--DF--------------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL 121 (170)
T ss_pred EEecCCCccccc--cc--------------------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE
Confidence 999999876542 00 012356789999999999885 999999999999
Q ss_pred eCCCCeEEEEecccccc
Q 015991 296 SEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~ 312 (397)
+ ++ .++++|||.+..
T Consensus 122 ~-~~-~~~liDf~~a~~ 136 (170)
T cd05151 122 D-DG-RLWLIDWEYAGM 136 (170)
T ss_pred E-CC-eEEEEecccccC
Confidence 9 44 899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.9e-12 Score=134.47 Aligned_cols=214 Identities=15% Similarity=0.151 Sum_probs=148.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
...+++.+.+-+-.|.|+.++.++-..++...+.+. .++...-..................++|.++.++..+ ....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v--~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-~~rs 877 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKV--HGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-PCRS 877 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhh--hccchhhccccccccCCccCccccCCCCceecccCCC-CCCC
Confidence 345788899999999999999887655553322111 1111100000000000111222335567777666652 4457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..+|+++|.++++|...++..+ ..+++..+.....+..+++|||...++|||+||.|+|.
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~--------------------~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSG--------------------CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI 937 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCC--------------------CcccccccchhHHHHhhhhccccchhhcccccccchhh
Confidence 7899999999999999988754 34555566677889999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccc------------------------------cccccccccCCCCCCCcccccccCCCCCC
Q 015991 296 SEGSRTFKIIDLGAAADLRVG------------------------------INYIPKEFLLDPRYAAPEQYIMSTQTPSA 345 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 345 (397)
..++ +.++.|||+......- .........+|+.|.+||.+.+......+
T Consensus 938 ~~~g-h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a 1016 (1205)
T KOG0606|consen 938 AYDG-HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA 1016 (1205)
T ss_pred cccC-CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc
Confidence 9987 9999999844321100 00112346889999999988877766554
Q ss_pred CCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCCCcC
Q 015991 346 PSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCPLAY 395 (397)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~~~~ 395 (397)
|+|++|++++|.++|..||.....+..|
T Consensus 1017 ----------------------d~~~~g~~l~e~l~g~pp~na~tpq~~f 1044 (1205)
T KOG0606|consen 1017 ----------------------DWWSSGVCLFEVLTGIPPFNAETPQQIF 1044 (1205)
T ss_pred ----------------------hhhhhhhhhhhhhcCCCCCCCcchhhhh
Confidence 9999999999999999999887776654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3e-11 Score=119.47 Aligned_cols=204 Identities=19% Similarity=0.179 Sum_probs=142.5
Q ss_pred ccCCeEEeeeecc--CCceEEEEEEe--cCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 137 RKDDFVLGKKLGE--GAFGVVYRASL--AKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 137 ~~~~f~i~~~LG~--G~fG~Vy~a~~--~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
....|.+.+.+|. |.+|.||.+.. ..+. ..+++|+-+.... .......+.........|.+.+....
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~-----~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~- 185 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESP-----HKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP- 185 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCC-----cccccccccCCCCCccccccccchhhcccccCccccccccCc-
Confidence 3356778889999 99999999987 4444 5666666332211 11111222233334455666666433
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHH----HHHHhHHCCcee
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLF----ALDGLHSTGIVH 285 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~----~L~yLH~~giiH 285 (397)
...+++..++-+|.++ .+|..+..... ..+....++....+... ||..+|+..++|
T Consensus 186 ~~e~~~~lfiqtE~~~-~sl~~~~~~~~-------------------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~ 245 (524)
T KOG0601|consen 186 AWEGSGILFIQTELCG-ESLQSYCHTPC-------------------NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVH 245 (524)
T ss_pred ccccCCcceeeecccc-chhHHhhhccc-------------------ccCCchhhhhHHhhhhhcccccccccCCCcccc
Confidence 3355678999999998 56666655432 12344556667777777 999999999999
Q ss_pred cCCCCCceEEeCCCCeEEEEeccccccccccccc----ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 286 rDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
-|+||+||+...+...++++|||+...+..+.-. ......|...|++||...+..
T Consensus 246 ~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--------------------- 304 (524)
T KOG0601|consen 246 DDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--------------------- 304 (524)
T ss_pred cccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc---------------------
Confidence 9999999999998459999999999887655311 112236788999999765443
Q ss_pred CCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
+...|+||+|.+..+-.++..++...
T Consensus 305 --~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 305 --TFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred --chHhhhcchhhhhHhhHhhcccccCC
Confidence 33459999999999999998877655
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.1e-10 Score=99.37 Aligned_cols=75 Identities=15% Similarity=0.309 Sum_probs=57.1
Q ss_pred eEEEEEEecCCCCHHH-HHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHh-HHCCceecCCCCCce
Q 015991 216 EYWLIWRYEGEATLAD-LMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGL-HSTGIVHRDIKPQNV 293 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yL-H~~giiHrDIKp~NI 293 (397)
..+|||||+++..+.. .++.. .+++.....+..|++.+|..| |+.|+||+|+++.||
T Consensus 98 ~~~lvME~Ig~~~~~~~~Lkd~---------------------~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 98 KHVLVMSFIGDDQVPAPKLKDA---------------------KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred CCEEEEEEcCCCCccchhhhcc---------------------ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 4679999998754321 12111 223345567789999999999 899999999999999
Q ss_pred EEeCCCCeEEEEeccccccc
Q 015991 294 IFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~ 313 (397)
|+++ + .++|+|||.|...
T Consensus 157 L~~~-~-~v~iIDF~qav~~ 174 (197)
T cd05146 157 LWHD-G-KVWFIDVSQSVEP 174 (197)
T ss_pred EEEC-C-cEEEEECCCceeC
Confidence 9986 3 7999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.4e-09 Score=93.25 Aligned_cols=126 Identities=21% Similarity=0.306 Sum_probs=82.4
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeec-----ccchhHHHHHHH------HHHHHhhc--cCCCceeeeeeccc
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKA-----TEYGAVEIWMNE------RVRRACAN--CCADFVYGFFENSS 211 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~-----~~~~~~e~~~~~------~~~~~~~~--~~~~~i~~~~~~~~ 211 (397)
..+++|+-..+|++.+.+. .+++|.- ....-.+....+ ++...+.. .+.|.++.+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv----- 69 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV----- 69 (204)
T ss_pred chhhCCcceeEEeeeccCc-------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-----
Confidence 4678999999999976442 3333321 112222222111 22222222 233333322
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
+.+...|+|||++|..|.+.+.... ..++..+-.-+.-||..||||+|+-+.
T Consensus 70 -D~~~~~I~me~I~G~~lkd~l~~~~---------------------------~~~~r~vG~~vg~lH~~givHGDLTts 121 (204)
T COG3642 70 -DPDNGLIVMEYIEGELLKDALEEAR---------------------------PDLLREVGRLVGKLHKAGIVHGDLTTS 121 (204)
T ss_pred -cCCCCEEEEEEeCChhHHHHHHhcc---------------------------hHHHHHHHHHHHHHHhcCeecCCCccc
Confidence 2345679999999999998887642 135667777777899999999999999
Q ss_pred ceEEeCCCCeEEEEecccccc
Q 015991 292 NVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~ 312 (397)
||++..+ .+.++|||++..
T Consensus 122 NiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 122 NIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred eEEEeCC--cEEEEECCcccc
Confidence 9999885 599999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4e-10 Score=111.57 Aligned_cols=195 Identities=19% Similarity=0.159 Sum_probs=129.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEec-CCCCCCCCCceEEeecccc----hhHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLA-KKPSSKNDGDLVLKKATEY----GAVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~-~~~~~~~~~~vavK~~~~~----~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
...+|.+...||.|.|+.|+..... .++ ..+++|.+.+. .+...-..+... ......|.+.+++...+.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~-----~~Y~~ke~~~~l~~~~~di~sl~ev~l-~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGD-----CIYAAKELLNGLATFASDIFSLGEVIL-EAILGSHLPSVGKNSSWS 336 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCC-----ceEeChhhhccccchHhhhcchhhhhH-hhHhhcccccCCCCCCcc
Confidence 4478999999999999999988744 233 56777765532 122222222222 222233444555544443
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
. ..+.++=-|||.++++....... ..+++...+++..|++.++.++|+..++|+|+||+
T Consensus 337 ~-~r~~~ip~e~~~~~s~~l~~~~~--------------------~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ps 395 (524)
T KOG0601|consen 337 Q-LRQGYIPLEFCEGGSSSLRSVTS--------------------QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPS 395 (524)
T ss_pred c-cccccCchhhhcCcchhhhhHHH--------------------HhcCcchhhhhHHHHHhccccccchhhhccccccc
Confidence 3 34456888999988876655221 13456667889999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCC--CcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYA--APEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
||++..++...++.|||+++.+... ......+-+++ +++ .+.+..+-.+.|+
T Consensus 396 ni~i~~~~~~~~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~----------------------~~e~~~~~~~~~~ 449 (524)
T KOG0601|consen 396 NILISNDGFFSKLGDFGCWTRLAFS----SGVFHHIDRLYPIAEI----------------------LLEDYPHLSKADI 449 (524)
T ss_pred ceeeccchhhhhcccccccccccee----cccccccccccccchh----------------------hcccccccccccc
Confidence 9999886458999999998753221 12223333444 344 2233344557799
Q ss_pred HHHHHHHHHHHcCCC
Q 015991 370 YSAGLIFLQMVCTVR 384 (397)
Q Consensus 370 ~SlGv~l~elltg~~ 384 (397)
+|||+.+.|.+++..
T Consensus 450 ~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 450 FSLGLSVDEAITGSP 464 (524)
T ss_pred ccccccccccccCcc
Confidence 999999999998873
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-08 Score=92.23 Aligned_cols=80 Identities=18% Similarity=0.235 Sum_probs=63.3
Q ss_pred CeEEEEEEecCCC-CHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 215 GEYWLIWRYEGEA-TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 215 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
..-++|+|++++. +|.+++.... ....+......++.+++..+.-||+.||+|+|+++.||
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~------------------~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~Ni 169 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA------------------TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHF 169 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhE
Confidence 4578999999986 8999875321 00123455668999999999999999999999999999
Q ss_pred EEeCC------CCeEEEEecccccc
Q 015991 294 IFSEG------SRTFKIIDLGAAAD 312 (397)
Q Consensus 294 Ll~~~------~~~~kL~DFGla~~ 312 (397)
|++.+ ...+.|+||+.++.
T Consensus 170 Ll~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 170 LLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred EEeccccCCCCCceEEEEECCcccc
Confidence 99852 34899999998853
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.4e-09 Score=88.97 Aligned_cols=139 Identities=17% Similarity=0.206 Sum_probs=87.7
Q ss_pred EeeeeccCCceEEEEEEecCCCCCCCCCceEEeec-----ccchhHHHHHHH---HHHHHhhc-----cCCCceeeeeec
Q 015991 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKA-----TEYGAVEIWMNE---RVRRACAN-----CCADFVYGFFEN 209 (397)
Q Consensus 143 i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~-----~~~~~~e~~~~~---~~~~~~~~-----~~~~~i~~~~~~ 209 (397)
....|-+|+-+.|+++.+.. +..++|.- ....-....... ++.+.+.. ...|.++ +++
T Consensus 11 ~l~likQGAEArv~~~~~~G-------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-~~D- 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-FID- 81 (229)
T ss_pred cceeeeccceeeEeeeccCC-------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-EEe-
Confidence 56789999999999998876 34444432 222111111111 12222221 1223222 111
Q ss_pred ccccCCeEEEEEEecCC-CCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 210 SSKKGGEYWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
...-.|+|||+.+ .++.+++.....+ ..+......++.++-+.+.-||..+|||+||
T Consensus 82 ----~~~~~i~ME~~~g~~~vk~~i~~~~~~------------------~~~d~~~~~~~~~iG~~igklH~ndiiHGDL 139 (229)
T KOG3087|consen 82 ----TYGGQIYMEFIDGASTVKDFILSTMED------------------ESEDEGLAELARRIGELIGKLHDNDIIHGDL 139 (229)
T ss_pred ----cCCCeEEEEeccchhHHHHHHHHHccC------------------cccchhHHHHHHHHHHHHHHhhhCCeecccc
Confidence 2345689999986 4788887765321 1112223567888888999999999999999
Q ss_pred CCCceEEeCCCCe--EEEEecccccc
Q 015991 289 KPQNVIFSEGSRT--FKIIDLGAAAD 312 (397)
Q Consensus 289 Kp~NILl~~~~~~--~kL~DFGla~~ 312 (397)
-.+||++.+++.. +.++|||++..
T Consensus 140 TTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 140 TTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cccceEEecCCCcCceEEEeecchhc
Confidence 9999999877654 48999999854
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-08 Score=101.11 Aligned_cols=161 Identities=14% Similarity=0.155 Sum_probs=112.0
Q ss_pred CceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccc
Q 015991 170 GDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249 (397)
Q Consensus 170 ~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~ 249 (397)
..+.+...+...........+-.+.+....||+|+.++..... ++..|||+|-+. .|..+++...
T Consensus 38 ~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~l~------------ 102 (690)
T KOG1243|consen 38 GPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKELG------------ 102 (690)
T ss_pred CceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHHhH------------
Confidence 4555555544333222223344556677889999999987755 458999999886 6777776542
Q ss_pred cccCCCcchhcHHHHHHHHHHHHHHHHHhH-HCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCC
Q 015991 250 VQDLPKGIERENRIIQTIMSQLLFALDGLH-STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP 328 (397)
Q Consensus 250 ~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH-~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~ 328 (397)
...+...+.||+.||.||| +.+++|++|..+.|+++..| ..||++|-++........ .......--
T Consensus 103 -----------~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~-~~~~~~~~~ 169 (690)
T KOG1243|consen 103 -----------KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNA-PAKSLYLIE 169 (690)
T ss_pred -----------HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCc-ccccchhhh
Confidence 4556778999999999998 67899999999999999998 999999998865433221 111111122
Q ss_pred CCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcC
Q 015991 329 RYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCT 382 (397)
Q Consensus 329 ~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg 382 (397)
.|..|+...... -..|.|.||++++|++.|
T Consensus 170 s~~~P~~~~~s~------------------------~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 170 SFDDPEEIDPSE------------------------WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccChhhcCccc------------------------cchhhhhHHHHHHHHhCc
Confidence 456666432222 114999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-08 Score=90.71 Aligned_cols=82 Identities=21% Similarity=0.209 Sum_probs=47.9
Q ss_pred eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh----HHHHHHHHHHHHhhcc--CCCceeeeeecccccCCeEE
Q 015991 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANC--CADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 145 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~e~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 218 (397)
+.|+.|.++.||+++..+ + +.+++|....... .....+.+....+... ..|.++.+..... ..+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g-----~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-G-----RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-VLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecC-C-----cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-ccCCce
Confidence 578999999999998754 2 5788887654321 2222222333333332 2344443332211 113568
Q ss_pred EEEEecCCCCHHHHH
Q 015991 219 LIWRYEGEATLADLM 233 (397)
Q Consensus 219 lv~e~~~~gsL~~~l 233 (397)
+||||++|.++.+.+
T Consensus 77 ~v~e~i~G~~l~~~~ 91 (223)
T cd05154 77 YVMERVDGRVLRDRL 91 (223)
T ss_pred EEEEEeCCEecCCCC
Confidence 999999998876654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.6e-07 Score=89.84 Aligned_cols=111 Identities=13% Similarity=0.147 Sum_probs=85.6
Q ss_pred hhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCccccc
Q 015991 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 337 (397)
Q Consensus 258 ~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 337 (397)
..+|....+.++.++.+...||..|.+-+|+.++|+|+.+++ .+.|.|=..-..-..+.. ....+|...|.+||.-.
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~ng~~--~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINANGTL--HLCPVGVSEFTPPELQT 189 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccceeeccCCce--EecccCccccCCHHHhc
Confidence 568889999999999999999999999999999999999987 999998553322222222 24568899999999654
Q ss_pred ccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcC-CCCCCC
Q 015991 338 MSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCT-VRRLCL 388 (397)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg-~~Pf~~ 388 (397)
-.... .-+.+.-.|.|.||+++++++.| ++||++
T Consensus 190 ~~sf~-----------------g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 190 LPSFV-----------------GFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccccc-----------------ccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 21111 11234456999999999999988 999975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.8e-07 Score=91.49 Aligned_cols=183 Identities=17% Similarity=0.181 Sum_probs=128.5
Q ss_pred ceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc---cCCeEEEEEEecCC-C
Q 015991 152 FGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK---KGGEYWLIWRYEGE-A 227 (397)
Q Consensus 152 fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~~~~~~lv~e~~~~-g 227 (397)
-.+.|++....++ ..+++|++...........-.+.+..+..+|.|++.|-+.+.+ .+..+++||+|.++ +
T Consensus 289 ~~Ttyk~~s~~DG-----~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDG-----NAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCC-----ceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3678999988887 8899999954433333233345556667789999988665542 23678999999986 5
Q ss_pred CHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEec
Q 015991 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307 (397)
Q Consensus 228 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DF 307 (397)
+|.++......... .........+....++.++.++.|+..||.++|+.|...+-|.+.+||++.+. .++|+-.
T Consensus 364 TL~d~~F~~~~~t~-----~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C 437 (655)
T KOG3741|consen 364 TLYDLYFANPPFTK-----RTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGC 437 (655)
T ss_pred hHHHHHccCCcccc-----ccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecc
Confidence 78887654432110 00012234566788999999999999999999999999999999999999876 8888877
Q ss_pred ccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCC
Q 015991 308 GAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRR 385 (397)
Q Consensus 308 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~P 385 (397)
|....+..+. + |-+.+.+ +-|.=.||.+++.|.||..-
T Consensus 438 ~i~Dvl~~d~--------~-------~~le~~Q-------------------------q~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 438 GIMDVLQEDP--------T-------EPLESQQ-------------------------QNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cceeeecCCC--------C-------cchhHHh-------------------------hhhHHHHHHHHHHHhhcccc
Confidence 7665443221 0 1111111 23999999999999999643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.2e-07 Score=85.08 Aligned_cols=95 Identities=23% Similarity=0.274 Sum_probs=71.6
Q ss_pred CCCceeeeeecccccCCeEEEEEEecCCC-CHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHH
Q 015991 199 CADFVYGFFENSSKKGGEYWLIWRYEGEA-TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDG 277 (397)
Q Consensus 199 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~y 277 (397)
..|..+.+...........++|+|++++. +|.+++.... ..+......++.+++..+.-
T Consensus 74 ~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--------------------~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 74 PTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--------------------QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred CCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--------------------ccchhhHHHHHHHHHHHHHH
Confidence 34555555443222224568999999874 8999987632 12344566789999999999
Q ss_pred hHHCCceecCCCCCceEEeCCC--CeEEEEeccccccc
Q 015991 278 LHSTGIVHRDIKPQNVIFSEGS--RTFKIIDLGAAADL 313 (397)
Q Consensus 278 LH~~giiHrDIKp~NILl~~~~--~~~kL~DFGla~~~ 313 (397)
||+.||+|+|+++.|||++.++ ..+.++||+.++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999998864 37999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.6e-07 Score=82.59 Aligned_cols=73 Identities=27% Similarity=0.434 Sum_probs=49.8
Q ss_pred EEEEEEecC--CCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHH-hHHCCceecCCCCCce
Q 015991 217 YWLIWRYEG--EATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDG-LHSTGIVHRDIKPQNV 293 (397)
Q Consensus 217 ~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~y-LH~~giiHrDIKp~NI 293 (397)
..|||||++ |..+..+.... ++......++.+++..+.. +|..||||+|+.+.||
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~----------------------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NI 138 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVD----------------------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNI 138 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCG----------------------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSE
T ss_pred CEEEEEecCCCccchhhHHhcc----------------------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhE
Confidence 469999999 66655443322 1123345677888886555 5799999999999999
Q ss_pred EEeCCCCeEEEEeccccccc
Q 015991 294 IFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~ 313 (397)
|++++ .+.|+|||.+...
T Consensus 139 lv~~~--~~~iIDf~qav~~ 156 (188)
T PF01163_consen 139 LVDDG--KVYIIDFGQAVDS 156 (188)
T ss_dssp EEETT--CEEE--GTTEEET
T ss_pred Eeecc--eEEEEecCcceec
Confidence 99985 7999999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.7e-08 Score=89.88 Aligned_cols=148 Identities=19% Similarity=0.183 Sum_probs=101.0
Q ss_pred ccCCCceeeeeecccc----cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHH
Q 015991 197 NCCADFVYGFFENSSK----KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272 (397)
Q Consensus 197 ~~~~~~i~~~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~ 272 (397)
...|.|++.|...+.. +.....+++||+..|++.++|++..+ ....+......+++.||+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~----------------~~~a~~~~~wkkw~tqIl 186 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK----------------NQKALFQKAWKKWCTQIL 186 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH----------------hhhhhhHHHHHHHHHHHH
Confidence 3445566665433222 33567889999999999999988752 234667777889999999
Q ss_pred HHHHHhHHC--CceecCCCCCceEEeCCCCeEEEEeccccccccccccc----ccccccCCCCCCCcccccccCCCCCCC
Q 015991 273 FALDGLHST--GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY----IPKEFLLDPRYAAPEQYIMSTQTPSAP 346 (397)
Q Consensus 273 ~~L~yLH~~--giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~ 346 (397)
.||.|||+. -|+|+++..+-|++..++ -+||.- +.-.......+. ....-.+-++|.+||.-..
T Consensus 187 sal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-------- 256 (458)
T KOG1266|consen 187 SALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-------- 256 (458)
T ss_pred hhhhhhhccCCccccCCcchhheeecCCc-eEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcc--------
Confidence 999999987 599999999999999876 666542 211111111110 0111234578999994332
Q ss_pred CccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCC
Q 015991 347 SAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVR 384 (397)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~ 384 (397)
.+.+..+|||+||.+.+||..+..
T Consensus 257 --------------tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 257 --------------TNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred --------------cccccchhhhhhhHHHHHHHHhee
Confidence 234445699999999999987664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.6e-06 Score=77.07 Aligned_cols=141 Identities=13% Similarity=0.124 Sum_probs=90.9
Q ss_pred eeccCCceEEEEEEecCCCCCCCCCceEEeecc---------cchhHHHHHHHHHHHHhhccCC--Cceeeeeecc-ccc
Q 015991 146 KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT---------EYGAVEIWMNERVRRACANCCA--DFVYGFFENS-SKK 213 (397)
Q Consensus 146 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~---------~~~~~e~~~~~~~~~~~~~~~~--~~i~~~~~~~-~~~ 213 (397)
--|+||-+-|++-...+ +.+-+|+-. ..+...+..+-..+..+..... |.++ +.+.. ...
T Consensus 25 N~~rgG~SgV~r~~~~g-------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~ 96 (216)
T PRK09902 25 NYRRNGMSGVQCVERNG-------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG 96 (216)
T ss_pred CcCCCCcceEEEEEeCC-------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence 34678999999876554 346677654 2223333333333333333333 3333 22211 111
Q ss_pred CCeEEEEEEecCC-CCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 GGEYWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.-.-+||+|-+++ .+|.+++..... ...+......+..+++..+.-||+.|+.|+|+-+.|
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~~------------------~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~kh 158 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHAV------------------SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRH 158 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCCc------------------CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhh
Confidence 2457899996664 589888865431 123445566899999999999999999999999999
Q ss_pred eEEeCCCC-eEEEEecccccc
Q 015991 293 VIFSEGSR-TFKIIDLGAAAD 312 (397)
Q Consensus 293 ILl~~~~~-~~kL~DFGla~~ 312 (397)
||++.++. .++++||--++.
T Consensus 159 Ill~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 159 IYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eeecCCCCeeEEEEEhhccch
Confidence 99986552 499999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.7e-07 Score=82.41 Aligned_cols=136 Identities=21% Similarity=0.189 Sum_probs=85.9
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc----------h------------hHHHHHHHHHHHHhhcc
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY----------G------------AVEIWMNERVRRACANC 198 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~----------~------------~~e~~~~~~~~~~~~~~ 198 (397)
..++..||.|--+.||.|.+... .++++|.-+.. . .......+++...+...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g------~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKG------RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred HhhccccccCccceEEEEECCCC------CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 45789999999999999988754 67787753210 0 00111111222222211
Q ss_pred CCC--ceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHH
Q 015991 199 CAD--FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD 276 (397)
Q Consensus 199 ~~~--~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~ 276 (397)
... .+..-+ ..+...+||||+.|..|...-- +.+....++..|++-+.
T Consensus 167 ~~~G~~VP~P~-----~~nRHaVvMe~ieG~eL~~~r~-------------------------~~en~~~il~~il~~~~ 216 (304)
T COG0478 167 YPEGVKVPKPI-----AWNRHAVVMEYIEGVELYRLRL-------------------------DVENPDEILDKILEEVR 216 (304)
T ss_pred hhcCCCCCCcc-----ccccceeeeehcccceeecccC-------------------------cccCHHHHHHHHHHHHH
Confidence 110 111111 1266789999999876654321 12223456666666666
Q ss_pred HhHHCCceecCCCCCceEEeCCCCeEEEEeccccccc
Q 015991 277 GLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 277 yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~ 313 (397)
-+-..||||+|+.+-||++++++ .+.++||--+...
T Consensus 217 ~~~~~GiVHGDlSefNIlV~~dg-~~~vIDwPQ~v~~ 252 (304)
T COG0478 217 KAYRRGIVHGDLSEFNILVTEDG-DIVVIDWPQAVPI 252 (304)
T ss_pred HHHHcCccccCCchheEEEecCC-CEEEEeCcccccC
Confidence 66689999999999999999997 9999999887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.53 E-value=2e-06 Score=76.69 Aligned_cols=139 Identities=16% Similarity=0.175 Sum_probs=87.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHH-------------HHHHHhhccCCCc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-------------RVRRACANCCADF 202 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~-------------~~~~~~~~~~~~~ 202 (397)
+..++|.+.+++-......|.+-...+ +.+++|...+.......... +........ ...
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~-------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g-~~~ 99 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDG-------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG-FTE 99 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECC-------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC-ccc
Confidence 455889999999988888888776554 67888876543221111111 111111111 111
Q ss_pred eeeeeeccc----ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHh
Q 015991 203 VYGFFENSS----KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGL 278 (397)
Q Consensus 203 i~~~~~~~~----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yL 278 (397)
...++.... .-....+++|||++|..|.++..- ++ .+..++.+.+.-|
T Consensus 100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i------------------------~e----~~~~ki~~~ikql 151 (229)
T PF06176_consen 100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIEDI------------------------DE----DLAEKIVEAIKQL 151 (229)
T ss_pred cccceeeeeeeeccceeEEEEEEEEecCeecccchhc------------------------CH----HHHHHHHHHHHHH
Confidence 111111000 112456799999999887665321 11 2445677889999
Q ss_pred HHCCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 279 HSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 279 H~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
|+.|+.|+|..|.|++++++ .++++||+..+.
T Consensus 152 H~~G~~HGD~hpgNFlv~~~--~i~iID~~~k~~ 183 (229)
T PF06176_consen 152 HKHGFYHGDPHPGNFLVSNN--GIRIIDTQGKRM 183 (229)
T ss_pred HHcCCccCCCCcCcEEEECC--cEEEEECccccc
Confidence 99999999999999999975 599999987754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.7e-06 Score=87.30 Aligned_cols=77 Identities=18% Similarity=0.331 Sum_probs=54.3
Q ss_pred CeEEEEEEecCCCCHHHH--HHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 215 GEYWLIWRYEGEATLADL--MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+...|+|||+.|..+.+. ++..+.. ...+.+..+..++.|+ -..|+.|.|..|.|
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~~g~d----------------~k~ia~~~~~~f~~q~-------~~dgffHaDpHpGN 295 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKSAGID----------------RKELAELLVRAFLRQL-------LRDGFFHADPHPGN 295 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHhcCCC----------------HHHHHHHHHHHHHHHH-------HhcCccccCCCccc
Confidence 345799999999998887 4443311 1122233333333333 34799999999999
Q ss_pred eEEeCCCCeEEEEeccccccccc
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRV 315 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~ 315 (397)
|+++.++ .+.+.|||+...+..
T Consensus 296 i~v~~~g-~i~~lDfGi~g~l~~ 317 (517)
T COG0661 296 ILVRSDG-RIVLLDFGIVGRLDP 317 (517)
T ss_pred eEEecCC-cEEEEcCcceecCCH
Confidence 9999997 999999999977654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.4e-07 Score=95.15 Aligned_cols=106 Identities=20% Similarity=0.339 Sum_probs=82.0
Q ss_pred HHHHHHHHHHhHHC-CceecCCCCCceEEeCCCCeEEEEeccccccccccccccc--------ccccCCCCCCCcccccc
Q 015991 268 MSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIP--------KEFLLDPRYAAPEQYIM 338 (397)
Q Consensus 268 ~~qi~~~L~yLH~~-giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~--------~~~~gt~~Y~aPE~~~~ 338 (397)
+.+++.||.|+|.. ++||+.|.|++|.++.++ .+||+-|+.+.....+..+.. .-..-...|.|||.+.+
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34566999999964 999999999999999987 999999999876655333211 11234568999998877
Q ss_pred cCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH-cCCCCCCCCCCCCcCC
Q 015991 339 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV-CTVRRLCLHSCPLAYS 396 (397)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell-tg~~Pf~~~~~~~~~~ 396 (397)
...++. +|+||+|+++|.+. .|+.-+...+.+.+|.
T Consensus 184 ~~~~~~----------------------sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~ 220 (700)
T KOG2137|consen 184 TTNTPA----------------------SDVFSLGVLIYTIYNGGKSIIAANGGLLSYS 220 (700)
T ss_pred cccccc----------------------ccceeeeeEEEEEecCCcchhhccCCcchhh
Confidence 665554 49999999999998 7777777777777664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.6e-05 Score=68.35 Aligned_cols=50 Identities=20% Similarity=0.347 Sum_probs=42.7
Q ss_pred HHHHHHHHHHHHHHHhHH-CCceecCCCCCceEEeCCCCeEEEEecccccccc
Q 015991 263 IIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (397)
Q Consensus 263 ~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~ 314 (397)
....+..++++.+.-|-. .++||+||..-|||+.+ + .+.|||||-|....
T Consensus 167 e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~-~-~p~iID~~QaV~~~ 217 (268)
T COG1718 167 EAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD-G-EPYIIDVSQAVTID 217 (268)
T ss_pred hHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC-C-eEEEEECccccccC
Confidence 566778888888888876 89999999999999994 4 89999999997654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=4e-05 Score=77.33 Aligned_cols=78 Identities=22% Similarity=0.371 Sum_probs=50.5
Q ss_pred CeEEEEEEecCCCCHHHH--HHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 215 GEYWLIWRYEGEATLADL--MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
....|+|||++|..+.|+ |.+.+. ....+.......++.|| -..|++|+|=.|.|
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~gi----------------~~~~i~~~l~~~~~~qI-------f~~GffHaDPHPGN 331 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRGI----------------SPHDILNKLVEAYLEQI-------FKTGFFHADPHPGN 331 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcCC----------------CHHHHHHHHHHHHHHHH-------HhcCCccCCCCCCc
Confidence 346899999999887665 333321 01111222222222332 34799999999999
Q ss_pred eEEeC---CCCeEEEEeccccccccc
Q 015991 293 VIFSE---GSRTFKIIDLGAAADLRV 315 (397)
Q Consensus 293 ILl~~---~~~~~kL~DFGla~~~~~ 315 (397)
|++++ .+..+.+-|||+...+..
T Consensus 332 ilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 332 ILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred EEEecCCCCCccEEEEcccccccccH
Confidence 99994 345999999999976643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00014 Score=65.59 Aligned_cols=80 Identities=26% Similarity=0.227 Sum_probs=48.3
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-hhHHHHHHHHHHHHhhcc--CCCceeeeeecccccCCeEEEE
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACANC--CADFVYGFFENSSKKGGEYWLI 220 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~e~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~lv 220 (397)
.+.|+.|..+.||+....+ +.+++|..... .......+..+.+.+... ..|.++... .........+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-------~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~-~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-------GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD-TSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-------SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE-EETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-------cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec-ccccccccceEE
Confidence 4689999999999998765 47888887655 222222222333333332 234444322 222233457999
Q ss_pred EEecCCCCHHH
Q 015991 221 WRYEGEATLAD 231 (397)
Q Consensus 221 ~e~~~~gsL~~ 231 (397)
|+++++.++..
T Consensus 74 ~~~i~g~~~~~ 84 (239)
T PF01636_consen 74 MEYIPGRPLDD 84 (239)
T ss_dssp EEEESSEEHHH
T ss_pred EEEeccccccc
Confidence 99999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.9e-06 Score=86.45 Aligned_cols=189 Identities=19% Similarity=0.113 Sum_probs=130.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCc-eeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADF-VYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~-i~~~~~~~~~~~~~~ 217 (397)
..+...+.+++|+++.++|.+...+ +.+..+.+... .+... ....+...+||+ .+..++.. +.++..
T Consensus 242 kws~~fh~fvK~altknpKkRptae------klL~h~fvs~~--l~~rl---~~eLLdK~n~P~~~v~~~~d~-~~E~~~ 309 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAE------KLLQHPFVSQT--LSRRL---AIELLDKVNNPNPVVRYLEDY-DGEDYL 309 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChh------hheeceeeccc--hhhHH---HHHHHHHccCCCCcccccccC-Cccccc
Confidence 4566677899999999999987655 45555555433 22222 234455566777 44444433 456789
Q ss_pred EEEEEecCCC-CHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 218 WLIWRYEGEA-TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 218 ~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
|+.++++.++ +....+.. ....+..-++..+++.-.++|+++|+.-=+||| ||+..
T Consensus 310 ~i~~~i~s~~rs~~~~~~~-------------------se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s 366 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTV-------------------SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS 366 (829)
T ss_pred chhhhhhcCCccccccCCh-------------------hhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc
Confidence 9999999987 22111111 112334445667788888999999998778999 88887
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
++ ..+..||+.+..+.... .+....+|+.+++||+....... .+.|+|++|+--
T Consensus 367 ~~--~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~----------------------~~p~~~~~~~~~ 420 (829)
T KOG0576|consen 367 EE--EVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTID----------------------GCPDSGSLAVSA 420 (829)
T ss_pred cc--ccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccc----------------------cCCCccCCCcch
Confidence 74 78999999998775543 45678899999999966655443 445999999988
Q ss_pred HHHHcCCCCCCC
Q 015991 377 LQMVCTVRRLCL 388 (397)
Q Consensus 377 ~elltg~~Pf~~ 388 (397)
.+|.-|..|-+.
T Consensus 421 ~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 421 IQMAPGLPPRSS 432 (829)
T ss_pred hhcCCCCCCCCC
Confidence 888877776543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00022 Score=65.38 Aligned_cols=31 Identities=29% Similarity=0.322 Sum_probs=27.0
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
..++|+|+.|.|||+++++ ...|+||+.|..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~-~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGK-FSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCc-EEEEEEcccccc
Confidence 4689999999999999865 788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00043 Score=62.94 Aligned_cols=29 Identities=31% Similarity=0.284 Sum_probs=25.4
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~--~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG--TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC--cEEEechhcCc
Confidence 578999999999999864 89999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00047 Score=59.25 Aligned_cols=129 Identities=24% Similarity=0.332 Sum_probs=80.7
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHH-HHHHHhhc-cCCCceeeeeecccccCCeEE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRACAN-CCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~-~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 218 (397)
.+..+.||+|.+|.||+|.+.+ ..+++|.-..+........+ ++...+.. ..-|.++.+ +.-+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~-------~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~ 88 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG-------GEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDF 88 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC-------ceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhh
Confidence 3446789999999999999876 57888877665544433333 32332222 223333322 2234
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC-C-CceEEe
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK-P-QNVIFS 296 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK-p-~NILl~ 296 (397)
+.|||+.|..|.+...... . +-...+++.---|-..||-|..|. | .||++.
T Consensus 89 i~me~i~G~~L~~~~~~~~-----------------------r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~ 141 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGGD-----------------------R----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN 141 (201)
T ss_pred hhhhhhcCcchhhhhhccc-----------------------H----HHHHHHHHHHHHHHHhccchhhhcCCceeEEec
Confidence 5699999888877654311 1 233445555445667899999987 3 466665
Q ss_pred CCCCeEEEEeccccccc
Q 015991 297 EGSRTFKIIDLGAAADL 313 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~ 313 (397)
+ . .+.|+||..|+.-
T Consensus 142 ~-~-~~~iIDFd~At~k 156 (201)
T COG2112 142 D-R-DVYIIDFDSATFK 156 (201)
T ss_pred C-C-cEEEEEccchhhc
Confidence 5 3 7999999999743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00096 Score=63.52 Aligned_cols=31 Identities=35% Similarity=0.599 Sum_probs=27.4
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.+++|+|+.+.||++++++ ...|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS-VKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence 5899999999999999875 678999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00094 Score=60.97 Aligned_cols=31 Identities=26% Similarity=0.478 Sum_probs=26.2
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.+++|+|+.+.|||++++. ..-|+||+.|..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence 3689999999999998754 667999998854
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0016 Score=62.35 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=26.4
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++||+|+.+.|||++.+. ..-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence 4899999999999999753 568999998853
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0013 Score=62.17 Aligned_cols=31 Identities=29% Similarity=0.478 Sum_probs=27.0
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.+++|+|+.|.|||+++++ .+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 4799999999999999865 678999998854
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0028 Score=56.07 Aligned_cols=39 Identities=41% Similarity=0.659 Sum_probs=32.8
Q ss_pred HHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccc
Q 015991 266 TIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310 (397)
Q Consensus 266 ~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla 310 (397)
.-+.+|.+-+..+|..||+-+|+|+.|.. +| ||+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G---~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG---KLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCCeeeccCcccccc---CC---EEEecccC
Confidence 34567888889999999999999999986 33 89999964
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0022 Score=69.45 Aligned_cols=32 Identities=31% Similarity=0.488 Sum_probs=26.2
Q ss_pred CceecCCCCCceEEeCC-CCeEEEEeccccccc
Q 015991 282 GIVHRDIKPQNVIFSEG-SRTFKIIDLGAAADL 313 (397)
Q Consensus 282 giiHrDIKp~NILl~~~-~~~~kL~DFGla~~~ 313 (397)
.+||+|+++.|||++.+ +...-|+||.++..-
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 59999999999999853 335689999998653
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0015 Score=59.44 Aligned_cols=32 Identities=28% Similarity=0.417 Sum_probs=26.8
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.+++|+|+.+.|||+++++..+.|+||-.|..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 36999999999999998323899999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0029 Score=62.17 Aligned_cols=29 Identities=24% Similarity=0.392 Sum_probs=25.3
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEeccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~ 311 (397)
..++|+|+.+.|||++++ .++++||-.|.
T Consensus 223 ~~l~HgDl~~gni~~~~~--~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE--ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC--CcEEEeccccc
Confidence 469999999999999885 69999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00047 Score=64.73 Aligned_cols=72 Identities=14% Similarity=0.243 Sum_probs=55.3
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++|||++.+-.|.+.-+-.+ ...+...+..-+--|-.+|+||+|..--||+
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~v~d--------------------------~~~ly~~lm~~Iv~la~~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRHVED--------------------------PPTLYDDLMGLIVRLANHGLIHGDFNEFNIM 234 (465)
T ss_pred cceeeHHHhhcccceeeeeecCC--------------------------hHHHHHHHHHHHHHHHHcCceecccchheeE
Confidence 56889999999877766543222 2245556666677788999999999999999
Q ss_pred EeCCCCeEEEEeccccccc
Q 015991 295 FSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~ 313 (397)
+++++ .++++||--....
T Consensus 235 v~dd~-~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 235 VKDDD-KIVVIDFPQMVST 252 (465)
T ss_pred EecCC-CEEEeechHhhcc
Confidence 99876 9999999866443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0041 Score=57.52 Aligned_cols=29 Identities=28% Similarity=0.477 Sum_probs=25.6
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++|+|+.|.||++++++ +.|+||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence 589999999999999864 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.017 Score=54.72 Aligned_cols=82 Identities=11% Similarity=0.102 Sum_probs=46.2
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhc---cCCCceeeeeecccccCC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACAN---CCADFVYGFFENSSKKGG 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~ 215 (397)
...-.+.||.|..+.||+....+ ..+++|..+..... ....+.+..+.+.. ...|.++...... ...+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~-------~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~-~~~g 86 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ-------GNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE-QSPG 86 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC-------CCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC-CcCC
Confidence 34446789999999999986543 34555554332122 22222222223322 3566666554432 2235
Q ss_pred eEEEEEEecCCCCH
Q 015991 216 EYWLIWRYEGEATL 229 (397)
Q Consensus 216 ~~~lv~e~~~~gsL 229 (397)
..++|||++++.++
T Consensus 87 ~~~LVmE~i~G~~~ 100 (297)
T PRK10593 87 PDVLLLERLRGVSV 100 (297)
T ss_pred CeEEEEeccCCEec
Confidence 57999999998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0045 Score=54.54 Aligned_cols=89 Identities=19% Similarity=0.197 Sum_probs=64.7
Q ss_pred ceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-
Q 015991 202 FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS- 280 (397)
Q Consensus 202 ~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~- 280 (397)
.+..+++.+. .+.+.||.+.+++...... +..-...+|..+.+|+.++++.+++|+.
T Consensus 21 ~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~-----------------l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 21 PFPKLLGSCG-----RFYVVEYVGAGSLYGIYRP-----------------LSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred CCCCeeeECC-----CEEEEEeecCccccccccc-----------------cccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 4455555541 2578899997766433000 0011134788899999999999999997
Q ss_pred --CCceecCCCCCceEEeCCCCeEEEEeccccccc
Q 015991 281 --TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 281 --~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~ 313 (397)
..+.-.|++++|+-+++++ .+|++|...+...
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~ 112 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence 4588899999999999887 9999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.00026 Score=77.85 Aligned_cols=135 Identities=12% Similarity=0.026 Sum_probs=99.2
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-----CceecC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-----GIVHRD 287 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-----giiHrD 287 (397)
.....|..++|+.+|.+++.+-..- .+...+++..+.....+.+....-+|+. -.+|++
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~----------------ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~ 1365 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGL----------------EESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKS 1365 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhcc----------------ccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhh
Confidence 3456789999999999999886542 1222334444444444546666666654 368999
Q ss_pred CCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
+|+-|.+|..+. .+|+.++|+.+...... ...+...+++.|+.|+ ......++.|+
T Consensus 1366 Lkf~lpmIVtny-~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~ql----------------------i~N~ik~t~rs 1421 (2724)
T KOG1826|consen 1366 LKFTLPMIVTNY-NVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQL----------------------IKNEIKFTKRS 1421 (2724)
T ss_pred hhhhccceecCC-cccccccccccccCchH-hhhhhhhCCHHHHHHH----------------------HHHHHhhhhHH
Confidence 999999999987 99999999998433222 2235567888899998 55556677788
Q ss_pred hhHHHHHHHHHHHcCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~ 387 (397)
|+|..|+.+|+..-|..+|-
T Consensus 1422 dilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1422 DILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHHHHHhcccHHHH
Confidence 99999999999999998873
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.037 Score=49.12 Aligned_cols=134 Identities=17% Similarity=0.175 Sum_probs=76.3
Q ss_pred eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-------------------hHHHHHHHHHHHHh---hccCCC
Q 015991 144 GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-------------------AVEIWMNERVRRAC---ANCCAD 201 (397)
Q Consensus 144 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-------------------~~e~~~~~~~~~~~---~~~~~~ 201 (397)
...||+|+.=.||.- ..+ ....+|...... ..+...+...-..+ ....+.
T Consensus 6 ~~~i~~G~~R~cy~H--P~d------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~ 77 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDD------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWS 77 (199)
T ss_pred CcccccCCCceEEEC--CCC------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccc
Confidence 457999999999963 332 334455444332 22222222211122 223344
Q ss_pred ceeeeeecccccCCeEEEEEEecCC------CCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHH
Q 015991 202 FVYGFFENSSKKGGEYWLIWRYEGE------ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFAL 275 (397)
Q Consensus 202 ~i~~~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L 275 (397)
.+..+++...+..+ .-+|+|.+.+ .||.+++.... +++ .+...+-+-.
T Consensus 78 ~i~r~~G~veT~~G-~Glv~e~I~d~dG~~s~TL~~~l~~~~---------------------~~~----~~~~~L~~f~ 131 (199)
T PF10707_consen 78 HIPRFYGFVETNLG-LGLVVELIRDADGNISPTLEDYLKEGG---------------------LTE----ELRQALDEFK 131 (199)
T ss_pred ccccEeEEEecCCc-eEEEEEEEECCCCCcCccHHHHHHcCC---------------------ccH----HHHHHHHHHH
Confidence 45555665544433 4566666542 36778776543 222 2333444455
Q ss_pred HHhHHCCceecCCCCCceEEeCCC--C-eEEEEe-ccccc
Q 015991 276 DGLHSTGIVHRDIKPQNVIFSEGS--R-TFKIID-LGAAA 311 (397)
Q Consensus 276 ~yLH~~giiHrDIKp~NILl~~~~--~-~~kL~D-FGla~ 311 (397)
+||-+.+|+.+|++|.||++..+. . .+.|+| ||...
T Consensus 132 ~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 132 RYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred HHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 688899999999999999996433 2 688888 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.04 Score=52.26 Aligned_cols=29 Identities=21% Similarity=0.492 Sum_probs=25.5
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEeccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~ 311 (397)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 47999999999999998 4 68999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.03 Score=53.05 Aligned_cols=31 Identities=19% Similarity=0.390 Sum_probs=26.6
Q ss_pred CceecCCCCCceEEeCC---CCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEG---SRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~---~~~~kL~DFGla~~ 312 (397)
.++|+|+.+.|||++++ ...++++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 68999999999999974 23899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.053 Score=52.54 Aligned_cols=32 Identities=31% Similarity=0.524 Sum_probs=27.3
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
..++|+|+++.|||++++...+.++||..|..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 36899999999999987544899999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.015 Score=63.14 Aligned_cols=162 Identities=18% Similarity=0.119 Sum_probs=103.9
Q ss_pred hHHHHHHHHHHHHhhccCCCceeeeeecccccCC---eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcch
Q 015991 182 AVEIWMNERVRRACANCCADFVYGFFENSSKKGG---EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258 (397)
Q Consensus 182 ~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (397)
..+....+.+...+....|+++.+++.....+.. ...+..+++...++...++... .
T Consensus 223 k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--------------------~ 282 (1351)
T KOG1035|consen 223 KKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--------------------S 282 (1351)
T ss_pred HHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--------------------c
Confidence 3455555556666777788888887765543322 1223446777777777776554 4
Q ss_pred hcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC---ceEEeCCCCeEEEE--ecccccccccccccccccccCCCCCCCc
Q 015991 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ---NVIFSEGSRTFKII--DLGAAADLRVGINYIPKEFLLDPRYAAP 333 (397)
Q Consensus 259 l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~---NILl~~~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~Y~aP 333 (397)
.+....+.+..+...||.|+|+....|.=+... +-..+.++ ...++ ||+..+.+.+... ......+..|.++
T Consensus 283 i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~ 359 (1351)
T KOG1035|consen 283 IPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNAD 359 (1351)
T ss_pred cCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccc-eeecchhhhcccccCCCccc--chhhcCccccccc
Confidence 566778889999999999999995555444433 33333433 56666 8888876644322 1223445567788
Q ss_pred ccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCC
Q 015991 334 EQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRL 386 (397)
Q Consensus 334 E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf 386 (397)
|.+...... ...+.|+|.+|..+..+..|..+-
T Consensus 360 e~~~~~~~~--------------------~~r~~dL~~lgll~~~~~~~~~i~ 392 (1351)
T KOG1035|consen 360 EDLKENTAK--------------------KSRLTDLWCLGLLLLQLSQGEDIS 392 (1351)
T ss_pred cccccccch--------------------hhhhhHHHHHHHHHhhhhhcCccc
Confidence 866544332 223469999999999999887653
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.073 Score=51.28 Aligned_cols=138 Identities=15% Similarity=0.218 Sum_probs=83.8
Q ss_pred EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecc---------------------------cchhHHHHHHHHHHHH
Q 015991 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT---------------------------EYGAVEIWMNERVRRA 194 (397)
Q Consensus 142 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~---------------------------~~~~~e~~~~~~~~~~ 194 (397)
.+..+|..|--..||.|...+. ..+|||..+ .......|.+.++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG------~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL 220 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDG------SEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL 220 (520)
T ss_pred ecccccccCccceeEeeecCCC------ceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence 3567899999999999976655 457777542 1112234554444332
Q ss_pred hhcc--CCCceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHH
Q 015991 195 CANC--CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272 (397)
Q Consensus 195 ~~~~--~~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~ 272 (397)
.... ..|---.++ -....|||+|++... ++. +..+...++...+..+-.|++
T Consensus 221 kRl~~aGIP~PePIl------Lk~hVLVM~FlGrdg---------w~a-----------PkLKd~~ls~~ka~~~Y~~~v 274 (520)
T KOG2270|consen 221 KRLNNAGIPCPEPIL------LKNHVLVMEFLGRDG---------WAA-----------PKLKDASLSTSKARELYQQCV 274 (520)
T ss_pred HHHHhcCCCCCCcee------eecceEeeeeccCCC---------CcC-----------cccccccCChHHHHHHHHHHH
Confidence 2211 111100000 024579999998432 111 111222445555666777777
Q ss_pred HHHHHh-HHCCceecCCCCCceEEeCCCCeEEEEeccccccc
Q 015991 273 FALDGL-HSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 273 ~~L~yL-H~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~ 313 (397)
.-+.-| |..+.||.||.--|+|+.++ .+.|+|-+-+...
T Consensus 275 ~~MR~lY~~c~LVHADLSEfN~LyhdG--~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 275 RIMRRLYQKCRLVHADLSEFNLLYHDG--KLYIIDVSQSVEH 314 (520)
T ss_pred HHHHHHHHHhceeccchhhhhheEECC--EEEEEEccccccC
Confidence 777766 46799999999999999883 8999999987643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.017 Score=55.87 Aligned_cols=31 Identities=26% Similarity=0.336 Sum_probs=25.8
Q ss_pred HCCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
...++|+|+.+.||+++++ .++++||-.+..
T Consensus 191 ~~~llHGDl~~gNi~~~~~--~~~~iD~e~~~~ 221 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEH--ETKVIDPEFAFY 221 (370)
T ss_pred cceeeeccCCcccEEEcCC--CCEEEcCccccc
Confidence 3478999999999999875 588999987643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.042 Score=52.35 Aligned_cols=30 Identities=17% Similarity=0.222 Sum_probs=27.1
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
+++|+|+.+.|+|+++++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 799999999999999876 899999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.17 Score=48.56 Aligned_cols=29 Identities=34% Similarity=0.698 Sum_probs=25.7
Q ss_pred ceecCCCCCceEEeCCCCeEEEEeccccc
Q 015991 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (397)
Q Consensus 283 iiHrDIKp~NILl~~~~~~~kL~DFGla~ 311 (397)
+||+|+.|.||+++.+.....++|||-|.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999875238999999885
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.079 Score=51.03 Aligned_cols=30 Identities=20% Similarity=0.375 Sum_probs=26.0
Q ss_pred ceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 283 iiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
+.|.|+-+.|||++++++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999986544899999998854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.18 Score=47.30 Aligned_cols=32 Identities=28% Similarity=0.437 Sum_probs=26.7
Q ss_pred CceecCCCCCceEEeCCCCeEEEEeccccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~~ 313 (397)
.++|+|+++.|||+++++...-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 58999999999999975435679999998654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.22 Score=46.99 Aligned_cols=76 Identities=14% Similarity=0.112 Sum_probs=35.1
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHh---hccCCCceeeeeecccccCCeE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC---ANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~---~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.+-.+.++.|....+|+... ++ +.+.+|.-..........+.+-.+.+ .....|.++..... ++..
T Consensus 19 i~~~~~v~GG~i~~a~~~~~--~~-----~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~----~~~~ 87 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDT--DG-----GSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY----DDDA 87 (288)
T ss_dssp --EEEEE--SSSSEEEEEET--TS------EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-----SSCC
T ss_pred eeeeEecCCCChhheEEEEC--CC-----ccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee----cCCc
Confidence 44467899999999999872 22 67888877643322222222222222 23344555544332 2345
Q ss_pred EEEEEecCCC
Q 015991 218 WLIWRYEGEA 227 (397)
Q Consensus 218 ~lv~e~~~~g 227 (397)
+|++||++.+
T Consensus 88 fLlle~l~~~ 97 (288)
T PF03881_consen 88 FLLLEFLEMG 97 (288)
T ss_dssp EEEEE-----
T ss_pred eEEEEeecCC
Confidence 8999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.17 Score=47.20 Aligned_cols=50 Identities=20% Similarity=0.345 Sum_probs=37.6
Q ss_pred HHHHHHHHHHHHHHHHhHHC--CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 262 RIIQTIMSQLLFALDGLHST--GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 262 ~~i~~i~~qi~~~L~yLH~~--giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
..+...+..+-..+.-.+.. -++|.|+.|+|+|.++.+ .++|+||-.|..
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~ 183 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence 33444555555555555544 689999999999999966 899999988854
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.29 Score=46.71 Aligned_cols=32 Identities=28% Similarity=0.389 Sum_probs=28.3
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~ 314 (397)
.++|+|+.+.|||+++++ -+-++||+++..-+
T Consensus 199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCC-eeEEEeccccccCC
Confidence 589999999999999987 69999999997543
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.12 Score=49.81 Aligned_cols=51 Identities=16% Similarity=0.219 Sum_probs=43.0
Q ss_pred cHHHHHHHHHHHHHHHHHhHHC-CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 260 ENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 260 ~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++++..++.+.+.-|+-+... .+=|||+.-.||||+ +| ++.|+||-+++.
T Consensus 319 ~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDfklsRl 370 (488)
T COG5072 319 RSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDFKLSRL 370 (488)
T ss_pred cHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEeeeeec
Confidence 4566778888888877777654 789999999999999 56 999999999983
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.38 Score=53.41 Aligned_cols=32 Identities=25% Similarity=0.503 Sum_probs=26.0
Q ss_pred CCceecCCCCCceEEeCCC--CeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGS--RTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~--~~~kL~DFGla~~ 312 (397)
.++||.|+.+.|||++.++ ...-|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999763 2345999998753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.96 Score=43.39 Aligned_cols=29 Identities=24% Similarity=0.374 Sum_probs=24.4
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++||+|+.+.|||+++ .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~d---~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWRD---GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhccccC---CcEEEeCCCCCC
Confidence 47899999999999953 478999998863
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.46 Score=46.69 Aligned_cols=30 Identities=20% Similarity=0.128 Sum_probs=25.0
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
..+.|.|+-+.|||.+++ .++++||-.|..
T Consensus 227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecCC--CEEEEEeccccC
Confidence 467999999999998654 699999988753
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.24 Score=48.50 Aligned_cols=62 Identities=18% Similarity=0.268 Sum_probs=42.7
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHh-HHCCceecCCCCCce
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGL-HSTGIVHRDIKPQNV 293 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yL-H~~giiHrDIKp~NI 293 (397)
....++.+|+.|.++..++.... ..++...+++.-.+++|.-+ --.+++|.|+.|.||
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~~---------------------~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNV 376 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWKS---------------------QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNV 376 (565)
T ss_pred ccceeeeeccccccHHhhhhccc---------------------ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcE
Confidence 34567778888888888776653 23344555555555555443 356899999999999
Q ss_pred EEeC
Q 015991 294 IFSE 297 (397)
Q Consensus 294 Ll~~ 297 (397)
++.-
T Consensus 377 lirf 380 (565)
T KOG1236|consen 377 LIRF 380 (565)
T ss_pred EEEe
Confidence 9964
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.56 E-value=0.34 Score=47.58 Aligned_cols=30 Identities=23% Similarity=0.392 Sum_probs=25.1
Q ss_pred HCCceecCCCCCceEEeCCCCeEEEEeccccc
Q 015991 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~~~~kL~DFGla~ 311 (397)
.+..+|+|+.|.|||++++ ..|++|.-.|-
T Consensus 226 ~~aLlHGDlHtGSI~v~~~--~~kvIDpEFAf 255 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKND--STKVIDPEFAF 255 (409)
T ss_pred chhhccCcCCCCCEEecCC--ceEEEcccccc
Confidence 3479999999999999985 69999966653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.50 E-value=0.084 Score=50.32 Aligned_cols=53 Identities=17% Similarity=0.249 Sum_probs=37.0
Q ss_pred HHHHHHHHHHHHHHHHHhH----HCCceecCCCCCceEEeCCC-----------------CeEEEEeccccccc
Q 015991 261 NRIIQTIMSQLLFALDGLH----STGIVHRDIKPQNVIFSEGS-----------------RTFKIIDLGAAADL 313 (397)
Q Consensus 261 ~~~i~~i~~qi~~~L~yLH----~~giiHrDIKp~NILl~~~~-----------------~~~kL~DFGla~~~ 313 (397)
.+.++.+..|++.-.--+- ...++|-||||+|||+-+.. -.++|.||.+++.-
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3557778888875442221 34799999999999994332 15788999998654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=92.31 E-value=1.7 Score=42.91 Aligned_cols=28 Identities=25% Similarity=0.436 Sum_probs=23.4
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla 310 (397)
...+|+|+.+.||+++++ ..+++|.-.+
T Consensus 230 ~~L~HGDl~~g~i~~~~~--~~~~id~ef~ 257 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPD--STQVIDPEFA 257 (418)
T ss_pred cceeecCCCCCcEEEcCC--CceEecchhh
Confidence 479999999999999986 4889996544
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.26 E-value=0.27 Score=43.43 Aligned_cols=33 Identities=18% Similarity=0.287 Sum_probs=27.1
Q ss_pred HCCceecCCCCCceEEeCCCC----eEEEEecccccc
Q 015991 280 STGIVHRDIKPQNVIFSEGSR----TFKIIDLGAAAD 312 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~~----~~kL~DFGla~~ 312 (397)
...++|+|+.+.||+++.++. .+.|+||..+..
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 346899999999999986432 689999998864
|
subfamily of choline kinases |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.09 E-value=0.14 Score=44.83 Aligned_cols=30 Identities=27% Similarity=0.434 Sum_probs=25.7
Q ss_pred CceecCCCCCceEEeCCCCeEEEEeccccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~~ 313 (397)
-.+|+|+.|.||++++++ ++|+||+.|...
T Consensus 78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG--LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC--EEEEeCCcccCC
Confidence 469999999999998764 889999998653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 397 | ||||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-07 | ||
| 3e7e_A | 365 | Structure And Substrate Recruitment Of The Human Sp | 7e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-04 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-04 |
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E7E|A Chain A, Structure And Substrate Recruitment Of The Human Spindle Checkpoint Kinase Bub Length = 365 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 49/268 (18%), Positives = 85/268 (31%), Gaps = 81/268 (30%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNER--- 190
++L LG+GA V+R K GDL + V++ M E
Sbjct: 8 NHLWLLSDILGQGATANVFRGR------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 191 --------VRRACANCCADFVYGFFENSSKKGGEYWLIWRY--EGEATLADLMISREFPY 240
V+ ++ E ++ + LI + G L ++ Y
Sbjct: 62 KKLNHKNIVK----------LFAIEEETTTR--HKVLIMEFCPCGS--LYTVLEEPSNAY 107
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS---E 297
+ E E I+ + ++ ++ L GIVHR+IKP N++ +
Sbjct: 108 GLP--------------ESEFLIV---LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED 150
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPEQYIMSTQTPSAPSAPVATA 353
G +K+ D GAA +L E + Y P+ + A
Sbjct: 151 GQSVYKLTDFGAARELE------DDEQFVSLYGTEEYLHPD--MYERAVLRKDHQKKYGA 202
Query: 354 LSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
D++S G+ F
Sbjct: 203 TV------------DLWSIGVTFYHAAT 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 48/268 (17%), Positives = 84/268 (31%), Gaps = 81/268 (30%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNER--- 190
++L LG+GA V+R K GDL + V++ M E
Sbjct: 8 NHLWLLSDILGQGATANVFRGR------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 191 --------VRRACANCCADFVYGFFENSSKKGGEYWLIWRY--EGEATLADLMISREFPY 240
V+ ++ E ++ + LI + G L ++ Y
Sbjct: 62 KKLNHKNIVK----------LFAIEEETTTR--HKVLIMEFCPCGS--LYTVLEEPSNAY 107
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS---E 297
+ E E ++ ++ ++ L GIVHR+IKP N++ +
Sbjct: 108 GLP--------------ESE---FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED 150
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPEQYIMSTQTPSAPSAPVATA 353
G +K+ D GAA +L E + Y P+ + A
Sbjct: 151 GQSVYKLTDFGAARELE------DDEQFVSLYGTEEYLHPD--MYERAVLRKDHQKKYGA 202
Query: 354 LSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
D++S G+ F
Sbjct: 203 TV------------DLWSIGVTFYHAAT 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 31/255 (12%), Positives = 73/255 (28%), Gaps = 27/255 (10%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRA-------SLAKK---PSSKNDGDLVLKKATEYGAVEIW 186
R V G LG+ A S + + + + + E + +
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 187 MNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
+ ++ +K + L+ + N+QT
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
+ + + Q++ L LH G+VH ++P +++ + +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTG 249
Query: 307 LGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366
+R G + + PE + + + + T ++
Sbjct: 250 FEHL--VRDGARV---VSSVSRGFEPPE--LEARRATISYHRDRRTLMTF---------S 293
Query: 367 FDIYSAGLIFLQMVC 381
FD ++ GL+ + C
Sbjct: 294 FDAWALGLVIYWIWC 308
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 36/260 (13%), Positives = 81/260 (31%), Gaps = 62/260 (23%)
Query: 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE 189
+ + + + K++G G V++ + + + ++ + NE
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 190 -----RVRRACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISRE-FPYNV 242
++++ +Y + +++ + L + ++
Sbjct: 77 IAYLNKLQQHSDKIIR--LYDYEITDQY----IYMVMECGNID--LNSWLKKKKSID--- 125
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
E ++ +L A+ +H GIVH D+KP N + +G
Sbjct: 126 ---------------PWE---RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG--ML 165
Query: 303 KIIDLGAAADLRVGINYIPKEFLL-DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361
K+ID G A ++ + K+ + Y PE I + +
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA-IKDMSSSRENGKSKSKISPKS---- 220
Query: 362 NLPDRFDIYSAGLIFLQMVC 381
D++S G I M
Sbjct: 221 ------DVWSLGCILYYMTY 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 38/255 (14%), Positives = 85/255 (33%), Gaps = 62/255 (24%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE----- 189
+ + K++G G V++ + + + ++ + NE
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 190 RVRRACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISRE-FPYNVQTLIL 247
++++ +Y + +++ + L + ++
Sbjct: 63 KLQQHSDKIIR--LYDYEITDQY----IYMVMECGNID--LNSWLKKKKSID-------- 106
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
E ++ +L A+ +H GIVH D+KP N + +G K+ID
Sbjct: 107 ----------PWE---RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG--MLKLIDF 151
Query: 308 GAAADLRVGINYIPKEFLL-DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366
G A ++ + K+ + Y PE + + S + + +SP +
Sbjct: 152 GIANQMQPDTTSVVKDSQVGTVNYMPPE--AIKDMSSSRENGKSKSKISP---------K 200
Query: 367 FDIYSAGLIFLQMVC 381
D++S G I M
Sbjct: 201 SDVWSLGCILYYMTY 215
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 36/258 (13%), Positives = 80/258 (31%), Gaps = 62/258 (24%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-- 189
+ + + K++G G V++ + + + ++ + NE
Sbjct: 54 KGRIYSILKQIGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNEIA 106
Query: 190 ---RVRRACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISRE-FPYNVQT 244
++++ +Y + +++ + L + ++
Sbjct: 107 YLNKLQQHSDKIIR--LYDYEITDQY----IYMVMECGNID--LNSWLKKKKSID----- 153
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
E ++ +L A+ +H GIVH D+KP N + +G K+
Sbjct: 154 -------------PWE---RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKL 195
Query: 305 IDLGAAADLRVGINYIPKEFLL-DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363
ID G A ++ + K+ + Y PE I + +
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA-IKDMSSSRENGKSKSKISPKS------ 248
Query: 364 PDRFDIYSAGLIFLQMVC 381
D++S G I M
Sbjct: 249 ----DVWSLGCILYYMTY 262
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 55/262 (20%), Positives = 88/262 (33%), Gaps = 58/262 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
DF LG+GAFG V A+ D K + ++ A+
Sbjct: 5 ASDFEEIAVLGQGAFGQVV---KARN---ALDSRYYAIKKIRHTEEKLSTILSEVMLLAS 58
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL- 253
+V Y + + L I E+ N G + DL
Sbjct: 59 LNHQYVVRYYAAWLERRNFV------KPMTAVKKKSTLFIQMEYCEN------GTLYDLI 106
Query: 254 -PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
+ + ++ + Q+L AL +HS GI+HRD+KP N+ E SR KI D G A +
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKN 165
Query: 313 LRVGINYIPKEFLLD-------------PRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359
+ ++ + + Y A E + T +
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV-LDGTGHYNEKI------------ 212
Query: 360 QLNLPDRFDIYSAGLIFLQMVC 381
D+YS G+IF +M+
Sbjct: 213 --------DMYSLGIIFFEMIY 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 30/264 (11%), Positives = 64/264 (24%), Gaps = 30/264 (11%)
Query: 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRA-------SLAKK---PSSKNDGDLVLKKA 177
VE R V G LG+ A S + + + + +
Sbjct: 69 VESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 126
Query: 178 TEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE 237
E + + + ++ +K + L+ +
Sbjct: 127 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 186
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297
N+QT + + + Q++ L LH G+VH ++P +++ +
Sbjct: 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 246
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 357
+ P A P+ +
Sbjct: 247 RGG-VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF------- 298
Query: 358 LWQLNLPDRFDIYSAGLIFLQMVC 381
D ++ GL + C
Sbjct: 299 ----------DTWTLGLAIYWIWC 312
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 38/263 (14%), Positives = 71/263 (26%), Gaps = 46/263 (17%)
Query: 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVR 192
+ + L + L G VV+ + LK T ER+
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVR------DVERLEDFALKVFTMGAENSRSELERLH 110
Query: 193 RACANCCADFVYGFFENSSKKGGEYWL-IWRYEGEATLADLMISREFPYNVQTLILGEV- 250
A E ++ + + A L ++ L+L
Sbjct: 111 EATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA 170
Query: 251 -QDLPKGIERENRIIQT-----------IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298
DL + + + +QL+ L S G+VH P N+
Sbjct: 171 SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD 230
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 358
R + D+ A +VG P AP +++ ++ +
Sbjct: 231 GR-LMLGDVSALW--KVGTRG---PASSVPVTYAPREFLNASTATFTHAL---------- 274
Query: 359 WQLNLPDRFDIYSAGLIFLQMVC 381
+ + GL ++ C
Sbjct: 275 ---------NAWQLGLSIYRVWC 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 43/262 (16%), Positives = 78/262 (29%), Gaps = 63/262 (24%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
+ LGEGAF VY A+ +KN VLK E ++ ++
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
Y + L+ TL + + + + +P
Sbjct: 124 SMQHMFMKFYSAHLFQNG----SVLVGELYSYGTLLNAINLYKNTPE---------KVMP 170
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF----------SEGSRTFKI 304
++ + ++L+ ++ +H I+H DIKP N I + S +
Sbjct: 171 ------QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 305 IDLGAAADLRVGINYIPKEFLLD-----PRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359
IDLG + D+++ PK + + E M + P
Sbjct: 225 IDLGQSIDMKL----FPKGTIFTAKCETSGFQCVE---MLSNKPWNYQI----------- 266
Query: 360 QLNLPDRFDIYSAGLIFLQMVC 381
D + M+
Sbjct: 267 --------DYFGVAATVYCMLF 280
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 48/230 (20%), Positives = 84/230 (36%), Gaps = 43/230 (18%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA------------SLAKKPSSKNDGDLVLKKATEYGAVEI 185
+ + L +G+G++GVV A + K + + V + TE V +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE---VRL 81
Query: 186 WMNERVRRACANCCADFVYGFFENSSK--------KGGE-YWLIWRYEGEATLADLMISR 236
+ + +Y +E+ GG + + ++T M
Sbjct: 82 M------KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 237 EFPYNVQTLILGEVQDLPKGIEREN-------RIIQTIMSQLLFALDGLHSTGIVHRDIK 289
+ E + RE+ ++I IM Q+ AL LH+ GI HRDIK
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195
Query: 290 PQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
P+N +F + S K++D G + + N + P + APE
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKL-NNGEYYGMTTKAGTPYFVAPE 244
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 49/265 (18%), Positives = 85/265 (32%), Gaps = 82/265 (30%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE----- 189
+ + ++LG G FG V R ++ G+ V ++ E W E
Sbjct: 14 GPWEMKERLGTGGFGYVLRWI------HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 190 RVRRACANCCADFVYGFFENSSK--KGGEYWLIWRY--EGEATLADLMISREFPYNVQTL 245
++ N + + K L Y G+ L + E ++
Sbjct: 68 KLN--HPNVVS--AREVPDGLQKLAPNDLPLLAMEYCEGGD--LRKYLNQFENCCGLK-- 119
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGSRTFK 303
E R + +S + AL LH I+HRD+KP+N++ K
Sbjct: 120 ------------EGPIRTL---LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHK 164
Query: 304 IIDLGAAADLRVGINYIPKEFLLD-----PRYAAPEQYIMSTQ--TPSAPSAPVATALSP 356
IIDLG A + + L +Y APE ++ + T +
Sbjct: 165 IIDLGYA-------KELDQGELCTEFVGTLQYLAPE--LLEQKKYTVTV----------- 204
Query: 357 VLWQLNLPDRFDIYSAGLIFLQMVC 381
D +S G + + +
Sbjct: 205 -----------DYWSFGTLAFECIT 218
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 52/257 (20%), Positives = 77/257 (29%), Gaps = 68/257 (26%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNERVR 192
K F LG GA G + D V L + + E+ ++
Sbjct: 23 KISFCPKDVLGHGAEGTIVYRG-------MFDNRDVAVKRILPECFSFADREV----QLL 71
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
R N + RY R+F Y L +Q+
Sbjct: 72 RESDEH---------PN----------VIRYF------CTEKDRQFQYIAIELCAATLQE 106
Query: 253 L--PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE----GSRTFKIID 306
K T++ Q L LHS IVHRD+KP N++ S G I D
Sbjct: 107 YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 307 LGAAADLRVGINYIPKEFLLD--PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364
G L VG + + + + APE + +
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV---------------- 210
Query: 365 DRFDIYSAGLIFLQMVC 381
DI+SAG +F ++
Sbjct: 211 ---DIFSAGCVFYYVIS 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 51/273 (18%), Positives = 82/273 (30%), Gaps = 82/273 (30%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERVRRACAN 197
DF + LG G FGVV+ A +K D +K+ + + E R
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAK------NKVDDCNYAIKR------IRLPNRELAREKVMR 52
Query: 198 ------------------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFP 239
+ S ++ + + L D M R
Sbjct: 53 EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-- 110
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299
ERE + I Q+ A++ LHS G++HRD+KP N+ F+
Sbjct: 111 ---------------TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-D 154
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD-----------PRYAAPEQYIMSTQTPSAPSA 348
K+ D G + + Y +PEQ + + S
Sbjct: 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQ--IHGNSYSHKV- 211
Query: 349 PVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
DI+S GLI +++
Sbjct: 212 -------------------DIFSLGLILFELLY 225
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 47/207 (22%), Positives = 73/207 (35%), Gaps = 36/207 (17%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLK--KATEYGAVEIWMNE 189
++ + F +LG G++G V++ SK DG L +K + G +
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVR------SKEDGRLYAVKRSMSPFRGPKDRARKL 104
Query: 190 RVRRACANCCA-DFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISREFPYNVQTLIL 247
+ + + ++GG +L +Q
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQ-AWEEGGILYLQTELCGPS---------------LQQHCE 148
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
LP E ++ + L AL LHS G+VH D+KP N IF K+ D
Sbjct: 149 AWGASLP-----EAQV-WGYLRDTLLALAHLHSQGLVHLDVKPAN-IFLGPRGRCKLGDF 201
Query: 308 GAAADLRVGINYIPKEFLLDPRYAAPE 334
G +L G + DPRY APE
Sbjct: 202 GLLVEL--GTAGAGEVQEGDPRYMAPE 226
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 42/209 (20%), Positives = 73/209 (34%), Gaps = 39/209 (18%)
Query: 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKK--ATEYGAVEIWMNE-RVRRAC 195
++ +KLGEG F V L + +DG LK+ E E E + R
Sbjct: 30 HYLFIQKLGEGGFSYVD---LVE---GLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 196 A--NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
N + + E WL+ + TL + + + L
Sbjct: 84 NHPNILR--LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERL----------KDKGNFL 131
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
E + I ++ + L+ +H+ G HRD+KP N++ + ++DLG+
Sbjct: 132 T---EDQ---ILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQA 184
Query: 314 RVGINYIPKEFLLD--------PRYAAPE 334
+ + + L Y APE
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPE 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 50/289 (17%), Positives = 87/289 (30%), Gaps = 69/289 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEY----------- 180
DF + +G G FGVV+ A + A K + +L +K
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 181 --GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGE-----ATLADLM 233
W+ + ++ + + +T +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 234 ISREFPYNVQTLI---LGEVQDLPKGI-------ERENRIIQTIMSQLLFALDGLHSTGI 283
+ V I L ++L + +RE+ + I Q+ A++ LHS G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-----------PRYAA 332
+HRD+KP N IF K+ D G + + Y +
Sbjct: 186 MHRDLKPSN-IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 333 PEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
PEQ + S DI+S GLI +++
Sbjct: 245 PEQ--IHGNNYSHKV--------------------DIFSLGLILFELLY 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 45/203 (22%), Positives = 76/203 (37%), Gaps = 38/203 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC--- 195
+ +V +K+GEG+FG S DG + K M+ + R
Sbjct: 24 EKYVRLQKIGEGSFGKAILVK------STEDGRQYVIKEINISR----MSSKEREESRRE 73
Query: 196 ----ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
AN + + E S ++ G +++ Y L + +++
Sbjct: 74 VAVLANMKHPNIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGVL----------- 121
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
E++I+ Q+ AL +H I+HRDIK QN IF T ++ D G A
Sbjct: 122 -FQ-----EDQILD-WFVQICLALKHVHDRKILHRDIKSQN-IFLTKDGTVQLGDFGIAR 173
Query: 312 DLRVGINYIPKEFLLDPRYAAPE 334
L + + + P Y +PE
Sbjct: 174 VLNSTVELA-RACIGTPYYLSPE 195
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 44/223 (19%), Positives = 72/223 (32%), Gaps = 70/223 (31%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR 192
+ + +G LG G FG VY + +D V ++K E+ RV
Sbjct: 41 LESQYQVGPLLGSGGFGSVY---SGIR---VSDNLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 193 R----------ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNV 242
+ + +FE + LI + E P V
Sbjct: 95 MEVVLLKKVSSGFSGVIR--LLDWFERPDS----FVLI------------L---ERPEPV 133
Query: 243 QTLILGEVQD-------LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
++ D L E R + Q+L A+ H+ G++HRDIK +N++
Sbjct: 134 -----QDLFDFITERGALQ---EELAR---SFFWQVLEAVRHCHNCGVLHRDIKDENILI 182
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ID G+ + D Y+ PE
Sbjct: 183 DLNRGELKLIDFGSG-------ALLKDTVYTDFDGTRVYSPPE 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 46/270 (17%), Positives = 78/270 (28%), Gaps = 79/270 (29%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERV 191
+F +K+G G FG V++ + DG + A + E V
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCV------KRLDGCIYAIKRSKKPLAGSVDEQNA-LRE-V 61
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
V +F + + + Y +LAD + E +
Sbjct: 62 YAHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISE----NYRIMSYFKEAE 116
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV------------------ 293
++ ++ Q+ L +HS +VH DIKP N+
Sbjct: 117 ------------LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164
Query: 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 353
++ FKI DLG + P+ D R+ A E
Sbjct: 165 DWASNKVMFKIGDLGHVTRISS-----PQVEEGDSRFLANE------------------- 200
Query: 354 LSPVLWQLNLPDRF--DIYSAGLIFLQMVC 381
+ Q N DI++ L +
Sbjct: 201 ----VLQENYTHLPKADIFALALTVVCAAG 226
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 46/204 (22%), Positives = 75/204 (36%), Gaps = 37/204 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERVRRAC-- 195
+F + KK+G G F VYRA+ DG LKK + M+ + R C
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAA------CLLDGVPVALKKVQIFDL----MDAKARADCIK 81
Query: 196 -----ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
V ++ S + E ++ L+ ++ + F + +
Sbjct: 82 EIDLLKQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLI----- 133
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
E + + QL AL+ +HS ++HRDIKP N +F + K+ DLG
Sbjct: 134 --------PERTVWK-YFVQLCSALEHMHSRRVMHRDIKPAN-VFITATGVVKLGDLGLG 183
Query: 311 ADLRVGINYIPKEFLLDPRYAAPE 334
+ P Y +PE
Sbjct: 184 RFFSSKTTA-AHSLVGTPYYMSPE 206
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 43/209 (20%), Positives = 85/209 (40%), Gaps = 41/209 (19%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC--- 195
+D+ + +G G++G + K+DG +++ K +YG+ M E ++
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIR------RKSDGKILVWKELDYGS----MTEAEKQMLVSE 55
Query: 196 ----ANCCADFVYGFFEN-SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ +++ + +++ Y LA ++ + Q L
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYL----- 108
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHS-----TGIVHRDIKPQNVIFSEGSRTFKII 305
E +++ +M+QL AL H ++HRD+KP N +F +G + K+
Sbjct: 109 --------DEEFVLR-VMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQNVKLG 158
Query: 306 DLGAAADLRVGINYIPKEFLLDPRYAAPE 334
D G A L ++ K F+ P Y +PE
Sbjct: 159 DFGLARILNHDTSFA-KTFVGTPYYMSPE 186
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 51/223 (22%), Positives = 82/223 (36%), Gaps = 79/223 (35%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKK--PSSKNDGDLVLKKATEYGAVEIWMN 188
+ +++ + LG G FG+V+R + K D LV K E + I +N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---E---ISI-LN 56
Query: 189 ----ERVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISR 236
+ ++ FE+ + G + + + + +
Sbjct: 57 IARHRNILH---------LHESFESMEELVMIFEFISGLD------------IFERINTS 95
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295
F N ERE I + + Q+ AL LHS I H DI+P+N+I+
Sbjct: 96 AFELN----------------ERE---IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ S T KII+ G A L+ P + P Y APE
Sbjct: 137 TRRSSTIKIIEFGQARQLK------PGDNFRLLFTAPEYYAPE 173
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 40/183 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
+ + + +LG+GAFG VY+A +K G L K E +E ++ E
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAK------NKETGALAAAKVIETKSEEE---LEDYIVEIE 68
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ C + ++ + G+ W++ + + +M+ + L E
Sbjct: 69 ILATCDH---PYIVKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRG-------LTEP 117
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q IQ + Q+L AL+ LHS I+HRD+K NV+ + ++ D G +
Sbjct: 118 Q------------IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDI-RLADFGVS 164
Query: 311 ADL 313
A
Sbjct: 165 AKN 167
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 48/220 (21%), Positives = 76/220 (34%), Gaps = 69/220 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
D + + LG+G+FG V K G + K + E + R
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCK------DKITGQECAVKVISKRQVKQKTDK---ESLLR 75
Query: 194 ACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISRE 237
N +Y FFE+ GGE L D +ISR+
Sbjct: 76 EVQLLKQLDHPNIMK--LYEFFEDKGYFYLVGEVYTGGE------------LFDEIISRK 121
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295
++ E + I+ Q+L + +H IVHRD+KP+N++
Sbjct: 122 R-FS----------------EVD---AARIIRQVLSGITYMHKNKIVHRDLKPENLLLES 161
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
S+ + +IID G + K+ + Y APE
Sbjct: 162 KSKDA-NIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE 198
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 46/219 (21%), Positives = 72/219 (32%), Gaps = 59/219 (26%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWM-NERVRRAC- 195
DF + +G G FG V++A + DG V+K + NE+ R
Sbjct: 11 MDFKEIELIGSGGFGQVFKAK------HRIDGKTYVIK--------RVKYNNEKAEREVK 56
Query: 196 --ANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
A + G ++ L M EF +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM---EF---------CDK 104
Query: 251 QDLPKGIERENRI------IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
L + IE+ + Q+ +D +HS +++RD+KP N IF ++ KI
Sbjct: 105 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN-IFLVDTKQVKI 163
Query: 305 IDLGAAADLR--------VGINYIPKEFLLDPRYAAPEQ 335
D G L+ G RY +PEQ
Sbjct: 164 GDFGLVTSLKNDGKRTRSKG----------TLRYMSPEQ 192
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 51/233 (21%), Positives = 79/233 (33%), Gaps = 55/233 (23%)
Query: 120 FDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------ 173
F F L ++ +D++++ K LG GA G V A + V
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF------ERKTCKKVAIRIIS 169
Query: 174 LKKATEYGAVEIWMNERVRRACA--------NCCADFVYGFFENSSKKGGEYWLIWRY-- 223
+K A E V + FF+ Y+++
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIK--IKNFFDAED-----YYIVLELME 222
Query: 224 EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283
GE L D ++ + E + Q+L A+ LH GI
Sbjct: 223 GGE--LFDKVVGNKR-LK----------------EATCK---LYFYQMLLAVQYLHENGI 260
Query: 284 VHRDIKPQNVIFS--EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
+HRD+KP+NV+ S E KI D G + +G + + P Y APE
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCGTPTYLAPE 311
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 44/212 (20%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKK----PSSKNDGDLVLKKATEYGAVEIW 186
+DD+ L + +G GA VV A +A K + D +LK EI
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK--------EIQ 65
Query: 187 MNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
+ C + ++ S E WL+ + ++ D++ ++ +
Sbjct: 66 A-------MSQCHHPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
L E I TI+ ++L L+ LH G +HRD+K N++ E + +I D
Sbjct: 118 LDEST------------IATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIAD 164
Query: 307 LGAAADLRVGINYIPKE----FLLDPRYAAPE 334
G +A L G + + F+ P + APE
Sbjct: 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 44/183 (24%), Positives = 72/183 (39%), Gaps = 42/183 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
+ K+GEG+ G+V A K+ G V L+K E+ NE
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAR------EKHSGRQVAVKMMDLRKQQR---RELLFNEVV 94
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ R + V ++ S G E W++ + L D++ + L E
Sbjct: 95 IMRDYQH---FNVVEMYK-SYLVGEELWVLMEFLQGGALTDIV---------SQVRLNEE 141
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q I T+ +L AL LH+ G++HRDIK +++ + R K+ D G
Sbjct: 142 Q------------IATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRV-KLSDFGFC 188
Query: 311 ADL 313
A +
Sbjct: 189 AQI 191
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 49/271 (18%), Positives = 81/271 (29%), Gaps = 77/271 (28%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNER-- 190
K+ V K LG G+ G V G V L + +EI +
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQG-------SFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 191 -----VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
+R Y ++ L DL+ S+
Sbjct: 67 DHPNVIR----------YYCSETTDRF----LYIALELCN-LNLQDLVESKNVS------ 105
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF--- 302
++L E +++ Q+ + LHS I+HRD+KPQN++ S SR
Sbjct: 106 ----DENLKLQKEYN---PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158
Query: 303 ---------KIIDLGAAADLRVGINYIPKEFLLD---PRYAAPEQYIMSTQTPSAPSAPV 350
I D G L G + + APE ++ +
Sbjct: 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE--LLEESNNLQTKRRL 216
Query: 351 ATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
++ DI+S G +F ++
Sbjct: 217 TRSI-------------DIFSMGCVFYYILS 234
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 46/223 (20%), Positives = 78/223 (34%), Gaps = 65/223 (29%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNER 190
+ + +KLG GA+G V A K K+ + ++ +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQ--FDKGRYSDDNKNIEKFHEE 92
Query: 191 VRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMI 234
+ + N ++ FE+ +GGE L + +I
Sbjct: 93 IYNEISLLKSLDHPNIIK--LFDVFEDKKYFYLVTEFYEGGE------------LFEQII 138
Query: 235 SREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294
+R ++ E + IM Q+L + LH IVHRDIKP+N++
Sbjct: 139 NRHK-FD----------------ECD---AANIMKQILSGICYLHKHNIVHRDIKPENIL 178
Query: 295 F---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
+ KI+D G ++ Y ++ L Y APE
Sbjct: 179 LENKNSLL-NIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPE 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 43/218 (19%), Positives = 78/218 (35%), Gaps = 69/218 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERVRR 193
D + + + +G G++ V R K ++ K+ EI E + R
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCI------HKATNMEFAVKIIDKSKRDPTEEI---EILLR 71
Query: 194 A--CANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYNVQ 243
N + +++ KGGE L D ++ ++F ++
Sbjct: 72 YGQHPNIIT--LKDVYDDGKYVYVVTELMKGGE------------LLDKILRQKF-FS-- 114
Query: 244 TLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF---SEGSR 300
ERE ++ + ++ LH+ G+VHRD+KP N+++ S
Sbjct: 115 --------------EREAS---AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPE 157
Query: 301 TFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ +I D G A LR L+ + APE
Sbjct: 158 SIRICDFGFAKQLRAE-----NGLLMTPCYTANFVAPE 190
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 53/216 (24%), Positives = 75/216 (34%), Gaps = 62/216 (28%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA- 196
+ + KKLG GA+G V K K +V N ++ A
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCR------DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAV 89
Query: 197 -------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
N +Y FFE+ KGGE L D +I R +N
Sbjct: 90 LKLLDHPNIMK--LYDFFEDKRNYYLVMECYKGGE------------LFDEIIHRMK-FN 134
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF---SEG 298
E + I+ Q+L + LH IVHRD+KP+N++ +
Sbjct: 135 ----------------EVD---AAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKD 175
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
+ KI+D G +A KE L Y APE
Sbjct: 176 A-LIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE 208
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 44/183 (24%), Positives = 71/183 (38%), Gaps = 42/183 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
K + +K+G+GA G VY A G V L++ + E+ +NE
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPK---KELIINEIL 69
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
V R N + + + S G E W++ Y +L D++ + E
Sbjct: 70 VMRENKN---PNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTET---------CMDEG 116
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q I + + L AL+ LHS ++HRDIK N++ K+ D G
Sbjct: 117 Q------------IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV-KLTDFGFC 163
Query: 311 ADL 313
A +
Sbjct: 164 AQI 166
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 46/225 (20%), Positives = 74/225 (32%), Gaps = 82/225 (36%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNER 190
D + + ++LG GAFGVV+R K +
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAK---------FINTPYPLDK------YT 94
Query: 191 VRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMI 234
V+ + ++ FE+ + GGE L D +
Sbjct: 95 VKNEISIMNQLHHPKLIN--LHDAFEDKYEMVLILEFLSGGE------------LFDRIA 140
Query: 235 SREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294
+ ++ + E E + M Q L +H IVH DIKP+N++
Sbjct: 141 AEDYKMS----------------EAE---VINYMRQACEGLKHMHEHSIVHLDIKPENIM 181
Query: 295 F-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
++ + + KIID G A L P E + +AAPE
Sbjct: 182 CETKKASSVKIIDFGLATKLN------PDEIVKVTTATAEFAAPE 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 9e-15
Identities = 48/218 (22%), Positives = 78/218 (35%), Gaps = 63/218 (28%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNE-RVR 192
D F+ +KLG GAFG V+ ++ G + K +E E V
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVE------ERSSGLERVIKTINKDRSQVPMEQIEAEIEVL 74
Query: 193 RAC--ANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYNV 242
++ N ++ FE+ +GGE L + ++S +
Sbjct: 75 KSLDHPNIIK--IFEVFEDYHNMYIVMETCEGGE------------LLERIVSAQARGKA 120
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGSR 300
+ E + +M Q++ AL HS +VH+D+KP+N++F
Sbjct: 121 LS-------------EGY---VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 301 TFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
KIID G A + E + Y APE
Sbjct: 165 PIKIIDFGLA------ELFKSDEHSTNAAGTALYMAPE 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 44/227 (19%), Positives = 74/227 (32%), Gaps = 63/227 (27%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR 192
+ ++ LG LG+G FG V+ + D V + + G + +
Sbjct: 29 FEAEYRLGPLLGKGGFGTVF---AGHR---LTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 193 R------------ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPY 240
+ +FE + L+ + E P
Sbjct: 83 LEVALLWKVGAGGGHPGVIR--LLDWFETQEG----FMLV------------L---ERPL 121
Query: 241 NVQTLILGEVQDL--PKG--IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
++ D KG E +R Q++ A+ HS G+VHRDIK +N++
Sbjct: 122 PA-----QDLFDYITEKGPLGEGPSR---CFFGQVVAAIQHCHSRGVVHRDIKDENILID 173
Query: 297 EGSRTFKIIDLGAAADLRVG--------INYIPKEFLLDPRYAAPEQ 335
K+ID G+ A L Y P E++ +Y A
Sbjct: 174 LRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPA 220
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 41/220 (18%), Positives = 73/220 (33%), Gaps = 70/220 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RV 191
+ + + LG+G+FG V + + K + + + E +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCK------DRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 192 RRAC--ANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
+ N ++ E+SS GGE L D +I R+ ++
Sbjct: 75 LKKLDHPNIMK--LFEILEDSSSFYIVGELYTGGE------------LFDEIIKRKR-FS 119
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF---SEG 298
E + I+ Q+ + +H IVHRD+KP+N++ +
Sbjct: 120 ----------------EHD---AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
KIID G + + + D Y APE
Sbjct: 161 C-DIKIIDFGLS------TCFQQNTKMKDRIGTAYYIAPE 193
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 47/216 (21%), Positives = 76/216 (35%), Gaps = 52/216 (24%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAV--E 184
Y D+ LG+G +G+VY ++ + + + + E
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGR------DLSNQVRIAIKEIPERDSRYSQPLHEE 69
Query: 185 IWMNER------VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF 238
I +++ V+ G S + G + +L+ L+ S+
Sbjct: 70 IALHKHLKHKNIVQ----------YLG----SFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298
P ++ + I Q+L L LH IVHRDIK NV+ +
Sbjct: 116 P-----------------LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY 158
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
S KI D G + L GIN + F +Y APE
Sbjct: 159 SGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPE 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 47/232 (20%), Positives = 74/232 (31%), Gaps = 77/232 (33%)
Query: 134 TTYRKDDF----VLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEI 185
T +R+++ G++LG G F VV + K+ G +KK +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCR------EKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 186 WMNERVRR--------ACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATL 229
E + R N ++ +EN + GGE L
Sbjct: 56 VSREDIEREVSILKEIQHPNVIT--LHEVYENKTDVILILELVAGGE------------L 101
Query: 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
D + +E E E + Q+L + LHS I H D+K
Sbjct: 102 FDFLAEKES-LT----------------EEE---ATEFLKQILNGVYYLHSLQIAHFDLK 141
Query: 290 PQNVIF---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
P+N++ + KIID G A + P + APE
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLA------HKIDFGNEFKNIFGTPEFVAPE 187
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 49/217 (22%), Positives = 79/217 (36%), Gaps = 66/217 (30%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNE- 189
D + + ++LG GAFGVV+R + A K E ++ M+
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE---IQT-MSVL 211
Query: 190 ---RVRRACANCCADFVYGFFENSSKKGGEYWLIWRYE----GEATLADLMISREFPYNV 242
+ ++ FE+ + E +I YE GE L + + +
Sbjct: 212 RHPTLVN---------LHDAFEDDN----EMVMI--YEFMSGGE--LFEKVADEHNKMS- 253
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRT 301
E E M Q+ L +H VH D+KP+N++F ++ S
Sbjct: 254 ---------------EDE---AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE 295
Query: 302 FKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ID G A L PK+ + +AAPE
Sbjct: 296 LKLIDFGLTAHLD------PKQSVKVTTGTAEFAAPE 326
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 42/219 (19%), Positives = 73/219 (33%), Gaps = 68/219 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RV 191
+ + + LG+G+FG V + + K + + + E +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCK------DRITQQEYAVKVINKASAKNKDTSTILREVEL 74
Query: 192 RRACA--NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
+ N ++ E+SS GGE L D +I R+ ++
Sbjct: 75 LKKLDHPNIMK--LFEILEDSSSFYIVGELYTGGE------------LFDEIIKRKR-FS 119
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGS 299
E + I+ Q+ + +H IVHRD+KP+N++ E
Sbjct: 120 ----------------EHD---AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKD 160
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
KIID G + + + D Y APE
Sbjct: 161 CDIKIIDFGLSTCFQ------QNTKMKDRIGTAYYIAPE 193
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 3e-14
Identities = 45/224 (20%), Positives = 72/224 (32%), Gaps = 73/224 (32%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWMNERVRR 193
+D + +G++LG G F +V + K G +KK + E + R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCR------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 57
Query: 194 ACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISRE 237
N ++ FEN + GGE L D + +E
Sbjct: 58 EVNILREIRHPNIIT--LHDIFENKTDVVLILELVSGGE------------LFDFLAEKE 103
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295
E E + Q+L + LHS I H D+KP+N++
Sbjct: 104 S-LT----------------EDE---ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD 143
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ + K+ID G A + P + APE
Sbjct: 144 KNVPNPRIKLIDFGIA------HKIEAGNEFKNIFGTPEFVAPE 181
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 49/222 (22%), Positives = 71/222 (31%), Gaps = 69/222 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERV 191
+D++++ K LG GA G V A + V +K A E V
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAF------ERKTCKKVAIKIISKRKFAIGSAREADPALNV 62
Query: 192 RRACANC------CADFVYGFFENSSK-------KGGEYWLIWRYEGEATLADLMISREF 238
C + FF+ +GGE L D ++ +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGE------------LFDKVVGNKR 110
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-- 296
E + Q+L A+ LH GI+HRD+KP+NV+ S
Sbjct: 111 -LK----------------EATCK---LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
E KI D G + L + P Y APE
Sbjct: 151 EEDCLIKITDFGHSKILG------ETSLMRTLCGTPTYLAPE 186
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 40/182 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERV 191
++ F + +KLGEG++G VY+A K G +V ++ + EI +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAI------HKETGQIVAIKQVPVESDLQEIIKEISI---- 77
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
C + V ++ S K + W++ Y G +++D++ R L E +
Sbjct: 78 ---MQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-------LTEDE 126
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
I TI+ L L+ LH +HRDIK N++ + K+ D G A
Sbjct: 127 ------------IATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHA-KLADFGVAG 173
Query: 312 DL 313
L
Sbjct: 174 QL 175
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 45/224 (20%), Positives = 80/224 (35%), Gaps = 61/224 (27%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWM 187
F+ +D + +G++LG G F +V + K+ G +KK +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCR------EKSTGLEYAAKFIKKRQSRASRRGVS 58
Query: 188 NERVRRACA--------NCCADFVYGFFENSSKKGGEYWLIWRY--EGEATLADLMISRE 237
E + R + N ++ +EN + + LI GE L D + +E
Sbjct: 59 REEIEREVSILRQVLHHNVIT--LHDVYENRT----DVVLILELVSGGE--LFDFLAQKE 110
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295
+ E E + + Q+L ++ LH+ I H D+KP+N++
Sbjct: 111 S-LS----------------EEE---ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ K+ID G A + P + APE
Sbjct: 151 KNIPIPHIKLIDFGLA------HEIEDGVEFKNIFGTPEFVAPE 188
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 47/218 (21%), Positives = 74/218 (33%), Gaps = 61/218 (27%)
Query: 138 KDDFVLGKKLGEGAFGVVYRAS-------LAKKPSSKNDGDLVLKKATEYGAVEIWMNE- 189
+++ + LG G VV R A K G + + E + E
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ-ELREATLKEV 74
Query: 190 RV-RRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPY 240
+ R+ + + +E ++ K GE L D + +
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE------------LFDYLTEKVT-L 121
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR 300
+ E+E R IM LL + LH IVHRD+KP+N++ +
Sbjct: 122 S----------------EKETR---KIMRALLEVICALHKLNIVHRDLKPENILLDDDM- 161
Query: 301 TFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ D G + L P E L + P Y APE
Sbjct: 162 NIKLTDFGFSCQLD------PGEKLREVCGTPSYLAPE 193
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 38/184 (20%), Positives = 68/184 (36%), Gaps = 40/184 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
+ F +++G G+FG VY A + ++V + + E R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFAR------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 106
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISREFPYNVQTLILGE 249
+ + + + WL+ Y G + +DL+ + P L E
Sbjct: 107 FLQKLRH---PNTIQYRG-CYLREHTAWLVMEYCLG--SASDLLEVHKKP-------LQE 153
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
V+ I + L L LHS ++HRD+K N++ SE K+ D G+
Sbjct: 154 VE------------IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV-KLGDFGS 200
Query: 310 AADL 313
A+ +
Sbjct: 201 ASIM 204
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 45/222 (20%), Positives = 70/222 (31%), Gaps = 70/222 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERV 191
+ +G G VV R + G + + E
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCV------HRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 192 RRACANCCADF-------VYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISR 236
RR + +E+SS + GE L D + +
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE------------LFDYLTEK 194
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
+ E+E R +IM LL A+ LH+ IVHRD+KP+N++
Sbjct: 195 VA-LS----------------EKETR---SIMRSLLEAVSFLHANNIVHRDLKPENILLD 234
Query: 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ ++ D G + L P E L + P Y APE
Sbjct: 235 DNM-QIRLSDFGFSCHLE------PGEKLRELCGTPGYLAPE 269
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 36/182 (19%), Positives = 60/182 (32%), Gaps = 45/182 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRR---A 194
++G G+FG V+R K G AV ++ + A
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMK------DKQTGFQC--------AVKKVRLEVFRVEELVA 103
Query: 195 CANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
CA + + YG ++G + +L L+ ++
Sbjct: 104 CAGLSSPRIVPLYGAV----REGPWVNIFMELLEGGSLGQLI--KQM------------- 144
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
G E+ + Q L L+ LH+ I+H D+K NV+ S + D G A
Sbjct: 145 ----GCLPED-RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199
Query: 312 DL 313
L
Sbjct: 200 CL 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 44/230 (19%), Positives = 78/230 (33%), Gaps = 73/230 (31%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKATEYGAVEIWM 187
F+ +D + +G++LG G F +V + K+ G +KK +
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCR------EKSTGLEYAAKFIKKRQSRASRRGVC 58
Query: 188 NERVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLAD 231
E + R + N ++ +EN + GGE L D
Sbjct: 59 REEIEREVSILRQVLHPNIIT--LHDVYENRTDVVLILELVSGGE------------LFD 104
Query: 232 LMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
+ +E + E E + + Q+L ++ LH+ I H D+KP+
Sbjct: 105 FLAQKES-LS----------------EEE---ATSFIKQILDGVNYLHTKKIAHFDLKPE 144
Query: 292 NVIF---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
N++ + K+ID G A + P + APE
Sbjct: 145 NIMLLDKNIPIPHIKLIDFGLA------HEIEDGVEFKNIFGTPEFVAPE 188
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 49/183 (26%), Positives = 76/183 (41%), Gaps = 41/183 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-R 190
++ F +K+G+G+FG V++ +V L++A + +E E
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGI------DNRTQKVVAIKIIDLEEAED--EIEDIQQEIT 72
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
V C + +V ++ S K + W+I Y G + DL+ L E
Sbjct: 73 VLSQCDS---PYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPG---------PLDET 119
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q I TI+ ++L LD LHS +HRDIK NV+ SE K+ D G A
Sbjct: 120 Q------------IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV-KLADFGVA 166
Query: 311 ADL 313
L
Sbjct: 167 GQL 169
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 48/249 (19%), Positives = 81/249 (32%), Gaps = 71/249 (28%)
Query: 111 ATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDG 170
+PG++ G + +A + LF Y L + +G+G F VV R ++ G
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYE-----LCEVIGKGPFSVVRRCI------NRETG 49
Query: 171 DL----VLKKATEYGAVEIWMNERVRRACANCCADF-------VYGFFENSSK------- 212
++ A ++ + E ++R A+ C + + +
Sbjct: 50 QQFAVKIVDVA-KFTSSPGLSTEDLKRE-ASICHMLKHPHIVELLETYSSDGMLYMVFEF 107
Query: 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQL 271
G + L ++ R V + E M Q+
Sbjct: 108 MDGAD------------LCFEIVKRADAGFVYS-------------EAVAS---HYMRQI 139
Query: 272 LFALDGLHSTGIVHRDIKPQNVIFS--EGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
L AL H I+HRD+KP V+ + E S K+ G A L
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-----GESGLVAGGRV 194
Query: 328 --PRYAAPE 334
P + APE
Sbjct: 195 GTPHFMAPE 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 42/224 (18%), Positives = 75/224 (33%), Gaps = 77/224 (34%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNERVR 192
+++ L ++LG+GAF VV R G K + E
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCV------KVLAGQEYAAMIINTKKLSARDHQKLERE--- 60
Query: 193 RACANCCADF-------VYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISRE 237
A C ++ GGE L + +++RE
Sbjct: 61 ---ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE------------LFEDIVARE 105
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295
+ Y+ E + + Q+L A+ H G+VHR++KP+N++
Sbjct: 106 Y-YS----------------EADAS---HCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+G+ K+ D G A ++ ++ P Y +PE
Sbjct: 146 KLKGA-AVKLADFGLAIEVEG-----EQQAWFGFAGTPGYLSPE 183
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 30/227 (13%), Positives = 65/227 (28%), Gaps = 68/227 (29%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKK----------PSSKNDGDLVLKKATEYGAVEIWMN 188
+D+ + + L +G F + L +K S + K+
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 189 ERVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADL 232
+ + C G N + + +
Sbjct: 88 DDFKNELQIITDIKNEYCLT--CEGIITNYDEVYIIYEYMENDS---------------I 130
Query: 233 MISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQ 291
++ +L + I+ II+ +L + +H+ I HRD+KP
Sbjct: 131 -----LKFDEYFFVLDKNYTCFIPIQVIKCIIK----SVLNSFSYIHNEKNICHRDVKPS 181
Query: 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
N++ + + K+ D G + Y+ + + + PE
Sbjct: 182 NILMDK-NGRVKLSDFGES-------EYMVDKKIKGSRGTYEFMPPE 220
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 53/217 (24%), Positives = 74/217 (34%), Gaps = 58/217 (26%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LK-----KATEYGAVEIWMNER 190
+ LG GAFG V+ A K V +K K E +E +
Sbjct: 22 YSQKYSTMSPLGSGAFGFVWTAV------DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 191 VRRACA--------NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNV 242
V A N V FEN + L+ G DL F +
Sbjct: 76 VTLEIAILSRVEHANIIK--VLDIFENQGF----FQLVMEKHGSG--LDL-----FAFID 122
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
+ P+ E I QL+ A+ L I+HRDIK +N++ +E T
Sbjct: 123 RH---------PRLDEPLAS---YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE-DFTI 169
Query: 303 KIIDLGAAADLRVGINYIPKEFLLD-----PRYAAPE 334
K+ID G+A Y+ + L Y APE
Sbjct: 170 KLIDFGSA-------AYLERGKLFYTFCGTIEYCAPE 199
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 42/219 (19%), Positives = 71/219 (32%), Gaps = 70/219 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA- 196
+ L +G G++G V A K K VE +R ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAV------QKGTRIRRAAKKIPKYFVE--DVDRFKQEIEI 59
Query: 197 -------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
N +Y FE+++ GGE L + ++ + +
Sbjct: 60 MKSLDHPNIIR--LYETFEDNTDIYLVMELCTGGE------------LFERVVHKRV-FR 104
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGS 299
E + IM +L A+ H + HRD+KP+N +F
Sbjct: 105 ----------------ESDAA---RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 145
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ID G AA + P + + P Y +P+
Sbjct: 146 SPLKLIDFGLAARFK------PGKMMRTKVGTPYYVSPQ 178
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 48/220 (21%), Positives = 81/220 (36%), Gaps = 70/220 (31%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RV 191
D++ + ++LG+GAF VV R K G K + E R+
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCV------HKTTGLEFAAKIINTKKLSARDFQKLEREARI 58
Query: 192 RRACA--NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREFPYN 241
R N ++ + S GGE L + +++REF Y+
Sbjct: 59 CRKLQHPNIVR--LHDSIQEESFHYLVFDLVTGGE------------LFEDIVAREF-YS 103
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF---SEG 298
E + + Q+L ++ HS GIVHR++KP+N++ ++G
Sbjct: 104 ----------------EADAS---HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKG 144
Query: 299 SRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ K+ D G A ++ E P Y +PE
Sbjct: 145 A-AVKLADFGLAIEVN------DSEAWHGFAGTPGYLSPE 177
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 29/116 (25%), Positives = 46/116 (39%), Gaps = 32/116 (27%)
Query: 266 TIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL-RVGINYIPKEF 324
+ ++L AL LHS G+V+ D+KP+N++ +E K+IDLGA + + G
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGY------L 237
Query: 325 LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
P + APE + P DIY+ G +
Sbjct: 238 YGTPGFQAPEI---------VRTGPT--------------VATDIYTVGRTLAALT 270
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 49/223 (21%), Positives = 79/223 (35%), Gaps = 67/223 (30%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWM 187
+TT + F+ + LG GAF V+ + G L +KK+
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVK------QRLTGKLFALKCIKKSPA-FRDSSLE 54
Query: 188 NE-RVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREF 238
NE V + + + +E+++ GGE L D ++ R
Sbjct: 55 NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE------------LFDRILERGV 102
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF--- 295
Y E++ ++ Q+L A+ LH GIVHRD+KP+N+++
Sbjct: 103 -YT----------------EKDAS---LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP 142
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
E S I D G + + P Y APE
Sbjct: 143 EENS-KIMITDFGLSK-------MEQNGIMSTACGTPGYVAPE 177
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 48/226 (21%), Positives = 83/226 (36%), Gaps = 82/226 (36%)
Query: 138 KDDFVLGKKLGEGAFGVVYRA------------SLAKKPSSKNDGDLVLKKATEYGAVEI 185
D++ + ++LG+GAF VV R + K S D + + E
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER--------EA 79
Query: 186 WMNERVRRACA--NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMIS 235
R+ R N ++ + S GGE L + +++
Sbjct: 80 ----RICRKLQHPNIVR--LHDSIQEESFHYLVFDLVTGGE------------LFEDIVA 121
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
REF Y+ E + + Q+L ++ HS GIVHR++KP+N++
Sbjct: 122 REF-YS----------------EADAS---HCIQQILESIAYCHSNGIVHRNLKPENLLL 161
Query: 296 ---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
++G+ K+ D G A ++ E P Y +PE
Sbjct: 162 ASKAKGA-AVKLADFGLAIEVN------DSEAWHGFAGTPGYLSPE 200
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-13
Identities = 45/188 (23%), Positives = 73/188 (38%), Gaps = 43/188 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-------VEIWMNER 190
F L + +G G +G VY+ G L K + EI M
Sbjct: 23 AGIFELVELVGNGTYGQVYKGR------HVKTGQLAAIKVMDVTGDEEEEIKQEINM--- 73
Query: 191 VRRACANCCADFV---YGFF--ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
+++ + + YG F +N + WL+ + G ++ DL+ N +
Sbjct: 74 LKKYSHH---RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI------KNTKGN 124
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
L E I I ++L L LH ++HRDIK QNV+ +E + K++
Sbjct: 125 TLKEEW------------IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV-KLV 171
Query: 306 DLGAAADL 313
D G +A L
Sbjct: 172 DFGVSAQL 179
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 46/223 (20%), Positives = 75/223 (33%), Gaps = 76/223 (34%)
Query: 138 KDDFVLGKK--LGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMN 188
+ + K LG G FG V++ LA K + E + + MN
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE---ISV-MN 141
Query: 189 E----RVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISR 236
+ + + +Y FE+ + GGE L D +I
Sbjct: 142 QLDHANLIQ---------LYDAFESKNDIVLVMEYVDGGE------------LFDRIIDE 180
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295
+ E + M Q+ + +H I+H D+KP+N++
Sbjct: 181 SYNLT----------------ELD---TILFMKQICEGIRHMHQMYILHLDLKPENILCV 221
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ ++ KIID G A Y P+E L P + APE
Sbjct: 222 NRDAKQIKIIDFGLA------RRYKPREKLKVNFGTPEFLAPE 258
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 57/236 (24%), Positives = 89/236 (37%), Gaps = 57/236 (24%)
Query: 111 ATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDG 170
A PG A D ++ D F + +LG GA +VYR +K + K
Sbjct: 30 AAPGTASLVPDYWIDGS-----NRDALSDFFEVESELGRGATSIVYRCK--QKGTQKPYA 82
Query: 171 DLVLKKATEYGAVEIWMNE-RVRRACANCCADFVYGFFENSSK--------KGGEYWLIW 221
VLKK + V E V ++ + FE ++ GGE
Sbjct: 83 LKVLKKTVDKKIVR---TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----- 134
Query: 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281
L D ++ + + Y+ ER+ + Q+L A+ LH
Sbjct: 135 -------LFDRIVEKGY-YS----------------ERDAA---DAVKQILEAVAYLHEN 167
Query: 282 GIVHRDIKPQNVIF---SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
GIVHRD+KP+N+++ + + KI D G + + + K P Y APE
Sbjct: 168 GIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPE 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 50/207 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR----- 193
DDF +LG G GVV++ S KPS + K + + + +R
Sbjct: 33 DDFEKISELGAGNGGVVFKVSH--KPSGLV---MARKL------IHLEIKPAIRNQIIRE 81
Query: 194 --ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
C + ++ YG F GE + + +L ++ + +
Sbjct: 82 LQVLHECNSPYIVGFYGAFY----SDGEISICMEHMDGGSLDQVLK--------KAGRIP 129
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IVHRDIKPQNVIFSEGSRTFKIIDL 307
E +I+ + ++ L L I+HRD+KP N++ + K+ D
Sbjct: 130 E------------QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDF 176
Query: 308 GAAADLRVGINYIPKEFLLDPRYAAPE 334
G + L I+ + F+ Y +PE
Sbjct: 177 GVSGQL---IDSMANSFVGTRSYMSPE 200
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 46/228 (20%), Positives = 76/228 (33%), Gaps = 70/228 (30%)
Query: 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVE-IW 186
++ + D V + LG G G V + K T ++ A++ +
Sbjct: 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIF---------------NKRTQEKF-ALKMLQ 96
Query: 187 MNERVRR---------ACANCCADFVYGFFENSSKKGGEYWLIWRYE----GEATLADLM 233
+ RR C + + +EN ++ E GE L +
Sbjct: 97 DCPKARREVELHWRASQCPHIVR--IVDVYENLYAGRKCLLIV--MECLDGGE--LFSRI 150
Query: 234 ISR-EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
R + + ERE IM + A+ LHS I HRD+KP+N
Sbjct: 151 QDRGDQAFT----------------EREAS---EIMKSIGEAIQYLHSINIAHRDVKPEN 191
Query: 293 VIFS--EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
++++ + K+ D G A + L P Y APE
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETT------SHNSLTTPCYTPYYVAPE 233
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 50/231 (21%), Positives = 74/231 (32%), Gaps = 84/231 (36%)
Query: 138 KDDFVLGKK-LGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVEI------WMN 188
+D + L + LGEGA V T EY AV+I +
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCI---------------NLITSQEY-AVKIIEKQPGHIR 54
Query: 189 ERVRR---------ACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLAD 231
RV R N + FFE + +GG +
Sbjct: 55 SRVFREVEMLYQCQGHRNVLE--LIEFFEEEDRFYLVFEKMRGGS------------ILS 100
Query: 232 LMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
+ R +N E E ++ + ALD LH+ GI HRD+KP+
Sbjct: 101 HIHKRRH-FN----------------ELEAS---VVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 292 NVIFS--EGSRTFKIIDLGAAADLRVGINYIP--KEFLLD----PRYAAPE 334
N++ KI D + +++ + P LL Y APE
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 53/184 (28%), Positives = 81/184 (44%), Gaps = 34/184 (18%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKA---TEYGAVEIWMNERVRRACANCCA 200
K +G G+FGVVY+A L + G+LV +KK + E+ + ++
Sbjct: 60 KVIGNGSFGVVYQAKL------CDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 113
Query: 201 DFVYGFFENSSKKGGEY-WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259
F F+ + KK Y L+ Y E T+ + R + QTL
Sbjct: 114 YF---FYSSGEKKDEVYLNLVLDYVPE-TVYRVA--RHYSRAKQTL-------------- 153
Query: 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG--- 316
++ M QL +L +HS GI HRDIKPQN++ + K+ D G+A L G
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 317 INYI 320
++YI
Sbjct: 214 VSYI 217
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 41/217 (18%), Positives = 63/217 (29%), Gaps = 49/217 (22%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LK---KATEYGAVEIWMNERVRRACA 196
+ + L EG F VY A G LK E I + +
Sbjct: 30 LRVRRVLAEGGFAFVYEAQ------DVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 197 NC-----CADFVYGFFENSSKKGGEYWLIWRY-EGEATLADLMISREFPYNVQTLILGEV 250
E S E+ L+ +G+ L + + E
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ--LVEFLKKME-----------SR 130
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHS--TGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
L + I Q A+ +H I+HRD+K +N++ S T K+ D G
Sbjct: 131 GPLS---CDT---VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFG 183
Query: 309 AAADLRVGINYIPKEFLLD-----------PRYAAPE 334
+A + +Y P Y PE
Sbjct: 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 44/224 (19%), Positives = 73/224 (32%), Gaps = 83/224 (37%)
Query: 142 VLGKKLGEGAFGVVYRA------------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNE 189
+ K+LG G F VV + L K+ ++ +L E + + +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH---E---IAV-LEL 84
Query: 190 -----RVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISR 236
RV ++ +EN+S+ GGE + L +
Sbjct: 85 AKSCPRVIN---------LHEVYENTSEIILILEYAAGGE------------IFSLCLPE 123
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
+ E + ++ Q+L + LH IVH D+KPQN++ S
Sbjct: 124 LAEM------VSE------------NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165
Query: 297 --EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
KI+D G + L + P Y APE
Sbjct: 166 SIYPLGDIKIVDFGMS------RKIGHACELREIMGTPEYLAPE 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 43/183 (23%), Positives = 66/183 (36%), Gaps = 23/183 (12%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATE---YGAVEIWMNERVRRACANCCA 200
K LG G+FG+V G LKK + Y E+ + + +
Sbjct: 13 KTLGTGSFGIVCEVFD------IESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ-----DLPK 255
D+ Y + K + G+ + Q L + L K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 256 GIERENRI--------IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDL 307
++ R I + QL A+ +HS GI HRDIKPQN++ + T K+ D
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 308 GAA 310
G+A
Sbjct: 187 GSA 189
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 7e-12
Identities = 40/234 (17%), Positives = 71/234 (30%), Gaps = 79/234 (33%)
Query: 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEY 180
+ + + +V G+ LG+G F + A K ++ K+
Sbjct: 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---------IVPKSL-- 52
Query: 181 GAVEIWMNERVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYE 224
++ E++ + + +GFFE++ +
Sbjct: 53 -LLKPHQREKMSMEISIHRSLAHQHVVG--FHGFFEDNDFVFVVLELCRRRS-------- 101
Query: 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284
L +L R + E E R + Q++ LH ++
Sbjct: 102 ----LLELHKRR-----------KALT------EPEAR---YYLRQIVLGCQYLHRNRVI 137
Query: 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL----DPRYAAPE 334
HRD+K N+ +E KI D G A + E P Y APE
Sbjct: 138 HRDLKLGNLFLNE-DLEVKIGDFGLATKVEY-----DGERKKVLCGTPNYIAPE 185
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 46/219 (21%), Positives = 74/219 (33%), Gaps = 68/219 (31%)
Query: 138 KDDFVLGKK-LGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVE-IWMNERVRR 193
DD+ L K+ LG G G V + T + A++ ++ + + R+
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECF---------------HRRTGQKC-ALKLLYDSPKARQ 70
Query: 194 ---------ACANCCADFVYGFFENSSKKGGEYWLIWRY--EGEATLADLMISR-EFPYN 241
+ + +EN +I GE L + R + +
Sbjct: 71 EVDHHWQASGGPHIVC--ILDVYENMHHGKRCLLIIMECMEGGE--LFSRIQERGDQAFT 126
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGS 299
ERE IM + A+ LHS I HRD+KP+N++++ E
Sbjct: 127 ----------------EREAA---EIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKD 167
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
K+ D G A + L P Y APE
Sbjct: 168 AVLKLTDFGFAK-------ETTQNALQTPCYTPYYVAPE 199
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 53/183 (28%), Positives = 80/183 (43%), Gaps = 33/183 (18%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKA---TEYGAVEIWMNERVRRACANCCAD 201
K +G G+FGVV++A L ++ +KK + E+ + V+
Sbjct: 46 KVIGNGSFGVVFQAKL------VESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 202 FVYGFFENSSKKGGEY-WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERE 260
F F+ N KK + L+ Y E T+ R + QT+
Sbjct: 100 F---FYSNGDKKDEVFLNLVLEYVPE-TVYRAS--RHYAKLKQTM--------------P 139
Query: 261 NRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---I 317
+I+ M QLL +L +HS GI HRDIKPQN++ S K+ID G+A L G +
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 318 NYI 320
+YI
Sbjct: 200 SYI 202
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 48/222 (21%), Positives = 79/222 (35%), Gaps = 67/222 (30%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERV 191
+ + DDF +G+ LG+G FG VY LA++ +K L VL K+ + + ++
Sbjct: 8 KRKFTIDDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQ---LEKEGVEHQL 61
Query: 192 RR---ACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEATLADLMISR 236
RR ++ + Y +F + + GE Y + +
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK------------HG 109
Query: 237 EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296
F E+ + T M +L AL H ++HRDIKP+N++
Sbjct: 110 RFD------------------EQRSA---TFMEELADALHYCHERKVIHRDIKPENLLMG 148
Query: 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLL----DPRYAAPE 334
KI D G + + P Y PE
Sbjct: 149 Y-KGELKIADFGWSV-------HAPSLRRRTMCGTLDYLPPE 182
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 34/214 (15%), Positives = 65/214 (30%), Gaps = 49/214 (22%)
Query: 138 KDDFVLGKKLGEGA--FGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE 189
+ L +G+G V A K G+ V L+ + + E
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLAR------YKPTGEYVTVRRINLEACSNEMVTFL-QGE 76
Query: 190 RVRRACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
+ F E W++ + + DL+ +
Sbjct: 77 L--HVSKLFNHPNIVPYRATF----IADNELWVVTSFMAYGSAKDLICTH---------- 120
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
G+ I I+ +L ALD +H G VHR +K +++ S +
Sbjct: 121 ------FMDGMNEL--AIAYILQGVLKALDYIHHMGYVHRSVKASHILISV-DGKVYLSG 171
Query: 307 LGAAADL------RVGINYIPKEFLLDPRYAAPE 334
L + + + ++ PK + + +PE
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 2e-11
Identities = 53/225 (23%), Positives = 84/225 (37%), Gaps = 78/225 (34%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNE 189
+ +DF +G LG+G+F VYRA +A K K + KA M +
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA----MYKAG--------MVQ 56
Query: 190 RVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLM 233
RV+ + +Y +FE+S+ GE + +
Sbjct: 57 RVQNEVKIHCQLKHPSILE--LYNYFEDSNYVYLVLEMCHNGE------------MNRYL 102
Query: 234 ISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293
+R P++ E E R M Q++ + LHS GI+HRD+ N+
Sbjct: 103 KNRVKPFS----------------ENEAR---HFMHQIITGMLYLHSHGILHRDLTLSNL 143
Query: 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL----DPRYAAPE 334
+ + + KI D G A L++ P E P Y +PE
Sbjct: 144 LLTR-NMNIKIADFGLATQLKM-----PHEKHYTLCGTPNYISPE 182
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 40/234 (17%), Positives = 71/234 (30%), Gaps = 79/234 (33%)
Query: 128 VERLFRTTYRKDDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEY 180
+ + + +V G+ LG+G F + A K ++ K+
Sbjct: 30 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---------IVPKSL-- 78
Query: 181 GAVEIWMNERVRRACA--------NCCADFVYGFFENSSK--------KGGEYWLIWRYE 224
++ E++ + + +GFFE++ +
Sbjct: 79 -LLKPHQREKMSMEISIHRSLAHQHVVG--FHGFFEDNDFVFVVLELCRRRS-------- 127
Query: 225 GEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284
L +L R + E E R + Q++ LH ++
Sbjct: 128 ----LLELHKRR-----------KALT------EPEAR---YYLRQIVLGCQYLHRNRVI 163
Query: 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL----DPRYAAPE 334
HRD+K N+ +E KI D G A + E P Y APE
Sbjct: 164 HRDLKLGNLFLNE-DLEVKIGDFGLATKVEY-----DGERKKVLCGTPNYIAPE 211
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 47/222 (21%), Positives = 75/222 (33%), Gaps = 67/222 (30%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-----VLKKATEYGAVEIW 186
F Y D + K LGEG+F + + K + K+ EI
Sbjct: 6 FYQHY--DLDLKDKPLGEGSFSICRKCV------HKKSNQAFAVKIISKRMEANTQKEIT 57
Query: 187 MNERVRRACANCCADFVYGFFENSSK--------KGGEYWLIWRYEGEATLADLMISREF 238
+ N ++ F + GGE L + + ++
Sbjct: 58 ALKLCE-GHPNIVK--LHEVFHDQLHTFLVMELLNGGE------------LFERIKKKKH 102
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-- 296
++ E E IM +L+ A+ +H G+VHRD+KP+N++F+
Sbjct: 103 -FS----------------ETEAS---YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE 142
Query: 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ KIID G A + L YAAPE
Sbjct: 143 NDNLEIKIIDFGFARLKPPD-----NQPLKTPCFTLHYAAPE 179
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 47/225 (20%), Positives = 82/225 (36%), Gaps = 73/225 (32%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMN 188
+ + +DF +G+ LG+G FG VY LA+ K ++ L KA + +
Sbjct: 3 KRQWALEDFEIGRPLGKGKFGNVY---LAR---EKQSKFILALKVLFKAQ---LEKAGVE 53
Query: 189 ERVRR---ACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEATLADLM 233
++RR ++ + YG+F ++++ G Y + +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----------- 102
Query: 234 ISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293
+F E+ T +++L AL HS ++HRDIKP+N+
Sbjct: 103 -LSKFD------------------EQRTA---TYITELANALSYCHSKRVIHRDIKPENL 140
Query: 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAPE 334
+ KI D G + + P D Y PE
Sbjct: 141 LLGSAG-ELKIADFGWSV-------HAPSSRRTDLCGTLDYLPPE 177
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 44/228 (19%), Positives = 78/228 (34%), Gaps = 69/228 (30%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCA 200
+ L ++G+G++GVV LA ++ND A+++ +++ R
Sbjct: 15 YTLKDEIGKGSYGVVK---LAY---NENDNTYY--------AMKVLSKKKLIRQAGFPRR 60
Query: 201 DFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF--------PYNVQT-------- 244
G I + + +E P V+
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQ-----------VYQEIAILKKLDHPNVVKLVEVLDDPN 109
Query: 245 -----LIL-----GEVQDLPKG---IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
++ G V ++P E + R L+ ++ LH I+HRDIKP
Sbjct: 110 EDHLYMVFELVNQGPVMEVPTLKPLSEDQAR---FYFQDLIKGIEYLHYQKIIHRDIKPS 166
Query: 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-----PRYAAPE 334
N++ E KI D G + + + + LL P + APE
Sbjct: 167 NLLVGE-DGHIKIADFGVSNEFK------GSDALLSNTVGTPAFMAPE 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 22/47 (46%), Positives = 30/47 (63%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+ M ++L ALD HS GI+HRD+KP NV+ R ++ID G A
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 1e-10
Identities = 30/205 (14%), Positives = 58/205 (28%), Gaps = 20/205 (9%)
Query: 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPS--------SKNDGDLVLKKATEYGAV 183
F + +K+GEG FG V++ P + + +K E
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 184 EI---WMNERVRRACANCCADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREF 238
EI + N F+ W + + F
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 239 PYNVQTLIL-----GEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQN 292
+ ++L G + + ++I+ QL +L ++ HRD+ N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGI 317
V+ + S K+ +
Sbjct: 193 VLLKKTSLK-KLHYTLNGKSSTIPS 216
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 47/269 (17%), Positives = 81/269 (30%), Gaps = 77/269 (28%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL------AKKPSSKNDGDLVLKKATEYGAVEIWMNERVR 192
D+ L + +G G +G VY+ SL K S N + E I+ +
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNF----INE---KNIYRVPLME 65
Query: 193 RACANCCADFVYGFF----ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
N + F ++ EY L+ Y +L + +
Sbjct: 66 --HDN-----IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDW-------- 110
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHST---------GIVHRDIKPQNVIFSEGS 299
R+ ++ L + LH+ I HRD+ +N + +
Sbjct: 111 ---------VSSCRLAHSVTRGLAY----LHTELPRGDHYKPAISHRDLNSRN-VLVKND 156
Query: 300 RTFKIIDLGAAADLRVGINYIPKEFLLD-------PRYAAPEQYIMSTQTPSAPSAPVAT 352
T I D G + L P E RY APE + + +
Sbjct: 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESAL-- 213
Query: 353 ALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
+ D+Y+ GLI+ ++
Sbjct: 214 ------------KQVDMYALGLIYWEIFM 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 40/197 (20%), Positives = 67/197 (34%), Gaps = 60/197 (30%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYGAVE-IWMNE 189
+ D V + LG G G V + K T ++ A++ +
Sbjct: 12 KNAIIDDYKVTSQVLGLGINGKVLQIF---------------NKRTQEKF-ALKMLQDCP 55
Query: 190 RVRR---------ACANCCADFVYGFFENSSKKGGEYWLIWRYE----GEATLADLMISR 236
+ RR C + + +EN ++ E GE L + R
Sbjct: 56 KARREVELHWRASQCPHIVR--IVDVYENLYAGRKCLLIV--MECLDGGE--LFSRIQDR 109
Query: 237 -EFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
+ + ERE IM + A+ LHS I HRD+KP+N+++
Sbjct: 110 GDQAFT----------------EREAS---EIMKSIGEAIQYLHSINIAHRDVKPENLLY 150
Query: 296 S--EGSRTFKIIDLGAA 310
+ + K+ D G A
Sbjct: 151 TSKRPNAILKLTDFGFA 167
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 40/207 (19%), Positives = 73/207 (35%), Gaps = 48/207 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-----ATEYGAVEIWMNERVRR 193
+D ++G G G V++ + G ++ K + I M+ V
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRF------RKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 194 ACANCCADFV---YG-FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+C ++ +G F + ++ G T A+ + R
Sbjct: 79 KSHDC--PYIVQCFGTFI-----TNTDVFIAMELMG--TCAEKLKKR------------- 116
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+ I E I+ + ++ AL L G++HRD+KP N++ E K+ D G
Sbjct: 117 ---MQGPIP-ER-ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFG 170
Query: 309 AAADLRVGINYIPK-EFLLDPRYAAPE 334
+ L ++ K Y APE
Sbjct: 171 ISGRL---VDDKAKDRSAGCAAYMAPE 194
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 37/187 (19%), Positives = 65/187 (34%), Gaps = 44/187 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRAS-------LAKKPSSKNDGDLVLKKATEYGAVEIWMNERV 191
+D ++G GA+G V + +A K + K ++ M+ V
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK--------QLLMDLDV 73
Query: 192 RRACANCCADFV---YG-FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL 247
++C ++ YG F + G+ W+ +
Sbjct: 74 VMRSSDC--PYIVQFYGALF-----REGDCWICMELMS-TSFDK--------------FY 111
Query: 248 GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IVHRDIKPQNVIFSEGSRTFKIID 306
V + + E I+ I + AL+ L I+HRDIKP N++ S K+ D
Sbjct: 112 KYVYSVLDDVIPEE-ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCD 169
Query: 307 LGAAADL 313
G + L
Sbjct: 170 FGISGQL 176
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 37/178 (20%), Positives = 60/178 (33%), Gaps = 65/178 (36%)
Query: 214 GGEYWLIWRY-EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLL 272
G+ ++ R G LA + + R+ P + I+ Q+
Sbjct: 106 DGQLYVDMRLINGV-DLAAM-LRRQGPLAPPRAV-------------------AIVRQIG 144
Query: 273 FALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG---AAADLR-------VGINYIPK 322
ALD H+ G HRD+KP+N++ S ++D G A D + VG
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFA-YLVDFGIASATTDEKLTQLGNTVG------ 197
Query: 323 EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
Y APE++ S T R DIY+ + + +
Sbjct: 198 ----TLYYMAPERFSESHATY----------------------RADIYALTCVLYECL 229
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 31/115 (26%), Positives = 44/115 (38%), Gaps = 25/115 (21%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG-AAADLRVGINYIPKEFL 325
+Q+L + H IVHRDIKPQN++ KI D G A A + L
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTL-KIFDFGIAKALSETSLTQ-TNHVL 173
Query: 326 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380
+Y +PEQ A + DIYS G++ +M+
Sbjct: 174 GTVQYFSPEQ---------AKGEA-TDECT------------DIYSIGIVLYEML 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 48/211 (22%), Positives = 80/211 (37%), Gaps = 53/211 (25%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR----- 193
DD +LG GA+GVV + G ++ K + +N + ++
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRH------VPSGQIMAVKR-----IRATVNSQEQKRLLMD 55
Query: 194 ---ACANCCADFV---YG-FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
+ F YG F + G+ W+ +L
Sbjct: 56 LDISMRTVDCPFTVTFYGALF-----REGDVWICMELMD-TSLDK--------------F 95
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-IVHRDIKPQNV-IFSEGSRTFKI 304
+V D + I E+ I+ I ++ AL+ LHS ++HRD+KP NV I + G K+
Sbjct: 96 YKQVIDKGQTIP-ED-ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKM 151
Query: 305 IDLGAAADLRVGINYIPKE-FLLDPRYAAPE 334
D G + L ++ + K+ Y APE
Sbjct: 152 CDFGISGYL---VDDVAKDIDAGCKPYMAPE 179
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 27/117 (23%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL 326
+++ AL+ H GI+HRD+KP N++ S + K++D G A
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAV-KVMDFGIAR--------------- 164
Query: 327 DPRYAAPEQYIMSTQTPSAPSAPVATA--LSPVLWQLNLPD-RFDIYSAGLIFLQMV 380
A + TQT +A + TA LSP + + D R D+YS G + +++
Sbjct: 165 ----AIADSGNSVTQT----AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 32/217 (14%), Positives = 70/217 (32%), Gaps = 51/217 (23%)
Query: 141 FVLGKKLGEGAFGVVYRASL------------AKKPSSKNDGDL-----VLKKATEYGAV 183
+ +G +G+G FG +Y A + K ++G L ++A + +
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 184 EIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMI--SREFPYN 241
+ W+ R + +G + ++I G L + ++ F
Sbjct: 97 QKWIRTRKLKYLGVPK---YWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFS-- 150
Query: 242 VQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG-SR 300
+T++ + ++L L+ +H VH DIK N++ +
Sbjct: 151 RKTVLQ-------------------LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191
Query: 301 TFKIIDLGAA-----ADLRVGINYIP-KEFLLDPRYA 331
++D G A + P + +
Sbjct: 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 43/228 (18%), Positives = 81/228 (35%), Gaps = 61/228 (26%)
Query: 126 AFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--E 179
F ++ + ++DF + K +G GAFG V + K KN + +L K +
Sbjct: 61 PFTSKVKQMRLHREDFEILKVIGRGAFGEVA---VVKL---KNADKVFAMKILNKWEMLK 114
Query: 180 YGAVEIWMNERVRRACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEA 227
+ ER + ++ + F++ + GG+ L+ ++E
Sbjct: 115 RAETACFREERDVLVNGDS--KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR- 171
Query: 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287
P E + +++++ A+D +H VHRD
Sbjct: 172 ----------LP--------------------EEMA-RFYLAEMVIAIDSVHQLHYVHRD 200
Query: 288 IKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
IKP N++ G ++ D G+ L + P Y +PE
Sbjct: 201 IKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 48/254 (18%), Positives = 86/254 (33%), Gaps = 51/254 (20%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASL-----AKKPSSKNDGDLVLKKATEYGAVEIWMNERV 191
+ L + G FG V++A L A K D + E++ +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNE------YEVYSLPGM 75
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ N F+ G + + + WLI + + +L+D + + +N I +
Sbjct: 76 K--HENILQ-FI-GAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI---AE 128
Query: 252 DLPKGIERENRIIQTIMSQL---LFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+ +G ++ L + L H I HRDIK +NV+ + T I D G
Sbjct: 129 TMARG-----------LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFG 176
Query: 309 AAADLRVGINYIPKEFLLD-PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367
A G + + RY APE + +
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRI---------------- 219
Query: 368 DIYSAGLIFLQMVC 381
D+Y+ GL+ ++
Sbjct: 220 DMYAMGLVLWELAS 233
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 33/211 (15%), Positives = 59/211 (27%), Gaps = 39/211 (18%)
Query: 141 FVLGKKLGEGAFGVVYRA---SLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
+ L G++Y A S S LK + G + N R A
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI---LGEVQDLP 254
+ I G + Y L+ LG + L
Sbjct: 104 QVNKW-------KKLYSTPLLAIPTCMGFG-------VHQDKYRF--LVLPSLG--RSLQ 145
Query: 255 KGIERENR-------IIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR-TFKIID 306
++ + ++Q + +LL AL+ LH VH ++ +N+ + +
Sbjct: 146 SALDVSPKHVLSERSVLQ-VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAG 204
Query: 307 LGAA---ADLRVGINYIP---KEFLLDPRYA 331
G A + Y+ D +
Sbjct: 205 YGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 34/214 (15%), Positives = 64/214 (29%), Gaps = 48/214 (22%)
Query: 141 FVLGKKLGEGAFGVVYR----------ASLAKKPSSKNDGDL-----VLKKATEYGAVEI 185
+VLGKK+G G FG++Y A K + +G L ++ + ++
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 186 WMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMI-SREFPYNVQT 244
W+ + YG K +++ G L + + F T
Sbjct: 99 WIERKQLDYLGIPL---FYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFK--KST 152
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG-SRTFK 303
++ + ++L L+ +H VH DIK N++
Sbjct: 153 VLQ-------------------LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193
Query: 304 IIDLGAA---ADLRVGINYIPKE---FLLDPRYA 331
+ D G + Y +
Sbjct: 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 26/70 (37%), Positives = 35/70 (50%), Gaps = 10/70 (14%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
QL+ L+ LHS GIVH+DIKP N++ + G T KI LG A L + +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEAL----HPFAADDTCRTS 171
Query: 328 ---PRYAAPE 334
P + PE
Sbjct: 172 QGSPAFQPPE 181
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 27/70 (38%), Positives = 34/70 (48%), Gaps = 10/70 (14%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
QL+ + LH GI HRDIKP+N++ E KI D G A R +E LL+
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYN----NRERLLNKM 167
Query: 328 ---PRYAAPE 334
Y APE
Sbjct: 168 CGTLPYVAPE 177
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 27/70 (38%), Positives = 34/70 (48%), Gaps = 10/70 (14%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
QL+ + LH GI HRDIKP+N++ E KI D G A R +E LL+
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYN----NRERLLNKM 167
Query: 328 ---PRYAAPE 334
Y APE
Sbjct: 168 CGTLPYVAPE 177
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 24/81 (29%), Positives = 35/81 (43%), Gaps = 14/81 (17%)
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
E+E R + Q++ A+ H IVHRD+K +N++ KI D G +
Sbjct: 113 EKEAR---SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA-DMNIKIADFGFSN------ 162
Query: 318 NYIPKEFLL----DPRYAAPE 334
+ L P YAAPE
Sbjct: 163 EFTVGGKLDAFCGAPPYAAPE 183
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 39/179 (21%), Positives = 65/179 (36%), Gaps = 29/179 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKA---TEYGAVEIWMNERVRRA 194
D F + + G+G FG V K+ G V +KK + E+ + + +
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKE------KSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL 76
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYE-GEATLADLMISREFPYNVQTLILGEVQDL 253
F+ + + +L E TL R +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCC--RNYYRRQVAP-------- 126
Query: 254 PKGIERENRIIQTIMSQLLFALDGLH--STGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+I+ + QL+ ++ LH S + HRDIKP NV+ +E T K+ D G+A
Sbjct: 127 ------PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 46/249 (18%), Positives = 85/249 (34%), Gaps = 66/249 (26%)
Query: 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNE-RVRRAC 195
++G G+F VY+ V +K T+ + + E + +
Sbjct: 30 FDIEIGRGSFKTVYKGL------DTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGL 82
Query: 196 ANCCADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ + V Y +E++ K L+ TL + + F ++
Sbjct: 83 QH--PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFK------VMKI---- 128
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHS--TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
+++++ Q+L L LH+ I+HRD+K N+ + + + KI DLG A
Sbjct: 129 --------KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
R K + P + APE S D+Y+
Sbjct: 181 LKR---ASFAKAVIGTPEFMAPE-MYEEKYDESV----------------------DVYA 214
Query: 372 AGLIFLQMV 380
G+ L+M
Sbjct: 215 FGMCMLEMA 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 46/226 (20%), Positives = 82/226 (36%), Gaps = 61/226 (26%)
Query: 127 FVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EY 180
+ ++ + +D+ + K +G GAFG V L + K+ + +L K +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQ---LVRH---KSTRKVYAMKLLSKFEMIKR 110
Query: 181 GAVEIWMNERVRRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATL 229
+ ER A AN +V + F++ GG+ L
Sbjct: 111 SDSAFFWEERDIMAFANS--PWVVQLFYAFQDDRYLYMVMEYMPGGD------------L 156
Query: 230 ADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289
+LM + + P E + ++++ ALD +HS G +HRD+K
Sbjct: 157 VNLMSNYDVP--------------------EKWA-RFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 290 PQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
P N++ G K+ D G + + P Y +PE
Sbjct: 196 PDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 46/228 (20%), Positives = 82/228 (35%), Gaps = 61/228 (26%)
Query: 126 AFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--E 179
V RL ++DDF + K +G GAF V + K K G + ++ K +
Sbjct: 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVA---VVKM---KQTGQVYAMKIMNKWDMLK 101
Query: 180 YGAVEIWMNERVRRACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEA 227
G V + ER + ++ + F++ + GG+ L+ ++
Sbjct: 102 RGEVSCFREERDVLVNGDR--RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG--- 156
Query: 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287
P + +++++ A+D +H G VHRD
Sbjct: 157 --------ERIP--------------------AEMA-RFYLAEIVMAIDSVHRLGYVHRD 187
Query: 288 IKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
IKP N++ G ++ D G+ LR + P Y +PE
Sbjct: 188 IKPDNILLDRCGH--IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 23/75 (30%), Positives = 38/75 (50%), Gaps = 7/75 (9%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT-FKIIDLGAAADLRVGI-NY 319
+++ +L LD LH I+H D+KP+N++ + R+ K+ID G++ + Y
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259
Query: 320 IPKEFLLDPRYAAPE 334
I F Y APE
Sbjct: 260 IQSRF-----YRAPE 269
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 33/99 (33%), Positives = 45/99 (45%), Gaps = 18/99 (18%)
Query: 251 QDLPKGIERENRI------IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFK 303
QDL +++ I+ +M Q L LD LH+ IVHRD+KP+N+ + S G T K
Sbjct: 103 QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVK 160
Query: 304 IIDLGAAADLRVGINYIPK---------EFLLDPRYAAP 333
+ D G A + P E LL YA P
Sbjct: 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 13/70 (18%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
Q++ A++ H IVHRD+KP+N++ + + KI D G + N + L
Sbjct: 116 QIICAIEYCHRHKIVHRDLKPENLLLDD-NLNVKIADFGLS-------NIMTDGNFLKTS 167
Query: 328 ---PRYAAPE 334
P YAAPE
Sbjct: 168 CGSPNYAAPE 177
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 27/69 (39%), Positives = 35/69 (50%), Gaps = 11/69 (15%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLL--- 326
Q+L A+D H +VHRD+KP+NV+ KI D G + + G EFL
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDG------EFLRTSC 171
Query: 327 -DPRYAAPE 334
P YAAPE
Sbjct: 172 GSPNYAAPE 180
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 18/66 (27%), Positives = 32/66 (48%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENR-----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
+ ++R R ++++I Q L A++ H +HRD+KP+N+ I K+
Sbjct: 86 HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKL 143
Query: 305 IDLGAA 310
D G A
Sbjct: 144 CDFGFA 149
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 21/68 (30%), Positives = 36/68 (52%), Gaps = 8/68 (11%)
Query: 251 QDLPKGIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF---- 302
DL K +++ + I++ + QL+ ++ HS +HRD+KPQN++ S +
Sbjct: 117 NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 303 KIIDLGAA 310
KI D G A
Sbjct: 177 KIGDFGLA 184
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 42/211 (19%), Positives = 74/211 (35%), Gaps = 57/211 (27%)
Query: 141 FVLGKKLGEGAFGVVYRAS--------LAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR 192
+ +G+++GEG+FGV++ + K ++D + + Y ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTY---------KLL 62
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMI--SREFPYNVQTLILGEV 250
C VY F + G L+ G +L DL+ R+F + +
Sbjct: 63 AGCTGIPN--VYYFGQE----GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT-VAMAAK- 113
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN-VIFSEGSRTFK---IID 306
Q+L + +H +V+RDIKP N +I S+ ++D
Sbjct: 114 -------------------QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154
Query: 307 LGAAADLRVGINY--IP----KEFLLDPRYA 331
G R + IP K RY
Sbjct: 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 33/99 (33%), Positives = 44/99 (44%), Gaps = 18/99 (18%)
Query: 251 QDLPKGIERENRI------IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFK 303
QDL +++ I+ +M QLL LD LHS +VHRD+KPQN+ + S G K
Sbjct: 103 QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIK 160
Query: 304 IIDLGAAADLRVGINYIPK---------EFLLDPRYAAP 333
+ D G A + E LL YA P
Sbjct: 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 199
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 21/66 (31%), Positives = 37/66 (56%), Gaps = 5/66 (7%)
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
IL +++ P G++ + +Q + Q++ + HS I+HRDIKP+N+ + G K+
Sbjct: 110 ILDDLELFPNGLDYQV--VQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKL 165
Query: 305 IDLGAA 310
D G A
Sbjct: 166 CDFGFA 171
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 27/80 (33%), Positives = 34/80 (42%), Gaps = 12/80 (15%)
Query: 262 RIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSR-----TFKIIDLGAAADLRV 315
++ I QLL LD +H GI+H DIKP+NV+ KI DLG A
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 316 GI-NYIPKEFLLDPRYAAPE 334
N I Y +PE
Sbjct: 191 HYTNSIQTRE-----YRSPE 205
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 55/266 (20%), Positives = 84/266 (31%), Gaps = 49/266 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
VL + +G+G FG V+R G+ V K W E
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKW--------RGEEVAVKIFSSREERSWFREAEIYQTVML 93
Query: 199 CADFVYGFFENSSKKGG---EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ + GF +K G + WL+ Y +L D + +
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA---LSTAS 150
Query: 256 GIERENRIIQTIMSQL-LFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
G ++ L + + I HRD+K +N++ + + T I DLG A
Sbjct: 151 G-----------LAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHD 198
Query: 315 VGINYIPKEFLLD---PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
+ I RY APE S S R DIY+
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF----------------KRADIYA 242
Query: 372 AGLIFLQMVCTVRRLCLHSCPLAYSL 397
GL+F ++ RR + Y L
Sbjct: 243 MGLVFWEI---ARRCSIGGIHEDYQL 265
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 42/211 (19%), Positives = 70/211 (33%), Gaps = 60/211 (28%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL------AKKPSSKNDGDLVLKKATEYGAVEIWMNERVR 192
+ + + +G GAFGVV +A K+ S+++ + E+ RV
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIV--------ELRQLSRVN 59
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
N +YG N L+ Y +L +++ E
Sbjct: 60 --HPNIVK--LYGACLNP------VCLVMEYAEGGSLYNVLHGAEPLPY----------- 98
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHS---TGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
+ + Q + LHS ++HRD+KP N++ G KI D G
Sbjct: 99 ----YTAAHAMS--WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152
Query: 310 AADLR------VGINYIPKEFLLDPRYAAPE 334
A D++ G + APE
Sbjct: 153 ACDIQTHMTNNKG----------SAAWMAPE 173
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 24/70 (34%), Positives = 32/70 (45%), Gaps = 13/70 (18%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD-- 327
Q+L +D H +VHRD+KP+NV+ KI D G + N + L
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDA-HMNAKIADFGLS-------NMMSDGEFLRTS 175
Query: 328 ---PRYAAPE 334
P YAAPE
Sbjct: 176 CGSPNYAAPE 185
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 6e-08
Identities = 25/67 (37%), Positives = 37/67 (55%), Gaps = 9/67 (13%)
Query: 251 QDLPKGIERENR------IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFK 303
QDL K ++ +I++ + QLL L HS ++HRD+KPQN+ I +EG K
Sbjct: 86 QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIK 143
Query: 304 IIDLGAA 310
+ D G A
Sbjct: 144 LADFGLA 150
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 6e-08
Identities = 23/66 (34%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENR-----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
QDL K ++ ++ + QLL + H ++HRD+KPQN+ I EG KI
Sbjct: 84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKI 141
Query: 305 IDLGAA 310
D G A
Sbjct: 142 ADFGLA 147
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 51/257 (19%), Positives = 85/257 (33%), Gaps = 60/257 (23%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASL------AKKPSSKNDGDLVLKKATEYGAVEIW 186
RT R D L + +G+G +G V+R S K SS+++ + E++
Sbjct: 4 RTVAR--DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET-------ELY 54
Query: 187 MNERVRRACANCCADFVYGFF---ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQ 243
+R + GF S + WLI Y +L D +
Sbjct: 55 NTVMLRHEN-------ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC 107
Query: 244 TLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFSEGSRTF 302
I+ + G ++ L + G I HRD+K +N++ + +
Sbjct: 108 LRIV---LSIASG-----------LAHLHIEIFGTQGKPAIAHRDLKSKNILVKK-NGQC 152
Query: 303 KIIDLGAAADLRVGINYIPKEFLLD---PRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359
I DLG A N + RY APE ++ + V
Sbjct: 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE--VLD----ETIQVDCFDSYKRV-- 204
Query: 360 QLNLPDRFDIYSAGLIF 376
DI++ GL+
Sbjct: 205 --------DIWAFGLVL 213
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 8e-08
Identities = 24/66 (36%), Positives = 35/66 (53%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENR-----IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
QDL K + N I+++ + QLL L HS ++HRD+KPQN+ I G K+
Sbjct: 85 QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG--ELKL 142
Query: 305 IDLGAA 310
+ G A
Sbjct: 143 ANFGLA 148
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 8e-08
Identities = 23/66 (34%), Positives = 34/66 (51%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENRI-----IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
+DL K ++ I+ + QLL + H I+HRD+KPQN+ I S+G K+
Sbjct: 103 KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKL 160
Query: 305 IDLGAA 310
D G A
Sbjct: 161 ADFGLA 166
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 22/66 (33%), Positives = 30/66 (45%), Gaps = 3/66 (4%)
Query: 270 QLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP 328
QLL + HS I HRD+K +N + + KI D G + + PK + P
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTP 181
Query: 329 RYAAPE 334
Y APE
Sbjct: 182 AYIAPE 187
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 21/66 (31%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENRI-----IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
+DL + ++ I ++ + QLL L H ++HRD+KPQN+ I G K+
Sbjct: 84 KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG--ELKL 141
Query: 305 IDLGAA 310
D G A
Sbjct: 142 ADFGLA 147
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 23/77 (29%), Positives = 37/77 (48%), Gaps = 9/77 (11%)
Query: 262 RIIQTIMSQLLFALDGLHST--GIVHRDIKPQNVIFSEGSRTF-KIIDLGAAADLRVGIN 318
+ + Q+ AL L + I+H D+KP+N++ R+ KI+D G++ L I
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 319 -YIPKEFLLDPRYAAPE 334
YI F Y +PE
Sbjct: 217 QYIQSRF-----YRSPE 228
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 17/51 (33%), Positives = 32/51 (62%), Gaps = 3/51 (5%)
Query: 263 IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRT--FKIIDLGAA 310
++++++ Q+L + LH+ ++HRD+KP N+ + EG KI D+G A
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 19/48 (39%), Positives = 26/48 (54%), Gaps = 3/48 (6%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
I+ +M LL L +H I+HRD+K NV I +G K+ D G A
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLA 171
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 47/260 (18%), Positives = 78/260 (30%), Gaps = 76/260 (29%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL-----AKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR 193
+ K++G+G +G V+ A K + ++ EI+ +R
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE------TEIYQTVLMRH 90
Query: 194 ACANCCADFVYGFF---ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ GF + + +LI Y +L D + S +
Sbjct: 91 EN-------ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLA--- 140
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHST--------GIVHRDIKPQNVIFSEGSRTF 302
G+ LH+ I HRD+K +N++ + + T
Sbjct: 141 YSSVSGLCH------------------LHTEIFSTQGKPAIAHRDLKSKNILVKK-NGTC 181
Query: 303 KIIDLGAAADLRVGINYIPKEFLLD------PRYAAPEQYIMSTQTPSAPSAPVATALSP 356
I DLG A I+ + + RY PE S S +A
Sbjct: 182 CIADLGLA---VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA----- 233
Query: 357 VLWQLNLPDRFDIYSAGLIF 376
D+YS GLI
Sbjct: 234 -----------DMYSFGLIL 242
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 21/66 (31%), Positives = 31/66 (46%), Gaps = 8/66 (12%)
Query: 251 QDLPKGIERENRI-----IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKI 304
DL I+ + + I+ M L L+ LH I+HRD+KP N+ + G K+
Sbjct: 96 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKL 153
Query: 305 IDLGAA 310
D G A
Sbjct: 154 ADFGLA 159
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 18/47 (38%), Positives = 25/47 (53%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ M QLL L +HS ++HRD+KP N+ + KI D G A
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 12/53 (22%), Positives = 15/53 (28%), Gaps = 5/53 (9%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSR----TFKII-DLGAAADLR 314
M L A D H G+ P V S + D D+R
Sbjct: 134 AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIR 186
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 13/71 (18%)
Query: 251 QDLPKGIERENR----------IIQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGS 299
DL K ++ +++ QLL L H I+HRD+KPQN+ I G
Sbjct: 87 NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG- 145
Query: 300 RTFKIIDLGAA 310
K+ D G A
Sbjct: 146 -QLKLGDFGLA 155
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 42/211 (19%), Positives = 76/211 (36%), Gaps = 48/211 (22%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNE 189
+DF + + +G G FG VY +K + G + L K + +NE
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVY---GCRK---ADTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 190 R-VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
R + + F+ + + + L + L+ G
Sbjct: 240 RIMLSLVSTGDCPFIVC-------------MSYAFHTPDKL----------SFILDLMNG 276
Query: 249 EVQDLPKGIERENRIIQTIM----SQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFK 303
DL + + + M ++++ L+ +H+ +V+RD+KP N++ G +
Sbjct: 277 --GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VR 332
Query: 304 IIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
I DLG A D P + Y APE
Sbjct: 333 ISDLGLACD---FSKKKPHASVGTHGYMAPE 360
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 174
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 40/213 (18%), Positives = 68/213 (31%), Gaps = 61/213 (28%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVR-RACANCC 199
F +GKK+G G FG + + + V A+++ E ++ RA
Sbjct: 11 FRVGKKIGCGNFGELRLG------KNLYTNEYV--------AIKL---EPMKSRAPQLHL 53
Query: 200 ADFVYGFFENSS---------KKGGEYWLIWRYEGEATLADLMI--SREFPYNVQTLILG 248
Y + G ++ G +L DL R F L++
Sbjct: 54 EYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKT-VLMIA 111
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG----SRTFKI 304
QL+ ++ +HS +++RD+KP+N + + I
Sbjct: 112 I--------------------QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHI 151
Query: 305 IDLGAAADLRVGINY--IP----KEFLLDPRYA 331
ID A + IP K RY
Sbjct: 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 19/48 (39%), Positives = 29/48 (60%), Gaps = 3/48 (6%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAA 310
I+T++ LL + +HS GI+HRD+KP N + + S K+ D G A
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLA 203
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 9e-07
Identities = 45/225 (20%), Positives = 76/225 (33%), Gaps = 67/225 (29%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
R K+ F + LG+G FG V + + G + L+K + +
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVC---ACQV---RATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 187 MNERVRRACANCCADFVYGF---FENSSK--------KGGEYWLIWRYEGEATLADLMIS 235
+NE+ N FV +E GG DL
Sbjct: 232 LNEKQILEKVNS--RFVVSLAYAYETKDALCLVLTLMNGG---------------DLKF- 273
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
+ + + E R + +++ L+ LH IV+RD+KP+N++
Sbjct: 274 -------------HIYHMGQAGFPEARAVFYA-AEICCGLEDLHRERIVYRDLKPENILL 319
Query: 296 -SEGSRTFKIIDLGAAADLRVG---------INYIPKEFLLDPRY 330
G +I DLG A + G + Y+ E + + RY
Sbjct: 320 DDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 21/47 (44%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ ++ Q+L L +HS G+VHRD+KP N+ +E KI+D G A
Sbjct: 128 IQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLA 173
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 41/196 (20%), Positives = 69/196 (35%), Gaps = 60/196 (30%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
+ T + D F K LG G+FG V L K K G+ +L K + +E
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVM---LVKH---KESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 187 MNERVRRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLMIS 235
+NE+ N F+ F+++S GGE + R G
Sbjct: 89 LNEKRILQAVNF--PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--------- 137
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
F ++ + + LHS +++RD+KP+N++
Sbjct: 138 --FSEPHARFYAAQI---------------------VLTFEYLHSLDLIYRDLKPENLLI 174
Query: 296 -SEGSRTFKIIDLGAA 310
+G ++ D G A
Sbjct: 175 DQQGY--IQVTDFGFA 188
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+Q ++ Q+L L +HS I+HRD+KP N+ +E KI+D G A
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLA 179
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 50/220 (22%), Positives = 82/220 (37%), Gaps = 57/220 (25%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
+D F+ + LG G FG V+ + K G L L K + +
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVF---ACQM---KATGKLYACKKLNKKRLKKRKGYQGA 232
Query: 187 MNERVRRACANCCADFVYGF---FENSSK--------KGGEYWLIWRYEGEATLADLMIS 235
M E+ A + F+ FE + GG D+
Sbjct: 233 MVEKKILAKVHS--RFIVSLAYAFETKTDLCLVMTIMNGG---------------DIR-- 273
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
Y++ + +E R I +Q++ L+ LH I++RD+KP+NV+
Sbjct: 274 ----YHIYNVDEDN------PGFQEPRAIFYT-AQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
+G+ +I DLG A +L+ G K + P + APE
Sbjct: 323 DDDGN--VRISDLGLAVELKAG-QTKTKGYAGTPGFMAPE 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 18/47 (38%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+TI+ LL + +H +GI+HRD+KP N + ++ + K+ D G A
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLA 176
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+ ++ Q+L + LHS GI+HRD+KP N++ T KI+D G A
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLA 211
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 17/47 (36%), Positives = 25/47 (53%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ M +L L LH G+VHRD+ P N++ ++ + I D A
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNLA 181
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ ++ Q+L L +H+ GI+HRD+KP N+ +E KI+D G A
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 175
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 16/67 (23%), Positives = 31/67 (46%), Gaps = 18/67 (26%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF------------------K 303
I+ + Q+ +++ LHS + H D+KP+N++F + T K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 304 IIDLGAA 310
++D G+A
Sbjct: 178 VVDFGSA 184
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 17/47 (36%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I + Q+L L +HS ++HRD+KP N++ + KI D G A
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLA 175
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 52/257 (20%), Positives = 89/257 (34%), Gaps = 55/257 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRA---SLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRAC 195
D LGK LG GAFG V A + K + + +LK+ + M+E ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE-LKILI 80
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISRE---FPYNVQTLILGEVQD 252
V +K GG +I + L+ + S+ PY + + +D
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 253 LPKGIERE--NRIIQTIMSQ-----------------------------------LLFAL 275
I + R+ SQ + ++
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 276 D------GLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK-EFLLDP 328
L S +HRD+ +N++ SE KI D G A D+ +Y+ K + L
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 329 RYAAPE---QYIMSTQT 342
++ APE + + Q+
Sbjct: 260 KWMAPETIFDRVYTIQS 276
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 21/73 (28%), Positives = 33/73 (45%), Gaps = 8/73 (10%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI--IDLGAAADLRVGINY--IP- 321
+ Q++ ++ +HS +HRD+KP N + G + + ID G A R + IP
Sbjct: 110 LADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169
Query: 322 ---KEFLLDPRYA 331
K RYA
Sbjct: 170 RENKNLTGTARYA 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 18/67 (26%)
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF------------------K 303
++ + QL AL LH + H D+KP+N++F +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 304 IIDLGAA 310
+ D G+A
Sbjct: 183 VADFGSA 189
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 16/47 (34%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
Q ++ QL+ + LHS G++HRD+KP N++ + K+ D G +
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLS 156
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 23/73 (31%), Positives = 33/73 (45%), Gaps = 8/73 (10%)
Query: 267 IMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG--SRTFKIIDLGAAADLRVGINY--IP- 321
+ Q++ ++ +HS +HRDIKP N + G + IID G A R + IP
Sbjct: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Query: 322 ---KEFLLDPRYA 331
K RYA
Sbjct: 168 RENKNLTGTARYA 180
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 54/233 (23%), Positives = 74/233 (31%), Gaps = 86/233 (36%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
R + DF LG+G+FG V L+++ K +L +LKK + VE
Sbjct: 335 RDRMKLTDFNFLMVLGKGSFGKVM---LSER---KGTDELYAVKILKKDVVIQDDDVECT 388
Query: 187 MNERVRRACANCCADFV--YGFFENSSK--------KGGEYWLIWRYEGEATLADLM--I 234
M E+ A + F+ + GG DLM I
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHI 433
Query: 235 SRE--FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292
+ F E+ L L S GI++RD+K N
Sbjct: 434 QQVGRFKEPHAVFYAAEI---------------------AIGLFFLQSKGIIYRDLKLDN 472
Query: 293 VIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
V+ SEG KI D G KE + D P Y APE
Sbjct: 473 VMLDSEGH--IKIADFGMC-----------KENIWDGVTTKTFCGTPDYIAPE 512
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 17/47 (36%), Positives = 27/47 (57%), Gaps = 1/47 (2%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
IQ + Q L A+ LH + ++HRD+KP N++ + K+ D G A
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLA 159
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 14/59 (23%), Positives = 27/59 (45%)
Query: 264 IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPK 322
I+ ++L AL+ L + H D+KP+N++ + +I + D + Y K
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 23/101 (22%), Positives = 39/101 (38%), Gaps = 12/101 (11%)
Query: 259 RENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
R+ +I+ + A + G LH+ GI+H+D+K +NV + G I D G +
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG--KVVITDFGLFSI 178
Query: 313 LRVGINYIPKEFLLDP----RYAAPEQYIMSTQTPSAPSAP 349
V ++ L + APE + P
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 23/73 (31%), Positives = 34/73 (46%), Gaps = 15/73 (20%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLL 326
+ +L+ ALD L + I+HRD+KP N++ G I D AA +P+E +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAM-------LPRETQI 171
Query: 327 D-----PRYAAPE 334
Y APE
Sbjct: 172 TTMAGTKPYMAPE 184
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 15/36 (41%), Positives = 24/36 (66%), Gaps = 1/36 (2%)
Query: 262 RIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIFS 296
++ I+ Q+L LD LH+ I+H DIKP+N++ S
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 49/227 (21%), Positives = 73/227 (32%), Gaps = 86/227 (37%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNERVR 192
DF L + +G G++ V L + K + V+KK + ++ E+
Sbjct: 52 QDFDLLRVIGRGSYAKVL---LVRL---KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV 105
Query: 193 RACANCCADFV--YGFFENSSK--------KGGEYWLIWRYEGEATLADLM--ISRE--F 238
A+ V + F+ S+ GG DLM + R+
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG---------------DLMFHMQRQRKL 150
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SE 297
P E+ AL+ LH GI++RD+K NV+ SE
Sbjct: 151 PEEHARFYSAEI---------------------SLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
G K+ D G KE L P Y APE
Sbjct: 190 GH--IKLTDYGMC-----------KEGLRPGDTTSTFCGTPNYIAPE 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 56/235 (23%), Positives = 77/235 (32%), Gaps = 90/235 (38%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
+ + +DF+L K LG+G+FG V+ LA+ K LKK VE
Sbjct: 11 QIKLKIEDFILHKMLGKGSFGKVF---LAEF---KKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 187 MNER-VRRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLM- 233
M E+ V F+ + F+ GG DLM
Sbjct: 65 MVEKRVLSLAWEHP--FLTHMFCTFQTKENLFFVMEYLNGG---------------DLMY 107
Query: 234 -ISRE--FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290
I F + T E+ + L LHS GIV+RD+K
Sbjct: 108 HIQSCHKFDLSRATFYAAEI---------------------ILGLQFLHSKGIVYRDLKL 146
Query: 291 QNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
N++ +G KI D G KE +L P Y APE
Sbjct: 147 DNILLDKDGH--IKIADFGMC-----------KENMLGDAKTNTFCGTPDYIAPE 188
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 56/229 (24%), Positives = 78/229 (34%), Gaps = 90/229 (39%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNER-V 191
D+F + LG+G+FG V LA+ K GDL VLKK + VE M E+ +
Sbjct: 23 DNFEFIRVLGKGSFGKVM---LARV---KETGDLYAVKVLKKDVILQDDDVECTMTEKRI 76
Query: 192 RRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLM--ISRE- 237
N F+ + F+ + GG DLM I +
Sbjct: 77 LSLARNHP--FLTQLFCCFQTPDRLFFVMEFVNGG---------------DLMFHIQKSR 119
Query: 238 -FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295
F E+ + AL LH GI++RD+K NV+
Sbjct: 120 RFDEARARFYAAEI---------------------ISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
EG K+ D G KE + + P Y APE
Sbjct: 159 HEGH--CKLADFGMC-----------KEGICNGVTTATFCGTPDYIAPE 194
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 43/176 (24%), Positives = 71/176 (40%), Gaps = 59/176 (33%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNE 189
Y DF + + LG G+FG V+ L + +++G VLKK VE +E
Sbjct: 3 YSLQDFQILRTLGTGSFGRVH---LIRS---RHNGRYYAMKVLKKEIVVRLKQVEHTNDE 56
Query: 190 RVRRACANCCADFV---YGFFENSSK--------KGGE-YWLIWRYEGEATLADLMISRE 237
R+ + F+ +G F+++ + +GGE + L+ + S+
Sbjct: 57 RLMLSIVTH--PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK------------SQR 102
Query: 238 FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293
FP V EV AL+ LHS I++RD+KP+N+
Sbjct: 103 FPNPVAKFYAAEV---------------------CLALEYLHSKDIIYRDLKPENI 137
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 55/234 (23%), Positives = 76/234 (32%), Gaps = 88/234 (37%)
Query: 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIW 186
R + DF LG+G+FG V L+++ K +L +LKK + VE
Sbjct: 14 RDRMKLTDFNFLMVLGKGSFGKVM---LSER---KGTDELYAVKILKKDVVIQDDDVECT 67
Query: 187 MNERVRRACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLM-- 233
M E+ A F+ + F+ + GG DLM
Sbjct: 68 MVEKRVLALPGKPP-FLTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYH 111
Query: 234 ISRE--FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291
I + F E+ L L S GI++RD+K
Sbjct: 112 IQQVGRFKEPHAVFYAAEI---------------------AIGLFFLQSKGIIYRDLKLD 150
Query: 292 NVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
NV+ SEG KI D G KE + D P Y APE
Sbjct: 151 NVMLDSEGH--IKIADFGMC-----------KENIWDGVTTKTFCGTPDYIAPE 191
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 51/229 (22%), Positives = 75/229 (32%), Gaps = 90/229 (39%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNER-V 191
DF L + +G G++ V L + K + V+KK + ++ E+ V
Sbjct: 9 QDFDLLRVIGRGSYAKVL---LVRL---KKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 192 RRACANCCADFVYGF---FENSSK--------KGGEYWLIWRYEGEATLADLM--ISRE- 237
+N F+ G F+ S+ GG DLM + R+
Sbjct: 63 FEQASNHP--FLVGLHSCFQTESRLFFVIEYVNGG---------------DLMFHMQRQR 105
Query: 238 -FPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295
P E+ AL+ LH GI++RD+K NV+
Sbjct: 106 KLPEEHARFYSAEI---------------------SLALNYLHERGIIYRDLKLDNVLLD 144
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----------PRYAAPE 334
SEG K+ D G KE L P Y APE
Sbjct: 145 SEGH--IKLTDYGMC-----------KEGLRPGDTTSTFCGTPNYIAPE 180
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 48/223 (21%), Positives = 73/223 (32%), Gaps = 55/223 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
+ GK LG GAFG V A A + V LK + E M+E
Sbjct: 23 NRLSFGKTLGAGAFGKVVEA-TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE----- 76
Query: 195 CAN----------------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF 238
C GG +I Y L + + +
Sbjct: 77 -LKVLSYLGNHMNIVNLLGACT------------IGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQN 292
+ ++D + + L F+ G L S +HRD+ +N
Sbjct: 124 SFICSKTSPAIMEDDELAL--------DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
++ + G R KI D G A D++ NY+ K P ++ APE
Sbjct: 176 ILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 21/69 (30%), Positives = 36/69 (52%), Gaps = 4/69 (5%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADL-RVGINYIPKEFL 325
++++ AL+ LH GI+HRD+KP+N++ + +I D G A L F+
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFV 193
Query: 326 LDPRYAAPE 334
+Y +PE
Sbjct: 194 GTAQYVSPE 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 38/210 (18%), Positives = 66/210 (31%), Gaps = 46/210 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKP----SSKNDGDLVLKKATEYGAVEIWMNERVRRA 194
+ L + +G G FG VYRA ++++D D + + E E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH- 65
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
N A K L+ + L ++ + P ++ +
Sbjct: 66 -PNIIA------LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA---VQIA 115
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTG---IVHRDIKPQNVIFSEGSR-------TFKI 304
+G M+ L H I+HRD+K N++ + KI
Sbjct: 116 RG-----------MNYL-------HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
D G A R + APE
Sbjct: 158 TDFGLA---REWHRTTKMSAAGAYAWMAPE 184
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 53/217 (24%), Positives = 79/217 (36%), Gaps = 66/217 (30%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL----VLKKAT--EYGAVEIWMNERVR 192
++F K LG+G FG V L K+ K G +LKK V + E
Sbjct: 148 NEFEYLKLLGKGTFGKVI---LVKE---KATGRYYAMKILKKEVIVAKDEVAHTLTEN-- 199
Query: 193 RACANCCADFV---YGFFENSSK--------KGGEYWLIWRYEGEATLADLM--ISREFP 239
R N F+ F+ + GGE L +SRE
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE---------------LFFHLSRE-- 242
Query: 240 YNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQNVIF-SE 297
+ E+R + ++++ ALD LHS +V+RD+K +N++ +
Sbjct: 243 ----------------RVFSEDRA-RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 285
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPE 334
G KI D G + + K F P Y APE
Sbjct: 286 GH--IKITDFGLCKE-GIKDGATMKTFCGTPEYLAPE 319
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 18/61 (29%), Positives = 24/61 (39%), Gaps = 8/61 (13%)
Query: 278 LHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD----PRYAAP 333
LH+ I+HRD+K N+ E T KI D G A + + AP
Sbjct: 136 LHAKSIIHRDLKSNNIFLHE-DNTVKIGDFGLA---TEKSRWSGSHQFEQLSGSILWMAP 191
Query: 334 E 334
E
Sbjct: 192 E 192
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 22/79 (27%), Positives = 36/79 (45%), Gaps = 25/79 (31%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLL 326
+ +++ AL+ LH GI++RDIK +N++ S G + D G + KEF+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLS-----------KEFVA 211
Query: 327 D-----------PRYAAPE 334
D Y AP+
Sbjct: 212 DETERAYDFCGTIEYMAPD 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 51/215 (23%), Positives = 73/215 (33%), Gaps = 40/215 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
D LGK LG GAFG V A A V LK+ + M+E
Sbjct: 27 DRLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE----- 80
Query: 195 CANCCADFVYGFFEN-------SSKKGGEYWLIWRYEGEATLAD-LMISREFPYNVQTLI 246
G N +K GG +I + L+ L R
Sbjct: 81 -LKILIHI--GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR---------- 127
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSR 300
E E + T+ + ++ G L S +HRD+ +N++ SE
Sbjct: 128 -NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-N 185
Query: 301 TFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
KI D G A D+ +Y+ K P ++ APE
Sbjct: 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 24/77 (31%), Positives = 36/77 (46%), Gaps = 24/77 (31%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADLRVGINYIPKEFLLD 327
++++ AL+ LHS +V+RDIK +N++ +G KI D G KE + D
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLC-----------KEGISD 158
Query: 328 ----------PRYAAPE 334
P Y APE
Sbjct: 159 GATMKTFCGTPEYLAPE 175
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 14/26 (53%), Positives = 22/26 (84%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNV 293
+++L ALD LHS GI++RD+KP+N+
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENI 157
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 11/26 (42%), Positives = 20/26 (76%)
Query: 268 MSQLLFALDGLHSTGIVHRDIKPQNV 293
++++ AL LH GI++RD+KP+N+
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENI 152
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 6/46 (13%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATE 179
+ ++LG+G FG V P N G++V L+ +TE
Sbjct: 40 ERHLKFLQQLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTE 83
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 48/196 (24%), Positives = 72/196 (36%), Gaps = 49/196 (25%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
K + LGEG FG V P++ G++V LK W E
Sbjct: 30 KRYLKKIRDLGEGHFGKVSLYCY--DPTNDGTGEMVAVKALKADAGPQHRSGWKQE---- 83
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEG---EATLADLMISREFPYNVQTLILGEV 250
+ + E+ I +Y+G +A A L + E+ + LG +
Sbjct: 84 --IDILRTLYH---EH----------IIKYKGCCEDAGAASLQLVMEY------VPLGSL 122
Query: 251 QD-LPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSRTFK 303
+D L + I + LLFA G LH+ +HRD+ +NV+ R K
Sbjct: 123 RDYL-----PRHSI--GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVK 174
Query: 304 IIDLGAAADLRVGINY 319
I D G A + G Y
Sbjct: 175 IGDFGLAKAVPEGHEY 190
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 52/223 (23%), Positives = 82/223 (36%), Gaps = 50/223 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE----- 189
+ VLGK LGEG FG V +A A + V LK+ + ++E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKA-TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 190 RVRRACAN------CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREF----- 238
+V + C+ + G LI Y A L R F
Sbjct: 82 QVN--HPHVIKLYGACS------------QDGPLLLIVEY---AKYGSL---RGFLRESR 121
Query: 239 PYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQN 292
L G ++ + R + T+ + FA G L +VHRD+ +N
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERAL-TMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180
Query: 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDP-RYAAPE 334
++ +EG R KI D G + D+ +Y+ + P ++ A E
Sbjct: 181 ILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 13/46 (28%), Positives = 21/46 (45%), Gaps = 6/46 (13%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATE 179
+ ++LG+G FG V P N G++V L+ +TE
Sbjct: 9 ERHLKFLQQLGKGNFGSVEMCRY--DPLQDNTGEVVAVKKLQHSTE 52
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 9/30 (30%), Positives = 14/30 (46%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKN 168
+D +GEG FG V +A + K +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMD 54
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 23/77 (29%), Positives = 34/77 (44%), Gaps = 24/77 (31%)
Query: 269 SQLLFALDGLHSTGIVHRDIKPQNV-IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLD 327
+++ AL LHS IV+RD+KP+N+ + S+G + D G KE +
Sbjct: 146 AEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLC-----------KENIEH 192
Query: 328 ----------PRYAAPE 334
P Y APE
Sbjct: 193 NSTTSTFCGTPEYLAPE 209
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 44/196 (22%), Positives = 66/196 (33%), Gaps = 47/196 (23%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
K + LGEG FG V P N G+ V LK + + E
Sbjct: 20 KRFLKRIRDLGEGHFGKVELCRY--DPEGDNTGEQVAVKSLKPESGGNHIADLKKE---- 73
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEG---EATLADLMISREFPYNVQTLILGEV 250
+ + EN I +Y+G E + + EF L G +
Sbjct: 74 --IEILRNLYH---EN----------IVKYKGICTEDGGNGIKLIMEF------LPSGSL 112
Query: 251 QD-LPKGIERENRIIQTIMSQLLFALD---G---LHSTGIVHRDIKPQNVIFSEGSRTFK 303
++ L +N+ + QL +A+ G L S VHRD+ +NV+ K
Sbjct: 113 KEYL-----PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVK 166
Query: 304 IIDLGAAADLRVGINY 319
I D G + Y
Sbjct: 167 IGDFGLTKAIETDKEY 182
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 397 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.37 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.9 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.22 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.03 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.1 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.23 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 82.49 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=371.84 Aligned_cols=205 Identities=22% Similarity=0.331 Sum_probs=173.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|+++++||+|+||+||+|++..++ +.+|+|.+.... ........++...+...+||||+.+++.+. +
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~ 103 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-D 103 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred CccccEEEEEEecccCeEEEEEEECCCC-----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-e
Confidence 4578999999999999999999999887 889999886432 122233445667778889999999998775 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++.+|+|||||.+|+|.++++..+ .+++..++.++.||+.||+|||++|||||||||+||
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~~--------------------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNI 163 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKIG--------------------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 163 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCEEEEEEecCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence 578999999999999999998764 578899999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||+.++ .+||+|||+|+.+.... .....+.+||+.|||||++.+ ..|+.++||||+
T Consensus 164 Ll~~~g-~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~----------------------~~y~~~~DiWSl 220 (311)
T 4aw0_A 164 LLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE----------------------KSACKSSDLWAL 220 (311)
T ss_dssp EECTTS-CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH----------------------SCBCHHHHHHHH
T ss_pred EEcCCC-CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC----------------------CCCCcHHHHHHH
Confidence 999987 99999999998775433 233567899999999996544 456678899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||+||||+||+.||...+
T Consensus 221 Gvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 221 GCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp HHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=375.25 Aligned_cols=205 Identities=21% Similarity=0.315 Sum_probs=166.5
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|.+.... ..+.....++...+...+|+||+.+++.+. +++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-~~~ 96 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDG-----RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-ENG 96 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTC-----CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-ECC
Confidence 479999999999999999999998887 889999886432 333344456677778889999999998774 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+|||||||++|+|.+++...+ +..+++..++.++.||+.||+|||++|||||||||+||||
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~------------------~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 158 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQK------------------GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL 158 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTT------------------TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 8999999999999999997653 2346788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+|+.+..... ..+..+||+.|||||++.+ ..|+.++|||||||+
T Consensus 159 ~~~g-~vKl~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~l~~----------------------~~y~~~~DiwSlGvi 214 (350)
T 4b9d_A 159 TKDG-TVQLGDFGIARVLNSTVE-LARACIGTPYYLSPEICEN----------------------KPYNNKSDIWALGCV 214 (350)
T ss_dssp CTTC-CEEECSTTEESCCCHHHH-HHHHHHSCCTTCCHHHHTT----------------------CCCCHHHHHHHHHHH
T ss_pred CCCC-CEEEcccccceeecCCcc-cccccCCCccccCHHHHCC----------------------CCCCcHHHHHHHHHH
Confidence 9987 999999999987654322 2345789999999996654 356778899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
||||+||+.||...+
T Consensus 215 lyemltG~~PF~~~~ 229 (350)
T 4b9d_A 215 LYELCTLKHAFEAGS 229 (350)
T ss_dssp HHHHHHSSCSCCCSS
T ss_pred HHHHHHCCCCCCCcC
Confidence 999999999997654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=373.22 Aligned_cols=202 Identities=21% Similarity=0.309 Sum_probs=169.9
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|++............++...+...+|+||+.+++.+.. ++.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCC-----CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEE
Confidence 467999999999999999999999887 8899998864433222233445666777789999999987754 5789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
|||||||++|+|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 147 ~ivmEy~~gg~L~~~l~~~---------------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 205 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTHT---------------------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205 (346)
T ss_dssp EEEECCCTTEEHHHHHHHS---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EEEEeCCCCCcHHHHHHcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence 9999999999999998754 3678889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||+|+.+..... ...+.+||+.|||||++. ...|+.++|||||||+||
T Consensus 206 ~g-~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~----------------------~~~y~~~~DiWSlGvily 261 (346)
T 4fih_A 206 DG-RVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELIS----------------------RLPYGPEVDIWSLGIMVI 261 (346)
T ss_dssp TC-CEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHT----------------------TCCBCTHHHHHHHHHHHH
T ss_pred CC-CEEEecCcCceecCCCCC-cccccccCcCcCCHHHHC----------------------CCCCCcHHHHHHHHHHHH
Confidence 87 999999999987654432 345689999999999554 345777899999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||++|+.||...+
T Consensus 262 eml~G~~PF~~~~ 274 (346)
T 4fih_A 262 EMVDGEPPYFNEP 274 (346)
T ss_dssp HHHHSSCTTTTSC
T ss_pred HHHHCCCCCCCcC
Confidence 9999999997653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=376.11 Aligned_cols=203 Identities=21% Similarity=0.306 Sum_probs=170.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||+||+|++..++ +.||+|++............++...+...+|+||+.+++.+.. ++.
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~ 222 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDE 222 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCC-----CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCE
Confidence 4468999999999999999999999887 8899998864433222233445666777789999999987754 578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+|||||||.+|+|.++++.. .+++..++.++.||+.||+|||++|||||||||+||||+
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~---------------------~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~ 281 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT---------------------RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 281 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC
T ss_pred EEEEEeCCCCCcHHHHHhcc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 99999999999999998754 367888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||+|+.+..... ...+.+||+.|||||++. ...|+.++|||||||+|
T Consensus 282 ~~g-~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~----------------------~~~y~~~~DiWSlGvil 337 (423)
T 4fie_A 282 HDG-RVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELIS----------------------RLPYGPEVDIWSLGIMV 337 (423)
T ss_dssp TTC-CEEECCCTTCEECCSSCC-CBCCCEECTTTCCHHHHT----------------------TCCBCTHHHHHHHHHHH
T ss_pred CCC-CEEEecCccceECCCCCc-cccccccCcCcCCHHHHC----------------------CCCCCcHHHHHHHHHHH
Confidence 987 999999999987654432 345689999999999554 34577789999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 338 yeml~G~~PF~~~~ 351 (423)
T 4fie_A 338 IEMVDGEPPYFNEP 351 (423)
T ss_dssp HHHHHSSCTTTTSC
T ss_pred HHHHHCCCCCCCcC
Confidence 99999999997653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=367.02 Aligned_cols=203 Identities=19% Similarity=0.134 Sum_probs=167.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||+||+|++..++ +.+|+|++...... .++...+...+||||+.+++.+. .++.
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g-----~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~-~~~~ 124 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTG-----FQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR-EGPW 124 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEE-ETTE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCC-----CEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEE-ECCE
Confidence 3468999999999999999999999887 88999988754322 23556777789999999998764 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+|||||||++|+|.++++..+ .+++..++.++.||+.||+|||++|||||||||+||||+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 184 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMG--------------------CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC
T ss_pred EEEEEeccCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe
Confidence 999999999999999998764 578899999999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccc----ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINY----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
.++..+||+|||+|+.+..+... .....+||+.|||||++.+ ..|+.++|||||
T Consensus 185 ~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~----------------------~~y~~~~DiwSl 242 (336)
T 4g3f_A 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG----------------------KPCDAKVDIWSS 242 (336)
T ss_dssp TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT----------------------CCCCTHHHHHHH
T ss_pred CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC----------------------CCCCcHHHHHHH
Confidence 88656999999999877543211 1234689999999996654 356778899999
Q ss_pred HHHHHHHHcCCCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~~ 392 (397)
||+||||+||+.||......
T Consensus 243 GvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 243 CCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp HHHHHHHHHSSCSSTTTCCS
T ss_pred HHHHHHHHHCcCCCCCCCHH
Confidence 99999999999999775543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=361.73 Aligned_cols=225 Identities=19% Similarity=0.254 Sum_probs=176.3
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|.+.++||+|+||+||+|++.+.........||+|+++...........++...+...+||||+.+++.+.. +
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~ 87 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-G 87 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-C
Confidence 456689999999999999999999987543333347899999986655555556667788888999999999997754 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.++||||||++|+|.++++..+..... .........+++..+..++.|++.||+|||+++||||||||+|||
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~-------~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NIL 160 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVL-------MAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL 160 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHH-------C----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCccccc-------ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEE
Confidence 6799999999999999999875310000 000112346889999999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++++ .+||+|||+|+......... .....||+.|||||+ +....|+.|+||||||
T Consensus 161 l~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~----------------------~~~~~~~~k~DVwS~G 217 (299)
T 4asz_A 161 VGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES----------------------IMYRKFTTESDVWSLG 217 (299)
T ss_dssp ECGGG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHH----------------------HHHCCCCHHHHHHHHH
T ss_pred ECCCC-cEEECCcccceecCCCCceeecCceecChhhcCHHH----------------------HcCCCCCchhhHHHHH
Confidence 99987 99999999998765443322 334579999999994 4455677889999999
Q ss_pred HHHHHHHc-CCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~ 390 (397)
|+||||+| |+.||....
T Consensus 218 vvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 218 VVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp HHHHHHHTTTCCTTTTSC
T ss_pred HHHHHHHcCCCCCCCCCC
Confidence 99999998 999997644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=359.41 Aligned_cols=208 Identities=19% Similarity=0.228 Sum_probs=165.7
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
+++..++++++++||+|+||+||+|++. ..+|+|.++.. .........++...+...+|+||+.+++.+.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4567789999999999999999999865 35788877532 2333444556777888899999999998653
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
++.++||||||++|+|.+++.... ..+++..+..|+.|++.||+|||+++||||||||+
T Consensus 103 --~~~~~iVmEy~~gGsL~~~l~~~~-------------------~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~ 161 (307)
T 3omv_A 103 --KDNLAIVTQWCEGSSLYKHLHVQE-------------------TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSN 161 (307)
T ss_dssp --SSSCEEEEECCSSCBHHHHHHTSC-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSS
T ss_pred --CCeEEEEEEcCCCCCHHHHHhhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHH
Confidence 356899999999999999997643 24678889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
||||++++ .+||+|||+|+...... .......+||+.|||||++.+... ..|+.|+|||
T Consensus 162 NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~-------------------~~y~~ksDVw 221 (307)
T 3omv_A 162 NIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN-------------------NPFSFQSDVY 221 (307)
T ss_dssp SEEEETTE-EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSS-------------------CCCCHHHHHH
T ss_pred HEEECCCC-cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCC-------------------CCCCcHHHhH
Confidence 99999987 99999999998765432 223456789999999997754322 2477899999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+||||+||+.||....
T Consensus 222 S~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 222 SYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp HHHHHHHHHHHSSCTTTTCC
T ss_pred hHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999997644
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=353.02 Aligned_cols=204 Identities=24% Similarity=0.306 Sum_probs=153.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.+.||+|+||+||+|++..++ +.+|+|.+...... ......++...+...+||||+.+++.+. .
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~ 84 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTG-----QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-S 84 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTC-----CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-E
Confidence 4589999999999999999999998887 88999988643211 1223345566677778999999998764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++.+|+||||+ +|+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+||
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NI 143 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQRD--------------------KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL 143 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHSC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred CCEEEEEEeCC-CCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHe
Confidence 57899999999 579999987654 578899999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|+++++ .+||+|||+|+...... ...+.+||+.|||||++.+..+ ++.++||||+|
T Consensus 144 Ll~~~~-~vkl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y---------------------~~~~~DiwSlG 199 (275)
T 3hyh_A 144 LLDEHL-NVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLY---------------------AGPEVDVWSCG 199 (275)
T ss_dssp EECTTC-CEEECCSSCC-----------------CTTSCHHHHSSSSC---------------------CCTHHHHHHHH
T ss_pred EECCCC-CEEEeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCC---------------------CCChhhhHHHH
Confidence 999987 99999999998754432 2356799999999997765433 23578999999
Q ss_pred HHHHHHHcCCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~ 391 (397)
|+||||+||+.||...+.
T Consensus 200 vily~lltg~~PF~~~~~ 217 (275)
T 3hyh_A 200 VILYVMLCRRLPFDDESI 217 (275)
T ss_dssp HHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHCCCCCCCCCH
Confidence 999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=352.83 Aligned_cols=200 Identities=20% Similarity=0.278 Sum_probs=165.6
Q ss_pred CCe-EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc---
Q 015991 139 DDF-VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (397)
Q Consensus 139 ~~f-~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (397)
++| ++.++||+|+||+||+|++..++ ..+|+|++.... ..+.....++...+...+||||+.+++.+..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCC-----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC
Confidence 455 78889999999999999998887 789999886432 2333344566777888899999999886543
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--ceecCCCC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKP 290 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiHrDIKp 290 (397)
.+..+|||||||++|+|.+++.... .+++..++.++.||+.||+|||++| ||||||||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp 159 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--------------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCG
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccCh
Confidence 2456899999999999999998754 5678889999999999999999998 99999999
Q ss_pred CceEEeC-CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 291 QNVIFSE-GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 291 ~NILl~~-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+||||+. ++ .+||+|||+|+..... ...+.+||+.|||||++.+ .|+.++||
T Consensus 160 ~NILl~~~~g-~vKl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-----------------------~y~~~~Di 212 (290)
T 3fpq_A 160 DNIFITGPTG-SVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-----------------------KYDESVDV 212 (290)
T ss_dssp GGEEESSTTS-CEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-----------------------CCCTHHHH
T ss_pred hheeEECCCC-CEEEEeCcCCEeCCCC---ccCCcccCccccCHHHcCC-----------------------CCCcHHHH
Confidence 9999985 55 9999999999754322 2456799999999996532 46778999
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||+||||+||+.||....
T Consensus 213 wSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 213 YAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp HHHHHHHHHHHHSSCTTTTCS
T ss_pred HHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999997543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=361.46 Aligned_cols=207 Identities=21% Similarity=0.270 Sum_probs=163.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++|++.+.||+|+||+||+|++..+... .+.+|+|.+.... ..+.....++...+...+||||+.+++.+.. +
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~ 98 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDA--RQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-E 98 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTT--TCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-T
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCC--CEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-C
Confidence 347899999999999999999987543211 1678899875322 1111123345666778899999999987754 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+|+|||||.+|+|.+++...+ .+++..++.++.|++.||+|||++|||||||||+|||
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 158 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV--------------------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENIL 158 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeE
Confidence 78999999999999999998764 5788999999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+|+....... ...+.+||+.|||||++.+ ..|+.++||||+||
T Consensus 159 l~~~g-~vKl~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~~~~----------------------~~y~~~~DiwSlGv 214 (304)
T 3ubd_A 159 LDEEG-HIKLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNR----------------------RGHTQSADWWSFGV 214 (304)
T ss_dssp ECTTS-CEEEESSEEEEC-----C-CCCSCCCCGGGCCHHHHHT----------------------SCCCTHHHHHHHHH
T ss_pred EcCCC-CEEecccccceeccCCCc-cccccccCcccCCHHHhcc----------------------CCCCCCCcccchHH
Confidence 99987 999999999986544322 3456799999999996543 45677889999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
+||||+||+.||...+
T Consensus 215 ilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 215 LMFEMLTGTLPFQGKD 230 (304)
T ss_dssp HHHHHHHSSCSSCCSS
T ss_pred HHHHHHhCCCCCCCcC
Confidence 9999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=359.42 Aligned_cols=227 Identities=19% Similarity=0.236 Sum_probs=169.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|.+.++||+|+||+||+|++.+.........||+|+++...........++...+...+|+||+.+++.+.. +
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~ 115 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-G 115 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-C
Confidence 345689999999999999999999986533233337899999987655555556667788888999999999998754 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.++||||||++|+|.++++.......... .........+++..+..|+.|++.||+|||+++||||||||+|||
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~-----~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL 190 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLA-----GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC----------------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCccccccc-----ccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence 679999999999999999987642111000 001112346889999999999999999999999999999999999
Q ss_pred EeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++++ .+||+|||+|+.+...... ......||+.|||||++ ....|+.++||||||
T Consensus 191 l~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~----------------------~~~~~~~~sDvwS~G 247 (329)
T 4aoj_A 191 VGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI----------------------LYRKFTTESDVWSFG 247 (329)
T ss_dssp EETTT-EEEECCCC----------------CCCCGGGCCHHHH----------------------TTCCCCHHHHHHHHH
T ss_pred ECCCC-cEEEcccccceeccCCCcceecCcccccccccChhhh----------------------cCCCCCccccccchH
Confidence 99987 9999999999876544332 23457899999999954 444677789999999
Q ss_pred HHHHHHHc-CCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~ 390 (397)
|+||||+| |+.||....
T Consensus 248 vvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 248 VVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp HHHHHHHTTSCCTTCSSC
T ss_pred HHHHHHHcCCCCCCCCCC
Confidence 99999998 999997644
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=364.71 Aligned_cols=232 Identities=19% Similarity=0.207 Sum_probs=180.6
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (397)
+++..++|+++++||+|+||+||+|++...+...+.+.|++|++..... .+.....++...+... +|+||+.+++.+.
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 4567789999999999999999999998887777778899999875432 2222233344444444 5689999999877
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..++.++||||||++|+|.++++.....+..... ..+......+++..+..++.||+.||+|||+++||||||||+
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV----APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-----------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccc----cchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 7677899999999999999999875421110000 000112345789999999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|||+++++ .+||+|||+|+.+..+..+ ......||+.||||| ++....|+.++|||
T Consensus 215 NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE----------------------~l~~~~y~~ksDVw 271 (353)
T 4ase_A 215 NILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE----------------------TIFDRVYTIQSDVW 271 (353)
T ss_dssp GEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH----------------------HHHHCCCCHHHHHH
T ss_pred ceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHH----------------------HHhcCCCCCcccEe
Confidence 99999987 9999999999877554433 234578999999999 44555677889999
Q ss_pred HHHHHHHHHHc-CCCCCCCCCCC
Q 015991 371 SAGLIFLQMVC-TVRRLCLHSCP 392 (397)
Q Consensus 371 SlGv~l~ellt-g~~Pf~~~~~~ 392 (397)
||||+||||+| |+.||......
T Consensus 272 S~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 272 SFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999998 99999875543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=354.59 Aligned_cols=229 Identities=20% Similarity=0.235 Sum_probs=173.4
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
..+..+++++.++||+|+||+||+|++.........+.||+|+++..... ......++...+...+||||+.+++.+..
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34566899999999999999999999765333333378999998754322 12233445666777889999999998754
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++.++||||||++|+|.+++............ .........+++..+..++.||+.||+|||+++||||||||+|
T Consensus 101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N 175 (308)
T 4gt4_A 101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST----DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 175 (308)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC---------CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhhCcccccccc----ccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence 56789999999999999999765321110000 0011123467899999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++++ .+||+|||+|+.+...... ......||+.||||| ++....|+.++||||
T Consensus 176 ILl~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE----------------------~l~~~~~s~ksDVwS 232 (308)
T 4gt4_A 176 VLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE----------------------AIMYGKFSIDSDIWS 232 (308)
T ss_dssp EEECGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH----------------------HHHHCCCCHHHHHHH
T ss_pred eEECCCC-CEEECCcccceeccCCCceeEecccccCCcccCHH----------------------HHhCCCCCccchhhh
Confidence 9999987 9999999999877554332 244578999999999 445556778899999
Q ss_pred HHHHHHHHHc-CCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~ 390 (397)
|||+||||+| |..||....
T Consensus 233 fGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 233 YGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp HHHHHHHHHTTTCCTTTTCC
T ss_pred HHHHHHHHHhCCCCCCCCCC
Confidence 9999999998 899997654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=346.84 Aligned_cols=202 Identities=25% Similarity=0.305 Sum_probs=154.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccC---
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (397)
++|++.+.||+|+||+||+|++..++ +.+|+|++.... ........++...+...+||||+.+++.+...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDD-----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTC-----CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCC-----CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 57999999999999999999998887 889999886433 223334455677788889999999988765433
Q ss_pred --------CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 215 --------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 215 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
..+|+|||||.+|+|.+++..... ....++..++.++.||+.||+|||++|||||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-----------------~~~~~~~~~~~i~~qi~~al~ylH~~~IiHR 142 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-----------------IEERERSVCLHIFLQIAEAVEFLHSKGLMHR 142 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCS-----------------GGGSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCC-----------------CChhHHHHHHHHHHHHHHHHHHHHHCcCccc
Confidence 247999999999999999987541 1234566788999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEeccccccccccccc-----------ccccccCCCCCCCcccccccCCCCCCCCccccccch
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-----------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~ 355 (397)
||||+||||+.++ .+||+|||+|+.+..+... ..++.+||+.|||||++.+
T Consensus 143 DlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~----------------- 204 (299)
T 4g31_A 143 DLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG----------------- 204 (299)
T ss_dssp CCCGGGEEECTTC-CEEECCCCCC--------------------------CCCTTSCHHHHTT-----------------
T ss_pred cCcHHHeEECCCC-cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-----------------
Confidence 9999999999987 9999999999876543221 1234689999999996654
Q ss_pred hhhhccCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 015991 356 PVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 356 ~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
..|+.++|||||||+||||++ ||..
T Consensus 205 -----~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 205 -----NSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp -----CCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred -----CCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 356778899999999999996 6653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=349.70 Aligned_cols=205 Identities=23% Similarity=0.337 Sum_probs=162.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC---C
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG---G 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~ 215 (397)
++|.+.++||+|+||+||+|++.+ +.||+|++......+. ..+.+...+...+|+||+.+++.+...+ .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g-------~~VAvK~l~~~~~~~~-~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT-------EEEEEEEECGGGHHHH-HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccchhhH-HHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 579999999999999999998743 7899999876554443 3344555566678999999998876543 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC--------CceecC
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--------GIVHRD 287 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~--------giiHrD 287 (397)
.+|||||||++|+|.++++.. .++++.+.+++.|++.||+|||++ +|||||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~---------------------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRD 133 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY---------------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---------------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSC
T ss_pred EEEEEecCCCCCcHHHHHHhC---------------------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeecc
Confidence 689999999999999999765 356778889999999999999987 999999
Q ss_pred CCCCceEEeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
|||+||||+.++ .+||+|||+|+........ .....+||+.|||||++.+..... ...++
T Consensus 134 lKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~----------------~~~~~ 196 (303)
T 3hmm_A 134 LKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK----------------HFESF 196 (303)
T ss_dssp CCGGGEEECTTS-CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTT----------------CHHHH
T ss_pred CCcccEEECCCC-CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccccccc----------------CCccC
Confidence 999999999987 9999999999876543322 233468999999999886543221 12356
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
.|+|||||||+||||+||..||...
T Consensus 197 ~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 197 KRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred hhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 7899999999999999998887543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=352.34 Aligned_cols=204 Identities=22% Similarity=0.313 Sum_probs=167.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccc----
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (397)
++|+++++||+|+||+||+|++..++ +.||+|++..... .......++...+...+|+||+.+++.+..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTG-----QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCC-----CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence 68999999999999999999999887 8899999864332 222333456667777889999999886543
Q ss_pred -cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 213 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+.+|||||||+ |+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~--------------------~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~ 187 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQ--------------------PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 187 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcc
Confidence 3467999999997 67999987653 5788999999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccc---ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGI---NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|||++.++ .+||+|||+|+.+.... .....+.+||+.|||||++.+.. .|+.++|
T Consensus 188 NIl~~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~---------------------~~~~~~D 245 (398)
T 4b99_A 188 NLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLH---------------------EYTQAID 245 (398)
T ss_dssp GEEECTTC-CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCS---------------------CCCTHHH
T ss_pred ccccCCCC-CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCC---------------------CCCChhh
Confidence 99999987 99999999998764432 22345689999999999765433 3567789
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+||++|||++|+.||.+.+
T Consensus 246 iWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 246 LWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp HHHHHHHHHHHHHTSCSSCCSS
T ss_pred eehhHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999998754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=371.30 Aligned_cols=206 Identities=18% Similarity=0.252 Sum_probs=172.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHH-HHHHHHHHHhhccCCCceeeeee
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEI-WMNERVRRACANCCADFVYGFFE 208 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~-~~~~~~~~~~~~~~~~~i~~~~~ 208 (397)
.+..++|+++++||+|+||+||+|++..++ +.+|+|.+.... .... ..+..+...+...+||||+.++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg-----~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~ 259 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCC-----CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence 556789999999999999999999999887 889999875322 2222 22334455667789999999998
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+.. .+.+|+|||||.||+|.+++...+ .+++..++.++.||+.||+|||++|||||||
T Consensus 260 ~f~~-~~~lylVmEy~~GGdL~~~l~~~~--------------------~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDL 318 (689)
T 3v5w_A 260 AFHT-PDKLSFILDLMNGGDLHYHLSQHG--------------------VFSEADMRFYAAEIILGLEHMHNRFVVYRDL 318 (689)
T ss_dssp EEEC-SSEEEEEECCCCSCBHHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred EEEE-CCEEEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 7754 578999999999999999998764 5788999999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+||||+.++ ++||+|||+|+.+... ...+.+||+.|||||++... ..|+.++|
T Consensus 319 KPeNILld~~G-~vKL~DFGlA~~~~~~---~~~t~~GTp~YmAPEvl~~~---------------------~~y~~~vD 373 (689)
T 3v5w_A 319 KPANILLDEHG-HVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKG---------------------VAYDSSAD 373 (689)
T ss_dssp SGGGEEECTTS-CEEECCCTTCEECSSC---CCCSCCSCGGGCCHHHHSTT---------------------CCCCTHHH
T ss_pred chHHeEEeCCC-CEEecccceeeecCCC---CCCCccCCcCccCHHHHhCC---------------------CCCCcHHH
Confidence 99999999988 9999999999876543 24567999999999965422 24677899
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~~ 391 (397)
||||||+||||++|+.||.....
T Consensus 374 iWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 374 WFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp HHHHHHHHHHHHHSSCTTCGGGC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999976544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=338.34 Aligned_cols=204 Identities=23% Similarity=0.309 Sum_probs=157.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhh-ccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA-NCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.++||+|+||+||+|+++.... ..+.+|+|++.......... ++...+. ..+|+|++.+++.+. .+++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~--~~~~vAiK~i~~~~~~~~~~--~E~~~l~~~~~h~nIv~l~~~~~-~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVG--PEEKIALKHLIPTSHPIRIA--AELQCLTVAGGQDNVMGVKYCFR-KNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTS--CEEEEEEEEECTTSCHHHHH--HHHHHHHHTCSBTTBCCCSEEEE-ETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCC--CCCEEEEEEEccccCHHHHH--HHHHHHHHhcCCCCCceEEEEEE-ECCE
Confidence 3789999999999999999998753211 12689999886554333222 2233333 346899999887664 4678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+++++|.+++. .+++..++.++.|++.||+|||++|||||||||+|||++
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----------------------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----------------------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN 151 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred EEEEEeCCCcccHHHHHc-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe
Confidence 999999999999999884 246788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccc---------------------------cccccccCCCCCCCcccccccCCCCCCCCcc
Q 015991 297 EGSRTFKIIDLGAAADLRVGIN---------------------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~ 349 (397)
.+.+.+||+|||+|+....... ......+||+.|||||++.+..
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--------- 222 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP--------- 222 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS---------
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC---------
Confidence 8745999999999976543211 1123458999999999765432
Q ss_pred ccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 350 VATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 350 ~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.|+.++||||+||++|||++|+.||....
T Consensus 223 ------------~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 223 ------------NQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp ------------CCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ------------CCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 36677899999999999999999996554
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.97 Aligned_cols=205 Identities=20% Similarity=0.235 Sum_probs=172.2
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++++.||+|+||+||+|++..++ +.+|+|.+......+.....++...+...+|+||+.+++.+. .++.+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg-----~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATG-----NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-CSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEE
Confidence 478999999999999999999999887 889999887655544445556677777889999999998764 46789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|||||.+|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~-------------------~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~ 290 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEH-------------------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTT-------------------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEeecCCCcHHHHHHHhC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC
Confidence 99999999999999986532 25788999999999999999999999999999999999986
Q ss_pred C-CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 G-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 ~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+ .+.+||+|||+|+.+..... ....+||+.|||||++.+ ..|+.++||||+||+|
T Consensus 291 ~~~~~vKl~DFG~a~~~~~~~~--~~~~~GT~~y~APEv~~~----------------------~~y~~~~DiWSlGvil 346 (573)
T 3uto_A 291 KRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG----------------------KPVGYYTDMWSVGVLS 346 (573)
T ss_dssp SSCCCEEECCCSSCEECCTTSE--EEEECSSGGGCCHHHHTT----------------------CCBCHHHHHHHHHHHH
T ss_pred CCCCCEEEeeccceeEccCCCc--eeeeEECccccCHHHhCC----------------------CCCCcHHHHHHHHHHH
Confidence 4 23899999999988754432 345789999999996654 3466678999999999
Q ss_pred HHHHcCCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHSC 391 (397)
Q Consensus 377 ~elltg~~Pf~~~~~ 391 (397)
|||++|+.||.....
T Consensus 347 yeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 347 YILLSGLSPFGGEND 361 (573)
T ss_dssp HHHHHSCCSSCCSSH
T ss_pred HHHHHCCCCCCCcCH
Confidence 999999999976543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=327.56 Aligned_cols=216 Identities=19% Similarity=0.282 Sum_probs=172.4
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeec
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
...+..++|++.++||+|+||+||+|++..++ +.+|+|.+....... .....++...+...+|++++.+++.
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCC-----cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34566789999999999999999999998876 788999886432211 1112234445556789999999886
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. .++.+++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++||||||||
T Consensus 143 ~~-~~~~~~lV~Ey~~gg~L~~~l~~~~-------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLK 202 (437)
T 4aw2_A 143 FQ-DDNNLYLVMDYYVGGDLLTLLSKFE-------------------DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIK 202 (437)
T ss_dssp EE-CSSEEEEEECCCTTCBHHHHHHTTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred Ee-eCCEEEEEEecCCCCcHHHHHHHcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccC
Confidence 64 4578999999999999999997632 246788899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++ .+||+|||+|+.............+||+.|+|||++...... ...++.++||
T Consensus 203 p~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-----------------~~~~~~~~Dv 264 (437)
T 4aw2_A 203 PDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG-----------------KGRYGPECDW 264 (437)
T ss_dssp GGGEEECTTS-CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTS-----------------CCEECTHHHH
T ss_pred HHHeeEcCCC-CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccC-----------------CCCCCCcCee
Confidence 9999999987 999999999987655444444557899999999976521110 2246778999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~ 391 (397)
|||||++|||++|+.||...+.
T Consensus 265 wSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 265 WSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSH
T ss_pred HHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999976543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=317.78 Aligned_cols=216 Identities=18% Similarity=0.224 Sum_probs=171.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.++||+|+||+||+|.+..+......+.+++|.+......+...+.++...+....|++++.+++.+.. +
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-~ 139 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-Q 139 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-S
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-C
Confidence 345688999999999999999999754433333448999999987776666666677777777779999998887644 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+|+|.+++..... .....+++..++.++.|++.||+|||++|||||||||+|||
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIl 204 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKN---------------TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFI 204 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHT---------------STTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred CCcEEEEeccCCCcHHHHHHHhhc---------------ccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 678999999999999999976421 12335788999999999999999999999999999999999
Q ss_pred EeC-----------CCCeEEEEecccccccccc-cccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC
Q 015991 295 FSE-----------GSRTFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362 (397)
Q Consensus 295 l~~-----------~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
++. ++ .+||+|||+|+.+... .........||+.|+|||++.+ ..
T Consensus 205 l~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~ 261 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN----------------------KP 261 (365)
T ss_dssp ECGGGTCC------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT----------------------CC
T ss_pred ecccccCccccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC----------------------CC
Confidence 987 65 9999999999765422 1222355789999999996544 34
Q ss_pred CCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 363 LPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 363 ~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
++.++|||||||++|||++|+.||...
T Consensus 262 ~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 262 WNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp BSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred CCccccHHHHHHHHHHHHhCCCccccC
Confidence 667889999999999999999999643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=315.64 Aligned_cols=206 Identities=18% Similarity=0.261 Sum_probs=159.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhc-cCCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACAN-CCADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~-~~~~~i~~~~~~~ 210 (397)
.+..++|++.++||+|+||+||+|++..++ +.+|+|.+..... .......++...+.. .+|++++.+++.+
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETG-----DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCC-----CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 356689999999999999999999998877 7899998864321 111112222333333 3699999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. ..+.+++||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||
T Consensus 94 ~-~~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp 152 (353)
T 3txo_A 94 Q-TPDRLFFVMEFVNGGDLMFHIQKSR--------------------RFDEARARFYAAEIISALMFLHDKGIIYRDLKL 152 (353)
T ss_dssp E-CSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred E-eCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCH
Confidence 4 4568999999999999999998754 467888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+|+..... .......+||+.|+|||++. ...++.++|||
T Consensus 153 ~NILl~~~g-~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~----------------------~~~~~~~~Diw 208 (353)
T 3txo_A 153 DNVLLDHEG-HCKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQ----------------------EMLYGPAVDWW 208 (353)
T ss_dssp GGEEECTTS-CEEECCCTTCBCSCC----------CCGGGCCHHHHH----------------------HHHCTTHHHHH
T ss_pred HHEEECCCC-CEEEccccceeecccC-CccccccCCCcCeEChhhcC----------------------CCCcCCccCCC
Confidence 999999987 9999999999764322 22345678999999999554 34566788999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 209 slG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 209 AMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred cchHHHHHHHhCCCCCCCCC
Confidence 99999999999999997654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=310.70 Aligned_cols=204 Identities=21% Similarity=0.226 Sum_probs=167.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.+.||+|+||+||+|++..++ +.+++|.+.... ..+.....++...+....|++++.+++.+..
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 76 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT- 76 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-
Confidence 4589999999999999999999998877 789999886432 1122233344556667789999999887644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+.+++||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 136 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRER--------------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHE
Confidence 568999999999999999987654 467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++...... ......+||+.|+|||++.+. .++.++|+||||
T Consensus 137 ll~~~g-~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG 192 (337)
T 1o6l_A 137 MLDKDG-HIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDN----------------------DYGRAVDWWGLG 192 (337)
T ss_dssp EECTTS-CEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSS----------------------CBCTTHHHHHHH
T ss_pred EECCCC-CEEEeeccchhhcccCC-CcccccccChhhCChhhhcCC----------------------CCCchhhcccch
Confidence 999987 99999999998643222 224567899999999966543 455678999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|++|||++|..||....
T Consensus 193 ~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 193 VVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp HHHHHHHHSSCSSCCSS
T ss_pred hHHHHHhcCCCCCCCCC
Confidence 99999999999997654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=322.15 Aligned_cols=213 Identities=19% Similarity=0.295 Sum_probs=171.0
Q ss_pred hhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeee
Q 015991 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFE 208 (397)
Q Consensus 132 ~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~ 208 (397)
.......++|++.++||+|+||+||+|++..++ +.+|+|.+....... .....++...+...+|++++.+++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCC-----cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 344567789999999999999999999998877 788999876432111 111223344555668999999988
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+. .+..+++||||+++|+|.++++.. .+++..++.++.|++.||+|||++||+||||
T Consensus 137 ~~~-~~~~~~lV~E~~~gg~L~~~l~~~---------------------~~~e~~~~~~~~qi~~aL~~LH~~givHrDL 194 (410)
T 3v8s_A 137 AFQ-DDRYLYMVMEYMPGGDLVNLMSNY---------------------DVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194 (410)
T ss_dssp EEE-CSSEEEEEECCCTTEEHHHHHHHC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EEE-ECCEEEEEEeCCCCCcHHHHHHcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccC
Confidence 764 467899999999999999998764 3567888999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+|||++.++ .+||+|||+|+.............+||+.|+|||++...... ..++.++|
T Consensus 195 Kp~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~------------------~~~~~~~D 255 (410)
T 3v8s_A 195 KPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD------------------GYYGRECD 255 (410)
T ss_dssp SGGGEEECTTS-CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTT------------------CEEETHHH
T ss_pred CHHHeeECCCC-CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCC------------------cCCCCcce
Confidence 99999999987 999999999987655443344567899999999977543311 11567889
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||||++|||++|+.||....
T Consensus 256 iwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 256 WWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp HHHHHHHHHHHHHSSCTTCCSS
T ss_pred EecchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999997654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=321.30 Aligned_cols=218 Identities=19% Similarity=0.289 Sum_probs=172.9
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeec
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
......++|++.++||+|+||+||+|++..++ +.+|+|.+...... +.....++...+...+|++++.++..
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~-----~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG-----QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 34567789999999999999999999998877 88999988643211 11112234445566789999999886
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. .++.+++||||+.+|+|.+++...+ ..+++..++.++.|++.||+|||++||||||||
T Consensus 130 ~~-~~~~~~lVmE~~~gg~L~~~l~~~~-------------------~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLK 189 (412)
T 2vd5_A 130 FQ-DENYLYLVMEYYVGGDLLTLLSKFG-------------------ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189 (412)
T ss_dssp EE-CSSEEEEEECCCCSCBHHHHHHHHS-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred Ee-eCCEEEEEEcCCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccC
Confidence 64 4578999999999999999997643 146788899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++ ++||+|||+|+.............+||+.|+|||++........ ...++.++||
T Consensus 190 p~NILld~~g-~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~---------------~~~~~~~~Di 253 (412)
T 2vd5_A 190 PDNILLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG---------------TGSYGPECDW 253 (412)
T ss_dssp GGGEEECTTS-CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTT---------------CSEECTHHHH
T ss_pred HHHeeecCCC-CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcC---------------CCCCChHHhh
Confidence 9999999987 99999999998765544333445789999999997753211100 1246778999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~ 391 (397)
|||||++|||++|+.||.....
T Consensus 254 wSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 254 WALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSH
T ss_pred hHHhHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999976543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=300.77 Aligned_cols=207 Identities=23% Similarity=0.284 Sum_probs=163.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
....++|++.+.||+|+||.||+|++..++ +.+++|.+... .........++...+....|+|++.+++.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~- 80 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILN-----IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD- 80 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTC-----SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCC-----CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-
Confidence 345589999999999999999999988776 78999987532 222233344556667777899999998875
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..++..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~ 140 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG--------------------PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ 140 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 44578999999999999999997654 4678889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++..............||+.|+|||++.+. .++.++||||
T Consensus 141 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Di~s 197 (294)
T 4eqm_A 141 NILIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE----------------------ATDECTDIYS 197 (294)
T ss_dssp GEEECTTS-CEEECCCSSSTTC-------------CCSSCCHHHHHTC----------------------CCCTTHHHHH
T ss_pred HEEECCCC-CEEEEeCCCccccccccccccCccccCccccCHhHhcCC----------------------CCCchHhHHH
Confidence 99999987 999999999987654433334556899999999966543 4556789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|||++|+.||....
T Consensus 198 lG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 198 IGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp HHHHHHHHHHSSCSSCSSC
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=302.34 Aligned_cols=206 Identities=20% Similarity=0.299 Sum_probs=168.1
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.....++|++.++||+|+||+||+|.+..++ +.+++|.+............++...+....|+|++.+++.+..
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 88 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV- 88 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCC-----cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-
Confidence 3445579999999999999999999988877 7899998764433222233344555666789999999886644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+.+++|.+++... .+++..+..++.|++.||+|||++||+||||||+||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni 147 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTET---------------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCEEEEEEECCCCCCHHHHHhhc---------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHE
Confidence 56899999999999999998764 256788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 148 l~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwslG 203 (297)
T 3fxz_A 148 LLGMDG-SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR----------------------KAYGPKVDIWSLG 203 (297)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHC----------------------SCBCTHHHHHHHH
T ss_pred EECCCC-CEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcC----------------------CCCCcHHHHHHHH
Confidence 999987 999999999987654332 2345689999999996543 3466788999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|++|||++|+.||....
T Consensus 204 ~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 204 IMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp HHHHHHHHSSCTTTTSC
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999996543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=315.75 Aligned_cols=205 Identities=18% Similarity=0.246 Sum_probs=163.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHh-hccCCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRAC-ANCCADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~-~~~~~~~i~~~~~~~ 210 (397)
.+..++|++.++||+|+||+||+|++..++ +.+|+|.+...... ......++...+ ...+|++|+.+++.+
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTD-----RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 456689999999999999999999998877 78888887643211 111111222222 223799999998866
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. .++.+++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||
T Consensus 123 ~-~~~~~~lV~E~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp 181 (396)
T 4dc2_A 123 Q-TESRLFFVIEYVNGGDLMFHMQRQR--------------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKL 181 (396)
T ss_dssp E-CSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred E-ECCEEEEEEEcCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCH
Confidence 4 4578999999999999999998654 467888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+|+..... .......+||+.|+|||++.+ ..++.++|||
T Consensus 182 ~NILl~~~g-~ikL~DFGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~----------------------~~~~~~~Diw 237 (396)
T 4dc2_A 182 DNVLLDSEG-HIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRG----------------------EDYGFSVDWW 237 (396)
T ss_dssp GGEEECTTS-CEEECCCTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTT----------------------CCBCTHHHHH
T ss_pred HHEEECCCC-CEEEeecceeeecccC-CCccccccCCcccCCchhhcC----------------------CCCChHHHHH
Confidence 999999987 9999999999863222 223456789999999996644 3466778999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
||||++|||++|+.||...
T Consensus 238 slGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 238 ALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp HHHHHHHHHHHSSCSSTTT
T ss_pred HHHHHHHHHHhCCCCCccc
Confidence 9999999999999999653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=309.32 Aligned_cols=204 Identities=24% Similarity=0.338 Sum_probs=163.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhh-ccCCCceeeeee
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACA-NCCADFVYGFFE 208 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~-~~~~~~i~~~~~ 208 (397)
....++|++.+.||+|+||.||+|++..++ +.+++|.+.... ..+... .+...+. ...|++++.+++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~--~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTN-----QFFAIKALKKDVVLMDDDVECTM--VEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHH--HHHHHHHHHTTCTTBCCEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhHHhhhhhhHHHHH--HHHHHHHhcCCCCCCCcEEE
Confidence 456789999999999999999999998876 789999886532 112212 2222222 247999999888
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+.. .+.+++||||+.+|+|.+++.... .+++..++.++.|++.||+|||++||+||||
T Consensus 86 ~~~~-~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 144 (345)
T 1xjd_A 86 TFQT-KENLFFVMEYLNGGDLMYHIQSCH--------------------KFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144 (345)
T ss_dssp EEEC-SSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred EEEe-CCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 7644 568999999999999999998654 4678889999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+|||++.++ .+||+|||+++...... ......+||+.|+|||++.+ ..++.++|
T Consensus 145 kp~NIll~~~g-~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~D 200 (345)
T 1xjd_A 145 KLDNILLDKDG-HIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLG----------------------QKYNHSVD 200 (345)
T ss_dssp CGGGEEECTTS-CEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT----------------------CCBCTHHH
T ss_pred ChhhEEECCCC-CEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcC----------------------CCCCChhh
Confidence 99999999987 99999999998643322 22456789999999996644 34567789
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
+|||||++|||++|..||....
T Consensus 201 iwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 201 WWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS
T ss_pred hHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=313.69 Aligned_cols=205 Identities=20% Similarity=0.240 Sum_probs=164.0
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHH-HhhccCCCceeeeeeccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRR-ACANCCADFVYGFFENSS 211 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~-~~~~~~~~~i~~~~~~~~ 211 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|.+...... +......+.. .+....|++++.++..+.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEE-----VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTC-----CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCC-----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 45689999999999999999999998876 78899988654321 1111111222 245678999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
. .+.+|+||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+
T Consensus 110 ~-~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 168 (373)
T 2r5t_A 110 T-ADKLYFVLDYINGGELFYHLQRER--------------------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 168 (373)
T ss_dssp C-SSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred e-CCEEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 4 578999999999999999998654 4577888999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++..... .......+||+.|+|||++.+ ..++.++||||
T Consensus 169 NIll~~~g-~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diws 224 (373)
T 2r5t_A 169 NILLDSQG-HIVLTDFGLCKENIEH-NSTTSTFCGTPEYLAPEVLHK----------------------QPYDRTVDWWC 224 (373)
T ss_dssp GEEECTTS-CEEECCCCBCGGGBCC-CCCCCSBSCCCCCCCHHHHTT----------------------CCCCTHHHHHH
T ss_pred HEEECCCC-CEEEeeCccccccccC-CCccccccCCccccCHHHhCC----------------------CCCCchhhhHH
Confidence 99999987 9999999999864322 223456789999999996543 34667889999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|..||....
T Consensus 225 lG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 225 LGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp HHHHHHHHHHSSCTTCCSB
T ss_pred HHHHHHHHHcCCCCCCCCC
Confidence 9999999999999997654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=309.74 Aligned_cols=206 Identities=18% Similarity=0.192 Sum_probs=164.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhc-cCCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACAN-CCADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~-~~~~~i~~~~~~~ 210 (397)
.+..++|++.+.||+|+||.||+|++..++ +.+|+|.+..... ........+...+.. .+|++++.+...+
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTD-----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEE-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 456789999999999999999999998776 7899998865321 111122223333433 3789999888766
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. ..+.+++||||+.+|+|.+++...+ .+++..++.++.|++.||+|||++||+||||||
T Consensus 91 ~-~~~~~~lv~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp 149 (353)
T 2i0e_A 91 Q-TMDRLYFVMEYVNGGDLMYHIQQVG--------------------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 149 (353)
T ss_dssp E-CSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred E-cCCEEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCH
Confidence 4 4568999999999999999998654 467888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+|+...... ......+||+.|+|||++.+ ..++.++|||
T Consensus 150 ~NIll~~~g-~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diw 205 (353)
T 2i0e_A 150 DNVMLDSEG-HIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY----------------------QPYGKSVDWW 205 (353)
T ss_dssp GGEEECTTS-CEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTT----------------------CCBSTHHHHH
T ss_pred HHEEEcCCC-cEEEEeCCcccccccCC-cccccccCCccccChhhhcC----------------------CCcCCccccc
Confidence 999999987 99999999998643222 23456789999999996643 3466778999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 206 slG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 206 AFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred chHHHHHHHHcCCCCCCCCC
Confidence 99999999999999997654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.08 Aligned_cols=202 Identities=21% Similarity=0.304 Sum_probs=166.5
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
+..++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.+.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~- 76 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ- 76 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-
Confidence 45689999999999999999999998877 78999988643211 1222233455566678999999988764
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
....+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 136 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKSQ--------------------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPEN 136 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhe
Confidence 4578999999999999999997653 46788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||+++..... ....+||+.|+|||++.+ ..++.++|+|||
T Consensus 137 Ill~~~g-~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diwsl 189 (318)
T 1fot_A 137 ILLDKNG-HIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST----------------------KPYNKSIDWWSF 189 (318)
T ss_dssp EEECTTS-CEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTT----------------------CCBCTTHHHHHH
T ss_pred EEEcCCC-CEEEeecCcceecCCc----cccccCCccccCHhHhcC----------------------CCCCcccchhhh
Confidence 9999987 9999999999865432 345689999999996643 345667899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||++|||++|+.||....
T Consensus 190 G~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 190 GILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp HHHHHHHHHSSCTTCCSS
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999999999997644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.76 Aligned_cols=205 Identities=21% Similarity=0.292 Sum_probs=168.8
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|++.... ........++...+...+|+|++.+++.+. .
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTG-----REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-T 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-E
Confidence 45689999999999999999999998877 889999886532 222233334556667778999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+..++||||+.+++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NI 145 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHG--------------------RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCEEEEEEECCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHE
Confidence 578999999999999999997654 467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++....+. ......||+.|+|||++.+.... +.++||||+|
T Consensus 146 ll~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DiwslG 201 (328)
T 3fe3_A 146 LLDADM-NIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYD---------------------GPEVDVWSLG 201 (328)
T ss_dssp EECTTS-CEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCC---------------------SHHHHHHHHH
T ss_pred EEcCCC-CEEEeeccCceecCCCC--ccccccCCcceeCcccccCCCcC---------------------CchhhhhhhH
Confidence 999987 99999999998665432 23567899999999976544321 2468999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|++|||++|+.||....
T Consensus 202 ~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 202 VILYTLVSGSLPFDGQN 218 (328)
T ss_dssp HHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=305.91 Aligned_cols=204 Identities=19% Similarity=0.240 Sum_probs=164.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhc-cCCCceeeeeeccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACAN-CCADFVYGFFENSS 211 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~ 211 (397)
+..++|++.+.||+|+||.||+|++..++ +.+++|.+.... ........++...+.. .+|++++.+++.+.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTD-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 45689999999999999999999998876 788999886432 2222222233333333 37999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++.+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+
T Consensus 81 -~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 139 (345)
T 3a8x_A 81 -TESRLFFVIEYVNGGDLMFHMQRQR--------------------KLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139 (345)
T ss_dssp -CSSEEEEEECCCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred -eCCEEEEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 4578999999999999999997654 4678889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++...... ......+||+.|+|||++.+ ..++.++||||
T Consensus 140 NIll~~~g-~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diws 195 (345)
T 3a8x_A 140 NVLLDSEG-HIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRG----------------------EDYGFSVDWWA 195 (345)
T ss_dssp GEEECTTS-CEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTT----------------------CCBCTHHHHHH
T ss_pred HEEECCCC-CEEEEeccccccccCCC-CcccccCCCccccCccccCC----------------------CCCChHHhHHH
Confidence 99999987 99999999998643222 22456789999999996644 34566789999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~ 389 (397)
|||++|||++|+.||...
T Consensus 196 lG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 196 LGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp HHHHHHHHHHSSCTTTTT
T ss_pred HHHHHHHHHhCCCCcCCc
Confidence 999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.23 Aligned_cols=208 Identities=19% Similarity=0.247 Sum_probs=170.0
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.+..++|++.+.||+|+||.||+|++..++ +.+|+|.+...... ......++...+....|++++.+++.+.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTK-----KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456689999999999999999999998887 78999987643311 1222334555666778999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
. ...+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+
T Consensus 86 ~-~~~~~lv~e~~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 144 (384)
T 4fr4_A 86 D-EEDMFMVVDLLLGGDLRYHLQQNV--------------------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPD 144 (384)
T ss_dssp C-SSEEEEEECCCTTEEHHHHHHTTC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred e-CCEEEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence 4 568999999999999999997653 4678889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+|+.+.... ......||+.|+|||++..... ..++.++||||
T Consensus 145 NIll~~~g-~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~-------------------~~~~~~~DiwS 202 (384)
T 4fr4_A 145 NILLDEHG-HVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKG-------------------AGYSFAVDWWS 202 (384)
T ss_dssp GEEECTTS-CEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSS-------------------CCBCTTHHHHH
T ss_pred HeEECCCC-CEEEeccceeeeccCCC--ceeccCCCccccCCeeeccCCC-------------------CCCCccceeec
Confidence 99999987 99999999998764332 2356789999999998754221 23667889999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|..||....
T Consensus 203 lG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 203 LGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp HHHHHHHHHHSSCSSCCCT
T ss_pred hHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=296.24 Aligned_cols=208 Identities=18% Similarity=0.229 Sum_probs=169.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|+++++||+|+||+||+|++..++ +.+++|++............++...+....|+|++.+++.+. .+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~ 79 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETG-----EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-KD 79 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ET
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCC-----cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-cC
Confidence 345689999999999999999999998876 788999876655444445555666777778999999988764 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+++|.++++... ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 140 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMD-------------------SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL 140 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCC-------------------TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred CeeEEEEEecCCCcHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEE
Confidence 78999999999999999998743 24677889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccc-------------cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYI-------------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~-------------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
++.++ .+||+|||+++......... .....||+.|+|||++.+ .
T Consensus 141 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~ 197 (310)
T 3s95_A 141 VRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING----------------------R 197 (310)
T ss_dssp ECTTS-CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT----------------------C
T ss_pred ECCCC-CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC----------------------C
Confidence 99987 99999999998664332211 114679999999996643 3
Q ss_pred CCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++.++||||||+++|||++|..||....
T Consensus 198 ~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred CCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 46678899999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=303.31 Aligned_cols=202 Identities=17% Similarity=0.242 Sum_probs=167.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+...+|++++.++..+.
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~- 111 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK- 111 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCC-----CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 45689999999999999999999998877 78999988643221 1222334455667778999999987664
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+..+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 171 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIG--------------------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccce
Confidence 4578999999999999999998654 46788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||
T Consensus 172 Ill~~~g-~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diwsl 224 (350)
T 1rdq_E 172 LLIDQQG-YIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS----------------------KGYNKAVDWWAL 224 (350)
T ss_dssp EEECTTS-CEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT----------------------CCBCTHHHHHHH
T ss_pred EEECCCC-CEEEcccccceeccCC----cccccCCccccCHHHhcC----------------------CCCCCcCCEecc
Confidence 9999987 9999999999876432 245689999999996643 345667899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||++|||++|..||....
T Consensus 225 G~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 225 GVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp HHHHHHHHHSSCSSCCSS
T ss_pred cHhHhHHhhCCCCCCCCC
Confidence 999999999999997654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=303.73 Aligned_cols=204 Identities=20% Similarity=0.270 Sum_probs=166.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH------HHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
..++|++++.||+|+||+||+|++..++ +.+++|.+...... ......++...+....|+|++.+++.+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTG-----LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCC-----CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 3478999999999999999999998877 78888887643221 122333455666777899999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. .++.+++||||+.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||
T Consensus 85 ~-~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp 143 (361)
T 2yab_A 85 E-NRTDVVLILELVSGGELFDFLAQKE--------------------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKP 143 (361)
T ss_dssp E-CSSEEEEEEECCCSCBHHHHHTTCS--------------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred E-eCCEEEEEEEcCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 4 4578999999999999999987543 468889999999999999999999999999999
Q ss_pred CceEEeCCCC---eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 291 QNVIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 291 ~NILl~~~~~---~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
+|||+++++. .+||+|||+++....+.. .....||+.|+|||++.+ ..++.++
T Consensus 144 ~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------~~~~~~~ 199 (361)
T 2yab_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNY----------------------EPLGLEA 199 (361)
T ss_dssp GGEEESCTTSSSCCEEECCCSSCEECCTTCC--CCCCCSCGGGCCHHHHTT----------------------CCCCTHH
T ss_pred HHEEEeCCCCCccCEEEEecCCceEcCCCCc--cccCCCCccEECchHHcC----------------------CCCCccc
Confidence 9999987653 799999999987654322 345689999999996543 3466788
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||||++|||++|..||....
T Consensus 200 DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 200 DMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp HHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=303.35 Aligned_cols=234 Identities=20% Similarity=0.198 Sum_probs=172.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
.+..++|++.++||+|+||.||+|++.........+.+++|.+..... .+.....++...+... +|+|++.+++.+..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 566789999999999999999999976544444458899999875432 2222233334444444 78999999998777
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchh----------------------h------------------------hh
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQ----------------------T------------------------LI 246 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----------------------~------------------------~~ 246 (397)
.+...++||||+.+++|.+++.......... . ..
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 6777999999999999999998764210000 0 00
Q ss_pred ccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEeccccccccccccc-cccccc
Q 015991 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFL 325 (397)
Q Consensus 247 ~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~ 325 (397)
............+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++........ ......
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccC
Confidence 00000001122378899999999999999999999999999999999999887 9999999999866443322 234567
Q ss_pred CCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 015991 326 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 326 gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt-g~~Pf~~~~~ 391 (397)
||+.|+|||++. ...++.++||||||+++|||++ |..||.....
T Consensus 257 ~t~~y~aPE~~~----------------------~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 257 LPLKWMAPETIF----------------------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp ECGGGCCHHHHH----------------------HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CCceeEChhhhc----------------------CCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 899999999554 3456678899999999999998 9999976543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=293.17 Aligned_cols=206 Identities=23% Similarity=0.308 Sum_probs=161.7
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--------hHHHHHHHHHHHHhhccCCCceeeee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--------AVEIWMNERVRRACANCCADFVYGFF 207 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--------~~e~~~~~~~~~~~~~~~~~~i~~~~ 207 (397)
...++|++.++||+|+||+||+|++..++ +.+++|.+.... ......+.++...+....|+|++.++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSG-----HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTC-----CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 34589999999999999999999988876 788899876322 12233333444445555689998888
Q ss_pred ecccccCC----eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCc
Q 015991 208 ENSSKKGG----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (397)
Q Consensus 208 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gi 283 (397)
+.+..... ..++||||++ ++|.+++.... ...+++..++.++.|++.||+|||++||
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i 141 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP------------------PPGLPAETIKDLMRQFLRGLDFLHANCI 141 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC------------------TTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 76654332 5899999998 59999998653 1237888999999999999999999999
Q ss_pred eecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 284 iHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..+
T Consensus 142 vH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~----------------------~~~ 196 (308)
T 3g33_A 142 VHRDLKPENILVTSGG-TVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQ----------------------STY 196 (308)
T ss_dssp CCSCCCTTTEEECTTS-CEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHT----------------------SCC
T ss_pred ccCCCCHHHEEEcCCC-CEEEeeCccccccCCCc--ccCCccccccccCchHHcC----------------------CCC
Confidence 9999999999999987 99999999998654332 2355789999999996543 345
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
+.++|||||||++|||++|+.||....
T Consensus 197 ~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 197 ATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred CchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 667899999999999999999997644
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=297.64 Aligned_cols=209 Identities=20% Similarity=0.284 Sum_probs=158.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch----hHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
.+..++|++.+.||+|+||.||++++..... ..+.+++|.+.... ........++...+....|++++.+++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGAN--TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTT--TTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCC--CCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 4566899999999999999999998752111 11788999876432 11222233345556667799999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ++.+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||
T Consensus 91 ~~-~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp 149 (327)
T 3a62_A 91 QT-GGKLYLILEYLSGGELFMQLEREG--------------------IFMEDTACFYLAEISMALGHLHQKGIIYRDLKP 149 (327)
T ss_dssp EC-SSCEEEEEECCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCT
T ss_pred Ec-CCEEEEEEeCCCCCcHHHHHHhCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCH
Confidence 44 568999999999999999997654 456788889999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++....... ......||+.|+|||++.+ ..++.++|||
T Consensus 150 ~Nill~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diw 205 (327)
T 3a62_A 150 ENIMLNHQG-HVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMR----------------------SGHNRAVDWW 205 (327)
T ss_dssp TTEEECTTS-CEEECCCSCC-----------CTTSSCCTTSCHHHHTT----------------------SCCCTHHHHH
T ss_pred HHeEECCCC-cEEEEeCCcccccccCCc-cccccCCCcCccCHhhCcC----------------------CCCCCcccch
Confidence 999999987 999999999976433222 2345689999999996643 3456678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+++|||++|+.||....
T Consensus 206 slG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 206 SLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp HHHHHHHHHHHSSCSCCCSS
T ss_pred hHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999997654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=327.40 Aligned_cols=208 Identities=18% Similarity=0.189 Sum_probs=164.5
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhh-ccCCCceeeeeec
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACA-NCCADFVYGFFEN 209 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~-~~~~~~i~~~~~~ 209 (397)
..+..++|++.++||+|+||.||+|++..++ +.+|+|.+..... .+......+...+. ..+|++++.++..
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~-----~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~ 410 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTD-----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 410 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSC-----CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCC-----cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 3456789999999999999999999998877 7899998864321 11111122223333 3478888888776
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. ..+.+++||||+.+++|.++++..+ .+++..++.++.||+.||+|||++||||||||
T Consensus 411 ~~-~~~~~~lV~E~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLK 469 (674)
T 3pfq_A 411 FQ-TMDRLYFVMEYVNGGDLMYHIQQVG--------------------RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469 (674)
T ss_dssp CB-CSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCC
T ss_pred EE-eCCEEEEEEeCcCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCC
Confidence 64 4578999999999999999998754 46788899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+||||+.++ .+||+|||+|+...... ......+||+.|+|||++.+ ..|+.++||
T Consensus 470 p~NILl~~~g-~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~----------------------~~~~~~~Dv 525 (674)
T 3pfq_A 470 LDNVMLDSEG-HIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAY----------------------QPYGKSVDW 525 (674)
T ss_dssp STTEEECSSS-CEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTC----------------------CCBSTHHHH
T ss_pred hhhEEEcCCC-cEEEeecceeeccccCC-cccccccCCCcccCHhhhcC----------------------CCCCccceE
Confidence 9999999987 99999999998643222 23456789999999996543 356678899
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~ 391 (397)
|||||+||||++|+.||.....
T Consensus 526 wSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 526 WAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSH
T ss_pred echHHHHHHHHcCCCCCCCCCH
Confidence 9999999999999999987543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=303.12 Aligned_cols=210 Identities=15% Similarity=0.139 Sum_probs=162.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHH--------HHHHhhccCCCceee
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNER--------VRRACANCCADFVYG 205 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~--------~~~~~~~~~~~~i~~ 205 (397)
..++|++.++||+|+||+||+|.+..+......+.+++|.+...... +.....+ .........|++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 44699999999999999999999887655555588999987654321 1111111 112345567999998
Q ss_pred eeeccccc---CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC
Q 015991 206 FFENSSKK---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG 282 (397)
Q Consensus 206 ~~~~~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g 282 (397)
+++.+... ....++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++|
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-------------------~~l~~~~~~~i~~qi~~~l~~lH~~~ 172 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-------------------KRFSRKTVLQLSLRILDILEYIHEHE 172 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 88766543 25689999999 899999997642 24678889999999999999999999
Q ss_pred ceecCCCCCceEEe--CCCCeEEEEecccccccccccccc------cccccCCCCCCCcccccccCCCCCCCCccccccc
Q 015991 283 IVHRDIKPQNVIFS--EGSRTFKIIDLGAAADLRVGINYI------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (397)
Q Consensus 283 iiHrDIKp~NILl~--~~~~~~kL~DFGla~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~ 354 (397)
|+||||||+|||++ .++ .+||+|||+|+.+....... .....||+.|+|||++.+
T Consensus 173 iiHrDlkp~Nill~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------------- 235 (364)
T 3op5_A 173 YVHGDIKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG---------------- 235 (364)
T ss_dssp EECCCCCGGGEEEESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT----------------
T ss_pred eEEecCCHHHEEEecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC----------------
Confidence 99999999999999 665 99999999998765432211 134569999999996543
Q ss_pred hhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 355 SPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 355 ~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
..++.++|||||||++|||++|+.||...
T Consensus 236 ------~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 236 ------VAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp ------CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred ------CCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 34566889999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=296.43 Aligned_cols=207 Identities=21% Similarity=0.266 Sum_probs=159.5
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|.+.... ........++...+....|+|++.+++.+..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDH-----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCC-----ceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 45589999999999999999999998776 889999886532 1222333455666777789999998876544
Q ss_pred cC---CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 213 KG---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 213 ~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
.. ...++||||+.+++|.++++... .+++..+..++.|++.||+|||++||+|||||
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 143 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--------------------PMTPKRAIEVIADACQALNFSHQNGIIHRDVK 143 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 32 24599999999999999997654 46788899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|+|||++.++ .+||+|||+++.+...... ......||+.|+|||++.+ ..++.++
T Consensus 144 p~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~ 200 (311)
T 3ork_A 144 PANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG----------------------DSVDARS 200 (311)
T ss_dssp GGGEEEETTS-CEEECCCSCC------------------CCTTCCHHHHHT----------------------CCCCHHH
T ss_pred HHHEEEcCCC-CEEEeeccCcccccccccccccccccCcCcccCCHHHhcC----------------------CCCCchH
Confidence 9999999987 9999999999876543221 2334679999999996543 3456678
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||||+++|||++|+.||....
T Consensus 201 Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 201 DVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=295.70 Aligned_cols=218 Identities=18% Similarity=0.228 Sum_probs=169.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
....++|++.++||+|+||+||+|++..++ +.+++|.+..... .......++...+....|++++.+++.+...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTG-----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 345579999999999999999999998876 7899998864332 1122223445556666799999998766543
Q ss_pred C-CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 G-GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
. ...++||||+.+++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPS-----------------NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGG-----------------GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhc-----------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHH
Confidence 3 47899999999999999998753 12237888899999999999999999999999999999
Q ss_pred eEE----eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 293 VIF----SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 293 ILl----~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+ +.++ .+||+|||+++....... .....||+.|+|||++........ ....++.++|
T Consensus 143 Ill~~~~~~~~-~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~--------------~~~~~~~~~D 205 (319)
T 4euu_A 143 IMRVIGEDGQS-VYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKD--------------HQKKYGATVD 205 (319)
T ss_dssp EEEEECTTSCE-EEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCC--------------CCCCBCTTHH
T ss_pred EEEeccCCCCc-eEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhcccccc--------------ccCCCCcHHH
Confidence 999 5554 899999999987654432 245679999999997764322111 0235677899
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~~ 391 (397)
||||||++|||++|+.||.....
T Consensus 206 iwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 206 LWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp HHHHHHHHHHHHHSSCSEECTTC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999976544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=298.51 Aligned_cols=208 Identities=21% Similarity=0.272 Sum_probs=168.6
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
...++|++.+.||+|+||+||+|++..++ +.+++|.+....... .....++...+....|+|++.+++.+..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQ-----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 35589999999999999999999998877 789999876432111 1233445666677789999999887644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+..++||||+ +|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|
T Consensus 81 -~~~~~lv~E~~-~g~l~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~N 138 (336)
T 3h4j_B 81 -PTDIVMVIEYA-GGELFDYIVEKK--------------------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPEN 138 (336)
T ss_dssp -SSEEEEEECCC-CEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTT
T ss_pred -CCEEEEEEECC-CCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhh
Confidence 56899999999 578988887654 46788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||+++++ .+||+|||++.....+.. ....+||+.|+|||++.+..+ .+.++|||||
T Consensus 139 Ill~~~~-~~kl~DFG~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~Diwsl 194 (336)
T 3h4j_B 139 LLLDDNL-NVKIADFGLSNIMTDGNF--LKTSCGSPNYAAPEVINGKLY---------------------AGPEVDVWSC 194 (336)
T ss_dssp EEECTTC-CEEECCSSCTBTTTTSBT--TCCCTTSTTTSCGGGSCCSGG---------------------GCHHHHHHHH
T ss_pred EEEcCCC-CEEEEEeccceeccCCcc--cccccCCcCcCCHHHHcCCCC---------------------CCCccchhHH
Confidence 9999987 999999999987654332 345689999999998765432 1346899999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCc
Q 015991 373 GLIFLQMVCTVRRLCLHSCPLA 394 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~~~~ 394 (397)
||++|||++|+.||.....++.
T Consensus 195 G~il~~ll~g~~Pf~~~~~~~~ 216 (336)
T 3h4j_B 195 GIVLYVMLVGRLPFDDEFIPNL 216 (336)
T ss_dssp HHHHHHHHHSSCSSBCSSSTTC
T ss_pred HHHHHHHHhCCCCCCCccHHHH
Confidence 9999999999999987665543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.41 Aligned_cols=202 Identities=22% Similarity=0.319 Sum_probs=165.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.+.||+|+||.||+|.+..++ +.+++|.+.... ..+.....++...+....|+|++.+++.+. .++.
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~ 102 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESF 102 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCE
Confidence 68999999999999999999998877 789999886432 223333445566667778999999988664 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+.+++|.+.+.... .+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~ 162 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE--------------------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEES
T ss_pred EEEEEecCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 999999999999999887543 467888999999999999999999999999999999998
Q ss_pred CCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 EGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
.++ ..+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||
T Consensus 163 ~~~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwslG~ 218 (362)
T 2bdw_A 163 SKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKK----------------------DPYSKPVDIWACGV 218 (362)
T ss_dssp CSSTTCCEEECCCTTCBCCTTCCS--CCCSCSCTTTCCHHHHTT----------------------CCCCTHHHHHHHHH
T ss_pred cCCCCCCEEEeecCcceEecCCcc--cccCCCCccccCHHHHcc----------------------CCCCchhhHHHHHH
Confidence 653 2699999999987654322 345689999999996543 34667889999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|||++|..||....
T Consensus 219 il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 219 ILYILLVGYPPFWDED 234 (362)
T ss_dssp HHHHHHHSSCSSCCSS
T ss_pred HHHHHHHCCCCCCCCC
Confidence 9999999999997543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=311.83 Aligned_cols=206 Identities=20% Similarity=0.227 Sum_probs=163.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.+..++|++.++||+|+||.||+|++..++ +.+|+|.+.... ..+.....++...+....|+|++.+++.+.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATG-----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCC-----CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 345689999999999999999999998877 889999886432 222223334556677788999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKP 290 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp 290 (397)
. ++.+++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .||+||||||
T Consensus 219 ~-~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp 277 (446)
T 4ejn_A 219 T-HDRLCFVMEYANGGELFFHLSRER--------------------VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277 (446)
T ss_dssp E-TTEEEEEECCCSSCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCG
T ss_pred e-CCEEEEEEeeCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCH
Confidence 4 568999999999999999987654 46788899999999999999998 9999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+|+....... ......||+.|+|||++. ...++.++|||
T Consensus 278 ~NIll~~~~-~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~----------------------~~~~~~~~Diw 333 (446)
T 4ejn_A 278 ENLMLDKDG-HIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLE----------------------DNDYGRAVDWW 333 (446)
T ss_dssp GGEEECSSS-CEEECCCCCCCTTCC------CCSSSCGGGCCHHHHH----------------------TSCCCTHHHHH
T ss_pred HHEEECCCC-CEEEccCCCceeccCCCc-ccccccCCccccCHhhcC----------------------CCCCCCccchh
Confidence 999999987 999999999986433222 235678999999999554 34567788999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+||||++|+.||....
T Consensus 334 slG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 334 GLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred hhHHHHHHHhhCCCCCCCCC
Confidence 99999999999999997654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=298.23 Aligned_cols=209 Identities=22% Similarity=0.278 Sum_probs=167.8
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
+..++|++.++||+|+||+||+|++.+ +.+|+|++....... ...+++...+....|+|++.+++.+....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLN-------EYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETT-------EEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cchhhchhhheecccCceEEEEEEECC-------CEEEEEEeecCchHH-HHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 455799999999999999999998763 789999886544333 33344556677778999999988765543
Q ss_pred --CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC----------C
Q 015991 215 --GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST----------G 282 (397)
Q Consensus 215 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~----------g 282 (397)
..+++||||+.+++|.++++.. .+++..++.++.|++.||+|||+. |
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~~---------------------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ 151 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKAN---------------------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA 151 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC---------------------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE
T ss_pred CCceEEEEEecCCCCCHHHHHHhc---------------------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC
Confidence 3589999999999999999764 257788999999999999999999 9
Q ss_pred ceecCCCCCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 283 iiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
|+||||||+|||++.++ .+||+|||+++........ ......||+.|+|||++.+..... .
T Consensus 152 ivH~Dlkp~Nill~~~~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----------------~ 213 (322)
T 3soc_A 152 ISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQ-----------------R 213 (322)
T ss_dssp EECSCCSGGGEEECTTC-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCC-----------------H
T ss_pred EEeCCCChHhEEECCCC-eEEEccCCcccccccccCccccccCccCccccCHhhcccccccC-----------------c
Confidence 99999999999999987 9999999999876543322 233468999999999886543321 1
Q ss_pred CCCCchhhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
.++.++|||||||++|||++|+.||.....
T Consensus 214 ~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 214 DAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 245578999999999999999999976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.89 Aligned_cols=207 Identities=20% Similarity=0.292 Sum_probs=164.0
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-----HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-----EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-----e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.++|++.+.||+|+||+||+|++..++ +.+++|.+...... ......++...+....|+||+.+++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETG-----QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 368999999999999999999998877 78899987532211 12223344555566689999999886644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++.+++||||+.+++|.+.+.... ..+..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 98 -~~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~N 160 (351)
T 3c0i_A 98 -DGMLYMVFEFMDGADLCFEIVKRA----------------DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160 (351)
T ss_dssp -TTEEEEEEECCSSCBHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -CCEEEEEEeCCCCCCHHHHHHHhc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHH
Confidence 578999999999999988876542 012246788899999999999999999999999999999
Q ss_pred eEEeCCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
||++.++ ..+||+|||+++...... .......||+.|+|||++.+ ..++.++|||
T Consensus 161 Il~~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diw 217 (351)
T 3c0i_A 161 VLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKR----------------------EPYGKPVDVW 217 (351)
T ss_dssp EEECSSSTTCCEEECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTT----------------------CCBCTHHHHH
T ss_pred eEEecCCCCCcEEEecCcceeEecCCC-eeecCCcCCcCccCHHHHcC----------------------CCCCchHhhH
Confidence 9998654 249999999998765432 22345689999999996643 3456788999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
||||++|||++|..||...
T Consensus 218 slG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 218 GCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp HHHHHHHHHHHSSCSSCSS
T ss_pred HHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=312.16 Aligned_cols=211 Identities=18% Similarity=0.263 Sum_probs=170.5
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
.....++|++.+.||+|+||+||+|++..++ +.+++|.+....... .....++...+...+|++++.++..+
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATG-----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4566789999999999999999999998877 889999886433211 12223344555667899999988866
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ...+++||||+.+++|.+++.... .....+++..++.++.||+.||+|||++||+||||||
T Consensus 255 ~~-~~~l~lVmE~~~gg~L~~~l~~~~----------------~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP 317 (543)
T 3c4z_A 255 ET-KTDLCLVMTIMNGGDIRYHIYNVD----------------EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKP 317 (543)
T ss_dssp EC-SSEEEEEECCCTTCBHHHHHHTSS----------------TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred ee-CCEEEEEEEeccCCCHHHHHHHhh----------------cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCCh
Confidence 44 578999999999999999987643 1223578889999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++.+..... .....+||+.|+|||++.+ ..++.++|||
T Consensus 318 ~NILl~~~g-~vkL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~----------------------~~~~~~~Diw 373 (543)
T 3c4z_A 318 ENVLLDDDG-NVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLG----------------------EEYDFSVDYF 373 (543)
T ss_dssp GGEEECTTS-CEEECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTT----------------------CCBCTHHHHH
T ss_pred HHEEEeCCC-CEEEeecceeeeccCCCc-ccccccCCccccChhhhcC----------------------CCCChHHhcC
Confidence 999999987 999999999987654332 2345689999999996644 3466788999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 374 SlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 374 ALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp HHHHHHHHHHHSSCSSCCTT
T ss_pred cchHHHHHHHhCCCCCCCCc
Confidence 99999999999999997753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=295.91 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=165.4
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.+.||+|+||+||+|.+..++ +.+++|.+....... ....++...+....|+|++.+++.+. ..+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~-~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSK-----KTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE-SMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCTHHH-HHHHHHHHHHHHSCCTTBCCEEEEEE-ETTEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCC-----cEEEEEEEecCcccH-HHHHHHHHHHHhCCCCCCCeEeEEEe-cCCEE
Confidence 479999999999999999999998876 788888876543332 22334455566778999999988764 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-------------------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEEeCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 99999999999999986543 24678889999999999999999999999999999999987
Q ss_pred --CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 298 --GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 298 --~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++ .+||+|||+++....+.. .....||+.|+|||++.+. .++.++|||||||+
T Consensus 138 ~~~~-~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwslG~i 192 (321)
T 1tki_A 138 RRSS-TIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHD----------------------VVSTATDMWSLGTL 192 (321)
T ss_dssp SSCC-CEEECCCTTCEECCTTCE--EEEEESCGGGSCHHHHTTC----------------------EECHHHHHHHHHHH
T ss_pred CCCC-CEEEEECCCCeECCCCCc--cccccCChhhcCcHHhcCC----------------------CCCchhhHHHHHHH
Confidence 44 999999999987654332 2456799999999976543 34567899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|..||....
T Consensus 193 l~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 193 VYVLLSGINPFLAET 207 (321)
T ss_dssp HHHHHHSSCTTCCSS
T ss_pred HHHHHhCCCCCcCCC
Confidence 999999999997654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=299.43 Aligned_cols=229 Identities=19% Similarity=0.244 Sum_probs=168.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCC--CCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPS--SKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (397)
.+..++|++++.||+|+||.||+|++..... ......+++|.+..... .......++...+... .|+|++.+++.+
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3456899999999999999999999764321 12225688998875432 2222333444455555 799999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ++.+++||||+.+++|.+++.....+.....+.. .......+++..+..++.|++.||+|||++||+||||||
T Consensus 157 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 157 TQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI----NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp CS-SSSCEEEEECCTTCBHHHHHHHTCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred cc-CCCEEEEEEcCCCCCHHHHHHhhCCccccccccc----cccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 44 5679999999999999999987642211000000 001223567888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+|||++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++||
T Consensus 232 ~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~~Dv 288 (370)
T 2psq_A 232 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF----------------------DRVYTHQSDV 288 (370)
T ss_dssp GGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH----------------------TCCCCHHHHH
T ss_pred hhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhc----------------------CCCCCcHHHH
Confidence 999999987 9999999999876543322 223456788999999554 3456678899
Q ss_pred HHHHHHHHHHHc-CCCCCCCCCC
Q 015991 370 YSAGLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 370 ~SlGv~l~ellt-g~~Pf~~~~~ 391 (397)
|||||++|||++ |..||.....
T Consensus 289 wslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 289 WSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCG
T ss_pred HHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999 9999976543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=302.21 Aligned_cols=205 Identities=21% Similarity=0.310 Sum_probs=152.3
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhcc-CCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC-CADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~ 213 (397)
..++|++.++||+|+||+||+|.+..++ +.+|+|++.... ........++...+... .|+|++.+++.+...
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTG-----EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTC-----CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCC-----CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 3479999999999999999999998887 889999885421 22222222334444444 499999998876543
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
...+++||||++ ++|.+++... .+++..+..++.|++.||+|||++||+||||||+|
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~~---------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 139 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRAN---------------------ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSN 139 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHHT---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCCEEEEEecccC-cCHHHHHHcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence 347899999999 5899988764 35677788999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccc--------------------cccccccccCCCCCCCcccccccCCCCCCCCccccc
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVG--------------------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~--------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~ 352 (397)
||++.++ .+||+|||+|+.+... ........+||+.|+|||++.+.
T Consensus 140 Ill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------------- 205 (388)
T 3oz6_A 140 ILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS------------- 205 (388)
T ss_dssp EEECTTC-CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-------------
T ss_pred eEEcCCC-CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-------------
Confidence 9999987 9999999999865321 01122446899999999976542
Q ss_pred cchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 353 ALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 353 ~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++|||||||++|||++|+.||....
T Consensus 206 --------~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 206 --------TKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp --------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 246678899999999999999999997754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=306.22 Aligned_cols=204 Identities=22% Similarity=0.293 Sum_probs=164.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
.++|++.++||+|+||+||+|.+..++ +.+++|.+.... ..+....+++...+....|+||+.+++.+. .++
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~-----~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~ 83 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAG-----QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-EEG 83 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTT-----EEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-CSS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCC-----cEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-ECC
Confidence 378999999999999999999998877 788888776432 223333445566667778999999988664 567
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+.+++|.+.+.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~--------------------~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll 143 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVARE--------------------YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLL 143 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEE
T ss_pred EEEEEEEeCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 8999999999999999987654 46788899999999999999999999999999999999
Q ss_pred eCC--CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 296 SEG--SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 296 ~~~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+.+ +..+||+|||+|+....... ......||+.|+|||++.+ ..++.++||||+|
T Consensus 144 ~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~----------------------~~~~~~~DIwSlG 200 (444)
T 3soa_A 144 ASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRK----------------------DPYGKPVDLWACG 200 (444)
T ss_dssp SBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTT----------------------CCBCTHHHHHHHH
T ss_pred eccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcC----------------------CCCCCccccHHHH
Confidence 842 23899999999987654322 2345789999999996643 3466778999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|++|+|++|..||....
T Consensus 201 vilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 201 VILYILLVGYPPFWDED 217 (444)
T ss_dssp HHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHhCCCCCCCcc
Confidence 99999999999996543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=300.91 Aligned_cols=204 Identities=21% Similarity=0.225 Sum_probs=168.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.+.||+|+||+||+|.+..++ +.+++|.+......+.....++...+....|+|++.+++.+. .+...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-DKYEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-CSSEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCC-----CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-eCCEE
Confidence 478999999999999999999998876 788889887654444444556667777888999999988764 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 184 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAED-------------------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTT-------------------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEEcCCCCcHHHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec
Confidence 99999999999999887543 24678889999999999999999999999999999999985
Q ss_pred C-CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 G-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 ~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+ ...+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 185 ~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwSlG~il 240 (387)
T 1kob_A 185 KKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDR----------------------EPVGFYTDMWAIGVLG 240 (387)
T ss_dssp TTCCCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTT----------------------CCBCHHHHHHHHHHHH
T ss_pred CCCCceEEEecccceecCCCcc--eeeeccCCCccCchhccC----------------------CCCCCcccEeeHhHHH
Confidence 3 23899999999987644322 234579999999996643 3456678999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|..||....
T Consensus 241 ~elltg~~Pf~~~~ 254 (387)
T 1kob_A 241 YVLLSGLSPFAGED 254 (387)
T ss_dssp HHHHHSCCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=307.96 Aligned_cols=200 Identities=22% Similarity=0.314 Sum_probs=156.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|++.... ........++...+...+|+||+.+++.+...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTT-----EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCC-----CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 478999999999999999999998887 889999987532 222333334556667778999999988765432
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
...++||||++++ |.+.+.. .+++..++.++.|++.||+|||++||+||||||
T Consensus 136 ~~~~~~~~lv~E~~~~~-l~~~~~~----------------------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp 192 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDAN-LCQVIQM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192 (464)
T ss_dssp TTTCCEEEEEEECCSEE-HHHHHTS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred cccCCeEEEEEeCCCCC-HHHHHhh----------------------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence 5689999999964 6665532 256778899999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+|+..... .......||+.|+|||++.+ ..|+.++|||
T Consensus 193 ~NIll~~~~-~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diw 247 (464)
T 3ttj_A 193 SNIVVKSDC-TLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG----------------------MGYKENVDIW 247 (464)
T ss_dssp GGEEECTTS-CEEECCCCCC-----C--CCC----CCCTTCCHHHHTT----------------------CCCCTTHHHH
T ss_pred HhEEEeCCC-CEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcC----------------------CCCCHHHHHH
Confidence 999999987 9999999999875433 22356789999999996544 3566778999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+||||++|+.||.+..
T Consensus 248 SlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 248 SVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=292.49 Aligned_cols=204 Identities=24% Similarity=0.298 Sum_probs=160.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
.++|++.+.||+|+||+||+|++..++ +.+|+|++.... ........++...+....|+|++.+++.+....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDD-----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTC-----CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCC-----cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 368999999999999999999998776 789999886432 222333445566777778999999887653322
Q ss_pred ------------------------------------------------------CeEEEEEEecCCCCHHHHHHhcCCCc
Q 015991 215 ------------------------------------------------------GEYWLIWRYEGEATLADLMISREFPY 240 (397)
Q Consensus 215 ------------------------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~ 240 (397)
...++||||+.+++|.+++....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--- 156 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--- 156 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC---
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc---
Confidence 24899999999999999998764
Q ss_pred chhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccc--
Q 015991 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN-- 318 (397)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~-- 318 (397)
.....++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 157 --------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~ 221 (332)
T 3qd2_B 157 --------------SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQ 221 (332)
T ss_dssp --------------SGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC----
T ss_pred --------------CccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhc
Confidence 222445667889999999999999999999999999999999887 999999999987654321
Q ss_pred ---------cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCC
Q 015991 319 ---------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRL 386 (397)
Q Consensus 319 ---------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf 386 (397)
.......||+.|+|||++.+ ..++.++||||||+++|||++|..|+
T Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHG----------------------NNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp ----------CCCSCC-CGGGSCHHHHHC----------------------CCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred cccccccccccccccCCCcCccChHHhcC----------------------CCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 12234679999999996543 34667889999999999999998775
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=291.57 Aligned_cols=206 Identities=20% Similarity=0.227 Sum_probs=156.0
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.+..++|++.++||+|+||+||+|++.+ ..+++|.+.... ........++...+....|+|++.+++.+..
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWHG-------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhHceeeeEeecCCCeEEEEEEECC-------CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 4566899999999999999999998743 678888876433 2222233345556666789999999887644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--ceecCCCC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKP 290 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiHrDIKp 290 (397)
.+..++||||+.+++|.+++.... ....+++..+..++.|++.||+|||++| |+||||||
T Consensus 106 -~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp 167 (309)
T 3p86_A 106 -PPNLSIVTEYLSRGSLYRLLHKSG-----------------AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS 167 (309)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHSTT-----------------HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCG
T ss_pred -CCceEEEEecCCCCcHHHHHhhcC-----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCCh
Confidence 467899999999999999997653 1224788889999999999999999999 99999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++...... .......||+.|+|||++.+. .++.++|||
T Consensus 168 ~NIll~~~~-~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Diw 223 (309)
T 3p86_A 168 PNLLVDKKY-TVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDE----------------------PSNEKSDVY 223 (309)
T ss_dssp GGEEECTTC-CEEECCCC------------------CCTTSCHHHHTTC----------------------CCCTTHHHH
T ss_pred hhEEEeCCC-cEEECCCCCCccccccc-cccccCCCCccccChhhhcCC----------------------CCCchhhHH
Confidence 999999987 99999999997543322 223456899999999966543 455678999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
|||+++|||++|+.||...
T Consensus 224 slG~il~elltg~~Pf~~~ 242 (309)
T 3p86_A 224 SFGVILWELATLQQPWGNL 242 (309)
T ss_dssp HHHHHHHHHHHCCCTTTTS
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=301.15 Aligned_cols=203 Identities=20% Similarity=0.252 Sum_probs=152.5
Q ss_pred ccCCeEEe-eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccc---c
Q 015991 137 RKDDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS---K 212 (397)
Q Consensus 137 ~~~~f~i~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~---~ 212 (397)
..++|.+. ++||+|+||+||+|.+..++ +.+++|.+....... .++.......+|+|++.+++.+. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~~~~~----~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDCPKAR----REVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSHHHH----HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeccceeeeccCeEEEEEEECCCC-----CEEEEEEeCcchhHH----HHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 34678886 78999999999999998877 789999886433221 11122223346777777766543 2
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+..+|+||||+.+++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 191 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRG------------------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---------------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcce
Confidence 3567999999999999999998643 2246888999999999999999999999999999999
Q ss_pred eEEeC---CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 293 VIFSE---GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 293 ILl~~---~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
||++. ++ .+||+|||+++...... .....+||+.|+|||++.+ ..++.++||
T Consensus 192 ill~~~~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Di 246 (400)
T 1nxk_A 192 LLYTSKRPNA-ILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGP----------------------EKYDKSCDM 246 (400)
T ss_dssp EEESSSSTTC-CEEECCCTTCEECC-------------CTTCCGGGSCC----------------------CCSSSHHHH
T ss_pred EEEecCCCCc-cEEEEecccccccCCCC--ccccCCCCCCccCHhhcCC----------------------CCCCCcccH
Confidence 99987 44 89999999998654322 2345789999999996643 346678899
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~ 391 (397)
|||||++|||++|+.||.....
T Consensus 247 wslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 247 WSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp HHHHHHHHHHHHSSCSCCCCTT
T ss_pred HHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999999999999976543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=293.11 Aligned_cols=204 Identities=23% Similarity=0.250 Sum_probs=164.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH------HHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|+|++.+++.+
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY 83 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCC-----cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3368999999999999999999998877 78888877543211 122233345555666799999988866
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. .+...++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||
T Consensus 84 ~-~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 142 (326)
T 2y0a_A 84 E-NKTDVILILELVAGGELFDFLAEKE--------------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKP 142 (326)
T ss_dssp E-CSSEEEEEEECCCSCBHHHHHTTSS--------------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred E-eCCEEEEEEEcCCCCCHHHHHHhcC--------------------CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCH
Confidence 4 4578999999999999999986543 467888999999999999999999999999999
Q ss_pred CceEEeCCCC---eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 291 QNVIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 291 ~NILl~~~~~---~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
+|||++.++. .+||+|||+++....... .....||+.|+|||++.+ ..++.++
T Consensus 143 ~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------~~~~~~~ 198 (326)
T 2y0a_A 143 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNY----------------------EPLGLEA 198 (326)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTT----------------------CCCCTHH
T ss_pred HHEEEecCCCCCCCEEEEECCCCeECCCCCc--cccccCCcCcCCceeecC----------------------CCCCcHH
Confidence 9999987642 799999999987654322 345689999999996543 3456678
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||||++|||++|..||....
T Consensus 199 DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 199 DMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp HHHHHHHHHHHHHHSCCSSCCSS
T ss_pred HHHHHHHHHHHHHHCcCCCCCCC
Confidence 99999999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=293.33 Aligned_cols=213 Identities=15% Similarity=0.149 Sum_probs=165.6
Q ss_pred hhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 132 ~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
+...+..++|++.+.||+|+||+||+|++..++... ..+++|.+.... ........++...+....|+|++.+++.+
T Consensus 42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 119 (325)
T 3kul_A 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRD--VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV 119 (325)
T ss_dssp -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCC--EEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCC--ceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 445667789999999999999999999987655221 458999887532 22233344556667777899999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. .++..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||
T Consensus 120 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 179 (325)
T 3kul_A 120 T-RGRLAMIVTEYMENGSLDTFLRTHD-------------------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAA 179 (325)
T ss_dssp C-GGGCCEEEEECCTTCBHHHHHHTTT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred E-eCCccEEEeeCCCCCcHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCc
Confidence 4 4567899999999999999997542 2467788999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
+|||++.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++|
T Consensus 180 ~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----------------------~~~~~~~D 236 (325)
T 3kul_A 180 RNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF----------------------RTFSSASD 236 (325)
T ss_dssp GGEEECTTC-CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH----------------------CEECHHHH
T ss_pred ceEEECCCC-CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC----------------------CCCCcHHH
Confidence 999999987 9999999999876543221 2233456789999996543 34566789
Q ss_pred hHHHHHHHHHHHc-CCCCCCCC
Q 015991 369 IYSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 369 v~SlGv~l~ellt-g~~Pf~~~ 389 (397)
|||||+++|||++ |..||...
T Consensus 237 i~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 237 VWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTS
T ss_pred HHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999 99999654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.74 Aligned_cols=206 Identities=24% Similarity=0.275 Sum_probs=163.4
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.++||+|+||+||+|++..++ +.+++|.+......+ .....++...+....|+|++.+++.+. .++.
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~ 79 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-EGNI 79 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-CSSE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCC-----cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCCe
Confidence 489999999999999999999998776 788899875433221 122233445556667999999988664 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 139 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDI--------------------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--------------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred EEEEEEcCCCCcHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe
Confidence 899999999999988876442 467888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
.++ .+||+|||+++.+..... .......||+.|+|||++.+... ++.++|||||||+
T Consensus 140 ~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~DiwslG~i 197 (323)
T 3tki_A 140 ERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF---------------------HAEPVDVWSCGIV 197 (323)
T ss_dssp TTC-CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSB---------------------CHHHHHHHHHHHH
T ss_pred CCC-CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCC---------------------CCCcccHHHHHHH
Confidence 987 999999999986643322 22345789999999997654322 2446899999999
Q ss_pred HHHHHcCCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHSC 391 (397)
Q Consensus 376 l~elltg~~Pf~~~~~ 391 (397)
+|||++|+.||.....
T Consensus 198 l~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 198 LTAMLAGELPWDQPSD 213 (323)
T ss_dssp HHHHHHSSCSCSSSCT
T ss_pred HHHHHhCCCCCCCCch
Confidence 9999999999976443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=300.22 Aligned_cols=220 Identities=16% Similarity=0.187 Sum_probs=167.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.++||+|+||+||+|++.........+.+++|++.... ........++...+...+|+|++.+++.+..
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 34568999999999999999999997654333334789999986432 2222233344555666689999999887644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+...++||||+.+++|.+++...... ......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 212 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPR-------------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 212 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCC-------------SSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccc-------------cCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 56779999999999999999876421 11223578888999999999999999999999999999999
Q ss_pred EEeCCC--CeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 294 IFSEGS--RTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 294 Ll~~~~--~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|++.++ ..+||+|||+|+.+...... ......+|+.|+|||++. ...++.++|||
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~~Dvw 270 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM----------------------EGIFTSKTDTW 270 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH----------------------HCCCCHHHHHH
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhc----------------------CCCCCcHHHHH
Confidence 998543 26999999999865433222 234467899999999554 34566788999
Q ss_pred HHHHHHHHHHc-CCCCCCCCC
Q 015991 371 SAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~ellt-g~~Pf~~~~ 390 (397)
||||++|||++ |..||....
T Consensus 271 slG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 271 SFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp HHHHHHHHHHTTSCCSSTTCC
T ss_pred HHHHHHHHHHhCCCCCCCCCC
Confidence 99999999998 999997644
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=286.92 Aligned_cols=210 Identities=18% Similarity=0.220 Sum_probs=153.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.+.||+|+||.||+|.+..++... ..+++|....... .......++...+....|+|++.+++.+ .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~ 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--T 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CC--EEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--C
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCc--eEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE--c
Confidence 456689999999999999999999987643221 5688888765332 2223333455566667899999998875 3
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+.+++|.+++..... .+++..+..++.|++.||+|||++||+||||||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 147 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKY-------------------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 147 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTT-------------------TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cCccEEEEecCCCCCHHHHHHhcCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHE
Confidence 4568999999999999999976531 457788899999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++..............+|+.|+|||++.+ ..++.++||||||
T Consensus 148 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG 204 (281)
T 1mp8_A 148 LVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF----------------------RRFTSASDVWMFG 204 (281)
T ss_dssp EEEETT-EEEECC-------------------CCGGGCCHHHHHH----------------------CCCSHHHHHHHHH
T ss_pred EECCCC-CEEECccccccccCcccccccccCCCcccccChhhccc----------------------CCCCCccCchHHH
Confidence 999887 99999999998765544333344567889999996543 3456678999999
Q ss_pred HHHHHHHc-CCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~ 390 (397)
+++|||++ |..||....
T Consensus 205 ~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 205 VCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp HHHHHHHTTSCCTTTTCC
T ss_pred HHHHHHHhcCCCCCCcCC
Confidence 99999996 999997643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.62 Aligned_cols=208 Identities=19% Similarity=0.196 Sum_probs=169.2
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
..+..++|++.+.||+|+||.||+|++..++ +.+++|.+..... .......++...+...+|++++.+++.+
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 3466789999999999999999999998877 8899998864321 1122223345556667899999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. .++.+++||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++|||||||||
T Consensus 254 ~-~~~~l~lVmEy~~gg~L~~~l~~~~------------------~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKP 314 (576)
T 2acx_A 254 E-TKDALCLVLTLMNGGDLKFHIYHMG------------------QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314 (576)
T ss_dssp E-CSSEEEEEECCCCSCBHHHHHHSSS------------------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred e-eCCEEEEEEEcCCCCcHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCch
Confidence 4 4568999999999999999987643 12467888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+|+....+.. ....+||+.|+|||++.+ ..++.++|||
T Consensus 315 eNILld~~g-~vKL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~----------------------~~~~~~~Diw 369 (576)
T 2acx_A 315 ENILLDDHG-HIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKN----------------------ERYTFSPDWW 369 (576)
T ss_dssp GGEEECTTS-CEEECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTT----------------------CEESSHHHHH
T ss_pred heEEEeCCC-CeEEEecccceecccCcc--ccccCCCccccCHHHHcC----------------------CCCCccchHH
Confidence 999999987 999999999987654322 244689999999996643 3456678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|..||....
T Consensus 370 SLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 370 ALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp HHHHHHHHHHHSSCSSSCSS
T ss_pred HHHHHHHHHHhCCCCCcccc
Confidence 99999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=285.71 Aligned_cols=201 Identities=20% Similarity=0.284 Sum_probs=160.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||+||+|++..++ +.+++|.+.... ........++...+....|+|++.+++.+. .++.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCC-----ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-eCCE
Confidence 68999999999999999999998877 789999886432 222223334566667778999999988764 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++ ++.+.+.... ..+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 76 ~~lv~e~~~~-~l~~~~~~~~-------------------~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 76 LTLVFEFCDQ-DLKKYFDSCN-------------------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp EEEEEECCSE-EHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred EEEEEecCCC-CHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 9999999996 5555554422 2467888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||+++....... ......||+.|+|||++.+.. .++.++|||||||++
T Consensus 136 ~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwslG~il 192 (292)
T 3o0g_A 136 RNG-ELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAK---------------------LYSTSIDMWSAGCIF 192 (292)
T ss_dssp TTS-CEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCS---------------------CCCTHHHHHHHHHHH
T ss_pred CCC-CEEEeecccceecCCccc-cccCCccccCCcChHHHcCCC---------------------CcCchHHHHHHHHHH
Confidence 987 999999999987643322 234568899999999765432 256788999999999
Q ss_pred HHHHcCCCCCCC
Q 015991 377 LQMVCTVRRLCL 388 (397)
Q Consensus 377 ~elltg~~Pf~~ 388 (397)
|||++|..||..
T Consensus 193 ~~l~~~~~p~~~ 204 (292)
T 3o0g_A 193 AELANAGRPLFP 204 (292)
T ss_dssp HHHTTTSCCSCC
T ss_pred HHHHHcCCCCcC
Confidence 999999998643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=288.55 Aligned_cols=207 Identities=16% Similarity=0.202 Sum_probs=163.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEec----CCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLA----KKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~----~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
.+..++|++.++||+|+||+||+|++. .++ +.+++|++............++...+....|+|++.+++.+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 80 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG-----EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCC-----EEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCC-----cEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456689999999999999999999853 333 78999998765555444555666677777899999998865
Q ss_pred ccc-CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 211 SKK-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 211 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
... ...+++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+|||||
T Consensus 81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik 141 (295)
T 3ugc_A 81 YSAGRRNLKLIMEYLPYGSLRDYLQKHK-------------------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141 (295)
T ss_dssp CHHHHTSCEEEEECCTTCBHHHHHHHCG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ecCCCCceEEEEEeCCCCCHHHHHHhcc-------------------cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 433 356899999999999999997653 146788899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|+|||++.++ .+||+|||+++........ ......+|..|+|||++. ...++.++
T Consensus 142 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~ 198 (295)
T 3ugc_A 142 TRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT----------------------ESKFSVAS 198 (295)
T ss_dssp GGGEEEEETT-EEEECCCCSCC-------------CTTCGGGGCCHHHHH----------------------HCCCCHHH
T ss_pred HhhEEEcCCC-eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc----------------------CCCCChHH
Confidence 9999999987 9999999999876543321 123345777899999554 34566788
Q ss_pred hhHHHHHHHHHHHcCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~ 388 (397)
||||||+++|||++|..||..
T Consensus 199 Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 199 DVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp HHHHHHHHHHHHHHTTCTTCS
T ss_pred HHHHHHHHHHHHHhcccccCC
Confidence 999999999999999998854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=306.54 Aligned_cols=205 Identities=22% Similarity=0.289 Sum_probs=150.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc--
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|++.... ........++...+....|+||+.+++.+...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEK-----RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCC-----cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 378999999999999999999998877 889999886432 22233334556666777899999998876433
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 214 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++|||||||||+
T Consensus 127 ~~~~~~~lv~e~~~-~~L~~~~~~~~--------------------~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~ 185 (458)
T 3rp9_A 127 EKFDELYVVLEIAD-SDFKKLFRTPV--------------------YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPA 185 (458)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHSSC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred ccCceEEEEEeccc-cchhhhcccCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChh
Confidence 257999999986 68999887643 4678889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccc--------------------------cccccccCCCCCCCcccccccCCCCCC
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGIN--------------------------YIPKEFLLDPRYAAPEQYIMSTQTPSA 345 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 345 (397)
||||+.++ .+||+|||+|+....... ......+||+.|+|||++..
T Consensus 186 NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------- 257 (458)
T 3rp9_A 186 NCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL------- 257 (458)
T ss_dssp GEEECTTC-CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-------
T ss_pred hEEECCCC-CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-------
Confidence 99999987 999999999987643221 11244688999999996532
Q ss_pred CCccccccchhhhhccCCCCchhhHHHHHHHHHHHc-----------CCCCCCCCC
Q 015991 346 PSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC-----------TVRRLCLHS 390 (397)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ellt-----------g~~Pf~~~~ 390 (397)
...|+.++|||||||+||||++ |+.+|.+..
T Consensus 258 --------------~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 258 --------------QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp --------------CCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred --------------CCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence 2347778999999999999999 666665544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=293.26 Aligned_cols=209 Identities=21% Similarity=0.295 Sum_probs=168.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.+.||+|+||+||+|++.. + +.+++|+.............++...+....|+|++.+++.+. .++.
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~ 109 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRD-G-----AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-ERNE 109 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTT-C-----CEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-CTTC
T ss_pred HHhccCccceeecCCCeeEEEEEECC-C-----CEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-CCCe
Confidence 45899999999999999999999653 3 789999887654444444556677778888999999988764 4567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+.+++|.+++..... ....+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDL----------------PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD 173 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCC----------------CSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCC----------------CccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC
Confidence 8999999999999988865431 123578888999999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
.++ .+||+|||+++...... ........||+.|+|||++.+ ..++.++||||||++
T Consensus 174 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Di~slG~i 230 (321)
T 2qkw_B 174 ENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK----------------------GRLTEKSDVYSFGVV 230 (321)
T ss_dssp TTC-CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH----------------------CBCCTHHHHHHHHHH
T ss_pred CCC-CEEEeecccccccccccccccccccCCCccccCHHHhcC----------------------CCCCcccchHhHHHH
Confidence 987 99999999997654322 222344568999999995543 346678899999999
Q ss_pred HHHHHcCCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHSC 391 (397)
Q Consensus 376 l~elltg~~Pf~~~~~ 391 (397)
+|||++|+.||.....
T Consensus 231 l~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 231 LFEVLCARSAIVQSLP 246 (321)
T ss_dssp HHHHHHCCTTCSCSSS
T ss_pred HHHHHhCCCcccccCc
Confidence 9999999999976543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=297.49 Aligned_cols=205 Identities=20% Similarity=0.222 Sum_probs=154.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||+||++++..++ +.+|+|.+......... ..++...+....|+|++.+++.+. ..+.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~-~~~E~~~l~~l~hpniv~~~~~~~-~~~~ 90 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTK-----ELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVIL-TPTH 90 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTC-----CEEEEEEEESSTTSCHH-HHHHHHHHHHCCCTTBCCEEEEEE-CSSE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCC-----cEEEEEEEecCccccHH-HHHHHHHHHhCCCCCCCcEEEEEe-eCCE
Confidence 4589999999999999999999998877 78999988654322211 223344555667999999988764 4568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+.+++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~ 150 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAG--------------------RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD 150 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC
T ss_pred EEEEEEeCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence 999999999999999997654 467888999999999999999999999999999999998
Q ss_pred CCC-CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC-chhhHHHHH
Q 015991 297 EGS-RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD-RFDIYSAGL 374 (397)
Q Consensus 297 ~~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-k~Dv~SlGv 374 (397)
.++ ..+||+|||+++...... ......||+.|+|||++.+.. ++. ++|||||||
T Consensus 151 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~~DiwslG~ 206 (361)
T 3uc3_A 151 GSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQE----------------------YDGKIADVWSCGV 206 (361)
T ss_dssp SSSSCCEEECCCCCC-----------------CTTSCHHHHHCSS----------------------CCHHHHHHHHHHH
T ss_pred CCCCceEEEeecCccccccccC--CCCCCcCCCCcCChhhhcCCC----------------------CCCCeeeeehhHH
Confidence 765 149999999997533222 234568999999999765433 333 379999999
Q ss_pred HHHHHHcCCCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~~~ 392 (397)
++|||++|+.||.....+
T Consensus 207 il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 207 TLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp HHHHHHHSSCSCC----C
T ss_pred HHHHHHhCCCCCCCCccH
Confidence 999999999999875543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=293.12 Aligned_cols=204 Identities=18% Similarity=0.255 Sum_probs=161.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhc--cCCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACAN--CCADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~--~~~~~i~~~~~~~ 210 (397)
....++|++.++||+|+||+||+|++..++ +.+++|.+....... ...+.++...+.. ..|+|++.+++.+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNK-----KYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCC-----eEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 345589999999999999999999998776 789999886433222 2222223333322 2489999998866
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. .+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 106 ~~-~~~~~lv~e~~-~~~L~~~~~~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 165 (360)
T 3llt_A 106 MY-YDHMCLIFEPL-GPSLYEIITRNNY------------------NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKP 165 (360)
T ss_dssp EE-TTEEEEEECCC-CCBHHHHHHHTTT------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eE-CCeeEEEEcCC-CCCHHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCc
Confidence 44 56899999999 7899999987541 2467788999999999999999999999999999
Q ss_pred CceEEeC-------------------------CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCC
Q 015991 291 QNVIFSE-------------------------GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345 (397)
Q Consensus 291 ~NILl~~-------------------------~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 345 (397)
+|||++. ++ .+||+|||+|+..... .....||+.|+|||++.+
T Consensus 166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~------- 233 (360)
T 3llt_A 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST-GIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILN------- 233 (360)
T ss_dssp GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCC-CEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTT-------
T ss_pred ccEEEccccccccccchhcccccccccccccCCC-CEEEEeccCceecCCC----CcCccCcccccCcHHHcC-------
Confidence 9999975 44 8999999999764322 245689999999996643
Q ss_pred CCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 346 PSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++|||||||++|||++|+.||....
T Consensus 234 ---------------~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 234 ---------------LGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp ---------------CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 346667899999999999999999997644
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=290.73 Aligned_cols=199 Identities=21% Similarity=0.272 Sum_probs=163.5
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEE
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 219 (397)
.|...++||+|+||+||+|++..++ +.+++|.+............++...+....|+|++.+++.+.. ++..++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSG-----RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCC-----cEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEE
Confidence 5888899999999999999998776 7899998865433323333345566677789999999886644 568999
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
||||+.+++|.+++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++
T Consensus 120 v~e~~~~~~L~~~l~~~---------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQV---------------------RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp EECCCCSCBHHHHHTTC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EEecCCCCCHHHHHHhc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 99999999999988643 357788999999999999999999999999999999999987
Q ss_pred CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 300 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||+++|||
T Consensus 179 -~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Dv~slG~il~el 234 (321)
T 2c30_A 179 -RVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISR----------------------SLYATEVDIWSLGIMVIEM 234 (321)
T ss_dssp -CEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTT----------------------CCBCTHHHHHHHHHHHHHH
T ss_pred -cEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcC----------------------CCCCchhhHHHHHHHHHHH
Confidence 999999999987654322 2345689999999996643 3456678999999999999
Q ss_pred HcCCCCCCCC
Q 015991 380 VCTVRRLCLH 389 (397)
Q Consensus 380 ltg~~Pf~~~ 389 (397)
++|+.||...
T Consensus 235 ~~g~~pf~~~ 244 (321)
T 2c30_A 235 VDGEPPYFSD 244 (321)
T ss_dssp HHSSCTTTTS
T ss_pred HhCCCCCCCC
Confidence 9999999654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=297.74 Aligned_cols=209 Identities=19% Similarity=0.268 Sum_probs=160.1
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch------hHHHHHHHHHHHHhhcc-CCCceeeeee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVEIWMNERVRRACANC-CADFVYGFFE 208 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~e~~~~~~~~~~~~~~-~~~~i~~~~~ 208 (397)
...++|++.++||+|+||+||+|++..... ..+.+++|.+.... ..+... ++...+... +|++++.++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~--~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHD--TGKLYAMKVLKKATIVQKAKTTEHTR--TERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTT--TTCEEEEEEESEEEEEEEESSGGGCC--CHHHHHHHHHTCTTBCCEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCC--CCeEEEEEEEeHHHhhhhhhHHHHHH--HHHHHHHHccCCCceeEEEE
Confidence 345899999999999999999999853111 12788888775321 111111 111222222 5888888877
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+. .++.+++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||
T Consensus 127 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dl 185 (355)
T 1vzo_A 127 AFQ-TETKLHLILDYINGGELFTHLSQRE--------------------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 185 (355)
T ss_dssp EEE-ETTEEEEEECCCCSCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEe-eCceEEEEeecCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 653 3568999999999999999997654 4677889999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+|||++.++ .+||+|||+++.+............||+.|+|||++.+.. ..++.++|
T Consensus 186 kp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~~~~~~~D 244 (355)
T 1vzo_A 186 KLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD--------------------SGHDKAVD 244 (355)
T ss_dssp CGGGEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC-----------------------CTHHH
T ss_pred CHHHEEECCCC-cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCC--------------------CCCCchhh
Confidence 99999999987 9999999999876554444445678999999999776432 13566889
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||||+||||++|+.||....
T Consensus 245 vwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 245 WWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp HHHHHHHHHHHHHSSCTTSCTT
T ss_pred HHHHHHHHHHHHHCCCCCccCC
Confidence 9999999999999999997543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=295.70 Aligned_cols=210 Identities=15% Similarity=0.142 Sum_probs=169.3
Q ss_pred ccCCeEEeeeeccC--CceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 137 RKDDFVLGKKLGEG--AFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G--~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
..++|++.++||+| +||+||+|++..++ +.+++|++.... ........++...+....|+||+.+++.+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~- 96 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTG-----EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI- 96 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCC-----CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-
Confidence 44799999999999 99999999998877 889999886543 222333444566677778999999988765
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++.+++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 158 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHF------------------MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASH 158 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTC------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 4568999999999999999998652 1246788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccc------cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
||++.++ .+||+|||.+........ .......||+.|+|||++.+.. ..++.+
T Consensus 159 Ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~~~~~~ 217 (389)
T 3gni_B 159 ILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL--------------------QGYDAK 217 (389)
T ss_dssp EEECTTC-CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS--------------------SCBCTH
T ss_pred EEEcCCC-CEEEcccccceeeccccccccccccccccccccccccCHHHHhccC--------------------CCCCcH
Confidence 9999987 999999999865432211 1223457899999999775421 246678
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
+|||||||++|||++|+.||.....
T Consensus 218 ~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 218 SDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp HHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred hHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 8999999999999999999976543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=292.99 Aligned_cols=203 Identities=18% Similarity=0.163 Sum_probs=159.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhcc-CCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.+.||+|+||+||+|++..++ +.+++|.+......+... ++...+... .|++++.+++.... ++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~--~E~~~l~~l~~h~~i~~~~~~~~~-~~ 78 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTN-----EYVAIKLEPMKSRAPQLH--LEYRFYKQLGSGDGIPQVYYFGPC-GK 78 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTT-----EEEEEEEEETTCSSCCHH--HHHHHHHHHCSCTTSCCEEEEEEE-TT
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCC-----cEEEEEEeccccchHHHH--HHHHHHHHhhCCCCCCEEEEEEec-CC
Confidence 3478999999999999999999988776 789999876443222111 122222333 67888887775533 57
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill 138 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCD-------------------RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ccEEEEEeC-CCCHHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 889999999 899999998642 146788899999999999999999999999999999999
Q ss_pred eCCCCe-----EEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 296 SEGSRT-----FKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 296 ~~~~~~-----~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
+.++ . +||+|||+++.+...... ......||+.|+|||++.+ ..++
T Consensus 139 ~~~~-~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~ 195 (330)
T 2izr_A 139 GRPG-NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG----------------------KEQS 195 (330)
T ss_dssp CCGG-GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT----------------------CCCC
T ss_pred ccCC-CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC----------------------CCCC
Confidence 9876 5 999999999876443221 1245789999999996654 3456
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++|||||||++|||++|+.||....
T Consensus 196 ~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 196 RRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred chhHHHHHHHHHHHHhcCCCCccccc
Confidence 67899999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=296.04 Aligned_cols=200 Identities=18% Similarity=0.266 Sum_probs=159.5
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.+.||+|+||.||+|++..++ +.+++|.+......... ++........|+|++.+++.+ ..++..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~---E~~~l~~~~~hp~iv~~~~~~-~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATN-----MEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKDVY-DDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTTCCCHH---HHHHHHHHTTSTTBCCEEEEE-ECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEcccCChHH---HHHHHHHhcCCCCcCeEEEEE-EcCCEE
Confidence 368999999999999999999998877 78999988654322111 111122234689999988866 446789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+.+
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK--------------------FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred EEEEeCCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEec
Confidence 99999999999999987653 4678889999999999999999999999999999999855
Q ss_pred CC---CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 298 GS---RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 298 ~~---~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+. ..+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwslG~ 208 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLER----------------------QGYDAACDIWSLGV 208 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHH----------------------HHHHHHHHHHHHHH
T ss_pred CCCCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcC----------------------CCCCCccCeeeHhH
Confidence 42 2599999999987654322 2345789999999996543 33556789999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|..||...
T Consensus 209 il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 209 LLYTMLTGYTPFANG 223 (342)
T ss_dssp HHHHHHHSSCSSCSS
T ss_pred HHHHHhcCCCCCCCC
Confidence 999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.95 Aligned_cols=202 Identities=21% Similarity=0.382 Sum_probs=159.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++|++.+.||+|+||+||+|++..++ +.+|+|++.... ........++...+....|+|++.+++.+....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTE-----KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCC-----cEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 3489999999999999999999998877 889999886432 222333345566667778999999988765543
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
...|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||||
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~--------------------~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp 157 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTPI--------------------FLTEEHIKTILYNLLLGENFIHESGIIHRDLKP 157 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSSC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 57999999998 59999987643 467889999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccc---------------------ccccccCCCCCCCcccccccCCCCCCCCcc
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY---------------------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~---------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~ 349 (397)
+|||++.++ .+||+|||+|+........ .....+||+.|+|||++...
T Consensus 158 ~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---------- 226 (432)
T 3n9x_A 158 ANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ---------- 226 (432)
T ss_dssp GGEEECTTC-CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTC----------
T ss_pred HHeEECCCC-CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC----------
Confidence 999999987 9999999999876443211 12567899999999965322
Q ss_pred ccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCC
Q 015991 350 VATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRL 386 (397)
Q Consensus 350 ~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf 386 (397)
..++.++|||||||++|||++|..||
T Consensus 227 -----------~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 227 -----------ENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------SCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred -----------CCCCcccccchHHHHHHHHHhccccc
Confidence 34677899999999999999865554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=287.34 Aligned_cols=206 Identities=21% Similarity=0.276 Sum_probs=160.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
...++|++.++||+|+||+||+|++.. + +.+++|++......+ .....++...+....|+|++.+++.+. .
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~ 90 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ-G-----RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-S 90 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETT-S-----CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-C
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECC-C-----CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-c
Confidence 355899999999999999999999854 3 789999886433221 222334455666678999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+++ +|.+.+.... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI 150 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENK-------------------TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCEEEEEEcCCCC-CHHHHHHhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence 5689999999995 7888876543 2467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++....... ......||+.|+|||++.+.. .++.++||||||
T Consensus 151 l~~~~~-~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwslG 207 (311)
T 3niz_A 151 LINSDG-ALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSK---------------------KYSTSVDIWSIG 207 (311)
T ss_dssp EECTTC-CEEECCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCC---------------------SCCTHHHHHHHH
T ss_pred EECCCC-CEEEccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCC---------------------CCCchHHhHHHH
Confidence 999987 999999999987643322 234467899999999765422 356788999999
Q ss_pred HHHHHHHcCCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~ 391 (397)
|++|||++|+.||.....
T Consensus 208 ~il~~ll~g~~pf~~~~~ 225 (311)
T 3niz_A 208 CIFAEMITGKPLFPGVTD 225 (311)
T ss_dssp HHHHHHHHSSCSCCCSST
T ss_pred HHHHHHHhCCCCCCCCCh
Confidence 999999999999976543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=305.98 Aligned_cols=208 Identities=21% Similarity=0.301 Sum_probs=170.6
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
.....++|.+++.||+|+||.||+|++..++ +.+++|.+....... .....++...+....|+|++.+++.+
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTG-----HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTC-----CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4556789999999999999999999998777 889999886543211 22334455666778899999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. .+.+++||||+.+++|.+++...+ .+++..++.++.|++.||+|||++||+||||||
T Consensus 86 ~~-~~~~~lv~E~~~gg~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp 144 (476)
T 2y94_A 86 ST-PSDIFMVMEYVSGGELFDYICKNG--------------------RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKP 144 (476)
T ss_dssp EC-SSEEEEEEECCSSEEHHHHTTSSS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSG
T ss_pred EE-CCEEEEEEeCCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccH
Confidence 44 568999999999999999987543 467888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++....+. .....+||+.|+|||++.+..+ .+.++|||
T Consensus 145 ~NIll~~~~-~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~Diw 200 (476)
T 2y94_A 145 ENVLLDAHM-NAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLY---------------------AGPEVDIW 200 (476)
T ss_dssp GGEEECTTC-CEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCB---------------------CSHHHHHH
T ss_pred HHEEEecCC-CeEEEeccchhhccccc--cccccCCCcCeEChhhccCCCC---------------------CCCcceeh
Confidence 999999987 99999999998765432 2345689999999997765432 13468999
Q ss_pred HHHHHHHHHHcCCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~~ 391 (397)
||||++|||++|+.||.....
T Consensus 201 SlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 201 SSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp HHHHHHHHHHHSSCSSCCSSS
T ss_pred hhHHHHHHHhhCCCCCCCCCH
Confidence 999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=289.18 Aligned_cols=207 Identities=16% Similarity=0.244 Sum_probs=160.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--------------------------HHHHHH
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--------------------------EIWMNE 189 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--------------------------e~~~~~ 189 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDN-----TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVY 84 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTT-----EEEEEEEEECC-------------------------------CHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCC-----cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHH
Confidence 45689999999999999999999998876 78888887643211 012233
Q ss_pred HHHHHhhccCCCceeeeeecccc-cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHH
Q 015991 190 RVRRACANCCADFVYGFFENSSK-KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIM 268 (397)
Q Consensus 190 ~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~ 268 (397)
++...+....|+|++.+++.+.. .+...++||||+++++|.+++.. ..+++..+..++
T Consensus 85 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------------------~~~~~~~~~~~~ 143 (298)
T 2zv2_A 85 QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---------------------KPLSEDQARFYF 143 (298)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---------------------SCCCHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---------------------CCCCHHHHHHHH
Confidence 45556667789999999887654 35789999999999988664322 246788899999
Q ss_pred HHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCc
Q 015991 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSA 348 (397)
Q Consensus 269 ~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 348 (397)
.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....... ......||+.|+|||++.+....
T Consensus 144 ~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~------ 215 (298)
T 2zv2_A 144 QDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKI------ 215 (298)
T ss_dssp HHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCC------
T ss_pred HHHHHHHHHHHHCCeeccCCCHHHEEECCCC-CEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCC------
Confidence 9999999999999999999999999999987 999999999987654322 23456899999999987644321
Q ss_pred cccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 349 PVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 349 ~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
.++.++|||||||++|||++|+.||...
T Consensus 216 -------------~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 216 -------------FSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp -------------EESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -------------CCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 0244679999999999999999999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=281.89 Aligned_cols=206 Identities=14% Similarity=0.194 Sum_probs=165.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.+.||+|+||.||+|++..+ +.+++|++......+. ...++...+....|++++.+++.+.. +
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 77 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCLE-Q 77 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEEECTTSBCHH-HHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred EeChhhceeeheecCCCccEEEEEEecCC------CeEEEEEecccccCHH-HHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 34568999999999999999999998754 6789998875443222 22334555666679999999887644 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil 138 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQR-------------------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 138 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CceEEEEEeCCCCcHHHHHHhcC-------------------cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEE
Confidence 67999999999999999997643 14577889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++..............+|+.|+|||++.+ ..++.++||||+|+
T Consensus 139 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~ 195 (269)
T 4hcu_A 139 VGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF----------------------SRYSSKSDVWSFGV 195 (269)
T ss_dssp ECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH----------------------CCCCHHHHHHHHHH
T ss_pred EcCCC-CEEeccccccccccccccccccCcccccccCCHHHhcC----------------------CCCCchhhhHHHHH
Confidence 99887 99999999998765443333445667889999996543 34666789999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |+.||....
T Consensus 196 ~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 196 LMWEVFSEGKIPYENRS 212 (269)
T ss_dssp HHHHHHTTSCCTTTTCC
T ss_pred HHHHHhcCCCCCCCCCC
Confidence 9999999 999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=291.77 Aligned_cols=214 Identities=20% Similarity=0.234 Sum_probs=163.2
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeec----
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFEN---- 209 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~---- 209 (397)
+.+..++|++.+.||+|+||.||+|++.+ +.+++|.+.......... +..........|++++.+++.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~-e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDE-------RPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETT-------EEEEEEEEEGGGHHHHHH-HHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECC-------eEEEEEEeeccchhhHHH-HHHHHHHHhccCcchhhheeccccc
Confidence 35677999999999999999999997743 789999887554443333 334444556789999888752
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC--------
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-------- 281 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-------- 281 (397)
.......+++||||+++++|.+++.... .++..+..++.|++.||+|||+.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~ 138 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT---------------------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC---------------------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCB
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc---------------------cchhHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 2233456899999999999999997653 35677889999999999999999
Q ss_pred -CceecCCCCCceEEeCCCCeEEEEecccccccccccc-------cccccccCCCCCCCcccccccCCCCCCCCcccccc
Q 015991 282 -GIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 353 (397)
Q Consensus 282 -giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~ 353 (397)
||+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||++.+.....
T Consensus 139 ~~ivH~Dikp~Nill~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---------- 207 (336)
T 3g2f_A 139 PAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR---------- 207 (336)
T ss_dssp CCEECSSCSGGGEEECTTS-CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG----------
T ss_pred cceeecccccceEEEcCCC-cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc----------
Confidence 999999999999999987 999999999987643221 1123457999999999886532211
Q ss_pred chhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 015991 354 LSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 354 ~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
....++.++|||||||++|||++|..||......
T Consensus 208 -----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 208 -----DXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp -----GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred -----cccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 1123456789999999999999998887655443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.89 Aligned_cols=199 Identities=22% Similarity=0.262 Sum_probs=156.2
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|++.... ........++........|++++.+++.+. .+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-~~ 129 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDG-----RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-EG 129 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTS-----CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred hhheeeeheeccCCCeEEEEEEECCCC-----eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-eC
Confidence 368999999999999999999998776 789999875422 222222223333444457999999888664 46
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||++ ++|.+++...+ ..+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 189 (311)
T 3p1a_A 130 GILYLQTELCG-PSLQQHCEAWG-------------------ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189 (311)
T ss_dssp TEEEEEEECCC-CBHHHHHHHHC-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CEEEEEEeccC-CCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 78999999995 68988887653 24678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||
T Consensus 190 l~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------------------~~~~~~DiwslG~ 243 (311)
T 3p1a_A 190 LGPRG-RCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-----------------------SYGTAADVFSLGL 243 (311)
T ss_dssp ECGGG-CEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-----------------------CCSTHHHHHHHHH
T ss_pred ECCCC-CEEEccceeeeecccCC--CCcccCCCccccCHhHhcC-----------------------CCCchhhHHHHHH
Confidence 99987 99999999997664332 2345679999999996542 3566889999999
Q ss_pred HHHHHHcCCCCCCC
Q 015991 375 IFLQMVCTVRRLCL 388 (397)
Q Consensus 375 ~l~elltg~~Pf~~ 388 (397)
++|||++|..||..
T Consensus 244 il~el~~g~~~~~~ 257 (311)
T 3p1a_A 244 TILEVACNMELPHG 257 (311)
T ss_dssp HHHHHHHTCCCCSS
T ss_pred HHHHHHhCCCCCCC
Confidence 99999999776643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=291.13 Aligned_cols=200 Identities=23% Similarity=0.303 Sum_probs=142.0
Q ss_pred CCeEEe---eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhcc-CCCceeeeeecccccC
Q 015991 139 DDFVLG---KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSSKKG 214 (397)
Q Consensus 139 ~~f~i~---~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (397)
++|++. +.||+|+||+||+|.+..++ +.+++|.+.......... +...+... .|+||+.+++.+. .+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~---e~~~l~~l~~h~niv~~~~~~~-~~ 78 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSN-----QAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFH-DQ 78 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTC-----CEEEEEEEEGGGHHHHHH---HHHHHHHTTTCTTBCCEEEEEE-CS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCC-----CEEEEEEEChhhhhhHHH---HHHHHHHhcCCCCeeEEEEEEE-cC
Confidence 456664 78999999999999998877 889999987554333322 22222333 4899999888764 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 138 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKK--------------------HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEE
Confidence 78999999999999999997654 4678889999999999999999999999999999999
Q ss_pred EeCCCC--eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 295 FSEGSR--TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 295 l~~~~~--~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++.++. .+||+|||+++...... .......||+.|+|||++.+ ..++.++|||||
T Consensus 139 l~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~----------------------~~~~~~~Diwsl 195 (325)
T 3kn6_A 139 FTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQ----------------------NGYDESCDLWSL 195 (325)
T ss_dssp EEC----CEEEECCCTTCEECCC---------------------------------------------CCCCHHHHHHHH
T ss_pred EecCCCcccEEEeccccceecCCCC-CcccccCCCcCccCHHHhcC----------------------CCCCCccchHHH
Confidence 986542 79999999998654332 22345678999999996543 346667899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
|+++|||++|..||....
T Consensus 196 G~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 196 GVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp HHHHHHHHHSSCTTC---
T ss_pred HHHHHHHHhCCCCCCCCc
Confidence 999999999999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=280.87 Aligned_cols=200 Identities=21% Similarity=0.291 Sum_probs=164.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
++|++.++||+|+||+||+|.+..++ ..+++|++......+.....++...+....|++++.+++.+. .+...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTR-----IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-DNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCC-----cEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCeEE
Confidence 68999999999999999999998876 788899886543332333344555666678999999988764 457899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE---
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF--- 295 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl--- 295 (397)
+||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 142 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR--------------------VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD 142 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred EEEeccCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC
Confidence 9999999999999887654 46788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||++........ .....||+.|+|||++.+ .++.++||||||++
T Consensus 143 ~~~~-~~~l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~-----------------------~~~~~~Di~slG~~ 196 (277)
T 3f3z_A 143 SPDS-PLKLIDFGLAARFKPGKM--MRTKVGTPYYVSPQVLEG-----------------------LYGPECDEWSAGVM 196 (277)
T ss_dssp STTC-CEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-----------------------CBCTTHHHHHHHHH
T ss_pred CCCC-cEEEEecccceeccCccc--hhccCCCCCccChHHhcc-----------------------cCCchhhehhHHHH
Confidence 5655 999999999987654332 345679999999996642 24567899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 197 l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 197 MYVLLCGYPPFSAPT 211 (277)
T ss_dssp HHHHHHSSCSSCCSS
T ss_pred HHHHHHCCCCCCCCC
Confidence 999999999997643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=292.34 Aligned_cols=212 Identities=16% Similarity=0.166 Sum_probs=161.7
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
..+..++|++.++||+|+||+||+|++..++..++ ..+++|.+..... .......++...+....|+|++.+++.+.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~-~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIK-IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCC-EEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEE-EEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34566899999999999999999999887764432 2366776643221 11111223344455567999999988653
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+...++|+||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N 145 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHR-------------------GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARN 145 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSG-------------------GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTT
T ss_pred -CCccEEEEEeCCCCCHHHHHHHcc-------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchhe
Confidence 456899999999999999987642 245677889999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++||||
T Consensus 146 il~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~Di~s 202 (325)
T 3kex_A 146 VLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH----------------------FGKYTHQSDVWS 202 (325)
T ss_dssp EEESSSS-CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHH----------------------HCCCCHHHHHHH
T ss_pred EEECCCC-eEEECCCCcccccCcccccccccCCCCcccccChHHhc----------------------cCCCChhhHhHH
Confidence 9999987 9999999999876544322 234567888999999554 345667889999
Q ss_pred HHHHHHHHHc-CCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~ 390 (397)
||+++|||++ |..||....
T Consensus 203 lG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 203 YGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp HHHHHHHHHTTSCCTTTTSC
T ss_pred hHHHHHHHHhCCCCCccccC
Confidence 9999999999 999997654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=280.19 Aligned_cols=206 Identities=17% Similarity=0.214 Sum_probs=164.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.+.||+|+||.||+|.+..+ ..+++|.+......... ..++...+....|++++.+++.+. .+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~-~~~E~~~l~~l~h~~i~~~~~~~~-~~ 75 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ------YDVAVKMIKEGSMSEDE-FFQEAQTMMKLSHPKLVKFYGVCS-KE 75 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECBTTBCHHH-HHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCc------eeEEEEEeccCCCcHHH-HHHHHHHHHhCCCCCEeeEEEEEc-cC
Confidence 35668999999999999999999987653 57899988754432222 223344555567999999988764 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 136 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG-------------------KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEE
T ss_pred CceEEEEEccCCCcHHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEE
Confidence 67999999999999999997653 24678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++..............+|+.|+|||++.+. .++.++||||||+
T Consensus 137 ~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~ 193 (268)
T 3sxs_A 137 VDRDL-CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF----------------------KYSSKSDVWAFGI 193 (268)
T ss_dssp ECTTC-CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS----------------------EEETTHHHHHHHH
T ss_pred ECCCC-CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc----------------------CCchhhhhHHHHH
Confidence 99987 999999999987655433333445677889999966443 4556789999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |..||....
T Consensus 194 il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 194 LMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp HHHHHHTTTCCTTTTSC
T ss_pred HHHHHHcCCCCCccccC
Confidence 9999999 999996543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=288.07 Aligned_cols=209 Identities=21% Similarity=0.259 Sum_probs=151.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.++||+|+||+||+|.+..++ +.+++|.+...... ......++...+....|+|++.+++.+.. ++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTG-----VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSC-----CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCC-----cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCe
Confidence 378999999999999999999988776 78899987643221 11222344556677789999999887644 568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||++ ++|.+++...... .....+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~~--------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~ 142 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTVG--------------NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN 142 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHSS--------------SCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred EEEEEEecC-CCHHHHHHhcccc--------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc
Confidence 999999999 5999998765311 1123467888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||+++....... ......||+.|+|||++.+. ..++.++|||||||++
T Consensus 143 ~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---------------------~~~~~~~DiwslG~il 199 (317)
T 2pmi_A 143 KRG-QLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGS---------------------RTYSTSIDIWSCGCIL 199 (317)
T ss_dssp TTC-CEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTC---------------------CCCCTHHHHHHHHHHH
T ss_pred CCC-CEEECcCccceecCCCcc-cCCCCcccccccCchHhhCC---------------------CCCCcHHHHHHHHHHH
Confidence 987 999999999987643322 22456789999999976532 1356788999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||....
T Consensus 200 ~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 200 AEMITGKPLFPGTN 213 (317)
T ss_dssp HHHHHSSCSCCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.49 Aligned_cols=230 Identities=20% Similarity=0.203 Sum_probs=171.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
.+..++|++.+.||+|+||+||+|++.........+.+++|.+...... +.....++...+... +|++++.+++.+..
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 4566899999999999999999999765444444478999988754322 222223333344443 68999999988766
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+..+++||||+.+++|.+++............. ........+++..+..++.|++.||.|||++||+||||||+|
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA----PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-----------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred CCCceEEEEEcCCCCcHHHHHHhccccccccccc----chhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 6677999999999999999998764211100000 000012237888999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++||||
T Consensus 179 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~~Di~s 235 (316)
T 2xir_A 179 ILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF----------------------DRVYTIQSDVWS 235 (316)
T ss_dssp EEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH----------------------HCCCCHHHHHHH
T ss_pred EEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhc----------------------cccccchhHHHH
Confidence 9999887 9999999999876443322 234467789999999554 345667889999
Q ss_pred HHHHHHHHHc-CCCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~~ 391 (397)
||+++|||++ |..||.....
T Consensus 236 lG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 236 FGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp HHHHHHHHHTTSCCSSTTCCC
T ss_pred HHHHHHHHHhCCCCCCcccch
Confidence 9999999998 9999976543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.24 Aligned_cols=234 Identities=19% Similarity=0.247 Sum_probs=168.1
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhcc-CCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (397)
..+..++|++.+.||+|+||.||+|++...........+++|.+...... ......++...+... .|++++.+++.+.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 35566899999999999999999999855433333367999988643221 122223334444444 7999999988765
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhcc---ccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG---EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
. ++..++||||+++++|.+++......+........ ..........+++..+..++.|++.||+|||++||+||||
T Consensus 120 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 120 L-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp S-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred e-CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 4 56789999999999999999876533222111110 0111122345788999999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
||+|||++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++
T Consensus 199 kp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~~ 255 (344)
T 1rjb_A 199 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF----------------------EGIYTIKS 255 (344)
T ss_dssp SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH----------------------HCCCCHHH
T ss_pred ChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhc----------------------cCCCChhH
Confidence 99999999987 9999999999876544322 233456788999999554 34466688
Q ss_pred hhHHHHHHHHHHHc-CCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 368 Dv~SlGv~l~ellt-g~~Pf~~~~~ 391 (397)
||||||+++|||++ |..||.....
T Consensus 256 Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 256 DVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999998 9999977543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=289.63 Aligned_cols=232 Identities=17% Similarity=0.184 Sum_probs=170.8
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
..+..++|++.+.||+|+||.||+|++.........+.+++|.+..... .......++...+....|+|++.+++.+..
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 4567789999999999999999999987644333347899998875432 223334455666677789999999887644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcch----hhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNV----QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
++..++||||+.+++|.+++......... ................+++..++.++.|++.||+|||++||+||||
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 56789999999999999999875311000 0000000000111246788999999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
||+|||++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++
T Consensus 201 kp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~~ 257 (343)
T 1luf_A 201 ATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF----------------------YNRYTTES 257 (343)
T ss_dssp SGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH----------------------HCCCCHHH
T ss_pred CcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhc----------------------cCCcCccc
Confidence 99999999987 9999999999866443222 233457889999999554 33466788
Q ss_pred hhHHHHHHHHHHHc-CCCCCCCC
Q 015991 368 DIYSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 368 Dv~SlGv~l~ellt-g~~Pf~~~ 389 (397)
||||||+++|||++ |..||...
T Consensus 258 Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 258 DVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999 99999654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.09 Aligned_cols=201 Identities=23% Similarity=0.301 Sum_probs=151.0
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.+.||+|+||+||+|++..++ +.+++|.+......+. ..++...+....|++++.+++.+. ..+.
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~--~~~E~~~l~~l~h~niv~~~~~~~-~~~~ 122 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQ-----KPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIFE-TPTE 122 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-CSSE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCC-----cEEEEEEeccchhHHH--HHHHHHHHHhCCCCCCcceeeeEe-cCCe
Confidence 3478999999999999999999998876 7899998875443322 223444555667999999888764 4568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~ 182 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKG--------------------YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred EEEEEEeCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEe
Confidence 999999999999999987643 467888999999999999999999999999999999997
Q ss_pred C---CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 297 E---GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 297 ~---~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
. ++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||
T Consensus 183 ~~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwslG 237 (349)
T 2w4o_A 183 TPAPDA-PLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRG----------------------CAYGPEVDMWSVG 237 (349)
T ss_dssp SSSTTC-CEEECCCC------------------CGGGSCHHHHTT----------------------CCCCTHHHHHHHH
T ss_pred cCCCCC-CEEEccCccccccCccc--ccccccCCCCccCHHHhcC----------------------CCCCcccchHHHH
Confidence 5 54 99999999998654322 2345679999999996543 3466788999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|++|||++|..||....
T Consensus 238 ~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 238 IITYILLCGFEPFYDER 254 (349)
T ss_dssp HHHHHHHHSSCTTCCTT
T ss_pred HHHHHHHhCCCCCCCCc
Confidence 99999999999996544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.17 Aligned_cols=232 Identities=19% Similarity=0.215 Sum_probs=171.3
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.+.||+|+||.||+|++.........+.+++|.+.... ..+.....++...+....|+|++.+++.+..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ- 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-
Confidence 45668999999999999999999998554333334778999887543 2333334455666777789999999887644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcch--h--hhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNV--Q--TLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~--~--~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
++..++||||+.+++|.+++......... . ...............+++..+..++.|++.||+|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 56789999999999999999875421000 0 0000000011123457889999999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|+|||++.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++|
T Consensus 178 p~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~D 234 (314)
T 2ivs_A 178 ARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD----------------------HIYTTQSD 234 (314)
T ss_dssp GGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH----------------------CEECHHHH
T ss_pred hheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC----------------------CCcCchhh
Confidence 9999999987 9999999999866443322 2334567889999996543 34566789
Q ss_pred hHHHHHHHHHHHc-CCCCCCCCC
Q 015991 369 IYSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
|||||+++|||++ |..||....
T Consensus 235 i~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 235 VWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCC
T ss_pred HHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999 999997654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=305.69 Aligned_cols=206 Identities=18% Similarity=0.225 Sum_probs=165.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.++||+|+||+||+|.+..+ ..+++|.+....... ....++...+....|+|++.+++.+. +
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~------~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~~iv~l~~~~~--~ 254 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT--K 254 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTT------EEEEEEEECTTSBCH-HHHHHHHHHHTTCCCTTBCCEEEEEC--S
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCc------cEEEEEEecCCCccH-HHHHHHHHHHhhCCCCCEeeEEEEEe--C
Confidence 45668999999999999999999998653 679999887543222 22334455667778999999988764 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++||||+.+|+|.++++... +..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 316 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDE------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHH------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred CccEEEEeecCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 57899999999999999997542 124567788899999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++..............+|+.|+|||++. ...++.++|||||||
T Consensus 317 l~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~DvwslG~ 373 (454)
T 1qcf_A 317 VSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN----------------------FGSFTIKSDVWSFGI 373 (454)
T ss_dssp ECTTC-CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHH----------------------HCCCCHHHHHHHHHH
T ss_pred ECCCC-cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhc----------------------cCCCCcHHHHHhHHH
Confidence 99987 9999999999876543322234456788999999554 345677889999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
+||||++ |+.||....
T Consensus 374 ~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 374 LLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp HHHHHHTTSCCSSTTCC
T ss_pred HHHHHHhCCCCCCCCCC
Confidence 9999999 999997643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=299.96 Aligned_cols=219 Identities=11% Similarity=0.042 Sum_probs=154.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHH---HHhhccCCCceeeeeecc-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVR---RACANCCADFVYGFFENS- 210 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~---~~~~~~~~~~i~~~~~~~- 210 (397)
.++|++.+.||+|+||+||+|++..++ +.+|+|.+... .........++. ..+....|+|++.+++.+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCC-----CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCC-----cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 478999999999999999999987776 78999987632 111222222333 556666899998776322
Q ss_pred ------cccCC----------------eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHH
Q 015991 211 ------SKKGG----------------EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIM 268 (397)
Q Consensus 211 ------~~~~~----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~ 268 (397)
...+. ..++||||++ |+|.+++...... -.....+++..+..++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~-------------~~~~~~l~~~~~~~i~ 212 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSH-------------SSTHKSLVHHARLQLT 212 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHT-------------TTTTHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhcccc-------------ccccccccHHHHHHHH
Confidence 11111 3789999995 7999999865310 0112355678888999
Q ss_pred HHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCc
Q 015991 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSA 348 (397)
Q Consensus 269 ~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 348 (397)
.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ......| +.|+|||++.+.......
T Consensus 213 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~--- 283 (377)
T 3byv_A 213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYH--- 283 (377)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHH---
T ss_pred HHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEechhheecCC----cccCCCC-cCccChhhhccccccccc---
Confidence 9999999999999999999999999999987 999999999986432 2244567 999999976544000000
Q ss_pred cccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 015991 349 PVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 349 ~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
......++.++|||||||+||||++|+.||......
T Consensus 284 --------~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 284 --------RDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp --------HCCEEECCHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred --------ccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc
Confidence 000014677899999999999999999999765543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=282.31 Aligned_cols=205 Identities=17% Similarity=0.217 Sum_probs=162.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.+.||+|+||+||+|.+..+ ..+++|.+......+.. ..++...+....|++++.+++.+. .+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vavK~~~~~~~~~~~-~~~E~~~l~~l~h~~i~~~~~~~~-~~ 91 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCT-KQ 91 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTT------EEEEEEEECTTSBCHHH-HHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCC------CeEEEEEecCCCCCHHH-HHHHHHHHhcCCCCCEeeEEEEEe-cC
Confidence 45668999999999999999999987643 67899988754432222 233455566667999999988764 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 152 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR-------------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL 152 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG-------------------GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred CCeEEEEeccCCCcHHHHHHHhc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEE
Confidence 67999999999999999997632 14678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++..............+|+.|+|||++. ...++.++||||||+
T Consensus 153 i~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~Dv~slG~ 209 (283)
T 3gen_A 153 VNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM----------------------YSKFSSKSDIWAFGV 209 (283)
T ss_dssp ECTTS-CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHH----------------------HCCCSHHHHHHHHHH
T ss_pred EcCCC-CEEEccccccccccccccccccCCccCcccCCHHHhc----------------------cCCCCchhhHHHHHH
Confidence 99987 9999999999876544333334456788999999654 334666789999999
Q ss_pred HHHHHHc-CCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLH 389 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~ 389 (397)
++|||++ |+.||...
T Consensus 210 ~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 210 LMWEIYSLGKMPYERF 225 (283)
T ss_dssp HHHHHHTTTCCTTTTS
T ss_pred HHHHHHhCCCCCcccc
Confidence 9999998 99999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=293.80 Aligned_cols=199 Identities=19% Similarity=0.211 Sum_probs=157.1
Q ss_pred EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEE
Q 015991 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (397)
Q Consensus 142 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~ 221 (397)
...+.||+|+||.||+|++..++ +.+++|.+............++...+....|+|++.+++.+.. .+.+++||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~ 165 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATG-----LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVM 165 (373)
T ss_dssp EEEEECC-----CEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCC-----cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEE
Confidence 33678999999999999998876 7899998876544444444556677777889999999887644 56899999
Q ss_pred EecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe--CCC
Q 015991 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGS 299 (397)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~--~~~ 299 (397)
||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++ .++
T Consensus 166 E~~~~~~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 226 (373)
T 2x4f_A 166 EYVDGGELFDRIIDES-------------------YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK 226 (373)
T ss_dssp ECCTTCEEHHHHHHTG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT
T ss_pred eCCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC
Confidence 9999999999886542 2467788889999999999999999999999999999994 444
Q ss_pred CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHH
Q 015991 300 RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 379 (397)
Q Consensus 300 ~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~el 379 (397)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 227 -~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwslG~il~el 281 (373)
T 2x4f_A 227 -QIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNY----------------------DFVSFPTDMWSVGVIAYML 281 (373)
T ss_dssp -EEEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTT----------------------CBCCHHHHHHHHHHHHHHH
T ss_pred -cEEEEeCCCceecCCccc--cccccCCCcEeChhhccC----------------------CCCCcHHhHHHHHHHHHHH
Confidence 899999999987654332 244579999999996643 3456678999999999999
Q ss_pred HcCCCCCCCCC
Q 015991 380 VCTVRRLCLHS 390 (397)
Q Consensus 380 ltg~~Pf~~~~ 390 (397)
++|..||....
T Consensus 282 ltg~~pf~~~~ 292 (373)
T 2x4f_A 282 LSGLSPFLGDN 292 (373)
T ss_dssp HHSSCTTCCSS
T ss_pred HhCCCCCCCCC
Confidence 99999997654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=290.14 Aligned_cols=211 Identities=18% Similarity=0.153 Sum_probs=159.0
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.++||+|+||+||+|++..++..++ ..+++|.+..... .......++...+....|+|++.+++.+..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CC-EEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEE-EEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-
Confidence 3556899999999999999999999877664332 2467787754322 112223344555666789999999887654
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...++++||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 89 -~~~~~v~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI 148 (327)
T 3poz_A 89 -STVQLITQLMPFGCLLDYVREHK-------------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 148 (327)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHST-------------------TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred -CCeEEEEEecCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheE
Confidence 34789999999999999997643 2467788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|++.++ .+||+|||+|+........ ......+|+.|+|||++. ...++.++|||||
T Consensus 149 ll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~~Di~sl 205 (327)
T 3poz_A 149 LVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL----------------------HRIYTHQSDVWSY 205 (327)
T ss_dssp EEEETT-EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHH----------------------HCCCCHHHHHHHH
T ss_pred EECCCC-CEEEccCcceeEccCCcccccccCCCccccccChHHhc----------------------cCCCCchhhhhhh
Confidence 999987 9999999999876443322 223456788999999554 4456678899999
Q ss_pred HHHHHHHHc-CCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~ 390 (397)
||++|||++ |+.||....
T Consensus 206 G~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 206 GVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCC
T ss_pred HHHHHHHHhcCCCCccCCC
Confidence 999999999 999997643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=291.25 Aligned_cols=206 Identities=19% Similarity=0.202 Sum_probs=165.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
...++|++.+.||+|+||.||+|++.. + +.+++|++....... .....++...+....|+|++.+++.+.. .
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLAD-G-----TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-P 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCSS-S-----CCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-S
T ss_pred HHhhccccceeEecCCCcEEEEEEecC-C-----CEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-C
Confidence 355899999999999999999998543 3 789999887543221 1123445566777889999999887644 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC---CceecCCCCC
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST---GIVHRDIKPQ 291 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~---giiHrDIKp~ 291 (397)
+..++||||+.+++|.+++..... ....+++..+..++.|++.||+|||++ ||+||||||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPE----------------SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCST----------------TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred CceEEEEEeccCCCHHHHHHhccc----------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 678899999999999999987541 233578888999999999999999999 9999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++..............||+.|+|||++.+ ..++.++||||
T Consensus 164 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Di~s 220 (326)
T 3uim_A 164 NILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST----------------------GKSSEKTDVFG 220 (326)
T ss_dssp GEEECTTC-CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH----------------------SEECHHHHHHH
T ss_pred hEEECCCC-CEEeccCccccccCcccccccccccCCcCccCHHHhcc----------------------CCCCccccchh
Confidence 99999987 99999999998765444444455679999999996543 34566789999
Q ss_pred HHHHHHHHHcCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLC 387 (397)
Q Consensus 372 lGv~l~elltg~~Pf~ 387 (397)
||+++|||++|+.||.
T Consensus 221 lG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 221 YGVMLLELITGQRAFD 236 (326)
T ss_dssp HHHHHHHHHHCCCSBC
T ss_pred HHHHHHHHHhCCCccc
Confidence 9999999999999995
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=279.20 Aligned_cols=204 Identities=21% Similarity=0.278 Sum_probs=163.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.+..++|++.+.||+|+||+||+|.+..++ ..+++|.+....... .....++...+....|++++.+++.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCC-----cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 456789999999999999999999998876 788999875432211 122334555667778999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+..++||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 80 -~~~~~~lv~e~~~~~~l~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~ 138 (279)
T 3fdn_A 80 -DATRVYLILEYAPLGTVYRELQKLS--------------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138 (279)
T ss_dssp -CSSEEEEEECCCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGG
T ss_pred -cCCEEEEEEecCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChH
Confidence 4578999999999999999987654 4677889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||++...... ......||+.|+|||++.+. .++.++||||
T Consensus 139 Nili~~~~-~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~s 192 (279)
T 3fdn_A 139 NLLLGSAG-ELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGR----------------------MHDEKVDLWS 192 (279)
T ss_dssp GEEECTTS-CEEECSCCEESCC-----------CCCCTTCCHHHHTTC----------------------CCCTTHHHHH
T ss_pred hEEEcCCC-CEEEEeccccccCCcc---cccccCCCCCccCHhHhccC----------------------CCCccchhHh
Confidence 99999987 9999999998654332 22456789999999976543 3455679999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|||++|..||....
T Consensus 193 lG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 193 LGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp HHHHHHHHHHSSCTTCCSS
T ss_pred HHHHHHHHHHCCCCCCCCc
Confidence 9999999999999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=292.01 Aligned_cols=200 Identities=23% Similarity=0.332 Sum_probs=156.9
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.++|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+...+|+|++.+++.+...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCC-----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 378999999999999999999998877 889999885432 222223334556666778999998887765432
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
..+++||||+ +++|.+++... .+++..+..++.|++.||+|||++||+||||||
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~---------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp 156 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKHE---------------------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 156 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHHC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred cccCceEEEEEecC-CCCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCH
Confidence 4579999999 68999998764 356788899999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++..... .....+|+.|+|||++.+. ..++.++|||
T Consensus 157 ~NIll~~~~-~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~---------------------~~~~~~~Diw 210 (367)
T 1cm8_A 157 GNLAVNEDC-ELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNW---------------------MRYTQTVDIW 210 (367)
T ss_dssp GGEEECTTC-CEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTT---------------------TCCCTTHHHH
T ss_pred HHEEEcCCC-CEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCC---------------------CCCChhhhHH
Confidence 999999987 9999999999865322 3456889999999966542 2466778999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|+||++|||++|+.||....
T Consensus 211 slG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 211 SVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=282.02 Aligned_cols=201 Identities=23% Similarity=0.290 Sum_probs=157.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||+||+|++. ++ +.+++|++......+ .....++...+....|+|++.+++.+.. ++.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN-YG-----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TS-----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSC
T ss_pred ccchhhhhcccCCCEEEEEEEcC-CC-----CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCe
Confidence 68999999999999999999983 33 788999876432211 1223345666777789999999887644 568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++ +|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 134 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVCE-------------------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTST-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred EEEEEEecCC-CHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 9999999995 8999887542 1457788899999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||+++....... ......+|+.|+|||++.+.. .++.++|||||||++
T Consensus 135 ~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwslG~il 191 (288)
T 1ob3_A 135 REG-ELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSK---------------------KYSTTIDIWSVGCIF 191 (288)
T ss_dssp TTS-CEEECCTTHHHHHCC----------CCCTTCCHHHHTTCC---------------------SCCTHHHHHHHHHHH
T ss_pred CCC-CEEEeECccccccCcccc-ccccccccccccCchheeCCC---------------------CCCcHHHHHHHHHHH
Confidence 987 999999999976543222 223457899999999765322 356788999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|+.||...
T Consensus 192 ~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 192 AEMVNGTPLFPGV 204 (288)
T ss_dssp HHHHHSSCSCCCS
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=285.31 Aligned_cols=207 Identities=21% Similarity=0.274 Sum_probs=160.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc---
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (397)
...++|++.++||+|+||+||+|++. + +.+++|.+..........+. .........|+|++.+++....
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~-----~~vavK~~~~~~~~~~~~e~-~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQ--G-----ENVAVKIFSSRDEKSWFRET-ELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEET--T-----EEEEEEEECGGGHHHHHHHH-HHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEEC--C-----EEEEEEEeccccchhhHHHH-HHHHHhhccCcCeeeEEEeeccccC
Confidence 34589999999999999999999874 2 78999988765444333332 2333333679999988775432
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH--------HCCce
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH--------STGIV 284 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH--------~~gii 284 (397)
.....++||||+.+++|.++++.. .+++..+..++.|++.||+||| +.||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~---------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 135 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT---------------------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC---------------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEE
T ss_pred CCceeEEehhhccCCCHHHHHhhc---------------------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCee
Confidence 245689999999999999999643 3577889999999999999999 99999
Q ss_pred ecCCCCCceEEeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 285 HRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 285 HrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
||||||+|||++.++ .+||+|||+|+........ ......||+.|+|||++.+.......
T Consensus 136 H~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~---------------- 198 (301)
T 3q4u_A 136 HRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF---------------- 198 (301)
T ss_dssp CSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCH----------------
T ss_pred cCCCChHhEEEcCCC-CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcc----------------
Confidence 999999999999987 9999999999765443322 12345899999999988655332110
Q ss_pred CCCCchhhHHHHHHHHHHHcC----------CCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCT----------VRRLCL 388 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg----------~~Pf~~ 388 (397)
.++.++||||||+++|||++| ..||..
T Consensus 199 ~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred cCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 234578999999999999999 777754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=299.37 Aligned_cols=218 Identities=18% Similarity=0.237 Sum_probs=168.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
...++|++.++||+|+||+||+|++..++ +.+++|.+..... .......++...+....|+|++.+++.+...+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTG-----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 45579999999999999999999998877 7899998864332 11222234455566667999999987665433
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 215 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...++||||+.+++|.+++.... ....+++..++.++.|++.||+|||++||+||||||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 143 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPS-----------------NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGG-----------------GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhh-----------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHE
Confidence 47899999999999999997653 122378888999999999999999999999999999999
Q ss_pred EE----eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 294 IF----SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 294 Ll----~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+ +.++ .+||+|||+++....... .....||+.|+|||++........ ....++.++||
T Consensus 144 ll~~~~~~~~-~~kL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~--------------~~~~~~~~~Di 206 (396)
T 4eut_A 144 MRVIGEDGQS-VYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKD--------------HQKKYGATVDL 206 (396)
T ss_dssp EEEECTTSCE-EEEECCGGGCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--C--------------HHHHHHHHHHH
T ss_pred EEeecCCCce-eEEEecCCCceEccCCCc--cccccCCccccCHHHhhccccccc--------------cccCCCcHHHH
Confidence 99 5554 899999999987654432 245679999999997754322110 01235567899
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
|||||++|||++|+.||.....+
T Consensus 207 wSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 207 WSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp HHHHHHHHHHHHSSCSEECTTCT
T ss_pred HHHHHHHHHHHHCCCCCCCCCcc
Confidence 99999999999999999765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=278.14 Aligned_cols=204 Identities=22% Similarity=0.313 Sum_probs=165.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++|++.++||+|+||.||+|.+..++ +.+++|.+.... ..+.....++...+....|++++.+++.+ ..+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 77 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEE 77 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCC-----ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-EcC
Confidence 4589999999999999999999998877 788899876433 22233334455666667899999998876 445
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 137 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVARE--------------------FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL 137 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEE
Confidence 77899999999999999887654 4677889999999999999999999999999999999
Q ss_pred EeCCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 295 FSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 295 l~~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++.++ ..+||+|||++........ .....||+.|+|||++.+ ..++.++|||||
T Consensus 138 ~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~sl 193 (284)
T 3kk8_A 138 LASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKK----------------------DPYSKPVDIWAC 193 (284)
T ss_dssp ESSSSTTCCEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTT----------------------CCBCTHHHHHHH
T ss_pred EecCCCCCcEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcC----------------------CCCCcccchHHH
Confidence 98654 2499999999976644322 245679999999996643 345667899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
|+++|||++|+.||....
T Consensus 194 G~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 194 GVILYILLVGYPPFWDED 211 (284)
T ss_dssp HHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHCCCCCCCCc
Confidence 999999999999996543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=282.76 Aligned_cols=204 Identities=18% Similarity=0.263 Sum_probs=153.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.+.||+|+||+||+|++..++ +.+++|........+ ...+.++...+ .|++++..+......++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~e~~~l~~l---~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHIESKIYKMM---QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEC---CCCHHHHHHHHHHH---TTSTTCCCEEEEEEETTE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCC-----ceEEEEeecccccchHHHHHHHHHHHh---cCCCCCCeeeeecCCCCc
Confidence 378999999999999999999988776 788888765433222 22222223333 344444444444455678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE-
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl- 295 (397)
.++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCS-------------------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 99999999 899999987542 146788899999999999999999999999999999999
Q ss_pred --eCCCCeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 296 --SEGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 296 --~~~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
++++ .+||+|||+++........ ......||+.|+|||++.+ ..++.++
T Consensus 140 ~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~ 196 (296)
T 4hgt_A 140 LGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG----------------------IEQSRRD 196 (296)
T ss_dssp CGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT----------------------CCCCHHH
T ss_pred ccCCCC-eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC----------------------CCCCchh
Confidence 5665 9999999999876544321 2335689999999996543 3456678
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
|||||||++|||++|+.||......
T Consensus 197 Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 197 DLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp HHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred HHHHHHHHHHHHhcCCCCCcccchh
Confidence 9999999999999999999875443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=283.82 Aligned_cols=204 Identities=21% Similarity=0.290 Sum_probs=159.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
.++|++.++||+|+||+||+|++..++ +.+++|++....... .....++...+....|++++.+++.+. .++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTG-----QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-RKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-cCC
Confidence 378999999999999999999998876 789999876443222 223334555666678999999988764 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~ 135 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQR--------------------GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI 135 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTSS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred eEEEEEEeCCCchHHHHHhhhc--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE
Confidence 8999999999999999876543 46788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+++........ .....||+.|+|||++.+. ..++.++||||||++
T Consensus 136 ~~~~-~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~Di~slG~i 192 (311)
T 4agu_A 136 TKHS-VIKLCDFGFARLLTGPSDY-YDDEVATRWYRSPELLVGD---------------------TQYGPPVDVWAIGCV 192 (311)
T ss_dssp CTTS-CEEECCCTTCEECC-------------GGGCCHHHHHTC---------------------SCCCTHHHHHHHHHH
T ss_pred cCCC-CEEEeeCCCchhccCcccc-cCCCcCCccccChHHHhcC---------------------CCCCcchhhHHHHHH
Confidence 9987 9999999999876533322 3456789999999976532 245678899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|..||....
T Consensus 193 l~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 193 FAELLSGVPLWPGKS 207 (311)
T ss_dssp HHHHHHSSCSCCCSS
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=281.48 Aligned_cols=206 Identities=17% Similarity=0.222 Sum_probs=156.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
....++|++.+.||+|+||+||+|++..++ +.+++|.+......+ ...+.++...+ ..|+++..++... ..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~e~~~~~~l--~~~~~i~~~~~~~-~~ 77 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNN-----QQVAIKFEPRRSDAPQLRDEYRTYKLL--AGCTGIPNVYYFG-QE 77 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTT-----EEEEEEEEECCTTSCCHHHHHHHHHHT--TTCTTCCCEEEEE-EE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCC-----cEEEEEEeccCCccHHHHHHHHHHHHH--hcCCCCCeEEeec-CC
Confidence 345589999999999999999999987776 789999876443322 22222222232 1344444444333 34
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG-------------------RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred CceeEEEEEec-CCCHHHHHHHhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 57899999999 899999998643 1367888999999999999999999999999999999
Q ss_pred EEeCCCC----eEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 294 IFSEGSR----TFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 294 Ll~~~~~----~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
|++.++. .+||+|||+++........ ......||+.|+|||++.+ ..+
T Consensus 138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~ 195 (298)
T 1csn_A 138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG----------------------REQ 195 (298)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT----------------------CCC
T ss_pred EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC----------------------CCC
Confidence 9987651 3999999999876543221 2345689999999996543 345
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
+.++||||||+++|||++|+.||....
T Consensus 196 ~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 196 SRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 667899999999999999999998743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=299.22 Aligned_cols=205 Identities=16% Similarity=0.217 Sum_probs=164.9
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..+..++|++.++||+|+||.||+|.+.+ +.+++|.++.....+. ..++...+....|+|++.+++.+...
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~vavK~~~~~~~~~~--~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETT-------EEEEEEEESSCTTSHH--HHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEecC-------CeEEEEEeCCchHHHH--HHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 45667899999999999999999998763 6799999876543332 23345556667899999999887666
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+..+++||||+.+++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 320 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGR------------------SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 320 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCT------------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 6689999999999999999987541 1356788899999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++..... .....+|+.|+|||++. ...++.++||||||
T Consensus 321 ll~~~~-~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~----------------------~~~~~~~sDvwslG 373 (450)
T 1k9a_A 321 LVSEDN-VAKVSDFGLTKEASST----QDTGKLPVKWTAPEALR----------------------EKKFSTKSDVWSFG 373 (450)
T ss_dssp EECTTS-CEEECCCTTCEECC----------CCCTTTSCHHHHH----------------------SSCCCHHHHHHHHH
T ss_pred EECCCC-CEEEeeCCCccccccc----ccCCCCCcceeCHHHhc----------------------CCCCCcHHHHHHHH
Confidence 999987 9999999999854322 22346788999999554 34566788999999
Q ss_pred HHHHHHHc-CCCCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHSCP 392 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~~~ 392 (397)
++||||++ |+.||......
T Consensus 374 ~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 374 ILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp HHHHHHHTTTCCSSTTSCTT
T ss_pred HHHHHHHhCCCCCCCCCCHH
Confidence 99999998 99999765443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.65 Aligned_cols=207 Identities=21% Similarity=0.303 Sum_probs=155.8
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--------HHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--------VEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--------~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
.++|++.+.||+|+||+||+|.+..++ +.+|+|.+..... .......++...+...+|+|++.+++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTC-----KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCC-----cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 479999999999999999999998887 7888888764321 111122344555666789999988876
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. ....++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+|||||
T Consensus 209 ~~--~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk 266 (419)
T 3i6u_A 209 FD--AEDYYIVLELMEGGELFDKVVGNK--------------------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 266 (419)
T ss_dssp EE--SSEEEEEEECCTTCBGGGGTSSSC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred Ee--cCceEEEEEcCCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 53 456899999999999988775433 56788899999999999999999999999999
Q ss_pred CCceEEeCCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 290 PQNVIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 290 p~NILl~~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|+|||++.++ ..+||+|||+|+...... ......||+.|+|||++.+.. ...++.++
T Consensus 267 p~NIll~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------------------~~~~~~~~ 325 (419)
T 3i6u_A 267 PENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVG-------------------TAGYNRAV 325 (419)
T ss_dssp GGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC-----------------------CTTHHHH
T ss_pred hHhEEEecCCCcceEEEeecccceecCCCc--cccccCCCCCccCceeeecCC-------------------CCCCCchh
Confidence 9999997543 259999999998764332 234578999999999775321 12456688
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
|||||||++|||++|..||......
T Consensus 326 DiwslG~il~~lltg~~pf~~~~~~ 350 (419)
T 3i6u_A 326 DCWSLGVILFICLSGYPPFSEHRTQ 350 (419)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred hhHhHHHHHHHHHHCCCCCCCCcch
Confidence 9999999999999999999765443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=289.29 Aligned_cols=212 Identities=16% Similarity=0.217 Sum_probs=153.1
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhcc--CCCceeeeeeccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC--CADFVYGFFENSS 211 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~--~~~~i~~~~~~~~ 211 (397)
+..++|++.+.||+|+||.||++.+.. + +.+++|++.... ........++...+... ++++++.+++.+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTT-S-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCC-C-----CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 455789999999999999999998754 3 678999876432 22222222333333333 3388888888654
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.+...++||| +.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 80 -~~~~~~lv~e-~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~ 137 (343)
T 3dbq_A 80 -TDQYIYMVME-CGNIDLNSWLKKKK--------------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 137 (343)
T ss_dssp -CSSEEEEEEC-CCSEEHHHHHHHSC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred -eCCEEEEEEe-CCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 4568999999 56689999998654 4677888999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|||+++ + .+||+|||+++........ ......||+.|+|||++.+....... ......++.++|||
T Consensus 138 NIll~~-~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-----------~~~~~~~~~~~Diw 204 (343)
T 3dbq_A 138 NFLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN-----------GKSKSKISPKSDVW 204 (343)
T ss_dssp GEEEET-T-EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC----------------------CCHHHHHH
T ss_pred eEEEEC-C-cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccc-----------cccccCCCchhhHH
Confidence 999985 4 8999999999876544322 23456899999999987653322111 01124577789999
Q ss_pred HHHHHHHHHHcCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~ 388 (397)
||||++|||++|+.||..
T Consensus 205 slG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 205 SLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp HHHHHHHHHHHSSCTTTT
T ss_pred HHHHHHHHHHhCCCcchh
Confidence 999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=285.61 Aligned_cols=203 Identities=21% Similarity=0.282 Sum_probs=163.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH------HHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTG-----LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCC-----eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 368999999999999999999998876 78888887643211 1222333445556667999999888664
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~ 144 (321)
T 2a2a_A 86 -NRTDVVLILELVSGGELFDFLAQKE--------------------SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPE 144 (321)
T ss_dssp -CSSEEEEEECCCCSCBHHHHHHTCS--------------------CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -cCCEEEEEEEcCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChH
Confidence 4578999999999999999997643 4678889999999999999999999999999999
Q ss_pred ceEEeCCCC---eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 292 NVIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 292 NILl~~~~~---~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|||++.++. .+||+|||+++....... .....||+.|+|||++.+ ..++.++|
T Consensus 145 NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------~~~~~~~D 200 (321)
T 2a2a_A 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNY----------------------EPLGLEAD 200 (321)
T ss_dssp GEEESCTTSSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTT----------------------CCCCTHHH
T ss_pred HEEEecCCCCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccC----------------------CCCCCccc
Confidence 999988753 699999999987654322 245679999999996643 34566789
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||+++|||++|..||....
T Consensus 201 i~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 201 MWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp HHHHHHHHHHHHHSCCSSCCSS
T ss_pred cHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999997643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=292.03 Aligned_cols=227 Identities=19% Similarity=0.228 Sum_probs=169.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCC--CCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (397)
++..++|+++++||+|+||+||+|++...+.. .....+++|++..... .......++...+... .|++++.+++.+
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 45668999999999999999999998654321 2235688998865432 2222333344444444 799999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ++..++||||+.+++|.+++...........+ .........+++..++.++.|++.||+|||++||+||||||
T Consensus 145 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 145 TQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSY----NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp CS-SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCC----CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cc-CCceEEEEEecCCCcHHHHHHHhccccccccc----ccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 44 56789999999999999999876421100000 00011234678999999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+|||++.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++||
T Consensus 220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----------------------~~~~~~~Di 276 (382)
T 3tt0_A 220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD----------------------RIYTHQSDV 276 (382)
T ss_dssp GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS----------------------CCCCHHHHH
T ss_pred ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC----------------------CCCCchhHH
Confidence 999999987 9999999999876543221 2334567889999996543 346678899
Q ss_pred HHHHHHHHHHHc-CCCCCCCC
Q 015991 370 YSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~ellt-g~~Pf~~~ 389 (397)
|||||++|||++ |..||...
T Consensus 277 wslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 277 WSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp HHHHHHHHHHHTTSCCSSTTC
T ss_pred HHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999 99999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.37 Aligned_cols=204 Identities=19% Similarity=0.217 Sum_probs=166.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.+.||+|+||.||++++..++ +.+++|.+.... ........++...+....|+|++.+++.+. .
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 112 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTK-----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-D 112 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 4579999999999999999999998876 778888775432 222233334455666778999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~--------------------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 172 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRK--------------------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred CCeEEEEEecCCCCCHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence 578999999999999999987653 467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 173 l~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Di~slG 228 (335)
T 2owb_A 173 FLNEDL-EVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSK----------------------KGHSFEVDVWSIG 228 (335)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHT----------------------SCBCTHHHHHHHH
T ss_pred EEcCCC-CEEEeeccCceecccCcc-cccccCCCccccCHHHhcc----------------------CCCCchhhHHHHH
Confidence 999987 999999999987643322 2345679999999996543 3456678999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
+++|||++|+.||....
T Consensus 229 ~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 229 CIMYTLLVGKPPFETSC 245 (335)
T ss_dssp HHHHHHHHSSCTTCCSS
T ss_pred HHHHHHHHCcCCCCCCC
Confidence 99999999999997643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.73 Aligned_cols=209 Identities=14% Similarity=0.201 Sum_probs=167.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.++||+|+||.||+|.+..++ ..+++|.+....... ....++...+....|+|++.+++.+.. +
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~~~~-~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 288 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTR-E 288 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGT-----EEEEEEECCSSSSCH-HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCC-----eEEEEEEecCcccch-HHHHHHHHHHHhcCCCCEeeEEEEEec-C
Confidence 455678999999999999999999998765 789999987543222 122334455566689999999887644 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
..+++||||+.+++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 350 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECN------------------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSC------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CcEEEEEEccCCCCHHHHHHhcC------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 67899999999999999998643 224677889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++..............+|+.|+|||++.+ ..++.++|||||||
T Consensus 351 l~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~sDvwSlG~ 407 (495)
T 1opk_A 351 VGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY----------------------NKFSIKSDVWAFGV 407 (495)
T ss_dssp ECGGG-CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH----------------------CEECHHHHHHHHHH
T ss_pred ECCCC-cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc----------------------CCCCcHHhHHhHHH
Confidence 99887 99999999998765443333344567789999995543 34667889999999
Q ss_pred HHHHHHc-CCCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~~ 391 (397)
+||||++ |..||.....
T Consensus 408 ~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 408 LLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp HHHHHHTTSCCSSTTCCG
T ss_pred HHHHHHhCCCCCCCCCCH
Confidence 9999999 9999976543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=287.06 Aligned_cols=226 Identities=19% Similarity=0.231 Sum_probs=171.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
.+..++|++.+.||+|+||.||+|.+..++...+.+.+++|.+..... .+.....++...+... .|+|++.+++.+..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 456689999999999999999999998887666667899998875432 2222233344444444 79999999887644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++..++||||+.+++|.+++........... .-......+++..+..++.|++.||+|||++||+||||||+|
T Consensus 122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 194 (333)
T 2i1m_A 122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDP------AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 194 (333)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -CCceEEEEecCCCCcHHHHHHHhcccccccc------cccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccce
Confidence 5678999999999999999986531000000 000012346888899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++||||
T Consensus 195 Il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~s 251 (333)
T 2i1m_A 195 VLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD----------------------CVYTVQSDVWS 251 (333)
T ss_dssp CEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH----------------------CCCCHHHHHHH
T ss_pred EEECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhcc----------------------CCCChHHHHHH
Confidence 9999987 9999999999876543322 2334567889999995543 34666789999
Q ss_pred HHHHHHHHHc-CCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~ 390 (397)
||+++|||++ |..||....
T Consensus 252 lG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 252 YGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp HHHHHHHHTTTSCCSSTTCC
T ss_pred HHHHHHHHHcCCCCCCcccc
Confidence 9999999998 999997654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=295.39 Aligned_cols=208 Identities=15% Similarity=0.226 Sum_probs=165.0
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|+|++.+++.+..
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 183 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADN-----TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ- 183 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCC-----eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-
Confidence 345679999999999999999999998766 78999988754322 22223345566677789999999987644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+++++|.++++..+ ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 244 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEG-------------------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNC 244 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHE
Confidence 467899999999999999997643 2467788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccccc-ccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|++.++ .+||+|||+++....+..... ....+|+.|+|||++.+ ..++.++|||||
T Consensus 245 l~~~~~-~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Dvwsl 301 (377)
T 3cbl_A 245 LVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY----------------------GRYSSESDVWSF 301 (377)
T ss_dssp EECTTC-CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH----------------------CEEEHHHHHHHH
T ss_pred EEcCCC-cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc----------------------CCCCchhhHHHH
Confidence 999987 999999999986543322111 22345778999996543 345667899999
Q ss_pred HHHHHHHHc-CCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~ 390 (397)
||++|||++ |..||....
T Consensus 302 G~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 302 GILLWETFSLGASPYPNLS 320 (377)
T ss_dssp HHHHHHHHTTSCCSSTTSC
T ss_pred HHHHHHHHhCCCCCCCCCC
Confidence 999999998 999997643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=298.34 Aligned_cols=204 Identities=24% Similarity=0.288 Sum_probs=158.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc----
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK---- 213 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~---- 213 (397)
..+|++.+.||+|+||+||+|++..++ +.+++|++....... .++...+....|+|++.+++.+...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~~~~~----~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDKRFK----NRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEECCTTSC----CHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCC-----cEEEEEEecccchhH----HHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 358999999999999999999998876 789999886543211 1234455566789998876655321
Q ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 -GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
...+++||||+++ +|.+++.... .....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 186 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYS----------------RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred cceeEEeehhcccc-cHHHHHHHHh----------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence 2347799999995 6766665321 012356788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++..+||+|||+|+.+..+.. .....||+.|+|||++.+.. .++.++|||||
T Consensus 187 ILl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwSl 243 (420)
T 1j1b_A 187 LLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGAT---------------------DYTSSIDVWSA 243 (420)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCS---------------------SCCTHHHHHHH
T ss_pred EEEeCCCCeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCC---------------------CCCchhhhHHH
Confidence 99997655899999999987644322 24568899999999764321 46678899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||+||||++|+.||....
T Consensus 244 G~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 244 GCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp HHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999999999998654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=278.80 Aligned_cols=209 Identities=16% Similarity=0.176 Sum_probs=160.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.+.||+|+||+||+|++...... ...+++|.+.... ........++...+....|++++.+++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 83 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGE--KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-- 83 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCC--EEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC--
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCC--cceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc--
Confidence 34568999999999999999999997654321 1458889887542 222223334445555567999999988754
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 144 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLERNK-------------------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNI 144 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHT-------------------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred CCCCEEEEecCCCCCHHHHHHhcc-------------------ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence 345789999999999999997653 1357788899999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++..............+|+.|+|||++.+ ..++.++||||||
T Consensus 145 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG 201 (281)
T 3cc6_A 145 LVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF----------------------RRFTTASDVWMFA 201 (281)
T ss_dssp EEEETT-EEEECCCCGGGCC---------CCCCCGGGCCHHHHHH----------------------CCCCHHHHHHHHH
T ss_pred EECCCC-cEEeCccCCCcccccccccccccCCCCcceeCchhhcc----------------------CCCCchhccHHHH
Confidence 999987 99999999998765544333445567889999996543 3456678999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
+++|||++ |+.||...
T Consensus 202 ~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 202 VCMWEILSFGKQPFFWL 218 (281)
T ss_dssp HHHHHHHTTTCCTTTTS
T ss_pred HHHHHHHhCCCCCcccC
Confidence 99999998 99999654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=287.73 Aligned_cols=206 Identities=23% Similarity=0.278 Sum_probs=157.8
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
...++|++.++||+|+||+||+|++..++ +.+++|.+......+ .....++...+....|+|++.+++.+. .
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 104 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTN-----ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-H 104 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-E
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCC-----ceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-c
Confidence 35589999999999999999999988877 889999886443222 222334566677778999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+++ +|.+++.... .+++..++.++.|++.||+|||++||+||||||+||
T Consensus 105 ~~~~~lv~e~~~~-~L~~~~~~~~--------------------~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 105 NHRLHLIFEYAEN-DLKKYMDKNP--------------------DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCEEEEEEecCCC-CHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 5789999999994 9999987654 467888999999999999999999999999999999
Q ss_pred EEeCCC----CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 294 IFSEGS----RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 294 Ll~~~~----~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|++.++ ..+||+|||+++....... ......||+.|+|||++.+.. .++.++||
T Consensus 164 ll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Di 221 (329)
T 3gbz_A 164 LLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSR---------------------HYSTSVDI 221 (329)
T ss_dssp EEEC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCC---------------------CCCTHHHH
T ss_pred EEecCCCCccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCC---------------------CCCcHHHH
Confidence 995332 2699999999987643322 234467899999999765422 35678899
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||++|||++|+.||....
T Consensus 222 wslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 222 WSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHCCCCcCCCC
Confidence 999999999999999997643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=282.28 Aligned_cols=230 Identities=18% Similarity=0.212 Sum_probs=168.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
++..++|++.+.||+|+||.||+|++.........+.+++|.+..... .+.....++...+... .|++++.+++.+..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 456689999999999999999999975433233337899998875432 2222233344444444 79999999887644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++..++||||+.+++|.+++................ .......+++..+..++.|++.||.|||++||+||||||+|
T Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 99 -GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI--MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTC----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccccccccccccc--cccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 567899999999999999998764211100000000 00112357889999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++||||
T Consensus 176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~Di~s 232 (313)
T 1t46_A 176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF----------------------NCVYTFESDVWS 232 (313)
T ss_dssp EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH----------------------HCCCCHHHHHHH
T ss_pred EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhc----------------------CCCCChHHHHHH
Confidence 9999987 9999999999876544332 233456788999999554 345667889999
Q ss_pred HHHHHHHHHc-CCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~ 390 (397)
||+++|||++ |..||....
T Consensus 233 lG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 233 YGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp HHHHHHHHHTTTCCSSTTCC
T ss_pred HHHHHHHHHhCCCCCCCccc
Confidence 9999999999 999997654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=293.00 Aligned_cols=212 Identities=14% Similarity=0.171 Sum_probs=154.5
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
...+..++|++.+.||+|+||.||+|++...... ...+++|.+.... ........++...+....|+|++.+++.+.
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKK--EISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSC--BCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCC--ceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3455668999999999999999999987633211 1679999887532 222333445566677778999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+
T Consensus 117 -~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 176 (373)
T 2qol_A 117 -KSKPVMIVTEYMENGSLDSFLRKHD-------------------AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAAR 176 (373)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHTTT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -eCCceEEEEeCCCCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence 4567899999999999999997643 24677888999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|||++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++||
T Consensus 177 NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~Dv 233 (373)
T 2qol_A 177 NILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA----------------------YRKFTSASDV 233 (373)
T ss_dssp GEEECTTC-CEEECCC----------------------CTTSCHHHHH----------------------HCCCCHHHHH
T ss_pred eEEEcCCC-CEEECcCccccccccCCccceeccCCCcCCCccChhhhc----------------------cCCcCchhcH
Confidence 99999987 9999999999876543221 122234578899999554 3456678899
Q ss_pred HHHHHHHHHHHc-CCCCCCCC
Q 015991 370 YSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~ellt-g~~Pf~~~ 389 (397)
||||+++|||++ |+.||...
T Consensus 234 ~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 234 WSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp HHHHHHHHHHHTTC-CTTTTC
T ss_pred HHHHHHHHHHHhCCCCCCCCC
Confidence 999999999997 99999654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=280.32 Aligned_cols=203 Identities=18% Similarity=0.268 Sum_probs=156.0
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.+.||+|+||.||+|++..++ +.+++|.+...... +...+.++...+ .|++++..+......+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~e~~~l~~l---~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLHIESKIYKMM---QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEEESCSSCCHHHHHHHHHHHH---TTSTTCCCEEEEEEETTE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCC-----cEEEEEEecCCcchhHHHHHHHHHHHh---hcCCCCCccccccCCCCc
Confidence 479999999999999999999987776 78999987644332 222222233333 333333333444455678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCS-------------------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred eEEEEEec-CCCHHHHHHhhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 89999999 799999997532 1467888999999999999999999999999999999995
Q ss_pred ---CCCCeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 297 ---EGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 297 ---~~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
+++ .+||+|||+++........ ......||+.|+|||++.+ ..++.++
T Consensus 140 ~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~ 196 (296)
T 3uzp_A 140 LGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG----------------------IEQSRRD 196 (296)
T ss_dssp CGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT----------------------CCCCHHH
T ss_pred cCCCCC-eEEEeeCCCcccccccccccccccccccccccccccCChhhhcC----------------------CCCCcch
Confidence 555 9999999999876544321 1245689999999996544 3456678
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
||||||+++|||++|+.||.....
T Consensus 197 Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 197 DLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp HHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred hhHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999986443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=287.13 Aligned_cols=219 Identities=17% Similarity=0.202 Sum_probs=152.5
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
..+..++|++.+.||+|+||+||+|++..++... ..+++|.+... .........++...+....|++++.+++.+.
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSF--VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcc--eeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3456689999999999999999999987765221 37889988643 2223333445566667778999999888665
Q ss_pred ccCC-----eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 212 KKGG-----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 212 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
..+. ..++||||+.+++|.+++...... .....+++..+..++.|++.||+|||++||+||
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~ 161 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG--------------ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR 161 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhcc--------------ccccccCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 4332 248999999999999999765311 112246788899999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (397)
||||+|||+++++ .+||+|||+++......... .....+|+.|+|||++.+ ..++.
T Consensus 162 Dikp~NIli~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~ 218 (323)
T 3qup_A 162 DLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD----------------------NLYTV 218 (323)
T ss_dssp CCSGGGEEECTTS-CEEECCCCC-----------------CCGGGCCHHHHHH----------------------CCCCH
T ss_pred CCCcceEEEcCCC-CEEEeeccccccccccccccccccccCcccccCchhhcC----------------------CCCCC
Confidence 9999999999987 99999999998764433221 234567889999995543 44667
Q ss_pred chhhHHHHHHHHHHHc-CCCCCCCCCC
Q 015991 366 RFDIYSAGLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 366 k~Dv~SlGv~l~ellt-g~~Pf~~~~~ 391 (397)
++||||||+++|||++ |..||.....
T Consensus 219 ~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 219 HSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ccchhhHHHHHHHHHhCCCCCccccCh
Confidence 8899999999999999 9999976543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=277.68 Aligned_cols=204 Identities=19% Similarity=0.221 Sum_probs=165.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|.+.... ........++...+....|+|++.+++.+. .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTK-----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-D 86 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-C
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCC-----ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-c
Confidence 4579999999999999999999998876 778888775432 222223334455666778999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni 146 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRK--------------------ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 578999999999999999887653 467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++....... ......||+.|+|||++.+. .++.++||||||
T Consensus 147 l~~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG 202 (294)
T 2rku_A 147 FLNEDL-EVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKK----------------------GHSFEVDVWSIG 202 (294)
T ss_dssp EECTTC-CEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTS----------------------CBCTHHHHHHHH
T ss_pred EEcCCC-CEEEEeccCceecccCcc-ccccccCCCCcCCcchhccC----------------------CCCchhhHHHHH
Confidence 999987 999999999987543322 23456799999999966433 355678999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
+++|||++|+.||....
T Consensus 203 ~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 203 CIMYTLLVGKPPFETSC 219 (294)
T ss_dssp HHHHHHHHSSCTTCCSS
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=295.41 Aligned_cols=203 Identities=21% Similarity=0.276 Sum_probs=161.3
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHh---hccCCCceeeeeeccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRAC---ANCCADFVYGFFENSS 211 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~---~~~~~~~i~~~~~~~~ 211 (397)
..++|++.++||+|+||+||+|.+..++ +.+|+|.+....... ...+.++...+ ...+|++++.+++.+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~-----~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVH-----QHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCC-----cEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 4478999999999999999999998876 889999887543322 22222233333 3347889999888664
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
. .+.+++||||++ ++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 170 ~-~~~~~lv~e~~~-~~L~~~l~~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~ 229 (429)
T 3kvw_A 170 F-RNHICMTFELLS-MNLYELIKKNKF------------------QGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229 (429)
T ss_dssp E-TTEEEEEECCCC-CBHHHHHHHTTT------------------CCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGG
T ss_pred c-CCeEEEEEeccC-CCHHHHHHhccC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 4 578999999997 689999877541 23678889999999999999999999999999999
Q ss_pred ceEEeCCCC-eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 292 NVIFSEGSR-TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 292 NILl~~~~~-~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|||++.++. .+||+|||+|+..... .....||+.|+|||++. ...++.++|||
T Consensus 230 NILl~~~~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~----------------------~~~~~~~~Diw 283 (429)
T 3kvw_A 230 NILLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVIL----------------------GARYGMPIDMW 283 (429)
T ss_dssp GEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHH----------------------TBCCCTHHHHH
T ss_pred HeEEccCCCcceEEeecccceecCCc----ccccCCCCCccChHHHh----------------------CCCCCchHHHH
Confidence 999998862 2999999999764322 34568999999999554 34566788999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+||||++|..||....
T Consensus 284 SlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 284 SLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred hHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=285.34 Aligned_cols=210 Identities=19% Similarity=0.197 Sum_probs=156.7
Q ss_pred cCCeEEe-eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhc-cCCCceeeeeecccccCC
Q 015991 138 KDDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSKKGG 215 (397)
Q Consensus 138 ~~~f~i~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~~~ 215 (397)
.++|++. +.||+|+||+||+|++..++ +.+++|.+............++...+.. ..|+|++.+++.+. .++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-~~~ 84 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITS-----QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-EED 84 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSC-----CEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETT
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCC-----cEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-eCC
Confidence 4789995 78999999999999988776 7899998865432212222223333333 57999999888764 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 144 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRR--------------------HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred EEEEEEEcCCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE
Confidence 8999999999999999997653 45778899999999999999999999999999999999
Q ss_pred eCCCC--eEEEEecccccccccccc------cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 296 SEGSR--TFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 296 ~~~~~--~~kL~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
+.++. .+||+|||+++....... .......||+.|+|||++..... ....++.++
T Consensus 145 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----------------~~~~~~~~~ 207 (316)
T 2ac3_A 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE-----------------EASIYDKRC 207 (316)
T ss_dssp SCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH-----------------HHHHHTTTH
T ss_pred ccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc-----------------cccCCCccc
Confidence 87652 399999999976543211 11224569999999997653210 012356678
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||||++|||++|+.||....
T Consensus 208 DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 208 DLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccHhHHHHHHHHHHCCCCCcccc
Confidence 99999999999999999997654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=281.12 Aligned_cols=210 Identities=21% Similarity=0.277 Sum_probs=155.8
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+..++|++.++||+|+||+||+|++..++ +.+++|++.... ..+.....++........|++++.+++.+. .
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-~ 77 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSG-----QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-R 77 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCC-----eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-c
Confidence 45689999999999999999999998776 889999886542 222233334444567778999999988765 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCCCc
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQN 292 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~N 292 (397)
++..++||||++ ++|.+++.... ..+..+++..++.++.|++.||+|||++ ||+||||||+|
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~N 140 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVI----------------DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGG
T ss_pred cCCEEEEEehhc-cchHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence 567999999998 48888776531 1233578899999999999999999998 99999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||+++....... .....||+.|+|||++... .....++.++|||||
T Consensus 141 il~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~------------------~~~~~~~~~~Di~sl 199 (290)
T 3fme_A 141 VLINALG-QVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPE------------------LNQKGYSVKSDIWSL 199 (290)
T ss_dssp CEECTTC-CEEBCCC-----------------CCCCCCSCHHHHSCC------------------TTC--CCHHHHHHHH
T ss_pred EEECCCC-CEEEeecCCccccccccc--ccccCCCccccChhhcChh------------------hcCcCCCcHHHHHHH
Confidence 9999987 999999999986644322 2345799999999976322 122346678999999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~ 389 (397)
|+++|||++|+.||...
T Consensus 200 G~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 200 GITMIELAILRFPYDSW 216 (290)
T ss_dssp HHHHHHHHHTSCSSCCC
T ss_pred HHHHHHHHHCCCCcccc
Confidence 99999999999999753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.92 Aligned_cols=205 Identities=21% Similarity=0.223 Sum_probs=156.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRE-----RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCC-----eEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 34589999999999999999999988776 78999988654221 12333445666777789999998886644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++..++|+||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|
T Consensus 106 -~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 164 (309)
T 2h34_A 106 -DGQLYVDMRLINGVDLAAMLRRQG--------------------PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPEN 164 (309)
T ss_dssp -TTEEEEEEECCCCEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -CCeEEEEEEecCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHH
Confidence 578999999999999999998653 46778899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||++...............||+.|+|||++.+. .++.++|||||
T Consensus 165 Il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~sl 221 (309)
T 2h34_A 165 ILVSADD-FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES----------------------HATYRADIYAL 221 (309)
T ss_dssp EEECTTS-CEEECSCCC----------------CCGGGCCGGGTCC--------------------------CCCHHHHH
T ss_pred EEEcCCC-CEEEecCccCccccccccccccccCCCcCccCHHHHcCC----------------------CCCchHhHHHH
Confidence 9999987 999999999977654433333456799999999976543 34556799999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~ 389 (397)
|+++|||++|+.||...
T Consensus 222 G~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 222 TCVLYECLTGSPPYQGD 238 (309)
T ss_dssp HHHHHHHHHSSCSSCSC
T ss_pred HHHHHHHHHCCCCCCCc
Confidence 99999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=281.64 Aligned_cols=210 Identities=15% Similarity=0.201 Sum_probs=169.5
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..+..++|++.++||+|+||+||+|.+..++ ..+++|.+........ ...++...+....|++++.+++.+. .
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~~-~ 80 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT-R 80 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGT-----EEEEEEEECSCSTHHH-HHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCC-----EEEEEEecCcCHHHHH-HHHHHHHHHHhCCCCCEeeEEEEEc-c
Confidence 3456789999999999999999999998876 7899998875443322 2233455556667999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+.+++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 142 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECN------------------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 142 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCC------------------TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGE
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcc------------------cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceE
Confidence 567899999999999999997643 22467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++.++ .+||+|||+++..............+|+.|+|||++.+ ..++.++||||||
T Consensus 143 l~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG 199 (288)
T 3kfa_A 143 LVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY----------------------NKFSIKSDVWAFG 199 (288)
T ss_dssp EECGGG-CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH----------------------CCCCHHHHHHHHH
T ss_pred EEcCCC-CEEEccCccceeccCCccccccCCccccCcCChhhhcc----------------------CCCCchhhHHHHH
Confidence 999887 99999999998765444333445567889999995543 3456678999999
Q ss_pred HHHHHHHc-CCCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~~ 391 (397)
+++|||++ |..||.....
T Consensus 200 ~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 200 VLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp HHHHHHHTTSCCSSTTCCG
T ss_pred HHHHHHHhCCCCCCCCCCH
Confidence 99999999 9999976543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=281.56 Aligned_cols=200 Identities=22% Similarity=0.286 Sum_probs=159.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc-CC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK-GG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~ 215 (397)
..++|++.++||+|+||+||+|++..++ +.+++|.+..........+.++...+ ..|++++.+++.+... ..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~E~~~l~~l--~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILENL--RGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECSCCHHHHHHHHHHHHHH--TTSTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCC-----cEEEEEEecccchHHHHHHHHHHHHc--CCCCCEEEeeeeeccCCCC
Confidence 4579999999999999999999988876 88999988755444333322222222 2488888887766542 46
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+.+++|.++++. +++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~-----------------------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~ 163 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT-----------------------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG-----------------------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ceEEEEeccCchhHHHHHHh-----------------------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 78999999999999988743 4567788999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++..+||+|||+++....... .....+|+.|+|||++.+. ..++.++|||||||+
T Consensus 164 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~DiwslG~i 220 (330)
T 3nsz_A 164 DHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDY---------------------QMYDYSLDMWSLGCM 220 (330)
T ss_dssp ETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTC---------------------CCCCTHHHHHHHHHH
T ss_pred cCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcCC---------------------CcCCchhhHHHHHHH
Confidence 97766899999999986654332 3456789999999976432 235678899999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|+.||...
T Consensus 221 l~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 221 LASMIFRKEPFFHG 234 (330)
T ss_dssp HHHHHHTCSSSSCC
T ss_pred HHHHHhCCCCcccC
Confidence 99999999999543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=289.37 Aligned_cols=206 Identities=20% Similarity=0.277 Sum_probs=167.2
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
...+..++|++.++||+|+||+||+|++..++ +.+++|.+.... ........++...+....|++++.+++.+.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSG-----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCC-----cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 34566789999999999999999999998776 788888876542 222233445566677788999999988664
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKP 290 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp 290 (397)
.++..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+. ||+||||||
T Consensus 102 -~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp 160 (360)
T 3eqc_A 102 -SDGEISICMEHMDGGSLDQVLKKAG--------------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 160 (360)
T ss_dssp -ETTEEEEEECCCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSG
T ss_pred -ECCEEEEEEECCCCCCHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccH
Confidence 4578999999999999999997654 467788999999999999999996 999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++..... ......||+.|+|||++.+ ..++.++|||
T Consensus 161 ~Nil~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Di~ 214 (360)
T 3eqc_A 161 SNILVNSRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG----------------------THYSVQSDIW 214 (360)
T ss_dssp GGEEECTTC-CEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTT----------------------CCCSHHHHHH
T ss_pred HHEEECCCC-CEEEEECCCCcccccc---cccCCCCCCCeECHHHHcC----------------------CCCCchhhHH
Confidence 999999987 9999999999765332 2345689999999996643 3456678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+++|||++|+.||....
T Consensus 215 slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 215 SMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HHHHHHHHHHHTSCCSSCCC
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=280.38 Aligned_cols=206 Identities=14% Similarity=0.136 Sum_probs=162.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCC--CCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSK--NDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~--~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
++..++|++.+.||+|+||+||+|++..++... ....+++|.+............++...+....|+|++.+++.+..
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 456789999999999999999999988765211 113588888765443333344455666677789999999887654
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 143 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKKNK-------------------NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKN 143 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHHTG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred -CCCCEEEEECCCCCCHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcce
Confidence 567899999999999999998653 136778899999999999999999999999999999
Q ss_pred eEEeCCCCe--------EEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 293 VIFSEGSRT--------FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 293 ILl~~~~~~--------~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
||++.++ . +||+|||++...... ....+|+.|+|||++.+. ..++
T Consensus 144 Ill~~~~-~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~---------------------~~~~ 196 (289)
T 4fvq_A 144 ILLIREE-DRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENP---------------------KNLN 196 (289)
T ss_dssp EEEEECC-BGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCG---------------------GGCC
T ss_pred EEEecCC-cccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCC---------------------CCCC
Confidence 9999876 5 999999999765322 234678999999976542 2356
Q ss_pred CchhhHHHHHHHHHHHcCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~ 387 (397)
.++||||||+++|||++|..|+.
T Consensus 197 ~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 197 LATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTT
T ss_pred chhHHHHHHHHHHHHHcCCCCCc
Confidence 67899999999999999655443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=287.16 Aligned_cols=226 Identities=20% Similarity=0.245 Sum_probs=163.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
++|++.+.||+|+||+||+|++..++ +.+++|.+.... ..+.....++...+...+|+|++.+++.+. .
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~ 99 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTR-----AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-D 99 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred hheeecceeeecCCeEEEEEEECCCC-----ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-c
Confidence 68999999999999999999998876 788899875432 122233344555666667999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCc---c---------------hhhhhccccccC--CCcchhcHHHHHHHHHHHHH
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPY---N---------------VQTLILGEVQDL--PKGIERENRIIQTIMSQLLF 273 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~---------------~~~~~~~~~~~~--~~~~~l~~~~i~~i~~qi~~ 273 (397)
++..++||||+.+++|.+++....... . ......+.+... .....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 578999999999999999986321000 0 000000000000 11335578889999999999
Q ss_pred HHHHhHHCCceecCCCCCceEEeCCCC-eEEEEeccccccccccc---ccccccccCCCCCCCcccccccCCCCCCCCcc
Q 015991 274 ALDGLHSTGIVHRDIKPQNVIFSEGSR-TFKIIDLGAAADLRVGI---NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 349 (397)
Q Consensus 274 ~L~yLH~~giiHrDIKp~NILl~~~~~-~~kL~DFGla~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~ 349 (397)
||+|||++||+||||||+|||++.++. .+||+|||+++.+.... ........||+.|+|||++.+..
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------- 250 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN--------- 250 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS---------
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC---------
Confidence 999999999999999999999986542 79999999998654322 12234568999999999775321
Q ss_pred ccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 350 VATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 350 ~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++||||||+++|||++|+.||....
T Consensus 251 -----------~~~~~~~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 251 -----------ESYGPKCDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp -----------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 246678999999999999999999996543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=287.63 Aligned_cols=204 Identities=21% Similarity=0.277 Sum_probs=163.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccC---
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (397)
++|++.++||+|+||.||+|++..++ +.+++|++...... ......++...+....|+|++.+++.+....
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCC-----eEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 68999999999999999999988776 78999988743322 2233344556666678999998877654332
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 215 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...++||||++ ++|.+++... .+++..++.++.|++.||+|||++||+||||||+||
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~---------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 159 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQ---------------------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cceEEEEEcccC-cCHHHHHHhC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhE
Confidence 57899999999 5899988754 357788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|++.++ .+||+|||+++......... .....||+.|+|||++.... .++.++||||
T Consensus 160 l~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Diws 217 (364)
T 3qyz_A 160 LLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK---------------------GYTKSIDIWS 217 (364)
T ss_dssp EECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC---------------------SCSTHHHHHH
T ss_pred EECCCC-CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC---------------------CCCcchhHHH
Confidence 999987 99999999998765433221 24568999999999654322 3567889999
Q ss_pred HHHHHHHHHcCCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~~ 391 (397)
|||++|||++|+.||.....
T Consensus 218 lG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 218 VGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp HHHHHHHHHHSSCSSCCSSG
T ss_pred HHHHHHHHHHCCCCCCCCCh
Confidence 99999999999999977643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=277.70 Aligned_cols=205 Identities=20% Similarity=0.267 Sum_probs=165.8
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
..+..++|++.+.||+|+||.||+|++..++ +.+++|.+....... .....++...+....|++++.+++.+
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNK-----FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCC-----cEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 3566789999999999999999999998776 788999876432111 12233445556667899999988876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. .++..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||
T Consensus 84 ~-~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 142 (284)
T 2vgo_A 84 H-DRKRIYLMLEFAPRGELYKELQKHG--------------------RFDEQRSATFMEELADALHYCHERKVIHRDIKP 142 (284)
T ss_dssp E-CSSEEEEEECCCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred E-cCCEEEEEEEeCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCH
Confidence 4 4578999999999999999997654 467788999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||+++.++ .+||+|||++...... ......||+.|+|||++.+. .++.++|||
T Consensus 143 ~Nil~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~ 196 (284)
T 2vgo_A 143 ENLLMGYKG-ELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMIEGK----------------------THDEKVDLW 196 (284)
T ss_dssp GGEEECTTC-CEEECCCTTCEECSSS---CBCCCCSCGGGCCHHHHTTC----------------------CBCTTHHHH
T ss_pred HHEEEcCCC-CEEEecccccccCccc---ccccccCCCCcCCHHHhccC----------------------CCCcccchh
Confidence 999999887 9999999999765332 23456799999999966543 355678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+++|||++|..||....
T Consensus 197 slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 197 CAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp HHHHHHHHHHHSSCTTCCSS
T ss_pred hHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999997543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.43 Aligned_cols=206 Identities=19% Similarity=0.318 Sum_probs=163.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch------hHH--HHHHHHHHHHhhcc-CCCceeeeeec
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVE--IWMNERVRRACANC-CADFVYGFFEN 209 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~e--~~~~~~~~~~~~~~-~~~~i~~~~~~ 209 (397)
++|++.+.||+|+||.||+|++..++ +.+++|.+.... ..+ .....++...+... .|++++.+++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATG-----HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCC-----cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 68999999999999999999998776 789999775322 111 11122233334443 68999988876
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. .....++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.||+|||||
T Consensus 169 ~~-~~~~~~lv~e~~~g~~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlk 227 (365)
T 2y7j_A 169 YE-SSSFMFLVFDLMRKGELFDYLTEKV--------------------ALSEKETRSIMRSLLEAVSFLHANNIVHRDLK 227 (365)
T ss_dssp EE-BSSEEEEEECCCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred Ee-eCCEEEEEEEeCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 53 4578999999999999999997643 46788899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||+++++ .+||+|||++..+..... .....||+.|+|||++.+...... ..++.++||
T Consensus 228 p~NIl~~~~~-~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~----------------~~~~~~~Di 288 (365)
T 2y7j_A 228 PENILLDDNM-QIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETH----------------PGYGKEVDL 288 (365)
T ss_dssp GGGEEECTTC-CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTS----------------CCBCTTHHH
T ss_pred HHHEEECCCC-CEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccC----------------cCCCchhhH
Confidence 9999999987 999999999987654332 345789999999998765433221 246778999
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~ 389 (397)
|||||++|||++|..||...
T Consensus 289 ~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 289 WACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp HHHHHHHHHHHHSSCSSCCS
T ss_pred HhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=288.68 Aligned_cols=208 Identities=18% Similarity=0.197 Sum_probs=154.6
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHH--------HHHHHHHhhccCCCcee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWM--------NERVRRACANCCADFVY 204 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~--------~~~~~~~~~~~~~~~i~ 204 (397)
...++|++.+.||+|+||.||+|++..++.. ...+++|........ +... ..++........|++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEK--DARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGG--GCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCc--cceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 3457999999999999999999998763222 167888887644221 1111 11223345566899998
Q ss_pred eeeeccccc---CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC
Q 015991 205 GFFENSSKK---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281 (397)
Q Consensus 205 ~~~~~~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~ 281 (397)
.+++.+... +...++||||+ +++|.+++.... .+++..++.++.|++.||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~ 170 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--------------------TFKKSTVLQLGIRMLDVLEYIHEN 170 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--------------------BCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 888766542 57899999999 899999987643 567888999999999999999999
Q ss_pred CceecCCCCCceEEeCCC-CeEEEEecccccccccccccc------cccccCCCCCCCcccccccCCCCCCCCccccccc
Q 015991 282 GIVHRDIKPQNVIFSEGS-RTFKIIDLGAAADLRVGINYI------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~-~~~kL~DFGla~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~ 354 (397)
||+||||||+|||++.++ ..+||+|||+++.+....... .....||+.|+|||++.+
T Consensus 171 ~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------------- 234 (345)
T 2v62_A 171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG---------------- 234 (345)
T ss_dssp TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT----------------
T ss_pred CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC----------------
Confidence 999999999999998753 389999999998765432211 144689999999996543
Q ss_pred hhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCC
Q 015991 355 SPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 355 ~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
..++.++|||||||++|||++|+.||..
T Consensus 235 ------~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 235 ------VALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp ------CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred ------CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 3466788999999999999999999965
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=292.19 Aligned_cols=205 Identities=24% Similarity=0.314 Sum_probs=160.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc---
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (397)
..++|++.++||+|+||+||+|++..++ +.+|+|++....... .++...+....|+|++.+++.+...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~~~~~~~~~----~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESG-----KRFALKKVLQDPRYK----NRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTC-----CEEEEEEEECCTTSC----CHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCC-----CEEEEEEEecCcchH----HHHHHHHHHcCCCCccchhheeeecCcc
Confidence 4579999999999999999999998877 889999886543221 1244555666899999887765332
Q ss_pred ----------------------------------CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchh
Q 015991 214 ----------------------------------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER 259 (397)
Q Consensus 214 ----------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (397)
+..+++||||++ ++|.+.+.... ..+..+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~~~~~l 138 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI----------------RSGRSI 138 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHH----------------HTTCCC
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH----------------hcCCCC
Confidence 345889999999 58888776531 123357
Q ss_pred cHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCccccccc
Q 015991 260 ENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMS 339 (397)
Q Consensus 260 ~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 339 (397)
++..++.++.|++.||+|||++||+||||||+|||++.+...+||+|||+|+.+..... .....+|+.|+|||++.+.
T Consensus 139 ~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~ 216 (383)
T 3eb0_A 139 PMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGA 216 (383)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTC
T ss_pred CHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCC
Confidence 88889999999999999999999999999999999985334999999999987644332 3456789999999976543
Q ss_pred CCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 340 TQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
. .++.++||||+||++|||++|+.||....
T Consensus 217 ~---------------------~~~~~~DiwslG~il~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 217 T---------------------EYTPSIDLWSIGCVFGELILGKPLFSGET 246 (383)
T ss_dssp S---------------------SCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C---------------------CCCcchhhhhHHHHHHHHHhCCCCCCCCC
Confidence 2 35678899999999999999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=288.57 Aligned_cols=200 Identities=22% Similarity=0.310 Sum_probs=151.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.++|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+....|+|++.+++.+...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCC-----ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 479999999999999999999988776 789999886432 222223334455666678999999888765433
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~~----------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 155 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 155 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHHS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cccccceEEEEEcCCC-CHHHHHhh----------------------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCH
Confidence 378999999985 78877753 246778889999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||
T Consensus 156 ~NIl~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diw 210 (371)
T 2xrw_A 156 SNIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG----------------------MGYKENVDIW 210 (371)
T ss_dssp GGEEECTTS-CEEECCCCC------------------CTTCCHHHHTT----------------------CCCCTTHHHH
T ss_pred HHEEEcCCC-CEEEEEeeccccccccc--ccCCceecCCccCHHHhcC----------------------CCCCchHhHH
Confidence 999999987 99999999998654322 2345689999999996643 3466678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 211 slG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 211 SVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=292.36 Aligned_cols=212 Identities=16% Similarity=0.215 Sum_probs=153.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhcc--CCCceeeeeecccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC--CADFVYGFFENSSK 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~--~~~~i~~~~~~~~~ 212 (397)
..++|++.+.||+|+||+||+|.+.. + +.+++|.+.... ........++...+... +|++++.+++....
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~-----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-C-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-C-----CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 34679999999999999999998765 3 788999875432 22222222333333332 36899998876544
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++.+++||| +.+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 128 -~~~~~lv~E-~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~N 185 (390)
T 2zmd_A 128 -DQYIYMVME-CGNIDLNSWLKKKK--------------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 185 (390)
T ss_dssp -SSEEEEEEE-CCSEEHHHHHHHCS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGG
T ss_pred -CCEEEEEEe-cCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 567999999 67789999998654 45677788999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||+++ + .+||+|||+++.+...... ......||+.|+|||++.+....... ......++.++||||
T Consensus 186 Ill~~-~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-----------~~~~~~~~~~~DiwS 252 (390)
T 2zmd_A 186 FLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN-----------GKSKSKISPKSDVWS 252 (390)
T ss_dssp EEESS-S-CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC-----------------------CCHHHHHHH
T ss_pred EEEEC-C-eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccc-----------cccccCCCChhhHHH
Confidence 99965 4 8999999999876544322 23456899999999987653222110 011135778899999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~ 389 (397)
|||+||||++|+.||...
T Consensus 253 lGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 253 LGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp HHHHHHHHHHSSCTTTTC
T ss_pred HHHHHHHHHHCCCcchhh
Confidence 999999999999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=280.77 Aligned_cols=199 Identities=20% Similarity=0.284 Sum_probs=154.5
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|++.+.||+|+||+||+|++.+ +.+++|++......+. ..++...+....|+|++.+++.+. +
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~--~~~E~~~l~~l~hp~iv~~~~~~~---~ 72 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL---N 72 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETT-------EEEEEEECSSTTHHHH--HHHHHHHHHHCCCTTBCCEEEBCT---T
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECC-------eeEEEEEecChhHHHH--HHHHHHHHhcCCCCCcCeEEEEEc---C
Confidence 455799999999999999999998753 6799999875443332 233455566668999999988764 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH---CCceecCCCCCc
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS---TGIVHRDIKPQN 292 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~---~giiHrDIKp~N 292 (397)
..++||||+.+++|.+++.... ....+++..+..++.|+++||+|||+ +||+||||||+|
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N 135 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAE-----------------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSS-----------------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred CcEEEEEcCCCCCHHHHHhccC-----------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence 4799999999999999998653 12245677888999999999999999 899999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++..+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 136 Ill~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Di~sl 189 (307)
T 2eva_A 136 LLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEG----------------------SNYSEKCDVFSW 189 (307)
T ss_dssp EEEETTTTEEEECCCCC----------------CCTTSSCHHHHTC----------------------CCCCTHHHHHHH
T ss_pred EEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhhhCC----------------------CCCCcHHHHHHH
Confidence 999988745899999999765332 234568999999996643 345678899999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~ 389 (397)
|+++|||++|+.||...
T Consensus 190 G~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 190 GIILWEVITRRKPFDEI 206 (307)
T ss_dssp HHHHHHHHHTCCTTTTT
T ss_pred HHHHHHHHHCCCCchhh
Confidence 99999999999999754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=285.33 Aligned_cols=211 Identities=18% Similarity=0.152 Sum_probs=157.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.++||+|+||+||+|++..++..++ ..+++|.+.... ........++...+....|++++.+++.+..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~-~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCC-EEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEE-EEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-
Confidence 4566899999999999999999999887764443 245777664322 1122223344556667789999999887654
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...+++++|+.+++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 89 -~~~~~v~~~~~~g~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 148 (327)
T 3lzb_A 89 -STVQLITQLMPFGCLLDYVREHK-------------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNV 148 (327)
T ss_dssp -SSEEEEECCCSSCBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred -CCceEEEEecCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHE
Confidence 34889999999999999997643 1467788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++|||||
T Consensus 149 l~~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~~Di~sl 205 (327)
T 3lzb_A 149 LVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL----------------------HRIYTHQSDVWSY 205 (327)
T ss_dssp EEEETT-EEEECCTTC----------------CCCGGGSCHHHHH----------------------HCCCCHHHHHHHH
T ss_pred EEcCCC-CEEEccCcceeEccCccccccccCCCccccccCHHHHc----------------------CCCCChHHHHHHH
Confidence 999987 9999999999876443222 223456788999999654 3456678899999
Q ss_pred HHHHHHHHc-CCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~ 390 (397)
|+++|||++ |..||....
T Consensus 206 G~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 206 GVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp HHHHHHHHTTSCCTTTTCC
T ss_pred HHHHHHHHHCCCCCCCCCC
Confidence 999999999 999997643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=275.57 Aligned_cols=206 Identities=19% Similarity=0.290 Sum_probs=149.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|.+......+ .....++...+....|++++.+++.+. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 82 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTG-----LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-D 82 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-C
T ss_pred ccccceeeeeecCCCceEEEEEEEccCC-----ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-c
Confidence 4578999999999999999999987776 789999886443221 123334455666778999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 143 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRV-------------------KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCS-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGE
T ss_pred CCeEEEEEecCCCCcHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 578999999999999999987642 2467788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++.++ .+||+|||++........ ......||+.|+|||++.+.. ++.++||||||
T Consensus 144 li~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~Di~slG 199 (278)
T 3cok_A 144 LLTRNM-NIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSA----------------------HGLESDVWSLG 199 (278)
T ss_dssp EECTTC-CEEECCCTTCEECC---------------------------------------------------CTHHHHHH
T ss_pred EEcCCC-CEEEEeecceeeccCCCC-cceeccCCCCcCCcchhcCCC----------------------CCchhhHHHHH
Confidence 999987 999999999987643322 123467899999999765433 44567999999
Q ss_pred HHHHHHHcCCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~ 391 (397)
+++|||++|+.||.....
T Consensus 200 ~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 200 CMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp HHHHHHHHSSCSSCCCSC
T ss_pred HHHHHHHhCCCCCCChhH
Confidence 999999999999986543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=284.48 Aligned_cols=211 Identities=18% Similarity=0.247 Sum_probs=167.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc-c
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK-K 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~ 213 (397)
-+..++|++.+.||+|+||.||+|++..... ...+.+++|++............++...+....|++++.+++.+.. .
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGD-NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSS-SCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCC-CcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 3556899999999999999999998532111 1127899999876655544445556666777789999998876543 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
+...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NI 158 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR-------------------ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 158 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG-------------------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CceEEEEEeecCCCCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhE
Confidence 567899999999999999997643 1467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|++.++ .+||+|||+++........ ......+|+.|+|||++.+. .++.++||||
T Consensus 159 l~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~s 215 (327)
T 3lxl_A 159 LVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN----------------------IFSRQSDVWS 215 (327)
T ss_dssp EEEETT-EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC----------------------EEEHHHHHHH
T ss_pred EECCCC-CEEEcccccceecccCCccceeeccCCccccccCHHHhccC----------------------CCChHHhHHH
Confidence 999987 9999999999876443221 23345688899999966443 3556789999
Q ss_pred HHHHHHHHHcCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~ 388 (397)
||+++|||++|..||..
T Consensus 216 lG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 216 FGVVLYELFTYCDKSCS 232 (327)
T ss_dssp HHHHHHHHHTTTCGGGS
T ss_pred HHHHHHHHHhCCCCCcc
Confidence 99999999999999854
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.11 Aligned_cols=200 Identities=22% Similarity=0.283 Sum_probs=161.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+.|++.+.||+|+||+||+|++..++ +.+++|++.... ........++...+....|+|++.+++.+. .++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~ 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REH 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETT
T ss_pred hheeeeeEEccCCCEEEEEEEEccCC-----eEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECC
Confidence 56999999999999999999988776 789999886432 222223334555666678999999988664 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+. |+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~-------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 187 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHK-------------------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 187 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred eEEEEEecCC-CCHHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 8999999998 68888876542 146778899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+++..... ....||+.|+|||++.... ...++.++|||||||+
T Consensus 188 ~~~~-~~kL~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-------------------~~~~~~~~DiwslG~i 242 (348)
T 1u5q_A 188 SEPG-LVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMD-------------------EGQYDGKVDVWSLGIT 242 (348)
T ss_dssp ETTT-EEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTS-------------------SCCBCTHHHHHHHHHH
T ss_pred CCCC-CEEEeeccCceecCCC-----CcccCCcceeCHhhhcccc-------------------CCCCCcHHHHHHHHHH
Confidence 9987 9999999999765432 3467999999999764321 2346678999999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|+.||...
T Consensus 243 l~ell~g~~p~~~~ 256 (348)
T 1u5q_A 243 CIELAERKPPLFNM 256 (348)
T ss_dssp HHHHHHSSCTTTTS
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=290.68 Aligned_cols=208 Identities=16% Similarity=0.171 Sum_probs=153.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
..|++.++||+|+||+||+|++..++.. ...+++|.+.... ..+.....++...+....|+|++.+++.+...++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGK--KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTE--EEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCc--EEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4688999999999999999998654321 1457888776432 233333445566677788999999998766666788
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 227 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET-------------------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 227 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT-------------------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred EEEEECCCCCCHHHHHhhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC
Confidence 99999999999999997643 23567788899999999999999999999999999999999
Q ss_pred CCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++ .+||+|||+++........ ......+|+.|+|||++. ...++.++||||||+
T Consensus 228 ~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~DvwSlG~ 284 (373)
T 3c1x_A 228 KF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ----------------------TQKFTTKSDVWSFGV 284 (373)
T ss_dssp TC-CEEECCC---------------------CCGGGSCHHHHH----------------------HCCCCHHHHHHHHHH
T ss_pred CC-CEEEeeccccccccccccccccccCCCCCcccccChHHhc----------------------CCCCCcHHHHHHHHH
Confidence 87 9999999999866433221 123456788999999554 445667889999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |..||....
T Consensus 285 il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 285 LLWELMTRGAPPYPDVN 301 (373)
T ss_dssp HHHHHHTTSCCSCTTSC
T ss_pred HHHHHHhCcCCCCCCCC
Confidence 9999999 677776543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=278.03 Aligned_cols=206 Identities=16% Similarity=0.227 Sum_probs=163.3
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHH----HHHHHHHHHhhccCCCceeee
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEI----WMNERVRRACANCCADFVYGF 206 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~----~~~~~~~~~~~~~~~~~i~~~ 206 (397)
+.+..++|++.+.||+|+||+||+|++..++ +.+++|.+..... ... ....++...+...+|++++.+
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDK-----SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTC-----CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCc-----eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 4566789999999999999999999998776 7899998753221 111 233445566677789999999
Q ss_pred eecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--ce
Q 015991 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IV 284 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--ii 284 (397)
++.+... .++||||+.+++|.+.+.... ..+++..+..++.|++.||+|||++| |+
T Consensus 89 ~~~~~~~---~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~~iv 146 (287)
T 4f0f_A 89 YGLMHNP---PRMVMEFVPCGDLYHRLLDKA-------------------HPIKWSVKLRLMLDIALGIEYMQNQNPPIV 146 (287)
T ss_dssp EEEETTT---TEEEEECCTTCBHHHHHHCTT-------------------SCCCHHHHHHHHHHHHHHHHHHHTSSSCCB
T ss_pred heeecCC---CeEEEEecCCCCHHHHHhccc-------------------CCccHHHHHHHHHHHHHHHHHHHhCCCCee
Confidence 8876433 379999999999999886543 24677889999999999999999999 99
Q ss_pred ecCCCCCceEEeCCCC----eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhc
Q 015991 285 HRDIKPQNVIFSEGSR----TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 360 (397)
Q Consensus 285 HrDIKp~NILl~~~~~----~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (397)
||||||+|||++.++. .+||+|||+++..... .....||+.|+|||++....
T Consensus 147 H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~-------------------- 202 (287)
T 4f0f_A 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEE-------------------- 202 (287)
T ss_dssp CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSS--------------------
T ss_pred cCCCCcceEEEeccCCCCceeEEeCCCCcccccccc----ccccCCCccccCchhhccCC--------------------
Confidence 9999999999987651 2999999999754322 34567999999999774321
Q ss_pred cCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 361 LNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 361 ~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++||||||+++|||++|+.||....
T Consensus 203 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 203 ESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 235567899999999999999999997644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=290.34 Aligned_cols=201 Identities=23% Similarity=0.309 Sum_probs=162.0
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--------HHHHHHHHHHHhhccCCCceeeeeec
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--------EIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--------e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
.++|++.+.||+|+||+||+|++..++ +.+++|.+...... ......++...+....|+|++.+++.
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKN-----KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTT-----EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCC-----cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 378999999999999999999988877 78899987643211 11111223445566689999999887
Q ss_pred ccccCCeEEEEEEecCCC-CHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 210 SSKKGGEYWLIWRYEGEA-TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
+. .++..++||||+.++ +|.+++.... .+++..+..++.|++.||+|||++||+||||
T Consensus 98 ~~-~~~~~~lv~e~~~~g~~l~~~~~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 156 (335)
T 3dls_A 98 FE-NQGFFQLVMEKHGSGLDLFAFIDRHP--------------------RLDEPLASYIFRQLVSAVGYLRLKDIIHRDI 156 (335)
T ss_dssp EE-CSSEEEEEEECCTTSCBHHHHHHTCC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred Ee-eCCEEEEEEEeCCCCccHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEEecc
Confidence 64 457899999999777 9999987654 4678889999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+|||++.++ .+||+|||+++....... .....||+.|+|||++.+... ++.++|
T Consensus 157 kp~NIll~~~~-~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~D 212 (335)
T 3dls_A 157 KDENIVIAEDF-TIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPY---------------------RGPELE 212 (335)
T ss_dssp SGGGEEECTTS-CEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCB---------------------CSHHHH
T ss_pred CHHHEEEcCCC-cEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCC---------------------CCCccc
Confidence 99999999987 999999999987654332 345679999999997654332 145689
Q ss_pred hHHHHHHHHHHHcCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~ 388 (397)
|||||+++|||++|..||..
T Consensus 213 iwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 213 MWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp HHHHHHHHHHHHHSSCSCSS
T ss_pred chhHHHHHHHHHhCCCchhh
Confidence 99999999999999999965
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=278.00 Aligned_cols=208 Identities=17% Similarity=0.195 Sum_probs=159.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..+|++.++||+|+||+||+|++..++... ..+++|.+..... .......++...+....|+|++.+++.+...++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKK--IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----C--EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCce--eEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 357999999999999999999976543221 4578887765332 2233334455666777899999999876666778
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~ 162 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNET-------------------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTT-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred eEEEEeCCCCCCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC
Confidence 899999999999999997643 2356778889999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++||||||
T Consensus 163 ~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG 219 (298)
T 3f66_A 163 EKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT----------------------QKFTTKSDVWSFG 219 (298)
T ss_dssp TTC-CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH----------------------CCCCHHHHHHHHH
T ss_pred CCC-CEEECcccccccccccchhccccccCCCCCccccChHHhcC----------------------CCCChHHHHHHHH
Confidence 987 9999999999876543321 1234567889999996543 3456678999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
+++|||++ |..||...
T Consensus 220 ~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 220 VLLWELMTRGAPPYPDV 236 (298)
T ss_dssp HHHHHHHTTSCCSSTTS
T ss_pred HHHHHHHhCCCCCCccC
Confidence 99999999 55555443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=279.59 Aligned_cols=205 Identities=23% Similarity=0.323 Sum_probs=159.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.++||+|+||+||+|++..++ ..+++|++..... .......++...+....|++++.+++.+. .....
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~ 95 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSG-----LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-DYHNM 95 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEE
T ss_pred hheeecceeccCCCeEEEEEEEccCC-----ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-cCCeE
Confidence 78999999999999999999998776 7888888765432 12223334555666678999999988764 45689
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+.+++|.+.+.... ..+..+++..++.++.|++.||+|||++||+||||||+|||+++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~ 159 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQ----------------ARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD 159 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHH----------------HHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESS
T ss_pred EEEEEeCCCCcHHHHHHhhh----------------hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEec
Confidence 99999999999999886542 01235788889999999999999999999999999999999954
Q ss_pred C--CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 298 G--SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 298 ~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+ ...+||+|||+++...... ......||+.|+|||++. ..++.++||||||++
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-----------------------~~~~~~~Di~slG~i 214 (285)
T 3is5_A 160 TSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-----------------------RDVTFKCDIWSAGVV 214 (285)
T ss_dssp SSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT-----------------------TCCCHHHHHHHHHHH
T ss_pred CCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhc-----------------------cCCCcccCeehHHHH
Confidence 2 2389999999997654432 234567999999999653 235567899999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 215 l~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 215 MYFLLTGCLPFTGTS 229 (285)
T ss_dssp HHHHHHSSCSSCCSS
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=286.17 Aligned_cols=203 Identities=19% Similarity=0.248 Sum_probs=155.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH-HHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI-WMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.++||+|+||+||+|++..++ +.+++|.+........ ....++...+....|+|++.+++.+. .++..
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-TEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-CSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCC-----cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-eCCEE
Confidence 68999999999999999999998776 7899998764332211 01113445566678999999988764 45679
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||++ ++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 135 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDCG-------------------NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE 135 (324)
T ss_dssp EEEEECCS-EEHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT
T ss_pred EEEecccc-cCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC
Confidence 99999999 58988887643 14677889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||+++....... ......||+.|+|||++.+. ..++.++|||||||++|
T Consensus 136 ~~-~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---------------------~~~~~~~DiwslG~il~ 192 (324)
T 3mtl_A 136 RG-ELKLADFGLARAKSIPTK-TYDNEVVTLWYRPPDILLGS---------------------TDYSTQIDMWGVGCIFY 192 (324)
T ss_dssp TC-CEEECSSSEEECC-------------CGGGCCHHHHTTC---------------------CCCCTHHHHHHHHHHHH
T ss_pred CC-CEEEccCcccccccCCcc-ccccccCcccccChhhhcCC---------------------CCCCcHHHHHHHHHHHH
Confidence 87 999999999986543322 23446789999999976542 23567889999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||++|+.||....
T Consensus 193 ~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 193 EMATGRPLFPGST 205 (324)
T ss_dssp HHHHSSCSCCCSS
T ss_pred HHHhCCCCCCCCC
Confidence 9999999997654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=284.43 Aligned_cols=211 Identities=19% Similarity=0.225 Sum_probs=148.0
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhcc-CCCceeeeeeccc---
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSS--- 211 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~--- 211 (397)
+...+|++.++||+|+||.||+|++..++ +.+++|++............++...+... .|+|++.+++.+.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSG-----REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCC-----cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 44568999999999999999999998776 78999987654433333333333334443 5899998877652
Q ss_pred ----ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--cee
Q 015991 212 ----KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVH 285 (397)
Q Consensus 212 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiH 285 (397)
.....+++||||++ |+|.+++.... ....+++..++.++.|++.||+|||++| |+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH 161 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKME-----------------SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH 161 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHH-----------------TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBC
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhh-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEE
Confidence 34466899999997 79999887532 1224788889999999999999999999 999
Q ss_pred cCCCCCceEEeCCCCeEEEEecccccccccccccc-----------cccccCCCCCCCcccccccCCCCCCCCccccccc
Q 015991 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-----------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 354 (397)
Q Consensus 286 rDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-----------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~ 354 (397)
|||||+|||++.++ .+||+|||+++......... .....||+.|+|||++....
T Consensus 162 ~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------------- 226 (337)
T 3ll6_A 162 RDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS-------------- 226 (337)
T ss_dssp CCCCGGGCEECTTS-CEEBCCCTTCBCCSSCC-------------------------------CCT--------------
T ss_pred ccCCcccEEECCCC-CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc--------------
Confidence 99999999999987 99999999998765432211 11456899999999773211
Q ss_pred hhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 355 SPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 355 ~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
...++.++||||||+++|||++|..||...
T Consensus 227 -----~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 227 -----NFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp -----TSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred -----cCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 224566889999999999999999999654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=299.61 Aligned_cols=205 Identities=15% Similarity=0.210 Sum_probs=157.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.++||+|+||.||+|.+..+ ..+++|.+........ ...++...+....|+|++.+++.+..
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~~~~-~~~~E~~~l~~l~hp~iv~~~~~~~~-- 250 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE-- 250 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEECCTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCC------ceEEEEEeccCCCCHH-HHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 45668899999999999999999998764 5699998875432211 22334555566689999999887643
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++||||+.+++|.+++.... +..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil 312 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGET------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CceEEEehhhcCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence 56899999999999999997532 124677889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+++++ .+||+|||+++..............+|+.|+|||++. ...++.++||||||+
T Consensus 313 l~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~sDvwslG~ 369 (452)
T 1fmk_A 313 VGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL----------------------YGRFTIKSDVWSFGI 369 (452)
T ss_dssp ECGGG-CEEECCCCTTC--------------CCGGGSCHHHHH----------------------HCCCCHHHHHHHHHH
T ss_pred ECCCC-CEEECCCccceecCCCceecccCCcccccccCHhHHh----------------------cCCCCccccHHhHHH
Confidence 99887 9999999999876543322233456788999999554 345667889999999
Q ss_pred HHHHHHc-CCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLH 389 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~ 389 (397)
+||||++ |+.||...
T Consensus 370 ~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 370 LLTELTTKGRVPYPGM 385 (452)
T ss_dssp HHHHHHTTTCCSSTTC
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999 99999754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=277.10 Aligned_cols=206 Identities=16% Similarity=0.212 Sum_probs=162.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.+.||+|+||.||+|.+... ..+++|.+........ ...++...+....|++++.+++... +
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~-~~~~E~~~l~~l~h~~i~~~~~~~~--~ 79 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT--Q 79 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCC------cEEEEEEecCCcccHH-HHHHHHHHHHhCCCcCcceEEEEEc--C
Confidence 45568999999999999999999987643 5789998865432221 2233444555667999998887654 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+++|.+++.... +..+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 141 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPS------------------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCcEEEEecCCCCCHHHHHhcCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE
Confidence 56899999999999999986532 124678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+++++ .+||+|||+++..............+|+.|+|||++.+ ..++.++||||||+
T Consensus 142 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~ 198 (279)
T 1qpc_A 142 VSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY----------------------GTFTIKSDVWSFGI 198 (279)
T ss_dssp ECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH----------------------CEECHHHHHHHHHH
T ss_pred EcCCC-CEEECCCcccccccCcccccccCCCCccCccChhhhcc----------------------CCCCchhhhHHHHH
Confidence 99887 99999999998765443333344567889999996643 34556789999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |+.||....
T Consensus 199 il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 199 LLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp HHHHHHTTTCCSSTTCC
T ss_pred HHHHHHhCCCCCCcccC
Confidence 9999999 999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.34 Aligned_cols=210 Identities=17% Similarity=0.172 Sum_probs=161.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.++||+|+||.||+|++.... ....+.+++|.+..... .......++...+....|++++.+++.+...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 345578999999999999999999843211 11127899998874332 1222334455666667899999988876544
Q ss_pred C-CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 214 G-GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 214 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+ ..+++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 156 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK-------------------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN 156 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT-------------------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc-------------------ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchhe
Confidence 3 56899999999999999996543 146778899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
||++.++ .+||+|||+++....... .......+|..|+|||++.+ ..++.++|||
T Consensus 157 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~ 213 (302)
T 4e5w_A 157 VLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ----------------------SKFYIASDVW 213 (302)
T ss_dssp EEEEETT-EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH----------------------CEEEHHHHHH
T ss_pred EEEcCCC-CEEECcccccccccCCCcceeccCCCCCCccccCCeeecC----------------------CCCCcchhHH
Confidence 9999987 999999999987654432 22345678889999996544 3455678999
Q ss_pred HHHHHHHHHHcCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~ 387 (397)
|||+++|||++|..|+.
T Consensus 214 slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 214 SFGVTLHELLTYCDSDS 230 (302)
T ss_dssp HHHHHHHHHHTTTCGGG
T ss_pred HHHHHHHHHHHccCCCc
Confidence 99999999999998864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=273.21 Aligned_cols=201 Identities=19% Similarity=0.258 Sum_probs=162.3
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc--
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK-- 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-- 212 (397)
..+.|++.+.||+|+||+||+|.+..++ ..+++|.+.... ..+.....++...+....|++++.+++.+..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCc-----eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 4456999999999999999999998876 778888876432 2333334455666777789999988875432
Q ss_pred -cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--ceecCCC
Q 015991 213 -KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIK 289 (397)
Q Consensus 213 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiHrDIK 289 (397)
.+..+++||||+.+++|.+++.... .+++..+..++.|++.||.|||++| |+|||||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dik 158 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK--------------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCC
T ss_pred CCCceEEEEEEecCCCCHHHHHHHcc--------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCC
Confidence 3467899999999999999997653 4577889999999999999999999 9999999
Q ss_pred CCceEEe-CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 290 PQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 290 p~NILl~-~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|+|||++ +++ .+||+|||++...... ......||+.|+|||++.+ .++.++|
T Consensus 159 p~Nil~~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~-----------------------~~~~~~D 211 (290)
T 1t4h_A 159 CDNIFITGPTG-SVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-----------------------KYDESVD 211 (290)
T ss_dssp GGGEEESSTTS-CEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-----------------------CCCTHHH
T ss_pred HHHEEEECCCC-CEEEeeCCCccccccc---ccccccCCcCcCCHHHHhc-----------------------cCCCcch
Confidence 9999998 554 9999999999754332 2345679999999996642 3566889
Q ss_pred hHHHHHHHHHHHcCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~ 389 (397)
|||||+++|||++|+.||...
T Consensus 212 i~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 212 VYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp HHHHHHHHHHHHHSSCTTTTC
T ss_pred HHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=277.80 Aligned_cols=208 Identities=19% Similarity=0.252 Sum_probs=154.6
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.++..++|++.++||+|+||+||+|++. ..+++|.+... .........++...+....|++++.+++..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 4567789999999999999999999864 34788877533 223333444566677778899999988853
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.....++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~ 149 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASE-------------------TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN 149 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC----------------------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -cCCccEEEEEecCCCcHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 3456899999999999999986543 24677889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|||++.++ .+||+|||+++...... ........||+.|+|||++.... ...++.++|||
T Consensus 150 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------------------~~~~~~~~Di~ 209 (289)
T 3og7_A 150 NIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD-------------------SNPYSFQSDVY 209 (289)
T ss_dssp GEEEETTT-EEEECCCC------------------CCCTTCCHHHHC-----------------------CCSCHHHHHH
T ss_pred eEEECCCC-CEEEccceeccccccccccccccccCCCccccCchhhcccC-------------------CCCCCcccchH
Confidence 99999987 99999999997654322 12234567999999999775322 12456688999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+++|||++|+.||....
T Consensus 210 slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 210 AFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp HHHHHHHHHHHSSCTTSSCC
T ss_pred HHHHHHHHHHHCCCCccccc
Confidence 99999999999999997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=288.39 Aligned_cols=207 Identities=21% Similarity=0.243 Sum_probs=159.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhc-----cCCCceeeeee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACAN-----CCADFVYGFFE 208 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~-----~~~~~i~~~~~ 208 (397)
...++|++.++||+|+||+||+|++..++ +.+|+|.+...... ....+.++...+.+ .+|++++.+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGK-----KFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCC-----eEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 34589999999999999999999988876 78999988754322 12222233333333 24888888887
Q ss_pred cccc---cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-Cce
Q 015991 209 NSSK---KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIV 284 (397)
Q Consensus 209 ~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-gii 284 (397)
.+.. .+..+++||||++ ++|.+.+.... ...+++..++.++.||+.||+|||++ ||+
T Consensus 109 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~giv 169 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVLG-HHLLKWIIKSN------------------YQGLPLPCVKKIIQQVLQGLDYLHTKCRII 169 (397)
T ss_dssp EEEEEETTEEEEEEEECCCC-CBHHHHHHHTT------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred ceeecCCCCceEEEEEeccC-ccHHHHHHhcc------------------cCCCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 6642 4568999999996 55655554432 12467888999999999999999998 999
Q ss_pred ecCCCCCceEEeCCC------------------------------------------------CeEEEEecccccccccc
Q 015991 285 HRDIKPQNVIFSEGS------------------------------------------------RTFKIIDLGAAADLRVG 316 (397)
Q Consensus 285 HrDIKp~NILl~~~~------------------------------------------------~~~kL~DFGla~~~~~~ 316 (397)
||||||+|||++.++ ..+||+|||+++.....
T Consensus 170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~ 249 (397)
T 1wak_A 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249 (397)
T ss_dssp CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC
T ss_pred cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc
Confidence 999999999998763 27999999999875432
Q ss_pred cccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 015991 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 317 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
.....||+.|+|||++.+ ..++.++|||||||+||||++|+.||......
T Consensus 250 ----~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 299 (397)
T 1wak_A 250 ----FTEDIQTRQYRSLEVLIG----------------------SGYNTPADIWSTACMAFELATGDYLFEPHSGE 299 (397)
T ss_dssp ----SCSCCSCGGGCCHHHHHT----------------------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred ----CccCCCCCcccCChhhcC----------------------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence 345689999999996543 34667889999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=298.81 Aligned_cols=201 Identities=22% Similarity=0.255 Sum_probs=160.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||+||+|++..++ ..+++|.+.... ........++...+....|+||+.+++.+. ....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~ 110 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTH-----VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-DKRN 110 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTC-----CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCC-----cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCE
Confidence 57999999999999999999998877 788888876432 111222334556677778999999988764 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+.+++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 170 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM--------------------KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred EEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEe
Confidence 999999999999999887654 467888999999999999999999999999999999997
Q ss_pred CCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 EGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
.++ ..+||+|||+|+...... ......||+.|+|||++. ..++.++||||+||
T Consensus 171 ~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-----------------------~~~~~~~DiwslG~ 225 (494)
T 3lij_A 171 SKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-----------------------KKYDEKCDVWSIGV 225 (494)
T ss_dssp CSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-----------------------TCBCTHHHHHHHHH
T ss_pred CCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-----------------------ccCCCchhHHHHHH
Confidence 643 269999999998765432 234568999999999653 23667889999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|+|++|..||....
T Consensus 226 il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 226 ILFILLAGYPPFGGQT 241 (494)
T ss_dssp HHHHHHHSSCSSCCSS
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=286.53 Aligned_cols=207 Identities=23% Similarity=0.300 Sum_probs=160.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeeccccc-
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKK- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (397)
..++|++.++||+|+||+||+|++..++ +.+++|++......+ .....++...+....|++++.+++.+...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTC-----CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCC-----CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 4579999999999999999999998877 789999875332111 11122344455556788888887765443
Q ss_pred ------CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecC
Q 015991 214 ------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (397)
Q Consensus 214 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrD 287 (397)
++..++||||+++ +|.+.+.... ..+++..++.++.|++.||+|||++||+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~D 149 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-------------------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 149 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCC
Confidence 3578999999995 7777776542 1467888999999999999999999999999
Q ss_pred CCCCceEEeCCCCeEEEEecccccccccccc---cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
|||+|||++.++ .+||+|||+|+.+..... .......||+.|+|||++.+.. .++
T Consensus 150 lkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~ 207 (351)
T 3mi9_A 150 MKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER---------------------DYG 207 (351)
T ss_dssp CSGGGEEECTTS-CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC---------------------SCC
T ss_pred CCHHHEEEcCCC-CEEEccchhcccccccccccccccCCcccccCccCchhhcCCC---------------------CCC
Confidence 999999999987 999999999987643222 1234567899999999765422 356
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++|||||||++|||++|+.||....
T Consensus 208 ~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 208 PPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 68899999999999999999997653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=291.75 Aligned_cols=205 Identities=18% Similarity=0.156 Sum_probs=144.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHH---HHHHHhhccCCCceeeeeecc--
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNE---RVRRACANCCADFVYGFFENS-- 210 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~---~~~~~~~~~~~~~i~~~~~~~-- 210 (397)
.+|++.++||+|+||+||+|++..++ +.+|+|.+..... ....... +....+.. .|+|++.++..+
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERL-----EDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCC-----ceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEe
Confidence 46999999999999999999998776 7899998876332 1111111 22445555 789866543222
Q ss_pred -----cccC----------------CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHH-HHHH
Q 015991 211 -----SKKG----------------GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRII-QTIM 268 (397)
Q Consensus 211 -----~~~~----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i-~~i~ 268 (397)
...+ ..+++||||++ ++|.+++...+... .........+ ..++
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~--------------~~~~~~~~~vk~~i~ 200 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVY--------------VFRGDEGILALHILT 200 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSC--------------CCCHHHHHHHHHHHH
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcccc--------------chhhhhhhhhHHHHH
Confidence 1111 45899999999 89999998753111 0001111112 5667
Q ss_pred HHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCc
Q 015991 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSA 348 (397)
Q Consensus 269 ~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 348 (397)
.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+...... ....+|+.|+|||++.+..
T Consensus 201 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~-------- 267 (371)
T 3q60_A 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNAST-------- 267 (371)
T ss_dssp HHHHHHHHHHHHTTEEETTCSGGGEEECTTS-CEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSE--------
T ss_pred HHHHHHHHHHHHCCCccCcCCHHHEEECCCC-CEEEEecceeeecCCCc----cCccCCcCCcChhhccCCC--------
Confidence 9999999999999999999999999999987 99999999998654221 2456779999999764311
Q ss_pred cccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 349 PVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 349 ~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
..++.++|||||||+||||++|+.||...
T Consensus 268 ------------~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 268 ------------ATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp ------------EECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred ------------CCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 24667889999999999999999999876
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=278.33 Aligned_cols=206 Identities=22% Similarity=0.251 Sum_probs=158.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccc-----
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS----- 211 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~----- 211 (397)
..++|++.+.||+|+||.||+|.+..++ +.+++|++............++...+....|++++.+++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCD-----KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTT-----EEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCC-----eEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 4589999999999999999999998876 889999887554444444445566677778999998876542
Q ss_pred --------ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCc
Q 015991 212 --------KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (397)
Q Consensus 212 --------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gi 283 (397)
......++||||++ ++|.+++... .+++..++.++.|++.||+|||++||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---------------------~~~~~~~~~~~~qi~~~l~~lH~~~i 141 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---------------------PLLEEHARLFMYQLLRGLKYIHSANV 141 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTTC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhcC---------------------CccHHHHHHHHHHHHHHHHHHHhCCE
Confidence 23468899999998 5999988653 35677888999999999999999999
Q ss_pred eecCCCCCceEEeCCCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 284 iHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
+||||||+|||++.++..+||+|||+++....... .......+|+.|+|||++... .
T Consensus 142 ~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------------------~ 200 (320)
T 2i6l_A 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP---------------------N 200 (320)
T ss_dssp BCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT---------------------T
T ss_pred ecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCc---------------------c
Confidence 99999999999985545999999999987643221 122345779999999966432 2
Q ss_pred CCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++.++||||||+++|||++|+.||....
T Consensus 201 ~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 201 NYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 35668899999999999999999997654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=281.21 Aligned_cols=210 Identities=24% Similarity=0.384 Sum_probs=155.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhc-cCCCceeeeeeccccc--
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSKK-- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~~-- 213 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|.+............ +...+.. ..|++++.+++.+...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~-e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTGDEEEEIKQ-EINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSSTTHHHHH-HHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCC-----CeEEEEEEecCcccHHHHHH-HHHHHHhccCCCCeeeeeeEEeeccC
Confidence 4589999999999999999999998776 78899987643322222222 2222222 3688888888766543
Q ss_pred ---CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 214 ---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 214 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++||+||||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 157 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTK------------------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 157 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSG------------------GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcc------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcH
Confidence 468999999999999999998642 22467788999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||++........ ......||+.|+|||++...... ...++.++|||
T Consensus 158 ~NIl~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-----------------~~~~~~~~Di~ 218 (326)
T 2x7f_A 158 QNVLLTENA-EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENP-----------------DATYDFKSDLW 218 (326)
T ss_dssp GGEEECTTC-CEEECCCTTTC--------------CCGGGCCHHHHC-------------------------CCTTHHHH
T ss_pred HHEEEcCCC-CEEEeeCcCceecCcCcc-ccccccCCccccChhhhcccccc-----------------CcCCCccchHH
Confidence 999999887 999999999986543221 23456799999999987643211 12466788999
Q ss_pred HHHHHHHHHHcCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~ 389 (397)
|||+++|||++|..||...
T Consensus 219 slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 219 SLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp HHHHHHHHHHHSSCTTTTS
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=296.57 Aligned_cols=202 Identities=21% Similarity=0.288 Sum_probs=162.4
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-------------HHHHHHHHHHHhhccCCCcee
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-------------EIWMNERVRRACANCCADFVY 204 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-------------e~~~~~~~~~~~~~~~~~~i~ 204 (397)
.++|++.++||+|+||+||+|++..++ ..+|+|.+...... ......++...+....|+||+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGH-----SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTC-----CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred ccceEEEeEecccCCeEEEEEEECCCC-----cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 478999999999999999999998877 78888887643211 112233455566677899999
Q ss_pred eeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCce
Q 015991 205 GFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (397)
Q Consensus 205 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gii 284 (397)
.+++.+. .+..+++||||+.+++|.+.+.... .+++..+..++.|++.||.|||++||+
T Consensus 110 ~~~~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~iv 168 (504)
T 3q5i_A 110 KLFDVFE-DKKYFYLVTEFYEGGELFEQIINRH--------------------KFDECDAANIMKQILSGICYLHKHNIV 168 (504)
T ss_dssp CEEEEEE-CSSEEEEEEECCTTCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred eEEEEEE-cCCEEEEEEecCCCCcHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 9988764 4578999999999999999987654 467888999999999999999999999
Q ss_pred ecCCCCCceEEeCCCC--eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC
Q 015991 285 HRDIKPQNVIFSEGSR--TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362 (397)
Q Consensus 285 HrDIKp~NILl~~~~~--~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
||||||+|||++.++. .+||+|||+++...... ......||+.|+|||++. ..
T Consensus 169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-----------------------~~ 223 (504)
T 3q5i_A 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-----------------------KK 223 (504)
T ss_dssp CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-----------------------TC
T ss_pred eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-----------------------cC
Confidence 9999999999987652 69999999998765432 234568999999999653 23
Q ss_pred CCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 363 LPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 363 ~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
++.++||||+||++|+|++|..||....
T Consensus 224 ~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 224 YNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5678899999999999999999997654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=282.39 Aligned_cols=205 Identities=20% Similarity=0.296 Sum_probs=160.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|++...... ......++...+....|++++.+++.+. .+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTG-----RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-KK 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTC-----CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ET
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCC-----ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-cC
Confidence 4579999999999999999999998876 78999987543322 2222334555666677999999988764 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+++++|.++..... .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil 156 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPN--------------------GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTT--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CEEEEEEecCCcchHHHHHhhcc--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEE
Confidence 78999999999999988765433 4678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++....... ......||+.|+|||++.+. ..++.++||||||+
T Consensus 157 ~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---------------------~~~~~~~Di~slG~ 213 (331)
T 4aaa_A 157 VSQSG-VVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGD---------------------VKYGKAVDVWAIGC 213 (331)
T ss_dssp ECTTS-CEEECCCTTC-------------CCCCCTTCCHHHHTTC---------------------TTCCTHHHHHHHHH
T ss_pred EcCCC-cEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccCC---------------------CCcchHHHHHHHHH
Confidence 99987 999999999976544322 23456799999999976543 13566789999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|||++|+.||....
T Consensus 214 il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 214 LVTEMFMGEPLFPGDS 229 (331)
T ss_dssp HHHHHHHSSCSCCCSS
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=280.25 Aligned_cols=200 Identities=24% Similarity=0.319 Sum_probs=160.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.+.||+|+||.||+|++..++ +.+++|.+...........+++...+....|++++.+++.+. .++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 81 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTG-----KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-STTHY 81 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-CSSEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCC-----CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-cCCEE
Confidence 378999999999999999999998776 789999887544333333344555666678999999887654 45789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE--
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-- 295 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl-- 295 (397)
++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~ 141 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERG--------------------VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLT 141 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESS
T ss_pred EEEEEcCCCccHHHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 99999999999999987654 45778899999999999999999999999999999999
Q ss_pred -eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 -SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 -~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+.++ .+||+|||+++..... ......||+.|+|||++.+. .++.++||||||+
T Consensus 142 ~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~ 195 (304)
T 2jam_A 142 PEENS-KIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQK----------------------PYSKAVDCWSIGV 195 (304)
T ss_dssp SSTTC-CEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSC----------------------SCCHHHHHHHHHH
T ss_pred CCCCC-CEEEccCCcceecCCC---ccccccCCCCccChHHhccC----------------------CCCchhhHHHHHH
Confidence 5555 9999999999754322 22345789999999976533 3556789999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|..||...
T Consensus 196 il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 196 ITYILLCGYPPFYEE 210 (304)
T ss_dssp HHHHHHHSSCTTTTS
T ss_pred HHHHHHHCCCCCCCC
Confidence 999999999999654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.06 Aligned_cols=199 Identities=22% Similarity=0.293 Sum_probs=144.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc---
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (397)
++|++.+.||+|+||.||+|.+..++ +.+++|++.... ........++...+....|+|++.+++.+...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTT-----EEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred CceEEeeEEeecCCeEEEEEEECCCC-----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 79999999999999999999988877 889999986432 22223333455566667799999888765432
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 214 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
....++|+|++ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~~---------------------~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 161 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKCQ---------------------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 161 (367)
T ss_dssp GGCCCCEEEEECC-CEECC-----C---------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred ccCCeEEEEeccc-CCCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHh
Confidence 25689999999 47888877643 3677889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++..... .....||+.|+|||++.+. ..++.++||||
T Consensus 162 NIll~~~~-~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~---------------------~~~~~~~Diws 215 (367)
T 2fst_X 162 NLAVNEDC-ELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNW---------------------MHYNQTVDIWS 215 (367)
T ss_dssp GEEECTTC-CEEECC-------------------CCCTTCCHHHHTTC---------------------CSCCTTHHHHH
T ss_pred hEEECCCC-CEEEeecccccccccc----CCCcCcCcCccChHHHcCC---------------------cCCCchhhHHH
Confidence 99999987 9999999999865422 2456899999999976542 24566789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|+.||....
T Consensus 216 lG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 216 VGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp HHHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=273.53 Aligned_cols=205 Identities=13% Similarity=0.180 Sum_probs=163.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.+.||+|+||.||+|.+..+ +.+++|.+........ ...++...+....|++++.+++.+.. +
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~vaiK~~~~~~~~~~-~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 75 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCLE-Q 75 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTTBCHH-HHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCC------CeEEEEEccccCCCHH-HHHHHHHHHHhCCCCCEeeEEEEEcc-C
Confidence 34568999999999999999999998643 6789998875443222 22334455566679999999887644 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 136 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR-------------------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 136 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEE
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc-------------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEE
Confidence 67899999999999999997643 13567888999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++..............+|+.|+|||++.+ ..++.++||||||+
T Consensus 137 i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~ 193 (267)
T 3t9t_A 137 VGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF----------------------SRYSSKSDVWSFGV 193 (267)
T ss_dssp ECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH----------------------CCCCHHHHHHHHHH
T ss_pred ECCCC-CEEEcccccccccccccccccccccccccccChhhhcC----------------------CCccchhchhhhHH
Confidence 99887 99999999998764433223344567889999996543 34566789999999
Q ss_pred HHHHHHc-CCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLH 389 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~ 389 (397)
++|||++ |+.||...
T Consensus 194 il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 194 LMWEVFSEGKIPYENR 209 (267)
T ss_dssp HHHHHHTTSCCTTTTC
T ss_pred HHHHHhccCCCCCCCC
Confidence 9999999 89999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=281.73 Aligned_cols=201 Identities=22% Similarity=0.279 Sum_probs=155.3
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
..++|++.++||+|+||.||+|++.+ +.+++|.+.......... +..........|+|++.+++......
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~-e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRG-------EKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETT-------EEEEEEEEEGGGHHHHHH-HHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEECC-------ceEEEEEEeccccchhhh-HHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34799999999999999999998762 789999886554433333 33333334457999999887665432
Q ss_pred -CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC--------Ccee
Q 015991 215 -GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST--------GIVH 285 (397)
Q Consensus 215 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~--------giiH 285 (397)
...++||||+.+++|.++++.. .+++..+..++.|++.||+|||++ ||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~---------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 165 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST---------------------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC---------------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred CCceEEEEeccCCCcHHHHhhcc---------------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence 6799999999999999999754 356788999999999999999999 9999
Q ss_pred cCCCCCceEEeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC
Q 015991 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362 (397)
Q Consensus 286 rDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
|||||+|||++.++ .+||+|||+++.+...... ......||+.|+|||++.+....... .
T Consensus 166 ~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~----------------~ 228 (337)
T 3mdy_A 166 RDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF----------------Q 228 (337)
T ss_dssp SCCCGGGEEECTTS-CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCT----------------H
T ss_pred cccchHHEEECCCC-CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccc----------------c
Confidence 99999999999987 9999999999766443322 12356899999999988765443321 1
Q ss_pred CCCchhhHHHHHHHHHHHcCC
Q 015991 363 LPDRFDIYSAGLIFLQMVCTV 383 (397)
Q Consensus 363 ~~~k~Dv~SlGv~l~elltg~ 383 (397)
++.++|||||||++|||++|.
T Consensus 229 ~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 229 SYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTTB
T ss_pred CccccchHHHHHHHHHHHhcc
Confidence 112479999999999999993
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.82 Aligned_cols=203 Identities=27% Similarity=0.331 Sum_probs=155.3
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
...+|++.++||+|+||+||+|++..+ ..+++|++....... .++...+....|+|++.+++.+...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~------~~~aikk~~~~~~~~----~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVES------DEVAIKKVLQDKRFK----NRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTT------EEEEEEEEECCTTSC----CHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCC------CeEEEEEEecCcchH----HHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 446899999999999999999998776 458888876433221 12344455667999988877654332
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 215 ---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 215 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+++||||++++.+..+..... ....+++..++.++.|++.||+|||++||+||||||+
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAK-----------------LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHH-----------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCceEEEEEeeccCccHHHHHHHHHh-----------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 34789999999754433332211 1235678889999999999999999999999999999
Q ss_pred ceEEe-CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 292 NVIFS-EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 292 NILl~-~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|||++ .++ .+||+|||+|+....+.. .....+|+.|+|||++.+.. .++.++|||
T Consensus 171 Nill~~~~~-~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diw 226 (394)
T 4e7w_A 171 NLLLDPPSG-VLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGAT---------------------NYTTNIDIW 226 (394)
T ss_dssp GEEEETTTT-EEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCS---------------------SCCTHHHHH
T ss_pred HEEEcCCCC-cEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCC---------------------CCCcHHHHH
Confidence 99999 555 999999999987644332 34567899999999764432 366788999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||++|||++|+.||....
T Consensus 227 SlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 227 STGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=274.77 Aligned_cols=208 Identities=20% Similarity=0.278 Sum_probs=164.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-------h--HHHHHHHHHHHHhhcc-CCCceeee
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-------A--VEIWMNERVRRACANC-CADFVYGF 206 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-------~--~e~~~~~~~~~~~~~~-~~~~i~~~ 206 (397)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+.... . .......++...+... .|++++.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcC-----ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 4589999999999999999999998876 789999875432 1 1111122233333333 58999998
Q ss_pred eecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 207 FENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
++.+ ..+...++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||
T Consensus 90 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 148 (298)
T 1phk_A 90 KDTY-ETNTFFFLVFDLMKKGELFDYLTEKV--------------------TLSEKETRKIMRALLEVICALHKLNIVHR 148 (298)
T ss_dssp EEEE-ECSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred eeee-ccCCeEEEEEeccCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 8866 44578999999999999999997653 46778899999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
||||+||+++.++ .+||+|||++........ .....+|+.|+|||++.+..... ...++.+
T Consensus 149 dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~----------------~~~~~~~ 209 (298)
T 1phk_A 149 DLKPENILLDDDM-NIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDN----------------HPGYGKE 209 (298)
T ss_dssp CCSGGGEEECTTC-CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTT----------------SCCBCTH
T ss_pred CCCcceEEEcCCC-cEEEecccchhhcCCCcc--cccccCCccccCHHHhccccccc----------------cccCCcc
Confidence 9999999999987 999999999987654322 34567899999999876432211 1246678
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
+||||||+++|||++|..||...
T Consensus 210 ~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 210 VDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccHhHHHHHHHHHHCCCCCcCc
Confidence 99999999999999999999654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=280.83 Aligned_cols=212 Identities=18% Similarity=0.233 Sum_probs=165.1
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc---
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (397)
+..++|++.+.||+|+||.||++++..++ +.+++|.+............++...+....|++++.+++.+..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDG-----HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTC-----CEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCC-----cEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 34578999999999999999999988776 8899998865444444444455666677789999988776542
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.....++||||+.+++|.+++.... ..+..+++..++.++.|++.||.|||++||+||||||+|
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~N 164 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLK----------------DKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN 164 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHH----------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3457899999999999999997642 122357888999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc--------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY--------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~--------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
||++.++ .+||+|||++......... ......||+.|+|||++.+... ..++
T Consensus 165 Il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-------------------~~~~ 224 (317)
T 2buj_A 165 ILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH-------------------CVID 224 (317)
T ss_dssp EEECTTS-CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSE-------------------EEEC
T ss_pred EEEcCCC-CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCC-------------------cCCC
Confidence 9999987 9999999998765322110 0123467999999997754321 1245
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
.++||||||+++|||++|+.||..
T Consensus 225 ~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 225 ERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTHH
T ss_pred chhhHHHHHHHHHHHHhCCCChhh
Confidence 688999999999999999999953
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=276.37 Aligned_cols=209 Identities=21% Similarity=0.318 Sum_probs=164.1
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccc-cc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSS-KK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~ 213 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|.+.... ..+.....++...+....|++++.+++.+. ..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred chhheeeehhccCCCCcEEEEEEECCCC-----cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 3479999999999999999999998776 788899886432 222333344555566678999999988654 33
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC-----ceecCC
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-----IVHRDI 288 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g-----iiHrDI 288 (397)
+...++||||+++++|.+++..... ....+++..+..++.|++.||+|||+.| |+||||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl 142 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTK----------------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHH----------------TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcc----------------cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEecc
Confidence 5689999999999999999976431 1224688899999999999999999999 999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+|||++.++ .+||+|||+++....... ......||+.|+|||++.+ ..++.++|
T Consensus 143 ~p~NIl~~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~D 198 (279)
T 2w5a_A 143 KPANVFLDGKQ-NVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNR----------------------MSYNEKSD 198 (279)
T ss_dssp SGGGEEECSSS-CEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHC----------------------C-CCHHHH
T ss_pred chhhEEEcCCC-CEEEecCchheeeccccc-cccccCCCccccChHHhcc----------------------CCCCchhh
Confidence 99999999987 999999999987643322 1234578999999996543 34566789
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||+++|||++|..||....
T Consensus 199 i~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 199 IWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHCCCCCcccC
Confidence 9999999999999999997643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=273.36 Aligned_cols=200 Identities=19% Similarity=0.232 Sum_probs=149.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH----HHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE----IWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e----~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
+..++|++.+.||+|+||.||+|.+.+ +.+++|......... .....++...+....|++++.+++.+.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIG-------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETT-------EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcC-------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 456899999999999999999999753 678898876432221 122334455566677999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC---ceecCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG---IVHRDI 288 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g---iiHrDI 288 (397)
. ++..++||||+.+++|.+++... .+++..+..++.|++.||+|||++| |+||||
T Consensus 77 ~-~~~~~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~di 134 (271)
T 3dtc_A 77 K-EPNLCLVMEFARGGPLNRVLSGK---------------------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134 (271)
T ss_dssp C-C--CEEEEECCTTEEHHHHHTSS---------------------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCC
T ss_pred c-CCceEEEEEcCCCCCHHHHhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Confidence 4 56789999999999999988643 3577889999999999999999999 999999
Q ss_pred CCCceEEeCC-------CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhcc
Q 015991 289 KPQNVIFSEG-------SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361 (397)
Q Consensus 289 Kp~NILl~~~-------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
||+|||++.+ ...+||+|||+++...... .....||+.|+|||++.+ .
T Consensus 135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~----------------------~ 189 (271)
T 3dtc_A 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRA----------------------S 189 (271)
T ss_dssp SGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHH----------------------C
T ss_pred chHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhcc----------------------C
Confidence 9999999862 2389999999998654332 234578999999996543 3
Q ss_pred CCCCchhhHHHHHHHHHHHcCCCCCCCC
Q 015991 362 NLPDRFDIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 362 ~~~~k~Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
.++.++||||||+++|||++|+.||...
T Consensus 190 ~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 190 MFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp CCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4566789999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=273.93 Aligned_cols=202 Identities=21% Similarity=0.276 Sum_probs=158.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH------HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV------EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~------e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.+.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 78 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTG-----KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE- 78 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCC-----CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-
Confidence 68999999999999999999998776 78888877543210 1222233444555667999999888664
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+...++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 138 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEKE--------------------SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPEN 138 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCeEEEEEeecCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHH
Confidence 4568999999999999999997643 46788899999999999999999999999999999
Q ss_pred eEEeCCCC---eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 293 VIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 293 ILl~~~~~---~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+++.++. .+||+|||++........ .....||+.|+|||++.+ ..++.++||
T Consensus 139 il~~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di 194 (283)
T 3bhy_A 139 IMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNY----------------------EPLGLEADM 194 (283)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTT----------------------CCCCTHHHH
T ss_pred EEEecCCCCCCceEEEecccceeccCCCc--ccccCCCcCccCcceecC----------------------CCCCcchhh
Confidence 99987642 799999999987644322 234578999999996643 345667899
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+++|||++|..||....
T Consensus 195 ~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 195 WSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp HHHHHHHHHHHHSSCTTCCSS
T ss_pred hhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=271.82 Aligned_cols=207 Identities=22% Similarity=0.302 Sum_probs=158.2
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCCCceeeeeecc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
..+..++|++.+.||+|+||.||+|++..++ +.+++|.+....... .....++...+....|++++.+++.+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTG-----HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCC-----ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 3456789999999999999999999998776 789999886433211 12233445556667899999988866
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. ..+..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||
T Consensus 81 ~-~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 139 (276)
T 2h6d_A 81 S-TPTDFFMVMEYVSGGELFDYICKHG--------------------RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP 139 (276)
T ss_dssp E-CSSEEEEEEECCCSCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCG
T ss_pred e-cCCeEEEEEeccCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCh
Confidence 4 4578999999999999999997654 457788999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+||+++.++ .+||+|||++........ .....+|+.|+|||++.+... .+.++|||
T Consensus 140 ~Nil~~~~~-~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~---------------------~~~~~Di~ 195 (276)
T 2h6d_A 140 ENVLLDAHM-NAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLY---------------------AGPEVDIW 195 (276)
T ss_dssp GGEEECTTS-CEEECCCCGGGCCCC---------------CCTGGGTTSCC---------------------CHHHHHHH
T ss_pred hhEEECCCC-CEEEeecccccccCCCcc--eecccCCccccCHHHHcCCCC---------------------CCccchHH
Confidence 999999987 999999999987644322 234678999999997754322 13468999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+++|||++|..||....
T Consensus 196 slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 196 SCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=282.23 Aligned_cols=205 Identities=22% Similarity=0.306 Sum_probs=160.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--------HHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--------VEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--------~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
++|++.+.||+|+||.||+|++..++ +.+++|.+..... .......++...+....|++++.+++.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTC-----KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCC-----cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 68999999999999999999998876 7899998754321 1111223445556666899999988765
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ...++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||
T Consensus 85 ~~--~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 142 (322)
T 2ycf_A 85 DA--EDYYIVLELMEGGELFDKVVGNK--------------------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142 (322)
T ss_dssp ES--SSEEEEEECCTTEETHHHHSTTC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cC--CceEEEEecCCCCcHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 43 34899999999999999886543 467888999999999999999999999999999
Q ss_pred CceEEeCCCC--eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 291 QNVIFSEGSR--TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 291 ~NILl~~~~~--~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
+|||++.++. .+||+|||+++...... ......||+.|+|||++.... ...++.++|
T Consensus 143 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-------------------~~~~~~~~D 201 (322)
T 2ycf_A 143 ENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVG-------------------TAGYNRAVD 201 (322)
T ss_dssp GGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTT-------------------TTTCTTHHH
T ss_pred HHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCC-------------------CCCCCchhh
Confidence 9999987642 49999999998764322 123467999999999764211 124667899
Q ss_pred hHHHHHHHHHHHcCCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~~ 391 (397)
||||||++|||++|..||.....
T Consensus 202 i~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 202 CWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp HHHHHHHHHHHHHSSCSSCSTTC
T ss_pred HHHHHHHHHHHHhCCCCCcccch
Confidence 99999999999999999976544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=280.47 Aligned_cols=221 Identities=18% Similarity=0.219 Sum_probs=168.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.+.||+|+||.||+|++.........+.+++|.+..... .+.....++...+....|++++.+++.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ- 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc-
Confidence 345589999999999999999999887422222237799998875432 223334456667777889999999887644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+.+++|.+++....... ........+++..+..++.|++.||+|||++||+||||||+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NI 169 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAM----------ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 169 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHH----------HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhh----------ccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceE
Confidence 567899999999999999997643100 0000112457788999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|++.++ .+||+|||+++........ ......+|+.|+|||++. ...++.++|||||
T Consensus 170 li~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~Di~sl 226 (322)
T 1p4o_A 170 MVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK----------------------DGVFTTYSDVWSF 226 (322)
T ss_dssp EECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH----------------------HCCCCHHHHHHHH
T ss_pred EEcCCC-eEEECcCccccccccccccccccCCCCCCCccChhhhc----------------------cCCCCchhhHHHH
Confidence 999987 9999999999866443322 123456789999999554 3346667899999
Q ss_pred HHHHHHHHc-CCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~ 389 (397)
|+++|||++ |..||...
T Consensus 227 G~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 227 GVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp HHHHHHHHHTSCCTTTTS
T ss_pred HHHHHHHHhcCCCccccC
Confidence 999999999 89998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=304.19 Aligned_cols=204 Identities=15% Similarity=0.211 Sum_probs=162.7
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|++.++||+|+||.||+|.+..+ ..+++|.+........ ...++...+....|+|++.+++.+.. .
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~~vavK~~~~~~~~~~-~~~~E~~~l~~l~hpniv~~~~~~~~--~ 334 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE--E 334 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTT------EEEEEEEECTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred cchhhhhhheecccCCCeEEEEEEECCC------ceEEEEEeCCCCCCHH-HHHHHHHHHHhCCCCCEeeEEEEEee--c
Confidence 4557899999999999999999998764 5699998875432211 22334455566679999999887643 5
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+.+++|.+++.... +..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 396 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGET------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 396 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHH------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cceEeeehhcCCcHHHHHhhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE
Confidence 6899999999999999997532 1246778899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||+++..............+|..|+|||++. ...++.++|||||||+
T Consensus 397 ~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~sDvwSlGv~ 453 (535)
T 2h8h_A 397 GENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL----------------------YGRFTIKSDVWSFGIL 453 (535)
T ss_dssp CGGG-CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHH----------------------HCCCCHHHHHHHHHHH
T ss_pred cCCC-cEEEcccccceecCCCceecccCCcCcccccCHHHhc----------------------cCCCCchhhHHHHHHH
Confidence 9887 9999999999876543322233456788999999554 4456778899999999
Q ss_pred HHHHHc-CCCCCCCC
Q 015991 376 FLQMVC-TVRRLCLH 389 (397)
Q Consensus 376 l~ellt-g~~Pf~~~ 389 (397)
||||++ |+.||...
T Consensus 454 l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 454 LTELTTKGRVPYPGM 468 (535)
T ss_dssp HHHHTTTTCCSSTTC
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999 99999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=280.89 Aligned_cols=228 Identities=20% Similarity=0.243 Sum_probs=165.3
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCC--CCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPS--SKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~ 210 (397)
.+..++|++.+.||+|+||.||+|++..... ......+++|.+..... .......++...+... .|++++.+++.+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 4556899999999999999999999864321 12236789998875432 2222223334444444 799999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ++..++||||+.+++|.+++............. . .......+++..+..++.|++.||+|||++||+||||||
T Consensus 111 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 111 TQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYD---I-NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp CS-SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred cc-CCceEEEEECCCCCcHHHHHHHhcccccccccc---c-cccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 44 567899999999999999998764211000000 0 001123478888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+|||++.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++||
T Consensus 186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di 242 (334)
T 2pvf_A 186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD----------------------RVYTHQSDV 242 (334)
T ss_dssp GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH----------------------CEECHHHHH
T ss_pred ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC----------------------CCcChHHHH
Confidence 999999887 9999999999876543222 2234567889999996543 345667899
Q ss_pred HHHHHHHHHHHc-CCCCCCCCC
Q 015991 370 YSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
||||+++|||++ |..||....
T Consensus 243 ~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 243 WSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCC
T ss_pred HHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999 999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=274.72 Aligned_cols=207 Identities=17% Similarity=0.193 Sum_probs=161.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
-.|.+.++||+|+||+||+|++..+.... ..+++|.+..... .......++...+....|+|++.+++.+...+...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNR--IQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCE--EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCce--eeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 46778899999999999999986654221 4688888765333 22333344556667778999999998877666666
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++|+||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~ 159 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQ-------------------RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE 159 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTT-------------------CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred EEEEecccCCCHHHHHhccc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 99999999999999997643 24577888999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccc---cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++ .+||+|||+++....... .......+|+.|+|||.+.+ ..++.++||||||+
T Consensus 160 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~ 216 (298)
T 3pls_A 160 SF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT----------------------YRFTTKSDVWSFGV 216 (298)
T ss_dssp TC-CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT----------------------CCCCHHHHHHHHHH
T ss_pred CC-cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc----------------------CCCChhhchhhHHH
Confidence 87 999999999986644321 12234577889999996543 34566789999999
Q ss_pred HHHHHHcCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLH 389 (397)
Q Consensus 375 ~l~elltg~~Pf~~~ 389 (397)
++|||++|..||...
T Consensus 217 il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 217 LLWELLTRGAPPYRH 231 (298)
T ss_dssp HHHHHHHTSCCTTTT
T ss_pred HHHHHhhCCCCCCcc
Confidence 999999976665443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.05 Aligned_cols=202 Identities=21% Similarity=0.286 Sum_probs=164.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.++||+|+||.||+|++..++ +.+++|.+.... ........++...+....|+|++.+++.+. .
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~ 97 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITG-----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-D 97 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCC-----CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-e
Confidence 3378999999999999999999998877 789999875321 112223334556667778999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+.+++||||+.+++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 157 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEIISRK--------------------RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 157 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS--------------------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 578999999999999999987654 467888999999999999999999999999999999
Q ss_pred EEe---CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 294 IFS---EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 294 Ll~---~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|++ .++ .+||+|||+++....... .....||+.|+|||++.+ .++.++|||
T Consensus 158 l~~~~~~~~-~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-----------------------~~~~~~Diw 211 (484)
T 3nyv_A 158 LLESKSKDA-NIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-----------------------TYDEKCDVW 211 (484)
T ss_dssp EESSSSTTC-CEEECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-----------------------CCCTHHHHH
T ss_pred EEecCCCCC-cEEEEeeeeeEEcccccc--cccCCCCccccCceeecC-----------------------CCCCcceeH
Confidence 995 444 899999999987644322 245679999999996542 366788999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|+||++|+|++|..||....
T Consensus 212 slG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 212 STGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=274.65 Aligned_cols=204 Identities=24% Similarity=0.266 Sum_probs=163.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
++|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+++... .++..
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-EGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCC-----cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-cCCEE
Confidence 68999999999999999999998776 7889998764332 22223334455566678999999888664 45788
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 140 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDI--------------------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTT--------------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred EEEEEecCCCcHHHHHhhcc--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc
Confidence 99999999999988775432 4678889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
++ .+||+|||++........ .......||+.|+|||++.+... ++.++||||||+++
T Consensus 141 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---------------------~~~~~Di~slG~il 198 (276)
T 2yex_A 141 RD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF---------------------HAEPVDVWSCGIVL 198 (276)
T ss_dssp TC-CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSB---------------------CHHHHHHHHHHHHH
T ss_pred CC-CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCC---------------------CCCcchHHHHHHHH
Confidence 87 999999999986543321 22345679999999997754322 23468999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|..||....
T Consensus 199 ~~l~~g~~p~~~~~ 212 (276)
T 2yex_A 199 TAMLAGELPWDQPS 212 (276)
T ss_dssp HHHHHSSCCCSCSC
T ss_pred HHHHhCCCCCCCCc
Confidence 99999999997654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.03 Aligned_cols=201 Identities=20% Similarity=0.295 Sum_probs=161.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||+||+|++..++ +.+++|.+.... ........++...+....|+|++.+++.+. ....
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~ 95 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQ-----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-DSSS 95 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTC-----CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCC-----CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-cCCE
Confidence 78999999999999999999998776 789999875322 111222334455566678999999988764 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+.+++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~ 155 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK--------------------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEES
T ss_pred EEEEEEcCCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 999999999999999887654 467888999999999999999999999999999999996
Q ss_pred CCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 EGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
.++ ..+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||
T Consensus 156 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-----------------------~~~~~~DiwslG~ 210 (486)
T 3mwu_A 156 SKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-----------------------TYDEKCDVWSAGV 210 (486)
T ss_dssp SSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-----------------------CCCHHHHHHHHHH
T ss_pred cCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-----------------------CCCchhhHHHHHH
Confidence 432 379999999998764432 2345689999999997643 3556789999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|+|++|..||....
T Consensus 211 il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 211 ILYILLSGTPPFYGKN 226 (486)
T ss_dssp HHHHHHHSSCSSCCSS
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=296.07 Aligned_cols=204 Identities=20% Similarity=0.263 Sum_probs=155.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..++|++.++||+|+||.||+|++..++ +.+++|.+...... +...+.++...+.+..+...+.. +...++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~---~~~~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRW---FGVEGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTC-----CEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEE---EEEETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCC-----cEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEE---EEeeCC
Confidence 3479999999999999999999988776 78899976543322 22233333444443322222222 234567
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~-------------------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl 136 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCS-------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred EEEEEEECC-CCCHHHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEE
Confidence 889999999 799999997532 146788899999999999999999999999999999999
Q ss_pred ---eCCCCeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 296 ---SEGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 296 ---~~~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
+.++ .+||+|||+++.+...... ......||+.|+|||++.+ ..++.+
T Consensus 137 ~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----------------------~~~s~~ 193 (483)
T 3sv0_A 137 GLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG----------------------IEQSRR 193 (483)
T ss_dssp CCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT----------------------CCCCHH
T ss_pred ecCCCCC-eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC----------------------CCCChH
Confidence 4555 9999999999876544321 1235789999999995543 446678
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
+|||||||+||||++|+.||.....
T Consensus 194 sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 194 DDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred HHHHHHHHHHHHHHhCCCCCccccc
Confidence 8999999999999999999986443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.35 Aligned_cols=207 Identities=13% Similarity=0.092 Sum_probs=154.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCC---CCCceEEeecccchhHHHHHHHHHHHHhhccCCCceee---------
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSK---NDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYG--------- 205 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~---~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~--------- 205 (397)
.++|++.+.||+|+||.||+|++..+.... ..+.+++|.+....... ++...+....|+|++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~-----~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLF-----NEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHH-----HHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHH-----HHHHHHHHhcccchhhhhhhhccCC
Confidence 479999999999999999999988742110 12789999887542211 1122222234555544
Q ss_pred ------eeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH
Q 015991 206 ------FFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH 279 (397)
Q Consensus 206 ------~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH 279 (397)
+++.....+...++||||+ +++|.+++.... ...+++..+..++.|++.||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------------------~~~l~~~~~~~i~~qi~~~L~~LH 176 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP------------------KHVLSERSVLQVACRLLDALEFLH 176 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG------------------GGCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4444434467899999999 899999998641 225788899999999999999999
Q ss_pred HCCceecCCCCCceEEeCCC-CeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccc
Q 015991 280 STGIVHRDIKPQNVIFSEGS-RTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 352 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~-~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~ 352 (397)
++||+||||||+|||++.++ ..+||+|||+++.+...... ......||+.|+|||++.+
T Consensus 177 ~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------------- 242 (352)
T 2jii_A 177 ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-------------- 242 (352)
T ss_dssp HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------------
T ss_pred hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--------------
Confidence 99999999999999999864 27999999999876543321 1234589999999996543
Q ss_pred cchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 353 ALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 353 ~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++||||||++||||++|+.||....
T Consensus 243 --------~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 243 --------CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp --------CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred --------CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 345667899999999999999999998653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=274.17 Aligned_cols=197 Identities=22% Similarity=0.305 Sum_probs=158.6
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc------
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK------ 212 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~------ 212 (397)
++|++.+.||+|+||.||+|++..++ +.+++|.+...... ..++...+....|++++.+++.+..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDG-----KTYVIKRVKYNNEK----AEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTC-----CEEEEEEEECCSGG----GHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cccceeeeeccCCceEEEEEEEcCCC-----eEEEEEEeccccHH----HHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 68999999999999999999998776 78999988654321 1223344455578888887765422
Q ss_pred ---------cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCc
Q 015991 213 ---------KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGI 283 (397)
Q Consensus 213 ---------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gi 283 (397)
....+++||||+++++|.+++.... ...+++..+..++.|++.||.|||++||
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i 143 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR------------------GEKLDKVLALELFEQITKGVDYIHSKKL 143 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG------------------GSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 2356899999999999999997642 2246788899999999999999999999
Q ss_pred eecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 284 VHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 284 iHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
+||||||+|||+++++ .+||+|||+++....... .....||+.|+|||++.+ ..+
T Consensus 144 ~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----------------------~~~ 198 (284)
T 2a19_B 144 INRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISS----------------------QDY 198 (284)
T ss_dssp ECSCCSGGGEEEEETT-EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHC----------------------SCC
T ss_pred eeccCCHHHEEEcCCC-CEEECcchhheecccccc--ccccCCcccccChhhhcc----------------------CCC
Confidence 9999999999999987 999999999987654322 345679999999996543 346
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~elltg~~Pf~ 387 (397)
+.++||||||+++|||++|..||.
T Consensus 199 ~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 199 GKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp CTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred cchhhhHHHHHHHHHHHhcCCcch
Confidence 678899999999999999998874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=280.82 Aligned_cols=208 Identities=18% Similarity=0.210 Sum_probs=164.8
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEec----CCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeec
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLA----KKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFEN 209 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~----~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~ 209 (397)
..+..++|++.+.||+|+||.||+|++. .++ +.+++|++............++...+....|++++.+++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG-----EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCC-----EEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCc-----eEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3456688999999999999999999853 333 7899999876554444445556666777789999998886
Q ss_pred cccc-CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 210 SSKK-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 210 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
+... ....++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~di 171 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------------------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHST-------------------TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCC
Confidence 5443 347899999999999999997653 13577888999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
||+|||++.++ .+||+|||+++........ ......+|..|+|||++.+. .++.+
T Consensus 172 kp~NIli~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~ 228 (326)
T 2w1i_A 172 ATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES----------------------KFSVA 228 (326)
T ss_dssp CGGGEEEEETT-EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC----------------------EEEHH
T ss_pred CcceEEEcCCC-cEEEecCcchhhccccccccccccCCCCceeEECchhhcCC----------------------CCCch
Confidence 99999999987 9999999999876544321 12335677889999966433 35567
Q ss_pred hhhHHHHHHHHHHHcCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
+||||||+++|||++|..||..
T Consensus 229 ~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 229 SDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp HHHHHHHHHHHHHHHTTCGGGS
T ss_pred hhHHHHHHHHHHHHhcCCCCCC
Confidence 8999999999999999998863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=274.88 Aligned_cols=202 Identities=25% Similarity=0.356 Sum_probs=163.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
..+.|++.+.||+|+||.||+|++..++ +.+++|.+.... ........++...+....|++++.+++.+.. +.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCC-----cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CC
Confidence 3368999999999999999999988776 788999876432 1222233344555666789999998886644 56
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+++++|.+++... .+++..+..++.|++.||.|||+.||+||||||+||++
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~~---------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 152 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEPG---------------------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL 152 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTTS---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred eEEEEEEeCCCCcHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE
Confidence 899999999999999998653 35778899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||++........ ......||+.|+|||++.+ ..++.++||||||++
T Consensus 153 ~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~slG~i 208 (303)
T 3a7i_A 153 SEHG-EVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQ----------------------SAYDSKADIWSLGIT 208 (303)
T ss_dssp CTTS-CEEECCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTT----------------------CCBCTHHHHHHHHHH
T ss_pred CCCC-CEEEeecccceecCcccc-ccCccCCCcCccCHHHHhc----------------------CCCCchhhhHHHHHH
Confidence 9987 999999999987644322 2345689999999996643 345667899999999
Q ss_pred HHHHHcCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLH 389 (397)
Q Consensus 376 l~elltg~~Pf~~~ 389 (397)
+|||++|..||...
T Consensus 209 l~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 209 AIELARGEPPHSEL 222 (303)
T ss_dssp HHHHHHSSCTTTTS
T ss_pred HHHHccCCCCCCCc
Confidence 99999999999653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=279.03 Aligned_cols=213 Identities=16% Similarity=0.171 Sum_probs=158.9
Q ss_pred hcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 133 RTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 133 ~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
...+..++|++.+.||+|+||+||+|.+..++.. ....+++|.+..... .......++...+....|++++.+++.+.
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---C-CEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCC-ccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3456778999999999999999999998765321 114588898865322 22223344556667778999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+
T Consensus 117 -~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 176 (333)
T 1mqb_A 117 -KYKPMMIITEYMENGALDKFLREKD-------------------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR 176 (333)
T ss_dssp -SSSSEEEEEECCTTEEHHHHHHHTT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred -cCCCcEEEEeCCCCCcHHHHHHhCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh
Confidence 4567999999999999999997642 24677889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|||++.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++||
T Consensus 177 NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di 233 (333)
T 1mqb_A 177 NILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY----------------------RKFTSASDV 233 (333)
T ss_dssp GEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHS----------------------CCCCHHHHH
T ss_pred eEEECCCC-cEEECCCCcchhhccccccccccCCCCccccccCchhccc----------------------CCCCchhhh
Confidence 99999987 9999999999876543221 1223456789999996543 345667899
Q ss_pred HHHHHHHHHHHc-CCCCCCCC
Q 015991 370 YSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~ellt-g~~Pf~~~ 389 (397)
||||+++|||++ |+.||...
T Consensus 234 ~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 234 WSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp HHHHHHHHHHHTTSCCTTTTC
T ss_pred HHHHHHHHHHHcCCCCCcccC
Confidence 999999999998 99999653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=283.53 Aligned_cols=205 Identities=21% Similarity=0.262 Sum_probs=156.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-----HHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-----IWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-----~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|.+......+ .....++...+....|+|++.+++.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCC-----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCC-----cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence 4589999999999999999999998776 789999886432211 112223445556667999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+
T Consensus 83 -~~~~~~lv~e~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 141 (346)
T 1ua2_A 83 -HKSNISLVFDFMET-DLEVIIKDNS-------------------LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPN 141 (346)
T ss_dssp -CTTCCEEEEECCSE-EHHHHHTTCC-------------------SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred -eCCceEEEEEcCCC-CHHHHHHhcC-------------------cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHH
Confidence 45678999999996 8888886543 23566778899999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++.+.... .......||+.|+|||++.+.. .++.++||||
T Consensus 142 Nil~~~~~-~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diws 198 (346)
T 1ua2_A 142 NLLLDENG-VLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGAR---------------------MYGVGVDMWA 198 (346)
T ss_dssp GEEECTTC-CEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCS---------------------CCCHHHHHHH
T ss_pred HEEEcCCC-CEEEEecccceeccCCc-ccCCcccccccccCchHhhCCC---------------------CCCchhhhHh
Confidence 99999987 99999999998764332 2234568899999999765322 2556789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|..||....
T Consensus 199 lG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 199 VGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp HHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHCCCCCCCCC
Confidence 9999999999999987643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=279.60 Aligned_cols=220 Identities=16% Similarity=0.191 Sum_probs=160.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.+.||+|+||.||+|++...........+++|.+.... ........++...+....|++++.+++.+..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-
Confidence 34568999999999999999999996543322333789999886432 2222233344555666689999999887654
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
....++||||+.+++|.+++...... ......+++..+..++.|++.||.|||++||+||||||+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NI 171 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPR-------------PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 171 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCC-------------SSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhccc-------------ccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHE
Confidence 46789999999999999999876421 01223578888999999999999999999999999999999
Q ss_pred EEeCCC--CeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 294 IFSEGS--RTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 294 Ll~~~~--~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|++.++ ..+||+|||+++........ ......+|+.|+|||++. ...++.++|||
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----------------------~~~~~~~~Di~ 229 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM----------------------EGIFTSKTDTW 229 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH----------------------HCCCCHHHHHH
T ss_pred EEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhc----------------------CCCCCchhhHH
Confidence 998432 37999999999765433222 233457899999999554 33466688999
Q ss_pred HHHHHHHHHHc-CCCCCCCCC
Q 015991 371 SAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~ellt-g~~Pf~~~~ 390 (397)
|||+++|||++ |..||....
T Consensus 230 slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 230 SFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp HHHHHHHHHHTTSCCSSTTCC
T ss_pred HHHHHHHHHHcCCCCCCCCcC
Confidence 99999999998 999997543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=273.83 Aligned_cols=202 Identities=16% Similarity=0.233 Sum_probs=156.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|++.+.||+|+||+||+|++.+ +.+++|.+......+. ..++...+....|++++.+++.....+
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~--~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC--HH--HHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cCChhhceEEeEEecCCCceEEEEEEcC-------CEEEEEEecchhHHHH--HHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4556899999999999999999998753 6789998876543332 233455566678999999998766666
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 149 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRG------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 149 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHH------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CceEEEEecCCCCCHHHHHHhcc------------------cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEE
Confidence 68999999999999999997653 113577889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||++...... .....+|+.|+|||++. ...++.++||||||+
T Consensus 150 ~~~~~-~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~----------------------~~~~~~~~Di~slG~ 202 (278)
T 1byg_A 150 VSEDN-VAKVSDFGLTKEASST----QDTGKLPVKWTAPEALR----------------------EKKFSTKSDVWSFGI 202 (278)
T ss_dssp ECTTS-CEEECCCCC----------------CCTTTSCHHHHH----------------------HCCCCHHHHHHHHHH
T ss_pred EeCCC-cEEEeecccccccccc----ccCCCccccccCHHHhC----------------------CCCCCchhcHHHHHH
Confidence 99887 9999999999765332 22346788999999654 334566789999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |..||....
T Consensus 203 il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 203 LLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp HHHHHHTTSCCSCTTSC
T ss_pred HHHHHHhCCCCCCCCCC
Confidence 9999998 999997643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=276.73 Aligned_cols=216 Identities=23% Similarity=0.324 Sum_probs=152.2
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
..+..++|++.+.||+|+||.||+|++..++ +.+++|.+..... .......++...+....|++++.+++.+..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 84 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKK-----EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCC-----cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence 3456789999999999999999999987766 7899998864332 122223344556677789999999887644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++..++||||+.+++|.+++..... ........+++..+..++.|++.||+|||++||+||||||+|
T Consensus 85 -~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 151 (303)
T 2vwi_A 85 -KDELWLVMKLLSGGSVLDIIKHIVA------------KGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151 (303)
T ss_dssp -SSCEEEEEECCTTCBHHHHHHHHHH------------TTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred -cCCcEEEehhccCCchHHHHHHHhh------------ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 4679999999999999999875310 000123357888999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccc----cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|+++.++ .+||+|||++........ .......||+.|+|||++... ..++.++|
T Consensus 152 il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---------------------~~~~~~~D 209 (303)
T 2vwi_A 152 ILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV---------------------RGYDFKAD 209 (303)
T ss_dssp EEECTTC-CEEECCCHHHHHCC---------------CCCTTCCHHHHHHH---------------------HCCCTHHH
T ss_pred EEEcCCC-CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccc---------------------cCCCchhh
Confidence 9999987 999999999976543321 122346799999999965432 24567889
Q ss_pred hHHHHHHHHHHHcCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~ 389 (397)
|||||+++|||++|+.||...
T Consensus 210 i~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 210 IWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp HHHHHHHHHHHHHSSCTTTTS
T ss_pred HHHHHHHHHHHHhCCCCCccC
Confidence 999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=272.96 Aligned_cols=208 Identities=17% Similarity=0.262 Sum_probs=161.4
Q ss_pred cccCCeEEee-eeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+..++|.+.+ .||+|+||.||+|.+..... ...+++|.+.... ........++...+....|++++.+++.+ .
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~ 80 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKK---QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--Q 80 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---C---CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--E
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCC---cceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe--c
Confidence 3457888887 99999999999998754321 1678899887532 22233334455556666899999998876 3
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 141 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR-------------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 141 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-------------------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC-------------------ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheE
Confidence 456899999999999999986542 2467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|++.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++||||
T Consensus 142 li~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~s 198 (287)
T 1u59_A 142 LLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF----------------------RKFSSRSDVWS 198 (287)
T ss_dssp EEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH----------------------CEECHHHHHHH
T ss_pred EEcCCC-CEEECcccceeeeccCcceeeccccccccccccCHHHhcc----------------------CCCCchhhHHH
Confidence 999987 9999999999876443322 1233467899999996543 34556789999
Q ss_pred HHHHHHHHHc-CCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~ 390 (397)
||+++|||++ |+.||....
T Consensus 199 lG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 199 YGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp HHHHHHHHHTTSCCTTTTCC
T ss_pred HHHHHHHHHcCCCCCcccCC
Confidence 9999999998 999997644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=274.96 Aligned_cols=207 Identities=22% Similarity=0.268 Sum_probs=152.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.+.||+|+||.||+|.+..++ +.+++|++... .........++...+....|++++.+++.+..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 103 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE- 103 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTC-----CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCC-----ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-
Confidence 4578999999999999999999988776 78999987642 22223333445566667789999999887644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+.+++|.+++.... .....+++..+..++.|++.||.|||++||+||||||+||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI 167 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFK----------------KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 167 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCcEEEEEecCCCCCHHHHHHHhc----------------ccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHE
Confidence 568999999999999999987532 0123467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++.++ .+||+|||+++....... ......||+.|+|||++.+ ..++.++||||||
T Consensus 168 l~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Dv~slG 223 (310)
T 2wqm_A 168 FITATG-VVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHE----------------------NGYNFKSDIWSLG 223 (310)
T ss_dssp EECTTS-CEEECCC-------------------CCSSCCHHHHTT----------------------CCCCHHHHHHHHH
T ss_pred EEcCCC-CEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCC----------------------CCCCchhhHHHHH
Confidence 999887 999999999976543322 2344678999999996543 3456678999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLH 389 (397)
Q Consensus 374 v~l~elltg~~Pf~~~ 389 (397)
+++|||++|..||...
T Consensus 224 ~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 224 CLLYEMAALQSPFYGD 239 (310)
T ss_dssp HHHHHHHHSSCTTC--
T ss_pred HHHHHHHhCCCCCccc
Confidence 9999999999999654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=280.54 Aligned_cols=203 Identities=21% Similarity=0.279 Sum_probs=154.4
Q ss_pred CCeEEe-eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 139 DDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 139 ~~f~i~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
++|.+. +.||+|+||+||+|.+..++ +.+++|.+..... .......++.......+|++++.+++.+. ..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTG-----QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-NT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-eC
Confidence 577887 89999999999999998877 7888888764221 11112222222223345789988887664 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++||||+.+++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl 163 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL------------------AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CeEEEEEEecCCCcHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEE
Confidence 78999999999999988875431 235678889999999999999999999999999999999
Q ss_pred EeC---CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 295 FSE---GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 295 l~~---~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
++. ++ .+||+|||+++....... .....||+.|+|||++.+ ..++.++||||
T Consensus 164 ~~~~~~~~-~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diws 218 (327)
T 3lm5_A 164 LSSIYPLG-DIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNY----------------------DPITTATDMWN 218 (327)
T ss_dssp ESCBTTBC-CEEECCGGGCEEC-----------CCCGGGCCHHHHTT----------------------CCCCTHHHHHH
T ss_pred EecCCCCC-cEEEeeCccccccCCccc--cccccCCcCccCCeeecC----------------------CCCCchhhHHH
Confidence 987 55 999999999987643322 245689999999996643 34666789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|||++|+.||....
T Consensus 219 lG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 219 IGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp HHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=279.61 Aligned_cols=205 Identities=23% Similarity=0.309 Sum_probs=161.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc--
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK-- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-- 213 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|.+..... .......++...+....|++++.+++.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTG-----EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCC-----cEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 3479999999999999999999998776 7899998864332 2222333455566667899999988765433
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 214 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
....++||||++ ++|.+++... .+++..+..++.|++.||+|||++||+||||||+
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~~---------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~ 141 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVISTQ---------------------MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS 141 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHHC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred CccceEEEEEeccC-ccHHHHHhhc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 367899999998 5899988754 3567889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc---------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY---------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
|||++.++ .+||+|||+++........ ......||+.|+|||++... ..
T Consensus 142 Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------~~ 199 (353)
T 2b9h_A 142 NLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS---------------------AK 199 (353)
T ss_dssp GEEECTTC-CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSC---------------------CC
T ss_pred HeEEcCCC-cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccC---------------------CC
Confidence 99999987 9999999999876432211 12235789999999965432 23
Q ss_pred CCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 363 LPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 363 ~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
++.++|||||||++|||++|+.||....
T Consensus 200 ~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 200 YSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5668899999999999999999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=275.77 Aligned_cols=204 Identities=24% Similarity=0.309 Sum_probs=160.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEec-CCCCCCCCCceEEeecccchh-----HHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLA-KKPSSKNDGDLVLKKATEYGA-----VEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~-~~~~~~~~~~vavK~~~~~~~-----~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.++|++.+.||+|+||.||+|++. .++ +.+++|.+..... .....+..+...+....|+|++.+++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCC-----EEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 479999999999999999999985 444 6788887753221 12222333344444557899988877654
Q ss_pred ----ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecC
Q 015991 212 ----KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (397)
Q Consensus 212 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrD 287 (397)
......++||||++ ++|.+++.... ...+++..+..++.|++.||+|||++||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~d 145 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVP------------------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSC------------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcc------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 24567999999999 69999987653 12367888999999999999999999999999
Q ss_pred CCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++
T Consensus 146 lkp~Nili~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~ 200 (326)
T 1blx_A 146 LKPQNILVTSSG-QIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQ----------------------SSYATPV 200 (326)
T ss_dssp CCGGGEEECTTC-CEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTT----------------------CCCCTHH
T ss_pred CCHHHeEEcCCC-CEEEecCcccccccCCC--CccccccccceeCHHHHhc----------------------CCCCcch
Confidence 999999999987 99999999998654332 2345678999999996543 3466778
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||||+++|||++|+.||....
T Consensus 201 Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 201 DLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999997643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=274.26 Aligned_cols=212 Identities=22% Similarity=0.213 Sum_probs=164.8
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..+..++|.....||+|+||.||+|++..++ ..+++|.+............++...+....|++++.+++.+. .
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 90 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQ-----VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-E 90 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTC-----CEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-E
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCC-----eEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-e
Confidence 3455566777779999999999999998776 789999887554433333445556666778999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+..++||||+.+++|.+++.... ....+++..+..++.|++.||+|||++||+||||||+||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 153 (295)
T 2clq_A 91 NGFIKIFMEQVPGGSLSALLRSKW-----------------GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV 153 (295)
T ss_dssp TTEEEEEEECCSEEEHHHHHHHTT-----------------CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCcEEEEEEeCCCCCHHHHHHhhc-----------------cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhE
Confidence 568999999999999999998653 122456788889999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+++.+.+.+||+|||+++....... ......||+.|+|||++.+.. ..++.++||||||
T Consensus 154 l~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--------------------~~~~~~~Di~slG 212 (295)
T 2clq_A 154 LINTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGP--------------------RGYGKAADIWSLG 212 (295)
T ss_dssp EEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCHHHHHHGG--------------------GGCSHHHHHHHHH
T ss_pred EEECCCCCEEEeecccccccCCCCC-cccccCCCccccChhhhcCCC--------------------CCCCcHHHHHHHH
Confidence 9998334999999999987543221 234567899999999765432 1256678999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLH 389 (397)
Q Consensus 374 v~l~elltg~~Pf~~~ 389 (397)
+++|||++|+.||...
T Consensus 213 ~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 213 CTIIEMATGKPPFYEL 228 (295)
T ss_dssp HHHHHHHHTSCTTGGG
T ss_pred HHHHHHHHCCCCccCC
Confidence 9999999999999653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=269.43 Aligned_cols=204 Identities=12% Similarity=0.098 Sum_probs=164.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.+..++|++.+.||+|+||+||+|++.+ +.+++|.+.... ........++...+....|+|++.+++.+..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQG-------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETT-------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECC-------eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 4566899999999999999999999853 678888876432 2223334455666777889999999987655
Q ss_pred c-CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--ceecCCC
Q 015991 213 K-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIK 289 (397)
Q Consensus 213 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiHrDIK 289 (397)
. +...++||||+.+++|.+++.... ...+++..+..++.|++.||.|||++| |+|||||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik 140 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGT------------------NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCS------------------SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcc------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence 4 367899999999999999998653 224678889999999999999999999 9999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++ .++|+|||++.... .....||+.|+|||++.+..... ++.++||
T Consensus 141 p~Nil~~~~~-~~~l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~-------------------~~~~~Di 194 (271)
T 3kmu_A 141 SRSVMIDEDM-TARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDT-------------------NRRSADM 194 (271)
T ss_dssp GGGEEECTTS-CEEEEGGGSCCTTS------CTTCBSCGGGSCHHHHHSCGGGS-------------------CHHHHHH
T ss_pred cceEEEcCCc-ceeEEeccceeeec------ccCccCCccccChhhhccCCCCC-------------------CCchhhH
Confidence 9999999987 99999999876432 23457899999999876543321 2236899
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~ 389 (397)
||||+++|||++|+.||...
T Consensus 195 ~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 195 WSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp HHHHHHHHHHHHCSCTTTTS
T ss_pred HHHHHHHHHHHhCCCCcccc
Confidence 99999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=270.89 Aligned_cols=202 Identities=21% Similarity=0.194 Sum_probs=156.5
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.++|++.+.||+|+||+||+|++..++ +.+++|.+... ...+.....++........|++++.+++.+. .+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-~~ 83 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDG-----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-ED 83 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-ET
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCC-----ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-cC
Confidence 378999999999999999999998776 78999987642 1222222223333333338999999988664 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||++||+||||||+|||
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl 147 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYR----------------IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHH----------------HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CeEEEEEEecCCCcHHHHHHhhcc----------------cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEE
Confidence 789999999999999999976520 1124678889999999999999999999999999999999
Q ss_pred EeCCC------------------CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchh
Q 015991 295 FSEGS------------------RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP 356 (397)
Q Consensus 295 l~~~~------------------~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~ 356 (397)
++.++ ..+||+|||.+...... ....||+.|+|||++.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~---------------- 206 (289)
T 1x8b_A 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENY---------------- 206 (289)
T ss_dssp EC--------------------CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCC----------------
T ss_pred EcCCCCCcccccccccccccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCC----------------
Confidence 98432 37999999999876432 2346899999999775431
Q ss_pred hhhccCCCCchhhHHHHHHHHHHHcCCCCCC
Q 015991 357 VLWQLNLPDRFDIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 357 ~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~ 387 (397)
.++.++||||||+++|||++|..++.
T Consensus 207 -----~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 207 -----THLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----TTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred -----CCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 23457899999999999999997764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=276.13 Aligned_cols=218 Identities=15% Similarity=0.193 Sum_probs=157.3
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.+..++|.+.+.||+|+||.||+|++...... ...+++|.+.... ..+.....++...+....|++++.+++.+..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGT--SLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSC--EEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCc--eeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 44568999999999999999999988764321 1578999886432 2223333445566677789999998886654
Q ss_pred cC----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 213 KG----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 213 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+ ...++||||+.+++|.+++...... .....+++..++.++.|++.||.|||++||+||||
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~di 173 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLE--------------TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDL 173 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBT--------------TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCC
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhh--------------cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 33 2469999999999999998654210 12345788899999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
||+|||++.++ .+||+|||+++......... .....+++.|+|||.+.+ ..++.++
T Consensus 174 kp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~ 230 (313)
T 3brb_A 174 AARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD----------------------RVYTSKS 230 (313)
T ss_dssp SGGGEEECTTS-CEEECSCSCC----------------CCGGGSCHHHHHS----------------------SCCCHHH
T ss_pred CcceEEEcCCC-cEEEeecCcceecccccccCcccccCCCccccCchhhcC----------------------CCccchh
Confidence 99999999987 99999999998765433222 234567889999996543 3456678
Q ss_pred hhHHHHHHHHHHHc-CCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 368 Dv~SlGv~l~ellt-g~~Pf~~~~~ 391 (397)
||||||+++|||++ |..||.....
T Consensus 231 Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 231 DVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhHHHHHHHHHHHhcCCCCCccCCH
Confidence 99999999999999 8999976543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=281.44 Aligned_cols=202 Identities=21% Similarity=0.281 Sum_probs=139.2
Q ss_pred ccCCeEEee-eeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccc---c
Q 015991 137 RKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS---K 212 (397)
Q Consensus 137 ~~~~f~i~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~---~ 212 (397)
..++|++.+ .||+|+||+||+|.+..++ +.+++|.+........ ++........|++++.+++.+. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~----e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTG-----QKCALKLLYDSPKARQ----EVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEESSHHHHH----HHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCC-----CEEEEEEecCcHHHHH----HHHHHHHhcCCCChHHHHHHHhhccC
Confidence 447999955 6999999999999998877 8899998865433222 2222233345666666655443 2
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+..+++||||+.+++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~N 158 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERG------------------DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-------------------CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCceEEEEEeccCCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 3456899999999999999998653 2256888999999999999999999999999999999
Q ss_pred eEEeCCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
||++.++ ..+||+|||+++..... ......+|+.|+|||++... .++.++|||
T Consensus 159 Ill~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~Di~ 213 (336)
T 3fhr_A 159 LLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPE----------------------KYDKSCDMW 213 (336)
T ss_dssp EEESCSSTTCCEEECCCTTCEEC-------------------------C----------------------HHHHHHHHH
T ss_pred EEEEecCCCceEEEeccccceecccc---ccccCCCCcCccChhhhCCC----------------------CCCchhhHH
Confidence 9998643 26999999999765432 22456789999999966432 345578999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+++|||++|..||....
T Consensus 214 slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 214 SLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp HHHHHHHHHHHSSCCC----
T ss_pred HHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999996544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=282.68 Aligned_cols=203 Identities=19% Similarity=0.264 Sum_probs=156.0
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhh---ccCCCceeeeeecc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACA---NCCADFVYGFFENS 210 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~---~~~~~~i~~~~~~~ 210 (397)
...++|++.++||+|+||+||+|++..++ +.+|+|.+...... +...+.++...+. +..+.+++.+.+.+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQ-----EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCC-----cEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 34589999999999999999999998776 78999988754322 1222222222222 22334567666655
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH--HCCceecCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH--STGIVHRDI 288 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH--~~giiHrDI 288 (397)
. .++..++||||++ ++|.+++..... ..+++..++.++.|++.||.||| +.||+||||
T Consensus 126 ~-~~~~~~lv~e~~~-~~L~~~l~~~~~------------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDl 185 (382)
T 2vx3_A 126 M-FRNHLCLVFEMLS-YNLYDLLRNTNF------------------RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185 (382)
T ss_dssp E-ETTEEEEEEECCC-CBHHHHHHHTTT------------------SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCC
T ss_pred c-cCCceEEEEecCC-CCHHHHHhhcCc------------------CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCC
Confidence 3 3578999999997 599999987531 24677889999999999999999 579999999
Q ss_pred CCCceEEeC--CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 289 KPQNVIFSE--GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 289 Kp~NILl~~--~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
||+|||++. ++ .+||+|||+|+..... .....||+.|+|||++.+ ..++.+
T Consensus 186 kp~NIll~~~~~~-~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~----------------------~~~~~~ 238 (382)
T 2vx3_A 186 KPENILLCNPKRS-AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLG----------------------MPYDLA 238 (382)
T ss_dssp SGGGEEESSTTSC-CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTT----------------------CCCCTH
T ss_pred CcccEEEecCCCC-cEEEEeccCceecccc----cccccCCccccChHHHcC----------------------CCCCcH
Confidence 999999954 44 8999999999876432 245689999999996543 346678
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
+|||||||++|||++|+.||....
T Consensus 239 ~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 239 IDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCC
Confidence 899999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=276.01 Aligned_cols=209 Identities=22% Similarity=0.309 Sum_probs=159.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.+.||+|+||.||+|++..++ +.+++|.+............++...+....|++++.+++.+.. ++.
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETG-----ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTC-----CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-C
T ss_pred CccceeecceeccCCCeEEEEEEEcCCC-----cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCe
Confidence 4478999999999999999999998776 7888888765433222233334455566689999999887654 467
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELD-------------------RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhhc-------------------cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC
Confidence 999999999999999987643 1367788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||++....... .......||+.|+|||++..... ....++.++||||||+++
T Consensus 152 ~~~-~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-----------------~~~~~~~~~Di~slG~il 212 (302)
T 2j7t_A 152 LEG-DIRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETM-----------------KDTPYDYKADIWSLGITL 212 (302)
T ss_dssp TTS-CEEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHT-----------------TSTTTTTHHHHHHHHHHH
T ss_pred CCC-CEEEEECCCCccccccc-cccccccCChhhcCCeeeccccC-----------------CCCCCchhhhHHHHHHHH
Confidence 887 99999999986432221 12244679999999997743211 123467789999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|..||...
T Consensus 213 ~~l~~g~~p~~~~ 225 (302)
T 2j7t_A 213 IEMAQIEPPHHEL 225 (302)
T ss_dssp HHHHHSSCTTTTS
T ss_pred HHHhcCCCCCccC
Confidence 9999999999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=274.14 Aligned_cols=206 Identities=17% Similarity=0.218 Sum_probs=159.1
Q ss_pred cccCCeEEee-eeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
+..++|++.+ .||+|+||+||+|.+..... .+.+++|.+..... .......++...+....|++++.+++.+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-- 87 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKV---VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-- 87 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSS---EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCc---eeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--
Confidence 4457899998 99999999999996543211 16788998764322 1122334455566667899999998876
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
..+..++||||+.+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N 147 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNR--------------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 147 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCc--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcce
Confidence 4567899999999999999998653 46778899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
||++.++ .+||+|||+++......... .....+|+.|+|||++.+ ..++.++|||
T Consensus 148 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~ 204 (291)
T 1xbb_A 148 VLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY----------------------YKFSSKSDVW 204 (291)
T ss_dssp EEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH----------------------CEEEHHHHHH
T ss_pred EEEeCCC-cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc----------------------CCCChhhhHH
Confidence 9999987 99999999998765433221 223456789999996543 3455678999
Q ss_pred HHHHHHHHHHc-CCCCCCCC
Q 015991 371 SAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 371 SlGv~l~ellt-g~~Pf~~~ 389 (397)
|||+++|||++ |..||...
T Consensus 205 slG~il~~l~~~g~~p~~~~ 224 (291)
T 1xbb_A 205 SFGVLMWEAFSYGQKPYRGM 224 (291)
T ss_dssp HHHHHHHHHHTTTCCSSTTC
T ss_pred HHHHHHHHHHhcCCCCCCCC
Confidence 99999999999 99999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=274.85 Aligned_cols=205 Identities=19% Similarity=0.249 Sum_probs=155.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEec-CCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhc---cCCCceeeeee
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLA-KKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACAN---CCADFVYGFFE 208 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~-~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~---~~~~~i~~~~~ 208 (397)
....++|++.+.||+|+||+||+|.+. .++ +.+++|.+...... ....+.++...+.+ ..+++++.+++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGG-----RHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCC-----cEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 345589999999999999999999984 344 77889988653322 11122222223322 23445677766
Q ss_pred cccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 209 NSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+. .++..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++||+||||
T Consensus 85 ~~~-~~~~~~lv~e~~-~~~l~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 144 (339)
T 1z57_A 85 WFE-HHGHICIVFELL-GLSTYDFIKENG------------------FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDL 144 (339)
T ss_dssp EEE-ETTEEEEEEECC-CCBHHHHHHHTT------------------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred ccc-cCCcEEEEEcCC-CCCHHHHHHhcC------------------CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 553 356899999999 789999987653 124577889999999999999999999999999
Q ss_pred CCCceEEeCC------------------CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccc
Q 015991 289 KPQNVIFSEG------------------SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 350 (397)
Q Consensus 289 Kp~NILl~~~------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~ 350 (397)
||+|||++.+ ...+||+|||+++..... .....||+.|+|||++.+
T Consensus 145 kp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~------------ 208 (339)
T 1z57_A 145 KPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILA------------ 208 (339)
T ss_dssp CGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTT------------
T ss_pred CHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhC------------
Confidence 9999999873 127999999999764322 245689999999996543
Q ss_pred cccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 351 ATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 351 ~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++|||||||++|||++|..||....
T Consensus 209 ----------~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 209 ----------LGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ----------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 346678899999999999999999997654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=278.19 Aligned_cols=224 Identities=17% Similarity=0.225 Sum_probs=161.5
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhcc-CCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANC-CADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (397)
+.+..++|++.+.||+|+||.||+|++..++.. ..+++|.+..... .......++...+... .|++++.+++.+.
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEE---EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcc---cceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 345668999999999999999999998876511 1347787764322 1222223344445555 8999999988764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++..++||||+++++|.+++............. ........+++..++.++.|++.||+|||++||+||||||+
T Consensus 97 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 171 (327)
T 1fvr_A 97 -HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA----IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171 (327)
T ss_dssp -ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHH----HHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred -eCCceEEEEecCCCCCHHHHHHhccccccccccc----ccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccc
Confidence 4578999999999999999998653100000000 00012235788899999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||
T Consensus 172 NIl~~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di~s 226 (327)
T 1fvr_A 172 NILVGENY-VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNY----------------------SVYTTNSDVWS 226 (327)
T ss_dssp GEEECGGG-CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHH----------------------CEECHHHHHHH
T ss_pred eEEEcCCC-eEEEcccCcCccccccc--cccCCCCCccccChhhhcc----------------------ccCCchhcchH
Confidence 99999887 99999999997543221 2234567889999996543 34556789999
Q ss_pred HHHHHHHHHc-CCCCCCCCC
Q 015991 372 AGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~ellt-g~~Pf~~~~ 390 (397)
||+++|||++ |..||....
T Consensus 227 lG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 227 YGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp HHHHHHHHHTTSCCTTTTCC
T ss_pred HHHHHHHHHcCCCCCCCCCc
Confidence 9999999998 999997653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=273.05 Aligned_cols=202 Identities=23% Similarity=0.333 Sum_probs=158.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.+.||+|+||.||+|.+..++ +.+++|.+......+.. .++...+....|++++.+++.+.. ++.
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~--~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 98 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETG-----QIVAIKQVPVESDLQEI--IKEISIMQQCDSPHVVKYYGSYFK-NTD 98 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTC-----CEEEEEEEETTSCCHHH--HHHHHHHHTCCCTTBCCEEEEEEE-TTE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCC-----CEEEEEecCchHHHHHH--HHHHHHHHhCCCCCCccEEEEEEe-CCE
Confidence 4578999999999999999999998776 78999988754433322 233445556689999998886644 568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 159 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-------------------KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN 159 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred EEEEeecCCCCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC
Confidence 999999999999999987432 2467788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||++........ ......||+.|+|||++.+. .++.++||||||+++
T Consensus 160 ~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~il 215 (314)
T 3com_A 160 TEG-HAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEI----------------------GYNCVADIWSLGITA 215 (314)
T ss_dssp TTC-CEEECCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSS----------------------CBCTTHHHHHHHHHH
T ss_pred CCC-CEEEeecccchhhhhhcc-ccCccCCCCCccChhhcCCC----------------------CCCccccHHHHHHHH
Confidence 987 999999999977644322 23456789999999966443 455678999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|..||...
T Consensus 216 ~~l~~g~~p~~~~ 228 (314)
T 3com_A 216 IEMAEGKPPYADI 228 (314)
T ss_dssp HHHHHSSCTTTTS
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.10 Aligned_cols=209 Identities=19% Similarity=0.221 Sum_probs=160.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
.+..++|++.+.||+|+||.||+|.+..++... ..+++|+...... .......++...+....|+|++.+++.+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-- 461 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 461 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCC--EEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCcc--EEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--
Confidence 445678999999999999999999987643221 5688888764332 22223334455666678999999988763
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..|+||||+.+++|.++++.... .+++..+..++.|++.||+|||++||+||||||+||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~-------------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NI 522 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKF-------------------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 522 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTT-------------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cCceEEEEEcCCCCcHHHHHHhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhE
Confidence 4568999999999999999986532 356788889999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+++..............+|+.|+|||++. ...++.++||||||
T Consensus 523 Ll~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~~DiwSlG 579 (656)
T 2j0j_A 523 LVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN----------------------FRRFTSASDVWMFG 579 (656)
T ss_dssp EEEETT-EEEECCCCCCCSCCC----------CCGGGCCHHHHH----------------------HCCCCHHHHHHHHH
T ss_pred EEeCCC-CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhc----------------------CCCCCchhhHHHHH
Confidence 999987 9999999999877554443344556788999999554 34566788999999
Q ss_pred HHHHHHHc-CCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~ 389 (397)
+++|||++ |..||...
T Consensus 580 ~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 580 VCMWEILMHGVKPFQGV 596 (656)
T ss_dssp HHHHHHHTTSCCTTTTC
T ss_pred HHHHHHHHcCCCCCCCC
Confidence 99999997 99999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=282.06 Aligned_cols=207 Identities=22% Similarity=0.283 Sum_probs=146.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
..++|++.+.||+|+||+||+|++..++ +.+++|++........ ...++...+....|+|++.+++.+...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~-~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTG-----MSVAIKKVIQDPRFRN-RELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTC-----CEEEEEEEECCTTCCC-HHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEecCccccH-HHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 4489999999999999999999998876 7899998754322111 1122333344457888888877654322
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH--HCCceecCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH--STGIVHRDI 288 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH--~~giiHrDI 288 (397)
..+++||||+++ +|.+.+.... .....+++..+..++.|++.||.||| ++||+||||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dl 157 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYY----------------RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDI 157 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHH----------------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCC
T ss_pred cccceeEEEEeecccc-cHHHHHHHHh----------------hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcC
Confidence 237899999996 5554443321 12235677889999999999999999 999999999
Q ss_pred CCCceEEeC-CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 289 KPQNVIFSE-GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 289 Kp~NILl~~-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
||+|||++. ++ .+||+|||+++....... .....||+.|+|||++.+.. .++.++
T Consensus 158 kp~NIll~~~~~-~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~ 213 (360)
T 3e3p_A 158 KPHNVLVNEADG-TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQ---------------------HYTTAV 213 (360)
T ss_dssp CGGGEEEETTTT-EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCS---------------------SCCTHH
T ss_pred CHHHEEEeCCCC-cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCC---------------------CCCcHH
Confidence 999999997 55 999999999987654332 24567899999999764322 356788
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||||++|||++|+.||....
T Consensus 214 Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 214 DIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999999999999999997654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=280.54 Aligned_cols=198 Identities=24% Similarity=0.345 Sum_probs=156.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccCC-
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGG- 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~- 215 (397)
++|++.+.||+|+||+||+|.+..++ +.+++|++..... .......++...+....|+|++.+++.+...+.
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSG-----EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCC-----CEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 79999999999999999999998877 8899998875322 222333345556666789999988887654432
Q ss_pred ----eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 216 ----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 216 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.+++||||+. ++|.+++.. .+++..+..++.|++.||+|||++||+||||||+
T Consensus 117 ~~~~~~~lv~e~~~-~~l~~~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 173 (371)
T 4exu_A 117 RNFYDFYLVMPFMQ-TDLQKIMGM----------------------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 173 (371)
T ss_dssp TTCCCCEEEEECCC-EEHHHHTTS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ccceeEEEEEcccc-ccHHHHhhc----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHH
Confidence 3499999999 578777632 2578889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++..... .....||+.|+|||++.+. ..++.++||||
T Consensus 174 NIll~~~~-~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~---------------------~~~~~~~Diws 227 (371)
T 4exu_A 174 NLAVNEDC-ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSW---------------------MHYNQTVDIWS 227 (371)
T ss_dssp GEEECTTC-CEEECSTTCC------------CTTCCCTTSCHHHHSCC---------------------SCCCTTHHHHH
T ss_pred HeEECCCC-CEEEEecCcccccccC----cCCcccCccccCHHHhcCC---------------------CCCCcHHhHHH
Confidence 99999987 9999999999865332 2456789999999976542 24566789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||++|||++|+.||....
T Consensus 228 lG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 228 VGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp HHHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999997654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=279.52 Aligned_cols=206 Identities=22% Similarity=0.327 Sum_probs=160.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC---
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (397)
.++|++.+.||+|+||.||+|++. + +.+++|.+..........+.++. ......|+|++.+++......
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~-----~~vavK~~~~~~~~~~~~e~~~~-~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR--G-----EEVAVKIFSSREERSWFREAEIY-QTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--T-----EEEEEEEECGGGHHHHHHHHHHH-HHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEEc--C-----ccEEEEEeCchhHHHHHHHHHHH-HHhhcCCCcEEEEEeeecccCCcc
Confidence 368999999999999999999874 2 78999998765444333322222 222367999999888765544
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH--------HCCceec
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH--------STGIVHR 286 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH--------~~giiHr 286 (397)
...++||||+.+++|.+++... .+++..+..++.|++.||.||| +.||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 171 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---------------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---------------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred ceeEEEEeecCCCcHHHHHhcc---------------------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence 3789999999999999999764 3567888999999999999999 8999999
Q ss_pred CCCCCceEEeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
||||+|||++.++ .+||+|||+++........ ......||+.|+|||++.+...... ..+
T Consensus 172 Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----------------~~~ 234 (342)
T 1b6c_B 172 DLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH----------------FES 234 (342)
T ss_dssp CCSGGGEEECTTS-CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTC----------------HHH
T ss_pred CCCHHHEEECCCC-CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccc----------------ccc
Confidence 9999999999987 9999999999776543322 2345689999999998765432211 012
Q ss_pred CCchhhHHHHHHHHHHHcC----------CCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVCT----------VRRLCLH 389 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~elltg----------~~Pf~~~ 389 (397)
+.++||||||+++|||++| ..||...
T Consensus 235 ~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 3578999999999999999 7787654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.39 Aligned_cols=208 Identities=16% Similarity=0.243 Sum_probs=158.3
Q ss_pred ccCCeEEee-eeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..+++.+.+ +||+|+||.||+|.+...+.. ..+++|.++... ........++...+....|+|++.+++.+..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-- 407 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQ---IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-- 407 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCE---EEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCc---EEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--
Confidence 445677776 899999999999988643211 568999887532 1122233345566677789999999987643
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++|||||||||+|||
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 468 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR-------------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT-------------------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence 56999999999999999986542 24678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++.++ .+||+|||+++.+....... .....+|+.|+|||++ ....++.++|||||
T Consensus 469 l~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~----------------------~~~~~~~~sDvwSl 525 (613)
T 2ozo_A 469 LVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI----------------------NFRKFSSRSDVWSY 525 (613)
T ss_dssp EEETT-EEEECCCSTTTTCC--------------CCTTSCHHHH----------------------HHCCCCHHHHHHHH
T ss_pred EcCCC-cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhh----------------------cCCCCCcHHHHHHH
Confidence 99987 99999999998765433221 1233567899999954 44456778899999
Q ss_pred HHHHHHHHc-CCCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~~ 391 (397)
||+||||++ |+.||.....
T Consensus 526 Gv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 526 GVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp HHHHHHHHTTSCCTTTTCCS
T ss_pred HHHHHHHHHCCCCCCCCCCH
Confidence 999999998 9999976544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=271.54 Aligned_cols=208 Identities=20% Similarity=0.215 Sum_probs=161.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh----HHHHHHHHHHHHhhccCCCceeeeeeccc-c
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA----VEIWMNERVRRACANCCADFVYGFFENSS-K 212 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~----~e~~~~~~~~~~~~~~~~~~i~~~~~~~~-~ 212 (397)
.++|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++...+....|++++.+++.+. .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETL-----CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTC-----CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCC-----cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 379999999999999999999988776 7889998865321 12233344556667778999999988764 3
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+...++||||+.++ |.+++.... ...+++..+..++.|++.||+|||++||+||||||+|
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~N 139 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVP------------------EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN 139 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHST------------------TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCeEEEEehhccCC-HHHHHHhCc------------------ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence 346789999999976 777766532 2256788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||++.++ .+||+|||++....... ........||+.|+|||++.+... .++.++||||
T Consensus 140 Il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--------------------~~~~~~Di~s 198 (305)
T 2wtk_C 140 LLLTTGG-TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT--------------------FSGFKVDIWS 198 (305)
T ss_dssp EEECTTC-CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSC--------------------EESHHHHHHH
T ss_pred EEEcCCC-cEEeeccccccccCccccccccccCCCCCCCcChhhccCccc--------------------CCcchhhHHH
Confidence 9999987 99999999998664322 112345678999999997754321 1245789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|||++|..||....
T Consensus 199 lG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 199 AGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp HHHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHhCCCCCCCch
Confidence 9999999999999997643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=270.55 Aligned_cols=205 Identities=24% Similarity=0.324 Sum_probs=160.0
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch----hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
.|..+++||+|+||.||+|.+.+ +.+++|++.... ........++...+....|++++.+++.+.. ++
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 103 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNN-------TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-GD 103 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSS-------CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccCCccccCCCeEEEEEEECC-------ceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-CC
Confidence 35556999999999999998732 678888875421 1222233344555666689999999887644 56
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+.+++|.+++.... ....+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili 166 (307)
T 2nru_A 104 DLCLVYVYMPNGSLLDRLSCLD-----------------GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL 166 (307)
T ss_dssp SCEEEEECCTTCBHHHHHHTGG-----------------GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ceEEEEEecCCCcHHHHHHhcc-----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE
Confidence 7899999999999999987543 12346788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+.++ .+||+|||+++........ ......||+.|+|||++.+ .++.++||||||+
T Consensus 167 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------------------~~~~~~Dv~slG~ 222 (307)
T 2nru_A 167 DEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-----------------------EITPKSDIYSFGV 222 (307)
T ss_dssp CTTC-CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-----------------------EECTHHHHHHHHH
T ss_pred cCCC-cEEEeecccccccccccccccccccCCCcCcCChHHhcC-----------------------CCCccchhHHHHH
Confidence 9987 9999999999765433221 2344679999999997643 2456789999999
Q ss_pred HHHHHHcCCCCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~~~~ 393 (397)
++|||++|..||.....++
T Consensus 223 il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 223 VLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp HHHHHHHCCCSBCTTBSSS
T ss_pred HHHHHHHCCCCcccCcchH
Confidence 9999999999998765443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=279.05 Aligned_cols=205 Identities=18% Similarity=0.256 Sum_probs=152.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-----------HHHHHHHHHHHHhhccCCCcee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----------VEIWMNERVRRACANCCADFVY 204 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----------~e~~~~~~~~~~~~~~~~~~i~ 204 (397)
...++|++.+.||+|+||.||+|.+.. + +.+++|++..... .......++...+....|+|++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-G-----IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-S-----CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-C-----CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 355899999999999999999998765 3 7899998753211 1112333445556666799998
Q ss_pred eeeecccc----cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH
Q 015991 205 GFFENSSK----KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS 280 (397)
Q Consensus 205 ~~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~ 280 (397)
.+++.+.. ....+++||||++ ++|.+.+.... ..+++..+..++.|++.||.|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~ 152 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-------------------IVISPQHIQYFMYHILLGLHVLHE 152 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-------------------SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-------------------cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 88776532 2347899999999 68888877543 246788899999999999999999
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 360 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (397)
+||+||||||+|||++.++ .+||+|||+++...... ......+|+.|+|||++.+.
T Consensus 153 ~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--------------------- 208 (362)
T 3pg1_A 153 AGVVHRDLHPGNILLADNN-DITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQF--------------------- 208 (362)
T ss_dssp TTCCCCCCCGGGEEECTTC-CEEECCTTC-----------------CGGGCCHHHHTTC---------------------
T ss_pred CcCEecCCChHHEEEcCCC-CEEEEecCccccccccc--ccceecccceecCcHHhcCC---------------------
Confidence 9999999999999999887 99999999997543332 23456789999999976542
Q ss_pred cCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 361 LNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 361 ~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++|||||||++|||++|+.||....
T Consensus 209 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 209 KGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 235667899999999999999999997654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=271.10 Aligned_cols=209 Identities=16% Similarity=0.133 Sum_probs=153.3
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.+..++|++.+.||+|+||+||+|++....... ..+++|.+.... ........++...+....|++++.+++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCE--EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCce--eEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 345689999999999999999999875533111 357888876432 122233334455566668999999988765
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.. ..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+
T Consensus 92 ~~--~~~~v~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 150 (291)
T 1u46_A 92 TP--PMKMVTELAPLGSLLDRLRKHQ-------------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 150 (291)
T ss_dssp SS--SCEEEEECCTTCBHHHHHHHHG-------------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred cC--CceeeEecccCCCHHHHHHhcc-------------------CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchh
Confidence 43 4889999999999999997642 14677889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|||++.++ .+||+|||+++........ ......+|+.|+|||++.+ ..++.++||
T Consensus 151 Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------------------~~~~~~~Di 207 (291)
T 1u46_A 151 NLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT----------------------RTFSHASDT 207 (291)
T ss_dssp GEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH----------------------CEEEHHHHH
T ss_pred eEEEcCCC-CEEEccccccccccccccchhhhccCCCCceeeCchhhcC----------------------CCCCchhhH
Confidence 99999987 9999999999876443221 2234567889999996543 335567899
Q ss_pred HHHHHHHHHHHc-CCCCCCCC
Q 015991 370 YSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~ellt-g~~Pf~~~ 389 (397)
||||+++|||++ |+.||...
T Consensus 208 ~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 208 WMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp HHHHHHHHHHHTTSCCTTTTC
T ss_pred HHHHHHHHHHHhCCCCCcccC
Confidence 999999999999 99999654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.48 Aligned_cols=206 Identities=21% Similarity=0.268 Sum_probs=155.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhc--------cCCCcee
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACAN--------CCADFVY 204 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~--------~~~~~i~ 204 (397)
.+..++|++.+.||+|+||+||+|++..++ +.+++|.+....... ...+.++...+.+ ..|++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNN-----THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCC-----cEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 455689999999999999999999988776 889999887543221 1112222223332 2367787
Q ss_pred eeeeccccc---CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC
Q 015991 205 GFFENSSKK---GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST 281 (397)
Q Consensus 205 ~~~~~~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~ 281 (397)
.+++.+... +..+++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~------------------~~~~~~~~~~~i~~qi~~aL~~lH~~ 150 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE------------------HRGIPLIYVKQISKQLLLGLDYMHRR 150 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT------------------TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh------------------ccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 777665432 24789999999 789999997643 12467788999999999999999998
Q ss_pred -CceecCCCCCceEEeCC-----CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccch
Q 015991 282 -GIVHRDIKPQNVIFSEG-----SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355 (397)
Q Consensus 282 -giiHrDIKp~NILl~~~-----~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~ 355 (397)
||+||||||+|||++.+ ...+||+|||+++..... .....||+.|+|||++.+
T Consensus 151 ~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~----------------- 209 (373)
T 1q8y_A 151 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLG----------------- 209 (373)
T ss_dssp TCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHT-----------------
T ss_pred CCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhC-----------------
Confidence 99999999999999532 227999999999865432 234578999999996643
Q ss_pred hhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 356 PVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 356 ~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++|||||||++|||++|+.||....
T Consensus 210 -----~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 210 -----APWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp -----CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred -----CCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 346677899999999999999999998654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.40 Aligned_cols=204 Identities=17% Similarity=0.211 Sum_probs=154.2
Q ss_pred CCeEEe-eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+.+.+. ++||+|+||+||+|.+..... .+.+++|.++..... ......++...+....|+||+.+++.+. .+
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~ 442 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKV---VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AE 442 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSC---EEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE--SS
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCc---ceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cC
Confidence 345553 489999999999997643221 167899988753321 1222334455566667999999988763 35
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++||||+.+++|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||+
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl 502 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNR--------------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 502 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CEEEEEEccCCCCHHHHHhhCC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE
Confidence 6899999999999999997643 46788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+.++ .+||+|||+|+.+..+... ......+|+.|+|||++ ....++.++||||||
T Consensus 503 ~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~----------------------~~~~~~~~sDvwSlG 559 (635)
T 4fl3_A 503 VTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----------------------NYYKFSSKSDVWSFG 559 (635)
T ss_dssp EETT-EEEECCTTHHHHTTC-------------CGGGSCHHHH----------------------HHCCCCHHHHHHHHH
T ss_pred eCCC-CEEEEEcCCccccccCccccccccCCCCceeeeChhhh----------------------cCCCCCcHHHHHHHH
Confidence 9987 9999999999876544322 12334578899999955 444567788999999
Q ss_pred HHHHHHHc-CCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~ 390 (397)
|+||||++ |+.||....
T Consensus 560 v~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 560 VLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp HHHHHHHTTTCCSSTTCC
T ss_pred HHHHHHHhCCCCCCCCCC
Confidence 99999998 999997644
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=285.83 Aligned_cols=213 Identities=22% Similarity=0.326 Sum_probs=146.5
Q ss_pred CCeEE-eeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc-cCCe
Q 015991 139 DDFVL-GKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK-KGGE 216 (397)
Q Consensus 139 ~~f~i-~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~ 216 (397)
+.|++ +++||+|+||+||+|++..+.. .+.+|+|++......+.. .++...+....|+|++.+++.+.. .+..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~---~~~vaiK~~~~~~~~~~~--~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKD---DKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSC---CCCEEEEECSSSSCCHHH--HHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCC---CeEEEEEEECCCCCCHHH--HHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 56887 5689999999999999764211 178999988754433222 233445556679999988877643 3568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE-
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF- 295 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl- 295 (397)
.++||||++ ++|.+++...... ........+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~ 162 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRAS-----------KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVM 162 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHH-----------C-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred EEEEEeCCC-CCHHHHHHHhccc-----------cccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEe
Confidence 999999998 4888877643210 000122347889999999999999999999999999999999999
Q ss_pred ---eCCCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 296 ---SEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 296 ---~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+.++ .+||+|||+|+....... .......||+.|+|||++.+.. .++.++|||
T Consensus 163 ~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Diw 220 (405)
T 3rgf_A 163 GEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR---------------------HYTKAIDIW 220 (405)
T ss_dssp CSSTTTT-CEEECCTTCCC----------------CCCTTCCHHHHTTCC---------------------SCCHHHHHH
T ss_pred cCCCCCC-cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC---------------------cccchhhhH
Confidence 4555 999999999987643321 1234568999999999765432 356678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+||||++|+.||....
T Consensus 221 SlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 221 AIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp HHHHHHHHHHHSSCTTCCCC
T ss_pred HHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999997543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=275.74 Aligned_cols=205 Identities=16% Similarity=0.154 Sum_probs=159.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc-CCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK-GGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~ 216 (397)
+.|++.++||+|+||+||++.+..... ...+.+++|.+..... .......++...+....|++++.+++.+... ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345999999999999999886543221 1127899998875432 2233334455666667799999998877654 467
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+.+++|.+++.... +++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~ 168 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS---------------------IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred EEEEEecccCCcHHHHHhhCC---------------------CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc
Confidence 899999999999999987642 56788899999999999999999999999999999999
Q ss_pred CCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
.++ .+||+|||+++........ ......+|+.|+|||++.+. .++.++||||||+
T Consensus 169 ~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~ 225 (318)
T 3lxp_A 169 NDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY----------------------KFYYASDVWSFGV 225 (318)
T ss_dssp TTC-CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC----------------------EEEHHHHHHHHHH
T ss_pred CCC-CEEECCccccccccccccccccccCCCCCceeeChHHhcCC----------------------CCCcHHHHHHHHH
Confidence 987 9999999999876543321 23445788899999966543 4556789999999
Q ss_pred HHHHHHcCCCCCCC
Q 015991 375 IFLQMVCTVRRLCL 388 (397)
Q Consensus 375 ~l~elltg~~Pf~~ 388 (397)
++|||++|..||..
T Consensus 226 il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 226 TLYELLTHCDSSQS 239 (318)
T ss_dssp HHHHHHTTTCGGGS
T ss_pred HHHHHHhCCCcccc
Confidence 99999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=273.53 Aligned_cols=212 Identities=17% Similarity=0.227 Sum_probs=147.4
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.+..++|++.+.||+|+||.||+|.+..++ +.+++|.+..... .......++........|+|++.+++.+..
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSG-----QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTT-----EEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCC-----CEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 456689999999999999999999998776 7899998865422 222222333445666789999999887654
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCCC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQ 291 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~ 291 (397)
++..++||||+.+ +|.+++..... .....+++..+..++.|++.||.|||+. ||+||||||+
T Consensus 93 -~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~ 155 (327)
T 3aln_A 93 -EGDCWICMELMST-SFDKFYKYVYS---------------VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPS 155 (327)
T ss_dssp -SSEEEEEECCCSE-EHHHHHHHHHH---------------TTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGG
T ss_pred -CCceEEEEeecCC-ChHHHHHHHHh---------------hhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHH
Confidence 5689999999995 88887764210 0122567888999999999999999999 9999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++....... .....||+.|+|||++.... ....++.++||||
T Consensus 156 NIll~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~------------------~~~~~~~~~Di~s 214 (327)
T 3aln_A 156 NILLDRSG-NIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSA------------------SRQGYDVRSDVWS 214 (327)
T ss_dssp GEEEETTT-EEEECCCSSSCC--------------------------------------------------CCSHHHHHH
T ss_pred HEEEcCCC-CEEEccCCCceecccccc--cccCCCCccccCceeecccc------------------CcCCCCchhhHHH
Confidence 99999987 999999999987644322 23457999999999764321 1234677899999
Q ss_pred HHHHHHHHHcCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~ 389 (397)
||+++|||++|..||...
T Consensus 215 lG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 215 LGITLYELATGRFPYPKW 232 (327)
T ss_dssp HHHHHHHHHHSCCCSSCC
T ss_pred HHHHHHHHHHCCCCCCCc
Confidence 999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=267.51 Aligned_cols=197 Identities=26% Similarity=0.360 Sum_probs=151.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc------
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK------ 212 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~------ 212 (397)
++|++.+.||+|+||.||+|++..++ +.+++|.+...... .....++...+....|++++.+++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDS-----RYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEEEHHH-HHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCC-----eEEEEEEEeccHHH-HHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 68999999999999999999988776 78999988654322 2233345566677789999988775432
Q ss_pred ------cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceec
Q 015991 213 ------KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHR 286 (397)
Q Consensus 213 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHr 286 (397)
.....++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~ 140 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-------------------LNQQRDEYWRLFRQILEALSYIHSQGIIHR 140 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC-------------------GGGCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc-------------------cccchHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 2467899999999999999998643 245677888999999999999999999999
Q ss_pred CCCCCceEEeCCCCeEEEEeccccccccccc-------------ccccccccCCCCCCCcccccccCCCCCCCCcccccc
Q 015991 287 DIKPQNVIFSEGSRTFKIIDLGAAADLRVGI-------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 353 (397)
Q Consensus 287 DIKp~NILl~~~~~~~kL~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~ 353 (397)
||||+|||++.++ .+||+|||+++...... ........||+.|+|||++.+.
T Consensus 141 dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------------- 205 (303)
T 1zy4_A 141 DLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-------------- 205 (303)
T ss_dssp CCCGGGEEECTTS-CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC--------------
T ss_pred cCCHHhEEEcCCC-CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC--------------
Confidence 9999999999987 99999999997654321 1122346789999999976532
Q ss_pred chhhhhccCCCCchhhHHHHHHHHHHHcC
Q 015991 354 LSPVLWQLNLPDRFDIYSAGLIFLQMVCT 382 (397)
Q Consensus 354 ~~~~~~~~~~~~k~Dv~SlGv~l~elltg 382 (397)
..++.++||||||+++|||+++
T Consensus 206 -------~~~~~~~Di~slG~il~~l~~p 227 (303)
T 1zy4_A 206 -------GHYNEKIDMYSLGIIFFEMIYP 227 (303)
T ss_dssp -------SCCCTHHHHHHHHHHHHHHHSC
T ss_pred -------CCCcchhhHHHHHHHHHHHHhc
Confidence 1356788999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=273.45 Aligned_cols=205 Identities=18% Similarity=0.264 Sum_probs=152.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhcc---CCCceeeeeec
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANC---CADFVYGFFEN 209 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~---~~~~i~~~~~~ 209 (397)
.+..++|++.+.||+|+||+||+|.+..++. ..+++|.+....... ...+.++...+.+. ++..++.+.+.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGK----SQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCc----eEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 3455899999999999999999999876541 468888876533221 22222233333332 22335555444
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+ ...+..++||||++ ++|.+.+.... ...+++..++.++.|++.||+|||++||+|||||
T Consensus 91 ~-~~~~~~~lv~e~~~-~~l~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlk 150 (355)
T 2eu9_A 91 F-NFHGHMCIAFELLG-KNTFEFLKENN------------------FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK 150 (355)
T ss_dssp E-EETTEEEEEEECCC-CBHHHHHHHTT------------------TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred e-eeCCeEEEEEeccC-CChHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 3 34568999999995 56666665542 1246788899999999999999999999999999
Q ss_pred CCceEE-------------------eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccc
Q 015991 290 PQNVIF-------------------SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPV 350 (397)
Q Consensus 290 p~NILl-------------------~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~ 350 (397)
|+|||+ +.++ .+||+|||+++..... .....||+.|+|||++.+
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~------------ 213 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNT-SIRVADFGSATFDHEH----HTTIVATRHYRPPEVILE------------ 213 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCC-CEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTT------------
T ss_pred HHHEEEecccccccccccccccccccCCC-cEEEeecCcccccccc----ccCCcCCCcccCCeeeec------------
Confidence 999999 4555 9999999999764322 245689999999996543
Q ss_pred cccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 351 ATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 351 ~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
..++.++|||||||++|||++|..||....
T Consensus 214 ----------~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 214 ----------LGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp ----------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----------CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 346678899999999999999999997654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=275.99 Aligned_cols=198 Identities=23% Similarity=0.332 Sum_probs=154.9
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccC--
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKG-- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 214 (397)
++|.+.+.||+|+||.||+|++..++ +.+++|.+..... .......++...+....|+|++.+++.+...+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSG-----EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCC-----CEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence 78999999999999999999998877 8899998865322 22223334455666678999998887765443
Q ss_pred ---CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 215 ---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 215 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+++||||+. ++|.+++.. .+++..+..++.|++.||+|||++||+||||||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~~----------------------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 155 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMGL----------------------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 155 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTTS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG
T ss_pred ccceeEEEEecccc-CCHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 24699999998 577665422 3577889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+++..... .....+|+.|+|||++.+. ..++.++||||
T Consensus 156 NIl~~~~~-~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~---------------------~~~~~~~Di~s 209 (353)
T 3coi_A 156 NLAVNEDC-ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSW---------------------MHYNQTVDIWS 209 (353)
T ss_dssp GEEECTTC-CEEECSTTCTTC------------CCSBCCSCHHHHSCC---------------------SCCCTTHHHHH
T ss_pred HEeECCCC-cEEEeecccccCCCCC----ccccccCcCcCCHHHHhCc---------------------CCCCchhhHHH
Confidence 99999987 9999999999765322 2346789999999976542 23556789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
||+++|||++|+.||....
T Consensus 210 lG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 210 VGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp HHHHHHHHHHSSCSSBSSC
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=273.11 Aligned_cols=202 Identities=21% Similarity=0.308 Sum_probs=156.7
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---------HHHHHHHHHHHhhccCCCceeee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---------EIWMNERVRRACANCCADFVYGF 206 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---------e~~~~~~~~~~~~~~~~~~i~~~ 206 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|.+...... ....+..+...+. ..|++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~~~i~~~ 113 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS-SGFSGVIRL 113 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTT-----EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC-SSSCSBCCE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhc-cCCCCceEE
Confidence 35589999999999999999999988776 78999987643211 1111112222222 146888888
Q ss_pred eecccccCCeEEEEEEecCC-CCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCcee
Q 015991 207 FENSSKKGGEYWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVH 285 (397)
Q Consensus 207 ~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiH 285 (397)
++.+. .++..++|+|++.+ ++|.+++.... .+++..++.++.|++.||+|||++||+|
T Consensus 114 ~~~~~-~~~~~~lv~e~~~~~~~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivH 172 (320)
T 3a99_A 114 LDWFE-RPDSFVLILERPEPVQDLFDFITERG--------------------ALQEELARSFFWQVLEAVRHCHNCGVLH 172 (320)
T ss_dssp EEEEE-CSSEEEEEEECCSSEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEEEe-cCCcEEEEEEcCCCCccHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence 87664 45689999999986 89999987654 4677889999999999999999999999
Q ss_pred cCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC
Q 015991 286 RDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365 (397)
Q Consensus 286 rDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (397)
|||||+|||++.+...+||+|||+++..... ......||+.|+|||++.+... ++.
T Consensus 173 ~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~---------------------~~~ 228 (320)
T 3a99_A 173 RDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRY---------------------HGR 228 (320)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCB---------------------CHH
T ss_pred CCCCHHHEEEeCCCCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCC---------------------CCc
Confidence 9999999999943349999999999876432 2245679999999997654332 234
Q ss_pred chhhHHHHHHHHHHHcCCCCCCC
Q 015991 366 RFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 366 k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
++||||||+++|||++|+.||..
T Consensus 229 ~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 229 SAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cchHHhHHHHHHHHHHCCCCCCC
Confidence 67999999999999999999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=269.34 Aligned_cols=214 Identities=15% Similarity=0.214 Sum_probs=151.7
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhcc--CCCceeeeeecc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANC--CADFVYGFFENS 210 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~--~~~~i~~~~~~~ 210 (397)
.+..++|++.+.||+|+||.||++.+.. + +.+++|.+.... ........++...+... +|++++.+++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEK-K-----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-C-----CEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCC-C-----cEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 3455789999999999999999998754 3 678999875322 22222222223333322 368888888765
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. ++..++||| +.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||
T Consensus 98 ~~-~~~~~lv~e-~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 155 (313)
T 3cek_A 98 IT-DQYIYMVME-CGNIDLNSWLKKKK--------------------SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155 (313)
T ss_dssp EC-SSEEEEEEC-CCSEEHHHHHHHCS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred ec-CCEEEEEEe-cCCCcHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCc
Confidence 43 567999999 66789999998653 456778889999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
+|||+++ + .+||+|||+++........ ......||+.|+|||++.+....... ......++.++||
T Consensus 156 ~NIl~~~-~-~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-----------~~~~~~~~~~~Di 222 (313)
T 3cek_A 156 ANFLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN-----------GKSKSKISPKSDV 222 (313)
T ss_dssp GGEEEET-T-EEEECCCSSSCC--------------CCGGGCCHHHHTTCC---------------------CCCHHHHH
T ss_pred ccEEEEC-C-eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccccccc-----------ccccccCCchHHH
Confidence 9999976 4 9999999999876543221 23456799999999988653322110 0111346778999
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~ 389 (397)
||||+++|||++|+.||...
T Consensus 223 ~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 223 WSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp HHHHHHHHHHHHSSCTTTTC
T ss_pred HHHHHHHHHHHhCCCchhhH
Confidence 99999999999999999653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=272.09 Aligned_cols=202 Identities=20% Similarity=0.241 Sum_probs=151.5
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH------HHHHHHHHHHh----hccCCCceee
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE------IWMNERVRRAC----ANCCADFVYG 205 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e------~~~~~~~~~~~----~~~~~~~i~~ 205 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|.+....... .....++...+ ....|++++.
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDR-----LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTC-----CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCC-----eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 34579999999999999999999988776 789999886432211 10011112222 2237999999
Q ss_pred eeecccccCCeEEEEEEe-cCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCce
Q 015991 206 FFENSSKKGGEYWLIWRY-EGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIV 284 (397)
Q Consensus 206 ~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~gii 284 (397)
+++.+.. .+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||+|||++||+
T Consensus 103 ~~~~~~~-~~~~~~v~e~~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~ 161 (312)
T 2iwi_A 103 LLDWFET-QEGFMLVLERPLPAQDLFDYITEKG--------------------PLGEGPSRCFFGQVVAAIQHCHSRGVV 161 (312)
T ss_dssp EEEEC------CEEEEECCSSEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHHTEE
T ss_pred EEEEEec-CCeEEEEEEecCCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 9887644 4678899999 78999999998654 467888999999999999999999999
Q ss_pred ecCCCCCceEEe-CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCC
Q 015991 285 HRDIKPQNVIFS-EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 363 (397)
Q Consensus 285 HrDIKp~NILl~-~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
||||||+||+++ .++ .+||+|||+++...... .....||+.|+|||++.+... .
T Consensus 162 H~dlkp~Nil~~~~~~-~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~---------------------~ 216 (312)
T 2iwi_A 162 HRDIKDENILIDLRRG-CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQY---------------------H 216 (312)
T ss_dssp CCCCSGGGEEEETTTT-EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCB---------------------C
T ss_pred ecCCChhhEEEeCCCC-eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCC---------------------C
Confidence 999999999999 555 99999999998765432 245679999999997654322 1
Q ss_pred CCchhhHHHHHHHHHHHcCCCCCCC
Q 015991 364 PDRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 364 ~~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
+.++||||||+++|||++|+.||..
T Consensus 217 ~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 217 ALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CccchHHHHHHHHHHHHHCCCCCCC
Confidence 2368999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=265.98 Aligned_cols=201 Identities=20% Similarity=0.302 Sum_probs=160.7
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
.++|++.+.||+|+||.||+|++..++ +.+++|.+..... .......++...+....|++++.+++.+. ..+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 94 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQ-----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-DSS 94 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCC-----cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-CCC
Confidence 379999999999999999999998776 7889998754321 11222333455566678999999888664 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++|+||+.+++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv 154 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRK--------------------RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred eEEEEEEccCCCCHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEE
Confidence 8999999999999999887653 46778899999999999999999999999999999999
Q ss_pred eCCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 296 SEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 296 ~~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
+.++ ..+||+|||+++....... .....+|+.|+|||++.+ .++.++||||||
T Consensus 155 ~~~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----------------------~~~~~~Di~slG 209 (287)
T 2wei_A 155 ESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-----------------------TYDEKCDVWSAG 209 (287)
T ss_dssp SCSSTTCCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-----------------------CCCTHHHHHHHH
T ss_pred ecCCCcccEEEeccCcceeecCCCc--cccccCcccccChHHhcC-----------------------CCCCchhhHhHH
Confidence 7643 2799999999986543322 234568899999996642 255678999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLH 389 (397)
Q Consensus 374 v~l~elltg~~Pf~~~ 389 (397)
+++|+|++|..||...
T Consensus 210 ~~l~~l~~g~~p~~~~ 225 (287)
T 2wei_A 210 VILYILLSGTPPFYGK 225 (287)
T ss_dssp HHHHHHHHSSCSSCCS
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=268.47 Aligned_cols=208 Identities=17% Similarity=0.228 Sum_probs=146.6
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
...++|++.+.||+|+||.||+|++..++ +.+++|.+...... ......++...+....|++++.+++.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~- 95 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTG-----HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT- 95 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTC-----CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred hhhccccccceeeecCCeeEEEEEEecCC-----eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-
Confidence 35589999999999999999999998776 78999988654322 22222333445566789999999887644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHC-CceecCCCCCc
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHST-GIVHRDIKPQN 292 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~-giiHrDIKp~N 292 (397)
++..++||||++ +.+..+..... ..+++..+..++.|++.||.|||++ ||+||||||+|
T Consensus 96 ~~~~~lv~e~~~-~~~~~l~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~N 155 (318)
T 2dyl_A 96 NTDVFIAMELMG-TCAEKLKKRMQ-------------------GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 155 (318)
T ss_dssp SSEEEEEECCCS-EEHHHHHHHHT-------------------SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGG
T ss_pred CCcEEEEEeccC-CcHHHHHHHhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHH
Confidence 568999999994 56666554422 2467788999999999999999995 99999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||++........ .....+|+.|+|||++..... ....++.++|||||
T Consensus 156 il~~~~~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-----------------~~~~~~~~~Di~sl 215 (318)
T 2dyl_A 156 ILLDERG-QIKLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDP-----------------TKPDYDIRADVWSL 215 (318)
T ss_dssp EEECTTS-CEEECCCTTC----------------CCTTCCHHHHC-------------------------CCTHHHHHHH
T ss_pred EEECCCC-CEEEEECCCchhccCCcc--ccccCCCccccChhhcccccc-----------------cccCCccccchhhH
Confidence 9999987 999999999976544322 234579999999998754321 12346778999999
Q ss_pred HHHHHHHHcCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~ 389 (397)
|+++|||++|+.||...
T Consensus 216 G~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 216 GISLVELATGQFPYKNC 232 (318)
T ss_dssp HHHHHHHHHSSCTTTTC
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=274.77 Aligned_cols=212 Identities=17% Similarity=0.194 Sum_probs=163.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-----------------HHHHHHHHHHhhc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-----------------IWMNERVRRACAN 197 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-----------------~~~~~~~~~~~~~ 197 (397)
....++|++.+.||+|+||.||+|++ ++ +.+++|.+....... .....++...+..
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 99 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DN-----KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TT-----EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CC-----ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence 34558999999999999999999998 43 789999876432210 0233344556666
Q ss_pred cCCCceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHH
Q 015991 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDG 277 (397)
Q Consensus 198 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~y 277 (397)
..|++++.+++.+.. .+..++||||+.+++|.+++..... ........+++..++.++.|++.||.|
T Consensus 100 l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------------l~~~~~~~~~~~~~~~i~~qi~~~l~~ 166 (348)
T 2pml_X 100 IKNEYCLTCEGIITN-YDEVYIIYEYMENDSILKFDEYFFV------------LDKNYTCFIPIQVIKCIIKSVLNSFSY 166 (348)
T ss_dssp CCCTTBCCCSEEEES-SSEEEEEEECCTTCBSSEESSSEES------------SCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCcceEEEEEee-CCeEEEEEeccCCCcHHHHHHHhhh------------hhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 789999998886644 5789999999999999887332100 000013467889999999999999999
Q ss_pred hHH-CCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchh
Q 015991 278 LHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP 356 (397)
Q Consensus 278 LH~-~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~ 356 (397)
||+ +||+||||||+|||++.++ .+||+|||++...... ......||+.|+|||++.+..
T Consensus 167 lH~~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~---------------- 226 (348)
T 2pml_X 167 IHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNES---------------- 226 (348)
T ss_dssp HHHTSCEECCCCCGGGEEECTTS-CEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCC----------------
T ss_pred HhccCCEeecCCChHhEEEcCCC-cEEEeccccccccccc---cccCCCCCcCccCchhhcCCC----------------
Confidence 999 9999999999999999987 9999999999875433 234567999999999776442
Q ss_pred hhhccCCCC-chhhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 357 VLWQLNLPD-RFDIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 357 ~~~~~~~~~-k~Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
.++. ++||||||+++|||++|..||.....
T Consensus 227 -----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 227 -----SYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp -----CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred -----CCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2333 67999999999999999999976544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=293.18 Aligned_cols=207 Identities=23% Similarity=0.266 Sum_probs=161.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccc---
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (397)
..++|++.++||+|+||+||+|.+..++ +.+++|.+.... ........++...+....|+|++.+++.+..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg-----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTG-----EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTT-----CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 3489999999999999999999988776 789999876532 2222333345556666789999988776433
Q ss_pred --cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 213 --KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 213 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.++..++||||+.+++|.+++.... ....+++..++.++.|++.||+|||+.||+||||||
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~-----------------~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP 149 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFE-----------------NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKP 149 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSS-----------------CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCS
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcc-----------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH
Confidence 2567899999999999999998653 122466777889999999999999999999999999
Q ss_pred CceEEeCCCC--eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 291 QNVIFSEGSR--TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 291 ~NILl~~~~~--~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
+|||++.++. .+||+|||++....... ......||+.|+|||++.+. .++.++|
T Consensus 150 ~NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~----------------------~~s~ksD 205 (676)
T 3qa8_A 150 ENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQK----------------------KYTVTVD 205 (676)
T ss_dssp TTEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCS----------------------CCSTTHH
T ss_pred HHeEeecCCCceeEEEccccccccccccc--ccccccCCcccCChHHhccC----------------------CCCchhH
Confidence 9999997652 49999999998765432 23457899999999966543 4556789
Q ss_pred hHHHHHHHHHHHcCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~ 389 (397)
|||||+++|||++|..||...
T Consensus 206 IwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 206 YWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp HHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHCCCCCCcc
Confidence 999999999999999999764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.85 Aligned_cols=196 Identities=21% Similarity=0.256 Sum_probs=156.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecC-CCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAK-KPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~-~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
...++|++.++||+|+||+||+|.+.. ++ +.+++|.+..... .......++...+....|+||+.+++.+...
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNG-----RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTT-----EEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCC-----cEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 345899999999999999999999875 44 7799998865432 2223344556667778899999998876544
Q ss_pred CC----eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 214 GG----EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 214 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+. ..|+||||+++++|.+++.. .+++..++.++.||+.||+|||++||||||||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----------------------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlk 209 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----------------------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLK 209 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C----------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Confidence 33 27999999999999876543 35778899999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.+ .+||+|||+++..... ....||+.|+|||++.+. .+.++||
T Consensus 210 p~NIll~~~--~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~-----------------------~~~~sDi 259 (681)
T 2pzi_A 210 PENIMLTEE--QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG-----------------------PTVATDI 259 (681)
T ss_dssp GGGEEECSS--CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC-----------------------SCHHHHH
T ss_pred hHHeEEeCC--cEEEEecccchhcccC-----CccCCCccccCHHHHcCC-----------------------CCCceeh
Confidence 999999884 8999999999875432 456799999999976432 2457899
Q ss_pred HHHHHHHHHHHcCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~ 388 (397)
|||||+||||++|..||..
T Consensus 260 ~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 260 YTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp HHHHHHHHHHHSCCCEETT
T ss_pred hhhHHHHHHHHhCCCCCcc
Confidence 9999999999999998865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=274.85 Aligned_cols=212 Identities=19% Similarity=0.177 Sum_probs=147.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhh-ccCCCceeeeeecccccCCeE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA-NCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~ 217 (397)
+.|.+.+.||+|+||+||.+... ++ +.+|+|++......... ++...+. ...|+||+.+++.. ..++.+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~-~g-----~~vAvK~~~~~~~~~~~---~E~~~l~~l~~HpnIv~~~~~~-~~~~~~ 84 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF-QG-----RPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCSE-TTDRFL 84 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES-SS-----SEEEEEEEEGGGHHHHH---HHHHHHHHHTTSTTBCCEEEEE-ECSSEE
T ss_pred heeeccCeEeeCCCeEEEEEEEE-CC-----eEEEEEEEcHHHHHHHH---HHHHHHHhccCCCCcCeEEEEE-ecCCeE
Confidence 56777899999999999865433 33 78999988654332222 2222332 34799999998765 445789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||++ ++|.+++........ .....++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~-------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~ 150 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDE-------------NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC-------------------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEC
T ss_pred EEEEecCC-CCHHHHHhccCCCch-------------hhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 99999997 699999987642100 0001123345789999999999999999999999999999975
Q ss_pred C------------CCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccC
Q 015991 298 G------------SRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 362 (397)
Q Consensus 298 ~------------~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
+ ...+||+|||+++....+... ......||+.|+|||++.+..... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---------------~~~~ 215 (434)
T 2rio_A 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ---------------TKRR 215 (434)
T ss_dssp CHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTS---------------CCCC
T ss_pred CcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccc---------------cccC
Confidence 3 238999999999876543321 123468999999999887643211 1135
Q ss_pred CCCchhhHHHHHHHHHHHc-CCCCCCCC
Q 015991 363 LPDRFDIYSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 363 ~~~k~Dv~SlGv~l~ellt-g~~Pf~~~ 389 (397)
++.++|||||||++|||++ |..||...
T Consensus 216 ~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 216 LTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp CCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred cchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 7788999999999999999 99999654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=276.88 Aligned_cols=219 Identities=11% Similarity=0.015 Sum_probs=148.0
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH---HHHHHHHHHHhhccCC-Cc----------e
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE---IWMNERVRRACANCCA-DF----------V 203 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e---~~~~~~~~~~~~~~~~-~~----------i 203 (397)
..+|++++.||+|+||+||+|++..++ +.+|+|.+....... ....+++........| .+ +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCC-----CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 356999999999999999999998877 789999876322111 1122222222223222 10 0
Q ss_pred -----ee------eeecccc----cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHH
Q 015991 204 -----YG------FFENSSK----KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIM 268 (397)
Q Consensus 204 -----~~------~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~ 268 (397)
.. ++..... ....++++|+++. ++|.++++.... .......+++..+..++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~-------------~~~~~~~l~~~~~~~i~ 217 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLS-------------HSSTHKSLVHHARLQLT 217 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHH-------------HTTTSHHHHHHHHHHHH
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhc-------------ccccCCCCCHHHHHHHH
Confidence 00 0000000 0234677777655 799998863210 00123467888899999
Q ss_pred HHHHHHHHHhHHCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCc
Q 015991 269 SQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSA 348 (397)
Q Consensus 269 ~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~ 348 (397)
.|++.||+|||++|||||||||+|||++.++ .+||+|||+++..... .....| +.|+|||++........
T Consensus 218 ~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~---- 287 (413)
T 3dzo_A 218 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFG---- 287 (413)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTG----
T ss_pred HHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccc----
Confidence 9999999999999999999999999999987 8999999999865433 345677 99999998753320000
Q ss_pred cccccchhhhhccCCCCchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 015991 349 PVATALSPVLWQLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 349 ~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~~~ 393 (397)
-.....++.++|||||||++|||++|+.||......+
T Consensus 288 --------~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 324 (413)
T 3dzo_A 288 --------QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324 (413)
T ss_dssp --------GGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS
T ss_pred --------cccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 0012346778999999999999999999998765443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=270.45 Aligned_cols=213 Identities=17% Similarity=0.177 Sum_probs=157.8
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
..+..++|++.+.||+|+||.||+|++. ..+++|.+..... .......++...+....|++++.+++.+.
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWH--------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEES--------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEc--------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 4556789999999999999999999875 3477777653221 11111223344556678999999888764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
. .+..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+
T Consensus 100 ~-~~~~~iv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~ 159 (319)
T 2y4i_B 100 S-PPHLAIITSLCKGRTLYSVVRDAK-------------------IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSK 159 (319)
T ss_dssp C-SSCEEEECBCCCSEEHHHHTTSSC-------------------CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCST
T ss_pred c-CCceEEEeecccCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChh
Confidence 4 467999999999999999987643 24567889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccc----ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGI----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|||+++ + .+||+|||+++...... ........||+.|+|||++........ .....++.++
T Consensus 160 NIl~~~-~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-------------~~~~~~~~~~ 224 (319)
T 2y4i_B 160 NVFYDN-G-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE-------------EDKLPFSKHS 224 (319)
T ss_dssp TEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC---------------CCCSCCCHHH
T ss_pred hEEEeC-C-CEEEeecCCccccccccccccccccccCCCcccccChHHhhhcccccc-------------ccccCCCchh
Confidence 999984 4 89999999987543211 112234568999999998875432211 1123467789
Q ss_pred hhHHHHHHHHHHHcCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
||||||+++|||++|+.||...
T Consensus 225 Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 225 DVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp HHHHHHHHHHHHHHSSCSSSSC
T ss_pred hHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=274.00 Aligned_cols=196 Identities=17% Similarity=0.155 Sum_probs=145.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-----------HHHHHHHHHHHHhhc------c
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-----------VEIWMNERVRRACAN------C 198 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-----------~e~~~~~~~~~~~~~------~ 198 (397)
+..++|++.++||+|+||+||+|++ ++ +.+|+|.+..... .....+.++.+.+.. .
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~ 89 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DH-----TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TT-----EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred cccccchheeeecccCceEEEEEEe--CC-----ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence 3457899999999999999999988 33 7899998864321 222222222232221 1
Q ss_pred CCCceeeeee-----------------cccc------------cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccc
Q 015991 199 CADFVYGFFE-----------------NSSK------------KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249 (397)
Q Consensus 199 ~~~~i~~~~~-----------------~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~ 249 (397)
.|++++.+.+ .+.. .++.+++||||+.+|++.+.+...
T Consensus 90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------------- 156 (336)
T 2vuw_A 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------------- 156 (336)
T ss_dssp BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------------
T ss_pred cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------------
Confidence 3555554443 3322 257899999999998765555332
Q ss_pred cccCCCcchhcHHHHHHHHHHHHHHHHHhH-HCCceecCCCCCceEEeCCC-------------------CeEEEEeccc
Q 015991 250 VQDLPKGIERENRIIQTIMSQLLFALDGLH-STGIVHRDIKPQNVIFSEGS-------------------RTFKIIDLGA 309 (397)
Q Consensus 250 ~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH-~~giiHrDIKp~NILl~~~~-------------------~~~kL~DFGl 309 (397)
.+++..++.++.||+.||+||| ++||+||||||+|||++.++ ..+||+|||+
T Consensus 157 --------~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~ 228 (336)
T 2vuw_A 157 --------LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228 (336)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTT
T ss_pred --------CCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccc
Confidence 3578889999999999999999 99999999999999999864 2899999999
Q ss_pred ccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH-HHHHHcCCCCCCC
Q 015991 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI-FLQMVCTVRRLCL 388 (397)
Q Consensus 310 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~-l~elltg~~Pf~~ 388 (397)
|+.... ....||+.|+|||++.+.. +.++||||++++ .++++.|..||..
T Consensus 229 a~~~~~------~~~~gt~~y~aPE~~~g~~-----------------------~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 229 SRLERD------GIVVFCDVSMDEDLFTGDG-----------------------DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CBEEET------TEEECCCCTTCSGGGCCCS-----------------------SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cEecCC------CcEEEeecccChhhhcCCC-----------------------ccceehhhhhCCCCcccccccCCCcc
Confidence 987643 2458999999999776432 346799998777 7888999999853
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=274.02 Aligned_cols=205 Identities=23% Similarity=0.233 Sum_probs=145.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhcc-CCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC-CADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~ 214 (397)
+...+|++.+.||+|+||+||.... .++ +.||+|++......... ++...+... .|+||+.+++... .+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~-~~~-----~~vAvK~~~~~~~~~~~---~E~~~l~~l~~HpnIv~l~~~~~-~~ 90 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGM-FDN-----RDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTEK-DR 90 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEE-SSS-----SEEEEEEECTTTEEECH---HHHHHHHHSCCCTTBCCEEEEEE-ET
T ss_pred EccEEEecCCeeecCcCEEEEEEEE-eCC-----eEEEEEEECHHHHHHHH---HHHHHHHhccCCCCcCeEEEEEe-cC
Confidence 3445799999999999999654322 233 78999988653322111 122233333 7999999987654 45
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...++||||++ ++|.+++...... ..+..+..++.|++.||+|||++||+||||||+|||
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~-------------------~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIl 150 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFA-------------------HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNIL 150 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCC-------------------CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCC-------------------ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEE
Confidence 78899999998 5999999876422 122235679999999999999999999999999999
Q ss_pred EeCCC----CeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 295 FSEGS----RTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 295 l~~~~----~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
++.++ ..+||+|||+|+.+..... .......||+.|+|||++..... ..++.++|
T Consensus 151 l~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-------------------~~~t~~~D 211 (432)
T 3p23_A 151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK-------------------ENPTYTVD 211 (432)
T ss_dssp ECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC----------------------CCCTHHH
T ss_pred EecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccc-------------------cCCCcHHH
Confidence 95321 2688999999987654322 22345689999999997754221 23556889
Q ss_pred hHHHHHHHHHHHc-CCCCCCCC
Q 015991 369 IYSAGLIFLQMVC-TVRRLCLH 389 (397)
Q Consensus 369 v~SlGv~l~ellt-g~~Pf~~~ 389 (397)
||||||++|||++ |..||...
T Consensus 212 iwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 212 IFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp HHHHHHHHHHHHTTSCBTTBST
T ss_pred HHHHHHHHHHHHcCCCCCcchh
Confidence 9999999999999 99998543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-32 Score=253.93 Aligned_cols=178 Identities=11% Similarity=-0.025 Sum_probs=142.2
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
+..++|++.+.||+|+||.||+|++..++ +.+++|.+..... .......++...+....|+|++.+++.+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALD-----RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTT-----EEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCC-----ceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 34478999999999999999999998776 8899999875422 222223344455677789999999887644
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++..|+||||+.+++|.++++... ....+..++.|++.||+|||++||+||||||+|
T Consensus 103 -~~~~~lv~e~~~g~~L~~~l~~~~----------------------~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~N 159 (286)
T 3uqc_A 103 -RAGGLVVAEWIRGGSLQEVADTSP----------------------SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSR 159 (286)
T ss_dssp -TTEEEEEEECCCEEEHHHHHTTCC----------------------CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred -CCcEEEEEEecCCCCHHHHHhcCC----------------------ChHHHHHHHHHHHHHHHHHHHCCCccCCCCccc
Confidence 578999999999999999985421 234567899999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||+++++ .+||+++| |++| ++.++|||||
T Consensus 160 Ill~~~g-~~kl~~~~---------------------~~~~-----------------------------~~~~~Di~sl 188 (286)
T 3uqc_A 160 VRVSIDG-DVVLAYPA---------------------TMPD-----------------------------ANPQDDIRGI 188 (286)
T ss_dssp EEEETTS-CEEECSCC---------------------CCTT-----------------------------CCHHHHHHHH
T ss_pred EEEcCCC-CEEEEecc---------------------ccCC-----------------------------CCchhHHHHH
Confidence 9999987 89987443 3332 3346799999
Q ss_pred HHHHHHHHcCCCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~~ 392 (397)
||++|||++|+.||......
T Consensus 189 G~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 189 GASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp HHHHHHHHHSEECSCCCSBC
T ss_pred HHHHHHHHHCCCCCCcCCcc
Confidence 99999999999999876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=249.97 Aligned_cols=181 Identities=19% Similarity=0.274 Sum_probs=141.6
Q ss_pred ccCCeEEe-eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc---
Q 015991 137 RKDDFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (397)
Q Consensus 137 ~~~~f~i~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (397)
..++|.+. +.||+|+||.||+|.+..++ +.+++|.+....... .++........|+|++.+++.+..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~----~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDCPKAR----REVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSHHHH----HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCC-----cEEEEEEecccHHHH----HHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 44788887 78999999999999998776 889999886543221 112222234467888777665432
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+...++||||+.+++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 147 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRG------------------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCT------------------TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCceEEEEEeecCCCcHHHHHHhcc------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 3567899999999999999998753 2246888899999999999999999999999999999
Q ss_pred eEEeC---CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 293 VIFSE---GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 293 ILl~~---~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
||++. ++ .+||+|||++..... ..++.++||
T Consensus 148 il~~~~~~~~-~~kl~Dfg~a~~~~~---------------------------------------------~~~~~~~Di 181 (299)
T 3m2w_A 148 LLYTSKRPNA-ILKLTDFGFAKETTG---------------------------------------------EKYDKSCDM 181 (299)
T ss_dssp EEESSSSTTC-CEEECCCTTCEECTT---------------------------------------------CGGGGHHHH
T ss_pred EEEecCCCCC-cEEEecccccccccc---------------------------------------------ccCCchhhH
Confidence 99997 54 899999999865321 023446799
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||++|||++|+.||....
T Consensus 182 wslG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 182 WSLGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp HHHHHHHHHHHHSSCSCCC--
T ss_pred HHHHHHHHHHHHCCCCCCCCc
Confidence 999999999999999996543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=264.27 Aligned_cols=186 Identities=16% Similarity=0.081 Sum_probs=117.4
Q ss_pred eccCCceEEEEEEecCCCCCCCCCceEEeecccch----------hHHHHHHHHHHHHhhcc-CCCceeeeeecccccCC
Q 015991 147 LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----------AVEIWMNERVRRACANC-CADFVYGFFENSSKKGG 215 (397)
Q Consensus 147 LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----------~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~ 215 (397)
++.|++|.+..++....+ ..+++|.+.... ........++...+.+. .|+|++.+++.+ .++.
T Consensus 242 ~~~~~~~~h~~~rr~~fg-----~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-ed~~ 315 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFG-----EDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-ENAQ 315 (569)
T ss_dssp -C--------CCEEEEEC-----SSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-ECSS
T ss_pred cccCCccccccccccccc-----ceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EECC
Confidence 456666666555544444 677777764321 11122233444555554 688888888765 4467
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+||||||++|++|.+++...+ .+++. .|+.||+.||+|||++|||||||||+||||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~--------------------~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL 372 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE--------------------EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV 372 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC--------------------CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE
T ss_pred EEEEEEecCCCCcHHHHHHhCC--------------------CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE
Confidence 8999999999999999998764 23333 478999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ .+||+|||+|+....+.. ...+.+||+.|||||++.+. ++.++|+||+|++
T Consensus 373 ~~dg-~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g~-----------------------~~~~~d~~s~g~~ 427 (569)
T 4azs_A 373 DARQ-HARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAEN-----------------------KSWNGFWRSAPVH 427 (569)
T ss_dssp CTTS-CEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC---------------------------------------
T ss_pred CCCC-CEEEeecccCeeCCCCCc-cccCceechhhccHHHhCCC-----------------------CCCcccccccccc
Confidence 9987 999999999987654432 34567899999999988653 2234699999999
Q ss_pred HHHHHcCCCCC
Q 015991 376 FLQMVCTVRRL 386 (397)
Q Consensus 376 l~elltg~~Pf 386 (397)
+++|.++..+|
T Consensus 428 ~~~l~~~~~~~ 438 (569)
T 4azs_A 428 PFNLPQPWSNW 438 (569)
T ss_dssp -CCCCTTHHHH
T ss_pred hhhhccccchh
Confidence 88876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=235.55 Aligned_cols=185 Identities=18% Similarity=0.160 Sum_probs=131.5
Q ss_pred EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHH---HHHHHHHHHHhhccCCCcee--eeeeccc
Q 015991 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVE---IWMNERVRRACANCCADFVY--GFFENSS 211 (397)
Q Consensus 142 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e---~~~~~~~~~~~~~~~~~~i~--~~~~~~~ 211 (397)
...+.||+|+||+||+|.... +.+++|+..... ..+ .....++...+...+|+|++ .++..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-- 409 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLD-------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-- 409 (540)
T ss_dssp ---------CCEEEEEEECSS-------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE--
T ss_pred CCCCEEeeCCCEEEEEEEECC-------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE--
Confidence 346789999999999995443 556666543211 111 12234455566667889988 44443
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
..+..|+||||+++++|.+++.. +..++.|+++||+|||++||+||||||+
T Consensus 410 -~~~~~~lVmE~~~ggsL~~~l~~----------------------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~ 460 (540)
T 3en9_A 410 -DLDNKRIMMSYINGKLAKDVIED----------------------------NLDIAYKIGEIVGKLHKNDVIHNDLTTS 460 (540)
T ss_dssp -ETTTTEEEEECCCSEEHHHHSTT----------------------------CTHHHHHHHHHHHHHHHTTEECTTCCTT
T ss_pred -eCCccEEEEECCCCCCHHHHHHH----------------------------HHHHHHHHHHHHHHHHHCcCccCCCCHH
Confidence 34556999999999999998864 2368999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCC
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (397)
|||+++ .+||+|||+|+........ ......||+.|||||++.... ..|+.
T Consensus 461 NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~--------------------~~Y~~ 517 (540)
T 3en9_A 461 NFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFL--------------------EGYKS 517 (540)
T ss_dssp SEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHH--------------------HHHHH
T ss_pred HEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHH--------------------HHHHH
Confidence 999998 8999999999877543221 124578999999999775421 23556
Q ss_pred chhhHHHHHHHHHHHcCCCCCC
Q 015991 366 RFDIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 366 k~Dv~SlGv~l~elltg~~Pf~ 387 (397)
.+|+||..+-.++.+.++.+|.
T Consensus 518 ~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 518 VYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HCTTHHHHHHHHHHHHTCSCCC
T ss_pred HHhHHHHHHHHHHHHHhccccC
Confidence 7799999999999998888874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=193.91 Aligned_cols=147 Identities=19% Similarity=0.147 Sum_probs=105.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh------------------HHHHHHHHHHHHhhccC
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA------------------VEIWMNERVRRACANCC 199 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~------------------~e~~~~~~~~~~~~~~~ 199 (397)
...|++++.||+|+||.||+|++ .++ +.+++|.+..... .......++...+....
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g-----~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKF-----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTT-----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCC-----CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 45688889999999999999998 555 7899998853211 01111122222222222
Q ss_pred CCceeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhH
Q 015991 200 ADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLH 279 (397)
Q Consensus 200 ~~~i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH 279 (397)
|.++...+.. +..++||||+++++|.+ +... ....++.|++.||+|||
T Consensus 163 ~~~v~~~~~~-----~~~~lvmE~~~g~~L~~-l~~~--------------------------~~~~i~~qi~~~l~~lH 210 (282)
T 1zar_A 163 GLAVPKVYAW-----EGNAVLMELIDAKELYR-VRVE--------------------------NPDEVLDMILEEVAKFY 210 (282)
T ss_dssp TSSSCCEEEE-----ETTEEEEECCCCEEGGG-CCCS--------------------------CHHHHHHHHHHHHHHHH
T ss_pred CCCcCeEEec-----cceEEEEEecCCCcHHH-cchh--------------------------hHHHHHHHHHHHHHHHH
Confidence 3555554432 45699999999999987 4211 13369999999999999
Q ss_pred HCCceecCCCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccc
Q 015991 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM 338 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 338 (397)
++||+||||||+|||++ ++ .+||+|||+|+.. ..|+|||.+..
T Consensus 211 ~~giiHrDlkp~NILl~-~~-~vkl~DFG~a~~~--------------~~~~a~e~l~r 253 (282)
T 1zar_A 211 HRGIVHGDLSQYNVLVS-EE-GIWIIDFPQSVEV--------------GEEGWREILER 253 (282)
T ss_dssp HTTEECSCCSTTSEEEE-TT-EEEECCCTTCEET--------------TSTTHHHHHHH
T ss_pred HCCCEeCCCCHHHEEEE-CC-cEEEEECCCCeEC--------------CCCCHHHHHHH
Confidence 99999999999999999 66 9999999999642 35788997653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8e-20 Score=168.54 Aligned_cols=135 Identities=18% Similarity=0.195 Sum_probs=92.6
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCc--eEEeecccchh------------------------H---HHHHHHH
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGD--LVLKKATEYGA------------------------V---EIWMNER 190 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~--vavK~~~~~~~------------------------~---e~~~~~~ 190 (397)
-|++.+.||+|+||.||+|.+..++ +. +|+|....... . ....+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 122 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDG-----KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR 122 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETT-----EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCC-----cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence 4789999999999999999985554 66 88997532210 0 1111111
Q ss_pred HHHHhhcc--CCCceeeeeecccccCCeEEEEEEecCC-C----CHHHHHHhcCCCcchhhhhccccccCCCcchhcHHH
Q 015991 191 VRRACANC--CADFVYGFFENSSKKGGEYWLIWRYEGE-A----TLADLMISREFPYNVQTLILGEVQDLPKGIERENRI 263 (397)
Q Consensus 191 ~~~~~~~~--~~~~i~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 263 (397)
....+.+. .++.++.+ +..++||||+++ | +|.++.... ++..
T Consensus 123 ~l~~l~~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~~~-----------------------~~~~ 171 (258)
T 1zth_A 123 NLERAKEAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGREL-----------------------KELD 171 (258)
T ss_dssp HHHHHHHTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGGGG-----------------------GGSC
T ss_pred HHHHHHhCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhhcc-----------------------ChHH
Confidence 22222222 23333321 246899999953 3 666654321 1234
Q ss_pred HHHHHHHHHHHHHHhH-HCCceecCCCCCceEEeCCCCeEEEEeccccccc
Q 015991 264 IQTIMSQLLFALDGLH-STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 264 i~~i~~qi~~~L~yLH-~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~ 313 (397)
+..++.|++.+|.||| +.||+||||||+|||+++ .++|+|||+|...
T Consensus 172 ~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 172 VEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 6689999999999999 999999999999999987 7999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.5e-18 Score=165.98 Aligned_cols=137 Identities=15% Similarity=0.142 Sum_probs=88.8
Q ss_pred CeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch----------------hHHHHHH------HHHHHHhhc
Q 015991 140 DFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----------------AVEIWMN------ERVRRACAN 197 (397)
Q Consensus 140 ~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----------------~~e~~~~------~~~~~~~~~ 197 (397)
=|+++++||+|+||.||+|.+.. + +.+|+|..+... ....+.. +++...+..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~-G-----~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEK-G-----KQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTT-C-----CEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCC-C-----CEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 49999999999999999998764 3 678888653210 0001100 001111111
Q ss_pred cCCCc--eeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHH
Q 015991 198 CCADF--VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFAL 275 (397)
Q Consensus 198 ~~~~~--i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L 275 (397)
..+.. +...+.. ...+|||||+++++|.++... .....++.|++.+|
T Consensus 170 L~~~gv~vp~p~~~-----~~~~LVME~i~G~~L~~l~~~--------------------------~~~~~l~~qll~~l 218 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQ-----SRHTIVMSLVDALPMRQVSSV--------------------------PDPASLYADLIALI 218 (397)
T ss_dssp HHHTTCSCCCEEEE-----ETTEEEEECCSCEEGGGCCCC--------------------------SCHHHHHHHHHHHH
T ss_pred HHhcCCCCCeeeec-----cCceEEEEecCCccHhhhccc--------------------------HHHHHHHHHHHHHH
Confidence 11111 1111111 224799999998887543211 11346789999999
Q ss_pred HHhHHCCceecCCCCCceEEeCCCC---------eEEEEeccccccc
Q 015991 276 DGLHSTGIVHRDIKPQNVIFSEGSR---------TFKIIDLGAAADL 313 (397)
Q Consensus 276 ~yLH~~giiHrDIKp~NILl~~~~~---------~~kL~DFGla~~~ 313 (397)
.|||+.|||||||||.|||+++++. .+.|+||+-+...
T Consensus 219 ~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 219 LRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp HHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999999999999999999987652 3899999988654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.3e-10 Score=106.44 Aligned_cols=137 Identities=15% Similarity=0.117 Sum_probs=94.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc---hhHHHHHHHHHHHHhh-ccCCCceeeeeecccccC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY---GAVEIWMNERVRRACA-NCCADFVYGFFENSSKKG 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~e~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~ 214 (397)
+.|++...++.|+++.||++...+ +.+++|..... .......+.+....+. ....|.++.+.. ..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~-------~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~----~~ 82 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGEN-------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----HD 82 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSS-------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----ET
T ss_pred ccceeEeeccCCCCCeEEEEECCC-------CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe----cC
Confidence 579999999999999999997542 67889987641 1112222223333332 233444544433 24
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH--------------
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-------------- 280 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-------------- 280 (397)
+..|+||||++|.+|.+.+... .....++.+++++|..||+
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~~-------------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~ 137 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYEDE-------------------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCTT-------------------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHH
T ss_pred CceEEEEEecCCeehhhccCCc-------------------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHH
Confidence 6789999999999987763111 0122577788888888887
Q ss_pred ---------------------------------------------CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 ---------------------------------------------TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ---------------------------------------------~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
..++|+|+++.|||++++. .+.|+||+.+..
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T 3tm0_A 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence 4589999999999998753 667999998854
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=4.5e-10 Score=102.24 Aligned_cols=30 Identities=23% Similarity=0.278 Sum_probs=25.8
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
+++|+|++|.|||+++++ .+.|+|||.+..
T Consensus 185 ~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~ 214 (264)
T 1nd4_A 185 VVTHGDACLPNIMVENGR-FSGFIDCGRLGV 214 (264)
T ss_dssp EEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred EEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence 399999999999998764 667999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=1.1e-09 Score=102.62 Aligned_cols=93 Identities=17% Similarity=0.122 Sum_probs=51.4
Q ss_pred CceecCCCCCceEEeCC-CCeEEEEecccccccccccccccccccCCCCC---CCcccccccCCCCCCCCccccccchhh
Q 015991 282 GIVHRDIKPQNVIFSEG-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRY---AAPEQYIMSTQTPSAPSAPVATALSPV 357 (397)
Q Consensus 282 giiHrDIKp~NILl~~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y---~aPE~~~~~~~~~~~~~~~~~~~~~~~ 357 (397)
.++|+|+++.||+++++ +..+.|+||+.+........ ......+ ..|+..............+ ..
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~------~~ 260 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKILNHYKHKDIP------TV 260 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHHHHHHTCSCHH------HH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHHHHHcCCCCcH------HH
Confidence 58999999999999984 33789999999865322111 0011111 2333222100000000000 01
Q ss_pred hhccCCCCchhhHHHHHHHHHHHcCCCCCC
Q 015991 358 LWQLNLPDRFDIYSAGLIFLQMVCTVRRLC 387 (397)
Q Consensus 358 ~~~~~~~~k~Dv~SlGv~l~elltg~~Pf~ 387 (397)
... .....+.|+++.++|.+.+|..+|-
T Consensus 261 ~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 261 LEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 1122589999999999999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=4.2e-09 Score=101.03 Aligned_cols=142 Identities=17% Similarity=0.177 Sum_probs=89.9
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecc--cch----hHHHHHHHHHHHHhhc--cCCCceeeeeecccc
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT--EYG----AVEIWMNERVRRACAN--CCADFVYGFFENSSK 212 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~--~~~----~~e~~~~~~~~~~~~~--~~~~~i~~~~~~~~~ 212 (397)
....+.|+.|.++.||+....+ +.+++|+.. ... ......+.++...+.. ...|.++.+.... .
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~-------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~-~ 111 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG-------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE-S 111 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS-------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT-T
T ss_pred CceEEEcCCcccceEEEEEECC-------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC-C
Confidence 3346789999999999987643 567888775 221 1122222333334432 2244444443322 1
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH------------
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS------------ 280 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~------------ 280 (397)
..+..|+||||++|.++.+.. ...++......++.++++.|..||+
T Consensus 112 ~~g~~~~vme~v~G~~l~~~~----------------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~ 169 (359)
T 3dxp_A 112 VIGRAFYIMEFVSGRVLWDQS----------------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYG 169 (359)
T ss_dssp TTSSCEEEEECCCCBCCCCTT----------------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSS
T ss_pred ccCCeEEEEEecCCeecCCCc----------------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccC
Confidence 114578999999987663210 0123455666788888888888886
Q ss_pred ----------------------------------------------CCceecCCCCCceEEeCCCC-eEEEEecccccc
Q 015991 281 ----------------------------------------------TGIVHRDIKPQNVIFSEGSR-TFKIIDLGAAAD 312 (397)
Q Consensus 281 ----------------------------------------------~giiHrDIKp~NILl~~~~~-~~kL~DFGla~~ 312 (397)
.+++|+|+++.|||+++++. .+.|+||+.+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 170 KPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997652 479999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=6.6e-06 Score=76.98 Aligned_cols=33 Identities=27% Similarity=0.415 Sum_probs=26.9
Q ss_pred CCceecCCCCCceEEeC---CCCeEEEEeccccccc
Q 015991 281 TGIVHRDIKPQNVIFSE---GSRTFKIIDLGAAADL 313 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~---~~~~~kL~DFGla~~~ 313 (397)
..++|+|+++.|||+++ ++....|+||+.+...
T Consensus 190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 36899999999999987 3435689999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=8.5e-06 Score=74.38 Aligned_cols=80 Identities=15% Similarity=0.079 Sum_probs=46.8
Q ss_pred eeccCCce-EEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhh-ccCCCceeeeeecccccCCeEEEEEEe
Q 015991 146 KLGEGAFG-VVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACA-NCCADFVYGFFENSSKKGGEYWLIWRY 223 (397)
Q Consensus 146 ~LG~G~fG-~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~lv~e~ 223 (397)
.+..|..| .||+......+ ..+++|........+...+.+..+.+. ....|.++.+.. ..+..|+|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~-----~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~----~~~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNA-----PELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIR----TPDDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCTTC-----CCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEE----ETTEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecCCC-----eEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEE----ECCeEEEEEEe
Confidence 34445544 79998766554 678888766544333333333333332 233445544432 24678999999
Q ss_pred cCCCCHHHHHH
Q 015991 224 EGEATLADLMI 234 (397)
Q Consensus 224 ~~~gsL~~~l~ 234 (397)
++|.++.+...
T Consensus 102 l~G~~~~~~~~ 112 (272)
T 4gkh_A 102 IPGKTAFQVLE 112 (272)
T ss_dssp CCSEEHHHHHH
T ss_pred eCCcccccccc
Confidence 99988876554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=6.8e-05 Score=70.52 Aligned_cols=31 Identities=23% Similarity=0.396 Sum_probs=27.3
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.+++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence 5799999999999998765 899999998853
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=3.4e-05 Score=73.43 Aligned_cols=32 Identities=16% Similarity=0.240 Sum_probs=26.8
Q ss_pred HCCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
...++|+|+.+.|||++++. .+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~-~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQ-PVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCc-EEEEEccccccc
Confidence 35799999999999999633 689999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=7.4e-05 Score=72.25 Aligned_cols=31 Identities=26% Similarity=0.321 Sum_probs=26.4
Q ss_pred HCCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 280 STGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
...++|+|+.+.|||++++ .++|+||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~--~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH--ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC--CeEEEeCccccc
Confidence 4579999999999999875 589999987753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00018 Score=70.18 Aligned_cols=33 Identities=18% Similarity=0.304 Sum_probs=28.1
Q ss_pred HHCCceecCCCCCceEEeCCCCeEEEEeccccccc
Q 015991 279 HSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313 (397)
Q Consensus 279 H~~giiHrDIKp~NILl~~~~~~~kL~DFGla~~~ 313 (397)
+...++|+|+++.|||+++++ ++|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC--EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC--CEEEeCcccccC
Confidence 456899999999999998763 999999988643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0013 Score=61.21 Aligned_cols=31 Identities=29% Similarity=0.468 Sum_probs=26.3
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.+++|+|+.+.|||+++++ .+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 4799999999999999864 568999998854
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.011 Score=55.22 Aligned_cols=78 Identities=13% Similarity=0.083 Sum_probs=46.8
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhc---cCCCceeeeeecccccCCeE
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN---CCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~ 217 (397)
..-.+.|+.|.+..+|+.... + +.+++|............+.+..+.+.. ...|.++.... ..+..
T Consensus 38 i~~~~~l~gG~~n~~y~v~~~--~-----~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~----~~g~~ 106 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLINDE--V-----QTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN----SQGHS 106 (312)
T ss_dssp CCEEEEECCSSSSEEEEEESS--S-----CEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE----CSSEE
T ss_pred eeeeEEeCCccceeeeEEEEC--C-----CeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee----cCCce
Confidence 344678999999999998753 2 6788887654332222222233333332 33444444322 23578
Q ss_pred EEEEEecCCCCH
Q 015991 218 WLIWRYEGEATL 229 (397)
Q Consensus 218 ~lv~e~~~~gsL 229 (397)
|+||||+++.++
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0011 Score=61.29 Aligned_cols=29 Identities=21% Similarity=0.181 Sum_probs=24.2
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++|+|+.+.|||. +++ .+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil~-~~~-~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD-TGE-RMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE-CSS-CEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE-CCC-CEEEEecccccC
Confidence 58999999999994 444 789999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0023 Score=59.99 Aligned_cols=34 Identities=26% Similarity=0.313 Sum_probs=27.8
Q ss_pred HCCceecCCCCCceEEeCC---CCeEEEEeccccccc
Q 015991 280 STGIVHRDIKPQNVIFSEG---SRTFKIIDLGAAADL 313 (397)
Q Consensus 280 ~~giiHrDIKp~NILl~~~---~~~~kL~DFGla~~~ 313 (397)
...++|+|+.+.|||++.+ ...+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999874 137999999988643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.75 E-value=0.012 Score=54.77 Aligned_cols=29 Identities=21% Similarity=0.312 Sum_probs=25.1
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence 4689999999999998 3 789999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.021 Score=52.26 Aligned_cols=76 Identities=14% Similarity=0.074 Sum_probs=45.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhc---cCCCceeeeeecccc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACAN---CCADFVYGFFENSSK 212 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~---~~~~~i~~~~~~~~~ 212 (397)
.+..-.+.+|.|..+.||+.+..+. +.+++|+....... ....+.+..+.+.. ...|.++..
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG------~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~------ 82 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADG------TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW------ 82 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTS------CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE------
T ss_pred CCeEEEEecCCCCCeEEEEEEECCC------CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec------
Confidence 4677788999999999999987654 67888875432211 11122222333322 223333322
Q ss_pred cCCeEEEEEEecCCCC
Q 015991 213 KGGEYWLIWRYEGEAT 228 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gs 228 (397)
+.-++||||+.++.
T Consensus 83 --~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 83 --DDRTLAMEWVDERP 96 (288)
T ss_dssp --ETTEEEEECCCCCC
T ss_pred --cCceEEEEeecccC
Confidence 12378999998654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.011 Score=57.81 Aligned_cols=31 Identities=23% Similarity=0.432 Sum_probs=25.2
Q ss_pred CceecCCCCCceEEeCCC---------------------------CeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGS---------------------------RTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~---------------------------~~~kL~DFGla~~ 312 (397)
.++|+|+.+.|||++++. ..+.|+||..|..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 589999999999998851 3789999988853
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.019 Score=54.01 Aligned_cols=31 Identities=26% Similarity=0.334 Sum_probs=27.1
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
..++|+|+.+.||++++++ .+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence 4699999999999998765 799999988764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.22 E-value=0.012 Score=56.48 Aligned_cols=31 Identities=16% Similarity=0.363 Sum_probs=26.5
Q ss_pred CceecCCCCCceEEeCC---CCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEG---SRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~---~~~~kL~DFGla~~ 312 (397)
.++|+|+.+.|||++++ ...+.|+||..|..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 68999999999999876 23899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.024 Score=53.87 Aligned_cols=29 Identities=21% Similarity=0.393 Sum_probs=24.6
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++|+|+++.|||++++ .+.|+||..|..
T Consensus 213 ~l~HgDl~~~Nil~~~~--~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK--CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC---CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCC--cEEEEEecCCCC
Confidence 68999999999999864 589999998853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.10 E-value=0.041 Score=54.08 Aligned_cols=34 Identities=9% Similarity=0.142 Sum_probs=21.4
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecc
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKAT 178 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~ 178 (397)
+... .+.|+.|-...+|+....+.+ +.+++|...
T Consensus 109 ~~~~-i~~lsgG~tN~~y~v~~~~~~-----~~~vLRi~g 142 (458)
T 2qg7_A 109 DSLE-FQIINGGITNILIKVKDMSKQ-----AKYLIRLYG 142 (458)
T ss_dssp TTEE-EEEECC--CEEEEEEEETTTT-----EEEEEEEEC
T ss_pred cCeE-EEEcCCCeEeEEEEEEECCCC-----ceEEEEECC
Confidence 4444 467888888999999875422 466777653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.76 E-value=0.15 Score=49.43 Aligned_cols=29 Identities=21% Similarity=0.390 Sum_probs=25.1
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++|+|+.+.||+ ++++ .+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~-~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQN-NIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSS-CEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCC-cEEEEecccCCc
Confidence 5899999999999 6555 899999999864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.62 E-value=0.69 Score=44.29 Aligned_cols=31 Identities=19% Similarity=0.348 Sum_probs=24.9
Q ss_pred CceecCCCCCceEEeC-----CCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSE-----GSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~-----~~~~~kL~DFGla~~ 312 (397)
.++|+|+.+.|||+.+ +...++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 3679999999999943 234899999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.23 E-value=0.47 Score=41.47 Aligned_cols=97 Identities=12% Similarity=0.027 Sum_probs=60.6
Q ss_pred CCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCceEEeCCCCeEEEE
Q 015991 227 ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSRTFKII 305 (397)
Q Consensus 227 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NILl~~~~~~~kL~ 305 (397)
.+|.++++..+ ..+++++++.++.|.+..|.-+-. ..-..+=+-|..|+|..+| .+.+.
T Consensus 33 vSL~eIL~~~~-------------------~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~ 92 (229)
T 2yle_A 33 LSLEEILRLYN-------------------QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLA 92 (229)
T ss_dssp EEHHHHHHHHT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEEC
T ss_pred ccHHHHHHHcC-------------------CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceecc
Confidence 47999998765 367899999999999999877622 1112333457899999987 76655
Q ss_pred ecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHHHH
Q 015991 306 DLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMV 380 (397)
Q Consensus 306 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ell 380 (397)
+ +.+. .....+.+||... ...+.+.=|||||+++|.-+
T Consensus 93 ~-~~s~-------------~~~~~~~~pe~~~-----------------------~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 93 P-AADD-------------AGEPPPVAGKLGY-----------------------SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp C-C-------------------------CCSS-----------------------SSSCHHHHHHHHHHHHHHHH
T ss_pred c-cccc-------------ccccCCCChhhcc-----------------------ccchHHHHHHHHHHHHHHHh
Confidence 3 1110 0112355777431 12345679999999999876
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=82.49 E-value=3.4 Score=42.34 Aligned_cols=86 Identities=13% Similarity=0.122 Sum_probs=48.8
Q ss_pred EEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCC
Q 015991 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGS 299 (397)
Q Consensus 220 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~ 299 (397)
+.|++++.+|.+++...+ .+.+++.....+...........+..++.++|------+=.|| +|=.++||||+.+|
T Consensus 490 LIE~V~s~tl~~i~~~~~---~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YILGl--GDRH~~NILid~tG 564 (696)
T 2x6h_A 490 FLQYVDSCTVAEVLAREG---NIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLLGV--GDRHLDNLLLTTNG 564 (696)
T ss_dssp EEECCCCEEHHHHHHHSS---SHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHHTC--CCCCTTTEEECTTS
T ss_pred eeeeCCCccHHHHHHhcC---hHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHccC--CCCCCcceEEeCCC
Confidence 468888889999988654 2333332221111110111123344455554432222222344 68889999999876
Q ss_pred CeEEEEeccccc
Q 015991 300 RTFKIIDLGAAA 311 (397)
Q Consensus 300 ~~~kL~DFGla~ 311 (397)
++.-+|||.+-
T Consensus 565 -~v~HIDFG~~f 575 (696)
T 2x6h_A 565 -KLFHIDFGYIL 575 (696)
T ss_dssp -CEEECCCCSCT
T ss_pred -CEEEEeehhhh
Confidence 99999999873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 397 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-21 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-21 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-21 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-21 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-20 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-20 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-20 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-20 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-20 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-20 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-20 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-19 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-19 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-19 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-19 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-19 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-18 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-18 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-18 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-18 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-18 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-18 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-18 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-17 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-17 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-17 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-17 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-17 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-17 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-16 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-16 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-16 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-16 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-16 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-16 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-16 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-15 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-15 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-15 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-15 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-15 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-15 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-14 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-14 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-14 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-14 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-13 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-13 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-12 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 2e-23
Identities = 51/257 (19%), Positives = 89/257 (34%), Gaps = 52/257 (20%)
Query: 129 ERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVE 184
E + R +D + + +LG+GAFG VY+A K L + +E +
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQN------KETSVLAAAKVIDTKSEEELED 55
Query: 185 IWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQT 244
+ + +C + + F W++ + + +M+ E P
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYY----ENNLWILIEFCAGGAVDAVMLELERPLTESQ 111
Query: 245 LILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI 304
IQ + Q L AL+ LH I+HRD+K N++F+ K+
Sbjct: 112 -------------------IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL-DGDIKL 151
Query: 305 IDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364
D G +A I F+ P + APE + T
Sbjct: 152 ADFGVSAKNTRTIQRR-DSFIGTPYWMAPEVVMCETSKDRPYDYKA-------------- 196
Query: 365 DRFDIYSAGLIFLQMVC 381
D++S G+ ++M
Sbjct: 197 ---DVWSLGITLIEMAE 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 3e-22
Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 16/219 (7%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+++ GK LG GAFG V A+ S V LK+ + E M+E
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATA-YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 194 ACANCCADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ V G S G +LI+ Y L + + S+ ++ + +
Sbjct: 95 TQLGSHENIVNLLGACTLS----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 252 DLPKGIEREN---RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
L + + + Q+ ++ L VHRD+ +NV+ + G + KI D G
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFG 209
Query: 309 AAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAP 346
A D+ NY + L ++ APE T +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 1e-21
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 19/218 (8%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVR 192
++ GK LG GAFG V A+ + V LK + E M+E +V
Sbjct: 22 RNRLSFGKTLGAGAFGKVVEATA-YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 193 RACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
N + G GG +I Y L + + + +
Sbjct: 81 SYLGNH--MNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
++D ++ E+ + + Q+ + L S +HRD+ +N++ + G R KI D G
Sbjct: 135 MEDDELALDLEDLL--SFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGL 191
Query: 310 AADLRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAP 346
A D++ NY+ K L ++ APE T +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (225), Expect = 2e-21
Identities = 42/247 (17%), Positives = 77/247 (31%), Gaps = 57/247 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRR---A 194
+DF +G+ LG+G FG VY A K ++ LK + + + ++RR
Sbjct: 6 EDFEIGRPLGKGKFGNVYLARE------KQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
++ + + Y ++ +L +F
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR------------ 107
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
T +++L AL HS ++HRDIKP+N++ KI D G +
Sbjct: 108 ---------TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWS---V 154
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374
+ Y PE D++S G+
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV----------------------DLWSLGV 192
Query: 375 IFLQMVC 381
+ + +
Sbjct: 193 LCYEFLV 199
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 91.7 bits (227), Expect = 3e-21
Identities = 42/248 (16%), Positives = 80/248 (32%), Gaps = 58/248 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRRACAN 197
D + + ++LG GAFGVV+R + + G+ K + + + +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVT------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 79
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ + FE+ E +I+ + L + + +
Sbjct: 80 LRHPTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVADEHNKMSEDE---------- 125
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF-SEGSRTFKIIDLGAAADL 313
M Q+ L +H VH D+KP+N++F ++ S K+ID G A L
Sbjct: 126 ---------AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373
+ +AAPE D++S G
Sbjct: 177 DPKQSVKVTTG--TAEFAAPEVAEGKPVGYYT----------------------DMWSVG 212
Query: 374 LIFLQMVC 381
++ ++
Sbjct: 213 VLSYILLS 220
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 4e-21
Identities = 45/253 (17%), Positives = 87/253 (34%), Gaps = 66/253 (26%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR 192
+ DDF +LG G GVV++ S K G ++ + + + E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSH------KPSGLVMARKLIHLEIKPAIRNQIIRE--L 55
Query: 193 RACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+ C + ++ YG F + GE + + +L ++
Sbjct: 56 QVLHECNSPYIVGFYGAFYS----DGEISICMEHMDGGSLDQVLKKAGRI---------- 101
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
+I+ + ++ L L I+HRD+KP N++ + K+ D G
Sbjct: 102 ----------PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFG 150
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368
+ L I+ + F+ Y +PE+ + + + D
Sbjct: 151 VSGQL---IDSMANSFVGTRSYMSPERLQGTHYSVQS----------------------D 185
Query: 369 IYSAGLIFLQMVC 381
I+S GL ++M
Sbjct: 186 IWSMGLSLVEMAV 198
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.5 bits (219), Expect = 1e-20
Identities = 45/256 (17%), Positives = 92/256 (35%), Gaps = 59/256 (23%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR--- 193
R +D+ + +G G++G + K+DG +++ K +YG++ + +
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKI------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 194 ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ Y + + +++ Y LA ++
Sbjct: 56 LLRELKHPNIVRYYDRIID--RTNTTLYIVMEYCEGGDLASVI----------------T 97
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTG-----IVHRDIKPQNVIFSEGSRTFKII 305
+ + + + +M+QL AL H ++HRD+KP N +F +G + K+
Sbjct: 98 KGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN-VFLDGKQNVKLG 156
Query: 306 DLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365
D G A L ++ K F+ P Y +PEQ + +
Sbjct: 157 DFGLARILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKS-------------------- 195
Query: 366 RFDIYSAGLIFLQMVC 381
DI+S G + ++
Sbjct: 196 --DIWSLGCLLYELCA 209
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 88.8 bits (219), Expect = 2e-20
Identities = 40/260 (15%), Positives = 78/260 (30%), Gaps = 38/260 (14%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-R 190
Y +++ + +GEGAFG V++A +V LK+ + E
Sbjct: 10 YPRNNIEYVRDIGEGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ N + G G L++ Y L + + S
Sbjct: 69 LMAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 251 QDLPKGIERENRI----IQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIID 306
+ I Q+ + L VHRD+ +N + E + KI D
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIAD 183
Query: 307 LGAAADLRVGINYIPKE-FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365
G + ++ Y + R+ PE + T +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES-------------------- 223
Query: 366 RFDIYSAGLIFLQMVCTVRR 385
D+++ G++ ++ +
Sbjct: 224 --DVWAYGVVLWEIFSYGLQ 241
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (218), Expect = 2e-20
Identities = 50/249 (20%), Positives = 78/249 (31%), Gaps = 58/249 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVRR 193
+D+ L + LGEGA+G V A ++ + V + E E + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLA------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ YG G +L Y L D +
Sbjct: 59 MLNHENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGM-------------- 100
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
Q QL+ + LH GI HRDIKP+N++ E KI D G A
Sbjct: 101 ------PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVF 153
Query: 314 RVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372
R + + Y APE ++ + A D++S
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPE--LLKRREFHAEPV-------------------DVWSC 192
Query: 373 GLIFLQMVC 381
G++ M+
Sbjct: 193 GIVLTAMLA 201
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (218), Expect = 2e-20
Identities = 49/253 (19%), Positives = 82/253 (32%), Gaps = 61/253 (24%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR 192
R +DF GK LGEG+F V A L+K ++ R R
Sbjct: 6 RPEDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 193 RACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+ F Y F++ + + Y L + E
Sbjct: 60 DVMSRLDHPFFVKLYFTFQD----DEKLYFGLSYAKNGELLKYIRKIG--------SFDE 107
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG- 308
+ ++++ AL+ LH GI+HRD+KP+N++ +E +I D G
Sbjct: 108 TC------------TRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGT 154
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368
A F+ +Y +PE + S+ D
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS----------------------D 192
Query: 369 IYSAGLIFLQMVC 381
+++ G I Q+V
Sbjct: 193 LWALGCIIYQLVA 205
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (217), Expect = 2e-20
Identities = 45/245 (18%), Positives = 89/245 (36%), Gaps = 50/245 (20%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRACAN 197
+G+++G G+FG VY+ + K ++ A ++ + NE V R +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVK----MLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
G+ + ++ ++ ++L + E + + LI
Sbjct: 64 VNILLFMGYST-----APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI----------- 107
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL-RVG 316
I Q +D LH+ I+HRD+K N+ E T KI D G A R
Sbjct: 108 --------DIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWS 158
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376
++ ++ + APE M + P + + D+Y+ G++
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS-------------------DVYAFGIVL 199
Query: 377 LQMVC 381
+++
Sbjct: 200 YELMT 204
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.4 bits (216), Expect = 6e-20
Identities = 47/247 (19%), Positives = 90/247 (36%), Gaps = 57/247 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+ +++ + LG G FG+V+R + + K + + + ++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCV------ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA 58
Query: 199 CADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ + FE+ E +I+ + + + + + F N
Sbjct: 59 RHRNILHLHESFES----MEELVMIFEFISGLDIFERINTSAFELN-------------- 100
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADLR 314
R I + + Q+ AL LHS I H DI+P+N+I+ S T KII+ G A L+
Sbjct: 101 -----EREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374
G N+ + P Y APE + + + D++S G
Sbjct: 156 PGDNF--RLLFTAPEYYAPEVHQHDVVSTAT----------------------DMWSLGT 191
Query: 375 IFLQMVC 381
+ ++
Sbjct: 192 LVYVLLS 198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 86.8 bits (214), Expect = 7e-20
Identities = 41/254 (16%), Positives = 82/254 (32%), Gaps = 65/254 (25%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNE--RVRRACAN 197
+ +G+++GEG+FGV++ + + + V +K +E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGT------NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC 60
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
VY F + G L+ G +L DL+ ++V+T
Sbjct: 61 TGIPNVYYFGQE----GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKT------------- 102
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG----SRTFKIIDLGAAADL 313
+ Q+L + +H +V+RDIKP N + + ++D G
Sbjct: 103 ------VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
Query: 314 RVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367
R + K RY + ++ Q+
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD---------------------- 194
Query: 368 DIYSAGLIFLQMVC 381
D+ + G +F+ +
Sbjct: 195 DLEALGHVFMYFLR 208
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 9e-20
Identities = 60/283 (21%), Positives = 107/283 (37%), Gaps = 70/283 (24%)
Query: 104 SAISYLWATPGVAPGFFDMFVLAFVERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKK 163
S ++ + ATPG P ++ + K +G G+FGVVY+A L
Sbjct: 1 SKVTTVVATPGQGPD----------------RPQEVSYTDTKVIGNGSFGVVYQAKL--- 41
Query: 164 PSSKNDGDLV----LKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWL 219
+ G+LV + + + E+ + ++ N + FF +S +K E +L
Sbjct: 42 ---CDSGELVAIKKVLQDKRFKNRELQIMRKLD--HCNIVR--LRYFFYSSGEKKDEVYL 94
Query: 220 IWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIER-ENRIIQTIMSQLLFALDGL 278
+ V + + + + ++ M QL +L +
Sbjct: 95 NLVLD----------------YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 279 HSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIM 338
HS GI HRDIKPQN++ + K+ D G+A L G + ++ Y APE
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFG 196
Query: 339 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
+T S+ D++SAG + +++
Sbjct: 197 ATDYTSS---------------------IDVWSAGCVLAELLL 218
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.0 bits (210), Expect = 2e-19
Identities = 41/247 (16%), Positives = 79/247 (31%), Gaps = 60/247 (24%)
Query: 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RVRRACA 196
++G G+F VY+ V + + + E + +
Sbjct: 13 FDIEIGRGSFKTVYKGLD------TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 197 NCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
+ Y +E++ K L+ TL + +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM----------------- 109
Query: 257 IERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ +++++ Q+L L LH+ I+HRD+K N+ + + + KI DLG A
Sbjct: 110 ---KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---T 163
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374
+ K + P + APE Y + D+Y+ G+
Sbjct: 164 LKRASFAKAVIGTPEFMAPEMY---EEKYDESV--------------------DVYAFGM 200
Query: 375 IFLQMVC 381
L+M
Sbjct: 201 CMLEMAT 207
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.0 bits (210), Expect = 3e-19
Identities = 47/250 (18%), Positives = 82/250 (32%), Gaps = 63/250 (25%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKK--ATEYGAVEIWMNERVRRA 194
K + +K+G+GA G VY A G V +++ + E+ +NE
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEI--LV 70
Query: 195 CANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ + G E W++ Y +L D++
Sbjct: 71 MRENKNPNIVNYLDSYLV----GDELWVVMEYLAGGSLTDVVTETCMDEGQ--------- 117
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
I + + L AL+ LHS ++HRDIK N++ + K+ D G A
Sbjct: 118 ------------IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCA 164
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
+ + P + APE P DI+S
Sbjct: 165 QITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKV----------------------DIWS 201
Query: 372 AGLIFLQMVC 381
G++ ++M+
Sbjct: 202 LGIMAIEMIE 211
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 3e-19
Identities = 48/249 (19%), Positives = 82/249 (32%), Gaps = 57/249 (22%)
Query: 139 DDF-VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LK--KATEYGAVEIWMNERVRRA 194
DD+ V + LG G G V + +K + LK + E+ ++ R +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIF------NKRTQEKFALKMLQDCPKARREVELHWRASQ- 63
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
C + + +EN ++ L + R E
Sbjct: 64 CPHIVR--IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA------FTE----- 110
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE--GSRTFKIIDLGAAAD 312
R IM + A+ LHS I HRD+KP+N++++ + K+ D G A +
Sbjct: 111 -------REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372
+ + P Y APE S D++S
Sbjct: 164 TTSHNSLTTPCY--TPYYVAPEVLGPEKYDKSC----------------------DMWSL 199
Query: 373 GLIFLQMVC 381
G+I ++C
Sbjct: 200 GVIMYILLC 208
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.3 bits (208), Expect = 4e-19
Identities = 39/247 (15%), Positives = 80/247 (32%), Gaps = 56/247 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
++ L ++LG G FG V+ N V K+ + G++
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYY-------NGHTKVAVKSLKQGSMSPDAFLAEANLMKQ 64
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ Y ++I Y +L D + + P
Sbjct: 65 LQHQRLVRLYAVVTQ-----EPIYIITEYMENGSLVDFLKT------------------P 101
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
GI+ + + +Q+ + + +HRD++ N++ S+ + + KI D G A +
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD-TLSCKIADFGLARLIE 160
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374
+ ++ APE T T + D++S G+
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKS----------------------DVWSFGI 198
Query: 375 IFLQMVC 381
+ ++V
Sbjct: 199 LLTEIVT 205
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 85.5 bits (211), Expect = 5e-19
Identities = 47/248 (18%), Positives = 83/248 (33%), Gaps = 58/248 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRRACAN 197
D + + ++LG GAFGVV+R K G + K ++ + +
Sbjct: 29 DYYDILEELGSGAFGVVHRCV------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 82
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ + FE+ E LI + L D + + ++ +
Sbjct: 83 LHHPKLINLHDAFED----KYEMVLILEFLSGGELFDRIAAEDYKMSEAE---------- 128
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS-EGSRTFKIIDLGAAADL 313
+ M Q L +H IVH DIKP+N++ + + + KIID G A L
Sbjct: 129 ---------VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373
+ I K +AAPE D+++ G
Sbjct: 180 NP--DEIVKVTTATAEFAAPEIVDREPVGFYT----------------------DMWAIG 215
Query: 374 LIFLQMVC 381
++ ++
Sbjct: 216 VLGYVLLS 223
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 7e-19
Identities = 47/262 (17%), Positives = 81/262 (30%), Gaps = 59/262 (22%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
++ LG+ +GEG FG V++ S +N V K T E ++ E
Sbjct: 6 RERIELGRCIGEGQFGDVHQ---GIYMSPENPALAVAIKTCKNCTSDSVREKFLQE--AL 60
Query: 194 ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ G W+I L + R++ ++ +LIL
Sbjct: 61 TMRQFDHPHIVKLIGVITE-----NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL--- 112
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
QL AL L S VHRDI +NV+ S + K+ D G +
Sbjct: 113 ----------------YAYQLSTALAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLS 155
Query: 311 ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370
+ Y + L ++ APE + D++
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPE----------------------SINFRRFTSASDVW 193
Query: 371 SAGLIFLQMVCTVRRLCLHSCP 392
G+ +++ +
Sbjct: 194 MFGVCMWEILMHGVKPFQGVKN 215
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 83.6 bits (206), Expect = 7e-19
Identities = 48/252 (19%), Positives = 85/252 (33%), Gaps = 53/252 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRA-------SLAKKPSSKNDGDLVLKKATEYGAVEIWMNER- 190
+++ + LG G VV R A K G + + E + E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ-ELREATLKEVD 61
Query: 191 -VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+R+ + + +E ++ ++L++ + L D + + L E
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF----FFLVFDLMKKGELFDYLTEKV--------TLSE 109
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
+ + IM LL + LH IVHRD+KP+N++ + K+ D G
Sbjct: 110 KE------------TRKIMRALLEVICALHKLNIVHRDLKPENILLDD-DMNIKLTDFGF 156
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369
+ L G +E P Y APE S D+
Sbjct: 157 SCQLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGK----------------EVDM 198
Query: 370 YSAGLIFLQMVC 381
+S G+I ++
Sbjct: 199 WSTGVIMYTLLA 210
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 1e-18
Identities = 36/249 (14%), Positives = 80/249 (32%), Gaps = 54/249 (21%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-ATEYGAVEIWMNE-RVRRAC 195
++ L KLG+G FG V+ + + +K + E ++ E +V +
Sbjct: 16 RESLRLEVKLGQGCFGEVWMGTW------NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL 69
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ +Y +++ Y + +L D + Y ++
Sbjct: 70 RHEKLVQLYAVVSE-----EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-------- 116
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRV 315
+ +Q+ + + VHRD++ N++ E K+ D G A +
Sbjct: 117 ----------DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC-KVADFGLARLIED 165
Query: 316 GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375
+ ++ APE + T + D++S G++
Sbjct: 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKS----------------------DVWSFGIL 203
Query: 376 FLQMVCTVR 384
++ R
Sbjct: 204 LTELTTKGR 212
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 2e-18
Identities = 41/253 (16%), Positives = 80/253 (31%), Gaps = 51/253 (20%)
Query: 137 RKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNE-RVRRA 194
++D+ ++ +LG G FG V + + + VLK+ TE E M E ++
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
N + G + L+ G L ++ + V
Sbjct: 66 LDNPYIVRLIGVCQ-----AEALMLVMEMAGGGPLHKFLVGKREEIPVSN---------- 110
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ ++ Q+ + L VHRD+ +NV+ KI D G + L
Sbjct: 111 ---------VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALG 160
Query: 315 VGINYIPKE--FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372
+Y ++ APE + + D++S
Sbjct: 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRS----------------------DVWSY 198
Query: 373 GLIFLQMVCTVRR 385
G+ + + ++
Sbjct: 199 GVTMWEALSYGQK 211
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.0 bits (202), Expect = 2e-18
Identities = 38/244 (15%), Positives = 77/244 (31%), Gaps = 56/244 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNERVRRACAN 197
+ L + +G+G FG V G+ V +K + ++ E
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--------DYRGNKVAVKCIKNDATAQAFLAEA--SVMTQ 56
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ ++ G +++ Y + +L D + SR +LG
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS------VLGG-------- 102
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
+ + A++ L VHRD+ +NV+ SE K+ D G +
Sbjct: 103 ----DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKE----A 153
Query: 318 NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377
+ L ++ APE + + D++S G++
Sbjct: 154 SSTQDTGKLPVKWTAPEALREKKFSTKS----------------------DVWSFGILLW 191
Query: 378 QMVC 381
++
Sbjct: 192 EIYS 195
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 3e-18
Identities = 41/248 (16%), Positives = 78/248 (31%), Gaps = 35/248 (14%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+D +GEG FG V +A + K + +K+ + E
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 199 CADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
+ + G E+ G +L Y L D + R+
Sbjct: 70 HPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAFAIANSTAST 123
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+ + + + + +D L +HRD+ +N++ E + KI D G + V
Sbjct: 124 LSSQQLL--HFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVY 180
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376
+ L R+ A E S T ++ D++S G++
Sbjct: 181 VKK--TMGRLPVRWMAIESLNYSVYTTNS----------------------DVWSYGVLL 216
Query: 377 LQMVCTVR 384
++V
Sbjct: 217 WEIVSLGG 224
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 4e-18
Identities = 42/250 (16%), Positives = 80/250 (32%), Gaps = 56/250 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVRR 193
+ +GEGA+G+V A + V + + + E ++
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAY------DNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ + + + + + + A L L+ ++
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLS-------------- 107
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
N I + Q+L L +HS ++HRD+KP N++ + KI D G A
Sbjct: 108 -------NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVA 159
Query: 314 RVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
++ E++ Y APE + S + DI+S
Sbjct: 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI---------------------DIWS 198
Query: 372 AGLIFLQMVC 381
G I +M+
Sbjct: 199 VGCILAEMLS 208
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 5e-18
Identities = 43/230 (18%), Positives = 81/230 (35%), Gaps = 26/230 (11%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVR 192
++ + ++LG+G+FG+VY +AK V + +A ++NE V
Sbjct: 19 REKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + G G +I L + S + +
Sbjct: 78 KEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLR----------PAMAN 123
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
P + + ++ + L++ VHRD+ +N + +E T KI D G D
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRD 182
Query: 313 LRVGINYIPK-EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361
+ Y + LL R+ +PE T + + VLW++
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV----WSFGVVLWEI 228
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 6e-18
Identities = 48/250 (19%), Positives = 87/250 (34%), Gaps = 35/250 (14%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDL-----VLKKATEYGAVEIWMNERVR 192
+D VLGK LGEGAFG V A K + +LK + ++E
Sbjct: 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + + G ++I Y + L + + +R P L
Sbjct: 72 MKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPP----GLEYSYNPS 125
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
+ ++ + + Q+ ++ L S +HRD+ +NV+ +E KI D G A D
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIADFGLARD 184
Query: 313 L-RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
+ + L ++ APE T + D++S
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS----------------------DVWS 222
Query: 372 AGLIFLQMVC 381
G++ ++
Sbjct: 223 FGVLLWEIFT 232
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 1e-17
Identities = 33/257 (12%), Positives = 78/257 (30%), Gaps = 56/257 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+ +++G G FG+V+ + D V K GA+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-------LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 57
Query: 199 CADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ YG L++ + L+D + ++ + +TL+
Sbjct: 58 SHPKLVQLYGVCLE----QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL--------- 104
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRV 315
+ + + L ++HRD+ +N + E ++ K+ D G +
Sbjct: 105 ----------GMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLD 153
Query: 316 GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375
++A+PE + S + + D++S G++
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKS----------------------DVWSFGVL 191
Query: 376 FLQMVCTVRRLCLHSCP 392
++ + +
Sbjct: 192 MWEVFSEGKIPYENRSN 208
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 1e-17
Identities = 48/251 (19%), Positives = 77/251 (30%), Gaps = 48/251 (19%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL-----AKKPSSKNDGDLVLKKATEYGAVEIWMNERVRR 193
VL + +G+G FG V+R A K S + ++A EI+ +R
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA------EIYQTVMLR- 55
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
N + + WL+ Y +L D + +
Sbjct: 56 -HENILG--FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS---- 108
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
+ + + I HRD+K +N++ + I DLG A
Sbjct: 109 ---------TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRH 158
Query: 314 RVGINYI---PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370
+ I P + RY APE S S A DIY
Sbjct: 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA----------------DIY 202
Query: 371 SAGLIFLQMVC 381
+ GL+F ++
Sbjct: 203 AMGLVFWEIAR 213
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.9 bits (199), Expect = 1e-17
Identities = 49/250 (19%), Positives = 86/250 (34%), Gaps = 58/250 (23%)
Query: 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERV 191
Y DF + + LG G+FG V+ S+++G LKK ++
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIR------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
R + F+ + + ++ EG + L S+ FP
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP------------ 102
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
N + + +++ AL+ LHS I++RD+KP+N++ + KI D G A
Sbjct: 103 ---------NPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAK 152
Query: 312 DLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
+ + P Y APE S D +S
Sbjct: 153 Y----VPDVTYTLCGTPDYIAPEVVSTKPYNKSI----------------------DWWS 186
Query: 372 AGLIFLQMVC 381
G++ +M+
Sbjct: 187 FGILIYEMLA 196
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 1e-17
Identities = 47/206 (22%), Positives = 74/206 (35%), Gaps = 11/206 (5%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+D LGK LG GAFG V A V LK+ + M+E
Sbjct: 12 RDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
+ V +K GG +I + L+ + S+ + + +DL
Sbjct: 71 IHIGHHLNVVN-LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP---EDL 126
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
K +I Q+ ++ L S +HRD+ +N++ SE KI D G A D+
Sbjct: 127 YKDFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDI 184
Query: 314 RVGINYIPKEFLLDPRYAAPEQYIMS 339
+Y+ K P + I
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFD 210
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 79.8 bits (196), Expect = 2e-17
Identities = 47/252 (18%), Positives = 85/252 (33%), Gaps = 58/252 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
D + LG+ LG G V+ A V L+ R +
Sbjct: 7 DRYELGEILGFGGMSEVHLA------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 195 CANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
A + Y E + G +++ Y TL D++ +
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--------------- 105
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
G R I+ +++ AL+ H GI+HRD+KP N++ S + K++D G A
Sbjct: 106 ----GPMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIAR 159
Query: 312 DLRVGINYIPK--EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369
+ N + + + +Y +PEQ + + D+
Sbjct: 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARS----------------------DV 197
Query: 370 YSAGLIFLQMVC 381
YS G + +++
Sbjct: 198 YSLGCVLYEVLT 209
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.7 bits (196), Expect = 2e-17
Identities = 50/253 (19%), Positives = 86/253 (33%), Gaps = 59/253 (23%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+ + +G LG G FG VY +D V ++K E+ RV
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGI------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 194 -----ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
+ V + + ++ R E L D + R L
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQ 108
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
E + ++ Q+L A+ H+ G++HRDIK +N++ K+ID G
Sbjct: 109 E------------ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368
+ A L+ + + +F Y+ PE + SA
Sbjct: 157 SGALLK---DTVYTDFDGTRVYSPPEW--IRYHRYHGRSA-------------------A 192
Query: 369 IYSAGLIFLQMVC 381
++S G++ MVC
Sbjct: 193 VWSLGILLYDMVC 205
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 2e-17
Identities = 51/249 (20%), Positives = 92/249 (36%), Gaps = 58/249 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEY-GAVEIWMNE-RVR 192
++F +K+GEG +GVVY+A +K G++V ++ TE G + E +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKAR------NKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + + + +L++ + + + S
Sbjct: 56 KELNHPNIVKLLDVIHT----ENKLYLVFEFLHQDLKKFMDASALTGIP----------- 100
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
+I++ + QLL L HS ++HRD+KPQN++ + K+ D G A
Sbjct: 101 --------LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLARA 151
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372
V + ++ Y APE + +A DI+S
Sbjct: 152 FGVPVRT-YTHEVVTLWYRAPEILLGCKYYSTA---------------------VDIWSL 189
Query: 373 GLIFLQMVC 381
G IF +MV
Sbjct: 190 GCIFAEMVT 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 78.0 bits (191), Expect = 9e-17
Identities = 40/254 (15%), Positives = 77/254 (30%), Gaps = 63/254 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKKATEYGAVEIWMNER--VRRAC 195
+ + LG+K+G G+FG +Y + G+ V +K E +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGT------DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 196 ANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPK 255
+ G ++ G +L DL +++
Sbjct: 61 GGVGIPTIRWCGAE----GDYNVMVMELLGP-SLEDLFNFCSRKFSL------------- 102
Query: 256 GIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKI--IDLGAAADL 313
+ + + Q++ ++ +HS +HRD+KP N + G + + ID G A
Sbjct: 103 ------KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
Query: 314 RVG------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367
R K RYA+ ++ Q+
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD---------------------- 194
Query: 368 DIYSAGLIFLQMVC 381
D+ S G + +
Sbjct: 195 DLESLGYVLMYFNL 208
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 1e-16
Identities = 49/251 (19%), Positives = 80/251 (31%), Gaps = 62/251 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERVR 192
+DF+L K LG+G+FG V+ A K VE M E+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEF------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 55
Query: 193 RACANCCADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ A + F+ + + Y L + S
Sbjct: 56 LSLAWEHPFLTHMFCTFQT----KENLFFVMEYLNGGDLMYHIQSC-------------- 97
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
+R ++++ L LHS GIV+RD+K N++ + KI D G
Sbjct: 98 -----HKFDLSRATF-YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMC 150
Query: 311 ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370
+ +G + F P Y APE + S D +
Sbjct: 151 KENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSV----------------------DWW 187
Query: 371 SAGLIFLQMVC 381
S G++ +M+
Sbjct: 188 SFGVLLYEMLI 198
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 1e-16
Identities = 42/243 (17%), Positives = 76/243 (31%), Gaps = 48/243 (19%)
Query: 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDL-VLKKATEYGAVEIWMNERVRRACANCCAD 201
+ +G G FG VY +L K + L + T+ G V ++ E +
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE--GIIMKDFSHP 88
Query: 202 FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
V + G ++ Y L + + + V+ LI
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI--------------- 133
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG---IN 318
Q+ + L S VHRD+ +N + E T K+ D G A D+
Sbjct: 134 ----GFGLQVAKGMKFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSV 188
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
+ L ++ A E T + D++S G++ +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKS----------------------DVWSFGVLLWE 226
Query: 379 MVC 381
++
Sbjct: 227 LMT 229
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 2e-16
Identities = 36/251 (14%), Positives = 78/251 (31%), Gaps = 58/251 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-ATEYGAVEIWMNERVRRACAN 197
D K+LG G FGVV + D+ +K + + ++ E + N
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW------RGQYDVAIKMIKEGSMSEDEFIEE--AKVMMN 55
Query: 198 CCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
+ + YG ++I Y L + + + Q
Sbjct: 56 LSHEKLVQLYGVCTK----QRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------- 101
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ + + A++ L S +HRD+ +N + ++ K+ D G + +
Sbjct: 102 ---------LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVL 151
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374
R++ PE + S + + DI++ G+
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS----------------------DIWAFGV 189
Query: 375 IFLQMVCTVRR 385
+ ++ +
Sbjct: 190 LMWEIYSLGKM 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.9 bits (191), Expect = 2e-16
Identities = 40/253 (15%), Positives = 78/253 (30%), Gaps = 65/253 (25%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNER-V 191
+DF + + +G G FG VY + G + K+ + +NER +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRK------ADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57
Query: 192 RRACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILG 248
+ F+ F + I L +
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHT----PDKLSFILDLMNGGDLHYHLSQHGVFSEAD----- 108
Query: 249 EVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLG 308
++ ++++ L+ +H+ +V+RD+KP N++ E +I DLG
Sbjct: 109 ---------------MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLG 152
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368
A D P + Y APE + + + D
Sbjct: 153 LACDFS---KKKPHASVGTHGYMAPEV-LQKGVAYDSSA--------------------D 188
Query: 369 IYSAGLIFLQMVC 381
+S G + +++
Sbjct: 189 WFSLGCMLFKLLR 201
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 77.0 bits (189), Expect = 2e-16
Identities = 41/251 (16%), Positives = 82/251 (32%), Gaps = 62/251 (24%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+ F +++G G+FG VY A + ++V + + + + + R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFAR------DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 194 ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
G + WL+ Y + +DL+ + P
Sbjct: 68 FLQKLRHPNTIQYRGCYLR----EHTAWLVMEYC-LGSASDLLEVHKKPLQEVE------ 116
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I + L L LHS ++HRD+K N++ SE K+ D G+A
Sbjct: 117 -------------IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSA 162
Query: 311 ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370
+ + +++ P + APE + + D++
Sbjct: 163 SIMAPANSFVG-----TPYWMAPEVILAMDEGQYDGKV-------------------DVW 198
Query: 371 SAGLIFLQMVC 381
S G+ +++
Sbjct: 199 SLGITCIELAE 209
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.3 bits (187), Expect = 3e-16
Identities = 30/209 (14%), Positives = 62/209 (29%), Gaps = 26/209 (12%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN 197
+ D + KLG G +G VY K V K + +E+ +
Sbjct: 16 RTDITMKHKLGGGQYGEVYEGVW------KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69
Query: 198 CCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGI 257
+ +++ Y + L L + L+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL----------- 118
Query: 258 ERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGI 317
+ +Q+ A++ L +HRD+ +N + E + K+ D G + +
Sbjct: 119 --------YMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDT 169
Query: 318 NYIPKEFLLDPRYAAPEQYIMSTQTPSAP 346
++ APE + + +
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.5 bits (187), Expect = 3e-16
Identities = 52/252 (20%), Positives = 80/252 (31%), Gaps = 57/252 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGAVEIWMNERVR 192
+ ++GEGA+G V++A KN G V ++ E + V
Sbjct: 7 QQYECVAEIGEGAYGKVFKAR-----DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 193 RACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
R V + S + + L + P
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--------- 112
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
I+ +M QLL LD LHS +VHRD+KPQN++ + S K+ D G
Sbjct: 113 ---------VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGL 162
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369
A ++ Y APE + S+ D+
Sbjct: 163 ARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPV----------------------DL 198
Query: 370 YSAGLIFLQMVC 381
+S G IF +M
Sbjct: 199 WSVGCIFAEMFR 210
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.8 bits (188), Expect = 4e-16
Identities = 39/223 (17%), Positives = 70/223 (31%), Gaps = 40/223 (17%)
Query: 129 ERLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV------LKKATEYGA 182
E + T + D F K LG G+FG V K G+ +K +
Sbjct: 31 ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK------HKESGNHYAMKILDKQKVVKLKQ 84
Query: 183 VEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNV 242
+E +NE+ R F+ + Y ++ G + L F
Sbjct: 85 IEHTLNEK--RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-- 140
Query: 243 QTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTF 302
+ +Q++ + LHS +++RD+KP+N++ +
Sbjct: 141 -------------------PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
Query: 303 KIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
+ D G A + P APE + +
Sbjct: 182 -VTDFGFAKR----VKGRTWTLCGTPEALAPEIILSKGYNKAV 219
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 1e-15
Identities = 46/231 (19%), Positives = 78/231 (33%), Gaps = 37/231 (16%)
Query: 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RV 191
++ +F K LG GAFG VY+ P + V L++AT A + ++E V
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLW--IPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 192 RRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQ 251
+ N + G LI + L D + + Q L+
Sbjct: 65 MASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNIGSQYLL----- 114
Query: 252 DLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311
Q+ ++ L +VHRD+ +NV+ KI D G A
Sbjct: 115 --------------NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAK 159
Query: 312 DLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 361
L Y + + ++ A E + T + + +W+L
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS----DVWSYGVTVWEL 206
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 74.5 bits (182), Expect = 2e-15
Identities = 40/209 (19%), Positives = 72/209 (34%), Gaps = 35/209 (16%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
DD+ L +KLG G + V+ A + + + V+ K + + E
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAI------NITNNEKVVVKILKPVKKKKIKREIKILENLRG 88
Query: 199 CADFV--YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKG 256
+ + ++ + L++ + L +
Sbjct: 89 GPNIITLADIVKDPVSR--TPALVFEHVNNTDFKQLY--QTLT----------------- 127
Query: 257 IERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVG 316
+ I+ M ++L ALD HS GI+HRD+KP NV+ R ++ID G A G
Sbjct: 128 ----DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 317 INYIPKEFLLDPRYAAPEQYIMSTQTPSA 345
Y + + PE + +
Sbjct: 184 QEY--NVRVASRYFKGPELLVDYQMYDYS 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.7 bits (180), Expect = 4e-15
Identities = 47/247 (19%), Positives = 78/247 (31%), Gaps = 55/247 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRRA 194
+DF K LG+G FG V K G L+K E+ R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVR------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 195 CANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLP 254
N F+ +++ G +SRE + +
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEER---------- 106
Query: 255 KGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314
+ ++++ AL+ LHS +V+RDIK +N++ + KI D G +
Sbjct: 107 ---------ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGI 156
Query: 315 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374
K F P Y APE + + D + G+
Sbjct: 157 -SDGATMKTFCGTPEYLAPEVLEDNDYGRAV----------------------DWWGLGV 193
Query: 375 IFLQMVC 381
+ +M+C
Sbjct: 194 VMYEMMC 200
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (177), Expect = 5e-15
Identities = 38/250 (15%), Positives = 77/250 (30%), Gaps = 55/250 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-----ATEYGAVEIWMNE-RVR 192
D L +KLG+G+FGVV R S + +K ++ A++ ++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEW--DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + +YG ++ +L D + + + + T
Sbjct: 66 HSLDHRNLIRLYGVVLT-----PPMKMVTELAPLGSLLDRLRKHQGHFLLGT-------- 112
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
+ Q+ + L S +HRD+ +N++ + KI D G
Sbjct: 113 -----------LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RDLVKIGDFGLMRA 160
Query: 313 LRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
L +Y+ +E P + + + D +
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH---------------------ASDTWM 199
Query: 372 AGLIFLQMVC 381
G+ +M
Sbjct: 200 FGVTLWEMFT 209
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.0 bits (178), Expect = 6e-15
Identities = 49/252 (19%), Positives = 85/252 (33%), Gaps = 57/252 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKAT---EYGAVEIWMNER- 190
++F L K LG GA+G V+ L +K S + G L LKKAT + E ER
Sbjct: 24 ENFELLKVLGTGAYGKVF---LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 191 -VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGE 249
+ + ++ F+ + LI Y L
Sbjct: 81 VLEHIRQSPFLVTLHYAFQT----ETKLHLILDYINGGELFTH----------------- 119
Query: 250 VQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGA 309
L + +Q + +++ AL+ LH GI++RDIK +N++ + D G
Sbjct: 120 ---LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGL 175
Query: 310 AADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369
+ + +F Y AP+ D
Sbjct: 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV--------------------DW 215
Query: 370 YSAGLIFLQMVC 381
+S G++ +++
Sbjct: 216 WSLGVLMYELLT 227
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 6e-15
Identities = 42/250 (16%), Positives = 80/250 (32%), Gaps = 55/250 (22%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNE-RVRR 193
K +G G FG VY+ L K SS V LK ++ E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 194 ACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDL 253
++ + G +I Y L + ++ ++V L+
Sbjct: 65 QFSHHNIIRLEGVISK----YKPMMIITEYMENGALDKFLREKDGEFSVLQLV------- 113
Query: 254 PKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
++ + + L + VHRD+ +N++ + + K+ D G + L
Sbjct: 114 ------------GMLRGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVL 160
Query: 314 RVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371
Y + R+ APE I + SA D++S
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPE-AISYRKFTSAS---------------------DVWS 198
Query: 372 AGLIFLQMVC 381
G++ +++
Sbjct: 199 FGIVMWEVMT 208
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.6 bits (172), Expect = 7e-15
Identities = 27/172 (15%), Positives = 52/172 (30%), Gaps = 22/172 (12%)
Query: 142 VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCAD 201
+GK +GEG V+ V+ D
Sbjct: 3 AIGKLMGEGKESAVFNCYSE-------KFGEC--------VVKFHKVGHTSFKKVKEKRD 47
Query: 202 FVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIEREN 261
+ F + + + L L + + + + +L E+ D +
Sbjct: 48 YGDLHFSVLAIR----SARNEFRALQKLQGLAVPKVYAWE-GNAVLMELIDAKELYRVRV 102
Query: 262 RIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADL 313
++ +L + + GIVH D+ NV+ SE IID + ++
Sbjct: 103 ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEV 152
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.1 bits (176), Expect = 7e-15
Identities = 41/247 (16%), Positives = 76/247 (30%), Gaps = 56/247 (22%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKK-ATEYGAVEIWMNERVRRACANCCADFV 203
K+LG G FG V + K K +LK A + + + E ++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA--NVMQQLDNPYI 70
Query: 204 ---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERE 260
G E + L+ L L + +
Sbjct: 71 VRMIGICEA-----ESWMLVMEMAELGPLNKY--------------------LQQNRHVK 105
Query: 261 NRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGINYI 320
++ I ++ Q+ + L + VHRD+ +NV+ KI D G + LR NY
Sbjct: 106 DKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA-KISDFGLSKALRADENYY 164
Query: 321 PKE--FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
+ ++ APE + + D++S G++ +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKS----------------------DVWSFGVLMWE 202
Query: 379 MVCTVRR 385
++
Sbjct: 203 AFSYGQK 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 72.1 bits (176), Expect = 8e-15
Identities = 32/260 (12%), Positives = 70/260 (26%), Gaps = 48/260 (18%)
Query: 130 RLFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEI 185
R F + + +G G FG V V LK
Sbjct: 17 REFAKEIDISCVKIEQVIGAGEFGEVCSG---HLKLPGKREIFVAIKTLKSGYTEKQRRD 73
Query: 186 WMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTL 245
+++E V K +I + +L + + + V L
Sbjct: 74 FLSEA--SIMGQFDHPNVIHLE-GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL 130
Query: 246 ILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKII 305
+ ++ + + L VHRD+ +N++ + + K+
Sbjct: 131 V-------------------GMLRGIAAGMKYLADMNYVHRDLAARNILVNS-NLVCKVS 170
Query: 306 DLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD 365
D G + R+ + + + P+ +
Sbjct: 171 DFGLS------------------RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 212
Query: 366 RFDIYSAGLIFLQMVCTVRR 385
D++S G++ +++ R
Sbjct: 213 ASDVWSYGIVMWEVMSYGER 232
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (175), Expect = 8e-15
Identities = 36/249 (14%), Positives = 83/249 (33%), Gaps = 59/249 (23%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RVR 192
+ +K+GEG +G V++A ++ ++V + G + E +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAK------NRETHEIVALKRVRLDDDDEGVPSSALREICLL 55
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + ++ + + L++ + +
Sbjct: 56 KELKHKNIVRLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCNGDLDP----------- 100
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
I+++ + QLL L HS ++HRD+KPQN++ + K+ + G A
Sbjct: 101 ---------EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARA 150
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372
+ + ++ Y P+ + ++ D++SA
Sbjct: 151 FGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTS---------------------IDMWSA 188
Query: 373 GLIFLQMVC 381
G IF ++
Sbjct: 189 GCIFAELAN 197
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 1e-14
Identities = 52/266 (19%), Positives = 90/266 (33%), Gaps = 54/266 (20%)
Query: 117 PGFFDMFVLAFVERLFRTTYR-KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLK 175
P F+ + L +T + + + +G GA+G V A G V
Sbjct: 2 PTFYR-------QELNKTIWEVPERYQNLSPVGSGAYGSVCAA------FDTKTGLRVAV 48
Query: 176 KATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMIS 235
K I +R R E K ++ + T A +
Sbjct: 49 KKLSRPFQSIIHAKRTYR--------------ELRLLKHMKHENVIGLLDVFTPARSLEE 94
Query: 236 REFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295
Y V L+ ++ ++ K + + +Q ++ Q+L L +HS I+HRD+KP N+
Sbjct: 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 355
+E KI+D G A + ++ Y APE +
Sbjct: 155 NEDCE-LKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQTV--------- 200
Query: 356 PVLWQLNLPDRFDIYSAGLIFLQMVC 381
DI+S G I +++
Sbjct: 201 ------------DIWSVGCIMAELLT 214
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 1e-14
Identities = 45/253 (17%), Positives = 87/253 (34%), Gaps = 55/253 (21%)
Query: 139 DDFVLGKKLGEGAFGVVYRASL--------AKKPSSKNDGDLVLKKATEYGAVEIWMNER 190
+ K+G+G FG V++A KK +N+ + A EI + +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQL 65
Query: 191 VRRACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
++ + ++ G +L++ + E LA L+ + + +
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSE------ 118
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAA 310
I+ +M LL L +H I+HRD+K NV+ + K+ D G A
Sbjct: 119 -------------IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLA 164
Query: 311 ADLRVGINYIPKEF--LLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368
+ N P + + + P + ++ + P D
Sbjct: 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI--------------------D 204
Query: 369 IYSAGLIFLQMVC 381
++ AG I +M
Sbjct: 205 LWGAGCIMAEMWT 217
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.6 bits (175), Expect = 1e-14
Identities = 52/253 (20%), Positives = 80/253 (31%), Gaps = 65/253 (25%)
Query: 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVRR 193
+D + LG GAF V A K LV + K G NE
Sbjct: 8 RDIYDFRDVLGTGAFSEVILA------EDKRTQKLVAIKCIAKKALEGKEGSMENE--IA 59
Query: 194 ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEV 250
+ +E+ GG +LI + L D ++ + F
Sbjct: 60 VLHKIKHPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVEKGFY----------- 104
Query: 251 QDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS--EGSRTFKIIDLG 308
R ++ Q+L A+ LH GIVHRD+KP+N+++ + I D G
Sbjct: 105 ---------TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155
Query: 309 AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368
+ G P Y APE + + D
Sbjct: 156 LSKMEDPGSVL--STACGTPGYVAPEVLAQKPYSKAV----------------------D 191
Query: 369 IYSAGLIFLQMVC 381
+S G+I ++C
Sbjct: 192 CWSIGVIAYILLC 204
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 3e-14
Identities = 52/264 (19%), Positives = 82/264 (31%), Gaps = 67/264 (25%)
Query: 131 LFRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIW 186
+FR D + G++LG G F VV + K+ G +KK +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 187 MNERVRR---ACANCCADFV---YGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPY 240
E + R V + +EN + LI L D + +E
Sbjct: 56 SREDIEREVSILKEIQHPNVITLHEVYEN----KTDVILILELVAGGELFDFLAEKESLT 111
Query: 241 NVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE--- 297
+ Q+L + LHS I H D+KP+N++ +
Sbjct: 112 --------------------EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV 151
Query: 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV 357
KIID G A + G + K P + APE A
Sbjct: 152 PKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEA------------ 197
Query: 358 LWQLNLPDRFDIYSAGLIFLQMVC 381
D++S G+I ++
Sbjct: 198 ----------DMWSIGVITYILLS 211
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 70.3 bits (171), Expect = 3e-14
Identities = 46/249 (18%), Positives = 85/249 (34%), Gaps = 60/249 (24%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-----LKKATEYGAVEIWMNE-RVR 192
+ + +K+GEG +GVVY+A N G+ + + G + E +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-------NNYGETFALKKIRLEKEDEGIPSTTIREISIL 54
Query: 193 RACANCCADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQD 252
+ + +Y L++ + + L + +V
Sbjct: 55 KELKHSNIVKLYDVIHT----KKRLVLVFEHLDQDLKKLLDVCEGGLESVT--------- 101
Query: 253 LPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312
++ + QLL + H ++HRD+KPQN++ + KI D G A
Sbjct: 102 -----------AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARA 149
Query: 313 LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372
+ + ++ Y AP+ M ++ S DI+S
Sbjct: 150 FGIPVRKYTH-EIVTLWYRAPDVL-MGSKKYSTTI--------------------DIWSV 187
Query: 373 GLIFLQMVC 381
G IF +MV
Sbjct: 188 GCIFAEMVN 196
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 67.8 bits (164), Expect = 4e-13
Identities = 45/235 (19%), Positives = 76/235 (32%), Gaps = 41/235 (17%)
Query: 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-LKK------ATEYGAVEIWMNERVRR 193
++L +KLG G F V+ A + V +K TE EI + +RV
Sbjct: 15 YILVRKLGWGHFSTVWLA------KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVND 68
Query: 194 ACANCCADF-------VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLI 246
A + F + G +++ GE LA + +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY-- 126
Query: 247 LGEVQDLPKGIERENRIIQTIMSQLLFALDGL-HSTGIVHRDIKPQNVIFSEGSRTFKII 305
++ I QLL LD + GI+H DIKP+NV+ +I
Sbjct: 127 -----------------VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169
Query: 306 DLG-AAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359
+ A + + Y +PE + + A A + ++
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.3 bits (163), Expect = 5e-13
Identities = 49/243 (20%), Positives = 80/243 (32%), Gaps = 46/243 (18%)
Query: 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANC 198
+ K +G GA G+V A V K +R R
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY------DAVLDRNVAIKKLSRPFQNQTHAKRAYR----- 65
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
E K + I T + + Y V L+ + + +
Sbjct: 66 ---------ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 116
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
R+ ++ Q+L + LHS GI+HRD+KP N++ KI+D G A G +
Sbjct: 117 DHERMSY-LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLART--AGTS 172
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
++ +++ Y APE + + DI+S G I +
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENV----------------------DIWSVGCIMGE 210
Query: 379 MVC 381
MV
Sbjct: 211 MVR 213
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.8 bits (162), Expect = 7e-13
Identities = 49/274 (17%), Positives = 93/274 (33%), Gaps = 70/274 (25%)
Query: 117 PGFFDMFVLAFVERLFRTTYR-KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLV-- 173
GF+ + + +T + + + + +G GA+G V A G V
Sbjct: 2 SGFYR-------QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV------DGRTGAKVAI 48
Query: 174 ---LKKATEYGAVEIWMNE-RVRRACANCCADFVYGFF--ENSSKKGGEYWLIWRYEGEA 227
+ + E R+ + + + F + + +++L+ + G
Sbjct: 49 KKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD 108
Query: 228 TLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287
LM + IQ ++ Q+L L +H+ GI+HRD
Sbjct: 109 LG-KLMKHEKLG---------------------EDRIQFLVYQMLKGLRYIHAAGIIHRD 146
Query: 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPS 347
+KP N+ +E KI+D G A + +++ Y APE I++ +
Sbjct: 147 LKPGNLAVNEDCE-LKILDFGLARQ----ADSEMTGYVVTRWYRAPEV-ILNWMRYTQTV 200
Query: 348 APVATALSPVLWQLNLPDRFDIYSAGLIFLQMVC 381
DI+S G I +M+
Sbjct: 201 --------------------DIWSVGCIMAEMIT 214
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.3 bits (158), Expect = 2e-12
Identities = 41/243 (16%), Positives = 71/243 (29%), Gaps = 56/243 (23%)
Query: 145 KKLGEGAFGVVYRASLAKKPSSKNDGDLV----LKKATEYGAVEIWMNERVR--RACANC 198
LGEG F VY+A KN +V +K A + +R +
Sbjct: 4 DFLGEGQFATVYKARD------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 199 CADFVYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIE 258
+ G + + L++ + + +
Sbjct: 58 SHPNIIGLLD-AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH--------------- 101
Query: 259 RENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRTFKIIDLGAAADLRVGIN 318
I+ M L L+ LH I+HRD+KP N++ E K+ D G A
Sbjct: 102 -----IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNR 155
Query: 319 YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378
++ Y APE + D+++ G I +
Sbjct: 156 A-YTHQVVTRWYRAPELLFGARMYGVG---------------------VDMWAVGCILAE 193
Query: 379 MVC 381
++
Sbjct: 194 LLL 196
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 397 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.4 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=350.23 Aligned_cols=202 Identities=20% Similarity=0.312 Sum_probs=168.9
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|++............++...+...+|+||+.+++.+.. ++.+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCC-----CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEE
Confidence 468999999999999999999998887 7899998765433333334455666777889999999987654 5689
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
|+||||+++|+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 93 ~ivmEy~~gg~L~~~~~~~---------------------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTET---------------------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp EEEEECCTTCBHHHHHHHS---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EEEEEecCCCcHHHHhhcc---------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence 9999999999999987654 3578889999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||+|+.+..+.. .....+||+.|||||++.+ ..|+.++|||||||++|
T Consensus 152 ~~-~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~----------------------~~~~~~~DiwSlGvily 207 (293)
T d1yhwa1 152 DG-SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR----------------------KAYGPKVDIWSLGIMAI 207 (293)
T ss_dssp TC-CEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHSS----------------------SCBCTHHHHHHHHHHHH
T ss_pred CC-cEeeccchhheeeccccc-cccccccCCCccChhhhcC----------------------CCCCchhceehHhHHHH
Confidence 87 999999999987654432 3456789999999996654 34667889999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||++|+.||....
T Consensus 208 emltG~~Pf~~~~ 220 (293)
T d1yhwa1 208 EMIEGEPPYLNEN 220 (293)
T ss_dssp HHHHSSCTTTTSC
T ss_pred HHhhCCCCCCCCC
Confidence 9999999997643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=346.72 Aligned_cols=204 Identities=21% Similarity=0.268 Sum_probs=169.9
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
+..++|++++.||+|+||+||+|++..++ +.+|+|.+...... ......++...+...+||||+.+++.+.
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~- 76 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH- 76 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCC-----cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-
Confidence 45689999999999999999999998877 78999987643211 1223334566677788999999998764
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+++.+|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~--------------------~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~N 136 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLS--------------------KFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 136 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccc
Confidence 4578999999999999999998754 56888999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||+|+..... ......||+.|||||++.+. .|+.++|||||
T Consensus 137 ill~~~~-~~kl~DFG~a~~~~~~---~~~~~~Gt~~Y~APE~~~~~----------------------~~~~~~DiwSl 190 (263)
T d2j4za1 137 LLLGSAG-ELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR----------------------MHDEKVDLWSL 190 (263)
T ss_dssp EEECTTS-CEEECCCCSCSCCCCC---CCEETTEEGGGCCHHHHTTC----------------------CCCTTHHHHHH
T ss_pred ceecCCC-CEeecccceeeecCCC---cccccCCCCcccCHHHHcCC----------------------CCCchhhhhhH
Confidence 9999987 9999999999865433 23456899999999966543 45667899999
Q ss_pred HHHHHHHHcCCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~ 391 (397)
||+||||++|+.||...+.
T Consensus 191 Gvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 191 GVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp HHHHHHHHHSSCTTCCSSH
T ss_pred hHHHHHHhcCCCCCCCCCH
Confidence 9999999999999976543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=347.74 Aligned_cols=206 Identities=24% Similarity=0.275 Sum_probs=167.8
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|.+......+ .....++...+...+|+||+.+++.+.. ++.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Cce
Confidence 479999999999999999999998887 789999876443222 2223445667777889999999987744 578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+|+||||+.+|+|.+++.... .+++..++.++.|++.||+|||++|||||||||+|||++
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~--------------------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDI--------------------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--------------------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred eEEEEeccCCCcHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 999999999999999886543 578889999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+++ .+||+|||+|+.+..+.. ......+||+.|||||++.+..+ ++.++||||+||+
T Consensus 138 ~~~-~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~---------------------~~~~~DiwSlGvi 195 (271)
T d1nvra_ 138 ERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF---------------------HAEPVDVWSCGIV 195 (271)
T ss_dssp TTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB---------------------CHHHHHHHHHHHH
T ss_pred CCC-CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCC---------------------CCCceeeeHhHHH
Confidence 987 999999999987654432 23456789999999997654332 2356899999999
Q ss_pred HHHHHcCCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHSC 391 (397)
Q Consensus 376 l~elltg~~Pf~~~~~ 391 (397)
||||++|+.||.....
T Consensus 196 lyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 196 LTAMLAGELPWDQPSD 211 (271)
T ss_dssp HHHHHHSSCSCSSSST
T ss_pred HHHHHhCCCCCCCCCh
Confidence 9999999999976543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=354.05 Aligned_cols=204 Identities=21% Similarity=0.289 Sum_probs=169.1
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
+..++|++.++||+|+||+||+|++..++ +.+|+|++.... ........++...+...+||||+.+++.+.. +
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSG-----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-D 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTT-----EEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-S
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-C
Confidence 45689999999999999999999998877 788999876432 2222333456667788899999999997754 5
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCceecCCCCCce
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIVHRDIKPQNV 293 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~giiHrDIKp~NI 293 (397)
+++++||||+.+|+|.+++.+.+ .+++..++.++.|++.||.|||+ +||+||||||+||
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~--------------------~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NI 136 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAG--------------------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCcHHHHHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHe
Confidence 68999999999999999998654 46788899999999999999997 5999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|+++++ .+||+|||+|+.+... ...+.+||+.|||||++. ...|+.++||||+|
T Consensus 137 Ll~~~~-~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~----------------------~~~y~~~~DiWSlG 190 (322)
T d1s9ja_ 137 LVNSRG-EIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQ----------------------GTHYSVQSDIWSMG 190 (322)
T ss_dssp EECTTC-CEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHH----------------------CSCCCTTHHHHHHH
T ss_pred eECCCC-CEEEeeCCCccccCCC---ccccccCCccccCchHHc----------------------CCCCCcHHHHHHHH
Confidence 999987 9999999999876432 235679999999999554 44567788999999
Q ss_pred HHHHHHHcCCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~~ 391 (397)
|++|||++|+.||.....
T Consensus 191 vil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 191 LSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HHHHHHHHSSCCSSCCCT
T ss_pred HHHHHHHHCCCCCCCCCH
Confidence 999999999999987553
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=346.96 Aligned_cols=205 Identities=22% Similarity=0.335 Sum_probs=166.7
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+.++|++++.||+|+||+||+|++..++ +.+|+|.+..... .......++...+...+|+||+.+++.+. .
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~ 79 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-D 79 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-C
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-E
Confidence 4579999999999999999999998887 7899998764321 11223344555667778999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++.+|+||||+++|+|.+++...+ .+++..++.++.|++.||+|||++|||||||||+||
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~~--------------------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NI 139 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKIG--------------------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCEEEEEEEccCCCCHHHhhhccC--------------------CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccc
Confidence 578999999999999999988764 578889999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccc-ccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|+++++ .+||+|||+|+.+.... .......+||+.|||||++. ...|+.++|||||
T Consensus 140 ll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~----------------------~~~~~~~~DiwSl 196 (288)
T d1uu3a_ 140 LLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT----------------------EKSACKSSDLWAL 196 (288)
T ss_dssp EECTTS-CEEECCCTTCEECC----------CCCCGGGCCHHHHH----------------------TCCCCHHHHHHHH
T ss_pred ccCCCc-eEEecccccceecccCCcccccccccCCccccCceeec----------------------cCCCCcccceehh
Confidence 999987 99999999998765432 22345578999999999554 3456778899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||+||||++|+.||...+
T Consensus 197 Gvilyell~g~~Pf~~~~ 214 (288)
T d1uu3a_ 197 GCIIYQLVAGLPPFRAGN 214 (288)
T ss_dssp HHHHHHHHHSSCSSCCSS
T ss_pred hHHHHHHhhCCCCCCCcC
Confidence 999999999999998654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=345.01 Aligned_cols=208 Identities=20% Similarity=0.317 Sum_probs=160.0
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc-C
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK-G 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~ 214 (397)
.++|++.+.||+|+||+||+|++..++ +.+|+|.+.... ..+.....++...+...+||||+.+++.+... +
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 479999999999999999999998887 789999876432 33334445566778888999999999876543 4
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC-----ceecCCC
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG-----IVHRDIK 289 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g-----iiHrDIK 289 (397)
+.+|+||||+++|+|.+++.... ..+..+++..++.++.|++.||+|||++| |||||||
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~----------------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiK 141 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGT----------------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 141 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHH----------------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CC
T ss_pred CEEEEEEecCCCCcHHHHHHhcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCc
Confidence 67899999999999999987542 11235788999999999999999999976 9999999
Q ss_pred CCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 369 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv 369 (397)
|+|||++.++ .+||+|||+|+.+..+.. ......||+.|||||++.+ ..|+.++||
T Consensus 142 p~NIll~~~~-~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~----------------------~~~~~~~DI 197 (269)
T d2java1 142 PANVFLDGKQ-NVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNR----------------------MSYNEKSDI 197 (269)
T ss_dssp GGGEEECTTS-CEEECCHHHHHHC------------CCCSCCCHHHHTT----------------------CCCCHHHHH
T ss_pred hhhcCcCCCC-cEEEeeccceeecccCCC-ccccCCCCcccCCHHHHcC----------------------CCCChHHHH
Confidence 9999999987 999999999987754433 2456789999999996543 356778899
Q ss_pred HHHHHHHHHHHcCCCCCCCCC
Q 015991 370 YSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 370 ~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||||++|||+||+.||....
T Consensus 198 wSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 198 WSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp HHHHHHHHHHHHSSCSCCCSS
T ss_pred HhhCHHHHHHhhCCCCCCCCC
Confidence 999999999999999997644
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=348.10 Aligned_cols=208 Identities=23% Similarity=0.302 Sum_probs=171.0
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
+.|++.++||+|+||+||+|++..++ ..+|+|.+......+.....++...+...+||||+.+++.+.. ++.++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETS-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCC-----eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEE
Confidence 67999999999999999999998887 7889998865443333333445566677789999999987644 57899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 86 lvmEy~~~g~L~~~~~~~~-------------------~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELE-------------------RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD 146 (288)
T ss_dssp EEEECCTTEEHHHHHHHHT-------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred EEEecCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC
Confidence 9999999999999987543 146788899999999999999999999999999999999998
Q ss_pred CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 299 SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 299 ~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+ .+||+|||+|+....... ......||+.|||||++....... ..|+.++|||||||+|||
T Consensus 147 ~-~~Kl~DFG~a~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~-----------------~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 147 G-DIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKD-----------------RPYDYKADVWSLGITLIE 207 (288)
T ss_dssp S-CEEECCCTTCEECHHHHH-HHTCCCSCCTTCCHHHHTTCSTTT-----------------SSTTTHHHHHHHHHHHHH
T ss_pred C-CEEEEechhhhccCCCcc-cccccccccccCCHHHHhhcccCC-----------------CCCChhhhHHHHHHHHHH
Confidence 7 999999999976543322 234678999999999876543322 347889999999999999
Q ss_pred HHcCCCCCCCCC
Q 015991 379 MVCTVRRLCLHS 390 (397)
Q Consensus 379 lltg~~Pf~~~~ 390 (397)
|++|+.||...+
T Consensus 208 mltg~~Pf~~~~ 219 (288)
T d2jfla1 208 MAEIEPPHHELN 219 (288)
T ss_dssp HHHSSCTTTTSC
T ss_pred HhhCCCCCCCCC
Confidence 999999997654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=348.40 Aligned_cols=206 Identities=20% Similarity=0.219 Sum_probs=172.0
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
+..++|++++.||+|+||.||+|++..++ +.+|+|.+..... .+.....++...+...+||||+.+++.+.
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~- 75 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ- 75 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-
Confidence 35689999999999999999999998887 8899998864321 12223334566677788999999998774
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+++.+++||||+.+|+|.+++...+ .+++..++.++.|++.||+|||++|||||||||+|
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~--------------------~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~N 135 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRER--------------------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred cccccccceeccCCCchhhhhhccc--------------------CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHH
Confidence 4578999999999999999998765 56788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||+|+...... ......+||+.|||||++.+. .|+.++||||+
T Consensus 136 ILl~~~g-~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~~----------------------~y~~~~DiwSl 191 (337)
T d1o6la_ 136 LMLDKDG-HIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDN----------------------DYGRAVDWWGL 191 (337)
T ss_dssp EEECTTS-CEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSS----------------------CBCTTHHHHHH
T ss_pred eEecCCC-CEEEeecccccccccCC-cccccceeCHHHhhhhhccCC----------------------CCChhhcccch
Confidence 9999987 99999999998754332 234567899999999966543 46667899999
Q ss_pred HHHHHHHHcCCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~ 391 (397)
||+||||++|+.||...+.
T Consensus 192 Gvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 192 GVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp HHHHHHHHHSSCSSCCSSH
T ss_pred hhHHHHHHHCCCCCCCcCH
Confidence 9999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=335.12 Aligned_cols=201 Identities=20% Similarity=0.276 Sum_probs=164.6
Q ss_pred CCe-EEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc---
Q 015991 139 DDF-VLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK--- 212 (397)
Q Consensus 139 ~~f-~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~--- 212 (397)
++| ++.++||+|+||+||+|++..++ ..+|+|++.... ..+.....++...+...+||||+.+++.+..
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~-----~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCC-----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 445 78889999999999999998877 788899876532 3333444566777888899999999886543
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC--ceecCCCC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG--IVHRDIKP 290 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g--iiHrDIKp 290 (397)
.+..+|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ ||||||||
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp 142 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFK--------------------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 142 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG
T ss_pred cCCEEEEEEeCCCCCcHHHHHhccc--------------------cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcCh
Confidence 3467899999999999999998754 4678889999999999999999998 99999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++++.+.+||+|||+|+..... ......||+.|||||++.+ .++.++|||
T Consensus 143 ~NILl~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-----------------------~~~~~~DIw 196 (270)
T d1t4ha_ 143 DNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-----------------------KYDESVDVY 196 (270)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-----------------------CCCTHHHHH
T ss_pred hhceeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCC-----------------------CCCCcCchh
Confidence 99999753349999999999764332 2356789999999996532 366789999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+||||++|+.||....
T Consensus 197 SlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 197 AFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp HHHHHHHHHHHSSCTTTTCS
T ss_pred hHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999997644
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=339.59 Aligned_cols=207 Identities=19% Similarity=0.233 Sum_probs=163.8
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc--hhHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY--GAVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
++..++|+++++||+|+||+||+|++. ..+|+|.+... ...+.....++...+...+|+||+.+++...
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~- 74 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-
Confidence 456689999999999999999999754 45889987632 2333344455677778889999999988643
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++.+++||||+++|+|.+++...+ ..+++..+..++.|+++||+|||+++||||||||+|
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~N 134 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIE-------------------TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN 134 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSC-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -ccEEEEEEecCCCCCHHHHHhhcc-------------------CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHH
Confidence 456899999999999999997643 246788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccc-cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||+.++ .+||+|||+|+....... .......||+.|||||++.+... ..|+.++||||
T Consensus 135 iLl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-------------------~~~~~~sDiwS 194 (276)
T d1uwha_ 135 IFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK-------------------NPYSFQSDVYA 194 (276)
T ss_dssp EEEETTS-SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSS-------------------CCCCHHHHHHH
T ss_pred EEEcCCC-CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccC-------------------CCCCchhhhhh
Confidence 9999987 999999999987654322 23456789999999998764332 23677899999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||+||||+||+.||....
T Consensus 195 ~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 195 FGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp HHHHHHHHHHSSCTTTTCC
T ss_pred hHHHHHHHHHCCCCCCCCC
Confidence 9999999999999997644
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-44 Score=341.25 Aligned_cols=201 Identities=20% Similarity=0.288 Sum_probs=168.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|+++++||+|+||+||+|++..++ +.+|+|.+..... .......++...+...+||||+.+++.+. .
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~ 75 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-D 75 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-C
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCC-----CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-e
Confidence 3579999999999999999999998877 8899998864321 11223344566777889999999998764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++.+|+||||+.+++|..++.... .+++..++.++.||+.||+|||++|||||||||+||
T Consensus 76 ~~~~~ivmE~~~gg~l~~~~~~~~--------------------~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 135 (316)
T d1fota_ 76 AQQIFMIMDYIEGGELFSLLRKSQ--------------------RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135 (316)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTS--------------------SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred CCeeeeEeeecCCccccccccccc--------------------cccccHHHHHHHHHHHhhhhhccCcEEccccCchhe
Confidence 578999999999999999988765 456778889999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+|+..... ....+||+.|||||++.+. .|+.++||||||
T Consensus 136 Ll~~~g-~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~----------------------~y~~~~DiwSlG 188 (316)
T d1fota_ 136 LLDKNG-HIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTK----------------------PYNKSIDWWSFG 188 (316)
T ss_dssp EECTTS-CEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTC----------------------CBCTTHHHHHHH
T ss_pred eEcCCC-CEEEecCccceEeccc----cccccCcccccCHHHHcCC----------------------CCCchhhccccc
Confidence 999987 9999999999876432 3457899999999966443 456678999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|+||||++|+.||...+
T Consensus 189 vilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 189 ILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp HHHHHHHHSSCTTCCSS
T ss_pred hhHHHHHhCCCCCCCcC
Confidence 99999999999997654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=344.76 Aligned_cols=233 Identities=19% Similarity=0.261 Sum_probs=171.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhc-cCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACAN-CCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~ 212 (397)
++..++|+++++||+|+||+||+|++..++.......+++|.+...... +.....++...+.. .+|+||+.+++.+..
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4566899999999999999999999988765555567888887643322 22222233344433 479999999987754
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhc---cccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL---GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
.+.+++|||||++|+|.++++.....+....... ..+........+++..++.++.|++.||+|||+++|||||||
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 5678999999999999999987654332221111 111222234567899999999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|+|||++.++ .+||+|||+|+........ ......||+.|||||+ +....++.++|
T Consensus 192 p~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~----------------------l~~~~~~~~~D 248 (325)
T d1rjba_ 192 ARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES----------------------LFEGIYTIKSD 248 (325)
T ss_dssp GGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH----------------------HHHCCCCHHHH
T ss_pred hhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHH----------------------HcCCCCCccee
Confidence 9999999987 9999999999876554332 2345678999999994 44556777899
Q ss_pred hHHHHHHHHHHHc-CCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 369 v~SlGv~l~ellt-g~~Pf~~~~~ 391 (397)
||||||+||||+| |..||.....
T Consensus 249 iwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 249 VWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999997 8999976544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-45 Score=338.88 Aligned_cols=208 Identities=15% Similarity=0.192 Sum_probs=170.7
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
+++..++|++.++||+|+||+||+|++..++ +.+|+|++........ ...++...+...+|+||+.+++.+. .
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~-~~~~E~~il~~l~HpnIv~~~~~~~-~ 84 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT-R 84 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGT-----EEEEEEECCTTCSCHH-HHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCC-----eEEEEEEECCccchHH-HHHHHHHHHHhCCCCCEecCCccEe-e
Confidence 3456689999999999999999999998876 7899998875433222 2334556677788999999999774 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++.+++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++|||||||||+||
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NI 146 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECN------------------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSC------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred CCeeEEEeecccCcchHHHhhhcc------------------ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeE
Confidence 578899999999999999997643 23568888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
||++++ .+||+|||+|+....+.........||+.|||||++ ....|+.++||||||
T Consensus 147 Ll~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~----------------------~~~~~~~k~DiwS~G 203 (287)
T d1opja_ 147 LVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL----------------------AYNKFSIKSDVWAFG 203 (287)
T ss_dssp EECGGG-CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHH----------------------HHCCCSHHHHHHHHH
T ss_pred EECCCC-cEEEccccceeecCCCCceeeccccccccccChHHH----------------------cCCCCCchhhhhhHH
Confidence 999987 999999999987755444334455789999999954 445577789999999
Q ss_pred HHHHHHHcCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLH 389 (397)
Q Consensus 374 v~l~elltg~~Pf~~~ 389 (397)
|++|||++|..||...
T Consensus 204 v~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 204 VLLWEIATYGMSPYPG 219 (287)
T ss_dssp HHHHHHHTTSCCSSTT
T ss_pred HHHHHHHhCCCCCCCc
Confidence 9999999987776543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-44 Score=345.74 Aligned_cols=205 Identities=18% Similarity=0.244 Sum_probs=170.2
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch------hHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
..++|++.++||+|+||.||+|++..++ +.+|+|.+.... ......+.++...+...+||||+.+++.+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCC-----CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 4589999999999999999999998887 789999875322 12223334456677788899999998876
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
.. .+.+|+||||+.+|+|.+++.... .+++..++.++.||+.||+|||++|||||||||
T Consensus 77 ~~-~~~~~ivmE~~~gg~L~~~l~~~~--------------------~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP 135 (364)
T d1omwa3 77 HT-PDKLSFILDLMNGGDLHYHLSQHG--------------------VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 135 (364)
T ss_dssp EC-SSEEEEEECCCCSCBHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred EE-CCEEEEEEEecCCCcHHHHHHhcc--------------------cccHHHHHHHHHHHHHHHHHHHHCCccceeecc
Confidence 44 578999999999999999998764 457788999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+|+.+.... .....||+.|||||++... ..|+.++|||
T Consensus 136 ~NILl~~~g-~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~---------------------~~~~~~~Diw 190 (364)
T d1omwa3 136 ANILLDEHG-HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKG---------------------VAYDSSADWF 190 (364)
T ss_dssp GGEEECSSS-CEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTT---------------------CCCCTHHHHH
T ss_pred ceeEEcCCC-cEEEeeeceeeecCCCc---ccccccccccchhHHhhcC---------------------CCCCcccchh
Confidence 999999987 99999999998765432 3456899999999976432 2466789999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~~~ 392 (397)
||||+||||+||+.||......
T Consensus 191 SlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 191 SLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp HHHHHHHHHHHSSCSSCSSCSS
T ss_pred HHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999775543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-44 Score=340.49 Aligned_cols=203 Identities=22% Similarity=0.272 Sum_probs=152.8
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.+.|++.+.||+|+||+||+|++..++ +.+|+|.+...... .....+++...+...+||||+.+++.+. .++.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~ 81 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQ-----KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-SGGH 81 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTC-----CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-CSSE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCE
Confidence 367999999999999999999998877 78999988643321 1222334566777789999999998764 4578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||+.
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~ 141 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG--------------------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred EEEEEeccCCCcHHHhhhccc--------------------CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeec
Confidence 999999999999999997654 578899999999999999999999999999999999995
Q ss_pred C--CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 E--GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~--~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
. +.+.+||+|||+|+....+. ...+.+||+.|||||++.+ ..|+.++|||||||
T Consensus 142 ~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~----------------------~~~~~~~DiwSlGv 197 (307)
T d1a06a_ 142 SLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQ----------------------KPYSKAVDCWSIGV 197 (307)
T ss_dssp SSSTTCCEEECCC--------------------CTTSCHHHHTT----------------------CCCCTHHHHHHHHH
T ss_pred ccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcC----------------------CCCCcHHHhhhhhH
Confidence 3 22389999999998654432 2345789999999996543 45677899999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
+||||++|+.||....
T Consensus 198 ilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 198 IAYILLCGYPPFYDEN 213 (307)
T ss_dssp HHHHHHHSSCSCCCSS
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-44 Score=344.43 Aligned_cols=204 Identities=22% Similarity=0.236 Sum_probs=170.9
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|.+......+....+++...+...+|+||+.+++.+. .++.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~ 101 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-DKYEM 101 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-CSSEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEE
Confidence 368999999999999999999998877 889999887655555445556677788889999999998764 46789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
|+|||||.+|+|.+.+.... ..+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~-------------------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~ 162 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAED-------------------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTT-------------------CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEEcCCCChHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc
Confidence 99999999999998876543 25788999999999999999999999999999999999983
Q ss_pred -CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 -GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 -~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+.+.+||+|||+|+.+..+. ......||+.|||||++.+ ..|+.++|||||||+|
T Consensus 163 ~~~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~DiwSlGvil 218 (352)
T d1koba_ 163 KKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDR----------------------EPVGFYTDMWAIGVLG 218 (352)
T ss_dssp TTCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTT----------------------CCBCHHHHHHHHHHHH
T ss_pred cCCCeEEEeecccceecCCCC--ceeeccCcccccCHHHHcC----------------------CCCCCccchHHHHHHH
Confidence 22499999999998775432 2345789999999996543 3566788999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||+||+.||....
T Consensus 219 yelltG~~Pf~~~~ 232 (352)
T d1koba_ 219 YVLLSGLSPFAGED 232 (352)
T ss_dssp HHHHHSCCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997644
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-44 Score=344.52 Aligned_cols=204 Identities=20% Similarity=0.237 Sum_probs=170.5
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++++.||+|+||+||+|++..++ +.+|+|++......+.....++...+...+|+||+.+++.+. .++.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g-----~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~ 98 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATG-----NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDNEM 98 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-ETTEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEE
Confidence 478999999999999999999998877 889999987655554444555667777788999999998764 46789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-------------------~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~ 159 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-------------------NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-------------------SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEEcCCCCCHHHHHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc
Confidence 99999999999999986432 24788999999999999999999999999999999999964
Q ss_pred C-CCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 G-SRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 ~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+ .+.+||+|||+|+.+.... ......||+.|||||++.+ ..|+.++|||||||++
T Consensus 160 ~~~~~vkL~DFG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~----------------------~~~~~~~DiwSlGvil 215 (350)
T d1koaa2 160 KRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEG----------------------KPVGYYTDMWSVGVLS 215 (350)
T ss_dssp TTSCCEEECCCTTCEECCTTS--CEEEECSCTTTCCHHHHHT----------------------CCBCHHHHHHHHHHHH
T ss_pred CCCCeEEEeecchheeccccc--ccceecCcccccCHHHHcC----------------------CCCChhHhhhhhhHHH
Confidence 3 2389999999998765432 2345789999999996543 4466678999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||...+
T Consensus 216 yell~G~~Pf~~~~ 229 (350)
T d1koaa2 216 YILLSGLSPFGGEN 229 (350)
T ss_dssp HHHHHSSCSSCCSS
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-44 Score=337.57 Aligned_cols=201 Identities=21% Similarity=0.273 Sum_probs=166.8
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+.|++.++||+|+||+||+|++..++ +.+|+|.+.... ........++...+...+|+||+.+++.+. .++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCC-----cEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-ECC
Confidence 35999999999999999999998887 789999886432 222233445667778889999999998764 457
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+|+|||||.+|+|..++.... .+++..++.++.||+.||+|||++|||||||||+|||+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~--------------------~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl 148 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKK--------------------PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred EEEEEEEecCCCchHHHHHhCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE
Confidence 8999999999999977665443 56888999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
+.++ .+||+|||+|+.... .....||+.|||||++.+... ..|+.++|||||||+
T Consensus 149 ~~~~-~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~-------------------~~y~~~~DiwSlGvi 203 (309)
T d1u5ra_ 149 SEPG-LVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDE-------------------GQYDGKVDVWSLGIT 203 (309)
T ss_dssp ETTT-EEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTS-------------------CCBCTHHHHHHHHHH
T ss_pred CCCC-CEEEeecccccccCC-----CCccccCccccCHHHHhccCC-------------------CCcCchhhhhhHHHH
Confidence 9987 999999999986543 245689999999998754322 247788999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
+|||++|+.||....
T Consensus 204 lyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 204 CIELAERKPPLFNMN 218 (309)
T ss_dssp HHHHHHSSCTTTTSC
T ss_pred HHHHHHCCCCCCCCC
Confidence 999999999997543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=337.16 Aligned_cols=231 Identities=19% Similarity=0.202 Sum_probs=166.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH--HHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV--EIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.+..++|+++++||+|+||+||+|++...+...+.+.+|+|++...... ......++.......+|++++.++.....
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 4566899999999999999999999988776667788999998753322 22222233334445578899988887777
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+..+++|||||++|+|.++++.....+..... .........+++..+..++.|++.||+|||+++||||||||+|
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV----APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC---------------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCeEEEEEEecCCCcHHHHHHhcccccccccc----chhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 777899999999999999999876421111000 0011123457899999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++++ .+||+|||+|+........ ......||+.|||||++ .+..++.++||||
T Consensus 165 ILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l----------------------~~~~~~~~sDiwS 221 (299)
T d1ywna1 165 ILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI----------------------FDRVYTIQSDVWS 221 (299)
T ss_dssp EEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH----------------------HHCCCCHHHHHHH
T ss_pred eeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHh----------------------hcCCCCcccceee
Confidence 9999987 9999999999876543322 34457899999999954 4445677889999
Q ss_pred HHHHHHHHHcCC-CCCCCCCCC
Q 015991 372 AGLIFLQMVCTV-RRLCLHSCP 392 (397)
Q Consensus 372 lGv~l~elltg~-~Pf~~~~~~ 392 (397)
|||++|||++|. .||......
T Consensus 222 ~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 222 FGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCS
T ss_pred hHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999875 577655433
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=332.07 Aligned_cols=204 Identities=16% Similarity=0.223 Sum_probs=165.1
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
++..++|++.++||+|+||+||+|++..+ ..||+|++........ ...++...+...+|+||+.+++.+. +
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~~~~~~~~~~-~~~~E~~~l~~l~HpnIv~~~g~~~--~ 79 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT--Q 79 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTT------EEEEEEEECTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCC------CEEEEEEEccCcCCHH-HHHHHHHHHHhCCCCCEeEEEeeec--c
Confidence 35568999999999999999999997643 6799999875443222 2334455666778999999998653 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+..++||||+.+|+|.+++.... +..+++..+..++.||++||.|||+++|+||||||+|||
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~------------------~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl 141 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPS------------------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHH------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCeEEEEEeCCCCcHHHHHhhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence 56799999999999999876542 224788899999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
|++++ .+||+|||+|+.+............||+.|||||++. ...++.++|||||||
T Consensus 142 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~----------------------~~~~~~~sDvwS~Gv 198 (272)
T d1qpca_ 142 VSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN----------------------YGTFTIKSDVWSFGI 198 (272)
T ss_dssp ECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHH----------------------HCEECHHHHHHHHHH
T ss_pred eeccc-ceeeccccceEEccCCccccccccCCcccccChHHHh----------------------CCCCCchhhhhhhHH
Confidence 99987 9999999999987655444455678999999999554 344667889999999
Q ss_pred HHHHHHcCCCCCCC
Q 015991 375 IFLQMVCTVRRLCL 388 (397)
Q Consensus 375 ~l~elltg~~Pf~~ 388 (397)
+||||+||..||..
T Consensus 199 vl~ellt~~~~~~~ 212 (272)
T d1qpca_ 199 LLTEIVTHGRIPYP 212 (272)
T ss_dssp HHHHHHTTTCCSST
T ss_pred HHHHHHhCCCCCCC
Confidence 99999997666543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=335.43 Aligned_cols=203 Identities=24% Similarity=0.332 Sum_probs=166.6
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.++|+++++||+|+||+||+|++..++ +.+|+|.+.... ..+....+ +.......+||||+.+++.+.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~-----~~vAvK~i~k~~~~~~~~~~~~~~e-~~~l~~~~~hp~Iv~~~~~~~- 73 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTN-----QFFAIKALKKDVVLMDDDVECTMVE-KRVLSLAWEHPFLTHMFCTFQ- 73 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEEHHHHHHTTCHHHHHHH-HHHHHHHTTCTTBCCEEEEEE-
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCC-----CEEEEEEEchhhccChHHHHHHHHH-HHHHHHhCCCCcEEEEEEEEc-
Confidence 378999999999999999999999887 889999886432 12222222 222333568999999998764
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++.+|+||||+.+|+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|
T Consensus 74 ~~~~~yivmEy~~~g~L~~~i~~~~--------------------~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~N 133 (320)
T d1xjda_ 74 TKENLFFVMEYLNGGDLMYHIQSCH--------------------KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 133 (320)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred cCCceeEEEeecCCCcHHHHhhccC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccc
Confidence 4578999999999999999998764 46788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||+++++ .+||+|||+|+....... ......||+.|+|||++. +..|+.++|||||
T Consensus 134 iL~~~~~-~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~----------------------~~~~~~~~DiwSl 189 (320)
T d1xjda_ 134 ILLDKDG-HIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILL----------------------GQKYNHSVDWWSF 189 (320)
T ss_dssp EEECTTS-CEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHT----------------------TCCBCTHHHHHHH
T ss_pred eeecCCC-ceeccccchhhhcccccc-cccccCCCCCcCCHHHHc----------------------CCCCCchhhhhhh
Confidence 9999987 999999999986544332 345578999999999554 4456778899999
Q ss_pred HHHHHHHHcCCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~~ 391 (397)
||++|||++|+.||...+.
T Consensus 190 GvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 190 GVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp HHHHHHHHHSSCSSCCSSH
T ss_pred hHHHHHHHhCCCCCCCCCH
Confidence 9999999999999986543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-43 Score=332.05 Aligned_cols=214 Identities=14% Similarity=0.125 Sum_probs=159.4
Q ss_pred hhcccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeecc
Q 015991 132 FRTTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENS 210 (397)
Q Consensus 132 ~~~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~ 210 (397)
+...+..++|++.++||+|+||+||+|++..++... ..+++|++.... ..+.....++...+...+|+||+.+++.+
T Consensus 19 f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE--IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp HSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CC--EEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEE--EEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 445566789999999999999999999987665322 357788776432 22333445667777888999999999977
Q ss_pred cccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 211 SKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 211 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
. .++.+++||||+.+|+|.+++.... ..+++..+..++.|+++||+|||++|||||||||
T Consensus 97 ~-~~~~~~iv~Ey~~~g~L~~~~~~~~-------------------~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp 156 (299)
T d1jpaa_ 97 T-KSTPVMIITEFMENGSLDSFLRQND-------------------GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAA 156 (299)
T ss_dssp C-SSSSCEEEEECCTTEEHHHHHHTTT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred e-eCCEEEEEEEecCCCcceeeecccc-------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCccCcccc
Confidence 4 4567999999999999999887643 2467888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccc----cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYI----PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
+||||+.++ .+||+|||+|+.+....... .....||+.|||||.+. ...++.+
T Consensus 157 ~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~----------------------~~~~~~~ 213 (299)
T d1jpaa_ 157 RNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ----------------------YRKFTSA 213 (299)
T ss_dssp GGEEECTTC-CEEECCC-----------------------CGGGSCHHHHH----------------------SCCCCHH
T ss_pred ceEEECCCC-cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHh----------------------cCCCCcc
Confidence 999999987 99999999998765433221 12346799999999544 4456778
Q ss_pred hhhHHHHHHHHHHHc-CCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 367 ~Dv~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
+|||||||+||||+| |+.||....
T Consensus 214 sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 214 SDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccchHHHHHHHhCCCCCCCCCC
Confidence 899999999999998 899997543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=328.07 Aligned_cols=200 Identities=14% Similarity=0.204 Sum_probs=151.9
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||+||+|++.++ ..||+|++......+.. ..++...+...+|+||+.+++.+.. ++.
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~i~~~~~~~~~-~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 74 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNK------DKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVCLE-QAP 74 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTT------EEEEEEECCSSSSCHHH-HHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCC------CEEEEEEECCCcCcHHH-HHHHHHHHHhcCCCCcccccceecc-CCc
Confidence 347999999999999999999998654 57999998764433322 2345566667789999999997754 467
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+.+|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~-------------------~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~ 135 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQR-------------------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 135 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC
T ss_pred eEEEEEecCCCcHHHHhhccc-------------------cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec
Confidence 899999999999999987653 2457788889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||+|+..............||+.|||||++.+ ..|+.++|||||||++
T Consensus 136 ~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~----------------------~~~~~k~DVwS~Gvil 192 (263)
T d1sm2a_ 136 ENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF----------------------SRYSSKSDVWSFGVLM 192 (263)
T ss_dssp GGG-CEEECSCC------------------CTTSCCHHHHTT----------------------CCCCHHHHHHHHHHHH
T ss_pred CCC-CeEecccchheeccCCCceeecceecCcccCChHHhcC----------------------CCCCchhhhcchHHHH
Confidence 987 99999999998775544444455789999999996543 4566788999999999
Q ss_pred HHHHcCCCCC
Q 015991 377 LQMVCTVRRL 386 (397)
Q Consensus 377 ~elltg~~Pf 386 (397)
|||+|+..||
T Consensus 193 ~el~t~~~~~ 202 (263)
T d1sm2a_ 193 WEVFSEGKIP 202 (263)
T ss_dssp HHHHTTSCCT
T ss_pred HHHHHCCCCC
Confidence 9999964444
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-43 Score=339.81 Aligned_cols=201 Identities=16% Similarity=0.239 Sum_probs=168.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.+.||+|+||+||+|++..++ +.+|+|.+..... .......++...+...+|+||+.+++.+. .
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g-----~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~ 112 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-D 112 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-C
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCC-----CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-c
Confidence 3479999999999999999999998887 7899998764321 11223344566777889999999988764 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
....++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+||
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~--------------------~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NI 172 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIG--------------------RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred ccccccccccccccchhhhHhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHc
Confidence 567899999999999999997764 468889999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++ .+||+|||+|+.+... .....||+.|||||++.+ ..++.++||||||
T Consensus 173 Ll~~~g-~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~----------------------~~~~~~~DiwSlG 225 (350)
T d1rdqe_ 173 LIDQQG-YIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILS----------------------KGYNKAVDWWALG 225 (350)
T ss_dssp EECTTS-CEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTT----------------------CCBCTHHHHHHHH
T ss_pred ccCCCC-CEEeeeceeeeecccc----cccccCccccCCHHHHcC----------------------CCCCccccccchh
Confidence 999987 9999999999876432 345789999999996654 3466788999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|+||||+||+.||...+
T Consensus 226 vilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 226 VLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp HHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHhCCCCCCCcC
Confidence 99999999999997653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=329.90 Aligned_cols=203 Identities=23% Similarity=0.263 Sum_probs=166.5
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch------hHHHHHHHHHHHHhhccCCCceeeeeeccc
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG------AVEIWMNERVRRACANCCADFVYGFFENSS 211 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~ 211 (397)
.++|+++++||+|+||+||+|++..++ +.+|+|.+.... ........++...+...+|+||+.+++.+.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 367999999999999999999998887 788888775321 111223334555666678999999998764
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
.++.+|+|||||.+|+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+
T Consensus 84 -~~~~~~iv~E~~~gg~L~~~i~~~~--------------------~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~ 142 (293)
T d1jksa_ 84 -NKTDVILILELVAGGELFDFLAEKE--------------------SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPE 142 (293)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred -ECCEEEEEEEcCCCccccchhcccc--------------------ccchhHHHHHHHHHHHHHHhhhhcceeecccccc
Confidence 4578999999999999999998754 5688899999999999999999999999999999
Q ss_pred ceEEeCCCC---eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 292 NVIFSEGSR---TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 292 NILl~~~~~---~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|||++.++. .+||+|||+|+....+.. .....||+.|+|||++.+ ..++.++|
T Consensus 143 Nill~~~~~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~----------------------~~~~~~~D 198 (293)
T d1jksa_ 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNY----------------------EPLGLEAD 198 (293)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTT----------------------CCBCTHHH
T ss_pred eEEEecCCCcccceEecchhhhhhcCCCcc--ccccCCCCcccCHHHHcC----------------------CCCCCccc
Confidence 999987652 599999999987654332 345789999999996643 34667889
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||||+||||++|+.||...+
T Consensus 199 iwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 199 MWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhhHHHHHHHcCCCCCCCCC
Confidence 9999999999999999998654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-43 Score=325.60 Aligned_cols=208 Identities=20% Similarity=0.291 Sum_probs=170.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-------HH--HHHHHHHHHHhhcc-CCCceeeee
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-------VE--IWMNERVRRACANC-CADFVYGFF 207 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~e--~~~~~~~~~~~~~~-~~~~i~~~~ 207 (397)
.++|++.+.||+|+||+||+|++..++ +.+|+|++..... .+ .....++...+... .|+|++.++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCC-----CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 379999999999999999999998876 7899998754221 11 11222344444554 499999998
Q ss_pred ecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecC
Q 015991 208 ENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (397)
Q Consensus 208 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrD 287 (397)
+.+. +++..|+||||+++|+|.++++..+ .+++..++.++.||+.||+|||++||+|||
T Consensus 77 ~~~~-~~~~~~ivmE~~~~g~L~~~l~~~~--------------------~l~e~~~~~~~~qi~~al~~lH~~~ivHrD 135 (277)
T d1phka_ 77 DTYE-TNTFFFLVFDLMKKGELFDYLTEKV--------------------TLSEKETRKIMRALLEVICALHKLNIVHRD 135 (277)
T ss_dssp EEEE-CSSEEEEEEECCTTCBHHHHHHHHS--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eecc-cCcceEEEEEcCCCchHHHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCCcccc
Confidence 8764 5678999999999999999998764 578899999999999999999999999999
Q ss_pred CCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|||+|||++.++ .+||+|||+|+.+..+. ......||+.|+|||.+.+...... ..++.++
T Consensus 136 lkp~Nill~~~~-~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~----------------~~~~~~~ 196 (277)
T d1phka_ 136 LKPENILLDDDM-NIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNH----------------PGYGKEV 196 (277)
T ss_dssp CSGGGEEECTTC-CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTS----------------CCBCTHH
T ss_pred cccceEEEcCCC-CeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccC----------------CCCCchh
Confidence 999999999987 99999999998765433 2355789999999999876544332 2467889
Q ss_pred hhHHHHHHHHHHHcCCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||+||+||||++|+.||....
T Consensus 197 DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 197 DMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEcccchhhhhhccCCCCCCCCC
Confidence 99999999999999999998654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-43 Score=325.96 Aligned_cols=206 Identities=21% Similarity=0.266 Sum_probs=161.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
..++|++.+.||+|+||+||+|++..++ +.+|+|.+.... ........++...+...+|+|++.+++.....
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLH-----RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCC-----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 3478999999999999999999998877 889999886432 22223344566677788999999988876543
Q ss_pred C---CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 214 G---GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 214 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
+ ..+|+||||+.+++|.+++...+ .+++..++.++.||+.||+|||++|||||||||
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~--------------------~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP 139 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTEG--------------------PMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 139 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred cCCCceEEEEEECCCCCEehhhhcccC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCccCccccC
Confidence 3 35899999999999999887664 568888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
+|||++.++ ..+|+|||.++....... .......||+.|||||++.+ ..++.++|
T Consensus 140 ~NIll~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~----------------------~~~~~~~D 196 (277)
T d1o6ya_ 140 ANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG----------------------DSVDARSD 196 (277)
T ss_dssp GGEEEETTS-CEEECCCTTCEECC----------------TTCCHHHHTT----------------------CCCCHHHH
T ss_pred cccccCccc-cceeehhhhhhhhccccccccccccccCcccccCHHHHcC----------------------CCCCccee
Confidence 999999987 999999999876543322 23445789999999996643 34666889
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
||||||++|||+||+.||...+
T Consensus 197 iwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 197 VYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccchHHHHHHHhCCCCCCCcC
Confidence 9999999999999999997654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=326.46 Aligned_cols=212 Identities=18% Similarity=0.197 Sum_probs=157.5
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
++..++|++++.||+|+||+||+|++..++... ..+++|.+.... ........++...+...+||||+.+++.+.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~--~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-- 78 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 78 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CC--EEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCcee--EEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 455689999999999999999999987654222 457888876433 222334445666677788999999998764
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++.+++||||+.+|+|.+++.... ..+++..++.++.|+++||+|||++|||||||||+||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~-------------------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI 139 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK-------------------YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-------------------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cCeEEEEEEeccCCcHHhhhhccC-------------------CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhe
Confidence 467899999999999999887643 2467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|+++++ .+||+|||+|+.+............||+.|+|||++ ....++.++||||||
T Consensus 140 ll~~~~-~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l----------------------~~~~~~~~~DiwSlG 196 (273)
T d1mp8a_ 140 LVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI----------------------NFRRFTSASDVWMFG 196 (273)
T ss_dssp EEEETT-EEEECC-------------------CCGGGCCHHHH----------------------HHCCCSHHHHHHHHH
T ss_pred eecCCC-cEEEccchhheeccCCcceeccceecCcccchhhHh----------------------ccCCCCCccccccch
Confidence 999987 999999999987765554445567889999999954 444567788999999
Q ss_pred HHHHHHHc-CCCCCCCCCCC
Q 015991 374 LIFLQMVC-TVRRLCLHSCP 392 (397)
Q Consensus 374 v~l~ellt-g~~Pf~~~~~~ 392 (397)
|++|||++ |..||......
T Consensus 197 vil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 197 VCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp HHHHHHHTTSCCTTTTCCGG
T ss_pred HHHHHHHhcCCCCCCCCCHH
Confidence 99999998 89999776544
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=326.50 Aligned_cols=209 Identities=17% Similarity=0.254 Sum_probs=165.0
Q ss_pred ccCCeEEeee-eccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 137 RKDDFVLGKK-LGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 137 ~~~~f~i~~~-LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
..++|.+.+. ||+|+||+||+|.+..++.. ..||+|.+..... .......++...+...+|+||+.+++.+. .
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~---~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~ 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQ---IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--A 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CC---EEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--S
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCc---EEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec--c
Confidence 4578999984 99999999999987654321 4688998865332 22333445666777788999999998764 3
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|||||||||+|||
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~-------------------~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil 141 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKR-------------------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-------------------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CeEEEEEEeCCCCcHHHHhhccc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence 46899999999999999886542 24678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++.++ .+||+|||+|+.+...... ......||+.|||||++ ....++.++|||||
T Consensus 142 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------------------~~~~~~~ksDVwS~ 198 (285)
T d1u59a_ 142 LVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI----------------------NFRKFSSRSDVWSY 198 (285)
T ss_dssp EEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHH----------------------HHCEECHHHHHHHH
T ss_pred eccCC-ceeeccchhhhcccccccccccccccccCccccChHHH----------------------hCCCCCccchhhcc
Confidence 99987 9999999999876543322 23345789999999954 44456778899999
Q ss_pred HHHHHHHHc-CCCCCCCCCCC
Q 015991 373 GLIFLQMVC-TVRRLCLHSCP 392 (397)
Q Consensus 373 Gv~l~ellt-g~~Pf~~~~~~ 392 (397)
||++|||+| |+.||.....+
T Consensus 199 Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 199 GVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp HHHHHHHHTTSCCTTTTCCTH
T ss_pred hHHHHHHHhCCCCCCCCCCHH
Confidence 999999998 99999765543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=326.72 Aligned_cols=205 Identities=16% Similarity=0.214 Sum_probs=160.4
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+..++|++++.||+|+||+||+|++.++ +.||+|++........ ...++...+...+|+||+.+++.+. ++
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~------~~vAiK~l~~~~~~~~-~~~~E~~~l~~l~h~nIv~~~g~~~--~~ 84 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS--EE 84 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT------EEEEEEECCTTSSCHH-HHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC------CEEEEEEECcccCCHH-HHHHHHHHHHhcccCCEeEEEEEEe--cC
Confidence 4558999999999999999999998765 5699999875443322 2334556667788999999998763 35
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
.+|+||||+.+|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||||
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll 146 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGET------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 146 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHH------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CeEEEEEecCCCchhhhhhhcc------------------cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE
Confidence 6899999999999999887642 2246889999999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 375 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~ 375 (397)
++++ ++||+|||+|+....+.........||+.|+||| ++.+..++.++|||||||+
T Consensus 147 ~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE----------------------~~~~~~~~~ksDI~S~Gii 203 (285)
T d1fmka3 147 GENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE----------------------AALYGRFTIKSDVWSFGIL 203 (285)
T ss_dssp CGGG-CEEECCCCTTC--------------CCGGGSCHH----------------------HHHHCCCCHHHHHHHHHHH
T ss_pred CCCC-cEEEcccchhhhccCCCceeeccccccccccChH----------------------HHhCCCCCcHHhhhcchHH
Confidence 9987 9999999999876555444445578999999999 5555667778999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 015991 376 FLQMVCTVRRLCLHS 390 (397)
Q Consensus 376 l~elltg~~Pf~~~~ 390 (397)
||||++|..||....
T Consensus 204 l~el~t~~~p~~~~~ 218 (285)
T d1fmka3 204 LTELTTKGRVPYPGM 218 (285)
T ss_dssp HHHHHTTTCCSSTTC
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999877765544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=331.02 Aligned_cols=205 Identities=20% Similarity=0.243 Sum_probs=163.0
Q ss_pred ccCCeEEee-eeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeeccc---c
Q 015991 137 RKDDFVLGK-KLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSS---K 212 (397)
Q Consensus 137 ~~~~f~i~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~---~ 212 (397)
..++|++.+ .||+|+||+||+|++..++ +.+|+|.+....... .++.......+|+|++.+++.+. .
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~----~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDCPKAR----REVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEECSHHHH----HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCC-----CEEEEEEECCcHHHH----HHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 347899875 6999999999999998887 889999886543221 11222233456889888877653 2
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.+..+|+|||||++|+|.+++...+ ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~------------------~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~N 141 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRG------------------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCS------------------CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcC------------------CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccc
Confidence 3567999999999999999997643 2357899999999999999999999999999999999
Q ss_pred eEEeCCC--CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGS--RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~--~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
||+++++ ..+||+|||+|+...... ......||+.|||||++.+. .|+.++|||
T Consensus 142 Ill~~~~~~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~----------------------~y~~~~Diw 197 (335)
T d2ozaa1 142 LLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPE----------------------KYDKSCDMW 197 (335)
T ss_dssp EEESCSSTTCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGG----------------------GGSHHHHHH
T ss_pred cccccccccccccccccceeeeccCCC--ccccccCCcccCCcHHHcCC----------------------CCCHHHHHH
Confidence 9998632 379999999998765433 23567899999999966543 456688999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~~~ 392 (397)
||||+||||+||+.||......
T Consensus 198 SlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 198 SLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp HHHHHHHHHTTSSCSCEETTCC
T ss_pred hhchhHHHHhhCCCCCCCCCHH
Confidence 9999999999999999776543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=323.15 Aligned_cols=203 Identities=17% Similarity=0.217 Sum_probs=157.9
Q ss_pred CeEEe-eeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 140 DFVLG-KKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 140 ~f~i~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.+.+. ++||+|+||+||+|.+..++. .+.+|+|.++.... .......++...+...+|+||+.+++.+. .+.
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~~~ 81 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKV---VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AES 81 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSS---EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSS
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCc---CeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec--cCC
Confidence 44554 479999999999998754321 26789998864322 22223345566677789999999998763 345
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||+++|+|.++++... .+++..+..++.||+.||+|||+++||||||||+|||++
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~--------------------~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~ 141 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNR--------------------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV 141 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred EEEEEEcCCCCcHHHHHhhcc--------------------CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc
Confidence 789999999999999988654 568888999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccc--cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
.++ .+||+|||+|+.+....... .....||+.|||||++. ...++.++|||||||
T Consensus 142 ~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~----------------------~~~~~~~sDiwS~Gv 198 (277)
T d1xbba_ 142 TQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN----------------------YYKFSSKSDVWSFGV 198 (277)
T ss_dssp ETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH----------------------HCEEEHHHHHHHHHH
T ss_pred ccC-cccccchhhhhhccccccccccccccCCCceecCchhhc----------------------CCCCCchhhhccchh
Confidence 987 99999999998765443322 23467899999999554 445667889999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||++ |+.||....
T Consensus 199 ~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 199 LMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp HHHHHHTTTCCSSTTCC
T ss_pred hhhHHhhCCCCCCCCCC
Confidence 9999997 899997643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-43 Score=320.28 Aligned_cols=205 Identities=18% Similarity=0.230 Sum_probs=168.4
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
..++|++.++||+|+||+||+|+++++ ..||+|+++.....+. ...++...+...+|+||+.+++.+.. ++.
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~------~~vAvK~l~~~~~~~~-~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~ 73 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK-QRP 73 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTT------EEEEEEEEESSSSCHH-HHHHHHHHHHTCCCTTBCCEEEEECC-SSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCC------CEEEEEEECcCcCCHH-HHHHHHHHHHhcCCCceeeEEEEEee-CCc
Confidence 347999999999999999999998533 6899998875443322 23345566677789999999997654 568
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+.+|+|.+++.... ..+++..+.+++.|+++||+|||++||+||||||+|||++
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~-------------------~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~ 134 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMR-------------------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGG-------------------GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC
T ss_pred eEEEEEccCCCcHHHhhhccc-------------------cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc
Confidence 999999999999999977653 2456778889999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
+++ .+||+|||+|+.+............||+.|+||| ++.+..++.|+|||||||++
T Consensus 135 ~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE----------------------~~~~~~~~~ksDiwS~G~~l 191 (258)
T d1k2pa_ 135 DQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE----------------------VLMYSKFSSKSDIWAFGVLM 191 (258)
T ss_dssp TTC-CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHH----------------------HHHHCCCCHHHHHHHHHHHH
T ss_pred CCC-cEEECcchhheeccCCCceeecccCCCCCcCCcH----------------------HhcCCCCCcceeecccchhh
Confidence 987 9999999999877655444445578999999999 44455677789999999999
Q ss_pred HHHHc-CCCCCCCCCC
Q 015991 377 LQMVC-TVRRLCLHSC 391 (397)
Q Consensus 377 ~ellt-g~~Pf~~~~~ 391 (397)
|||+| |+.||.....
T Consensus 192 ~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 192 WEIYSLGKMPYERFTN 207 (258)
T ss_dssp HHHHTTSCCTTTTSCH
T ss_pred HhHHhcCCCCCCCCCH
Confidence 99998 8999976543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=329.26 Aligned_cols=204 Identities=22% Similarity=0.320 Sum_probs=169.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
.++|++++.||+|+||+||+|.+..++ +.+|+|.+......+. ...++...+...+|+||+.+++.+.. ++.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~-----~~~AiK~i~~~~~~~~-~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSK-----KTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESFES-MEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECCCTHHHH-HHHHHHHHHHHSCCTTBCCEEEEEEE-TTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC-----cEEEEEEEcCCcccHH-HHHHHHHHHHhCCCCCCCeEEEEEEE-CCEE
Confidence 478999999999999999999999887 7899998876554433 33445566777889999999987644 5789
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
|+|||||.+++|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-------------------~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~ 137 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-------------------FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEecCCCCcHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC
Confidence 99999999999999997643 24688899999999999999999999999999999999985
Q ss_pred CC-CeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 298 GS-RTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 298 ~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
++ ..+||+|||+++...... ......+|+.|+|||.+. ...|+.++||||+||++
T Consensus 138 ~~~~~ikl~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~----------------------~~~~~~~~DiWSlGvil 193 (321)
T d1tkia_ 138 RRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQ----------------------HDVVSTATDMWSLGTLV 193 (321)
T ss_dssp SSCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHT----------------------TCEECHHHHHHHHHHHH
T ss_pred CCceEEEEcccchhhccccCC--cccccccccccccchhcc----------------------CCCCCchhhcccHHHHH
Confidence 32 389999999998764432 234568999999999554 34466788999999999
Q ss_pred HHHHcCCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHSC 391 (397)
Q Consensus 377 ~elltg~~Pf~~~~~ 391 (397)
|||++|..||.....
T Consensus 194 y~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 194 YVLLSGINPFLAETN 208 (321)
T ss_dssp HHHHHSSCTTCCSSH
T ss_pred HHHHhCCCCCCCCCH
Confidence 999999999987653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=319.79 Aligned_cols=212 Identities=17% Similarity=0.182 Sum_probs=158.9
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
++..+.|++.+.||+|+||+||+|.+..++... ...||+|++..... .+.....++...+...+|+||+.+++.+..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~- 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKK-EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK- 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CC-EEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEE-EEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-
Confidence 345578999999999999999999987654221 24688998864332 222333456677777899999999987644
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
.+..++||||+.++++.+++.... ..+++..+..++.|++.||+|||+++||||||||+||
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-------------------~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NI 141 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-------------------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-------------------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCceEEEEEecccCcchhhhhccc-------------------ccccHHHHHHHHHHHHHhhhhccccccccCccccceE
Confidence 567899999999999999887653 2467788899999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccc--cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
||+.++ .+||+|||+|+.+..... .......||+.|||||++ ....++.++||||
T Consensus 142 Ll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l----------------------~~~~~~~~sDI~S 198 (283)
T d1mqba_ 142 LVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI----------------------SYRKFTSASDVWS 198 (283)
T ss_dssp EECTTC-CEEECCCCC-----------------CCCGGGSCHHHH----------------------HSCCCCHHHHHHH
T ss_pred EECCCC-eEEEcccchhhcccCCCccceEeccCCCCccccCHHHH----------------------ccCCCCCcccccc
Confidence 999987 999999999987654322 223345789999999954 4445677889999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
|||+||||++|..||....
T Consensus 199 ~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 199 FGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp HHHHHHHHHTTSCCTTTTC
T ss_pred cHHHHHHHHhCCCCccccC
Confidence 9999999999777765443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-42 Score=321.94 Aligned_cols=232 Identities=16% Similarity=0.172 Sum_probs=172.7
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.++..++|++.++||+|+||+||+|++.+.........||+|++......+ .....++...+...+|+|++.+++.+..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 455678999999999999999999998765544455789999987543332 3334456677788899999999987754
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhc----cccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLIL----GEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
.+..+++|||+.+|+|.+++.............. ...........+++..+..++.|++.||+|||+++||||||
T Consensus 88 -~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 88 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 5678999999999999999986543211111110 01111223346788999999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
||+|||++.++ .+||+|||+|+........ ......||+.|+|||.+ ....|+.++
T Consensus 167 Kp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~----------------------~~~~~t~ks 223 (301)
T d1lufa_ 167 ATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI----------------------FYNRYTTES 223 (301)
T ss_dssp SGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH----------------------HHCCCCHHH
T ss_pred cccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHH----------------------ccCCCChhh
Confidence 99999999987 9999999999876544332 23456789999999954 445677789
Q ss_pred hhHHHHHHHHHHHcCCC-CCCCC
Q 015991 368 DIYSAGLIFLQMVCTVR-RLCLH 389 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~-Pf~~~ 389 (397)
|||||||+||||++|.. ||...
T Consensus 224 DVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 224 DVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTS
T ss_pred hhccchhhHHHHHccCCCCCCCC
Confidence 99999999999999965 56543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=322.93 Aligned_cols=199 Identities=21% Similarity=0.226 Sum_probs=157.3
Q ss_pred EeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-----HHHHHHHHHHhhccCCCceeeeeecccccCCeE
Q 015991 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-----IWMNERVRRACANCCADFVYGFFENSSKKGGEY 217 (397)
Q Consensus 143 i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-----~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 217 (397)
..++||+|+||+||+|++..++ +.+|+|++......+ .....++...+...+|+||+.+++.+.. ++.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCC-----SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCC
T ss_pred cceEeccCcCeEEEEEEECCCC-----cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCce
Confidence 4689999999999999998877 789999886433211 1123345566777789999999987754 5679
Q ss_pred EEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeC
Q 015991 218 WLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSE 297 (397)
Q Consensus 218 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~ 297 (397)
++||||+.++++..+..... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 ~ivmE~~~~~~~~~~~~~~~--------------------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~ 135 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNSL--------------------VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 135 (299)
T ss_dssp EEEEECCSEEHHHHHTTCCS--------------------SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred eehhhhhcchHHhhhhhccc--------------------CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC
Confidence 99999999887766654332 4677789999999999999999999999999999999999
Q ss_pred CCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHH
Q 015991 298 GSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 377 (397)
Q Consensus 298 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~ 377 (397)
++ .+||+|||+|+....... .....+||+.|+|||++.... .|+.++||||+||++|
T Consensus 136 ~~-~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DiwSlGvil~ 192 (299)
T d1ua2a_ 136 NG-VLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGAR---------------------MYGVGVDMWAVGCILA 192 (299)
T ss_dssp TC-CEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCS---------------------CCCHHHHHHHHHHHHH
T ss_pred CC-ccccccCccccccCCCcc-cccceecChhhccHHHHccCC---------------------CCChhhhhhhcchHHH
Confidence 87 999999999987654332 234568999999999664332 3567899999999999
Q ss_pred HHHcCCCCCCCCC
Q 015991 378 QMVCTVRRLCLHS 390 (397)
Q Consensus 378 elltg~~Pf~~~~ 390 (397)
||++|..||...+
T Consensus 193 el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 193 ELLLRVPFLPGDS 205 (299)
T ss_dssp HHHHSSCSSCCSS
T ss_pred HHHhCcCCCCCCC
Confidence 9999999997643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=321.05 Aligned_cols=210 Identities=18% Similarity=0.152 Sum_probs=160.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccCC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKGG 215 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 215 (397)
+.++|++.++||+|+||+||+|++..++..++ ..+++|++..... .......++...+...+|+||+.+++.+.. +
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~ 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--S 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CC-EEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--S
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEE-EEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 44689999999999999999999887764443 3578888764322 122233445566667789999999987654 4
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEE
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIF 295 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl 295 (397)
..++++||+.+++|.+.+.... ..+++..+..++.||+.||+|||++|||||||||+|||+
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~-------------------~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll 144 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHK-------------------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 144 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTS-------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CeeEEEEeccCCcccccccccc-------------------cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee
Confidence 5788899999999999887653 246788899999999999999999999999999999999
Q ss_pred eCCCCeEEEEecccccccccccccc-cccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 296 SEGSRTFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 296 ~~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
+.++ .+||+|||+|+.+....... .....||+.|||||++ ....|+.++|||||||
T Consensus 145 ~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l----------------------~~~~~~~~sDvwS~Gv 201 (317)
T d1xkka_ 145 KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI----------------------LHRIYTHQSDVWSYGV 201 (317)
T ss_dssp EETT-EEEECCCSHHHHTTTTCC--------CCTTTSCHHHH----------------------HHCCCCHHHHHHHHHH
T ss_pred CCCC-CeEeeccccceecccccccccccccccCccccChHHH----------------------hcCCCChhhhhhhHHH
Confidence 9987 99999999998765443322 3345789999999954 4456777899999999
Q ss_pred HHHHHHc-CCCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~~ 391 (397)
+||||+| |..||.....
T Consensus 202 il~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 202 TVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp HHHHHHTTSCCTTTTSCG
T ss_pred HHHHHHHCCCCCCCCCCH
Confidence 9999998 7888876543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=317.70 Aligned_cols=204 Identities=25% Similarity=0.307 Sum_probs=162.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||+||+|++..++ +.+|+|.+......+ .....++...+...+|+||+.+++.+. .++.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-TENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-cccc
Confidence 79999999999999999999998877 789999886433222 223334566777889999999998774 4678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
+++||||+.++ +.+++.... ...+++..++.++.|++.||+|||++|||||||||+|||++
T Consensus 76 ~~iv~e~~~~~-~~~~~~~~~------------------~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 76 LYLVFEFLHQD-LKKFMDASA------------------LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 136 (298)
T ss_dssp EEEEEECCSEE-HHHHHHHTT------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred eeEEEeecCCc-hhhhhhhhc------------------ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec
Confidence 99999999865 444443321 23578899999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||+|+...... .......||+.|+|||++....+ ++.++|+||+||++
T Consensus 137 ~~~-~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~---------------------~~~~~DiwSlGvil 193 (298)
T d1gz8a_ 137 TEG-AIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKY---------------------YSTAVDIWSLGCIF 193 (298)
T ss_dssp TTS-CEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSS---------------------CCTHHHHHHHHHHH
T ss_pred ccC-cceeccCCcceeccCCc-ccceeecccceeeehhhhccccC---------------------CCccccccccchhh
Confidence 987 99999999998764332 23455689999999996654332 35678999999999
Q ss_pred HHHHcCCCCCCCCC
Q 015991 377 LQMVCTVRRLCLHS 390 (397)
Q Consensus 377 ~elltg~~Pf~~~~ 390 (397)
|||++|+.||...+
T Consensus 194 y~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 194 AEMVTRRALFPGDS 207 (298)
T ss_dssp HHHHHSSCSCCCSS
T ss_pred hHHhhCCCCCCCCC
Confidence 99999999997654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=315.29 Aligned_cols=201 Identities=21% Similarity=0.321 Sum_probs=157.8
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh---------HHHHHHHHHHHHhhccCCCceeeeee
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA---------VEIWMNERVRRACANCCADFVYGFFE 208 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---------~e~~~~~~~~~~~~~~~~~~i~~~~~ 208 (397)
.++|+++++||+|+||+||+|++..++ +.+|+|.+..... .....+..+...+. ..|+|++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-~~h~nIv~~~~ 76 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS-SGFSGVIRLLD 76 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHC-SSSCSBCCEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhc-cCCCCccEEEE
Confidence 368999999999999999999998887 7889998753211 00111122222222 35899999988
Q ss_pred cccccCCeEEEEEEecCC-CCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecC
Q 015991 209 NSSKKGGEYWLIWRYEGE-ATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (397)
Q Consensus 209 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrD 287 (397)
.+. ..+..++||||+.+ +++.+++.... .+++..++.++.|++.||+|||++||+|||
T Consensus 77 ~~~-~~~~~~lv~e~~~~~~~l~~~~~~~~--------------------~l~e~~~~~~~~qi~~al~~lH~~~iiHrD 135 (273)
T d1xwsa_ 77 WFE-RPDSFVLILERPEPVQDLFDFITERG--------------------ALQEELARSFFWQVLEAVRHCHNCGVLHRD 135 (273)
T ss_dssp EEE-CSSEEEEEEECCSSEEEHHHHHHHHC--------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEe-eCCeEEEEEEeccCcchHHHHHhccC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 764 45789999999975 67888887654 568889999999999999999999999999
Q ss_pred CCCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCch
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 367 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~ 367 (397)
|||+|||++.+...+||+|||+|+..... ..++..||+.|||||++.+..+ ++.++
T Consensus 136 iKp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~---------------------~~~~~ 191 (273)
T d1xwsa_ 136 IKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRY---------------------HGRSA 191 (273)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCB---------------------CHHHH
T ss_pred CcccceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCC---------------------CCccc
Confidence 99999999966559999999999765432 2356789999999997655432 23467
Q ss_pred hhHHHHHHHHHHHcCCCCCCCC
Q 015991 368 DIYSAGLIFLQMVCTVRRLCLH 389 (397)
Q Consensus 368 Dv~SlGv~l~elltg~~Pf~~~ 389 (397)
||||+||+||||++|+.||...
T Consensus 192 DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 192 AVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp HHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccceeeehhHhhCCCCCCCc
Confidence 9999999999999999999753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=313.33 Aligned_cols=202 Identities=17% Similarity=0.242 Sum_probs=159.0
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 214 (397)
.+..++|+++++||+|+||.||+|++.+ ..+|+|+++.....+. ..++...+...+|+||+.+++.+....
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~i~~~~~~~~--~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-------EEEEEEECCCCC--HH--HHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEECC-------eEEEEEEECcHHHHHH--HHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 4567899999999999999999999853 6799999976554443 234556777789999999999776656
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
+.+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+|+||||||+|||
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~------------------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil 135 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRG------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL 135 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHH------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CcEEEEEeccCCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhe
Confidence 67899999999999999997642 124678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++ .+||+|||+++..... .....+|+.|+||| ++.+..++.++||||||+
T Consensus 136 ~~~~~-~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE----------------------~l~~~~~t~~sDIwSfG~ 188 (262)
T d1byga_ 136 VSEDN-VAKVSDFGLTKEASST----QDTGKLPVKWTAPE----------------------ALREKKFSTKSDVWSFGI 188 (262)
T ss_dssp ECTTS-CEEECCCCC----------------CCTTTSCHH----------------------HHHHCCCCHHHHHHHHHH
T ss_pred ecCCC-CEeecccccceecCCC----CccccccccCCChH----------------------HHhCCCCChHHHHHhHHH
Confidence 99987 9999999999865432 23457889999999 455556777899999999
Q ss_pred HHHHHHc-CCCCCCCCC
Q 015991 375 IFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 375 ~l~ellt-g~~Pf~~~~ 390 (397)
++|||+| |+.||....
T Consensus 189 il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 189 LLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp HHHHHHTTSCCSCTTSC
T ss_pred HHHHHHHCCCCCCCCCC
Confidence 9999998 677776543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=318.80 Aligned_cols=204 Identities=23% Similarity=0.327 Sum_probs=162.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccC---C
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKG---G 215 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~---~ 215 (397)
++|.+.++||+|+||+||+|++.+ +.||+|++......+. ..+.+.......+|+||+.+++.+..++ .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g-------~~vAvK~~~~~~~~~~-~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT-------EEEEEEEECGGGHHHH-HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-------EEEEEEEECccchhHH-HHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 589999999999999999998743 7899998876544433 3334445556678999999988876544 3
Q ss_pred eEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH--------CCceecC
Q 015991 216 EYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS--------TGIVHRD 287 (397)
Q Consensus 216 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~--------~giiHrD 287 (397)
.+|+||||+.+|+|.+++++. .+++..+..++.|++.||.|||+ +||||||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---------------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrD 133 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---------------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---------------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred EEEEEEecccCCCHHHHHhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccc
Confidence 689999999999999999865 35678888999999999999996 5999999
Q ss_pred CCCCceEEeCCCCeEEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
|||+||||+.++ .+||+|||+++......+. ......||+.|||||++.+...... ..++
T Consensus 134 lKp~NILl~~~~-~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----------------~~~~ 196 (303)
T d1vjya_ 134 LKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH----------------FESF 196 (303)
T ss_dssp CCGGGEEECTTS-CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTC----------------HHHH
T ss_pred cCccceEEcCCC-CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccC----------------CCcC
Confidence 999999999987 9999999999876543322 2345789999999997765432211 2355
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCL 388 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~ 388 (397)
.|+|||||||+||||+||..||..
T Consensus 197 ~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 197 KRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cchhhhhhHHHHHHHhhCCCCCCc
Confidence 688999999999999999988754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=316.81 Aligned_cols=205 Identities=24% Similarity=0.306 Sum_probs=161.1
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-----hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-----AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-----~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
.++|++.++||+|+||+||+|++..++. +.+|+|++.... ......+..+.+.+...+|+|++.+++.+..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGG----RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCC----EEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 4799999999999999999999865531 467888875322 1122233345555666789999998876542
Q ss_pred ----cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCC
Q 015991 213 ----KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDI 288 (397)
Q Consensus 213 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDI 288 (397)
....+++++||+.++.+....... ...+++..++.++.|++.||+|||++|||||||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDi 142 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVP-------------------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 142 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSC-------------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred cccccCceEEEEEEeccCCchhhhhhcc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCC
Confidence 346789999999987765544332 225678889999999999999999999999999
Q ss_pred CCCceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 289 KPQNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 289 Kp~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
||+|||++.++ .+||+|||+++...... ......||+.|||||++. +..|+.++|
T Consensus 143 Kp~NILi~~~~-~~kl~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~----------------------~~~y~~~~D 197 (305)
T d1blxa_ 143 KPQNILVTSSG-QIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLL----------------------QSSYATPVD 197 (305)
T ss_dssp CGGGEEECTTC-CEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHT----------------------TCCCCTHHH
T ss_pred CccEEEEcCCC-Ceeecchhhhhhhcccc--cCCCcccChhhcCcchhc----------------------CCCCChheh
Confidence 99999999987 99999999998654332 235678999999999554 445777899
Q ss_pred hHHHHHHHHHHHcCCCCCCCCC
Q 015991 369 IYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~elltg~~Pf~~~~ 390 (397)
|||+||++|||++|+.||...+
T Consensus 198 iwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 198 LWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhchHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999997654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=314.29 Aligned_cols=230 Identities=18% Similarity=0.215 Sum_probs=169.7
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhc-cCCCceeeeeeccc
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACAN-CCADFVYGFFENSS 211 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~-~~~~~i~~~~~~~~ 211 (397)
+.+..++|+++++||+|+||.||+|++.........+.+|+|+++..... +.....++...+.. .+|+||+.+++.+.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 34566899999999999999999999866544445578999998754322 22222233333333 47999999999875
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
. ++.+++||||+++|+|.++++............... .......+++..+..++.||+.||+|||+++||||||||+
T Consensus 98 ~-~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 98 I-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI--MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp S-SSSCEEEEECCTTEEHHHHHHHTTTTC----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred e-CCEEEEEEEcCCCCCHHHHHHhcccccccccccccc--ccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 4 467899999999999999998765322211111111 1112346788999999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
|||++.++ .+||+|||+++........ ......||+.|+||| ++.+..++.++|||
T Consensus 175 NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------------~~~~~~~~~~~DIw 231 (311)
T d1t46a_ 175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE----------------------SIFNCVYTFESDVW 231 (311)
T ss_dssp GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHH----------------------HHHHCCCCHHHHHH
T ss_pred cccccccC-cccccccchheeccCCCcceEeeecccChHHcCHH----------------------HhcCCCCCCccccc
Confidence 99999987 9999999999876554332 234568899999999 45555677889999
Q ss_pred HHHHHHHHHHcC-CCCCCCC
Q 015991 371 SAGLIFLQMVCT-VRRLCLH 389 (397)
Q Consensus 371 SlGv~l~elltg-~~Pf~~~ 389 (397)
||||++|||+|+ .+||...
T Consensus 232 S~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 232 SYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp HHHHHHHHHHTTTCCSSTTC
T ss_pred chHHHHHHHHhCCCCCCCCC
Confidence 999999999995 4445443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=313.15 Aligned_cols=229 Identities=20% Similarity=0.227 Sum_probs=164.7
Q ss_pred cccccCCeEEeeeeccCCceEEEEEEecCCCCC--CCCCceEEeecccchhH-HHHHHHHH-HHHhhccCCCceeeeeec
Q 015991 134 TTYRKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEYGAV-EIWMNERV-RRACANCCADFVYGFFEN 209 (397)
Q Consensus 134 ~~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~~~~-e~~~~~~~-~~~~~~~~~~~i~~~~~~ 209 (397)
+.+..++|+++++||+|+||.||+|++..+++. .....||+|++...... +.....++ .......+|+||+.+++.
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 345668999999999999999999998765432 22346889988654432 22222222 333333479999999987
Q ss_pred ccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCC
Q 015991 210 SSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIK 289 (397)
Q Consensus 210 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIK 289 (397)
+.. ++..++||||+.+|+|.+++.............. .......+++..++.++.|++.||+|||+++|||||||
T Consensus 88 ~~~-~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~----~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 88 CTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP----SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp ECS-SSSCEEEECCCTTCBHHHHHHTTSCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ccc-CCeEEEEEEccCCCcHHHHHHhhcCCcccccccc----ccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence 754 5679999999999999999987653221111110 11123467899999999999999999999999999999
Q ss_pred CCceEEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchh
Q 015991 290 PQNVIFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 368 (397)
Q Consensus 290 p~NILl~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~D 368 (397)
|+|||++.++ .+||+|||+++........ ......+|+.|+||| ++.+..|+.|+|
T Consensus 163 p~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE----------------------~l~~~~y~~k~D 219 (299)
T d1fgka_ 163 ARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE----------------------ALFDRIYTHQSD 219 (299)
T ss_dssp GGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHH----------------------HHHHCCCCHHHH
T ss_pred ccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhh----------------------HhcCCCCCchhh
Confidence 9999999987 9999999999877554332 234467899999999 444556778899
Q ss_pred hHHHHHHHHHHHc-CCCCCCCCC
Q 015991 369 IYSAGLIFLQMVC-TVRRLCLHS 390 (397)
Q Consensus 369 v~SlGv~l~ellt-g~~Pf~~~~ 390 (397)
||||||++|||++ |..||....
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999998 688886544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=310.98 Aligned_cols=210 Identities=16% Similarity=0.132 Sum_probs=156.3
Q ss_pred cccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch---hHHHHHHHHHHHHhhccCCCceeeeeecccc
Q 015991 136 YRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG---AVEIWMNERVRRACANCCADFVYGFFENSSK 212 (397)
Q Consensus 136 ~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 212 (397)
+..++|++.+.||+|+||+||+|++....... ..||+|++.... ........++...+...+|+||+.+++.+..
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~--~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKT--VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCE--EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcE--EEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 45578999999999999999999876543221 467888876432 1112223345566777789999999987743
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
+..++||||+.++++.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 83 --~~~~lv~e~~~~~~l~~~~~~~~-------------------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~N 141 (273)
T d1u46a_ 83 --PPMKMVTELAPLGSLLDRLRKHQ-------------------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 141 (273)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHG-------------------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred --cchheeeeeecCcchhhhhhccc-------------------CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHH
Confidence 46789999999999999887643 246788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
||++.++ .+||+|||+++.+...... ......||..|+|||++. +..++.++|||
T Consensus 142 Ill~~~~-~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----------------------~~~~~~~~Di~ 198 (273)
T d1u46a_ 142 LLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK----------------------TRTFSHASDTW 198 (273)
T ss_dssp EEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH----------------------HCEEEHHHHHH
T ss_pred hcccccc-ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh----------------------CCCCCcchhhh
Confidence 9999987 9999999999877544322 233456788999999554 44556678999
Q ss_pred HHHHHHHHHHc-CCCCCCCCCC
Q 015991 371 SAGLIFLQMVC-TVRRLCLHSC 391 (397)
Q Consensus 371 SlGv~l~ellt-g~~Pf~~~~~ 391 (397)
|||+++|||+| |..||.....
T Consensus 199 S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 199 MFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp HHHHHHHHHHTTSCCTTTTCCH
T ss_pred hhHHHHHHHHhCCCCCCCCcCH
Confidence 99999999998 8999976543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=310.61 Aligned_cols=204 Identities=18% Similarity=0.203 Sum_probs=161.4
Q ss_pred EeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccc-hhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEEEEE
Q 015991 143 LGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEY-GAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYWLIW 221 (397)
Q Consensus 143 i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~ 221 (397)
+.++||+|+||+||+|++..++... ..+|+|++... ...+.....++...+...+|+|++.+++.+...++..++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~--~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKK--IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----C--EEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEE--EEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3789999999999999987654221 35788988643 33333445556677778899999999998766677899999
Q ss_pred EecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCCCCe
Q 015991 222 RYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEGSRT 301 (397)
Q Consensus 222 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~~~~ 301 (397)
||+++++|.+++..... ..++..+..++.|++.||.|||+.+|+||||||+||||++++ .
T Consensus 109 E~~~~g~l~~~~~~~~~-------------------~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~ 168 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETH-------------------NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-T 168 (311)
T ss_dssp ECCTTCBHHHHHHCTTC-------------------CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-C
T ss_pred EEeecCchhhhhccccc-------------------cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-C
Confidence 99999999999876532 345677889999999999999999999999999999999987 9
Q ss_pred EEEEeccccccccccccc---ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHHHH
Q 015991 302 FKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 378 (397)
Q Consensus 302 ~kL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l~e 378 (397)
+||+|||+++.+...... ......||+.|+||| ++....++.++||||||++|||
T Consensus 169 ~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE----------------------~~~~~~~~~ksDI~SfGivl~E 226 (311)
T d1r0pa_ 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE----------------------SLQTQKFTTKSDVWSFGVLLWE 226 (311)
T ss_dssp EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHH----------------------HHHHCCCCHHHHHHHHHHHHHH
T ss_pred EEEecccchhhccccccccceecccccccccccChH----------------------HHhcCCCCChhHhhhhHHHHHH
Confidence 999999999876543222 223457899999999 4455567778999999999999
Q ss_pred HHcCCCCCCCCC
Q 015991 379 MVCTVRRLCLHS 390 (397)
Q Consensus 379 lltg~~Pf~~~~ 390 (397)
|+||..||....
T Consensus 227 l~t~~~p~~~~~ 238 (311)
T d1r0pa_ 227 LMTRGAPPYPDV 238 (311)
T ss_dssp HHTTSCCSCC--
T ss_pred HHHCCCCCCCCC
Confidence 999888886544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-40 Score=312.19 Aligned_cols=205 Identities=19% Similarity=0.233 Sum_probs=154.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccccCCeEE
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSKKGGEYW 218 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 218 (397)
++|++++.||+|+||+||+|++..++ +.||+|.+......+... .+...+....|++++..+..+...++..+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~--~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAG-----EEVAIKLECVKTKHPQLH--IESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT-----EEEEEEEEESCTTSCCHH--HHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCC-----CEEEEEEEchhccCHHHH--HHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 57999999999999999999998877 789999776543322221 12233333444555544455556678899
Q ss_pred EEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEeCC
Q 015991 219 LIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFSEG 298 (397)
Q Consensus 219 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~~~ 298 (397)
+||||+++ +|.+.+.... ..+++..+..++.|++.||+|||++|||||||||+|||++..
T Consensus 80 ivme~~~~-~l~~~~~~~~-------------------~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~ 139 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCS-------------------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 139 (299)
T ss_dssp EEEECCCC-BHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG
T ss_pred EEEEEcCC-chhhhhhhcc-------------------CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc
Confidence 99999974 5666554432 256788899999999999999999999999999999998642
Q ss_pred --CCeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 299 --SRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 299 --~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
...+||+|||+|+.+...... ......||+.|||||++.+ ..++.++|||
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------~~~~~~~Diw 197 (299)
T d1ckia_ 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG----------------------IEQSRRDDLE 197 (299)
T ss_dssp GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT----------------------BCCCHHHHHH
T ss_pred CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC----------------------CCCCChhhEE
Confidence 237999999999877543321 2345689999999996544 3466788999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~~~ 392 (397)
||||++|||++|+.||......
T Consensus 198 SlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 198 SLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp HHHHHHHHHHHSSCTTCCCC--
T ss_pred ecCHHHHHHHhCCCcccccchH
Confidence 9999999999999999775543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=319.18 Aligned_cols=203 Identities=23% Similarity=0.270 Sum_probs=159.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhccCCCceeeeeecccc-----c
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACANCCADFVYGFFENSSK-----K 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~ 213 (397)
-+|+..++||+|+||+||+|++..++ +.+|+|++....... .++...+...+|+|++.+++.+.. .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~----~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDKRFK----NRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSSSC----CHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCC-----CEEEEEEECccchHH----HHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 37999999999999999999998887 789999886543221 123344455678999888776532 2
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
...+++||||++++.+..+..... ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~-----------------~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NI 153 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSR-----------------AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHH-----------------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred ceEEEEEEeccCCccHHHHHhhhh-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceE
Confidence 346899999999765444433221 223578899999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 373 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlG 373 (397)
|++.++..+||+|||+|+.+..... .....||+.|+|||.+.+. ..|+.++||||+|
T Consensus 154 Ll~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~---------------------~~~~~~~DIwSlG 210 (350)
T d1q5ka_ 154 LLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGA---------------------TDYTSSIDVWSAG 210 (350)
T ss_dssp EECTTTCCEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTC---------------------SSCCTHHHHHHHH
T ss_pred EEecCCCceeEecccchhhccCCcc--cccccccccccChHHhhcc---------------------cCCCcceeecccc
Confidence 9998766899999999987654332 3457899999999965432 3467789999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 015991 374 LIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 374 v~l~elltg~~Pf~~~~ 390 (397)
|++|||++|+.||....
T Consensus 211 ~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 211 CVLAELLLGQPIFPGDS 227 (350)
T ss_dssp HHHHHHHHTSCSSCCSS
T ss_pred eEEEehhhCCCCCCCCC
Confidence 99999999999997654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=316.11 Aligned_cols=223 Identities=18% Similarity=0.218 Sum_probs=173.6
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch-hHHHHHHHHHHHHhhccCCCceeeeeeccccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG-AVEIWMNERVRRACANCCADFVYGFFENSSKK 213 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 213 (397)
++..++|+++++||+|+||+||+|++...........||+|++.... ..+.....++...+...+|+|++.+++.+. .
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~ 94 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-Q 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-S
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-c
Confidence 45668999999999999999999998754333333679999987543 333344556677788889999999999774 4
Q ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCce
Q 015991 214 GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNV 293 (397)
Q Consensus 214 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NI 293 (397)
++..++||||+.+|+|.+++...... .........+++..+..++.|+++||.|||+++|+||||||+||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~Ni 164 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPA----------MANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNC 164 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHH----------HHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccc----------cccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCce
Confidence 56789999999999999998765310 00111223467888999999999999999999999999999999
Q ss_pred EEeCCCCeEEEEeccccccccccccc-ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 294 IFSEGSRTFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 294 Ll~~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
|++.++ ++||+|||+|+.+...... ......||+.|+|||.+. +..++.++|||||
T Consensus 165 Lld~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~----------------------~~~~~~~~Dv~S~ 221 (308)
T d1p4oa_ 165 MVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK----------------------DGVFTTYSDVWSF 221 (308)
T ss_dssp EECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH----------------------HCCCCHHHHHHHH
T ss_pred eecCCc-eEEEeecccceeccCCcceeeccceecccccCCHHHHc----------------------cCCCCcccccccH
Confidence 999987 9999999999876544332 233457899999999554 4456678899999
Q ss_pred HHHHHHHHcCC-CCCCCCCC
Q 015991 373 GLIFLQMVCTV-RRLCLHSC 391 (397)
Q Consensus 373 Gv~l~elltg~-~Pf~~~~~ 391 (397)
|++||||+||. .||.....
T Consensus 222 G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 222 GVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp HHHHHHHHHTSCCTTTTSCH
T ss_pred HHHHHHHHhCCCCCCCCCCH
Confidence 99999999985 66655443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-40 Score=309.51 Aligned_cols=201 Identities=22% Similarity=0.275 Sum_probs=160.1
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH--HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE--IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e--~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||+||+|++.. + +.+|+|++......+ .....++...+...+|+||+.+++.+.. ++.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~-~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNY-G-----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT-S-----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSC
T ss_pred CCceeccEEecCCCcEEEEEEeCC-C-----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCc
Confidence 799999999999999999999863 3 789999886433221 2334456677778899999999887754 567
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++++|++.++.+..+.+..+ .+++..++.++.||+.||+|||++|||||||||+|||++
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~ 134 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEG--------------------GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTT--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred eeEEEEeehhhhHHHHHhhcC--------------------CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc
Confidence 899999999887777765443 578899999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||.|....... .......+|+.|+|||.+.... .++.++|+||+||++
T Consensus 135 ~~~-~~kl~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~---------------------~~~~~~DiwslGv~l 191 (286)
T d1ob3a_ 135 REG-ELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSK---------------------KYSTTIDIWSVGCIF 191 (286)
T ss_dssp TTS-CEEECCTTHHHHHCC----------CCCTTCCHHHHTTCC---------------------SCCTHHHHHHHHHHH
T ss_pred CCC-CEEecccccceecccCc-cccceecccchhhhHHHHhCCC---------------------CCCcceeehhcCcHH
Confidence 987 99999999998754332 2234567899999999765432 356789999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|+.||...
T Consensus 192 ~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 192 AEMVNGTPLFPGV 204 (286)
T ss_dssp HHHHHSSCSCCCS
T ss_pred HHHHHCCCCCCCC
Confidence 9999999999754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-40 Score=307.28 Aligned_cols=205 Identities=18% Similarity=0.249 Sum_probs=155.2
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHH-HHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVE-IWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
.++|+++++||+|+||+||+|++..++ +.+|+|.+......+ ...+.++...+.+ ++++..++... ..+..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~e~~~~~~l~~--~~~i~~~~~~~-~~~~~ 75 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNN-----QQVAIKFEPRRSDAPQLRDEYRTYKLLAG--CTGIPNVYYFG-QEGLH 75 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTT-----EEEEEEEEECCTTSCCHHHHHHHHHHTTT--CTTCCCEEEEE-EETTE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEccccCcHHHHHHHHHHHHhcC--CCCCCEEEEEe-ecCCc
Confidence 378999999999999999999998876 789999875433222 2222233333333 23343333332 34678
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++|||||||||+|||++
T Consensus 76 ~~~vme~~~-~~l~~~~~~~~-------------------~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 76 NVLVIDLLG-PSLEDLLDLCG-------------------RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-------------------TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred cEEEEEecC-CCHHHHHHhhc-------------------cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 999999995 79999887653 2457788889999999999999999999999999999997
Q ss_pred CC----CCeEEEEeccccccccccccc------ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCc
Q 015991 297 EG----SRTFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 366 (397)
Q Consensus 297 ~~----~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 366 (397)
.+ ...+||+|||+|+.+...... ......||+.|||||++.+ ..++.+
T Consensus 136 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~----------------------~~~~~~ 193 (293)
T d1csna_ 136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG----------------------REQSRR 193 (293)
T ss_dssp CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT----------------------CCCCHH
T ss_pred CcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC----------------------CCCChH
Confidence 42 238999999999876543221 2345689999999996654 346678
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCC
Q 015991 367 FDIYSAGLIFLQMVCTVRRLCLHSCP 392 (397)
Q Consensus 367 ~Dv~SlGv~l~elltg~~Pf~~~~~~ 392 (397)
+|||||||++|||++|..||......
T Consensus 194 ~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 194 DDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp HHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred HHHHHhhHHHHHHHhCCCcCCCccch
Confidence 89999999999999999999865443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=312.15 Aligned_cols=223 Identities=17% Similarity=0.221 Sum_probs=164.2
Q ss_pred ccccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH-HHHHHHHHHHHhhcc-CCCceeeeeecccc
Q 015991 135 TYRKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV-EIWMNERVRRACANC-CADFVYGFFENSSK 212 (397)
Q Consensus 135 ~~~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-e~~~~~~~~~~~~~~-~~~~i~~~~~~~~~ 212 (397)
.+..++|+++++||+|+||+||+|++..++.. ..+++|++...... ......++...+... +|+||+.+++.+.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~- 81 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLR---MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE- 81 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEE---EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeE---EEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-
Confidence 34568999999999999999999999876522 24677776543222 222333445555554 7999999999765
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
.++.+++||||+++|+|.++++......... ...........+++..+.+++.||+.||.|||+++||||||||+|
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~N 157 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDP----AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 157 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCH----HHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccch----hhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccce
Confidence 4578999999999999999998653100000 000111234578899999999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+||+|||+|+....... .....||..|+|||.+. +..++.++|||||
T Consensus 158 IL~~~~~-~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~----------------------~~~~~~~sDvwSf 212 (309)
T d1fvra_ 158 ILVGENY-VAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLN----------------------YSVYTTNSDVWSY 212 (309)
T ss_dssp EEECGGG-CEEECCTTCEESSCEECC--C----CCTTTCCHHHHH----------------------HCEECHHHHHHHH
T ss_pred EEEcCCC-ceEEcccccccccccccc--ccceecCCcccchHHhc----------------------cCCCCccceeehh
Confidence 9999987 999999999986543322 24567899999999554 4456678899999
Q ss_pred HHHHHHHHcCCC-CCCCCC
Q 015991 373 GLIFLQMVCTVR-RLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~-Pf~~~~ 390 (397)
||++|||++|.. ||....
T Consensus 213 Gvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 213 GVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp HHHHHHHHTTSCCTTTTCC
T ss_pred HHHHHHHHhcCCCCCCCCC
Confidence 999999999765 675543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-39 Score=310.27 Aligned_cols=200 Identities=22% Similarity=0.283 Sum_probs=160.5
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHHHHHHHHHHHhhc-cCCCceeeeeecccc-cC
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEIWMNERVRRACAN-CCADFVYGFFENSSK-KG 214 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~~~~~~~~~~~~~-~~~~~i~~~~~~~~~-~~ 214 (397)
..++|++.++||+|+||+||+|++..++ +.+|+|+++......... +...+.. ..|+|++.+++.+.. ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~---Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSSCHHHHHH---HHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEECHHHHHHHHH---HHHHHHhccCCCCCcEEEEEEEecCC
Confidence 3478999999999999999999998877 889999987554433322 2333333 358899988876643 34
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
..+++||||+.+++|..+.+ .+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 105 ~~~~~v~e~~~~~~L~~~~~-----------------------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL 161 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLYQ-----------------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161 (328)
T ss_dssp CSEEEEEECCCSCBGGGTTT-----------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CceeEEEeecCCCcHHHHhc-----------------------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence 67999999999999855421 4678889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 374 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv 374 (397)
++.++..+||+|||+|+....... .....+|+.|+|||.+.+.. .++.++||||+||
T Consensus 162 i~~~~~~vkl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwslG~ 218 (328)
T d3bqca1 162 IDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQ---------------------MYDYSLDMWSLGC 218 (328)
T ss_dssp EETTTTEEEECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCC---------------------CCCTHHHHHHHHH
T ss_pred EcCCCCeeeecccccceeccCCCc--ccccccCccccCcccccCCC---------------------CCCcccchhhhhh
Confidence 997665899999999987654432 35568999999999765433 3567889999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 015991 375 IFLQMVCTVRRLCLHS 390 (397)
Q Consensus 375 ~l~elltg~~Pf~~~~ 390 (397)
++|||++|..||....
T Consensus 219 ~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 219 MLASMIFRKEPFFHGH 234 (328)
T ss_dssp HHHHHHHTCSSSSCCS
T ss_pred hhHHhccCCCCCCCCc
Confidence 9999999999997654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-40 Score=310.69 Aligned_cols=207 Identities=21% Similarity=0.254 Sum_probs=157.6
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh--HHHHHHHHHHHHhhccCCCceeeeeeccccc-
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA--VEIWMNERVRRACANCCADFVYGFFENSSKK- 213 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~- 213 (397)
..++|++.++||+|+||+||+|++..++ +.+|+|++..... .......++...+...+|+|++.+++.+...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 3589999999999999999999998877 7899998753321 1122223345556666788888887765332
Q ss_pred ------CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecC
Q 015991 214 ------GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRD 287 (397)
Q Consensus 214 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrD 287 (397)
++..|+||||+.++.+....... ..+++..++.++.|++.||+|||++||+|||
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~--------------------~~~~~~~~~~i~~qil~~l~~lH~~~ivHrD 142 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVL--------------------VKFTLSEIKRVMQMLLNGLYYIHRNKILHRD 142 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTT--------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ccccccCceEEEEEeccCCCccchhhhcc--------------------cccccHHHHHHHHHHHHHHHHhccCCEEecC
Confidence 35689999999987665543332 2567788899999999999999999999999
Q ss_pred CCCCceEEeCCCCeEEEEecccccccccccc---cccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCC
Q 015991 288 IKPQNVIFSEGSRTFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 364 (397)
Q Consensus 288 IKp~NILl~~~~~~~kL~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
|||+|||++.++ .+||+|||+++.+..... ......+||+.|+|||++.+. ..|+
T Consensus 143 lKp~NILl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~---------------------~~~~ 200 (318)
T d3blha1 143 MKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE---------------------RDYG 200 (318)
T ss_dssp CCGGGEEECTTS-CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC---------------------SSCC
T ss_pred cCchheeecCCC-cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCC---------------------CCCC
Confidence 999999999987 999999999976653321 123446799999999976543 2467
Q ss_pred CchhhHHHHHHHHHHHcCCCCCCCCC
Q 015991 365 DRFDIYSAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 365 ~k~Dv~SlGv~l~elltg~~Pf~~~~ 390 (397)
.++||||+||++|||++|+.||....
T Consensus 201 ~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 201 PPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cHHHcccCCceeeeHhhCCCCCCCCC
Confidence 78999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=309.80 Aligned_cols=204 Identities=22% Similarity=0.251 Sum_probs=158.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh-HHHHHHHHHHHHhhccCCCceeeeeecccccC---
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA-VEIWMNERVRRACANCCADFVYGFFENSSKKG--- 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~--- 214 (397)
++|++.++||+|+||+||+|++..++ +.+|+|++..... .......++...+...+|++++.+++.+....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTC-----SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCC-----cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 57999999999999999999998887 8899999864332 22223334556666778999888877654332
Q ss_pred CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceE
Q 015991 215 GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVI 294 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NIL 294 (397)
...+++++|+.+++|.+++... .+++..++.++.|++.||+|||++|||||||||+|||
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~---------------------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NIL 141 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ---------------------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 141 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cceEEEEEeecCCchhhhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEE
Confidence 2334455667789999999764 3578889999999999999999999999999999999
Q ss_pred EeCCCCeEEEEeccccccccccccc--ccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 295 FSEGSRTFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 295 l~~~~~~~kL~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
++.++ .+||+|||+|+........ .....+||+.|+|||++.... .++.++||||+
T Consensus 142 l~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~DiwSl 199 (345)
T d1pmea_ 142 LNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK---------------------GYTKSIDIWSV 199 (345)
T ss_dssp ECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC---------------------SCSTHHHHHHH
T ss_pred ECCCC-CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCC---------------------CCCchhhhhcc
Confidence 99987 9999999999866443322 234568999999999764332 35667899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||++|||++|+.||....
T Consensus 200 G~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 200 GCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp HHHHHHHHHSSCSCCCSS
T ss_pred CceehHHhhCCCCCCCCC
Confidence 999999999999997654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=311.81 Aligned_cols=213 Identities=19% Similarity=0.258 Sum_probs=162.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch----hHHHHHHHHHHHHhhcc-CCCceeeeeeccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG----AVEIWMNERVRRACANC-CADFVYGFFENSS 211 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~e~~~~~~~~~~~~~~-~~~~i~~~~~~~~ 211 (397)
..++|+++++||+|+||+||+|++...... .+.+|+|.+.... ........++...+... +|+||+.++..+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~--g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDT--GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTT--TCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCC--CcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 458999999999999999999987442211 1678888764321 11111111222222333 3578888877653
Q ss_pred ccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 212 KKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 212 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
....++++|||+.+++|.+++.... .+.+..+..++.|++.||+|||+++|+||||||+
T Consensus 100 -~~~~~~~v~e~~~~~~L~~~i~~~~--------------------~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~ 158 (322)
T d1vzoa_ 100 -TETKLHLILDYINGGELFTHLSQRE--------------------RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 158 (322)
T ss_dssp -ETTEEEEEECCCCSCBHHHHHHHHS--------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred -cCCceeeeeecccccHHHHHHHhcc--------------------cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCcc
Confidence 4568999999999999999998765 3466778899999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+||+|||+|+.+............||+.|++||.+.+... .++.++||||
T Consensus 159 Nill~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~--------------------~~~~ksDIWS 217 (322)
T d1vzoa_ 159 NILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS--------------------GHDKAVDWWS 217 (322)
T ss_dssp GEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC-----------------------CTHHHHHH
T ss_pred ceeecCCC-CEEEeeccchhhhcccccccccccccccccchhHHhhcCCc--------------------CCCchhhhHH
Confidence 99999987 99999999998776555544566789999999998764432 3567899999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHSCPL 393 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~~~~ 393 (397)
|||+||||++|+.||.......
T Consensus 218 lG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 218 LGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp HHHHHHHHHHSSCTTSCTTSCC
T ss_pred HHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999998765543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-39 Score=308.63 Aligned_cols=200 Identities=24% Similarity=0.339 Sum_probs=157.3
Q ss_pred cCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccC-
Q 015991 138 KDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKG- 214 (397)
Q Consensus 138 ~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 214 (397)
.++|++.++||+|+||+||+|++..++ +.+|+|++.... ........++...+...+|+|++.+++.+...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 479999999999999999999998877 889999987432 222333345566667778999999888765433
Q ss_pred ----CeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCC
Q 015991 215 ----GEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKP 290 (397)
Q Consensus 215 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp 290 (397)
..+++||||++ .+|..+++.. .+++..++.++.|++.||+|||++|||||||||
T Consensus 92 ~~~~~~~~lv~e~~~-~~l~~~~~~~---------------------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp 149 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMG-TDLGKLMKHE---------------------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 149 (346)
T ss_dssp TTTCCCCEEEEECCS-EEHHHHHHHC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred ccccceEEEEEeccc-ccHHHHHHhc---------------------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCc
Confidence 36799999994 6787777654 467888999999999999999999999999999
Q ss_pred CceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhH
Q 015991 291 QNVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 370 (397)
Q Consensus 291 ~NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~ 370 (397)
+|||++.++ .+||+|||+|+..... .+...||+.|+|||++.+.. .++.++|||
T Consensus 150 ~NIL~~~~~-~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diw 203 (346)
T d1cm8a_ 150 GNLAVNEDC-ELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWM---------------------RYTQTVDIW 203 (346)
T ss_dssp GGEEECTTC-CEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTT---------------------CCCTTHHHH
T ss_pred chhhccccc-ccccccccceeccCCc----cccccccccccCHHHHcCCC---------------------CCCccchhh
Confidence 999999987 9999999999876432 34578999999999664432 345678999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 015991 371 SAGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 371 SlGv~l~elltg~~Pf~~~~ 390 (397)
|+||++|||++|+.||...+
T Consensus 204 SlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 204 SVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred cchHHHHHHHHCcCCCCCCC
Confidence 99999999999999997653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-39 Score=298.88 Aligned_cols=202 Identities=19% Similarity=0.269 Sum_probs=165.3
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccccCCe
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKKGGE 216 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 216 (397)
++|++.++||+|+||+||+|++..++ +.+|+|+++... ........++...+....|+|++.+.+.+ .....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCC-----cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-ccccc
Confidence 68999999999999999999998887 788999875332 22333444556677788999999988766 44578
Q ss_pred EEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCceEEe
Q 015991 217 YWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQNVIFS 296 (397)
Q Consensus 217 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~NILl~ 296 (397)
.++|++++.+++|..++...+ .+++..++.++.|++.||+|||++|||||||||+|||++
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~--------------------~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNG--------------------DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT--------------------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred eeEEeeecccccccccccccc--------------------ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence 899999999999988876553 457788999999999999999999999999999999999
Q ss_pred CCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHHHHHH
Q 015991 297 EGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 376 (397)
Q Consensus 297 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~SlGv~l 376 (397)
.++ .+||+|||.|+........ .....+++.|+|||.+.... .++.++||||+||++
T Consensus 136 ~~~-~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~---------------------~~~~~~DiwSlG~il 192 (292)
T d1unla_ 136 RNG-ELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAK---------------------LYSTSIDMWSAGCIF 192 (292)
T ss_dssp TTC-CEEECCCTTCEECCSCCSC-CCSCCSCGGGCCHHHHTTCS---------------------CCCTHHHHHHHHHHH
T ss_pred cCC-ceeeeecchhhcccCCCcc-ceeeccccchhhhhHhccCC---------------------CCCchhhccccchHH
Confidence 987 9999999999876544332 34456788999999655432 256688999999999
Q ss_pred HHHHcCCCCCCCC
Q 015991 377 LQMVCTVRRLCLH 389 (397)
Q Consensus 377 ~elltg~~Pf~~~ 389 (397)
|||++|+.||...
T Consensus 193 ~ell~g~~p~~~~ 205 (292)
T d1unla_ 193 AELANAGRPLFPG 205 (292)
T ss_dssp HHHTTTSCCSCCC
T ss_pred HHHhhCCCCCCCC
Confidence 9999999997543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=304.11 Aligned_cols=200 Identities=22% Similarity=0.252 Sum_probs=157.5
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeecccc----
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSK---- 212 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~---- 212 (397)
++|++.++||+|+||+||+|++..++ +.+|+|++.... ........++...+....|++++.+++.+..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTT-----EEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 78999999999999999999998877 889999986432 2222333455666677789999887776542
Q ss_pred cCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCCc
Q 015991 213 KGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQN 292 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~N 292 (397)
++...+++++|+.+++|.++++.+ .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~---------------------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~N 151 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQ---------------------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 151 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTC---------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ccCceEEEEEeecCCchhhhcccc---------------------cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcc
Confidence 223456667778889999998654 36788899999999999999999999999999999
Q ss_pred eEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHHH
Q 015991 293 VIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 372 (397)
Q Consensus 293 ILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~Sl 372 (397)
||++.++ .+|++|||+|...... .....||+.|+|||++.+.. .++.++||||+
T Consensus 152 ILi~~~~-~~kl~dfg~a~~~~~~----~~~~~g~~~y~apE~~~~~~---------------------~~~~~~DiwSl 205 (348)
T d2gfsa1 152 LAVNEDC-ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWM---------------------HYNQTVDIWSV 205 (348)
T ss_dssp EEECTTC-CEEECCC----CCTGG----GSSSCHHHHTSCHHHHTTCS---------------------CCCTTHHHHHH
T ss_pred ccccccc-cccccccchhcccCcc----cccccccccccCchhhcCCc---------------------cCCcccchhhh
Confidence 9999987 9999999999765322 34567899999999765433 24567899999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 015991 373 GLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 373 Gv~l~elltg~~Pf~~~~ 390 (397)
||++|||++|+.||....
T Consensus 206 Gv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 206 GCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp HHHHHHHHHSSCSCCCSS
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-38 Score=301.31 Aligned_cols=199 Identities=22% Similarity=0.293 Sum_probs=150.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccch--hHHHHHHHHHHHHhhccCCCceeeeeeccccc---
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYG--AVEIWMNERVRRACANCCADFVYGFFENSSKK--- 213 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~e~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 213 (397)
++|++.++||+|+||+||+|++..++ +.+|+|++.... ........++...+...+|++++.+++.+...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTT-----EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCC-----CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence 78999999999999999999998887 889999986432 22223334555666777899999998876533
Q ss_pred --CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCCceecCCCCC
Q 015991 214 --GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTGIVHRDIKPQ 291 (397)
Q Consensus 214 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~giiHrDIKp~ 291 (397)
...+|+||||+.++.+ +.+.. .+++..++.++.|++.||+|||++||+||||||+
T Consensus 92 ~~~~~~~iv~Ey~~~~l~-~~~~~----------------------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~ 148 (355)
T d2b1pa1 92 EEFQDVYLVMELMDANLC-QVIQM----------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 148 (355)
T ss_dssp TTCCEEEEEEECCSEEHH-HHHTS----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ccCceeEEEEeccchHHH-Hhhhc----------------------CCCHHHHHHHHHHHHHHHHHhhhcccccccCCcc
Confidence 3689999999986544 44322 3577889999999999999999999999999999
Q ss_pred ceEEeCCCCeEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhhccCCCCchhhHH
Q 015991 292 NVIFSEGSRTFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 371 (397)
Q Consensus 292 NILl~~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~Dv~S 371 (397)
|||++.++ .+|++|||+++...... ......+|+.|+|||++.+ ..++.++||||
T Consensus 149 Nil~~~~~-~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~----------------------~~~~~~~DiwS 203 (355)
T d2b1pa1 149 NIVVKSDC-TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG----------------------MGYKENVDIWS 203 (355)
T ss_dssp GEEECTTC-CEEECCCCC-----------------CCTTCCHHHHTT----------------------CCCCTTHHHHH
T ss_pred cccccccc-ceeeechhhhhcccccc--ccccccccccccChhhhcC----------------------CCCCCCccccc
Confidence 99999987 99999999998654432 3356689999999996654 34566789999
Q ss_pred HHHHHHHHHcCCCCCCCCC
Q 015991 372 AGLIFLQMVCTVRRLCLHS 390 (397)
Q Consensus 372 lGv~l~elltg~~Pf~~~~ 390 (397)
+||++|||++|+.||...+
T Consensus 204 lG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 204 VGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp HHHHHHHHHHSSCSSCCSS
T ss_pred ccchHHHHhhCCCCCCCCC
Confidence 9999999999999997654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-34 Score=275.18 Aligned_cols=207 Identities=20% Similarity=0.234 Sum_probs=148.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhHHH--HHHHHHHHHhhc--------cCCCceeee
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAVEI--WMNERVRRACAN--------CCADFVYGF 206 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~e~--~~~~~~~~~~~~--------~~~~~i~~~ 206 (397)
..++|+++++||+|+||+||+|++..++ +.+|+|+++....... ..+.++.+.+.+ ..|++++.+
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g-----~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNN-----THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTT-----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 3357999999999999999999998887 8899999875532211 111122222222 246778877
Q ss_pred eeccccc-CCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHH-CCce
Q 015991 207 FENSSKK-GGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHS-TGIV 284 (397)
Q Consensus 207 ~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~-~gii 284 (397)
++.+... ....+++++++............. ....+++..++.++.|++.||+|||+ .||+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~i~~i~~qil~al~~lh~~~~Iv 148 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-----------------EHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHT-----------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred EEEeeeccccceeeeeeecccccccccccccc-----------------cccCCcHHHHHHHHHHHHHHHHHHhhhcCcc
Confidence 7665433 345666777766554333332221 22356778899999999999999998 8999
Q ss_pred ecCCCCCceEEeCCCC-----eEEEEecccccccccccccccccccCCCCCCCcccccccCCCCCCCCccccccchhhhh
Q 015991 285 HRDIKPQNVIFSEGSR-----TFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW 359 (397)
Q Consensus 285 HrDIKp~NILl~~~~~-----~~kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (397)
||||||+|||++.++. .++++|||.|..... ......||+.|+|||++.
T Consensus 149 HrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~---------------------- 202 (362)
T d1q8ya_ 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLL---------------------- 202 (362)
T ss_dssp CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHH----------------------
T ss_pred cccCChhHeeeeccCcccccceeeEeeccccccccc----ccccccccccccChhhcc----------------------
Confidence 9999999999986542 499999999976532 234578999999999554
Q ss_pred ccCCCCchhhHHHHHHHHHHHcCCCCCCCCCC
Q 015991 360 QLNLPDRFDIYSAGLIFLQMVCTVRRLCLHSC 391 (397)
Q Consensus 360 ~~~~~~k~Dv~SlGv~l~elltg~~Pf~~~~~ 391 (397)
...++.++|+||+||+++||++|+.||.....
T Consensus 203 ~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 203 GAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 34566788999999999999999999976543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6e-24 Score=185.17 Aligned_cols=134 Identities=21% Similarity=0.196 Sum_probs=92.2
Q ss_pred eEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchh------------------HHHHHHHHHHHHhhccCCCc
Q 015991 141 FVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGA------------------VEIWMNERVRRACANCCADF 202 (397)
Q Consensus 141 f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~------------------~e~~~~~~~~~~~~~~~~~~ 202 (397)
+.++++||+|+||+||+|++.+ + +.+|+|..+.... ......+.+...+....+.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-g-----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-F-----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-T-----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred chhCCEeeeCcceEEEEEECCC-C-----CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence 4689999999999999998754 3 7889986532100 00111112222333444555
Q ss_pred eeeeeecccccCCeEEEEEEecCCCCHHHHHHhcCCCcchhhhhccccccCCCcchhcHHHHHHHHHHHHHHHHHhHHCC
Q 015991 203 VYGFFENSSKKGGEYWLIWRYEGEATLADLMISREFPYNVQTLILGEVQDLPKGIERENRIIQTIMSQLLFALDGLHSTG 282 (397)
Q Consensus 203 i~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~i~~i~~qi~~~L~yLH~~g 282 (397)
+...+... ..+++|||+++..+.+ ++...+..++.|++.+|.|||++|
T Consensus 76 v~~~~~~~-----~~~lvme~~~~~~~~~---------------------------l~~~~~~~i~~ql~~~l~~lH~~g 123 (191)
T d1zara2 76 VPKVYAWE-----GNAVLMELIDAKELYR---------------------------VRVENPDEVLDMILEEVAKFYHRG 123 (191)
T ss_dssp SCCEEEEE-----TTEEEEECCCCEEGGG---------------------------CCCSCHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEec-----CCEEEEEeeccccccc---------------------------hhhHHHHHHHHHHHHHHHHHhhCC
Confidence 55444321 2379999999754322 122335578999999999999999
Q ss_pred ceecCCCCCceEEeCCCCeEEEEecccccccc
Q 015991 283 IVHRDIKPQNVIFSEGSRTFKIIDLGAAADLR 314 (397)
Q Consensus 283 iiHrDIKp~NILl~~~~~~~kL~DFGla~~~~ 314 (397)
|+||||||+|||++++ .++|+|||+|+...
T Consensus 124 iiHrDiKP~NILv~~~--~~~liDFG~a~~~~ 153 (191)
T d1zara2 124 IVHGDLSQYNVLVSEE--GIWIIDFPQSVEVG 153 (191)
T ss_dssp EECSCCSTTSEEEETT--EEEECCCTTCEETT
T ss_pred EEEccCChhheeeeCC--CEEEEECCCcccCC
Confidence 9999999999999975 68999999997653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.23 E-value=4e-06 Score=74.00 Aligned_cols=84 Identities=12% Similarity=-0.018 Sum_probs=49.2
Q ss_pred CCeEEeeeeccCCceEEEEEEecCCCCCCCCCceEEeecccchhH---HHHHHHHHHHHh-hccCCCceeeeeecccccC
Q 015991 139 DDFVLGKKLGEGAFGVVYRASLAKKPSSKNDGDLVLKKATEYGAV---EIWMNERVRRAC-ANCCADFVYGFFENSSKKG 214 (397)
Q Consensus 139 ~~f~i~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~---e~~~~~~~~~~~-~~~~~~~i~~~~~~~~~~~ 214 (397)
+.|++.+..+.++...||+....+ +.+++|+....... ....+......+ .....|.++.... .+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~-------~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----~~ 82 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGEN-------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----HD 82 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSS-------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----ET
T ss_pred hceEEEEcCCCCCCCcEEEEEeCC-------CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe----cC
Confidence 678887776666678999886433 56778876543221 111222222222 2233455554332 24
Q ss_pred CeEEEEEEecCCCCHHHHH
Q 015991 215 GEYWLIWRYEGEATLADLM 233 (397)
Q Consensus 215 ~~~~lv~e~~~~gsL~~~l 233 (397)
+..++||++++|.++.+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp TEEEEEEECCSSEEHHHHT
T ss_pred CceEEEEEecccccccccc
Confidence 6789999999998876543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=2.9e-05 Score=67.87 Aligned_cols=30 Identities=23% Similarity=0.278 Sum_probs=25.9
Q ss_pred CceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 282 GIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 282 giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++|+|+.|.|||++++. .+.|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~-~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGR-FSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCc-eEEEEEchhccc
Confidence 489999999999999864 678999998854
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=0.00019 Score=67.10 Aligned_cols=30 Identities=27% Similarity=0.319 Sum_probs=25.9
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
..++|+|+.+.|||++++ .++|+||-.|..
T Consensus 223 ~~LiHGDl~~gNIlv~~~--~~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEH--ETKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSS--CEEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCC--ceEEechhhccc
Confidence 369999999999999975 589999988753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0023 Score=57.74 Aligned_cols=29 Identities=24% Similarity=0.430 Sum_probs=23.8
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEecccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAAD 312 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~~ 312 (397)
.++||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~---~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG---PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS---EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC---ceEEechhccc
Confidence 378999999999999753 35899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.73 E-value=0.0042 Score=55.45 Aligned_cols=30 Identities=30% Similarity=0.459 Sum_probs=26.8
Q ss_pred CCceecCCCCCceEEeCCCCeEEEEeccccc
Q 015991 281 TGIVHRDIKPQNVIFSEGSRTFKIIDLGAAA 311 (397)
Q Consensus 281 ~giiHrDIKp~NILl~~~~~~~kL~DFGla~ 311 (397)
.|+||+|+.++||+++.+. ..-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~-v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cccccCCcchhhhhccccc-ceeEecccccc
Confidence 4899999999999999875 67899999985
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.40 E-value=0.053 Score=49.75 Aligned_cols=84 Identities=10% Similarity=0.147 Sum_probs=42.8
Q ss_pred ccCCeEEeeeeccCCceEEEEEEecCCCCC--CCCCceEEeecccc-hhHHHHHHHHHHHHhh-ccCCCceeeeeecccc
Q 015991 137 RKDDFVLGKKLGEGAFGVVYRASLAKKPSS--KNDGDLVLKKATEY-GAVEIWMNERVRRACA-NCCADFVYGFFENSSK 212 (397)
Q Consensus 137 ~~~~f~i~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~vavK~~~~~-~~~e~~~~~~~~~~~~-~~~~~~i~~~~~~~~~ 212 (397)
..+++++ +.|+.|-.-.+|+.+....... ...+.++++..... .......+.++.+.+. ....|.++.++..
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 3356665 5788889999999987653211 11234444443321 1111212222222222 2334555554431
Q ss_pred cCCeEEEEEEecCCCCH
Q 015991 213 KGGEYWLIWRYEGEATL 229 (397)
Q Consensus 213 ~~~~~~lv~e~~~~gsL 229 (397)
++|+||+.+.++
T Consensus 117 -----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -----GRLEEYIPSRPL 128 (395)
T ss_dssp -----EEEECCCCEEEC
T ss_pred -----ceEEEEeccccC
Confidence 588999987554
|